Program at a Glance 2016
Conference on Retroviruses and Opportunistic Infections
February 22-25, 2016 Boston, Massachusetts 2 CROI 2016 General Information 1 CROI 2016 5 2 7 7 2 6 3 3 4 General InformationGeneral 11 12 19 13 13 13 13 13 13 13 13 50 21 14 14 17 16 14 14 14 14 14 14 15 15 15 15 15 15 15 15 ver 134 128 165 137 over . Back Co Inside BackC ...... ubcommittee ...... edits or a Certificate of Participation Certificate a edits or Disabilities Act odcasts ...... inancial Relationships upport ducators ...... roductDisclaimer rogram Committee rogram ...... y Services estigators Reception Policies / Social Media Policies ...... e es ...... tional Scholars edit Information ed Activity Policies ence Etiquette ence ...... flow Accommodations for Session for Rooms Accommodations flow editation Statement editation ...... ement of Need ement Young Inv Young Interna Community E Community Accr Objectiv Stat CME Cr CME Cr Claiming of F Disclosure Drug and P Americans with Overview S Commercial Scientific P Liaison S Community Emergenc Embargo Welcome Wi-Fi Meals Over Website and P Webcasts Affiliat Mobile App Badges Car Child Confer CONTENTS HOTEL INFORMATION INFORMATION HOTEL PROCESS ABSTRACT SESSIONS ORAL CATEGORY BY SESSIONS, POSTER CONCERNS COMMERCIAL WITH RELATIONSHIPS FINANCIAL OF DISCLOSURE GENERAL INFORMATION GENERAL CONTINUING MEDICAL EDUCATION CONTINUING IAS–USA COMMITTEE PROGRAM 2016 CROI EXTERNALREVIEWERS AWARDEES SCHOLARSHIP CROI FOUNDATION CROI AUTHOR INDEX AUTHOR KEYWORDINDEX OVERVIEW SCHEDULE CONFERENCE PLANS FLOOR CENTER CONVENTION CONFERENCE SERVICES SERVICES CONFERENCE WOMEN TO RELATED STUDIES OF INDEX Printed in USA. Printed reserved. rights All 2016 IAS–USA/CROIFoundation. © Copyright 978-0-692-63523-0 ISBN # General Information CROI FOUNDATION The CROI Foundation is a 501(c)(3) tax-exempt organization in • Has the sole and absolute discretion to veto any policies, the United States that operates exclusively for the charitable and procedures, or actions taken or proposed to be taken by the educational purpose of organizing, promoting, and presenting the CROI PC or the CROI Secretariat that would pose a substantial Conference on Retroviruses and Opportunistic Infections (CROI). risk of preventing the Foundation at any time from qualifying or continuing to qualify as a 501(c)(3) organization or that might Roles and Responsibilities of the CROI Foundation cause the loss of such qualification Volunteer Board of Directors • Oversees the long-term financial and administrative integrity of • Works closely with the CROI Scientific Program Committee (CROI CROI General Information General PC) and IAS-USA to accomplish the mission of CROI • Approves nominations annually for members of the CROI PC and Composition of the CROI Foundation Board of Directors the CROI Chair and Vice Chairs The Board of Directors comprises current and previous CROI Chairs and • Ensures that the CROI PC is responsible for the scientific program Vice Chairs and selected members of the CROI PC. content of CROI • Enters into and oversees the partner agreement with IAS-USA
CROI Foundation Board of Directors Constance A. Benson, MD, President Kevin M. De Cock, MD University of California San Diego Centers for Disease Control and Prevention San Diego, CA, United States Nairobi, Kenya John M. Coffin, PhD, Secretary-Treasurer Scott M. Hammer, MD Tufts University Columbia University Medical Center/New York–Presbyterian Hospital Boston, MA, United States New York, NY, United States Elaine J. Abrams, MD John W. Mellors, MD International Center for AIDS Care and Treatment Programs University of Pittsburgh Columbia University Pittsburgh, PA, United States New York, NY, United States Julie M. Overbaugh, PhD Susan P. Buchbinder, MD Fred Hutchinson Cancer Research Center San Francisco Department of Public Health Seattle, WA, United States University of California San Francisco Robert T. Schooley, MD San Francisco, CA, United States University of California San Diego Judith S. Currier, MD, MsC San Diego, CA, United States University of California Los Angeles Richard A. Koup, MD Los Angeles, CA, United States Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda, MD, United States IAS–USA The International Antiviral Society–USA is a 501(c)(3) not-for-profit Contact: Executive Director, Donna M. Jacobsen professional education organization. The IAS–USA serves as the Address: 425 California Street, Suite 1450 Conference Secretariat for CROI. San Francisco, CA 94104-2120 The mission of the IAS–USA is to improve the treatment, care, and Phone: 415-544-9400 quality of life for people with HIV, hepatitis C virus, or other viral Website: www.iasusa.org infections through high-quality, relevant, balanced, and needs- oriented education and information for practitioners and scientists who are actively involved in medical care and research.
2 CROI 2016 General Information 3
CROI 2016
General InformationGeneral
Judith S. Currier, MD, MSc MD, Currier, S. Judith Chair Vice 2016 CROI of California University Angeles Los CA, Angeles, Los States United Scott M. Hammer, MD ScottHammer, M. Medical University Columbia Center Hospital York-Presbyterian New States United NY, York, New MD Havlir, V. Diane of California University SanFrancisco CA, SanFrancisco, States United PhD SharonHillier, L. Hospital Magee-Womens of Pittsburgh of University Medical Center States United PA, Pittsburgh, MD Hoxie, A. James of Pennsylvania University PA, Philadelphia, States United MD Hunt, W. Peter of California University SanFrancisco CA, SanFrancisco, States United MD Jaffe, W. Harold Disease for Control Centers and Prevention States GA, United Atlanta,
CROI 2016 Vice Chair Vice 2016 CROI DepartmentSanFrancisco Health of Public of California University Susan P. Buchbinder, MD Buchbinder, SusanP. SanFrancisco CA, SanFrancisco, United States United Timothy Hallett, PhD Hallett, Timothy London Imperial College Kingdom United London, John M. Coffin, PhD Coffin, M. John University Tufts States United Boston, MA, MD Cock, De M. Kevin Disease for Control Centers and Prevention Kenya Nairobi, El-Sadr, M. Wafaa MPH MD, University Columbia ICAPat States United NY, York, New Fletcher, CourtneyV. PharmD of Nebraska University Medical Center of PharmacyCollege States Omaha, NE,United Huldrych F. Günthard, MD Günthard, HuldrychF. Zurich Hospital University Switzerland Zurich,
Julie M. Overbaugh, PhD Overbaugh, M. Julie Chair2016 CROI Cancer Hutchinson Fred Center Research WA, Seattle, States United Richard E. Chaisson, MD E. Richard University Johns Hopkins The States United MD, Baltimore, Elaine J. Abrams, MD Abrams, J. Elaine University Columbia ICAPat States United NY, York, New PhD GalitAlter, MIT, of MGH, Ragon Institute and Harvard States United MA, Cambridge, MD Benson, A. Constance of California University SanDiego States CA, United SanDiego, MBBS MD, Brew, J. Bruce Hospital Vincent’s St. Australia Sydney, Chadwick,G. Ellen MD University Northwestern & RobertAnn H. Lurie of Chicago Hospital Children’s States IL, United Chicago,
COMMITTEE CROI 2016 SCIENTIFIC PROGRAM PROGRAM SCIENTIFIC 2016 CROI ScientificCommittee Program The Scientific Program Committee (PC) is a team of experts in their given field who volunteer to organize the scientific program for CROI. Members CROI. for program the scientific organize to experts of field who volunteer (PC) is a team given in their Committee ScientificProgram The subsequent years; 3 are Initial terms of the conference. the mission expertiseto of scientific selected commitment their and based on their area are of Board Foundation the CROI by and approved the PC by nominated are Members level. participation based on previous and interest are terms innovative ensure will that speakers and topics identifying for responsible also of CROI, PC members are ambassadors” “goodwill The Directors. symposia, workshops, and convening conducting, and organizing, development; and program planning; abstract review strategic programming; and special sessions. General Information
Ilesh V. Jani, MD, PhD Ronald T. Mitsuyasu, MD Serena S. Spudich, MD, MA Instituto Nacional de Saúde University of California Yale University Maputo, Mozambique Los Angeles New Haven, CT, United States Los Angeles, CA, United States
Frank Kirchhoff, PhD Andrew N. Phillips, PhD Mario Stevenson, PhD Institute of Molecular Virology University College London University of Miami Ulm, Germany London, England Miami, FL, United States
Dennis L. Kolson, MD, PhD
General Information General Peter Reiss, MD, PhD Wesley I. Sundquist, PhD University of Pennsylvania University of Amsterdam University of Utah Philadelphia, PA, Amsterdam, Netherlands School of Medicine United States Salt Lake City, UT, United States Richard A. Koup, MD Douglas D. Richman, MD Amalio Telenti, MD, PhD Vaccine Research Center University of California The J. Craig Venter Institute National Institute of Allergy San Diego La Jolla, CA, United States and Infectious Diseases La Jolla, CA, United States National Institutes of Health Bethesda, MD, United States Hermione Lyall, MD Jürgen K. Rockstroh, MD David L. Thomas, MD Imperial College Healthcare University of Bonn The Johns Hopkins University National Health Service Trust Bonn, Germany Baltimore, MD, United States London, England
James A. McIntyre, Robert T. Schooley, MD Alexandra Trkola, PhD MBChB, FRCOG University of California University of Zurich Anova Health Institute San Diego Zurich, Switzerland Johannesburg, South Africa La Jolla, CA, United States
John W. Mellors, MD Guido Silvestri, MD University of Pittsburgh Emory University and Yerkes Pittsburgh, PA, United States National Primate Research Center Atlanta, GA, United States
Community Liaison Subcommittee The Community Liaison Subcommittee is a group of community educators and advocates that provides feedback to the PC about the content and structure of the scientific program in general and specifically related to scientific topics of interest to the HIV/AIDS-affected community. Mark Hubbard Morenike Ukpong-Folayan, Tennessee Association of FWACS, MBA, BChD People With AIDS Obafemi Awolowo University Nashville, TN, United States Ile-Ife, Nigeria
Jeff Taylor Steven F. Wakefield AIDS Treatment HIV Vaccine Trials Network Activists Coalition Fred Hutchinson Cancer Palm Springs, CA, Research Center United States Seattle, WA, United States
4 CROI 2016 General Information 5
CROI 2016
General InformationGeneral
James G. Hakim, MD Hakim, G. James of Zimbabwe University Zimbabwe Harare, PhD Hallett, Timothy London College Imperial Kingdom United London, MD Harrigan, Richard P. in Excellence for Centre British Columbia HIV/AIDS BC, Canada Vancouver, MD Havlir, V. Diane San Francisco of California University States CA, United SanFrancisco, MD Hsue, Y. Priscilla San Francisco of California University States CA, United SanFrancisco, PhD Kouyos, Roger Zurich Hospital University Switzerland Zurich, MD SusanKrown, E. AIDS Malignancy Consortium States United NY, York, New MSc MD, Landovitz, J. Raphael Angeles Los of California University States CA, United Angeles, Los PhD Ledergerber, Bruno of Zurich University Switzerland Zurich, MD ScottLetendre, L. San Diego of California University States CA, United SanDiego, MD SharonLewin, R. DohertyThe Infection for Institute and Immunity Australia Melbourne, MD Luetkemeyer, F. Anne San Francisco of California University States CA, United SanFrancisco, MBBS Mallon, PhD, Patrick Dublin College University Dublin, Ireland Martin, Natasha DPhil San Diego of California University States CA, United SanDiego,
Elizabeth Connick, MD Connick, Elizabeth Denver of Colorado University States United CO, Aurora, MD Daar, S. Eric Angeles Los of California Harbor–University Medical Center States CA, United Torrance, PhD Evans, David University of Wisconsin–Madison States WI, United Madison, MD Flexner, W. Charles University Johns Hopkins The States United MD, Baltimore, MD Flynn, M. Patricia Hospital Research Jude Children’s St. States TN, United Memphis, PhD MD, Furin, Jennifer Reserve University Western Case States OH, United Cleveland, DanaGabuzda, MD Institute Cancer Dana-Farber States United Boston, MA, MPH MonicaGandhi, MD, San Francisco of California University States CA, United SanFrancisco, MPH MD, Geng, H. Elvin San Francisco of California University States CA, United SanFrancisco, PhD Garcia-Lerma, Gerardo J. and Prevention Disease for Control Centers States GA, United Atlanta, MD CarloGiaquinto, of Padova University Italy Padova, MD Gonzalez-Scarano, Francisco University of Texas TX, States United SanAntonio, K. MDGrinspoon, Steven and Hospital General Massachusetts Harvard University States United Boston, MA, MD Hahn, H. Beatrice of Pennsylvania University States United Philadelphia, PA, EXTERNAL REVIEWERSEXTERNAL We gratefully acknowledge the contributions of the following, who served as volunteer external reviewers of abstracts CROI 2016 . for reviewers external served who volunteer as of the following, the contributions acknowledge gratefully We PharmD Acosta, P. Edward Birmingham at of Alabama University States Birmingham,United AL, PharmD Anderson, L. Peter of Colorado University States United CO, Aurora, MSc ScD, PhD, TillMD, Bärnighausen, Harvard University States United Boston, MA, PhD Blandford, M. John and Prevention Disease for Control Centers States GA, United Atlanta, PhD MD, MartaBoffito, and Hospital Westminster and Chelsea Trust Service Health National Foundation Kingdom United London, PhD Bor, Jacob Helath SchoolBoston University of Public States United Boston, MA, MD Borkowsky, William School University Medicine of York New States United NY, York, New MD Brooks, T. John and Prevention Disease for Control Centers States GA, United Atlanta, PhD MD, Brown, T. Todd University Johns Hopkins States United MD, Baltimore, MD Casper, Corey Center Research Cancer Hutchinson Fred States United WA, Seattle, PhD Chomont, Nicolas of Florida Institute Therapy and Gene Vaccine States FL, United Lucie, St Port MD Clifford, B. David School University Medicine of Washington States United MO, Saint Louis, MD SusanCohn, E. University Northwestern States IL, United Chicago, MD Connick, Elizabeth Denver of Colorado University States United CO, Aurora, General Information
Nelly R. Mugo, MPH, MBChB, MMed Martina Penazzato, MD, PhD, Magdalena Sobieszczyk, MD, MPH Kenya Medical Research Institute MSc, DTMH Columbia University Thika, Kenya World Health Organization New York, NY, United States Victor Musiime, PhD, MBChB Geneva, Switzerland Serena S. Spudich, MD, MA Makerere University College of Health Paul Revill, MSc Yale University Sciences University of York Guilford, CT, United States Kampala, Uganda York, United Kingdom David L. Wyles, MD Landon Myer, MD, PhD Sharon A. Riddler, MD University of California San Diego University of Cape Town University of Pittsburgh San Diego, CA, United States Cape Town, South Africa Pittsburgh, PA, United States Robert Yarchoan, MD General Information General Susanna Naggie, MD, MHS Lesley Scott, MD National Cancer Institute Duke Clinical Research Institute National Health Laboratory Service Bethesda, MD, United States Durham, NC, United States Johannesburg, South Africa Michael T. Yin, MD Ariela Noy, MD Kenneth E. Sherman, MD Columbia University Medical Center Memorial Sloan Kettering Cancer Research University of Cincinnati New York, NY, United States Center Cincinnati, OH, United States Clement Zeh, PhD, MPH New York, NY, United States Davey M. Smith, MD Centers for Disease Control and Prevention Jean-Michel Pawlotsky, MD, PhD University of California San Diego Atlanta, GA, United States Henri Mondor University Hospital San Diego, CA, United States Creteil, France COMMERCIAL SUPPORT
CROI is largely supported by participant registration fees. In addition, the organizers seek grants from commercial companies, particularly from companies with competing products. These companies have no input in or control over the selection of faculty or content of the presentations. Please note, CROI registration fees cover all attendee meals (including the welcome reception) and travel expenses for selected invited participants (eg, speakers, leaders, moderators, and CROI PC), as well as selected meeting materials and other conference expenses. Commercial support is used to cover some of the costs of the convention center, audiovisual services, and other conference services. CROI 2016 received grant support commitments from the following commercial companies: Platinum Gold Merck & Co, Inc Bristol-Myers Squibb Gilead Sciences, Inc ViiV Healthcare Janssen Therapeutics
Additional support has been provided by AbbVie and Mylan, Inc.
6 CROI 2016 General Information 7
CROI 2016 General InformationGeneral Jennifer Dan Jennifer of California University SanDiego D’Avino Alessandro del Cattolica Università Cuore Sacro Davy Thibaut at of NorthUniversity Carolina Hill Chapel Soro LauraFuente la de for Institute Barcelona and Prevention DiMichelino Rosa of Catania University Dolling David London College University MaggieDorr University Washington George YiminDu at of Alabama University Birmingham Duchesne Léa INSERM U1136 Ericsen Adam University of Wisconsin-Madison Euler Zelda MIT, of MGH, Ragon Institute and Harvard García Fabra Amanda d’Investigacions Institut i Sunyer Pi Biomèdiques August Oliveira de Faria Michelli of California University SanDiego Global Health los de ChristinePaula Angeles University Northwestern Decloedt Eric University Stellenbosch DeGroote Nicholas Disease for Control Centers
Antoine Chaillon Antoine of California University SanDiego ChenJingxian at of NorthUniversity Carolina Hill Chapel SukruthaChettimada Institute Cancer Dana-Farber ChingChristopher Los of California University Angeles Chitre Avantika of California University SanFrancisco CalvinChiu Witwatersrand of the University AaronChristensen-Quick of California University SanDiego Shang-LinChung University Yale CiccarelliNicoletta of Rome University Catholic Cillo Anthony of Pittsburgh University Clement Meredith Hospital University Duke DamiCollier London College University Collini Paul of Sheffield University Cotugno Nicola Bambino Hospital Gesù Children Court Richard Town of Cape University SubathiraDakshina Trust Barts NHS Health DamoucheAbderaouf Sud Paris University
Fatai Bello Fatai Lagos Teaching University Hospital Bhagwat Priya of California University Angeles Los Sonia Boender Tamara Global for Institute Amsterdam and Development Health Boettiger David Wales South of New University Bonito Andrea of Brescia University Boon Denali University Johns Hopkins Borges Alvaro of Copenhagen University Brennan Alana Boston University Breton Yann de Québec Laval-CHU Université KatherineBruner University Johns Hopkins Budd Matthew of BritishUniversity Columbia MarcusBuggert of Pennsylvania University EllsworthCampbell Oak Ridge of Science Institute and Education Caplan Margaret Los of California University Angeles EmilyCartwright Emory University Cepeda Javier University Johns Hopkins MaddalenaCerrone of MilanUniversity
SCHOLARSHIP AWARDEES SCHOLARSHIP YOUNG INVESTIGATOR INVESTIGATOR YOUNG Enass Abdel-Hameed Enass of Cincinnati University Abdel-Mohsen Mohamed San of California University Francisco ShaheedAbdulhaqq and Science Health Oregon University KristinaAdachi Los of California University Angeles EmilyAdland of Oxford University SamaAdnan Emory University Akiyama Hisashi Boston University Alvarado Melanie of Alaska Anchorage University Anderson Brett of MinnesotaUniversity SophieAndrews of Oxford University KaitlinAnstett McGill University Arunachalam Prabhu for Centre Nehru Jawaharlal ScientificResearch Advanced SaraAuld Emory University Badia Roger IrsiCaixa Ballana Ester IrsiCaixa RiddhmaBanga Universitaire Hospitalier Centre Vaudois Battalora Linda School of Mines Colorado General Information
Alison Feder Chiraz Hamimi Palwasha Khan Weizhe Li Stanford University Institut National de la Santé et London School of Hygiene & University of Nebraska Michael Freeman de la Recherche Médicale Tropical Medicine Medical Center Case Western Reserve University Lisa Hamzah Catherine Kiama Xiang Li Mario Frías King’s College London Kenya Ministry of Health Yale University Instituo Maimonides de Jason Hataye Marion Kiguoya Naomi Lin Investigación Biomédica National Institutes of Health University of KwaZulu-Natal University College London de Córdoba Camilla Hatleberg Allison Kirkpatrick Pamela Lincez Matthew Gagne University of Copenhagen NIAID Children's Hospital of Boston University Los Angeles
General Information General Xuan He Maja Kiselinova Carolina Garrido Chinese Center for Disease Ghent University Claire Loiseau University of North Carolina at Control and Prevention Christian Körner INSERM U1043 Chapel Hill Joanna Hellmuth Heinrich Pette Institut, Leibniz Elisa López Varela Pascal Geldsetzer University of California Institute for Virology Barcelona Institute for Harvard University San Francisco Catherine Koss Global Health Varghese George Matthew Hernandez University of California Jesús Luévano University of Miami Icahn School of Medicine at San Francisco Ragon Institute of MGH, MIT, Matine Ghadrshenas Mount Sinai Rebecca Krakora and Harvard University of Washington Alison Hill National Institutes of Health Christine MacBrayne Joshua Gini Harvard University Nitasha Kumar University of Colorado Denver Federal Ministry of Mira Hleyhel Emory University, The University Edith Majonga Health Nigeria INSERM U1018 of Melbourne Biomedical Research and Julia Goldberg Raifman Martin Hoenigl Nathan Lachowsky Training Institute Johns Hopkins University University of California University of British Columbia Thokozile Malaba Monica Golumbeanu San Diego Steven Lada University of Cape Town ETH Zürich Louise Hogan University of California Jaclyn Mallard Elisabet Gómez-Mora University of California San Diego Boston College IrsiCaixa San Francisco Jessica Lakritz Lara Manganaro Anda Gonciulea Feiyu Hong Boston College Icahn School of Medicine at Johns Hopkins University University of Pittsburgh Camille Lange Mount Sinai Morgane Gossez Julia Hood National Institutes of Health Jennifer Manuzak University of Oxford Public Health Seattle & Sarah Laskey University of Washington King County Charitha Gowda Johns Hopkins University Christian Manzardo University of Pennsylvania Louisa Howard Guinevere Lee University of Barcelona National Institutes of Health Marielle Goyette Massachusetts General Hospital Julia Marcus University of Washington Sebastiaan Hullegie Ellen Leitman Kaiser Permanente Erasmus University University of Oxford Marianne Martinello Heather Grome Medical Center Vanderbilt University School Matthew Levy Kirby Institute, UNSW of Medicine Andrea Introini George Washington University Enrique Martin-Gayo Karolinska Institutet Analise Gruenewald Xiaojun Li Ragon Institute of MGH, MIT, University of Pennsylvania Jeffrey Jenks Jilin University and Harvard University of California Gloria Martrus Carolina Gutiérrez San Diego Yijia Li Hospital Ramon y Cajal Peking Union Medical Heinrich Pette Institut, Leibniz Erica Johnson College Hospital Institute for Virology Ahmad Haeri Mazanderani Emory University National Institute for Danny Li Alex Marzel Communicable Diseases Firmin Kabore University of California University Hospital Zurich Centre Hospitalier Universitaire San Francisco Michela Masetti Sourô Sanou University of Milan
8 CROI 2016 General Information 9
CROI 2016 General InformationGeneral Eliane Rohner Eliane of BernUniversity MollyRosenberg Harvard University CarmineRossi the McGill of Institute Research Centre Health University CristinaRovelli San Raffaele Vita-Salute University MariaRuperez Globalfor Institute Barcelona Health Ryom Lene of Copenhagen University Salantes Brenda of Pennsylvania University MariaSalgado IrsiCaixa Institute AIDS Research Sania Ayesha University Columbia SaulleIrma of MilanUniversity SchalkwijkStein Radboud Medical University Center Scherrer Alexandra Zürich Hospital University Schietroma Ivan Sapienza of Rome University LucaSchifanella of Health Institutes National EricaSchlesinger of California University SanFrancisco SchuettfortGundolf Frankfurt Hospital University am Main SchultzeAnna London College University SharpJoseph Town of Cape University Shepherd Leah London College University ShiauStephanie Medical University Columbia Center
and Prevention Patel Eshan of Health Institutes National Pavone Paolo Sapienza of Rome University MariaPernas III de SaludInstituto Carlos Phupitakphol Tanit AIDS Cross Red Thai HIV-NAT, Centre Research Ponte Rosalie of the McGill Institute Research Centre Health University RobertPower Centre Africa Trust Wellcome ChristinaPsomas of Hospital University Montpellier Rajoli Reddy Kumar Rajith of Liverpool University Reepalu Anton University Lund Registre Ludy Boston University Richardson Eugene GaryParker Research KwaZulu-Natal Institute TB-HIV for DanaPasquale GillingsUNC School of Global Health Public Patel Monita Disease for Control Centers Stanford University Stanford Riveira-Muñoz Eva IrsiCaixa Institute AIDS Research Pinto Rivera Javier IrsiCaixa RobertsOwain of Liverpool University SarahRoberts University of Washington RocafortMuntsa IrsiCaixa Institute AIDS Research Rodríguez-Arbolí Eduardo University del Rocio Virgen Hospital
Eirini Moysi Eirini of Miami University Mugwanya Kenneth University of Washington Mujugira Andrew University of Washington DanielMurray Infection of Institute Kirby The and ImmunitySociety in ZibusisoNdlovu SansMédecins Frontières NearyMegan of Liverpool University KarinNeukam Hospital University Valme AstridNewsum Service Health Public of Amsterdam Nguyen Thao Reserve University Western Case Nichols Brooke Medical University Erasmus Center MariiaNovikova Institute Cancer National Nowak Piotr Institutet Karolinska Odayar Jasantha Town of Cape University O’HalloranJane Dublin College University Olagunju Adeniyi of Liverpool University Oldenburg Catherine Harvard University Ozanne Alexandra de Bordeaux Université Page Iain of Manchester University The Palchaudhuri Riya Burnet Institute Palesch David Yerkes Emory and University Research Primate National Center LaurencePalk of California University Angeles Los
Yusuke Matsui Yusuke University Kyoto RobertMaughan Dublin College University CarlaMavian of Florida University McGettrick Padraig Dublin College University JessicaMcGillen London College Imperial Meggi Bindiya de Saúde Nacional Instituto de Mocambique Mehraj Vikram of the McGill Institute Research Centre Health University Menkova-Garnier Inna INSERM U955 SabrinaMerat AIMM Therapeutics Merchante Nicolás Valme de Universitario Hospital Merli Marco San Raffaele Vita-Salute University LucaMicci Emory University Miles Brodie Denver of Colorado University CaitlinMiller SchoolBoston University of Medicine ShannonMiller Denver of Colorado University Mohr Raphael Bonn Hospital University Monel Blandine Hughes Medical Howard Institute Moragas Matias SAMIC de Pediatría Hospital Garrahan” Dr Juan P. “Prof Morawski Bozena of MinnesotaUniversity Mori Masahiko of Oxford University Mothe Beatriz IrsiCaixa General Information
Carey Shive Tavitiya Sudjaritruk Priyanka Uprety Darcy White Cleveland VA Medical Center Johns Hopkins University Johns Hopkins University University of Washington Joshua Shorenstein Tahmina Sultana Emiko Urano Kate Wilson University of California Osaka University National Cancer Institute University of Washington San Diego Sara Sunshine Kimyata Valere Anni Winckelmann Jeanne Sibiude Brigham and Women’s Hospital, Rutgers University Aarhus University Hospital INSERM U1018 Harvard Medical School Christina Valiaveettil Joanne Winter Francesco Simonetti Talia Swartz University of Toronto University College London University of Milan Icahn School of Medicine at Joost Vanhommerig Sarah Wood Cassandra Simonich Mount Sinai Public Health Service of University of Pennsylvania General Information General Fred Hutchinson Cancer Jori Symons Amsterdam Yuanfei Wu Research Center Doherty Institute for Infection M.J. Vivancos-Gallego University of Massachusetts Ravesh Singh and Immunity Hospital Universitario Ramón Medical School University of KwaZulu-Natal Laura Tarancón y Cajal Beiqing Wu Urisha Singh Biomedicine Institute of Sevilla Thomas Vollbrecht University of Nebraska Medical University of KwaZulu-Natal Sushama Telwatte University of California Center Arjun Sinha Burnet Institute San Diego Shu Yang University of California Aurielle Thomas Catriona Waitt Harvard University San Francisco National Institutes of Health University of Liverpool Emine Yaylali Magdalena Sips Corbin Thompson Naomi Walker Centers for Disease Control and Ragon Institute of MGH, MIT, University of North Carolina at Imperial College London Prevention and Harvard Chapel Hill Victoria Walker-Sperling Christina Yek Shauna Stahlman Thierry Tiendrebeogo Johns Hopkins School of University of Texas Southwestern Johns Hopkins University INSERM U897 Medicine Mehwish Younas Arjen Stam Graham Treasure Jiayi Wang Institute of Human Genetics University Medical Center Brigham and Women’s Hospital, University of Minnesota Rebecca Zash Utrecht Harvard Medical School Bernard Weigel Beth Israel Deaconess Medical Gaby Steba Ming-Han Tsai University of California San Center Academic Medical Center University of Oxford Francisco Jennifer Zerbato Amsterdam Damien Tully Kevin Weiss University of Pittsburgh Karl Stefic Ragon Institute of MGH, MIT, Emory University Wenjing Zheng Centre Hospitalier Universitaire and Harvard Katherine Wetzel University of California de Tours Jonathan Underwood University of Pennsylvania San Francisco Natalia Stella Ascariz Imperial College London Hospital Universitario La Paz
10 CROI 2016 General Information 11 CROI 2016 General InformationGeneral Fredrick Odongo Fredrick Institute Medical Research Kenya Okoboi Stephen AIDS SupportThe Organization Remera Eric Disease of HIV/AIDS Prevention Institute and Control Ribakare Muhayimpundu Bio Medical Center Rwanda SchutzCharlotte Town of Cape University MazvitaSengayi Laboratory Service Health National SarahSteele Jane SansMédecins Frontières OmarSued Huésped Fundación Culsem Van Gilles SansMédecins Frontières
Mbae Japhet Mbae Mathari Hospital Consolata Kadede Kevin Institute Medical Research Kenya Karugaba Patrick Hopkins Johns - University Makerere Collaboration Research University CissyKityo Centre Clinical Research Joint DalsoneKwarisiima of California University-University Makerere Collaboration Research SanFrancisco StanziRoux le Town of Cape University SikhulileMoyo Partnership HarvardBotswana Institute AIDS Mwangwa Florence Infectious Collaboration Diseases Research LandonMyer Town of Cape University DamalieNakanjako of Health College University Makerere Sciences NicaiseNdembi Nigeria Virology, of Human Institute
AWARDEES INTERNATIONAL SCHOLARSHIP SCHOLARSHIP INTERNATIONAL Gbolahan AjibolaGbolahan Partnership HarvardBotswana AIDS Institute RitaAtugonza Children’s of Medicine College Baylor Uganda Foundation Avelino-Silva Vivian of SaoUniversity Paulo Avihingsanon Anchalee Thailand Australia HIV Netherlands The Collaboration Research Ayieko James Institute Medical Research Kenya Bienczak Andrzej Town of Cape University Cherutich Peter University of Washington DianaFaini Institute Health Ifakara Moise Guiteau Colette GHESKIO Centres Les Kumar Hemanth Kupparam Agibothu Tuberculosis in Research for Institute National CherylHendrickson and Epidemiology Economics Health Office Research General Information COMMUNITY EDUCATOR SCHOLARSHIP AWARDEES Joshua Agee Brandon Harrison Elias Phiri My Brother’s Keeper National Black Leadership Commission on Addington Afro-Ethnic Health Promotion Josephine Ayankoya AIDS, Inc Group
General Information General Bridge HIV, San Francisco Department of Angel Hernández Juan Pierce Public Health Community Scientific Subcommittee, ACTG Black AIDS Institute African American HIV Giorgio Barbareschi Shalaurey Jones University Science and Treatment College European AIDS Treatment Group University of California Los Angeles Ferran Pujol Roca Tamas Bereczky Tapiwanashe Kujinga Projecte dels NOMS-Hispanosida European AIDS Treatment Group Pan-African Treatment Access Movement Yvette Raphael Aisuluu Bolotbaeva Marreo McDonald Damelin College Central Asian HIV Foundation My Brother’s Keeper, Inc Jorge Saz Berges Danette Brown Michael Meulbroek Joves Positius Volunteers of America Greater Baton Rouge Asociación para el Trasplante de Órganos a Cissy Ssuuna Danielle Campbell Seropositivos Baylor College of Medicine Children’s Black Treatment Advocates Network Kennedy Mupeli Foundation Uganda Caitlit Conyngham Centre for Youth of Hope Nsubuga Supercharger Philadelphia FIGHT Jane Mwirumubi Pina Ugana and Joint Clinical Research Centre Giulio Corbelli Makerere University Business School Harry Tembo PLUS Onlus Robert Newells Zambia Community Advisory Platform Michael Dorosh AIDS Project of the East Bay DaShawn Usher Treatment Education Network Definate Nhamo New York Blood Center’s Project ACHIEVE Florita Durueke Pangaea Zimbabwe AIDS Trust Lisa White New HIV Vaccine and Microbicides Advocacy Simon Ondiek SisterLove, Inc. Society Jaramogi Oginga Odinga University of Ntando Yola Mardrequs Harris Science and Technology Desmond Tutu HIV Foundation Friends for Life Corporation Julia Patterson Case Western Reserve University
12 CROI 2016 General Information 13 CROI 2016 General InformationGeneral AMA PRA Category 1 PRAAMA Category 17 http://www.croiconference. for this activity. for This activity may contain information about the investigational uses the investigational about activity information This contain may Drug and the US Food by approved not are or products that of drugs before information full prescribing Please consult Administration. in this activity. or product mentioned medication using any DrugProductand Disclaimer Disclosure of Financial Relationships DisclosureFinancial of independence, It is the policybalance, ensure of the IAS–USA to activities. All rigor in all its educational and scientific objectivity, participating etc) IAS– in presenters, faculty(speakers, members program the disclose to to activities required USA-sponsored are that months past 12 within the financial interests any audience of potentially appearance the or give influence, to be perceived could defines ACCME (The presentation. oral or the written influencing, information The amount.) in any as an interest a financial interest and speaker of the IAS–USA aware audience make to is intended companies with commercial and commitments interests contributor own their form to members enabling the audience or other entities, about such associations. judgments this financial complete to required is author or contributor Each the IAS– with IAS–USA policy, accordance In declaration. disclosure conflicts possible ofany ahead of time and resolve will identify USA or exposition to CME activities influence regard with may that interest the Program included with will be information Disclosure conclusion. and Abstracts eBook on the web. and clinicians can receive a Certificate of Participation verifying their verifying of Participation Certificate a canand clinicians receive (AMA). MedicalAmerican the Association by as required attendance, ClaimingCertificateCreditsa or CME Participation of will be e-mailed all evaluations to daily During the conference, the for register CROI participants they used to the e-mail to account Februaryparticipantsall CROI 2016, 25, will Thursday, On conference. confirmation registration their e-mail a final will contain that receive CME credits obtain To evaluation. CROI the overall number and a link to must this final evaluation CROI, for of Participation Certificate or a is evaluation Once the 2016. 31, March Thursday, by be completed their and print claim link to the participants will receive submitted, certificate. canclaim, you that hours or credits number of CME the determine To including sessions, relevant the attending time spent your calculate you if example, For plenaryand workshops. symposia, sessions, 2 plenary a themed discussion 9:30 AM), attended to AM talks (8:30 you 6:00 PM), (4:00 PM to 2:45 PM), and a symposium (1:45 PM to that for CME credits toward apply hours to of 4 a total have would for attended hours you the total please add the end of CROI, At day. claim a maximum of may You certificate. your Credits™ here: canbe found A CME hour worksheet org/sites/default/files/uploads/croi2016_cme_worksheet.pdf AMA 17 to ) to (ACCME Physicians should claim only the credit should claim only the credit Physicians
Describe new current basic science research on the pathogenesis of pathogenesis on the research basic science Describe new current cure a toward HIV and on advances clinicalHIVin the field of trials findings from List the most recent state-of-the-artfor data of these and the implications treatment strategies of HIV prevalence on the epidemiologic data Describe current and retention and linkage to infection, treatment, transmission, these data of the implications worldwide; in populations in care in advances planning; and current public-health program for prevention biobehavioral
• • • CONTINUING MEDICAL EDUCATION MEDICAL CONTINUING Physicians (MD, DO, and international equivalents) are eligible to to eligible are equivalents) and international DO, (MD, Physicians participation for Other in CROI 2016. CME credit practitioners receive CME CreditCME Information Statement of Need of Statement global the to response scientific the identified, HIV was Since effort among basic researchers, has been a coordinated pandemic and epidemiologists, providers, health care clinicalinvestigators, treatment and potential information move community leaders to affected communities clinicaltrials and out to to research options from researchers in 1993 by founded CROI was as quickly as possible. as a science- its complications, in the field of HIV/AIDS and working theiramong findings research current exchanging for focused forum exchange, focus on scientific to CROI continues peers. international researchers, science in which basic an environment providing and epidemiologists, clinical investigators, researchers, translational research and discuss latest the public health experts present meet to of HIV and its complications. facets different on Objectives participatingAfter in CROI 2016, participants able to: will be The International Antiviral Society–USA (IAS–USA) is accredited by by Society–USA accredited is (IAS–USA) Antiviral International The MedicalEducation Continuing for Council the Accreditation physicians. for medical education continuing provide activitylive this of a maximum for IAS–USA designates The Credits™. 1 PRA Category their participation of with the extent activity. in the commensurate with Commendation. 2006, the IAS–USASince has held Accreditation thein organizations of group an elite AsIAS–USA such, the belongs to which, status, this prestigious been awarded have that States United truly are that programs for “reserved is of the ACCME, in the words exceptional.” plenarycan for be claimed opening symposia, credits CME lectures, cannot be claimed CME credits and special sessions. session lectures, or poster themed discussion sessions, abstract oral for sessions, sessions. Accreditation Statement Accreditation General Information GENERAL INFORMATION Overview Welcome Reception CROI was established in 1993 to provide a forum for basic scientists All registered CROI attendees are invited to join us for a Welcome and clinical investigators to present, discuss, and critique their Reception immediately following the Opening Reception on February investigations into the epidemiology and biology of human 22, 2016. The reception will be held in Hall C and Hall D and the retroviruses and associated diseases. The synergy of basic science corresponding pre-function areas. and clinical investigation has been a major contributor to the success This unique Welcome Reception will offer attendees the opportunity
General Information General of the meeting. CROI is the preeminent HIV research meeting in the to network with colleagues. world and attracts more than 4000 HIV and AIDS research leaders internationally. The goal of the conference is to help researchers Wi-Fi translate their laboratory and clinical findings into tangible progress Complimentary wireless internet is provided at the Hynes Convention against the HIV pandemic. CROI has facilitated the presentation of Center. As a courtesy to your fellow attendees please disable the Wi-Fi important discoveries in the field, thereby accelerating progress in HIV function on your unused devices. For example, if you have a tablet, and AIDS research. laptop, and a Wi-Fi enabled phone, please use one device at a time to Americans with Disabilities Act access Wi-Fi and disable the others. There are several Wi-Fi hot spots throughout the convention center. Please visit Attendee Services for a CROI 2016 endeavors to comply fully with the legal requirements of list of the hot spots. the Americans with Disabilities Act (ADA). If you require assistance on-site, please visit the Attendee Services booth on the Plaza level Meals during the conference. Morning coffee and light continental breakfast will be available to Emergency Services conference attendees in the Auditorium from 8:00 AM – 8:30 AM Tuesday to Thursday. An afternoon snack break will be available at In the event of an emergency please contact the command center, 2:30 PM in Poster Hall A. Attendees are on their own for lunch and open 24 hours daily, or notify CROI staff. The command center can dinner each day. Below is a list of food service options located in the be reached at (617) 954-2111 and is located by the Boylston Street Convention Center or within a short walking distance. entrance. In addition, security offices are located throughout the building and at each of the building’s entrances. A nurse is available CROI registration fees cover all food and beverage above provided by on-site and is accessible by contacting the command center, notifying the conference at the convention center. Attendees are responsible for CROI staff, or visiting the nurse’s office in the registration area. all other meal expenses. Selected restaurants and food outlets: Embargo Policy At the Convention Center Towne Stove and Spirits The research presented at CROI 2016 is embargoed until the conclusion The Capital Grill of the session in which it is presented. For example, if a study is presented from 1:45 PM to 2:00 PM as part of a session that ends at At the Prudential Center 2:45 PM, the embargo on that study lifts at 2:45 PM. Embargoes on (next to the South Lobby main entrance of the Convention Center) poster presentations lift at the conclusion of the session in which the 5 Napkin Burger Au Bon Pain poster is presented. If a study to be presented at CROI 2016 is included Barnes & Noble Cafe California Pizza Kitchen in an official CROI press conference and that press conference takes Cheesecake Factory Cold Stone Creamery place before the official presentation of the study at the conference, Crazy Dough’s Pizza Dunkin’ Donuts the embargo lifts at the conclusion of the press conference in which Fruitata Godiva that study is featured. Haru L’espalier P.F. Chang’s Pinkberry Social Media Star Market Teavana CROI embargo policies apply to any public dissemination of research Top of the Hub Wagamama information presented at the conference, including through electronic publications (eg, blogs) or social media (eg, Facebook, Twitter). No At the Sheraton Boston public dissemination of research information from the conference is SideBar & Grille permitted prior to the lifting of the conference embargo. Individuals Starbucks or organizations that violate the conference embargo policy may have their conference credentials revoked and may forfeit the opportunity to participate in future conferences.
14 CROI 2016 General Information 15 CROI 2016 Also, if you if you Also, General InformationGeneral DO NOT LOSE YOUR YOUR LOSE NOT DO mode. No flash photography is permitted in session rooms. session in is permitted flash photography No mode. ChildCare including room, meeting entry any not permitted into are Children please contactthe care, child require should If you area. the poster hotel. of your concierge Etiquette Conference in placed off or are phones and pagers are all cell Please ensure SILENT Mobile App Mobile experience. conference your enhance to CROI 2016 has a Mobile App e-mailview abstracts, other schedule sessions, to you enables App The in 2016” “CROI Search more. and announcements, participants,receive The App. the conference and download store, App mobile device your to restricted is Access supportsmobile App devices. iOS and Android will and password information log-in Your only. attendees registered materials. registration with your on site you to be provided Badges please bring lobby; the registration at Badgeavailable will be pickup your shows clearly that identification photo government-issued gain entry name badge to all official to your wear must You name. sessions. meeting activities,poster the including registration additional an of payment Unfortunately, BADGE. badge. lost a replace to required be will ($750) fee are of other attendees the affiliations or affiliation your that notice the Conference of in the office staff conference please inform incorrect, Secretariat. Affiliated Activity Policies Affiliated scientific high-level meaningful, promote to of CROI is goal The ways find better to order in and debate ideas of interchange goal, with this keeping HIV/AIDS. In and cure treat, prevent, to groups, not-for-profit companies, (commercial organizations host Affiliated to approved been have etc) agencies, government Activities are Affiliated Activities times. CROI session outside occurring or supported the IAS–USA, the CROI by endorsed by, by, not sponsored or CROI 2016. Foundation, the Guidelines violated activity have an affiliated If to is found organization, the sponsoring Activities (above), Affiliated for meeting of the the organizer the supporting and organization, activity future holding an affiliated at from be prohibited may revoked, registration their current have may CROI conferences, could and be subjectnon-compliance fines and damages, may to those of impact the registration/status/attendance negatively activity. affiliated an unapproved attending ts Bar s Boston s Market Champion’s Spor Champion’s Osushi Fisheries Turner Summer Shack Dunkin Donuts Whiskey’s Lir McGreevy’ & Louie’s Abe DeLuca’ Chipotle Good B.
Plenaries, symposia, scientific overviews, oral abstract sessions, and abstract oral sessions, overviews, symposia, scientific Plenaries, also are Webcasts and podcast. themed discussions will be webcast and iPhone. iPad the Apple video for as streaming available access to or www.CROIwebcasts.org www.CROIconference.org Visit available be will Webcasts podcasts. and the CROI 2016 webcasts session. relevant of the within 24 hours of the end Webcasts and Podcasts and Webcasts Website please visit the conference about the information additional For www.CROIconference.org. at website Legal SeaFoods Legal Session Rooms for OverflowAccommodations sessions will streamed Simultaneous with 5 concurrently overflow through will be played each session for up in Hall C. Audio be set accommodations overflow Additional each seat. up at headphones set of sessions assignment The 313. 309, 310, and in rooms will be set up as necessary. on-site determined will be room each overflow to (within 1 block of the Convention Center) the Convention block of (within 1 Bar10 Westin the at Huntington The Dirty Water Dough Company DirtyWater Scissors and Pie Sweetgreen Westin and Mall, Place Copley Marriott the Copley, At Place Copley Trader Joe’s Trader House Pour The Company Fish Atlantic Starbucks (within 1-3 blocks, listed by distance from the convention center) the convention from distance by listed blocks, (within 1-3 Tavern Bukowski Dillon’s Boloco Back Bay Neighborhood Bay Back General Information CONFERENCE SERVICES Services Location Hours Notes Boston Information Registration Area Sunday: 2:30 PM – 7:30 PM Local information and reservations on Plaza Level Monday: 8:30 AM – 7:35 PM assistance. Tuesday: 8:00 AM – 7:45 PM Wednesday: 8:00 AM – 6:30 PM Thursday: 8:00 AM – 6:30 PM Bag and Coat Check Plaza Level Monday: 8:00 AM – 10:30 PM Bag and coat check are free of charge. Tuesday: 7:30 AM – 8:15 PM
General Information General Wednesday: 7:30 AM – 6:30 PM Thursday: 7:30 AM - 6:30 PM Cyber Cafe Boylston Hallway Regular Conference Hours Two Cyber Cafés with Internet access are 3rd Floor available to download electronic materials Prefunction Hall A and for webcasts, abstract searches, and messages. Media Center Room 210 Monday: 10:00 AM–5:00 PM, The Media Center is a work space with Tuesday to Thursday: 8:00 AM–6:30 PM Wi-Fi and is the location of the daily press conferences open exclusively to registered, accredited media. Badge Pickup Registration Area Sunday: 3:00 PM–6:00 PM Location to pick up badges and conference • Speakers, Conveners, on the Plaza Level Monday: 8:00 AM–7:00 PM materials. There is no on-site registration for and Presenters Tuesday: 7:00 AM–6:00 PM attendees or media. • Attendees Wednesday: 8:00 AM–6:00 PM • Scholarship Recipients Thursday: 8:00 AM–12:00 PM • Media Housing Information Speaker Ready Room Room 200 Sunday: 3:00 PM–6:00 PM The speaker ready room is a space for Monday to Thursday: 7:30 AM–6:00 PM presenters to load their slides and rehearse their presentations. Use of the rehearsal services is on a first-come, first-served basis. Oral abstract, invited, and themed discussion session speakers must drop off presentations at the speaker ready room at least 24 hours before their presentation. Electronic Poster Drop-off Room 200 Sunday: 3:00 PM–6:00 PM Poster presenters must submit an Monday to Thursday: 7:30 AM–6:00 PM electronic version of their poster for placement on the CROI website. Upon submission of an electronic poster, presenters will be issued a special badge for early access to the poster halls for setup. Only badge holders and their assistants will be granted early access.
New Mother’s Room Room 307 Sunday: 3:00 PM–6:00 PM The New Mother’s Room is a room set aside Monday: 9:00 AM–6:00 PM for nursing mothers who require a short- Tuesday to Thursday: 8:30 AM–6:00 PM term private room. Use of this room is on a first-come, first-served basis. Personal Considerations Room 308 Sunday: 3:00 PM–6:00 PM The Personal Considerations Room is a room Room Monday: 9:00 AM–6:00 PM set aside for those who require a short-term Tuesday to Thursday: 8:30 AM–6:00 PM private space for personal health needs. Use of this room is on a first-come, first-served basis. Lost and Found Attendee Services Regular Conference Hours You may inquire about lost or stolen items counter in the at Lost and Found. Please turn in any found Registration Area items to CROI staff at the Attendee Services on the Plaza Level counter in the registration area. During the course of the conference, lost items will be held at the registration area. After the conference, lost items will be held by the Convention Center’s command center.
16 CROI 2016 General Information 17 CROI 2016 General InformationGeneral
The Lenox The Street 61 Exeter 02116 Boston, MA 536 5300 PH: +1 617 km Distance: 0.2 mi / 0.3 Plaza Copley Fairmont James Avenue St. 138 02116 Boston, MA 267 5300 PH: +1 617 Distance : 0.4 mi / 0.6 km Hotel Plaza Park Boston Plaza 50 Park 02116 Boston, MA 427 2000 PH: +1 617 km Distance: 0.8 mi / 1.3 500 ftm / 150 Station: Arlington T at Distance to (1 stop). Station Copley line to the green Take left. and turn Street Boylston onto Exit 0.2 miles and for Street Boylston on Continue on the left. Center the Convention enter Sheraton Boston Hotel Boston Sheraton Street 39 Dalton 02199 Boston, MA 236 2000 PH: +1 617 km Distance: 0.1 mi / 0.2 Boston MandarinOriental, Street Boylston 776 02199 Boston, MA 535 8888 PH: +1 617 km Distance: 0.1 mi / 0.2
HOTEL INFORMATION HOTEL 811 Massachusetts Avenue 811 02118 Boston, MA 445 6400 PH: +1 617 km Distance: 1.6 mi / 2.6 theserviceshuttle A daily and from to is provided. Center Convention Hampton Inn & Suites& Inn Hampton times. for Please check with the hotel the Hynes. to 1 bus route Take Transportation: Public The Midtown Hotel Midtown The Avenue Huntington 220 02115 Boston, MA 262 1000 PH: +1 617 km Distance: 0.5 mi / 0.8 The Colonnade Hotel Colonnade The Avenue Huntington 120 02116 Boston, MA 424 7000 PH: +1 617 km Distance: 0.3 mi / 0.5 Hilton Boston Back Bay Back Boston Hilton Street 40 Dalton 02115 Boston, MA 236 1100 PH: +1 617 km Distance: 0.2 mi / 0.3 Westin Copley Place Copley Westin Avenue 10 Huntington 02116 Boston, MA, 262 9600 PH: +1 617 km Distance: 0.4 mi / 0.6 HeadquarterHotel Avenue Huntington 110 02116 Boston, MA 236 5800 PH: +1 617 kmDistance: 0.3 mi / 0.5 Boston Marriott Copley Place Marriott Copley Boston CROI 2016 hotels are listed below. For more detailed housing information, please visit the CROI 2016 conference website: www.CROIConference. website: conference the CROI 2016 visit please detailed housing information, more For below. listed are CROI 2016 hotels who include registrants this to exceptions few The hotels. the official conference in one of stay to required are attendees Conference org/housing. CROI approved an with sharing a room are who registrants and Center) Convention Hynes of the radius a 50-mile within (ie, area in the Boston live via the CROI housing system. booked accommodations with attendee General Information
Charles St S 90
T
Tremont St. Tremont Boylston St Boylston UNION PARK ST UNION PARK
Arlington St Boston Back Bay Hilton Lenox Oriental Mandarin Hotel MidTown Boston Hotel Sheraton Boston Place / Copley Westin General Information General 3 7 8 9 11 12 10 T Berkeley St. ARLINGTON ike
P Columbus Ave. Columbus ass M
Clarendon St. W. Dedham St. Copley Pl Copley
BACK BAY BACK St. James Ave James St.
Boylston St Boylston Dartsmouth St. T
BACK BAY BACK SOUTH END Commonwealth Ave Commonwealth 5 FACILITIES Center Hynes Convention John B. Place Copley Boston Marriott Towers & Plaza Hotel Boston Park Hotel Colonnade Plaza Hotel Copley Fairmont Center Boston Crosstown Inn & Suites Hampton Inset) Center; the Convention (1.6 miles from 2 3 4 5 6 1 Sky Bridge END
SOUTH T St. Tremont 2 12 COPLEY PLACE COPLEY GREATER BOSTON GREATER Boston CONV. & VISITORS BUREAU VISITORS & CONV. Massachusetts Ave Medical Center Harrison Campus 8
6 Sky Bridge Ave. Columbus 4
PRUDENTIAL T 9 COMMONWEALTH AVENUE MALL AVENUE COMMONWEALTH CENTER PRUDENTIAL
Massachusetts Ave. Harrison Ave. Harrison
TOWER Boylston St Boylston PRUDENTIAL
T Avenue of the Arts Arts 10 the of Avenue 11
1 Beacon St. Beacon Massachusetts A HYNES CENTER MASSACHUSETTS CONVENTION
7 Commonwealth Ave Commonwealth T SYMPHONY Massachusetts Bay Massachusetts Authority Transportation Transit Rapid
Belvidere St. T T T
18 CROI 2016 General Information 19 94 52 25 27 4.6 1.7 1.6 951 857 198 13.5 22.7 54.9 1936 Percent CROI 2016 General InformationGeneral ......
84 77 N 222 652 ...... 1140 2644 ......
...... Information is not new enough is not new Information supportto or insufficient inadequate Methodology is conclusions the hypothesis does not summarize Background Submission is poorly written submissions of other Abstractduplicative is CROI for Abstractnot appropriate is or inadequate absent are Controls or absent inadequate is evaluation Statistical or absent Summary is inadequate results of essential support to or insufficient conclusions inadequate are Data unplanned Submission reports from clinicaldata trial and ongoing studies or or incomplete analysis section[s] missing, guidelines (eg, does not follow Format submitted) or figure table, than 1 graphic, more General oral abstracts oral General General poster abstracts poster General abstracts oral Late-breaking abstracts poster Late-breaking • • • • • • • • • • • • Asia America Latin/South Total general abstracts general accepted Total All Authors on Accepted Abstracts Accepted on Authors All Region Africa Statistics for Abstracts for Statistics abstract general submitted Total Common Reasons for Abstract for Reasons Rejection Common presentations, or rejected. Late-breaking abstract reviews abstract reviews Late-breaking or rejected. presentations, the work of nature of the late-breaking assessment an included submission). a late just being (versus Total late-breaking abstracts submitted late-breaking Total abstracts accepted late-breaking Total Australia Europe North America
Implementation Science and Health Care Delivery Care Science and Health Implementation Modeling and Economic Population Maternal/Fetal HIV Maternal/Fetal and Adolescents Pediatrics Women in and Sexual Health and Reproductive Contraception Studies and Intervention Prevention Cardiovascular Complications of HIV Infection and Complications Cardiovascular Therapy of HIV Infection and Antiretroviral Other Complications and Other Opportunistic Infections Tuberculosis Antiretroviral Therapy: ObservationalStudies Therapy: Antiretroviral HIV Drug Resistance HIV Diagnostics Malignancies and Non–HIV-Related HIV-related Clinical Pharmacology Clinical Studies Preclinical Therapy: Antiretroviral Therapy: Randomized Trials Clinical Antiretroviral Host Immune Responses to Infection, Vaccines, and Vaccines, Infection, Responses to Immune Host Including Eradication, Latency, Reservoirs, HIV Persistence, Virology HIV/SIV Evolution and Molecular Epidemiology Models Animal and Studies Human Pathogenesis: with been combined Models has Animal Pathogenesis: Antiretroviral Therapy Therapy Antiretroviral Immunotherapy Gene Therapy Category C) Category Epidemiology Hepatitis Viruses Hepatitis Neuropathogenesis
ABSTRACT PROCESS ABSTRACT AbstractProcess Review reviewed external reviewers PC and a panel of volunteer The abstract Each abstracts. was submitted 2000 approximately selected each abstract for category 10 reviewers 5 to by reviewed their individual expertise.based upon the expertsPC members and external in the field reviewed abstractsquality the for and scored and originalitythe work of abstain from instructed to were reviewers All them numerically. an author or coauthor, abstractthey are which any on scoring the not have or do conflict a financial or personal of interest, have (definite 1 from ranged Scores expertise evaluate. to appropriate 5 (rejected). to presentation) oral deviation and the standard averaged each abstract for were Scores outlierhigh, If variability was assess variability. to calculated was Abstracts variability with high and censored. identified are scores discussedof conference a series individually during were in scores poster for presentations, oral for accepted Abstracts were calls. Author names, institutions, abstract titles, and abstracts abstract in titles, institutions, names, Author as presented generally and Abstracts eBookare the Program author. the corresponding by submitted W. W. X. Y. AbstractContent S. T. U. V. P. P. Q. R. K. L. M. N. O. G. H. I. J. E. F. A. B. C. (D. ScientificCategories General Information General Information General
20 CROI 2016 Monday, February 22, 2016 • Oral Sessions 21 CROI 2016 Ballroom B/C Ballroom Program Agenda and International Community of of Community International Magee-Womens Hospital of the University University the of Hospital Magee-Womens David Geffen School of Medicine of UCLA, The Sero Project, Milford, USA PA, Univ of Chicago School of Social Service Obafemi Awolowo
CME Engaging Young Men of Color in Community Community in Color of Men Young Engaging Studies Prevention HIV Green, Keith USA IL, Chicago, Administration, Limits and Complexity Research on Stigma Stigma on Research Complexity and Limits andHIV Sprague, Laurel in Making Decision and Rights Women’s Contraception Hormonal Mthembu, Sethembiso Durban, Africa, Southern HIV/AIDS, with Living Women AfricaSouth Los Angeles, CA, USA of Pittsburgh Medical Pittsburgh, Center, USA PA, Long-Term of Complexities the Unraveling Infection HIV Treated of Complications JudithS. Currier, The Rapidly Changing Landscape of HIV HIV Landscape of Changing Rapidly The Prevention Hillier, L. Sharon
Panel Discussion on Stigma, Trauma, Discussion Trauma, Stigma, on Panel HIV for Stress:and Considerations Programs and Research
University, ILe-lfe, Nigeria ILe-lfe, University, 1:00 PM-2:001:00 PM the during annually held Presentation is MartinThe Delaney workshops Investigators, Internationalfor Young Scholars and Community Educatorsin honor of pioneeringactivist HIV/AIDS Martin Delaney It recognizes (1945–2009). theimportant contributions community research. of advocacy in engagement and TheMartin Delaney Presentation iscustomized to the Community LiaisonSubcommittee and ispresented as a panel discussion. Moderator Ukpong-Folayan, Morenike 2 Panelists SessionMD Ballroom Ballroom B/C University Hospital Zurich, Zurich, Hospital University University of Utah School of Medicine, Medicine, of School Utah of University Vaccine Research Center, National Institute Institute National Center, Research Vaccine CME
It is assumedthat participants have been Thisworkshop is directed toward new trainees Columbia University University Columbia University of of University Zurich, Switzerland Zurich, The HIV Latent Reservoir: Obstacles and and Obstacles Reservoir: Latent HIV The Strategiesto Curea Günthard, HuldrychF. Wesley I. Sundquist, I. Wesley Salt Lake USA City, UT, Vaccines and Immunology RichardA. Koup, of Institutes National Diseases, Infectious and Allergy of Health, Bethesda, MD, USA Molecular Virology: Advances in the the in Advances Virology: Molecular HIV of Understanding
At theAt completion of thesession, participants will be and Trainees: Session Summary Trainees: and Program Committee Workshop for New Investigators Investigators New for Workshop Committee Program
Describe current state-of-the-art the HIV selected of of areas clinical research and basic List the leading research themes being presented atCROI 2016 Better navigateCROI maximize 2016, the knowledge gained, andpursue interactions withresearch colleagues Clarify their individual researchinterests in relation to the priorities discussed at the workshop and CROI overall 2016 • • • •
ORAL SESSIONS ORAL MONDAY, FEBRUARYMONDAY, 2016 22, Pittsburgh, Pittsburgh, USA PA, 1 Conveners Conveners ScottM. Hammer, College of Physicians and Surgeons, USA New York, NY, Mellors, W. John conducting active research inthe field forless than3 years. Objectives: Target audience: Target students, postdoctoral graduate students, undergraduate (eg, fellows, and physician fellows) and new investigators (both international and domestic). It isopen to all CROIattendees, however. knowledge: of Level able to: SessionWorkshop W1 AM-12:309:00 PM Investigators New for Workshop Committee Program Trainees and Program and Agenda
Session W2 Workshop CME Ballroom B/C Session W3 Workshop CME Ballroom A 2:15 PM-4:00 PM 2:15 PM-4:00 PM Clinical Trial Design and Analysis Workshop Frontiers in Laboratory Science Workshop Target audience: This session is directed to clinicians and scientists Target audience: This session is directed to investigators and who are interested in designing or interpreting clinical and clinicians interested in learning about the main technological and epidemiologic studies. conceptual developments in life sciences that are influencing HIV Level of knowledge: It is assumed that participants are familiar research or hold a significant potential for research. with the basic design of randomized and observational clinical trials Level of knowledge: It is assumed that participants are familiar and basic HIV epidemiology. with the main technological and data analysis approaches used in Objectives: At completion of the session, participants will be HIV research. able to: Objectives: At the completion of the session, participants will be • Provide examples of big data and how these data can be used to able to: improve program impact • Recognize the potential of and directions in the field proteome • Describe approaches to incorporating pharmacokinetic and analysis. pharmacodynamics measures into clinical trials • Describe novel microfluidic approaches to single-cell analyses. • Describe how sexual and social network data can be used to • Visualize and learn of the establishment of organs-on-chips. evaluate HIV transmission patterns Conveners Conveners Galit Alter, Ragon Institute of MGH, MIT • Monday, February 22, 2016 22, February Monday, • Susan P. Buchbinder, San Francisco and Harvard, Cambridge, MA, USA Department of Public Health, Amalio Telenti, University of California San Francisco, CA, USA San Diego, San Diego, CA, USA Richard E. Chaisson, The Johns Hopkins University School of Medicine, Baltimore,
OralSessions MD, USA 6 Deciphering Mucosal Barrier Functionality and HIV Immunity by Mass 3 Key Considerations in Studies of Spectrometry Antiviral Pharmacokinetics and Adam Burgener, Univ of Manitoba, Winnipeg, Pharmacodynamics MB, Canada Jennifer Kiser, Univ of Colorado, Denver, CO, USA 7 Drop-Based Microfluidics for Single-Cell 4 Using Big Data to Improve the HIV Care Studies and Prevention Continuum David A. Weitz, Harvard Univ, Boston, MA, USA Patrick Sullivan, Emory Univ, Atlanta, GA, USA 8 Integration of Systems Biology with 5 HIV Transmission Networks and HIV Tissue Engineering and Organs-On- Prevention in the Era of TasP and PrEP Chips Martina Morris, Univ of Washington, Seattle, Linda Griffith, Massachusetts Inst of Tech, WA, USA Boston, MA, USA
22 CROI 2016 Monday, February 22, 2016 • Oral Sessions 23 CROI 2016 Auditorium Program Agenda and , Yale University School of Med, School Med, of University Yale , , Ragon Inst of MGH, MIT, and MIT, MGH, of Inst Ragon , , Kenneth Cole Productions, Inc, and Inc, Productions, Cole Kenneth , Center, Seattle,Center, WA, USA University of California Los Angeles, Angeles, Los California of University Los Angeles, CA, USA Fred Hutchinson Cancer Research Health, San Francisco, CA, USA David Geffen School of Medicine at CME
Chairman of the Board of amfAR of Board the of Chairman Harvard, Cambridge, MA, USA MA, Cambridge, Harvard, Bronx, the From TB and HIV Confronting South Africa Ferry, Tugela to NY, Friedland H. Gerald USA CT, Haven, New Style With AIDS Fighting Cole Kenneth T Cell Control of HIV: Implications for Implications for HIV: of Control Cell T Cure and Vaccines Walker Bruce D.
14 Special Event Foundation CROI honor will that segment programming unique A missed. be not should It surprise. and inform, achievement, Bernard Fields Lecture Fields Bernard TheBernard Fields Lecture, named in tribute tothe exemplary work of theesteemed microbiologist and virologistBernard Fields, is given during theOpening Session, usuallyby a basicscientist recognized for his or her important andrelevant contributionsto the pathogenesis. viral fields virology and of 13 Lecture N’Galy-Mann TheN’Galy-Mann Lecture recognizes researcher an HIV/AIDS for his or her important and relevantwork in the fields of epidemiology or clinical research. The Lecture is named in honor of Drs Bosenge N’Galy and Jonathan Mannfor their crucial, pioneering workin HIV science in Africa. SessionOS PM-7:005:00 PM OpeningSession Hosts Session Opening JulieM. Overbaugh, JudithS. Currier, CROIVice 2016 Chair CROIChair 2016 San FranciscoBuchbinder DepartmentP. Susan of Public CROIVice 2016 Chair
Room Room 304/306 , Johns Hopkins Univ, Univ, Hopkins Johns , , Univ of California San California of Univ , CME , Columbia Univ, New York, York, New Univ, Columbia , , Sorbonne Univs, Paris, France Paris, Univs, Sorbonne ,
It is assumed that participantsassumed that is It familiar are Thissession is directed to persons interested in Duke University School School University Duke University of California California of University At completionAt of the session, participantswill be NY, USA NY, Falade-Nwulia Oluwaseun USA MD, Baltimore, Elizabeth Elizabeth Verna C. HCVof Infection at Groups in Treatment Reinfection RiskHigh for KarineLaCombe and Before HCVTreatment Infection Transplant After Liver Treatment for Cirrhotic HCV for Genotype Treatment Prior With 3-InfectedPatients Failure Treatment Treatment for HCV for Genotype 1-Infected Treatment HIV/HCV With Coinfection Patients Luetkemeyer F. Anne CA, USA San Francisco, Francisco, Describe the diagnosis and staging of patients withHCV infection Describe the effective treatment ofHCV infection according to HCVgenotype andstate ofliver disease Recognize how treatment differs for persons withcirrhosis
• • •
12 11 10 9 San Diego, SanDiego, CA, USA Susanna Naggie, Susanna USA NC, Durham, Medicine, of DavidL. Wyles, 2:15 PM-4:002:15 PM C Hepatitis on Case-Based Interactive Workshop audience: Target themanagement of hepatitisC virus (HCV) infection. knowledge: of Level SessionWorkshop W4 with the generalprinciples ofHCV treatment and the medications used. Objectives: able to: Conveners Program and Agenda
10:45 20 The Sooty Mangabey Genome Sequence Reveals TUESDAY, FEBRUARY 23, 2016 New Insights in Natural SIV Infections David J. Palesch1; Steven E. Bosinger1; Gregory Tharp2; Yue Tuesday Plenary Session CME Auditorium Liu3; Muthuswamy Raveendran3; Donna Muzny3; Richard 8:30 AM-9:30 AM Gibbs3; Kim C. Worley3; Jeffrey Rogers3; Guido Silvestri1 8:30 15 Harnessing Antibodies for HIV-1 1Yerkes Natl Primate Rsr Cntr, Emory Univ, Atlanta, GA, USA; 2 3 Prevention and Treatment Emory Univ, Atlanta, GA, USA; Baylor Coll of Med, Houston, TX, USA John R. Mascola, Vaccine Research Center, National Institute of Allergy and Infectious 11:00 21 Hyperacute Microbial Translocation During Diseases, National Institutes of Health, Pathogenic SIV Infection Bethesda, MD, USA Adam J. Ericsen1; Michael Lauck1; Mariel S. Mohns1; Sarah R. 9:00 16 Antiretroviral Therapy: Where Are DiNapoli2; James P. Mutschler1; Justin M. Greene3; Benjamin 3 3 1 We Now? Where Are We Going? J. Burwitz ; Jonah B. Sacha ; Thomas C. Friedrich ; Jason M. Brenchley4; David H. O'Connor1 Joseph J. Eron, Jr., University of North 1Univ of Wisconsin-Madison, Madison, WI, USA; 2NIH, Bethesda, Carolina at Chapel Hill, Chapel Hill, NC, USA MD, USA; 3Oregon Hlth & Sci Univ, Beaverton, OR, USA; 4Frederick Natl Lab for Cancer Rsr, Frederick, MD, USA Session O-1 Oral Abstracts Room 302 11:15 22 CD8 T Cells Are Required to Suppress Viremia in 10:00 AM-12:00 PM SIV-Infected ART Treated Macaques Emily K. Cartwright1; Thomas H. Vanderford2; Kirk A. Easley3; SIV and HIV Pathogenesis Joern E. Schmitz4; Ann Chahroudi5; Steven E. Bosinger2; Mirko Oral Abstract Moderators Paiardini2; Jacob D. Estes6; Guido Silvestri2 Netanya S. Utay, University of Texas Medical Branch at Galveston, 1Emory Univ, Atlanta, GA, USA; 2Yerkes Natl Primate Rsr Cntr, Galveston, TX, USA Emory Univ, Atlanta, GA, USA; 3Emory Univ Rollins Sch of PH, 4 James B. Whitney, Beth Israel Deaconess Medical Center, Harvard, Atlanta, GA, USA; Beth Israel Deaconess Med Cntr, Harvard Med 5 • Tuesday, February 23, 2016 23, February Tuesday, • Boston, MA, USA Sch, Boston, MA, USA; Emory Univ Sch of Med, Atlanta, GA, USA; 6Frederick Natl Lab, Leidos Biomed Rsr, Frederick, MD, USA 10:00 17 Rare Host Genetic Variation Influencing Risk of Heterosexual HIV-1 Acquisition 11:30 23 Lack of CTL Attenuates, but Does Not Ablate Romel D. Mackelprang1; Mary Emond1; Michael J. Bamshad1; Compartmentalization of SIV Replication 1 1 2 3 Xuanlin Hou1; Jessica Chong1; Kati Buckingham1; Nelly Joy M. Folkvord ; Melissa Thomas ; Eva Rakasz ; Shengbin Li ;
OralSessions 3 4 R. Mugo2; Jared M. Baeten1; Connie M. Celum1; Jairam R. Pamela Skinner ; Elizabeth Connick 1 Lingappa1; for the Partners in Prevention HSV/HIV Transmission Univ of Colorado Anschutz Med Campus, Aurora, CO, USA; 2 3 and Partners PrEP Studies Wisconsin Natl Primate Rsr Cntr, Madison, WI, USA; Univ of 4 1Univ of Washington, Seattle, WA, USA; 2Kenya Med Rsr Inst, Minnesota, Minneapolis, MN, USA; Univ of Colorado, Denver, CO, Thika, Kenya USA 10:15 18LB HIV-1 Laboratory Contagion During 11:45 24 Sooty Mangabey CD4+ T Cells Express the Recombination Procedures With Defective SIVsmm Coreceptor CXCR6 Constructs Katherine Wetzel1; Emily Roberts1; Yanjie Yi1; Michael R. 1 2 2 1 1 2 1 Betts ; Guido Silvestri ; Mirko Paiardini ; Ronald Collman Claudia Alteri ; Alessandro Soria ; Ada Bertoli ; Alessandra 1 2 Bandera3; Gabriella Scarlatti4; Monica Tolazzi4; Emanuela Univ of Pennsylvania, Philadelphia, PA, USA; Yerkes Natl Balestra1; Andrea Gori3; Francesca Ceccherini-Silberstein1; Carlo Primate Rsr Cntr, Emory Univ, Atlanta, GA, USA Federico Perno5 1Univ of Rome Tor Vergata, Rome, Italy; 2San Gerardo Hosp, Monza, Italy; 3San Gerardo General Hosp, Monza, Italy; 4San Raffaele Scientific Inst, Milan, Italy; 5Univ of Rome Tor Vergata, Roma, Italy 10:30 19 Identification of a Highly Functional DC Subset in Controllers by Single-Cell RNA-Seq Enrique Martin-Gayo1; Michael Cole2; Kellie E. Kolb3; Zhengyu Ouyang1; Sam W. Kazer3; Bruce D. Walker1; Nir Yosef2; Alex K. Shalek1; Xu G. Yu1 1Ragon Inst of MGH,MIT and Harvard, Cambridge, MA, USA; 2Electrical Engineering & Computer Sch, Berkeley, CA, USA; 3MIT Inst for Med Engineering & Sci (IMES), Cambridge, MA, USA
24 CROI 2016 Tuesday, February 23, 2016 • Oral Sessions 25 ; 7 ; 4 ; ; 8 3 ; for ; for 1 Harvard Harvard ; 2 3 NIAID, NIAID, 6 ; Barney Orlando Orlando 5 6 ; Ann ; Ann YRG Cntr Cntr YRG 8 6 CROI 2016 ; Sandy 5 Inst for Hlth Rsr Hlth for Inst 2 Harvard Sch PH, of Harvard 2 ; Hans-Jürgen ; Hans-Jürgen ; Tebas Pablo ; Andrew Plummer ; Andrew 2 1 ; Cynthia Brinson ; Cynthia ; Williams Peter 7 3 1 Univ of California California of Univ ; Nagalingeswaran ; Nagalingeswaran Chu Hotel Dieu-Chu Hotel Chu 2 ; Babafemi Taiwo 5 3 2 Program Agenda and Univ of North Carolina at North of Univ Carolina ; Edgar T. Overton T. ; Edgar Janssen, Beerse, Belgium Beerse, Janssen, 7 2 8 Gilead Scis, Inc, Foster City, City, Foster Inc, Scis, Gilead ViiV Hlthcare, Durham, NC, Durham, Hlthcare, ViiV ICH Study Cntr, Hamburg, Hamburg, Cntr, Study ICH 7 6 3 ; John W. Mellors W. ; John 7 ; Edmund Capparelli ; Edmund Univ of Pittsburgh, Pittsburgh, Pittsburgh, Pittsburgh, of Univ
4 8 7 ; Mingjin Yan 6 Feinberg Sch of Med, Northwestern Northwestern Sch Med, of Feinberg 3 ; Francois Raffi ; Francois Central Texas Clinical Rsr, Austin, Austin, Rsr, Clinical Texas Central ; Peter S. Kim ; Peter 2 ; James A. Hoxie 4 ; Yazdan Yazdanpanah ; Yazdan 2 7 4 VRC, NIAID, NIH, Bethesda, MD, USA Bethesda, MD, NIH, VRC, NIAID, 7 BAR SA and Lancet Lab, Johannesburg, Johannesburg, Lab, Lancet and BAR SA 4 ; Kimberley Y. Smith Y. ; Kimberley ; Linda J. Harrison ; Linda J. 7 1 ; Juan González-García 1 ; Linda J. Harrison ; Linda J. Univ of Alabama at Birmingham, Birmingham, Birmingham, at Birmingham, Alabama of Univ 1 3 ; Eric Daar ; Eric
1 ; Lu Zheng ; Lu ; Martin S. Rhee 1 ; Michael Messer 4 7 1 ; Mina Hosseinipour DAIDS, NIAID, NIH, Rockville, MD, USA; USA; MD, Rockville, NIH, NIAID, DAIDS, 6 5 ; Edwin DeJesus ; Edwin 5 Univ of North Carolina at Chapel Hill, Chapel Hill, NC, Hill, Chapel Hill, at Chapel North of Univ Carolina ; Joseph J. Eron ; Joseph J. 4 3 Univ of Washington, Seattle, WA, USA WA, Seattle, Washington, of Univ Univ of Alabama School of Medicine, Birmingham, AL, Birmingham, School Medicine, of Alabama of Univ Peter J Ruane MD, Inc, Los Angeles, CA, USA; Angeles, Los Inc, MD, Ruane J Peter ; Richard A. Koup ; Richard 9 4 5 6 ; David Dorey ; David 6
9 Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ INSERM U1137, Paris, France; France; Paris, U1137, INSERM GSK, Canada; ON, Mississauga, 5 5 7 Univ of Pennsylvania, Philadelphia, PA, USA; USA; PA, Philadelphia, Pennsylvania, of Univ ViiV Hlthcare, Research Triangle Park, NC, USA; USA; NC, Park, Triangle Research Hlthcare, ViiV Asociación Civil Impacta Salud y Educación, Lima, Peru; Peru; Lima, ImpactaAsociación Salud Civil Educación, y Southwest Care Cntr, Santa Fe, NM, USA; USA; NM, Santa Fe, Cntr, Care Southwest Andrew Cheng Andrew USA; USA; the AIDS Clinical Trials Group (A5340 team) team) (A5340 Group Trials the AIDS Clinical South Africa; South Africa; PA, USA; USA; PA, Spreen William for AIDS Rsr and Educ, Chennai, India; India; Chennai, Educ, and Rsr AIDS for USA; USA; De Nantes, Nantes, France; France; Nantes, De Nantes, of La Paz Univ Hosp, Madrid, Spain; Madrid, Hosp, Univ Paz La of Chapel Hill, Chapel Hill, NC, USA; USA; NC, Hill, Chapel Hill, Chapel ACTG 5340:The Effect of VRC01 on Viral Kinetics Viral on VRC01 Effect 5340:The of ACTG AL, USA; Cabotegravir+Rilpivirine as Long-Actingas Cabotegravir+Rilpivirine 1 Interruption Treatment Analytic After Bar KatharineJ. 1 ACTG 5273 Randomized Trial of Second-Lineof ART Trial Randomized 5273 ACTG Results 32 Week LATTE-2 Therapy: Maintenance Margolis A. David Switching Tenofovir DF to Tenofovir Alafenamide Alafenamide Tenofovir to DF Tenofovir Switching SupportsWHO Guidance AlbertoLaM. Rosa 1 in VirologicallySuppressed Adults in Gallant E. Joel 1 TX, USA; Griffith Collier Los Angeles Med Cntr, Torrance, CA, USA; Torrance, Cntr, Angeles Med Los Peter Ruane Peter Boston, MA, USA; USA; MA, Boston, Immunology Cntr, Orlando, FL, USA; FL, USA; Orlando, Cntr, Immunology Mark Bardsley CA, USA Sch of PH, Boston, MA, USA; USA; MA, Sch Boston, PH, of Univ, Chicago, IL, USA; IL, USA; Chicago, Univ, Graham Stellbrink Carole Carole Wallis L. Kumarasamy NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, Germany; Germany; USA; USA;
32LB 31LB
29 30
11:45 11:30 11:00 11:15 ; 2 ; ; ; ; 1 2 4 2 Johns Johns 6
3 Miller 2 ; Stephen ; Stephen 5 ; Cynthia ; Cynthia ; Sara 1 1 ; Justin Ritz ; Ian Sanne; Ian 2 2 Univ of Texas Texas of Univ 7 ; Moupali Das ; Moupali DAIDS, NIAID, NIAID, DAIDS, Ballroom B/C Ballroom 3 5 ; for the ACTG the ACTG ; for 8 ; Allan Rodriguez ; Allan 7 ; Lars Østergaard ; Lars 2 Columbia Univ Univ Columbia Univ of Pittsburgh, Pittsburgh, of Univ 3 8 Natl Inst on Drug Abuse, Abuse, Drug on Inst Natl 8 Ole S. SøgaardS. Ole Bionor Pharma, Oslo, Oslo, Pharma, Bionor ; NIH, Bethesda, MD, Bethesda, MD, NIH, 2 3 3 Gilead Scis, Inc, Foster City, City, Foster Inc, Scis, Gilead 4 ; Given Malete ; Given ; Ronald Bosch ; Matthew P. Fox P. ; Matthew 2 1 2 ; Randall L. Tressler ; Randall L. Univ of the Witwatersrand, Wits Wits Witwatersrand, the of Univ ; Mamta Jain ; Mamta 4 2 6 ; Lauren Gooden ; Lauren
2 9 ; John W. Mellors W. ; John ; Mariane Schleimann; Mariane 7 1 ; Maja Sommerfelt Emory Univ Sch of Med, Atlanta, GA, Atlanta, Emory Sch Med, Univ of Bristol-Myers Squibb, Wallingford, CT, CT, Wallingford, Squibb, Bristol-Myers 2 9 6 ; Martin Tolstrup ; Cynthia Gay ; Cynthia 1 1 ; Carey Hwang ; Carey
; Mhairi Maskew 3
1 2 ; Maxine Stitzer 5 ; Carlos del Rio del ; Carlos ; Daniel Feaster 8 1 ; Jesper Højen 1 ; Richard A. Koup ; Richard 6 Aarhus Univ Hosp, Aarhus Nord, Denmark Nord, Aarhus Hosp, Univ Aarhus San Francisco Dept of PH, San Francisco, CA, USA; Dept San PH, of Francisco, San Francisco 3 5 ; Alejandra Mørk ; Alejandra 1 ; Constance Mongwenyana ; Constance University Hospital Geneva, University of Geneva, Geneva, of University Geneva, Hospital University Bristol-Myers Squibb, Princeton, NJ, USA; USA; NJ, Princeton, Squibb, Bristol-Myers USA; Bethesda, MD, NIH, VRC, NIAID, 2 4 7 Johns Hopkins University School of Medicine, Baltimore, Baltimore, Medicine, of School University Hopkins Johns Boston Univ, Boston, MA, USA; USA; MA, Boston, Univ, Boston Columbia Univ Mailman Sch of PH, New York, NY, USA; USA; NY, York, New Sch PH, of Mailman Univ Columbia Aarhus Univ Hosp, Aarhus, Denmark; Aarhus, Hosp, Univ Aarhus Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; USA; NC, Hill, Chapel Hill, at Chapel North of Univ Carolina USA; MA, Boston, Sch PH, of Harvard W. Mason W. A5326 Team Study Mailman Sch of PH, Miami, FL, USA; FL, Miami, USA; Sch PH, of Mailman Nyoni Raul Mandler Hopkins Bayview Med Cntr, Baltimore, MD, USA; USA; MD, Baltimore, BayviewHopkins Cntr, Med Pittsburgh, PA, USA PA, Pittsburgh, Hlth Consortium, Johannesburg, South Africa Johannesburg, Consortium, Hlth Tim Matheson Tim Steffen Steffen Leth NIH, Rockville, MD, USA; USA; MD, Rockville, NIH, Initiating ART at a Patient's First Clinic Visit: The The Visit: Clinic First Patient's a at ART Initiating A Patient Navigation/Contingency Management Navigation/Contingency Patient A EffectVacc-4x/GM-CSFSequentialof Safety, Immunologic and Virologic Activity Virologic of and Immunologic Safety, 1 1 Immunization and Romidepsin on the HIVthe on Romidepsin and Immunization Reservoir 1 Joseph J. Eron, Jr. Eron, J. Joseph 1 2 Anti-PD-L1Participants ART on HIV-1 in RapIT Trial Randomized Rosen Sydney RCTSubstanceHIV+ Users Hospitalized for Metsch Lisa Sch of Med, Univ of Miami, Miami, FL, USA; FL, USA; Miami, Miami, of Univ Sch Med, of CA, USA; Norway; Norway; NIH, Rockville, MD, USA; USA; MD, Rockville, NIH, Nissen USA USA; USA; Southwestern Med Cntr, Dallas, TX, Dallas, USA; Cntr, Med Southwestern Jason M. Hataye Thomas Rasmussen Thomas USA; USA; Lawrence Long Lawrence
28 27 26LB 25
10:15 10:00 Alexandra L. Calmy, L. Alexandra Switzerland Geneva, Durand, Christine MD, USA 10:00 AM-12:0010:00 PM Randomized Therapy Reservoirs/Antiretroviral Viral ClinicalTrials Moderators Abstract Oral SessionO-2 Oral Abstracts 10:45 10:30 Program and Agenda
Session O-3 Oral Abstracts Room 304/306 11:00 37 Similar Mortality With Cotrimoxazole vs Placebo 10:00 AM-12:00 PM in HIV-Exposed Uninfected Children Prevention and Treatment of Pediatric HIV Infections Roger L. Shapiro1; Michael Hughes1; Kathleen Powis2; Gbolahan Ajibola3; Kara Bennett4; Sikhulile Moyo3; Joseph Oral Abstract Moderators Makhema3; Sheryl Zwerski5; M. Essex1; Shahin Lockman6 Jason Brophy, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada 1Harvard Sch of PH, Boston, MA, USA; 2Massachusetts General Karin Nielsen-Saines, University of California Los Angeles, Los Angeles, CA, Hosp, Boston, MA, USA; 3Botswana Harvard AIDS Inst Partnership, USA Gaborone, Botswana; 4Bennett Statistical Consulting, Inc., 5 6 10:00 33 Breast Milk and In Utero HIV-1 Transmission Ballston Lake, NY, USA; NIH, Bethesda, MD, USA; Brigham and Select for Unique Envelope Signatures Women’s Hosp, Harvard Med Sch, Boston, MA, USA Thomas A. Wilkinson1; Kyle J. Nakamura1; Laura M. Heath2; 11:15 38 Urgent Versus Post-Stabilization ART in Katherine Semrau3; Chipepo Kankasa4; Nicholas E. Webb5; Hospitalized Children: A Randomized Trial Benhur Lee5; Louise Kuhn6; James I. Mullins2; Grace M. Irene N. Njuguna1; Lisa M. Cranmer2; Vincent O. Otieno1; Aldrovandi1 Helen M. Okinyi1; Sarah Benki-Nugent3; Joshua Stern3; Ken 1Children's Hosp of Los Angeles, Los Angeles, CA, USA; 2Univ of Tapia3; Elizabeth Maleche-Obimbo1; Dalton Wamalwa1; Grace C. Washington, Seattle, WA, USA; 3Boston Univ Sch of PH, Boston, John-Stewart3 MA, USA; 4Univ Teaching Hosp, Lusaka, Zambia; 5Univ of 1Univ of Nairobi, Nairobi, Kenya; 2Emory Univ Sch of Med, Atlanta, California Los Angeles, Los Angeles, CA, USA; 6Columbia Univ, New GA, USA; 3Univ of Washington, Seattle, WA, USA York, NY, USA 11:30 39 Three-Year Outcomes in PMTCT-Exposed Children 10:15 34 Impact of Option B+ on ART Uptake and Switched to EFV Once Suppressed on LPVr Retention in Swaziland: A Stepped-Wedge Trial Pamela Murnane1; Renate Strehlau2; Stephanie Shiau3; Sarah Elaine J. Abrams1; Nontokozo Langwenya2; Averie Gachuhi3; Ramteke4; Faeezah Patel2; Elaine J. Abrams5; Ashraf Coovadia2; Allison Zerbe3; Thabo Hlophe4; Simangele Mthethwa-Hleta5; Louise Kuhn4; for the NEVEREST III Study Team Harriet Nuwagaba-Biribonwoha4; Ruben Sahabo4; Velephi 1Columbia Univ, Johannesburg, South Africa; 2Univ of the Okello5; Landon Myer2 Witwatersrand, Johannesburg, South Africa; 3Columbia Univ 1 4 • Tuesday, February 23, 2016 23, February Tuesday, • ICAP, Columbia Univ Mailman Sch of PH, New York, NY, USA; Med Cntr, New York, NY, USA; Columbia Univ, New York, NY, USA; 2Univ of Cape Town, Cape Town, South Africa; 3ICAP at Columbia 5ICAP, Columbia Univ Mailman Sch of PH, New York, NY, USA Univ, New York, NY, USA; 4ICAP at Columbia Univ, Mbabane, Swaziland; 5Ministry of Hlth, Mbabane, Swaziland 11:45 40 Efavirenz Is Associated With Higher Bone Mass in South African Children With HIV 10:30 35LB National HIV Transmission in 4-12 Week Olds in Stephen M. Arpadi1; Stephanie Shiau1; Renate Strehlau2;
OralSessions Malawi’s PMTCT Option B+ Program Faeezah Patel2; Louise Kuhn3; Ashraf Coovadia2; Don McMahon1; Beth Tippett Barr1; Erik Schouten2; Joep van Oosterhout3; Jonathan J. Kaufman4; Michael T. Yin1; for the CHANGES Bone Sundeep K. Gupta4; Happy Phiri2; Deus Thindwa2; Christopher Study Team Blair2; Andreas Jahn5; Monique von Lettow6; for the NEMAPP 1Columbia Univ Med Cntr, New York, NY, USA; 2Univ of the Consortium Witwatersrand, Johannesburg, South Africa; 3Columbia Univ, New 1CDC, Harare, Zimbabwe; 2Management Sciences for Hlth, York, NY, USA; 4Mount Sinai Sch of Med, New York, NY, USA Lilongwe, Malawi; 3Dignitas Intl, Zomba, Malawi; 4CDC, 5 6 Lilongwe, Malawi; Ministry of Hlth, Lilongwe, Malawi; Dignitas Session O-4 Oral Abstracts Auditorium International, Lilongwe, Malawi 10:00 AM-12:00 PM 10:45 36 Impact of Maternal Tenofovir Use on HIV-Exposed Complications from Head to Toe Newborn Bone Mineral Oral Abstract Moderators George K. Siberry1; Camlin Tierney2; Lynda Stranix-Chibanda3; Caroline Marr2; John A. Shepherd4; Renee Browning5; Heidi J. Kristine M. Erlandson, University of Colorado, Denver, CO, US Kalkwarf6; Kathleen George7; Mary G. Fowler8; for the IMPAACT Chris T. Longenecker, Case Western Reserve University, Cleveland, OH, US P1084s Study Team 1 2 Eunice Kennedy Shriver NICHD, Bethesda, MD, USA; Harvard Sch 10:00 41 Early Antiretroviral Therapy Does Not Improve of PH, Boston, MA, USA; 3Univ of Zimbabwe, Harare, Zimbabwe; 4 5 Vascular Function: A START Substudy Univ of California San Francisco, San Francisco, CA, USA; NIAID, 1 2 6 Jason V. Baker ; Katherine Huppler Hullsiek ; Nicole Wyman NIH, Rockville, MD, USA; Cincinnati Children's Hosp Med Cntr, 2 2 Cincinnati, OH, USA; 7IMPAACT Operations, Durham, NC, USA; Engen ; Daniel Duprez ; for the INSIGHT START (Strategic Timing 8Johns Hopkins Univ Sch of Med, Baltimore, MD, USA of AntiRetroviral Treatment) Arterial Elasticity Substudy Team 1Hennepin County Med Cntr, Univ of Minnesota, Minneapolis, MN, USA; 2Univ of Minnesota, Minneapolis, MN, USA
26 CROI 2016 Tuesday, February 23, 2016 • Oral Sessions 27 ; 1
; 1 1 ; 3 ; 3 ; Fiocruz, Fiocruz, 2 8 ; for the ; for Desmond 1 6 ; Ruanne V. ; Ruanne V. ; Jeffrey L. ; Jeffrey ; Linda-Gail CROI 2016 1 1 ; Edwin ; Edwin ; Felix A. ; Felix 5 1 1 Ballroom A Ballroom ; Ellen McRobie ; Ellen ; Victor ; Victor Asila 4 ; David V. ; V. David 2 8 Emory Univ Rollins Emory Rollins Univ ; Vunnava Aswani ; M. N. Weitzmann ; M. N. 2 1 2 San Francisco Dept of San Francisco 3 Kenyatta Natl Hosp, Hosp, Natl Kenyatta Sch Washington of Univ Projeto Praça Onze, Onze, Praça Projeto ; Wamuti Beatrice Program Agenda and 2 2 7 2 ; Carey Farquhar ; Carey 1 ; Vanessa McMahan ; Vanessa 1 ; Cecile D. Lahiri D. ; Cecile Univ of Toronto, Toronto, ON, Toronto, Toronto, of Univ 1 2 Brown Univ, Providence, RI, RI, Providence, Univ, Brown ; Alfred Osoti ; Alfred ; Jeffrey W. Eaton W. ; Jeffrey ; Monisha Sharma 5
2 2 1 1
1 ; Suwat Chariyalertsak ; Suwat Investigaciones Médicas en Salud, Salud, en Médicas Investigaciones ; Sylvester Kimaiyo ; Sylvester 4 4 3 ; Kirk A. Easley ; Kirk ; Valdilea G. Veloso ; Valdilea Kenyatta Natl Hosp, Nairobi, Kenya Nairobi, Hosp, Natl Kenyatta ; Titanji Kehmia 2 7 3 1 ; Matt Dunbar ; Matt 3 ; Kristjana H. Ásbjörnsdóttir 1 ; Mathew R. Golden R. ; Mathew 1 ; John Kinuthia ; Jennifer Mark ; Jennifer ; Anandi N. Sheth N. ; Anandi
1 Univ of Nairobi, Nairobi, Kenya Nairobi, Nairobi, of Univ 3 1 ; Kathleen Mulligan ; Kathleen 3 1 ; Timothy ; Timothy Hallett ; Paula Braitstein ; Paula 5 1 ; Juan Guanira Univ of Chiang Mai, Chiang Mai, Thailand; Thailand; Mai, Chiang Mai, Chiang of Univ 3 5 Carey Farquhar Carey New City York Department of Health and Mental ; 1 Academic Model Providing Access to Hlthcare, Eldoret, Eldoret, Hlthcare, to Access Model Providing Academic ; for the iPrEx study team. study team. the iPrEx ; for 3 ; Andrea Knezevic ; Andrea 1 Moi Univ, Eldoret, Kenya; Kenya; Eldoret, Univ, Moi ; Mauro Schechter ; Mauro ; Betsy Sambai 1 4 6 3 ; Monicah Nyambura 3 Human Sciences Research Council, Durban, South Africa Imperial Coll London, London, UK; UK; London, London, Coll Imperial Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ USA; WA, Seattle, Washington, of Univ Emory Univ Sch of Med, Atlanta, GA, USA; Atlanta, Emory Sch Med, Univ of Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ CA, USA; San Francisco, Insts, Gladstone Otieno Albert Y. Liu Albert Y. South Africa; Town, Cape Cntr, HIV Tutu Canada; Canada; Barbra A. Richardson Bekker Nairobi, Kenya; Kenya; Nairobi, USA; WA, Seattle, Med, of Lima, Peru; Peru; Lima, Daisy Krakowiak Optimal Timing of Home-Based HIV Testing in Testing TimingHome-Basedof OptimalHIV Effectiveness of Partnerof Services Effectiveness inHIV for Western Kenya Western Olney J. Jack 1 Recovery of Bone Mineral Density After Stopping DensityMineral After Bone of Recovery Clinic vs Testing HIV Male Partner Home 1 Trial Randomized Cluster A Kenya: Cherutich Peter 1 Kenya; Kenya; Oral HIV Preexposure Prophylaxis OralPreexposure HIV Robert Grant Trial Pregnancy:in Randomized A Invitation A Single Dose Zoledronic Acid Prevents Prevents Acid SingleA Zoledronic Dose 1 Sang 1 2 Brazil Rio Janeiro, de Antiretroviral-Induced Bone Loss Bone Antiretroviral-Induced Ighovwerha Ofotokun USA Sch of PH, Atlanta, GA, USA Sch Atlanta, PH, of Lennox Joseph Hogan aPS Study Group Group Study aPS Molly Ann GoneMolly Ann PH, San Francisco, CA, USA; SanPH, Francisco, Universidade Fed do Rio de Janeiro, Rio de Janeiro, Brazil; Brazil; Rio Janeiro, de Rio do Janeiro, de Fed Universidade Barnabas Antonina Foster Antonina Glidden
50 51 49 48LB
47
10:15 10:30 Hygiene, Queens, USA NY, Rooyen, van Heidi SessionO-5 Oral Abstracts AM-12:0010:00 PM We Linkageand Are Care: to Testing for Strategies ClosingGap?the Moderators Abstract Oral Daskalakis, C. Demetre 10:00 11:45 11:30 ;
9 1 ; Univ Univ 3 5 ; Jean- Harvard Harvard Univ Univ 3 2 ; Tomazic ; Tomazic 5 6 ; Karin Harvard Harvard ; Abdel ; Abdel 3 2 ; Daniel 6 ; Jeffrey S. ; Jeffrey Univ Coll Coll Univ 2 6 2 ; Dalibor ; Ron Ellis 3 2 Vilnius Univ Hosp Hosp Univ Vilnius 6 ; Mari Kitahata 5 Hosp del Mar del Hosp Ohio State Univ, Univ, Ohio State ; Matthew J. J. ; Matthew 5 6 ; Jens D. Lundgren ; Jens D. 1 8 ; for the NEAT 001/ the NEAT ; for ; Wallet Cedrick Univ of Washington Sch Washington of Univ 1 2 Univ Med Cntr Ljubljana, Cntr Med Univ 2 7 ; Peter W. Hunt W. ; Peter 2 ; for the ACTG A5331 Study A5331 Study the ACTG ; for Inst of Trop Med Antwerp, Antwerp, Med Trop of Inst ; Jacques Reynes ; Jacques 1 3 ; Vilma ; Vilma Uzdaviniene 5 ; Wu Kunling ; Eric Florence ; Eric 5
1 2 4 ; Joseph A. Delaney 1 Univ Hosp Montpellier, Montpellier, Montpellier, Montpellier, Hosp Univ 6 Univ of California San Francisco, San Francisco, California of Univ Univ of California San Diego, San San Diego, California of Univ 3 3 ; Nicholas T. Funderburg T. ; Nicholas ; MichaelSaag S. 5 4 Northwestern Univ, Feinberg Sch of Med, Sch Med, of Feinberg Univ, Northwestern ; Rebekah Young 3 ; Jose R. Arribas NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, NIAID, 1 7 4 ; Douglas Kitch INSERM U897, Univ de Bordeaux, Bordeaux, Bordeaux, Bordeaux, de Univ U897, INSERM ; Amanda Mocroft ; Amanda 1 ; Judith Aberg 3 New York Univ School of Med, New York, NY, NY, York, New School Med, Univ of York New General Hosp of Athens "G. Gennimatas", Gennimatas", "G. Athens of Hosp General 1 8 7 8 Charles Univ Hosp Plzen, Plzen, Czech Czech Plzen, Plzen, Hosp Univ Charles ; Jennifer Hoy ; Jennifer 4 1 ; for the for EuroSIDA in EuroCOORD in EuroCOORD EuroSIDA the for ; for Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns ; Robin Nance 10 4 1 RigsHospet, Univ of Copenhagen, Copenhagen, Copenhagen, Copenhagen, of Univ RigsHospet, Boston Univ Sch of Med, Boston, MA, USA MA, Boston, Sch Med, Univ of Boston 9 4 ; Hernando Knobell ; Hernando ; Michael R. Wilson ; Michael R. ; Benjamin P. Linas ; Benjamin P. 4 1 2 Univ Coll London, London, UK London, London, Coll Univ ; James H. Stein ICH Study Cntr, Hamburg, Germany; Germany; Hamburg, Cntr, Study ICH 10 ; Richard Moore ; Richard 4 ; Hans-Jürgen Stellbrink ; Hans-Jürgen 5 3 4 ; François Raffi ; François Hopital Saint-Louis, Paris, France; France; Paris, Saint-Louis, Hopital France Nantes, Nantes, Hosp Univ 2 4 7 ; Tebas Pablo 7 ; Susan Heckbert ; Panagiotis Gargalianos-Kakolyris ; Panagiotis Univ of Pennsylvania, Philadelphia, PA, USA PA, Philadelphia, Pennsylvania, of Univ 1 7 8 CHIP, RigsHospet, Univ of Copenhagen, Copenhagen, Denmark; Copenhagen, Copenhagen, of Univ RigsHospet, CHIP, Australia; Melbourne, Hosp, Alfred Inst for Hlth Rsr of La Paz Univ Hosp, Madrid, Spain; Madrid, Hosp, Univ Paz La of Rsr Hlth for Inst Icahn Sch of Med at Mount Sinai, New York, NY, USA; USA; NY, York, at Sinai, New Sch Med Mount of Icahn Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ Amanda Mocroft Amanda of Alabama at Birmingham, Birmingham, AL, USA Birmingham, at Birmingham, Alabama of Chicago, IL, USA; IL, USA; Chicago, Athens, Greece; Greece; Athens, Feinstein Columbus, OH, USA; USA; OH, Columbus, Santariskiu Klinikos, Vilnius, Lithuania; Lithuania; Vilnius, Santariskiu Klinikos, France; France; Belgium; Antwerp, Babiker group ANRS 143 Study France; Team Michel Molina of PH, Seattle, WA, USA; USA; WA, Seattle, PH, of Sedlacek USA; USA; Antiretrovirals, Fractures, and Osteonecrosis in ain Osteonecrosis and Fractures, Antiretrovirals, Body Composition Changes Either+ BodyDRV/r on Composition Stroke Incidence Highest in Women and Black and Women in Highest Incidence Stroke 1 2 Aspirin Fails to Impact to or Activation Immune AspirinFails Comparing Cardiovascular Disease Risk Scores Cardiovascular for Comparing Large European HIV CohortHIV LargeEuropean Borges H. Alvaro Jose I. Bernardino I. Jose 1 1 ART As First-Line TDF/FTC or RAL 1 HIV Treated FunctionEndothelial in K.Meagan O’Brien Klingman 1 Cohort Participants ALLRT HIV-Infected in Chow Felicia Use in HIV-Infected Individuals HIV-Infected in Use CraneM. Heidi Ronald Bosch of Wisconsin-Madison, Madison, WI, USA; USA; WI, Madison, Wisconsin-Madison, of Republic; Republic; Denmark; Berger Janez Ljubljana, Slovenia; Ljubljana, Slovenia; London, London, UK; UK; London, London, San Francisco, CA, USA; San Francisco, Diego, CA, USA; Diego, Drozd Barcelona, Barcelona, Spain; Spain; Barcelona, Barcelona, Sch of PH, Boston, MA, USA; USA; MA, Sch Boston, PH, of Sch of PH, Boston, MA, USA; USA; MA, Sch Boston, PH, of
46 45 43 44LB 42
11:15 11:00 10:45 10:30 10:15 Program and Agenda
10:45 52 Estimating the Lifetime Risk of a Diagnosis of HIV 440 Nevirapine Dosing for Treatment in the First Month Infection in the United States of Life Kristen Hess; Xiaohong Hu; Amy Lansky; Jonathan Mermin; H. Mark Mirochnick1; Karin Nielsen-Saines2; Jose H. Pilotto3; Philippa Irene Hall Musoke4; Avinash Shetty5; Katherine Luzuriaga6; Edmund Capparelli7 CDC, Atlanta, GA, USA 1Boston Univ Sch of Med, Boston, MA, USA; 2Univ of California Los 3 11:00 53 Increased HIV Viral Suppression Among US Adults Angeles, Los Angeles, CA, USA; Hosp Geral de Nova Iguaçu, Rio de Janeiro, Brazil; 4Makerere Univ, Kampala, Uganda; 5Wake Forest Univ, Receiving Medical Care, 2009-2013 Winston Salem, NC, USA; 6Univ of Massachusetts Med Sch, Worcester, Heather Bradley; Christine Mattson; Linda Beer; Ping Huang; MA, USA; 7Univ of California San Diego, San Diego, CA, USA Roy L. Shouse CDC, Atlanta, GA, USA 441 Prediction of Infant Exposure to Maternal Drugs From Breast Milk Using PBPK Modeling 11:15 54 Narrowing the Gap in Life Expectancy for HIV+ Adeniyi Olagunju1; Rajith Kumar Reddy Rajoli1; Oluseye Bolaji2; David Compared With HIV- Individuals J. Back1; Saye Khoo1; Andrew Owen1; Marco Siccardi1 1 2 1 2 Julia L. Marcus ; Chun Chao ; Wendy Leyden ; Lanfang Xu ; 1Univ of Liverpool, Liverpool, UK; 2Obafemi Awolowo Univ, Ile-Ife, Nigeria Charles P. Quesenberry1; Daniel B. Klein3; William J. Towner2; Michael A. Horberg4; Michael J. Silverberg1 442 Predicting Utility of Long-Acting Injectables in 1Kaiser Permanente Northern California, Oakland, CA, USA; Paediatric Patients With PBPK Models 2Kaiser Permanente Southern California, Pasadena, CA, USA; Rajith Kumar Reddy Rajoli; David Back; Steve Rannard; Andrew 3Kaiser Permanente San Leandro Med Cntr, San Leandro, CA, USA; Owen; Marco Siccardi 4Mid-Atlantic Permanente Med Group, Rockville, MD, USA Univ of Liverpool, Liverpool, UK 11:30 55 Perception of Infectiousness in HIV-Infected Persons After Initiating ART: ACTG A5257 Session TD-2 Themed Discussion Room 312 Raphael J. Landovitz1; Thuy T. Tran2; Susan E. Cohn3; 1:45 PM-2:45 PM Ighovwerha Ofotokun4; George A. Bishopric5; Jeffrey L. Lennox4; Global Burden and Mortality of Cancer in HIV 1 2 Judith S. Currier ; Heather J. Ribaudo Themed Discussion Leader 1David Geffen Sch of Med at Univ of California Los Angeles, • Tuesday, February 23, 2016 23, February Tuesday, • William A. Blattner, Institute of Human Virology, Baltimore, MD, USA Los Angeles, CA, USA; 2Harvard Sch of PH, Boston, MA, USA; 3Northwestern Univ, Chicago, IL, USA; 4Emory Univ Sch of Med, 616 Excess Mortality Rates Among HIV-Infected Cancer Atlanta, GA, USA; 5Univ of Miami, Miami, FL, USA Patients in the United States Anna Coghill; Ruth Pfeiffer; Meredith Shiels; Eric Engels Session TD-1 Themed Discussion Room 311 NCI, Rockville, MD, USA OralSessions 1:45 PM-2:45 PM 617 Global Burden of Cervical Cancer in HIV-Positive Clinical Pharmacology: Pregnancy, Pediatrics, and Women on Antiretroviral Therapy Predictions Eliane Rohner1; Lukas Bütikofer2; Mhairi Maskew3; Yi-Ming A. 4 5 6 7 Themed Discussion Leader Chen ; Ruth Friedman ; Gypsyamber D. Souza ; Matthias Egger ; Julia Bohlius1; for the International Epidemiologic Databases to David M. Burger, Radboud University Medical Center, Nijmegen, Netherlands Evaluate AIDS (IeDEA) and the Collaboration of Observational HIV 438 Dolutegravir Pharmacokinetics in HIV-Infected Epidemiological Research in Europe (COHERE) in EuroCoord Pregnant and Postpartum Women 1Inst of Social and Preventive Med, Univ of Bern, Bern, Switzerland; 2 3 Nikki Mulligan1; Brookie M. Best1; Edmund Capparelli1; Alice Stek2; Univ of Bern, Bern, Switzerland; Univ of the Witwatersrand, Wits 4 Emily Barr3; Elizabeth Smith4; Nahida Chakhtoura5; Jiajia Wang6; Hlth Consortium, Johannesburg, South Africa; Kaohsiung Med Univ, 5 Sandra Burchett7; Mark Mirochnick8 Kaohsiung, Taiwan; Inst Nacional de Infectologia Evandro Chagas 6 1Univ of California San Diego, San Diego, CA, USA; 2Univ of Southern (INI), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil; Johns 7 California, Los Angeles, CA, USA; 3Univ of Colorado Anschutz Med Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; Univ Hosp Bern, Campus, Aurora, CO, USA; 4NIAID, NIH, Bethesda, MD, USA; 5Eunice Bern, Switzerland Kennedy Shriver NICHD, Bethesda, MD, USA; 6Harvard Sch of PH, Boston, 613 Risk of Cancer in HIV-Positive Adults on ART in South 7 8 MA, USA; Children's Hosp Boston, Boston, MA, USA; Boston Univ Sch of Africa: A Record Linkage Study Med, Boston, MA, USA Mazvita M. Sengayi1; Adrian Spoerri2; Matthias Egger3; Janet Giddy4; 439 Rilpivirine Female Genital Tract Concentrations in Mhairi Maskew5; Elvira Singh1; Julia Bohlius2; for the International Pregnant and Postpartum Women Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) 1 2 Mark Mirochnick1; Brookie M. Best2; Angela Kashuba3; Craig Sykes3; Natl Cancer Registry, NHLS, Johannesburg, South Africa; Inst of Social 3 Amanda Schauer3; Jiajia Wang4; Alice Stek5; Elizabeth Smith6; Nahida and Preventive Med, Univ of Bern, Bern, Switzerland; Univ Hosp Bern, 4 5 Chakhtoura7; Edmund Capparelli2 Bern, Switzerland; McCord Hosp, Durban, South Africa; Univ of the 1Boston Univ Sch of Med, Boston, MA, USA; 2Univ of California San Diego, Witwatersrand, Wits Hlth Consortium, Johannesburg, South Africa San Diego, CA, USA; 3Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 4Harvard Sch of PH, Boston, MA, USA; 5Univ of Southern California, Los Angeles, CA, USA; 6NIAID, NIH, Bethesda, MD, USA; 7Eunice Kennedy Shriver NICHD, Bethesda, MD, USA
28 CROI 2016 Tuesday, February 23, 2016 • Oral Sessions 29 ; 6 ; 3 ; Olga 2 ; 2 CROI 2016 INSERM INSERM
7 ; Moira ; Moira 1 2 ; Albert Minga 5 Room Room 304/306 ; for the DART the DART ; for 1 ; DenisNash ; David R. ; David ; Deenan Pillay 1 1 3 Univ of Abuja of Univ 4 Program Agenda and Harvard Med Sch, Boston, Sch, Med Boston, Harvard ; Eugene Messou ; Eugene 2 1
Cntr Médical de Suivi de de Médical Cntr 1 6 ; Renaud Becquet 7 ; Peter Nkurunziza ; Peter ; Marcel Zannou ; Marcel 2 4 ; Ruth Goodall 4 CePReF, ACONDA, Abidjan, Côte Côte Abidjan, ACONDA, CePReF, ; Rory Leisegang ; Kathrin Zürcher ; Kathrin 2 Sch of PH, City Univ of New York, New New York, Sch City New of PH, of Univ 1 ; Dickman Gareta 1 2 ; for the IeDEA and MESH Consortia the IeDEA ; for 2
1 London Sch of Hygiene & Trop Med, Med, & Trop Sch Hygiene of London Cntr de Prise en Charge des Personnes Personnes des Charge en Prise de Cntr 2 5 Patients on ART Lost to Follow- to Lost ART on Patients ; Robin Wood 1 ; Juan Burgos-Soto 1 ; Francois Dabis ; Francois 1 ; Deenan Pillay 3 ; Vivian ; Vivian Kwaghue ; Karen Cohen ; Karen
3 Sch of Pop Hlth, Univ of Queensland, Herston, Herston, Queensland, of Univ Hlth, Sch Pop of 1 ; Pontiano Kaleebu ; Pontiano ; Anne Mooser ; Anne 1 3 1 1 ; Kathy Baisley ; Kathy 1 University of Zimbabwe, Harare, Zimbabwe Harare, Zimbabwe, of University Africa Cntr for Hlth and Pop Studies, Mtubatuba, South Mtubatuba, Studies, Pop and Hlth for Cntr Africa 3 ; GaryMaartens ; Margaret Couvillon ; Margaret 2 Africa Cntr for Hlth and Pop Studies, Mtubatuba, South Mtubatuba, Africa Studies, Pop and Hlth for Cntr Africa 2 4 CHU de Treichville, Abidjan, Côte d'Ivoire; d'Ivoire; Côte Abidjan, Treichville, de CHU 3 ; Charles Gilks; Charles 1 Univ Coll London, London, UK; UK; London, London, Coll Univ Med Rsr Council Clinical Trials Unit at Univ Coll London, London, UK; London, London, at Coll Univ Unit Trials Clinical Council Rsr Med AIDS, on Unit Rsr Uganda Inst Rsr Virus Council/Uganda Rsr Med Univ of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of Univ Univ of Bern, Bern, Switzerland; Bern, Switzerland; Bern, of Univ INSERM U897, Bordeaux, France; France; Bordeaux, U897, INSERM MA, USA MA, Australia; Australia; London, UK; UK; London, Aristophane Tanon Aristophane Entebbe, Uganda; Uganda; Entebbe, d'Ivoire; d'Ivoire; Teaching Hosp, Abuja, Nigeria; Abuja, Nigeria; Hosp, Teaching 1 1 2 Second-Line PI-Based on Predicts Adherence Failure SouthRural in ART Africa DamiCollier A. 1 Mortality Suppression Late in Viral on of Rate High Uganda/Zimbabwe in ART First-Line Dolling I. David Spyer 1 PredictsBest Which Methods: Adherence Comparing Outcome? VirologicalResistance and Orrell Catherine 1 Declining Mortalityin Sub-Saharanin up Africa Egger Matthias 6-Year Retention and Immunologicaland ART to Retention Response 6-Year Africa West Gender: IeDEA by ThierryTiendrebeogo Vivant Avec le VIH, CHNU, Cotonou, Benin; Cotonou, CHNU, VIH, le Avec Vivant Bangsberg York, NY, USA NY, York, Virology Group Group Virology Africa Ravindra K. Gupta Ravindra Donneurs de Sang /CNTS/PRIMO-CI, Abidjan, Côte d'Ivoire; d'Ivoire; Côte Donneurs Sang de /CNTS/PRIMO-CI, Abidjan, Nathalie De Rekeneire Nathalie Tymejczyk U897, ISPED, Univ de Bordeaux, Bordeaux, France Bordeaux, Bordeaux, de Univ ISPED, U897,
1030 1027 1029 1021 SessionTD-4 Themed Discussion PM-2:451:45 PM of Shaping Experience: Future the from Learning Sub-Saharanin Therapy Antiretroviral Africa Discussion Leader Themed Mutasa-Apollo, Tsitsi 1015 ; 1 Univ Univ 2 ; Joop E. 3 ; Jean- 1 Univ of Univ 6
NIH, Bethesda, NIH, 4 ; Anuoluwapo ; Anuoluwapo ; Memory ; Lila Poiteau 3 3 ; Thijs J. van de van J. Thijs ; 1 ; Shahin 3 Ballroom Ballroom B/C 3 Academic Academic 2
6 ; Greet J. Boland J. ; Greet Inst of Human Virology, Virology, Human of Inst 3 2 Botswana MinistryBotswana Hlth, of 3 ; Tapela Neo ; Hongmei Mo ; Hongmei 5 ; Heluf Medhin ; Heluf 2 2 ; Stephane Chevaliez ; Stephane
2 2 ; Faydra I. Lieveld ; Faydra Univ Med Cntr Utrecht, Utrecht, Utrecht, Utrecht, Cntr Med Univ 2 ; Shyam Kottilil ; Shyam 3 ; Alexandre Soulier ; Alexandre 5 1
Inst Mondor de Recherche Biomédicale Biomédicale Recherche de Mondor Inst 2 ; GitaSuneja ; Anne M. Wensing M. ; Anne 1 5 ; Anita Kohli ; Anita Gaborone Private Hosp, Gaborone, Botswana; Botswana; Gaborone, Hosp, Private Gaborone 4 4 ; Cynthia K. Ho ; Cynthia ; Sarah Kattakuzhy ; Janke Schinkel ; Janke 1 Gilead Scis, Inc, Foster City, CA, USA; City, Foster Inc, Scis, Gilead 1 1 3
; Mukendi K. Kayembe ; Mukendi 1 4 ; Arne Frantzell; Christos Petropoulos; Wei Huang Wei Petropoulos; Christos Frantzell; ; Arne ; Christophe Rodriguez ; Christophe ; Christophe Hezode ; Christophe 1 Sanquin Blood Supply Fndn, Amsterdam, Netherlands; Netherlands; Amsterdam, Sanquin Blood Supply Fndn, 1 4 ; Alicia Newton; Arne Frantzell; Jennifer Cook; Dongmei Cook; Jennifer Frantzell; Arne Newton; ; Alicia Dignity Hlth, St. Joseph's Hosp, Phoenix, AZ, USA; USA; AZ, Phoenix, Hosp, Joseph's Dignity St. Hlth,
5 1 ; Henry Masur ; Maria Prins 3 3 , North, Florida/South Georgia Veterans Health System, ; Jan T. van der Meer van T. ; Jan 4 Inst of Human Virology, Baltimore, MD, USA; USA; MD, Baltimore, Virology, Human of Inst Cntr of Infectious Diseases and Immunology Amsterdam, Academic Med Academic Amsterdam, Diseases Infectious of Immunology and Cntr PH Service of Amsterdam, Amsterdam, Netherlands; Netherlands; Amsterdam, ServicePH Amsterdam, of INSERM U955, Créteil, France; France; Créteil, U955, INSERM Natl Hlth Lab, Gaborone, Botswana Gaborone, Lab, Hlth Natl Brigham and Women's Hosp, Harvard Med Sch, Boston, MA, USA; USA; MA, Sch, Med Boston, Harvard Hosp, Women's and Brigham Laar Lockman of Utah Sch of Med, Salt Lake City, UT, USA; USA; UT, City, Salt Lake Utahof Sch Med, of Gaborone, Botswana; Botswana; Gaborone, Maryland Med Cntr, Baltimore, MD, USA MD, Baltimore, Maryland Cntr, Med Cntr, Amsterdam, Netherlands Amsterdam, Cntr, Bvochora-Nsingo SYNERGY Trial SYNERGY Eleanor Wilson M. 1 Inhibitor Susceptibility Inhibitor Newton Alicia NIAIDthe From Data Variants: Associated Resistance 5 HCVof 28 Codon at ImpactNS5A Polymorphisms NS5A CA, USA South San BioScis, Francisco, Monogram AstridNewsum M. 1 1 Originthe HCVof HIV- Among Q80K NS3 Tracing InfectedNetherlands the in MSM HCV Across Daclatasvir/Sofosbuvir to Resistance Life GenotypesReal the in Different SlimFourati Wei Huang Wei GenotypicPhenotypicand Characterization Clinicalof HCVDrugNS5A Resistance Whitcomb; M. Jeannette Walworth; M. Charles Volpe; Joseph M. Yang; Petropoulos Christos Reeves; D. Jacqueline CA, USA South San BioScis, Francisco, Monogram 5 ScottDryden-Peterson 1 Cancer Versus Tuberculosis MortalityTuberculosis Among CancerVersus Marion Lavert Osinusi Bethesda, MD, USA; USA; Bethesda, MD, Med Cntr, Amsterdam, Netherlands; Netherlands; Amsterdam, Cntr, Med Arends MD, USA; USA; MD, INSERM U955, Créteil, France Créteil, U955, INSERM Michel Pawlotsky Netherlands; Netherlands; HIV-Infected Individuals in Botswana in Individuals HIV-Infected
580 578 543 577 Gainesville, FL, US Gary P. Wang GaryP. 579 SessionTD-3 Themed Discussion PM-2:451:45 PM HCVAbout Rants RAVS Discussion Leader Themed 615 Program and Agenda
Session TD-5 Themed Discussion Room 302 Session TD-6 Themed Discussion Ballroom A 1:45 PM-2:45 PM 1:45 PM-2:45 PM HIV Testing: A Crucial Foundation HIV Persistence and Latency Reversal Themed Discussion Leader Themed Discussion Leader Cheryl C. Johnson, World Health Organization, Geneva, Switzerland Sharon R. Lewin, Doherty Institute for Infection and Immunity, University of 975 Home-Based HIV Testing and New HIV Diagnoses in Melbourne, Melbourne, Australia Chókwè District, Mozambique 377 Naïve CD4+ T Cells Harbor a Large Inducible Reservoir Isabelle Casavant1; Duncan MacKellar2; Ricardo Thompson3; Robert of Latent HIV-1 Nelson2; Juvencio Bonzela4; Bertur Alface5; Stanley Wei1; Daniel Jennifer Zerbato; Deborah McMahon; Michele D. Sobolewski; John Shodell6; Judite Cardoso7; Nely Honwana1 W. Mellors; Nicolas Sluis-Cremer 1CDC, Maputo, Mozambique; 2CDC, Atlanta, GA, USA; 3Natl Inst of Hlth Univ of Pittsburgh, Pittsburgh, PA, USA 4 Mozambique, Maputo, Mozambique; CITSC, Chókwè, Mozambique; 378 Follicular Tregs Reduce HIV Replication and 5Provincial Directorate of PH, Xaixai, Mozambique; 6Colorado Dept of PH and Environment, Denver, CO, USA; 7JHpiego, Maputo, Mozambique Reactivation From Latency Ex Vivo Brodie Miles; Elizabeth Connick 988 Home-Based HIV Counseling and Testing Using Index Univ of Colorado, Denver, CO, USA Patients in Lesotho 375 Dendritic Cell-T-Cell Culture Facilitates HIV Latency in Abby L. DiCarlo1; Allison Zerbe1; Zach Peters2; Koen Frederix1; Joanne E. Mantell3; Robert Remien3; Wafaa M. El-Sadr1 Proliferating CD4+ T Cells 1 2 2 1ICAP at Columbia Univ, New York, NY, USA; 2ICAP, Columbia Univ Nitasha A. Kumar ; Renee M. van der Sluis ; Talia Mota ; Sharon R. 3 3 Mailman Sch of PH, New York, NY, USA; 3HIV Cntr for Clinical and Lewin ; Paul U. Cameron 1 2 Behavioral Studies, Columbia Univ and New York State Psychiatric Inst, Emory Univ, Atlanta, GA, USA; The Peter Doherty Inst, Univ of 3 New York, NY, USA Melbourne, Melbourne, Australia; Doherty Inst for Infection and Immunity, Univ of Melbourne, Melbourne, Australia 978 Effective, High-Yield HIV Testing for Partners of Newly Diagnosed Persons in Tanzania 379 A Subset of Infectious Proviruses Persist and Expand • Tuesday, February 23, 2016 23, February Tuesday, • Marya Plotkin1; Catherine Kahabuka2; Mbaraka Amuri3; Mustafa Following Activation Ex Vivo 1 2 1 1 Njozi3; Werner Maokola4; Erick Mlanga5; Mary Drake3; Kelly Curran6; John K. Bui ; Elias Halvas ; Elizabeth Fyne ; Michele D. Sobolewski ; 2 3 4 1 Charlene Brown7; Vincent Wong7 Dianna Koontz ; Mary F. Kearney ; Wei Shao ; Feiyu Hong ; John W. 1 1Jhpiego, Chapel Hill, NC, USA; 2Kahabuka Consulting, Dar es Salaam, Mellors 1 2 Tanzania; 3Jhpiego, Dar es Salaam, Tanzania; 4Natl AIDS Control Prog, Univ of Pittsburgh, Pittsburgh, PA, USA; Univ of Pittsburgh Sch of Med, 5 Pittsburgh, PA, USA; 3NCI, Frederick, MD, USA; 4Leidos Biomed Rsr, Inc, OralSessions Dar es Salaam, Tanzania; US Agency for Intl Develop-Tanzania, Dar es Salaam, Tanzania; 6Jhpiego, Baltimore, MD, USA; 7US Agency for Intl Frederick, MD, USA Develop, Washington, DC, USA 380 Transcription of Novel HIV-1 RNA Species in the Setting 983 HIV Testing and Linkage to Care in the Botswana of Undetectable Virus Combination Prevention Project Hiromi Imamichi1; Robin Dewar2; Joseph A. Adelsberger3; Catherine 4 4 5 4 4 Pamela J. Bachanas1; Mary G. Alwano2; Stephanie K. Behel1; John A. Rehm ; Catherine Seamon ; Gregg Roby ; Alice Pau ; H. Clifford Lane 1 2 Wen1; Winnie Sento3; Jan S. Moore1; Molly Pretorius Holme4; Tendani NIAID, NIH, Frederick, MD, USA; Frederick Cancer Rsr and Develop Cntr, 3 4 Gaolethe5; Refeletswe Lebelonyane6; Lisa A. Mills2 Frederick, MD, USA; Leidos Biomed Rsr, Inc, Frederick, MD, USA; NIAID, 5 1CDC, Atlanta, GA, USA; 2CDC, Gaborone, Botswana; 3Tebelopele NIH, Bethesda, MD, USA; NIAID, NIH, Rockville, MD, USA Counseling and Testing Cntr, Gaborone, Botswana; 4Harvard Sch of PH, Boston, MA, USA; 5Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; 6Ministry of Hlth, Gaborone, Botswana 979 94% Population HIV Testing Coverage With Repeat Hybrid Mobile Testing in East Africa Gabriel Chamie1; Jane Kabami2; Emmanuel Ssemmondo2; Tamara Clark1; Elizabeth Bukusi3; Maya Petersen4; Moses R. Kamya5; Diane V. Havlir1; Edwin Charlebois1; for the Sustainable East Africa Research for Community Health (SEARCH) team 1Univ of California San Francisco, San Francisco, CA, USA; 2Makerere Univ- Univ of California Rsr Collab, Kampala, Uganda; 3Cntr for Microbiology Rsr, Kenya Med Rsr Inst, Kisumu, Kenya; 4Univ of California Berkeley, Berkeley, CA, USA; 5Makerere Univ Coll of Hlth Scis, Kampala, Uganda
30 CROI 2016 Tuesday, February 23, 2016 • Oral Sessions 31 CROI 2016 Ballroom A Ballroom Program Agenda and
, Univ, of Torino, CME
It is assumed that participantsassumed that is It familiar are This session is directed to clinicians and scientists , Dana-Farber Cancer Cancer Dana-Farber , Instituto Nazionale Nazionale Instituto Torino, Italy Torino, Fluid and Blood Biomarkers Blood and Fluid Gothenburg, of Univ Gisslén , Magnus Sweden Gothenburg, Ances Washington, M. Beau Univ in St. Louis, St Louis, MO, USA Univ, Swanstrom ofI. NorthRonald Carolina at Chapel Hill, Chapel Hill, NC, USA Infection AndreaCalcagno CNS HIV Infection: Cerebrospinal Infection:HIV CNS Cerebrospinal Brain the in HIV of Neuroimaging ReservoirHIV an as CNS HIV With CNS the of Therapeutics At theAt completion of thesession, participants will be
62 63 60 61
Describe the implications ofviral reservoirs in theCNS for systemicneurologic and disease Be familiar withCNS biomarkers of HIVimmune activation CNS the on Describe therapies antiretroviral impact the of Critically biomarkersbrain disease CNS HIV evaluate of • • • • 5:00 5:30 who are interested in understanding the pathogenesis of HIV’s HIV’s of understanding pathogenesis in interested the are who effect onthe brain and itsclinical implications. knowledge: of Level with basic and clinical concepts of how HIV impacts the CNS. Objectives: able to: Conveners Antinori, Andrea Spallanzani”, “L. Infettive Malattie Italy Rome, Gabuzda H. Dana Institute, Boston, MA, USA 4:00 4:30 SessionS-2 Symposium PM-6:004:00 PM It Keeping Mind: Beautiful A audience: Target Room 304/306 Room face Howard Hughes Med Hughes Howard , Univ of Trento, Trento, Trento, Trento, of Univ , , Howard Hughes Med Inst, Inst, Med Hughes Howard , , Univ of California Berkeley, Berkeley, California of Univ , CME
It is assumed that participantsassumed that is It familiar are This session is directed to clinicians and scientists , Francis, Crick , University of of University , Michael F. Summers, F. Michael Reuben S. Harris S. Reuben Hijacks Vesicles Clathrin-Coated Hurley H. James CA, USA Berkeley, Numerous by Elucidated Approaches Experimental USA MN, Minneapolis, Packaging Signal Packaging Family Gene SERINC MassimoPizzato Italy Inst, Minneapolis, MN, USA MN, Minneapolis, Inst, How HIV-1 Nef Downregulation Downregulation Nef HIV-1 How Inter Binding APOBEC3F-Vif The Antiretroviral Activity theof Antiretroviral The StructureRNA HIV-1 the of At theAt completion of thesession, participants will be
59 58 57 56
Describe how HIV selects and packages its RNA genome Describe how the viral Nef protein subverts clathrin and clathrin from proteins antagonizing cellular remove to proteins adaptor membrane plasma the Describe the antiviral activity of the SERINC protein and how this protein is antagonized byHIV Nefand other retroviral proteins Describe how the viral Vifprotein recognizes antiviral APOBEC3 degradation for proteins • • • • 5:30 5:00 4:30 4:00 Celia A. Schiffer A. Celia Massachusetts Medical School, Worcester, MA, USA Stoye P. Jonathan Institute, USA able to: Conveners who are interested in understanding HIV andits interactionswith immune factorsinnate mechanistic in detail. knowledge: of Level with basic stagesof the viral life cycleand thefundamentals of immunity. innate Objectives: 4:00 PM-6:004:00 PM Host to Virus from MolecularInterplay audience: Target SessionS-1 Symposium Program and Agenda
Session S-3 Symposium CME Ballroom B/C Session S-4 Symposium CME Auditorium 4:00 PM-6:00 PM 4:00 PM-6:00 PM Global Impact of Hepatitis Innovations in PrEP Target audience: This session is directed to investigators and Target audience: This session is directed to clinicians and scientists clinicians who are interested in the epidemiology, basic science, who are interested in understanding antiretroviral preexposure public health impact, and future trends in hepatitis B and hepatitis C prophylaxis (PrEP) for HIV prevention. therapy. Level of knowledge: It is assumed that participants are familiar Level of knowledge: It is assumed that participants are familiar with basic concepts of how PrEP is used for HIV prevention. with the general principles of hepatitis B and hepatitis C virology Objectives: At the completion of the session, participants will be and treatment. able to: Objectives: At the completion of the session, participants will be • Describe the current experience in PrEP delivery models able to: • Describe the potential increases in sexually transmitted • Compare the global burden and epidemiology of hepatitis B infections associated with PrEP programs and C • Describe approaches to promoting the use of PrEP • Describe Egypt as a model for hepatitis C transmission around • List the potential advantages and disadvantages of current and the world and the approaches to disease eradication future potential PrEP modalities • Identify the mechanism of antiviral activity of hepatitis C • Describe opportunities for other prevention modalities in light medications including those effective against all genotypes of low uptake of PrEP in some populations • Compare immunologic and virologic mechanisms for Conveners eradication of hepatitis B Albert Y. Liu, San Francisco Department of Conveners Public Health, San Francisco, CA, USA Gottfried Hirnschall, World Health Dawn K. Smith, Centers for Disease Organization, Geneva, Switzerland Control and Prevention, Atlanta, Georgia, • Tuesday, February 23, 2016 23, February Tuesday, • Andri Rauch, Bern University Hospital and USA University of Bern, Bern, Switzerland 4:00 68 Delivery of PrEP: From Evidence to 4:00 64 Hepatitis C: Global Epidemiology Practice Imam Waked, Natl Liver Inst, Shebeen El C. Bradley Hare, Kaiser Permanente Northern California, San Francisco, CA, USA
OralSessions Kom, Egypt
4:30 69 Sexually Transmitted Infection 4:30 65 Refer to the CROI Mobile App Control in the Era of PrEP and the CROI website for updates Sheena McCormack, Univ Coll London, on this presentation London, UK
5:00 70 PrEP-4-Love: Transmitting Desire 5:00 66 Hepatitis C Therapeutics: Across Chicago Pangenotypic Therapeutics on the James Pickett, AIDS Fndn of Chicago, Horizon Chicago, IL, USA Karine LaCombe, Sorbonne Univs, Paris, 5:30 71 The Promise and Challenges of France Sustained Delivery of PrEP 5:30 67 Hepatitis B Virus: Is a Cure Ian McGowan, Univ of Pittsburgh Sch of Possible? Med, Pittsburgh, PA, USA Chloe Thio, Johns Hopkins Univ, Baltimore, MD, USA
32 CROI 2016 Tuesday, February 23, 2016 • Oral Sessions 33 ; 7 CROI 2016 CHU de CHU 7
; Abdoul H. ; Abdoul 3 ; Denis Malvy 10 6 Ministry Hlth, of Program Agenda and European Mobile Mobile European 10 ; Jacques Kolie ; Jacques 2 ; Jeremie Guedj ; Jeremie 5 Bernhard-Nocht Inst for Tropical Tropical for Inst Bernhard-Nocht ; Stephan Gunther ; Stephan 2 9 Ministry of Hlth Guinea, Conakry, Ministry Conakry, Guinea, Hlth of 3 Public Hlth England, Salisbury, UK; Salisbury, England, Hlth Public 8 Liberian Inst of BioMed RsrNIH Partnership, Partnership, RsrNIH BioMed of Inst Liberian ; Sophie Duraffour ; for the Multi-National PREVAIL II Study Team, Team, Study II PREVAIL the Multi-National ; for 1 ; for the Partnership for Research on Ebola Vaccines in Vaccines on Ebola Research for the Partnership ; for ; for the Prevail III Research Team, Team, III Research the Prevail ; for ; Xavier Anglaret ; Xavier 8 ; Thi Huyen Tram Nguyen ; Thi Tram Huyen 4 Cntr de Recherche en Santé Rurale de Mafèrinyah, Conakry, Conakry, Mafèrinyah, de Rurale Santé en Recherche de Cntr France; Paris, Diderot, Paris Université INSERM, 1137, UMR 4 5 French National Inst of Hlth and Med Rsr, Paris, France; France; Paris, Rsr, Med and Hlth of Inst National French d Côte Abidjan, INSERM, Coast); (Ivory Ivoire INSERM U897, Bordeaux, France; France; Bordeaux, U897, INSERM Laboratory Project, Hamburg, Germany Hamburg, Project, Laboratory Miles W. Carroll Miles W. Medicine, Hamburg, Germany; Germany; Hamburg, Medicine, NIAID, Bethesda, MD, USA Bethesda, MD, NIAID, A Randomized Controlled Trial of the Safetythe of and Trial Controlled Randomized A Vaccines Ebola Immunogenicity Two of Bolay Fatorma Team, 1) Liberia (PREVAIL USA Bethesda, MD, ZMapp™of Trial Controlled Randomized A II: PREVAIL Infection Virus Ebola Acute in Davey T. Richard 6 9 Guinea; Guinea; A CohortA StudyInfection Survivorsof Virus in Ebola of III) (PREVAIL Liberia MosokaFallah Clearance Semenin Virus Guinea in Dynamics Ebola of DaoudaSissoko 1 Monrovia, Liberia Monrovia, Beavogui Guinea; Guinea; Bordeaux, Bordeaux, France; France; Bordeaux, Bordeaux,
76LB 77LB 74LB 75LB ; CHU de CHU 1 7 ; 3 Harvard Harvard
4 4 ; Ibrahima ; Ibrahima 5 Ballroom B/C Ballroom ; George ; George 3 Institut de Recherche Recherche de Institut Inst Recherche et Recherche Inst 4 3 ; SandrineLeroy 2 ; Paul Farmer ; Paul 4 ; Mohamed B. Barrie ; Mohamed B. ; for the Postebogui study the Postebogui ; for 2 8 ; Taverne Bernard ; Sahr Karku 4 3 Univ of California San Francisco, San San Francisco, California of Univ 2
; Megan Murray 1 UMI 233-IRD/U1175-INSERM/Montpellier 233-IRD/U1175-INSERM/Montpellier UMI 8 ; J. Daniel Kelly Daniel ; J. ; Eric Delaporte ; Eric 1 7 ; Mamadou Saliou; Mamadou Sow 1 ; Komba Quiwa ; Komba 3 Macenta Prectoral Hosp, Macenta, Guinea; Guinea; Macenta, Hosp, Prectoral Macenta 6 Partners In Hlth, Freetown, Sierra Leone; Leone; Sierra Freetown, Hlth, In Partners 3 ; Abdoulaye I. Toure I. ; Abdoulaye 3 ; James H. Jones 2 , Centers, for Disease Control and Prevention, Nairobi, Kenya Donka National Hosp, Conakry, Guinea; Guinea; Conakry, Hosp, National Donka ; Moumié Barry 2 6 Institut de Recherche Pour le Développement UMI 233, INSERM U1175, U1175, INSERM 233, UMI Développement le Pour Recherche de Institut Institut de Recherche Pour le Développement, Montpellier, Montpellier, Développement, le Pour Recherche de Institut Stanford Univ, Stanford, CA, USA; Stanford, Univ, Stanford Savane group group Francisco, CA, USA; Francisco, Philippe Msellati Philippe Conakry, Conakry, Guinea; Guinea; Conakry, Conakry, Developpement, France, Montpellier, Cameroon; Cameroon; Montpellier, France, Developpement, Montpellier, France; France; Montpellier, France; France; 5 1 Sequelae of Ebola Virus Disease Survivingin Virus Sequelae Ebola of Patients Cohort Postebogui Guinea: in Etard Jean-François Eugene T. Richardson T. Eugene 1 Unreported Cases and Asymptomatic InfectionUnreported Cases anAsymptomatic in and “Hotspot” Ebola Annelies W. Mesman W. Annelies Pour le Développement UMI 233, INSERM U1176, Montpellier, France; France; Montpellier, U1176, INSERM 233, UMI Développement le Pour Rutherford Univ, Montpellier, France Montpellier, Univ, Med School, Boston, MA, USA MA, Boston, School, Med
73LB 72LB 6:15 PM-7:456:15 PM Later Year One Ebola: Moderators Abstract Oral KevinM. De Cock SpecialSession OralSS Abstracts Vaccine, Sullivan Nancy Research National Center, Institute of Allergy and USA MD, Bethesda, Health, of Institutes National Diseases, Infectious Program and Agenda
11:00 84 Clones of SIV-Infected Cells Are Present in Spleen WEDNESDAY, FEBRUARY 24, 2016 and Lymph Nodes in Rhesus Macaques Andrea Ferris1; Gregory Q. Del Prete2; Brandon Keele2; Xiaolin Wednesday Plenary Sessions CME Auditorium Wu2; Jeffrey Lifson2; Stephen H. Hughes1 8:30 AM-9:30 AM 1NCI, Frederick, MD, USA; 2Frederick Natl Lab, Frederick, MD, USA 8:30 78 Progress in Gene Therapy for HIV 11:15 85 ART Reduces Cellular HIV RNA but Not the Cure Fraction of Proviruses Transcribing RNA Paula M. Cannon, University of Southern Feiyu Hong1; Jonathan Spindler2; Andrew Musick3; Anthony California, Los Angeles, CA, USA R. Cillo1; Michael Bale2; Wei Shao4; John M. Coffin5; John W. Mellors1; Mary F. Kearney3 9:00 79 HIV in Transgender Populations: 1 Univ of Pittsburgh, Pittsburgh, PA, USA; 2HIV Dynamics and Charted and Uncharted Waters Replication Prog, Natl Cancer Inst, Frederick, MD, USA; 3NCI, 4 Tonia C. Poteat, The Johns Hopkins Frederick, MD, USA; Leidos Biomed Rsr, Inc, Frederick, MD, USA; 5 University, Baltimore, MD, USA Tufts Univ, Boston, MA, USA 11:30 86 Restricted HIV-1 Diversity and Clonal Expansion Following Cytoreductive Chemotherapy Session O-6 Oral Abstracts Ballroom B/C Timothy J. Henrich1; Eileen P. Scully2; Kristen S. Hobbs1; 10:00 AM-12:00 PM Emily Hanhauser1; Louise Hogan1; Christine D. Palmer3; Yvonne Reservoirs, Relapse, and Remission P. Robles4; Kaitlyn S. Leadabrand1; Ann S. LaCasce5; Daniel Kuritzkes6 Oral Abstract Moderators 1Univ of California San Francisco, San Francisco, CA, USA; Carolina Gutiérrez, Ramón y Cajal Hospital, IRYCIS, Madrid, Spain 2Massachusetts General Hosp, Boston, MA, USA; 3Ragon Inst Jonathan Z. Li, Brigham and Women's Hospital, Harvard Medical School, of MGH, MIT and Harvard, Cambridge, MA, USA; 4Brigham and Boston, MA, USA Women’s Hosp, Harvard Med Sch, Boston, MA, USA; 5Dana-Farber 10:00 80 Investigating the Mechanisms that Control HIV Cancer Inst, Boston, MA, USA; 6Harvard Med Sch, Boston, MA, USA Transcription and Latency In Vivo 11:45 87 Virological Remission After ART Interruption in Steven A. Yukl1; Philipp Kaiser1; Peggy Kim1; Sunil K. Joshi1; African HIV-1 Seroconverters Nicholas Kim1; Peilin Li1; Harry Lampiris1; Hongbing Liu2; Morgane Gossez1; Gita Ramjee2; Jacob Hurst1; Pontiano Andrew Rice2; Joseph K. Wong1; for the DARE Study Group Kaleebu3; Helen Rees4; Kholoud Porter5; Abdel Babiker6; Sarah J. 1San Francisco VA Med Cntr, San Francisco, CA, USA; 2Baylor Coll of Fidler7; John Frater1; for the SPARTAC Trial Investigators Med, Houston, TX, USA 1Univ of Oxford, Oxford, UK; 2South African Med Rsr Council, Cape Town, South Africa; 3Med Rsr Council/Uganda Virus Rsr Inst • Wednesday, February 24, 2016 24, February Wednesday, • 10:15 81 Human Galectin-9 Is a Potent Mediator of HIV 4 Transcription and Reactivation Uganda Rsr Unit on AIDS, Entebbe, Uganda; Wits Reproductive Hlth and HIV Inst, Johannesburg, South Africa; 5Med Rsr Council, Mohamed Abdel-Mohsen1; Leonard Chavez1; Glen M. Chew2; London, UK; 6Univ Coll London, London, UK; 7Imperial Coll London, Xutao Deng1; Ali Danesh1; Sheila M. Keating1; Rebecca Hoh3; London, UK Steven G. Deeks3; Lishomwa C. Ndhlovu2; Satish Pillai1 1Blood Systems Rsr Inst, San Francisco, CA, USA; 2Univ of Hawaii, Oral Sessions Honolulu, HI, USA; 3Univ of California San Francisco, San Session O-7 Oral Abstracts Room 304/306 Francisco, CA, USA 10:00 AM-12:00 PM 10:30 82 PD-1+ and Tfh Cells Represent the Major Source Pushing Frontiers of Adaptive Immunity of HIV-1 Replication-Competent Virus Oral Abstract Moderators Riddhima Banga1; Francesco Procopio1; Matthias Cavassini2; Gregory Q. Del Prete, Frederick National Laboratory, Frederick, MD, USA Jean-Marc Corpataux3; Giuseppe Pantaleo3; Matthieu Perreau1 Peter D. Kwong, Vaccine Research Center, NIAID/NIH, Bethesda, MD, USA 1CHUV, Epalinges, Switzerland; 2Univ Hosp Lausanne, Univ of Lausanne, Lausanne, Switzerland; 3CHU Vaudois, Lausanne, 10:00 88 An Infant bNAb With Low Somatic Switzerland Hypermutation Contributes to Polyclonal Breadth 10:45 83 Rapid Accumulation of Defective Proviruses Cassandra Simonich1; Katherine Williams1; Theodore Complicates HIV-1 Reservoir Measurements Gobillot2; Hadega Aamer3; Stephanie Rainwater1; Ruth Nduati4; Katherine M. Bruner1; Ross Pollack1; Alexandra Murray1; Julie M. Overbaugh1 Mary Soliman1; Sarah B. Laskey2; Matt F. Strain3; Douglas D. 1Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 2Univ of Richman3; Steven G. Deeks4; Janet Siliciano1; Robert Siliciano5 Washington, Seattle, WA, USA; 3Seattle Children’s Rsr Inst, Seattle, 1Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; 2Johns WA, USA ;4Univ of Nairobi, Nairobi, Kenya Hopkins Univ, Baltimore, MD, USA; 3Univ of California San Diego, San Diego, CA, USA; 4University of California San Francisco, San Francisco, CA, USA; 5Howard Hughes Med Inst, Baltimore, MD, USA
34 CROI 2016 Wednesday, February 24, 2016 • Oral Sessions 35 ; ; 1 2 ; 1 ; 1
2 ; Abel ; Abel 3 ; Sandra 1 ; Moses R. CROI 2016 Room 302 Room 2 ; for the ; for 1 ; Matt Soars ; Matt ; Jennifer Kiser ; Jennifer 1 7 ; Diana M. ; Jonathan Davis ; Jonathan 4 Duke Univ Sch Univ of Duke 1 Makerere Univ Coll Coll Univ Makerere ; Kimberly ; Ming-Tain Lai ; Ming-Tain 7 5 2 1 Bristol-Myers Bristol-Myers 2 Infectious DiseasesInfectious Rsr Program Agenda and ; Francesca Aweeka ; Francesca 4 2 dherence and dherence Merck & Co, Inc, Rahway, Rahway, Inc, Co, & Merck 2 Univ of California San California of Univ ; Norah Mwebaza ; Norah 2 2 Harvard Sch of PH, Boston, Boston, Sch PH, of Harvard Gilead Scis, Inc, Foster City, City, Foster Inc, Scis, Gilead 2 5 Infectious Diseases Rsr Collab DiseasesInfectious Collab Rsr 3 ; Daria J. Hazuda ; Daria J. ; Philip Rosenthal ; Xinhui Chen ; Xinhui ; Sharon Zhang ; Sharon 3 2 3 2 ; Yongnian Sun ; Yongnian ; Stephanie E. Barrett ; Stephanie ; Susanna Naggie 2 2 6 ; Michael Hughes ; Kerry L. Fillgrove 1 1 ; Diane V. Havlir V. ; Diane 2 , Univ of Colorado, Denver, CO, USA CO, Denver, Colorado, of Univ , ; Liusheng Huang 1
; Luisa M. Stamm; Anuoluwapo Osinusi; Gong Anuoluwapo M. Stamm; ; Luisa ; Jhoanna C. Roa ; Wensel David 2 1 ; Marian Iwamoto ; for the Combinectin Working Group Group Working the Combinectin ; for 1 ; Evan Friedman ; Evan 1 1 ; Thomas ; Thomas McDonagh 1 Social & Scientific Systems, Inc., Silver Spring, MD, USA; USA; MD, Spring, Silver Inc., Social Scientific & Systems, Harvard Med Sch, Boston, MA, USA; USA; MA, Sch, Med Boston, Harvard 3 ; Raymond T. Chung T. ; Raymond Merck & Co, Inc, Kenilworth, NJ, USA NJ, Kenilworth, Inc, Co, & Merck 6 ; Wendy Ankrom ; Wendy 5 3 1 ; Prasanna Jagannathan ; Prasanna ; Grant Dorsey ; Grant 4 5 , Hôpitaux, de Paris, Hôpitaux Universitaires Paris-Sud, Le , University, of Colorado, Denver, USA CO, Makerere Univ, Kampala,, Uganda; Uganda; Kampala,, Univ, Makerere Univ of Colorado, Denver, CO, USA; USA; CO, Denver, Colorado, of Univ USA; CO, Aurora, Colorado, of Univ Bristol-Myers Squibb, Wallingford, CT, USA; USA; CT, Wallingford, Squibb, Bristol-Myers USA; PA, Point, West Inc, Co, & Merck L. Wood NJ, USA; USA; NJ, Brainard Francisco, San Francisco, CA, USA; San Francisco, Francisco, Gilead Scis, Inc, Foster City, CA, USA City, Foster Inc, Scis, Gilead Marian Gindy M. Hollabaugh Kakuru EFV Reduced PK of Piperaquine for Malaria for Piperaquine of PK Reduced EFV Lower Ribavirin Exposures in HIV+ Patients That That Patients HIV+ in Exposures Ribavirin Lower USA NC, Durham, Med, DrugInteraction Sofosbuvir/ Studies Between Prevention in HIV+ Ugandan Pregnant Women Pregnant Ugandan HIV+ in Prevention Kajubi Richard 1 Long-Acting Oral and Parenteral Dosing ofDosing Long-ActingOral Parenteral and HCV Acute to Treatment Relapsed MacBrayne ChristineE. 1 4 Regimens ARV HIV Boosted and Velpatasvir Mogalian Erik Mathias John Ling; Anita Shen; KarimJohn McNally; Sajwani; Pharmacologic Measures of A of Measures Pharmacologic Combinectin HIV-1 BMS-986197: Long-ActingA 1 Prophylaxis or Treatment HIV for MK-8591 Jay Grobler 1 Relationship to Drug Response to Relationship Anderson L. Peter Actionof Modes Multiple With Inhibitor MarkKrystal Collab and Makerere Univ, Kampala, Uganda; Uganda; Kampala, Univ, Makerere and Collab and Makerere Univ, Kampala,, Uganda; Uganda; Kampala,, Univ, Makerere and Kamya for the A5327 Study Team Team the A5327 Study for Mark Cockett Squibb, Waltham, MA, USA MA, Waltham, Squibb, Zhufang Li Zhufang USA; MA, MK-8591 Early Development Team Team Development Early MK-8591 CA, USA; of Hlth Scis, KAMPALA, Uganda KAMPALA, Scis, Hlth of
100 101 99 98 96 97
11:15 11:30 11:00 10:45 Anne-Marie Taburet Anne-Marie Kremlin-Bicêtre, France SessionO-8 Oral Abstracts AM-12:0010:00 PM Challenges Discovery Clinicalin to Drugs:From Use Moderators Abstract Oral Anderson L. Peter 10:00 10:30 ; 1 ; 4 ; ; ; 1 1 3 ; Huldrych ; Srisowmya ; Srisowmya 2 ; Richard A. ; Richard 1
; Nicole ; Nicole ; Amarendra ; Amarendra 3 1 3 1 Duke Univ, Univ, Duke 2
5 ; Gordon J. J. ; Gordon ; Robert Bailer 1 4 ; Hanna Ebner 1 ; Adrian B. B. ; Adrian ; Michael Miller NIAID, NIH, Bethesda, NIH, NIAID, 1 2 ; Benton Lawson ; Benton 5
1 Gilead Scis, Inc, Foster Foster Inc, Scis, Gilead 2
; Galit Alter ; Anne Sophie; Anne Dugast Univ of Zurich, Zurich, Zurich, Zurich, of Univ 2 1 3 ; Yunda Huang ; Yunda 2 ; Christa E.; Christa Osuna ; John R. Mascola ; for the the Swiss HIV Cohort Swiss the the ; for 1 2 3 ; Rafi Ahmed 1 Dana-Farber Cancer Inst, Boston, Boston, Inst, Cancer Dana-Farber ; Dominique L. Braun 2 1 ; Barney Graham 5 ; Claus Kadelka; Claus ; Tomas Cihlar ; Tomas 2 2 Frederick Natl Lab for Cancer Rsr, Rsr, Cancer for Lab Natl Frederick ; Julie Ledgerwood 2 ; David Ambrozak ; David 3 ; Sara Ferrando-Martinez ; Sakeenah Hicks ; Sakeenah 1 1 3 1 ; Kelly Seaton ; Kelly ; So-Yon Lim ; So-Yon 1 ; Peter Brouckaert ; Peter VRC, NIAID, NIH, Bethesda, MD, USA Bethesda, MD, NIH, VRC, NIAID, 1 1 3 ; Joseph Hesselgesser Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, WA, Seattle, Cntr, Rsr Cancer Hutchinson Fred ; Marina Krykbaeva ; Benjamin Bar J. Scheinfeld; Katharine 2 3 1 ; MaryAllen 4 ; Michael Huber 1 Alexandra Trkola Alexandra ; Roger Kouyos ; Vijayakumar Velu ; Vijayakumar ; John Hural 1 ; ; Jason M. Brenchley 1 3 2 1 Yerkes Natl Primate Rsr Cntr, Emory Univ, Atlanta, GA, Atlanta, Emory Univ, Cntr, Rsr Primate Natl Yerkes ; Tiffany L. Barnes Tiffany ; ; Rama Amara 3 1 2
VRC, NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, VRC, NIAID, ; Sarah F. Andrews ; Sarah F. 3 4 1 Beth Israel Deaconess Med Cntr/Harvard, Boston, MA, USA; USA; MA, Boston, Cntr/Harvard, Med Deaconess Beth Israel CA, USA; City, Foster Inc, Sciences, Gilead NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, Ragon Inst of MGH, MIT and Harvard, Cambridge, MA, USA; USA; MA, Cambridge, Harvard, and MIT MGH, of Inst Ragon Belgium Gent, Univ, Ghent The Fenway Inst, Fenway Hlth, Boston, MA, USA; USA; MA, Boston, Hlth, Fenway Inst, Fenway The Inst of Med Virology, Univ of Zurich, Zurich, Switzerland; Switzerland; Zurich, Zurich, of Univ Virology, Med of Inst Switzerland; Zurich, Zurich, Hosp Univ Frederick, MD, USA; USA; MD, Frederick, McDermott Study Study Freeman F. Günthard F. MD, USA MD, Richard A. Koup A. Richard City, CA, USA City, Grunenberg Melon Nega USA; MA, USA Durham, NC, USA; USA; NC, Durham, Univ of Pennsylvania, Philadelphia, PA, USA PA, Philadelphia, Pennsylvania, of Univ Fernanda Cerqueira Fernanda Repeated TLR7 Agonist Treatment of SIV+ of Treatment Agonist TLR7 Repeated Follicular CTL Accumulate in SIV-Infected Lymph CTL Lymph SIV-Infected in Follicular Accumulate Potency and Kinetics of Autologous HIV-1 HIV-1 Kineticsand Potency Autologous of PD-1and ART to Blockade Adjunctan Therapy as Merle Schanz USA; Gp-120Functions by Neutrophil Induced Specific ClinicalSafety SCand IV of Pharmacokinetics and Virus, Host, and Disease Factors Govern HIV-1 HIV-1 Govern Diseaseand Factors Host, Virus, 1 2 Costantinos Petrovas Costantinos 1 Remission Viral to Can Lead ART on Monkeys James B. Whitney Potential to Destabilize SIV ReservoirSIV Destabilize to Potential Geetha Mylvaganam 1 Due Activation Immune Nodes to 1 2 During Antibody Responses Neutralizing ATI Salantes Brenda 1 Immunotherapy Clues IgG; and IgA for MagdalenaSips 1 2 mAb Neutralizing Broadly a VRC01, Mayer H. Kenneth Broadly Neutralizing Antibody Induction Neutralizing Broadly Rusert Peter Koup Switzerland Sanisetty Romas Geleziunas Pegu
95LB 94 93LB 92 91 90 89LB
11:45 11:30 11:15 11:00 10:45 10:30 10:15 Program and Agenda
11:45 102LB Concentrations of TFV and TFVdp in Female 11:00 107 Chemoprophylaxis With Oral FTC/TAF Protects Mucosal Tissues After a Single Dose of TAF Macaques From Rectal SHIV Infection Katy L. Garrett1; Mackenzie L. Cottrell1; Heather M. Prince1; Ivana Massud1; James Mitchell1; Darius Babusis2; Frank Craig Sykes1; Amanda Schauer1; Anne Peery1; James Rooney2; Deyounks1; Adrian Ray2; James Rooney2; Walid Heneine1; Scott McCallister2; Cynthia Gay1; Angela Kashuba1 Michael Miller2; Gerardo Garcia-Lerma1 1Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 1CDC, Atlanta, GA, USA; 2Gilead Scis, Inc, Foster City, CA, USA 2 Gilead Scis, Inc, Foster City, CA, USA 11:15 108LB MTN-017: Rectal Phase 2 Extended Safety and Acceptability Study of 1% Tenofovir Gel Session O-9 Oral Abstracts Auditorium Ross Cranston1; Javier Lama2; Barbra A. Richardson3; 10:00 AM-12:00 PM Alex Carballo-Diéguez4; Ratiya Kunjara Na Ayudhya5; Cindy Expanding the Toolbox for Prevention Jacobson5; Mark A. Marzinke6; Sherri Johnson7; Jeanna Piper8; Ian McGowan1 Oral Abstract Moderators 1Univ of Pittsburgh Sch of Med, Pittsburgh, PA, USA; 2Impacta Sinéad Delany-Moretlwe, Wits Reproductive Health and HIV Institute, Peru, Barranco, Lima, Peru; 3Univ of Washington, Seattle, WA, Johannesburg, South Africa USA; 4New York State Psychiatric Inst., New York, NY, USA; Nyaradzo Mgodi, Medical Research Council of Zimbabwe, Zimbabwe 5Magee-Womens Rsr Inst, Pittsburgh, PA, USA; 6Johns Hopkins Univ, Baltimore, MD, USA; 7FHI 360, Washington DC, DC, USA; 10:00 103 HPTN 069/ACTG 5305: Phase II Study of 8 Maraviroc-Based Regimens for HIV PrEP in MSM NIAID, NIH, Bethesda, MD, USA Roy Gulick1; Timothy J. Wilkin1; Ying Chen2; Raphael J. 11:30 109LB A Phase III Trial of the Dapivirine Vaginal Ring for Landovitz3; K. R. Amico4; Alicia Young5; Paul Richardson6; Mark HIV-1 Prevention in Women A. Marzinke6; Marybeth McCauley7; Kenneth H. Mayer8 Jared M. Baeten1; Thesla Palanee-Phillips2; Elizabeth R. 1 Weill Cornell Med Coll, New York, NY, USA; 2Fred Hutchison Cancer Brown3; Katie Schwartz4; Lydia E. Soto-Torres5; Annalene Nel6; Rsr Cntr, Seattle, WA, USA; 3David Geffen Sch of Med at Univ of Zeda Rosenberg7; Ian McGowan8; Sharon L. Hillier9; for the California Los Angeles, Los Angeles, CA, USA; 4Univ of Michigan MTN-020/ASPIRE Study Team Sch of PH, Ann Arbor, MI, USA; 5SCHARP, Seattle, WA, USA; 6Johns 1Univ of Washington, Seattle, WA, USA; 2Wits Reproductive Hlth Hopkins Univ, Baltimore, MD, USA; 7FHI 360, Washington, DC, and HIV Inst, Johannesburg, South Africa; 3Statistical Cntr for HIV/ USA; 8The Fenway Inst, Fenway Hlth, Boston, MA, USA AIDS Rsr & Prevention, Fred Hutchinson Cancer Rsr Cntr, Seattle, 4 5 10:15 104 PrEP Impact on T-Cell Activation and Explant WA, USA; FHI 360, Durham, NC, USA; NIAID, NIH, Bethesda, MD, USA; 6Intl Partnership for Microbicides, Paarl, South Africa; Infection: HPTN 069/ACTG 5305 Substudy 7 1 2 3 1 International Partnership for Microbicides, Silver Spring, MD, Ian McGowan ; Alexiy Nikiforov ; Alicia Young ; Ross Cranston ; 8 9 4 5 6 USA; Univ of Pittsburgh Sch of Med, Pittsburgh, PA, USA; Magee- Raphael J. Landovitz ; Rahul Bakshi ; Adriana Andrade ; Womens Hosp of the Univ of Pittsburgh Med Cntr, Pittsburgh, PA, Kenneth H. Mayer7; Timothy J. Wilkin8; Roy Gulick8 • Wednesday, February 24, 2016 24, February Wednesday, • USA 1 Univ of Pittsburgh Sch of Med, Pittsburgh, PA, USA; 2Magee- Womens Hosp of the Univ of Pittsburgh Med Cntr, Pittsburgh, PA, 11:45 110LB Safety and Efficacy of Dapivirine Vaginal Ring for USA; 3SCHARP, Seattle, WA, USA; 4David Geffen Sch of Med at Univ HIV-1 Prevention in African Women of California Los Angeles, Los Angeles, CA, USA; 5Johns Hopkins Annalene Nel1; Saidi Kapiga2; Linda-Gail Bekker3; Brid Devlin4; Univ, Baltimore, MD, USA; 6Johns Hopkins Univ Sch of Med, Maarten Borremans5; Zeda Rosenberg4; for the IPM 027/Ring 7 Oral Sessions Baltimore, MD, USA; The Fenway Inst, Fenway Hlth, Boston, MA, Study Research Center Teams USA; 8Weill Cornell Med Coll, New York, NY, USA 1Intl Partnership for Microbicides, Paarl, South Africa; 2London Sch 3 10:30 105 Cabotegravir Long-Acting Injection Protects of Hygiene & Trop Med, London, United Kingdom; Desmond Tutu HIV Cntr, Cape Town, South Africa; 4International Partnership for Macaques Against Intravenous Challenge 5 1 1 1 Microbicides, Silver Spring, MD, USA; SGS Life Science Services, Chasity D. Andrews ; Leslie St. Bernard ; Amanda Poon ; Mechelen, Belgium William Spreen2; Agegnehu Gettie1; Kasi Russell-Lodrigue3; Zhi Hong4; David D. Ho1; Martin Markowitz1 1Aaron Diamond AIDS Rsr Cntr, New York, NY, USA; 2ViiV Hlthcare, Research Triangle Park, NC, USA; 3Tulane Natl Primate Rsr Cntr, Covington, LA, USA; 4GSK, Research Triangle Park, NC, USA 10:45 106 ÉCLAIR: Phase 2A Safety and PK Study of Cabotegravir LA in HIV-Uninfected Men Martin Markowitz1; Ian Frank2; Robert Grant3; Kenneth H. Mayer4; David A. Margolis5; Krischan J. Hudson5; Britt S. Stancil5; Susan L. Ford5; Alex R. Rinehart5; William Spreen5 1 Aaron Diamond AIDS Rsr Cntr, New York, NY, USA; 2Perelman Sch of Med, Univ of Pennsylvania, Philadelphia, PA, USA; 3Univ of California San Francisco, San Francisco, CA, USA; 4The Fenway Inst, Fenway Hlth, Boston, MA, USA; 5ViiV Hlthcare, Research Triangle Park, NC, USA
36 CROI 2016 Wednesday, February 24, 2016 • Oral Sessions 37 ;
2 ; 1 ; ; ; 4 4 3 ; 5 1 Univ Coll Coll Univ 5 Jeffrey Jeffrey CROI 2016 ; 3 ; Joseph A. 1 ; Olivia Keiser Room Room 304/306 6 ; Jack J. Olney ; Jack J. Malawi MinistryMalawi of 2 3 ; James Ayieko 4 ; Christina Marra ; Christina 1 Program Agenda and ; for the HIV Modelling the HIV ; for ; Malango Msukwa 6 1 ; Joep van Oosterhout ; Joep van 1 Univ of California Berkeley, Berkeley, California of Univ 6 ; Asiphas Owaraganise ; Robin Nance 2 Inst for Disease Modeling, Disease Modeling, for Inst 1 indings of Next- of indings 2 ; Andrew Boulle ; Andrew 2 ; Moses R. Kamya; for the for ; Moses R. Kamya; Univ of California San Francisco, San Francisco, California of Univ 2 2 ; Daniel J. Klein ; Daniel J. ; Matthias Egger ; Matthias 4 Baobab Hlth Trust, Lilongwe, Malawi; Malawi; Lilongwe, Trust, Baobab Hlth 1 5 Inst of Social and Preventive Med, Univ Univ Med, Social of Inst Preventive and ; Kyra J. Becker J. ; Kyra
4 2 ; Vivek Jain ; Vivek 1 ; Andreas Haas ; Andreas ; Tenthani Lyson London Sch of Hygiene & Trop Med, London, London, Med, & Trop Sch Hygiene of London 1 3 6 ; Dathan Byonanebye ; Dathan Imperial Coll London, London, UK; UK; London, London, Coll Imperial 3 Cntr for Infectious Disease Epi and Rsr, Cape Cape Rsr, and Disease Infectious Epi for Cntr Univ of California San Francisco, San San Francisco, California of Univ Infectious Diseases Rsr Collab, Kampala, Kampala, DiseasesInfectious Collab, Rsr 4 ; Emma Slaymaker ; Emma
3 2 3 ; RIzwan Kilani 5 1 1 Univ of Washington Sch of PH and Community Community Sch and PH of Washington of Univ 3 ; Diane V. Havlir V. ; Diane ; Anna Bershteyn ; Anna ; Janne Estill 6 1 5 Dignitas Intl, Zomba, Malawi; Malawi; Zomba, Dignitas Intl, 2 ; Timothy ; Timothy Hallett ; Felicia Chow ; Felicia 4 Makerere Univ Coll of Hlth Scis, Kampala, Uganda; Uganda; Kampala, Scis, Hlth of Coll Univ Makerere 1 4 ; Emily L. Ho ; Emily 1 , University, of California San Francisco, San Francisco, CA, US ; Tirchwell David 3 Inst of Social and Preventive Med, Univ of Bern, Bern, of Univ Med, Social of Inst Preventive and Bern, Bern, Switzerland Hosp Univ Kenya Med Rsr Inst, Kisumu, Kenya; Kenya; Kisumu, Inst, Rsr Med Kenya CA, USA; Stanford, Univ, Stanford Makerere Univ-Univ of California San Francisco Rsr Collab, Collab, Rsr San Francisco California of Univ-Univ Makerere Andrew N. Phillips N. Andrew SEARCH Collaboration SEARCH Collaboration Bellevue, WA, USA; USA; WA, Bellevue, Francisco, CA, USA; Francisco, Maya Petersen Maya Switzerland; Switzerland; Kampala, Uganda; Uganda; Kampala, Consortium Writing Group on ART Eligibility Guidelines on ART Group Writing Consortium Town, South Africa; South Africa; Town, HIV MortalityHIV CascadeCare by Stage and Hlth, Lilongwe, Malawi; Malawi; Lilongwe, Hlth, Trends in ART Discontinuation by Age in Malawi, Malawi, in Age by Discontinuation ART in Trends 1 6 Virologic Efficacy Virologic CD4+ High at Begun ART of 5 Eligibility ART Universal Implicationsfor Bendavid Eran 1 2004–2014 Mugglin A. Catrina Counts via Streamlined Care in East AfricaEast in Streamlined Care via Counts DalsoneKwarisiima 1 W. Eaton W. London, London, UK; UK; London, London, Berkeley, CA, USA Berkeley, Gadabu Oliver Malawi; Bern,of Lilongwe, Uganda; Uganda; UK Chimbwandira Frank Florence Mwangwa Florence
Univ of Washington, Seattle, WA, USA; WA, Seattle, Washington, of Univ Delaney Med, Seattle, WA, USA WA, Seattle, Med, 117 Design, Implementation, and F and Implementation, Design, HIV in Adjudication Stroke Generation CraneM. Heidi 1 118 116 San Francisco, CA, USA; San Francisco, Joseph Zunt
1:45 PM-2:451:45 PM Riskand Incidence Factors Stroke: Discussion Leader Themed Price W. Richard 636 SessionTD-7 Themed Discussion 11:45 11:15 11:30 ; ; 1 2 ;
2 3 ; ; 4 2 ; 2 ; Eva ; David ; David 7 Boston Boston 3 2 Guthrie Guthrie ; Gavin ; Gavin 5 4 ; Tom ; Tom Aurum Inst, Inst, Aurum 3 2 Infectious 2 Brigham and and Brigham ; Shahin Ballroom A Ballroom 6 2 Natl DeptNatl of 6 Elvin H. Geng H. Elvin ; Sibuse Ginindza ; Helen Ayles ; Helen ; 2 2 Ministry Hlth, of 3 4 ; Jennifer Namusobya ; Jennifer 1 ; Kwame Shanaube ; Kwame ; David Dowdy ; David 3 Univ of California San California of Univ ; M. Essex ; Fareed Abdullah ; Fareed 2 3 5 6 ; Molly Pretorius Holme ; Molly Pretorius ; Jeanna Wallenta Botswana Harvard Harvard Botswana 2 2 3 5 ; Eric Tchetgen Tchetgen ; Tchetgen Eric London Sch of Hygiene & Trop & Trop Sch Hygiene of London ; Leigh F. Johnson F. ; Leigh 3 2 2 ; Blia Yang London Sch of Hygiene & Trop Med, Med, & Trop Sch Hygiene of London 2 3 South African Natl AIDS Council, Council, AIDS Natl South African 7 ; Tonderai Mabuto ; Tonderai The Aurum Inst, Johannesburg, South Johannesburg, Inst, Aurum The 1
; Lisa A. Mills ; Yogan Pillay ; Yogan 4 5 ; KaplanaSabapathy Univ of Cape Town, Cape Town, South Town, Cape Town, Cape of Univ 4 3 UNAIDS-South Africa, Pretoria, South Pretoria, Africa, UNAIDS-South CDC, Gaborone, Botswana; Botswana; Gaborone, CDC, 8 5 ; Griffiths Kubeka ; Wirth Kathleen 3 1 ; Leatitia Kampiire ; Leatitia ; Sikhulile Moyo Univ of Stellenbosch, Cape Town, South Africa; South Africa; Town, Cape Stellenbosch, of Univ 2 ; Fred Collins Semitala Collins ; Fred
1 3 1 ; Sian Floyd 1 ; for the HPTN 071 (PopART) study team team study the HPTN 071 (PopART) ; for 2 ; Gesine Meyer-Rath Johns Hopkins Univ Bloomberg School of Public School Public of Bloomberg Univ Hopkins Johns 1 4 ; Salome Charalambous 5 ; Ab Schaap ; Ab ; Moses R. Kamya; Diane V. Havlir V. Diane ; Moses R. Kamya; 3 3
; for the South African HIV and TB Investment Case Case Investment TB HIV and the South; for African 6 8 ; Teresa Guthrie ; Teresa 4 London Sch of Hygiene & Trop Med, London, UK; UK; London, Med, & Trop Sch Hygiene of London 4 Univ of the Witwatersrand, Johannesburg, South Africa; South Africa; Johannesburg, Witwatersrand, the of Univ Imperial Coll London, London, UK; UK; London, London, Coll Imperial Zambia Lusaka, ZAMBART, Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, Univ of Hopkins Johns Makerere Univ Coll of Hlth Scis, Kampala, Uganda; Uganda; Kampala, Scis, Hlth of Coll Univ Makerere Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; Botswana; Gaborone, Partnership, Inst AIDS Harvard Botswana USA; MA, Boston, Sch PH, of Harvard Pretoria, South Africa; South Africa; Pretoria, Churchyard Lockman V. Glidden V. Refeletswe Lebelonyane Refeletswe Joseph Makhema Med, London, UK; UK; London, Med, Hlth, Pretoria, South Africa; South Africa; Pretoria, Hlth, Francisco, San Francisco, CA, USA San Francisco, Francisco, Richard Katuramu Richard Hlth Financing Consult, Cape Town, South Africa; South Africa; Town, Cape Consult, Financing Hlth Women’s Hosp, Harvard Med Sch, Boston, MA, USA MA, Sch, Med Boston, Harvard Hosp, Women’s Optimising South Africa’s HIV Response: Results Results Response: HIV OptimisingSouth Africa’s Towards the Second UNAIDS Target: Population- Target: Secondthe UNAIDS Towards Streamlining Antiretroviral Therapy Uptake: A Uptake: Therapy StreamliningAntiretroviral Botswana Is Close to Meeting UNAIDS 2020 Goals 2020 UNAIDS Meeting CloseIs to Botswana 1 1 4 Case Investment TB and HIV the of Calvin Chiu 1 (PopART)071 HPTN in Coverage ART Level SarahFidler J. 1 DiagnosisHIV Following Initiation ART Christopher Hoffmann 1 2 Trial Randomized Cluster Stepped-Wedge Gideon Amanyire of 90-90-90 Coverage 90-90-90 of Gaolathe Tendani Gaborone, Botswana; Botswana; Gaborone, Africa; Africa; Peter Bock Peter London, UK; UK; London, Hlth, Baltimore, MD, USA; USA; MD, Baltimore, Hlth, Africa Africa Katherine L. Fielding Katherine AIDS Inst Partnership, Gaborone, Botswana; Botswana; Gaborone, Partnership, Inst AIDS Univ, Boston, MA, USA; USA; MA, Boston, Univ, Richard Hayes Richard Diseases Rsr Collab, Kampala, Uganda; Uganda; Kampala, Diseases Collab, Rsr Johannesburg, South Africa; South Africa; Johannesburg, A Randomized Trial to Accelerate HIV Care andCare HIV Accelerate to Trial Randomized A Task Team and Steering Committee Committee and Steering Team Task Kiwango Sumner , World, Health Organization, Geneva, Switzerland , U.S., Department of State, Washington DC, , USA
115 114 112 111
113LB
11:00 10:45 10:30 10:15 10:00 10:00 AM-12:0010:00 PM 90-90-90 to Getting Moderators Abstract Oral LisaNelsonJ. SessionO-10 Oral Abstracts Vitoria Marco Program and Agenda
637 Differences in Predictors for Ischaemic and 262 Altered Gut Microbes Enhance Mucosal CD4 T Cell Haemorrhagic Strokes in HIV+ Individuals Infection and Depletion Ex Vivo Camilla I. Hatleberg1; David Kamara2; Lene Ryom1; Stephane de Stephanie M. Dillon1; Eric L. Lee1; Andrew M. Donovan1; Kejun Guo1; Wit3; Matthew Law4; Peter Reiss5; Antonella d’Arminio Monforte6; Jens Michael S. Harper1; Daniel N. Frank1; Martin D. McCarter1; Mario L. D. Lundgren1; Caroline Sabin2; for the The Data Collection on Adverse Santiago1; Cara Wilson2 events of Anti-HIV drugs 1Univ of Colorado Anschutz Med Campus, Aurora, CO, USA; 2Univ of 1RigsHospet, Univ of Copenhagen, Copenhagen, Denmark; 2Univ Coll Colorado Hosp, Aurora, Aurora, CO, USA 3 4 London, London, UK; St Pierre Univ Hosp, Brussels, Belgium; Univ of 263 Enhancement of Microbiota in Macaques Leads to New South Wales, Sydney, Australia; 5Amsterdam Inst for Global Hlth and Develop, Amsterdam, Netherlands; 6Infectious Diseases Clinic, San Paolo Beneficial Immune Function Modulation 1 1 1 Hosp, Univ of Milan, MIlan, Italy Jennifer A. Manuzak ; Tiffany Hensley-McBain ; Charlene Miller ; Alexander Zevin1; Jason M. Brenchley2; Jacob D. Estes3; Stanley 638 Persistently Increased Ischemic Stroke Risk in HIV- Langevin1; R. Keith Reeves4; Elias Haddad5; Nichole Klatt1 Infected Women 1Univ of Washington, Seattle, WA, USA; 2Frederick Natl Lab for Cancer Rsr, Felicia Chow1; Susan Regan2; Sara E. Looby2; Markella V. Zanni2; James Frederick, MD, USA; 3Frederick Natl Lab, Leidos Biomed Rsr, Frederick, MD, B. Meigs2; Cheryl D. Bushnell3; Steven K. Feske4; Steven Grinspoon2; USA; 4Harvard Univ, Boston, MA, USA; 5Drexel Univ, Philadelphia, PA, USA 2 Virginia A. Triant 264 Fecal Microbial Transplantation: Safety and 1Univ of California San Francisco, San Francisco, CA, USA; 2Massachusetts General Hosp, Boston, MA, USA; 3Wake Forest Baptist Med Cntr, Winston Engraftment During Treated HIV Infection 1 2 1 1 Salem, NC, USA; 4Brigham and Women’s Hosp, Harvard Med Sch, Boston, Ma Somsouk ; Ivan Vujkovic-Cvijin ; Montha Pao ; Peter W. Hunt ; 1 1 MA, USA Susan V. Lynch ; Joseph M. McCune 1Univ of California San Francisco, San Francisco, CA, USA; 2NIH, Bethesda, 639 Stroke in HIV-Infected Patients in the Combination MD, USA Antiretroviral Therapy Era Juan Berenguer1; Alejandro Alvaro-Meca2; Asuncion Diaz3; Dariela Session TD-9 Themed Discussion Room 312 1 3 Micheloud ; Salvador Resino 1:45 PM-2:45 PM 1Hosp General Universitario Gregorio Marañón, Madrid, Spain; 2Univ Rey Juan Carlos, Alcorcón, Spain; 3Inst de Salud Carlos III, Madrid, Spain Cryptococcal Disease: Detection and Complications 640 Incidental Carotid Plaque in HIV Is Associated With Themed Discussion Leader Subsequent Cerebrovascular Events Ian M. Sanne, University of the Witwatersrand, Wits Health Consortium, Johannesburg, South Africa Sumbal Janjua; Pedro Staziaki; Richard Takx; Orla Hennessy; Michael Lu; Markella V. Zanni; Steven Grinspoon; Udo Hoffmann; Tomas G. 760 Maximizing Detection and Improving Outcomes of Neilan Cryptococcosis in Rural Tanzania Massachusetts General Hosp, Boston, MA, USA 1 2 3 3 • Wednesday, February 24, 2016 24, February Wednesday, • Diana Faini ; Aneth V. Kalinjuma ; Julie Neborak ; Alexa King ; Dorcas Mnzava2; Tracy Glass4; Hansjakob Furrer5; Christoph Hatz4; David R. Session TD-8 Themed Discussion Room 302 Boulware3; Emilio Letang4 1:45 PM-2:45 PM 1Ifakara Hlth Inst, Dar es Salaam, Tanzania; 2Ifakara Hlth Inst, Morogoro, HIV and Microbiomes Tanzania; 3Univ of Minnesota, Minneapolis, MN, USA; 4Swiss Trop Inst of PH, Basel, Switzerland; 5Bern Univ Hosp and Univ of Bern, Bern, Oral Sessions Themed Discussion Leader Switzerland Nichole Klatt, University of Washington, Seattle, WA, US 759 Evaluation of Provider-Initiated Cryptococcal Antigen 260 Distinct Gut Microbiota Composition in Gay Men Screening, South Africa Muntsa Rocafort1; Marc Noguera-Julian1; Yolanda Guillen2; Mariona Nicky Longley1; Snigdha Vallabhaneni2; Mariette Smith3; Rachel Parera1; Piotr Nowak3; Falk Hildebrand4; Georg Zeller4; Anders Smith2; Meg Osler3; Nicola Kelly3; Anna Cross3; Andrew Boulle4; Graeme Sönnerborg3; Peer Bork4; Roger Paredes1 Meintjes3; Nelesh Govender5 1IrsiCaixa Inst for AIDS Rsr, Badalona, Spain; 2IrsiCaixa Inst for AIDS Rsr, 1St George’s Univ of London, London, UK; 2CDC, Atlanta, GA, USA; 3Univ Barcelona, Spain; 3Karolinska Inst, Stockholm, Sweden; 4Structural and of Cape Town, Cape Town, South Africa; 4Cntr for Infectious Disease Epi Computational Biology, European Molecular Biology Lab, Heidelberg, and Rsr, Cape Town, South Africa; 5Natl Inst of Communicable Diseases, Germany Johannesburg, South Africa 261 Impact of HIV-Associated Changes in the Gut 762 Immunologic Discrimination of Cryptococcal IRIS From Microbiome on Disease Progression Culture-Positive Relapse Jesús Luévano; David B. Gootenberg; Jeffrey M. Paer; Bruce D. Walker; David R. Boulware1; Joshua R. Rhein1; Edward N. Janoff2; Abdu Douglas S. Kwon Musubire3; Andrew Kambugu3; Paul Bohjanen1; David B. Meya3; for Ragon Inst of MGH, MIT, and Harvard, Cambridge, MA, USA the COAT Trial Team 1Univ of Minnesota, Minneapolis, MN, USA; 2Univ of Colorado, Denver, CO, USA; 3Infectious Diseases Inst, Kampala, Uganda
38 CROI 2016 Wednesday, February 24, 2016 • Oral Sessions 39 ; 3 ; 4
5 ; 2 ; Pilar ; Pilar ; 2 3 ; Gilles 3
6 IAS, Cape Cape IAS, CROI 2016 5
Boston Boston Ballroom Ballroom A ; Till ; Till 4 Cntr for for Cntr 1 2 ; Laura M. ; Laura 3 Africa Cntr for for Cntr Africa ; Nancy L. Czaicki 4 2 Midlands Med Cntr, Cntr, Med Midlands 5 ; Thea ; Thea Savory Univ of California California of Univ 2 3 ; Carol Cragg ; Carol 2 Harvard Sch PH, of Harvard Boston Univ Sch Univ of Boston 5 2 ; Till ; Till Bärnighausen ; Maria Puzzovio Program Agenda and 4 1 ; Tessa Govender ; Tessa ; Elena Losina ; Elena ; Gianvincenzo Zuccotti ; Gianvincenzo Médecins Sans Frontières, SansMédecins Frontières, Ospedale Buzzi, Univ of Univ Ospedale Buzzi, San Scientific Raffaele 5 1 2 ; Atheendar ; Atheendar 2 4 2 2 Africa Cntr for Hlth and Pop Pop and Hlth for Cntr Africa
4 Boston Univ, Boston, MA, MA, Boston, Univ, Boston Boston Univ, Boston, MA, MA, Boston, Univ, Boston 1 ; Janet Giddy 2 2 2 ; Michael LaValley 2 ; Vivian ; Vivian Cox 2 ; Kafula Mulenga 2 ; Paola Erba ; Paola
2 ; Izukanji Sikazwe Brigham and Women’s Hosp, Harvard Harvard Hosp, Women’s and Brigham 2 ; Deenan Pillay ; Jacob Bor; Jacob 6 ; Douglas Ross 4 4
2 1 5 ; Sydney Rosen ; Sydney 2 Western Cape Dept of Hlth, Cape Town, South Town, Cape Dept Hlth, of Cape Western 3 ; Alessandro Ambrosi ; Alessandro 2 McCord Hosp, Durban, South Africa; Durban, Hosp, McCord ; Kenneth A. Freedberg ; Kenneth 3 1 ; Matthew P. Fox P. ; Matthew 1 ; Sharon M. Coleman ; Sharon 1 ; Katia Maruca ; Katia e and 1-Year Mortality Newly in 1-Year and e ; Carolyn Moore ; Carolyn ; Wilkinson Lynne 1 Univ of Milan, Milan, Italy; Milan, Milan, of Univ 2 1 3 ; Tanser Frank 3 ; Deenan Pillay ; Elvin H. Geng ; Elvin
; Charles Holmes ; Charles 3 3 2 1 ; Anna Grimsrud ; Anna 4 ; Matthew P. Fox P. ; Matthew 1 ; Silvia Capelli 3 ; Christine E.; Christine Chaisson Médecins Sans Frontières, Cape Town, South Africa; South Africa; Town, Cape SansMédecins Frontières, 4 4 Harvard Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, of Harvard Massachusetts General Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, General Massachusetts 3 3 Massachusetts General Hosp, Boston, MA, USA; MA, Boston, Hosp, General Massachusetts Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ South Africa; Town, Cape Town, Cape of Univ Boston Univ Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, Univ of Boston Boston Univ Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, Univ of Boston Luigi Sacco Hosp, Univ of Milan, Milan, Italy; Milan, Milan, of Univ Hosp, Sacco Luigi Khayelitsha, South Africa; South Africa; Khayelitsha, Town, South Africa Town, USA; USA; HIV-Infected Youths: A 10-Year Study 10-Year A Youths: HIV-Infected USA; USA; Africa; Africa; Boston, MA, USA MA, Boston, Children’s Hosp, Harvard Med Sch, Boston, MA, USA; MA, Sch, Med Boston, Harvard Hosp, Children’s Rochelle P. Walensky Rochelle P. 1 Van Cutsem Van 1 Car Barriers to Southin Africa DiagnosedPersons HIV+ Bassett V. Ingrid Hlth and Pop Studies, Mtubatuba, South Africa; South Africa; Mtubatuba, Studies, Pop and Hlth 1 Clubs Adherence ART in Enrolled OutcomesPatients of Viral Resuppression After Sharp T. Joseph 1 Improve to Patterns Appointment Evaluating Zambiain SustainabilityTreatment HIV of MonikaRoy Mwanza Mwanza 1 Sickest? the out Crowd Expansions Eligibility ART Do South Africa From Evidence SherylKlubergA. Retention in HIV Care HIV in Retention Bor Jacob 1 Impact onCriteria CD4-Eligibility of Real-World The South Africa Mtubatuba, Studies, Inst, Milan, Italy; Milan, Inst, Safety of Tenofovir on Bone Mineral DensityMineral inBone on SafetyTenofovir of Giacomet Vania Stefano Mora Stefano Italy Milan, Milan, Pietermaritzburg, South Africa; Pietermaritzburg, Bogart Berkeley, Berkeley, CA, USA Berkeley, Berkeley, Med Sch, Boston, MA, USA MA, Sch,Med Boston, Venkataramani Bärnighausen Nancy Padian PH, Boston, MA, USA; MA, Boston, PH, Nannini Infectious Disease Rsr in Zambia, Lusaka, Zambia; Zambia; Lusaka, DiseaseInfectious Zambia, in Rsr
1016 1031 1018 1012 SessionTD-11 Themed Discussion PM-2:451:45 PM Outcomes Treatment Enhance to Innovations Discussion Leader Themed Sciences, Health of College University Makerere , Kamya R. Moses 1011 Kampala, Uganda Kampala, 819 ; ; ; 4 4 1 ; ; 4 4 ; ; 4 8
GSK, 6 Harvard Harvard Queen Pfizer, Inc, Inc, Pfizer, 4 6 ; Jayvant ; Jayvant 4 7 Room Room 311 ; Devi ; Muchaneta 7
1 4 ViiV Hlthcare, Hlthcare, ViiV Eunice Kennedy Kennedy Eunice 9 6 Gilead Scis, Inc, Inc, Scis, Gilead 7 IMPAACT IMPAACT 4 ; David R. ; David ; Kathleen George ; Kathleen 3 3 Miller Children’s Hosp, Hosp, Children’s Miller ; Srinivas Rao Valluri Rao; Srinivas 4 Botswana Harvard Harvard Botswana ; Michael Hughes 5 2 3 ; Jagmohan Batra ; Bozena M. Morawski M. ; Bozena Joint Clinical Rsr Cntr, Cntr, Rsr Clinical Joint ; Annie Buchanan; Annie 3 2 2 7 Pfizer, Inc, Groton, CT, USA CT, Groton, Inc, Pfizer, ; Kulkanya ; Kulkanya Henry M. Jackson Fndn Henry Fndn Jackson M. 8 Harvard Sch of PH, Boston, Boston, Sch PH, of Harvard 2 3 Makerere Univ Coll of Hlth Hlth of Coll Univ Makerere 2 2 ; Steven Rossi ; Steven CDC, Atlanta, GA, USA Atlanta, CDC, ; Lynn McFadyen ; Lynn ; Yongwu Shao ; Yongwu 2 5 6 6 ; Renee DonahueCarlson 3
7 ; Roger L. Shapiro 6 ; Terry Fenton Terry ; 2 ; David B. Meya B. ; David Frontier Sci & Tech Rsr Fndn, Inc, Inc, Fndn, Rsr Sci Tech & Frontier 3 7 Univ of California San Diego, San San Diego, California of Univ
10 Sefako Makgatho Hlth Scis Univ, Pretoria, Pretoria, Scis Hlth Univ, Makgatho Sefako NIH, Rockville, MD, USA; USA; MD, Rockville, NIH, ; Elna van der Ryst der van ; Elna 2 5 4 ; Bobbie Graham ety, and Efficacyand in Maraviroc of ety, ; for the IMPAACT P1093 the IMPAACT ; for 6 Ragon Inst of MGH, MIT and Harvard, Harvard, and MIT MGH, of Inst Ragon 5 ; Rana Chakraborty 10 ; Erin Quirk; Erin ; Noeline Nakasujja; Noeline 2 7 1 ; Patrick Jean-Philippe ; Patrick 2 Infectious Diseases Inst, Kampala, Uganda; Uganda; Kampala, DiseasesInfectious Inst, 3 ; Kenneth Maswabi ; Kenneth Harvard Med Sch, Boston, MA, USA MA, Sch, Med Boston, Harvard Khon Kaen Univ, Khon Kaen, Thailand; Thailand; Kaen, Khon Univ, Kaen Khon 1 6 5 ; Elizabeth Nalintya ; Elizabeth ; Daniel Kuritzkes 1 Pfizer Inc, The Rsr Network, Sandwich, UK; Network, Rsr The Inc, Pfizer Emory Univ, Atlanta, GA, USA; GA,USA; Atlanta, EmoryUniv, 5 5 3 Pfizer, Inc, Sandwich, UK; Inc, Pfizer, ; Muthuhadini P. Mawela P. ; Muthuhadini ; Wicharn ; Wicharn Luesomboon ; Rebecca Zhang-Roper ; Rebecca 7 ; Carmelita Alvero ; Carmelita 1 GSK, Research Triangle Park, NC, USA; USA; NC, Park, Triangle GSK, Research 5 4 ; Annie Fang ; Annie 1 8 3 ; Andrew Kambugu ; Andrew 5 ; Rohan Hazra ; Hilda Kizito Siriraj Hosp, Mahidol Univ, Bangkok, Thailand; Thailand; Bangkok, Univ, Mahidol Hosp, Siriraj 5 1 3 , World, Health Organization, Geneva, Switzerland ; Rolando Viani 9 ; Martin S. Rhee ; for the COAT and ORCAS Trial Teams Teams Trial and ORCAS the COAT ; for SDAC, Harvard Sch of PH, Boston, MA, USA; USA; MA, Sch Boston, PH, of Harvard SDAC, 7 1 3 ; Sikhulile Moyo 2
8 St Jude Children’s Rsr Hosp, Memphis, TN, USA; USA; TN, Memphis, Hosp, Rsr Jude Children’s St Univ of Padova, Padova, Italy; Padova, Padova, of Univ Albert Einstein Coll of Med, Bronx, NY, USA; USA; NY, Bronx, Med, of Coll Albert Einstein Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ Univ of Minnesota, Minneapolis, MN, USA; USA; MN, Minneapolis, Minnesota, of Univ GA, USA; Atlanta, Emory Sch Med, Univ of Operations, Durham, NC, USA; USA; NC, Durham, Operations, New York, NY, USA; USA; NY, York, New Chokephaibulkit Heera Cindy Vavro Cindy Foster City, CA, USA City, Foster Manoli Vourvahis AIDS Inst Partnership, Gaborone, Botswana; Botswana; Gaborone, Partnership, Inst AIDS Mathias Lichterfeld Mathias Bhondai Buffalo, NY, USA; USA; NY, Buffalo, SenGupta Kampala, Uganda; Uganda; Kampala, Thailand; Buri, Chon Hosp, Memorial Vadhana Savang South Africa; South Africa; Sch of PH, Boston, MA, USA; USA; MA, Sch Boston, PH, of MA, USA; USA; MA, Long Beach,CA, USA; Long Pharmacokinetics, Saf Pharmacokinetics, HIV R5 With Patients Pediatric CarloGiaquinto 1 SafetyInfected Efficacy HIV-1 and in E/C/F/TAF of Adolescents Treatment-Naïve Gaur Aditya Radha Rajasingham 1 Andrew Wiznia Andrew 1 IMPAACT 1093: Dolutegravir in 6- to 12-Year-Old 12-Year-Old to 6- in Dolutegravir 1093: IMPAACT 1 Nevirapine (NVP) Concentrations in HIV-Infectedin Concentrations (NVP) Nevirapine Dosing Therapeutic Receiving Newborns Capparelli Edmund 1 4 CryptococcalAntigenemia Montgomery MarthaP. Neurocognitive Function in HIV-Infected Persons With With Function Persons HIV-Infected in Neurocognitive Stockley Park, UK; UK; Park, Stockley Jona E. Kaplan Diego, CA, USA Diego, for the Advancement of Military Med, Inc, Rockville, MD, USA; USA; MD, Rockville, Inc, Military of Med, Advancement the for Pope Kosalaraksa Pope Shriver NICHD, Bethesda, MD, USA; USA; Bethesda, MD, NICHD, Shriver Boulware Cambridge, MA, USA; USA; MA, Cambridge, Ellen Townley Ellen HIV-Infected Children: 48-Week Results Results Children:48-Week HIV-Infected Scis, Kampala, Uganda; Uganda; Kampala, Scis, Research Triangle Park, NC, USA; USA; NC, Park, Triangle Research
1120 817 816 Martina Penazzato Martina 815 SessionTD-10 Themed Discussion PM-2:451:45 PM Long? so Taking What's Kids: Drugs for New Discussion Leader Themed 761 Program and Agenda
Session TD-12 Themed Discussion Ballroom B/C Session S-5 Symposium CME Ballroom A 1:45 PM-2:45 PM 4:00 PM-6:00 PM It’s Complicated: Renal Function and STIs in PrEP Users Reaching 90-90-90 and Beyond: Challenges and Themed Discussion Leader Innovations Amanda Mocroft, University College London, London, United Kingdom Target audience: This session is directed to clinicians, scientists, 866 Higher Cumulative TFV/FTC Levels in PrEP Associated and public health practitioners who are interested in understanding With Decline in Renal Function the global HIV response targets, current status in terms of progress Monica Gandhi1; David V. Glidden1; Albert Y. Liu2; Howard Horng1; towards these targets and strategies that may enable their K. R. Amico3; Kathleen Mulligan1; Sybil Hosek4; Mauro Schechter5; achievement. Kenneth H. Mayer6; Robert Grant1; for the iPrEx Study Team 1 2 Level of knowledge: It is assumed that participants are familiar Univ of California San Francisco, San Francisco, CA, USA; San Francisco with basic concepts of the HIV global response and key elements of Dept of PH, San Francisco, CA, USA; 3Univ of Michigan Sch of PH, Ann Arbor, MI, USA; 4John H. Stroger Jr Hosp of Cook County, Chicago, IL, USA; HIV programming. 5Projeto Praça Onze, Universidade Fed do Rio de Janeiro, Rio de Janeiro, Objectives: At the completion of the session, participants will be Brazil; 6The Fenway Inst, Fenway Hlth, Boston, MA, USA able to: 867 Changes in Renal Function Associated With TDF/FTC • Describe the issues to be addressed in order to achieve global PrEP Use in the US Demo Project targets for HIV diagnosis and ART initiation, adherence and Albert Y. Liu1; Eric Vittinghoff2; Peter L. Anderson3; Stephanie Cohen1; retention Susanne Doblecki-Lewis4; Oliver Bacon1; Wairimu Chege5; Susan P. • Describe innovations to help overcome the implementation Buchbinder1; Michael Kolber4; Richard Elion6; for the Demo Project challenges Team • Assess progress toward achievement of targets over time 1San Francisco Dept of PH, San Francisco, CA, USA; 2Univ of California San Francisco, San Francisco, CA, USA; 3Univ of Colorado, Denver, CO, USA; Conveners 4Univ of Miami, Miami, FL, USA; 5DAIDS, NIAID, NIH, Bethesda, MD, USA; Serge Eholie, Treichville University 6George Washington Univ Sch of Med, Washington, DC, USA Teaching Hospital, Abidjan, Ivory Coast 868 Rare Incidence of Proximal Tubular Dysfunction With Catherine A. Hankins, Amsterdam Institute for Global Health and Tenofovir-Based Chemoprophylaxis Development, Amsterdam Netherlands Kenneth K. Mugwanya1; Jared M. Baeten1; Connie M. Celum1; Deborah Donnell2; Thomas Nickolas3; Nelly R. Mugo4; Andrea Branch5; 4:00 119 Option B+: A Stepping Stone to James K. Kairie6; Allan Ronald7; Christina Wyatt5; for the Partners PrEP Universal Treatment Study Team Andreas Jahn, Ministry of Hlth, Lilongwe, • Wednesday, February 24, 2016 24, February Wednesday, • 1Univ of Washington, Seattle, WA, USA; 2SCHARP, Fred Hutchinson Cancer Malawi Rsr Cntr, Seattle, WA, USA; 3Columbia Univ, New York, NY, USA; 4Kenya Med Rsr Inst, Thika, Kenya; 5Icahn Sch of Med at Mount Sinai, New York, 6 7 4:30 120 Missing But in Action: Where Are NY, USA; Univ of Nairobi, Nairobi, Kenya; Univ of Manitoba, Winnipeg, the Men? MB, Canada Helen Ayles, London Sch of Hygiene & Trop Oral Sessions 869 STI Data From Community-Based PrEP Med, London, UK Implementation Suggest Changes to CDC Guidelines Sarit A. Golub1; Stephanie Pena2; Kailip Boonrai3; Nora Douglas2; 2 2 5:00 121 Antiretroviral Therapy for Life: Machel Hunt ; Asa Radix Understanding and Improving 1Hunter Coll and the Grad Cntr, City Univ of New York, New York, NY, USA; 2Callen-Lorde Community Hlth Cntr, New York, NY, USA; 3Hunter HIV/AIDS Retention Rsr Team, Hunter Coll, New York, NY, USA Elvin H. Geng, Univ of California San Francisco, San Francisco, CA, USA 870 Quarterly STI Screening Optimizes STI Detection Among PrEP Users in the Demo Project 5:30 122 Innovations in Antiretroviral Therapy Delivery Stephanie Cohen1; Eric Vittinghoff2; Susan S. Philip1; Susanne Doblecki-Lewis3; Oliver Bacon1; Wairimu Chege4; Richard Elion5; Susan Anna Grimsrud, IAS, Cape Town, P. Buchbinder1; Michael Kolber3; Albert Y. Liu1 South Africa 1San Francisco Dept of PH, San Francisco, CA, USA; 2Univ of California San Francisco, San Francisco, CA, USA; 3Univ of Miami, Miami, FL, USA; 4DAIDS, NIAID, NIH, Bethesda, MD, USA; 5George Washington Univ Sch of Med, Washington, DC, USA
40 CROI 2016 Wednesday, February 24, 2016 • Oral Sessions 41 CROI 2016 Room 304/306 Room
Program Agenda and
o , Univ of Colorado, Colorado, of Univ , , Harvard Univ, Boston, Boston, Univ, Harvard , , Francis Crick Inst, Inst, Crick Francis , CME , Frederick Natl Lab, Leidos Leidos Lab, Natl Frederick ,
It is assumed that participantsassumed that is It familiar are This session is directed to clinicians and scientists , University of Minnesota, Minnesota, of University , London, UK London, and HIV/SIV InfectionsHIV/SIV and Connick Elizabeth USA CO, Denver, Antigen Recognition by B Cells B by Recognition Antigen Facundo Batista HIV? Reservoirfor Carroll C. Michael and Persistence Viral Understand Function Impaired Estes D. Jacob USA MD, Frederick, Rsr, Biomed Visualizing the Early Events of Earlythe Events Visualizing a Cells Dendritic Follicular Are Tissuest Imaging Lymphoid cell, T Cytotoxic Node, Lymph The MA, USA MA, At theAt completion of thesession, participants will be
, National Institutes of Health, Health, of Institutes National , 129 130 127 128
Describe the architecture of the lymph node, and where where and node, Describelymph architecture the the of responses generatedimmune are Describe how antigen presenting cells within lymph nodes are orchestrating in responses immune involved Describe where HIV/SIV replicates inlymph nodes Describe why antiviralCD8 T cells have difficulty suppressing HIV/SIV replicationin lymph nodes • • • • 5:00 5:30 who are interested in understanding HIV/SIV immunology, virology, virology, immunology, understanding in interested HIV/SIV are who pathogenesis. and knowledge: of Level with basic concepts of how immune responsesare generatedto infections or vaccines, and how HIV/SIV replicates. Objectives: able to: Conveners Symposium Moir Susan Infectious and Allergy of Institute National Diseases, Bethesda, MD, USA Hasse T. Ashley Minneapolis, MN, USA 4:00 4:30 SessionS-7 Symposium PM-6:004:00 PM Node Lymph The Location: Location, Location, audience: Target Ballroom B/C Ballroom
ection , Case Western Reserve Western Case , , Burnet Inst, Melbourne, Melbourne, Inst, Burnet , , Columbia Univ, New New Univ, Columbia , CME ; for the UCD HIV Molecular Molecular HIV UCD the for ;
It is assumed that participantsassumed that is It familiar are , Medical University of of University Medical , Research Group, Univ Coll Dublin, Dublin, Dublin, Coll Univ Group, Research Ireland SuzanneCrowe M. Australia Bone? to Do Therapy Patrick Mallon Elizabeth Elizabeth Verna C. USA NY, York, HIV Treated in Complications Infection HIV Treatment Era Treatment HIV McComsey A. Grace USA OH, Cleveland, Univ, What Exactly What Antiretroviral Does NAFLD and NASH in HIV Inf HIV in NASH NAFLD and Metabolic of Immunopathogenesis Visceral Adiposity in the Modernthe in Adiposity Visceral , The, Johns Hopkins At theAt completion of thesession, participants will be
126 125 124 123
Describe immunologic mechanisms thought to drive metabolic metabolic drive to thought Describe mechanisms immunologic infected HIV childrencomplications in adults and and pathogenesis Describe current understanding the the of clinical consequences of visceraladiposity, NASH/NAFLD,and bone disease in HIV infected adults andchildren • • 5:30 5:00 4:30 4:00 Todd T. Brown ToddT. University, Baltimore, MD, USA Eckard R. Allison South Carolina, Charleston, SC, USA able to: Conveners with the basic concept that HIV may cause immune activation and that HIV may increase the risk ofmetabolic complications. Objectives: 4:00 PM-6:004:00 PM Metabolicof Consequences and Pathogenesis Complications Thisaudience: sessionTarget is directed toclinicians and understanding pathogenesis in interested the scientists are who patients metabolic with HIV complications in consequences of and infection. Levelof knowledge: SessionS-6 Symposium Program and Agenda
11:00 137 The PPIP122-125 Motif in HIV-1 CA Is an Essential THURSDAY, FEBRUARY 25, 2016 Assembly and Maturation Element Mariia Novikova1; Muthukumar Balasubramaniam1; Sagar Thursday Plenary Session CME Auditorium Kudchodkar1; Ferri Soheilian2; Anna T. Gres3; Karen A. Kirby4; 8:30 AM-9:30 AM Stefan G. Sarafianos3; Eric O. Freed1 8:30 131 Tuberculosis: Why Do I Have to 1NCI, Frederick, MD, USA; 2Leidos Biomed Rsr, Inc, Frederick, MD, 3 4 Take So Many Pills? USA; Univ of Missouri, Columbia, MO, USA; Univ of Missouri Sch of Med, Columbia, MO, USA Eric J. Rubin, Harvard School of Public Health, Boston, MA, USA 11:15 138 Characterization of 2 CCR5 Tropic HIV-1 Viruses Exhibiting High Env Content 9:00 132 The Evolving Epidemiology of HIV Sean P. O’Brien1; Terra M. Ireland1; Julian W. Bess1; James Infection in Persons Who Inject D. Roser1; Elena N. Chertova1; Gregory Q. Del Prete2; Brandon 2 2 Drugs: Indiana 2015 Keele ; Jeffrey Lifson 1Leidos Biomed Rsr, Inc, Frederick, MD, USA; 2Frederick Natl Lab, John T. Brooks, Centers for Disease Control Frederick, MD, USA and Prevention, Atlanta, GA, USA 11:30 139 Nuclear Entry of HIV Requires Reshaping of Integrase Multimers Session O-11 Oral Abstracts Room 312 Frauke Christ1; Lieve Dirix2; Doortje Borrenberghs2; Flore De 10:00 AM-12:00 PM Wit1; Jolien Blokken1; Susana Rocha1; Jelle Hendrix2; Zeger HIV Virology: Putting It All Together Debyser1; Johan Hofkens2 1Katholieke Universiteit Leuven, Leuven, Belgium; 2Katholieke Oral Abstract Moderators Universiteit Leuven, Heverlee, Belgium Javier Martinez-Picado, IrsiCaixa Institute for AIDS Research, Badalona, Spain 11:45 140 1970s HIV-1 Genomes Reveal the Early History of Manish Sagar, Boston University, Boston, MA, USA the North American HIV/AIDS Epidemic Michael Worobey1; Thomas D. Watts1; Richard A. McKay2; 10:00 133 Type 1 Interferon Resistance Is a Hallmark of Timothy Granade3; Beryl A. Koblin4; Walid Heneine3; Harold W. Mucosally Transmitted HIV-1 Jaffe3 Frederic Bibollet-Ruche1; Shilpa Iyer1; Ronnie Russell1; 1Univ of Arizona, Tucson, AZ, USA; 2Univ of Cambridge, Andrew G. Smith1; Christiana M. Shaw1; Yingying Li1; Timothy Cambridge, UK; 3CDC, Atlanta, GA, USA; 4New York Blood Cntr, Decker1; George M. Shaw2; Persephone Borrow3; Beatrice Hahn1 New York, NY, USA 1Univ of Pennsylvania, Philadelphia, PA, USA; 2Perelman Sch 3 of Med, Univ of Pennsylvania, Philadelphia, PA, USA; Univ of Session O-12 Oral Abstracts Room 304/306 Oxford, Oxford, UK 10:00 AM-12:00 PM 10:15 134 Expression and Potency of IFNa Subtypes in an Ex Central Nervous System: Viral Dynamics, Biomarkers, Vivo Model of Acute HIV-1 Infection and Cognition Mario L. Santiago1; Michael S. Harper1; Kejun Guo1; Kathrin • Thursday, February 25, 2016 25, February Thursday, • Gibbert2; Eric L. Lee1; Stephanie M. Dillon1; Martin D. McCarter1; Oral Abstract Moderators Kim J. Hasenkrug3; Ulf Dittmer2; Cara Wilson4 Paola Cinque, San Raffaele Scientific Institute, Milano, Italy 1Univ of Colorado Anschutz Med Campus, Aurora, CO, USA; 2Univ Renaud Du Pasquier, Centre Hospitalier Universitaire Vaudois, Lausanne, of Duisburg-Essen, Essen, Germany; 3NIAID, NIH, Hamilton, MT, Switzerland USA; 4Univ of Colorado Hosp, Aurora, Aurora, CO, USA 10:00 141 SIV-Infected Brain Macrophages Leave the OralSessions 10:30 135 Novel Mechanism of Interferon Restriction of Central Nervous System HIV-1 in Humans Xavier Alvarez1; Cecily Midkiff1; Andrew Lackner1; Kenneth C. Ramy El-Diwany1; Michael Chattergoon1; Justin R. Bailey1; Williams2 Stuart C. Ray1; Sarah J. Wheelan1; Joel N. Blankson2; Robert 1Tulane Natl Primate Rsr Cntr, Covington, LA, USA; 2Boston Coll, Siliciano3; David L. Thomas2; Ashwin Balagopal1 Chestnut Hill, MA, USA 1Johns Hopkins Univ, Baltimore, MD, USA; 2Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; 3Howard Hughes Med Inst, 10:15 142 CSF Lymphocyte and Monocyte Activation and Baltimore, MD, USA Trafficking in Primary HIV Infection Xiang Li1; Fangyong Li2; Anji Yi2; Julia Peterson3; Brinda Emu1; 10:45 136 SERINC3 and SERINC5 Are Novel Antiviral Proteins Richard W. Price3; Elizabeth Sinclair3; Serena S. Spudich1 Antagonized by HIV-1 Nef 1Yale Univ Sch of Med, New Haven, CT, USA; 2Yale Univ Sch of Yuanfei Wu; Yoshiko Usami; Heinrich G. Gottlinger PH, New Haven, CT, USA; 3Univ of California San Francisco, San Univ of Massachusetts Med Sch, Worcester, MA, USA Francisco, CA, USA
42 CROI 2016 Thursday, February 25, 2016 • Oral Sessions 43 ; ; ; 4 1 ; 1 ; 1 4 ; ;
6 5 3 Yale Yale Natl ; 2 3 7
4 2 Univ Univ ; Maria ; for the ; for 6 2 1 ; Jessica ; Ruy 2 1 CROI 2016 ; Lisa ; Tamer Elbaz ; Tamer Ashwin 3 ; OlaNada 3 5 ; Academic Academic Ballroom B/C Ballroom 4 2 Presidio Presidio 7 ; William ; William Switzer ; Vincent Lo Re Lo Vincent ; 1 5 European Egyptian Egyptian European Imam Waked Imam 6 Los Alamos Natl Lab, Lab, Natl Alamos Los ; Virginia Virginia ; Dorien van de Berg ; Dorien van 3 7 2 2 ; Richard Moore ; Richard ; Janke Schinkel ; Janke Kaiser Permanente Permanente Kaiser 7 ; Richard Colonno ; Richard 1 Program Agenda and 7 6 ; Hadeel Gamal Eldeen ; Jennifer Shellenberger ; Jennifer 3 1 PH Service of Amsterdam, ServicePH Amsterdam, of ; Yury ; Yury Khudyakov 3 1 ; Mark Sulkowski Kasr Alaini Viral Hepatitis Hepatitis Viral Alaini Kasr ; Neeltje A. Kootstra A. ; Neeltje 2 ; Joseph J. Eron ; Joseph J. 4 2 ; Pamela Pontones ; Pamela 2 ; Asmaa Gomaa 1 2 ; David L. Thomas L. ; David ; Vig Pamela ; Teshale Eyasu 3 7 1 Antibodies Avert HCV Avert Antibodies ; Marina B. Klein ; Marina B. Univ of North Carolina at Chapel at Chapel North of Univ Carolina 4 3 Johns Hopkins Univ, Baltimore, Baltimore, Univ, Hopkins Johns Cairo Fatemic Hosp, Cairo, Egypt; Egypt; Cairo, Hosp, Fatemic Cairo 4 e in HCV-Genotypein e Patients 4 2 ; Alyaa Sabry ; Alyaa Indiana State Dept of Hlth, Indianapolis, Indianapolis, Dept Hlth, of State Indiana ; John Ward 2 2 ; Tim ; Tim Beaumont 2 Johns Hopkins Univ Sch of Med, Baltimore, Baltimore, Sch Med, of Univ Hopkins Johns 1 4 C, Alcohol, and CD4 Drive End- Drive CD4 and Alcohol, C, herapy Reduces Intrahepatic Intrahepatic Reduces herapy ; Mohammed Abdel-Hamid ; Richard Molenkamp ; Richard 2 1 MyLab Lab, Cairo, Egypt; Egypt; Cairo, Lab, MyLab
; Eric Ruby ; Eric 5 ; Merve Gurakar ; Michael J. Silverberg ; Michael J. 7 ; Amy C. Justice ; Amy 1 3 HCV Transmissions Among Persons Persons Among HCVTransmissions 1 ; Hanaa Abdel-Maguid 6 ; Abraham J. Kandathil J. ; Abraham ; Maissa El Raziky ; Maissa El 1 ; Romeo R. Galang 1 1
; Sylvie M. Koekkoek ; Sylvie 1 1 ; Alan S. Perelson ; Alan 3 McGill Univ Hlth Cntr, Montreal, QC, Canada; Canada; QC, Montreal, Cntr, Hlth Univ McGill ; Gregory D. Kirk ; Gregory D. 5 4 ; Sara J. Blosser ; Sara J. 2 ; Arjen Q. Bakker Q. ; Arjen 3 , Cornell, University, USA New York, NY, Cairo Univ, Cairo, Egypt; Egypt; Cairo, Univ, Cairo AIMM Therapeutics, Amsterdam, Netherlands; Netherlands; Amsterdam, Therapeutics, AIMM Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns CDC, Atlanta, GA, USA; Atlanta, CDC, USA; MD, Sch Baltimore, PH, of Bloomberg Hopkins Johns Med Cntr, Amsterdam, Netherlands; Netherlands; Amsterdam, Cntr, Med Cntr, Cairo, Egypt; Egypt; Cairo, Cntr, of Pennsylvania, Philadelphia, PA, USA; USA; PA, Philadelphia, Pennsylvania, of M. Ribeiro Gentry HIV-HCV Transmission Team Investigation Transmission HIV-HCV Northern California, Oakland, CA, USA Oakland, Northern California, Los Alamos, NM, USA; USA; NM, Alamos, Los Jacobson Commonwealth Univ, Richmond, VA, USA; USA; VA, Richmond, Univ, Commonwealth Gamal Esmat High Response Rat High Response Sofosbuvir and Ravidasvir With Treated 1 Hill, Chapel Hill, NC, USA; USA; NC, Hill, Chapel Hill, 1 Mohammed Karim Antiretroviral T Antiretroviral HIV-1/HCVin C CoinfectionHepatitis Quinn Jeffrey 1 Neutralizing Broadly ReInfectionSubsequentor Chronic Infection SabrinaMerat J. Who InjectWho Drugs: 2015 Indiana, SumathiRamachandran 1 and B Hepatitis Disease Adults HIV+ in StageLiver Althoff N. Keri 1 USA; MD, Networks of Networks IN, USA IN, Philip Peters Sherine Helmy CA, USA San Francisco, Pharmaceuticals, Univ, New Haven, CT, USA; USA; CT, Haven, New Univ, Liver Inst, Shebeen El Kom, Egypt; Egypt; Kom, Shebeen El Inst, Liver MD, USA MD, Balagopal Mahmoud Abouelkhair Prins Amsterdam, Netherlands Amsterdam, Brown Nathaniel Sonia Napravnik Ramy El-Diwany Ramy Egypt; Alexandria, Industries, Pharmaceutical Camille Bru Camille , Harvard, Medical School, Boston, MA, USA
153 152 151 149 150
11:00 10:45 10:30 SessionO-13 Oral Abstracts AM-12:0010:00 PM Population the Not but HCV:Patient the Curing Moderators Abstract Oral ArthurKim Y. KristenM. Marks 10:00 10:15 ; 4 ; ; 3 2 ; Todd ; Todd ; Justin 2 2 ; Cynthia ; Cynthia 1 ; for the ; for ; Joseph J. ; Joseph J. 5 NIH, NIH, 5 ; Caroline ; Caroline ; 2 ; Sudhir 1 2 2 Univ of Univ 5 Dana-Farber Dana-Farber ; Todd T. Brown T. ; Todd Cleveland Clinic/ Cleveland 2
Frontier Sci Frontier 3 2 2 ; Todd Hulgan ; Todd 5 5 ; Anthony Lee ; Anthony 2 ; Avindra Nath ; Avindra ; Matthan W. Caan W. ; Matthan 2 1 ; David Rusin ; David Feinberg Sch of Med, Sch Med, of Feinberg ; Vikas ; Vikas Misra 4 6 1 ; Winston Alan ; Yan Guo ; Yan 4 ; Robert Leech 2 3 ; Norman Haughey ; Norman Vanderbilt Univ, Nashville, Nashville, Univ, Vanderbilt Academic Med Cntr, Cntr, Med Academic 1 3 ; Anupriya Dutta ; Anupriya 2 3 Johns Hopkins Univ, Baltimore, Baltimore, Univ, Hopkins Johns Allele ImpactAllele Midlife 3 ; Dana Gabuzda Dana-Farber Cancer Inst, Inst, Cancer Dana-Farber y Number and Number y 4 3 ; Antoine Chaillon; Scott R. Chaillon; ; Antoine ; Scott R. Letendre Neurocognitive Impairment Neurocognitive ssociated With Poorer Poorer With ssociated 5 Univ Coll London, London, UK; London, London, Coll Univ 3 ; Peter Reiss ; Peter ; James H. Cole 2 ; Joseph Steiner 1 ; Baiba Berzins 1 2 ; for the AIDS Clinical Trials Group Team Team Group Trials the AIDS Clinical ; for 6 ; Sachiko Miyahara ; Sachiko 1 ; Joseph Locascio Northwestern Univ, Feinberg Sch of Med, Sch Med, of Feinberg Univ, Northwestern 1 4 ; Asha R. Kallianpur ; Ron Ellis 1 5 ; Davide De Francesco ; Davide ; Richard L. Skolasky ; Richard 1 Imperial Coll of Sci, Tech and Med, London, UK London, Med, and Sci, of Tech Coll Imperial 1 ; Alexander Holman ; Alexander 5 2 ; Wolinsky Steven 4
Northwestern Univ, Chicago, IL, USA; IL, USA; Chicago, Univ, Northwestern 1 Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns 4 ; Ellen S. Chan ; Ellen 4 3 ; Richard Moxley ; Richard 1 ; Charles B. Majoie B. ; Charles 3 ; Babafemi Taiwo 1 Imperial Coll London, London, UK; UK; London, London, Coll Imperial Amsterdam, Develop, and Hlth Global for Inst Amsterdam Harvard Univ, Boston, MA, USA; USA; MA, Boston, Univ, Harvard Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, of Univ Hopkins Johns USA; NC, Hill, Chapel Hill, at Chapel North of Univ Carolina Massachusetts General Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, General Massachusetts Vanderbilt Univ Sch of Med, Nashville, TN, USA; USA; TN, Nashville, Sch Med, Univ of Vanderbilt David J. Sharp J. David TN, USA; USA; TN, Sabin Amsterdam, Netherlands; Netherlands; Amsterdam, Northwestern Univ, Chicago, IL, USA Chicago, Univ, Northwestern Sanjay R. Mehta Sanjay Lorenz David Lorenz Netherlands; Netherlands; Univ of California San Diego, San Diego, CA, USA San Diego, San Diego, California of Univ California San Diego, San Diego, CA, USA San Diego, San Diego, California Brookline, MA, USA; USA; MA, Brookline, for the CHARTER study group study group the CHARTER for & Tech Rsr Fndn, Inc, Amherst, NY, USA; USA; NY, Amherst, Inc, Fndn, Rsr Tech & 1 4 2 ChangesBrain MRI A InfectionHIV Treated Function in Cognitive Underwood Jonathan 1 Reduce TDF MVC and A5303 ACTG ART: Initial in RobertsonR. Kevin 1 1 AHAND: for Therapy Fluconazole and Paroxetine Double-Blind, Placebo-ControlledTrial Ned Sacktor 1 APOE4 and Lipid Profiles ART on Men HIV+ in Decline Cognitive ShibaniMukerji S. Mitochondrial DNA Cop DNA Mitochondrial HIV-Infectedin Impairment Neurocognitive Persons David Samuels Compartmentalized HIV DNA Populations Persist Persist CompartmentalizedPopulations DNA HIV ART Suppressive Despite CSF in Oliveira de Faria Michelli Eron Penugonda 5303 MD, USA; USA; MD, Bethesda, MD, USA Bethesda, MD, The Co-morBidity in Relation to Aids (COBRA) Collaboration Collaboration (COBRA) Aids Co-morBidity to in Relation The Cancer Inst, Boston, MA, USA; USA; MA, Boston, Inst, Cancer T. Brown T. McArthur Letendre; Matt F. Strain; Ron Ellis; Sheldon R. Morris; Susan R. Morris; Sheldon J. Ron Ellis; Strain; F. Matt Letendre; Smith; M. Sara Gianella Little; Davey Lerner Rsr Inst, Cleveland, OH, USA; USA; OH, Cleveland, Inst, Rsr Lerner Chicago, IL, USA Chicago, Munro
148
147 146 145 144
143
11:45 11:30 11:15 11:00 10:45 10:30 Program and Agenda
11:15 154LB Ledipasvir/Sofosbuvir for 6 Weeks in HIV- 10:45 158LB Beta-Lactams Against TB: Teaching a New Trick Infected Patients With Acute HCV Infection to an Old Dog Jürgen K. Rockstroh1; Sanjay Bhagani2; Robert H. Hyland3; Andreas H. Diacon1; Lize van der Merwe2; Marinus Barnard2; Chohee Yun3; Wei Zhang3; Diana M. Brainard3; John G. Florian Von Groote-Bidlingmaier2; Christoph Lange3; Alberto L. McHutchison3; Patrick Ingiliz4; Thomas Lutz5; Mark Nelson6 García-Basteiro4; Esperança Sevene5; Lluís Ballell6; David Barros- 1Medizinische Univsklinik, Bonn, Germany; 2Royal Free Hosp, Aguirre6 London, United Kingdom; 3Gilead Scis, Inc, Foster City, CA, 1Stellenbosch Univ, Bellville, South Africa; 2Task Applied Science, USA; 4Cntr for Infectiology, Berlin, Germany; 5Infektiologikum, Bellville, South Africa; 3Rsr Cntr Borstel, Borstel, Germany; Frankfurt/Main, Frankfurt, Germany; 6Chelsea and Westminster 4Barcelona Inst for Global Hlth, Barcelona, Spain; 5Manhiça Hosp NHS Fndn Trust, London, UK Hlth Rsr Cntr (CISM), Manhiça, Mozambique; 6Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain Session O-14 Oral Abstracts Ballroom A 11:00 159 Pre-ART Cryptococcal Antigen Titer Associated 10:00 AM-12:00 PM With Preemptive Fluconazole Failure Tuberculosis and Other Opportunistic Infections/Cancer Bozena M. Morawski1; David R. Boulware1; Elizabeth Prevention: Hits and Misses Nalintya2; Agnes Kiragga2; Francis Kazooza2; Radha Rajasingham1; Benjamin J. Park3; Yukari C. Manabe4; Jona E. Oral Abstract Moderators Kaplan3; David B. Meya2 Andrew Kambugu, Infectious Diseases Institute, Kampala, Uganda 1Univ of Minnesota, Minneapolis, MN, USA; 2Infectious Diseases Susan E. Krown, AIDS Malignancy Consortium, New York, NY, USA Inst, Kampala, Uganda; 3CDC, Atlanta, GA, USA; 4Johns Hopkins 10:00 155 Empirical TB Treatment in Advanced HIV Disease: Univ, Baltimore, MD, USA Results of the TB Fast Track Trial 11:15 160 Immediate ART Initiation Reduces Risk of Alison Grant1; Salome Charalambous2; Mpho Tlali2; Suzanne Infection-Related Cancer in HIV Infection Johnson3; Susan Dorman4; Christopher Hoffmann4; Aaron Alvaro H. Borges1; Jacqueline Neuhaus2; Abdel Babiker3; Karat1; Anna Vassall1; Gavin Churchyard2; Katherine L. Fielding1 Timothy J. Wilkin4; Christian Hoffmann5; Keith Henry6; 1London Sch of Hygiene & Trop Med, London, UK; 2The Aurum Adrian Palfreeman7; Mamta K. Jain8; Sanjay Pujari9; Ronald T. Inst, Johannesburg, South Africa; 3Fndn for Professional Develop, Mitsuyasu10 Pretoria, South Africa; 4Johns Hopkins Univ Sch of Med, Baltimore, 1CHIP, RigsHospet, Univ of Copenhagen, Copenhagen, Denmark; MD, USA 2Univ of Minnesota, Minneapolis, MN, USA; 3Univ Coll London, 4 5 10:15 156 Acceptability of Large-Scale Household-Based TB London, UK; Weill Cornell Med Coll, New York, NY, USA; IPM StudyCntr, Hamburg and Univ of SchleswigHolstein, Campus Screening: HPTN 071(PopART) Trial 6 1 2 1 3 Kiel, Hamburg, Germany; Hennepin County Med Cntr, Univ of Comfort R. Phiri ; Sian Floyd ; Ab Schaap ; Sam Griffith ; 7 1 2 4 2 Minnesota, Minneapolis, MN, USA; Med Rsr Council Clinical Ephraim Sakala ; Richard Hayes ; Sarah j. Fidler ; Helen Ayles ; 8 1 Trials Unit, London, UK; Univ of Texas Southwestern Med Cntr, Kwame Shanaube ; for the HPTN071(PopART) 9 10 1 2 Dallas, TX, USA; Inst of Infectious Diseases, Pune, India; Univ of ZAMBART, Lusaka, Zambia; London Sch of Hygiene & Trop Med, California Los Angeles, Los Angeles, CA, USA London, UK; 3FHI 360, Research Triangle Park, NC, USA; 4Imperial Coll London, London, UK 11:30 161 ACTG A5298: A Phase 3 Trial of the Quadrivalent
• Thursday, February 25, 2016 25, February Thursday, • HPV Vaccine in Older HIV+ Adults 1 2 3 10:30 157 HIV-Associated XDR TB Is Transmitted in Timothy J. Wilkin ; Huichao Chen ; Michelle Cespedes ; Pawel Paczuski2; Catherine Godfrey4; Elizabeth Chiao5; Amneris Households and Hospitals in South Africa Luque6; Jennifer Y. Webster-Cyriaque7; Barbara Bastow8; Ross 1 2 3 Sara C. Auld ; James C. Brust ; Barun Mathema ; Thuli Cranston9; for the ACTG A5298 Protocol Team 4 5 6 7 Mthiyane ; Nazir Ismail ; Pravi Moodley ; Darius McDaniel ; 1Weill Cornell Med Coll, New York, NY, USA; 2Harvard Sch of PH, OralSessions 8 7 9 Salim Allana ; Neel Gandhi ; N. Sarita Shah Boston, MA, USA; 3Icahn Sch of Med at Mount Sinai, New York, NY, 1 2 Emory Univ, Atlanta, GA, USA; Albert Einstein Coll of Med, Bronx, USA; 4DAIDS, NIAID, NIH, Rockville, MD, USA; 5Baylor Coll of Med, 3 NY, USA; Columbia Univ Mailman Sch of PH, New York, NY, USA; Houston, TX, USA; 6Univ of Rochester Med Cntr, Rochester, NY, 4 5 Univ of KwaZulu-Natal, Westville, South Africa; Natl Inst for USA; 7Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 6 Communicable Diseases, Johannesburg, South Africa; Univ of 8Social & Scientific Systems, Inc., Silver Spring, MD, USA; 9Univ of 7 KwaZulu-Natal, Durban, South Africa; Emory Univ Rollins Sch of Pittsburgh Sch of Med, Pittsburgh, PA, USA PH, Atlanta, GA, USA; 8Rollins Sch of PH, Emory Univ, Atlanta, GA, USA; 9CDC, Atlanta, GA, USA 11:45 162 Is Intensive Cervical Cancer Screening Justified in Immunosuppressed Women? Michael J. Silverberg1; Wendy Leyden1; Steven Gregorich2; Karen K. Smith-McCune2; Megan Huchko2; Miriam Kuppermann2; Shalini Kulasingam3; George F. Sawaya2 1Kaiser Permanente Northern California, Oakland, CA, USA; 2Univ of California San Francisco, San Francisco, CA, USA; 3Sch of PH, Univ of Minnesota, Minneapolis, MN, USA
44 CROI 2016 Thursday, February 25, 2016 • Oral Sessions 45 ; 1
; 5 ; Peter L. ; Peter
3 ; Craig ; Craig CROI 2016 1 ; for the ; for 8 Harvard Harvard 6 ; Karen W. ; W. Karen Ballroom Ballroom B/C 1 ; Wm. ; Wm. Christopher St Michael’s Michael’s St 3 2 ; Kathy Baisley ; Kathy ; Joseph A. 3 INSERM, Bordeaux, Bordeaux, INSERM, 1 3 ImQuest Biosciences, Biosciences, ImQuest Africa Cntr for for Cntr Africa 2 2 Program Agenda and
; for the Center for AIDS for the Center ; for 2 1 ; Joanna Orne-; Joanna 2 ; Deenan Pillay 7 ; Jennifer Breakey ; Jennifer Univ of California San Francisco, San Francisco, California of Univ Univ of Washington Sch PH of Washington of Univ 2 3 ; P. Richard Harrigan Richard ; P. 2 ; Carolynne Schwarze-Zander ; Carolynne 2 1 ; Edward J. Fuchs J. ; Edward Africa Cntr for Hlth and Pop Studies, Studies, Pop and Hlth for Cntr Africa 1 8 INSERM U897, ISPED, Univ de Univ ISPED, U897, INSERM BC Cntr for Excellence in HIV/AIDS, HIV/AIDS, in Excellence for Cntr BC 7 ; Mélanie Plazy Medizinische Univsklinik, Bonn, Medizinische 3 4 2
Univ of Colorado, Denver, CO, USA CO, Denver, Colorado, of Univ 4 ; Collins Iwuji ; Collins 1 ; Mari M. Kitahata 5 ; Stephen Van Rompaey Van ; Stephen ; Katerina A. Christopoulos ; Katerina ; Francois Dabis ; Francois 1 1 6 ; Jürgen K. Rockstroh ; Jürgen ; Weld Ethel Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ ; Darrell H. Tan H. ; Darrell 1 1 4 1
; Nuala McGrath 4 3 ; Christoph Boesecke ; Christoph ; Robert W. Buckheit Jr W. ; Robert 1 2 Univ of Southampton, Southampton, United Kingdom; Kingdom; United Southampton, Southampton, of Univ 1 4 , University, of Cincinnati, Cincinnati, OH, USA ; Robin Nance 1 ; Richard Moore ; Richard 4 ; Heidi M. Crane ; Heidi Maple Leaf Med Clinic, Toronto, ON, Canada; Canada; ON, Toronto, Clinic, Med Leaf Maple 2 Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns London Sch of Hygiene & Trop Med, London, UK; UK; London, Med, & Trop Sch Hygiene of London Université Paris Descartes, Paris, France; France; Paris, Descartes, Paris Université David C. Knox C. David 1 Hosp, Toronto, ON, Canada; Canada; ON, Toronto, Hosp, Canada; BC, Vancouver, Anderson ANRS 12249 TasP Study Group Group Study TasP ANRS 12249 Gliemann Till Bärnighausen Till France; France; Sch of PH, Boston, MA, USA; USA; MA, Sch Boston, PH, of Population Hlth, Mtubatuba, South Africa; South Mtubatuba, Africa; Hlth, Population Hendrix Inc, Frederick, MD, USA MD, Frederick, Inc, Measuring the Impact of Test & Treat on the HIVthe on Treat & Impact the Measuring Test of Despite Preexposure Prophylaxis (PrEP) Prophylaxis Preexposure Despite Rectal Coverage HIV Mucosal Poor Provides Eugenie Shieh 1 5 Resistance Multiclass With Infection HIV-1 Cascade:Challenge Mobilityof The LarmarangeJoseph 1 Buckheit Mtubatuba, South Africa Mtubatuba, Gel Applied as Anal Lube Without Applicator Without Lube Anal as Applied Gel Bordeaux, Bordeaux, France; France; Bordeaux, Bordeaux,
Johns Hopkins Univ, Baltimore, MD, USA MD, Baltimore, Univ, Hopkins Johns Bonn, Bonn, Germany; Hosp Univ Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ San Francisco, CA, USA; San Francisco, Research Network of Integrated Clinical Systems Clinical Systems of Integrated Network Research Delaney and Community Med, Seattle, WA, USA; USA; WA, Seattle, Med, Community and 1 5 a Play Factors Which Patients: HIV in Fibrosis Liver Role? Mohr Raphael 1 Liver Fibrosis in CNICS CohortCNICS in Fibrosis Liver KimNina Poorly Controlled HIV Infection Is a Risk Factor for Infectionfor HIV Riska Is Factor Controlled Poorly
Jan-Christian Wasmuth Germany Mathews 169LB 169bLB 169aLB
560 SessionTD-13 Themed Discussion PM-2:451:45 PM Steatosis and Fibrosis EffectsHIV Liver on Discussion Leader Themed Sherman E. Kenneth 558 11:45 11:45 11:30 11:30 11:15 11:15 ; 2 ; ; 2 3 ; Alice ; Alice ; Nulda 3 2 ; Nelly R. ; Nelly 2 ; Augustin ; Augustin 2 ; Christophe ; Christophe 2 Room 311 Room
1 ; for the Partners ; for 1 ; Tanser Frank 1 ; Edward Mills ; Edward 1 ; Helen Ayles ; Helen 2 Household Household ; Allan Ronald ; Allan Univ of Manitoba, Manitoba, of Univ 1 2 Brown Univ Sch PH, Univ of Brown 3 Africa Cntr for Hlth and Hlth for Cntr Africa ; Matthew Mimiaga ; Matthew 2 ; Steve Kanters ; Steve 1 1 ; Sundeep K. Gupta ; Richard Hayes ; Richard 2 London Sch of Hygiene & Trop & Trop Sch Hygiene of London 1 ; GuyHarling 2 2
; Sian Floyd 2 1 ; Jared M. Baeten ; Jared 1 Ministry of Hlth, Lilongwe, Malawi; Malawi; Ministry Lilongwe, Hlth, of 2 tiveness of Traditional Traditional of tiveness ; Till ; Till Bärnighausen Kenya Med Rsr Inst, Thika, Kenya Thika, Inst, Rsr Med Kenya 1 3 HIV-1 RNA SheddingRNA Africanin HIV-1 Global Evaluative Scis, Vancouver, BC, Vancouver, Scis, Evaluative Global 2 ; Andreas Jahn ; Andreas The Fenway Inst, Fenway Hlth, Boston, MA, MA, Boston, Hlth, Fenway Inst, Fenway The ; Connie M. Celum M. ; Connie ; Sarah j. Fidler ; Sarah j. herapy and HIV Acquisition in ain Acquisition HIV and herapy 1 4 1
4 ; Deenan Pillay ; George R. Seage ; George 3 Univ of Stellenbosch, Tygerberg, South Africa; South Africa; Tygerberg, Stellenbosch, of Univ ; Anne Cori ; Anne
4 1 3 1 ; Mwumvaneza Mutagoma ; Mwumvaneza ; Jean Paul Uwizihiwe ; Jean Paul 1 1 Rwanda Biomed Cntr, Kigali, Rwanda Kigali, Cntr, Biomed Rwanda 3 ; Peter Bock ; Peter ; Frank Chimbwandira ; Frank ; for the HPTN 071 (PopART) Study Team Team Study the HPTN 071 (PopART) ; for 3 ; Robert W. Coombs W. ; Robert 3 1 3 , Instituto de Pesquisa Clínica Evandro Chagas (IPEC)/ Chagas Evandro Clínica Pesquisa de Instituto , , Centers, for Disease Control and Prevention, Atlanta, GA, USA CDC, Harare, Zimbabwe; Zimbabwe; Harare, CDC, Malawi Lilongwe, CDC, Inst of HIV/AIDS Disease Prevention and Control, Rwanda Biomed Biomed Rwanda Control, and Disease HIV/AIDS Prevention of Inst USA; MA, Boston, Sch PH, of Harvard Imperial Coll London, London, UK; UK; London, London, Coll Imperial South Africa Town, Cape Stellenbosch, of Univ Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ Beyers Fraser Med, London, UK; UK; London, Med, Providence, RI, USA; USA; RI, Providence, Cntr, Kigali, Rwanda; Rwanda; Kigali, Cntr, Sabin nsanzimana USA Mulindabigwi Winnipeg, MB, Canada; Canada; MB, Winnipeg, Shown That 90-90-90 Is Achievable? Is 90-90-90 That Shown TippettBeth Barr 1 3 PrEP Study Team PrEP Team Study Antiretroviral T Antiretroviral Cohort SouthAfrican Population-Based Oldenburg Catherine 1 1 4 Incidence HIV 2013-14 Rwanda Rwanda in Epidemic HIV Understanding Survey: Eric Remera 1 1 Effec Exploring the CircumcisionHIV Practices Preventing in Pickles Michael Isolated Seminal Isolated Partners With Men UninfectedWomen Mujugira Andrew Victor De Gruttola Victor Maida Pop Studies, Mtubatuba, South Africa; South Mtubatuba, Africa; Studies, Pop Mugo Kenneth H. Mayer Kenneth Canada; Canada; Option B+ in Malawi: Have 4 Years of “Treat All” All” “Treat of Years 4 Have OptionMalawi: in B+ Withdrawn
167 166 165 164 163 168LB
11:00 11:00 10:45 10:30 10:15 10:00 Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil TimothyH. Holtz 10:00 AM-12:0010:00 PM Challenges and Cascadethe in Acquisition HIV on Focus Moderators Abstract Oral Grinsztejn Beatriz SessionO-15 Oral Abstracts Program and Agenda
568 Alcohol Use, Hepatitis B, and Liver Fibrosis Among 792 Continuity of Care Among Pregnant Women Lost to HIV-Infected Persons in West Africa Follow-up After Initiating ART Antoine Jaquet1; Gilles Wandeler2; Marcellin Nouaman3; Didier Kate Clouse1; Sten H. Vermund1; Mhairi Maskew2; Given Malete2; Ekouevi4; Judicaël Tine5; Ahuatchi P. Coffie3; Aristophane Tanon6; Matthew P. Fox3 Moussa Seydi5; Alain Attia7; Francois Dabis1 1Vanderbilt Inst for Global Hlth, Nashville, TN, USA; 2Univ of the 1INSERM U897, ISPED, Univ de Bordeaux, Bordeaux, France; 2Univ Hosp Witwatersrand, Wits Hlth Consortium, Johannesburg, South Africa; Bern, Bern, Switzerland; 3Prog PACCI, CHU Treichville, Abidjan, Côte 3Boston Univ, Boston, MA, USA 4 d Ivoire; INSERM U897, ISPED, Univ de Bordeaux, Abidjan, Côte d Ivoire; 793 Disclosure and Knowledge Are Associated With 5CHU de Fann, Dakar, Senegal; 6CHU de Treichville, Abidjan, Côte d’Lvoire; 7CHU de Yopougon, Abidjan, Côte d’Ivoire Retention in Malawi’s Option B+ Program Risa M. Hoffman1; Khumbo Phiri2; Julie Parent2; Jonathan F. Grotts1; 561 NASH Is Associated With a Unique Biomarker Signature Sara Yeatman3; Paul Kawale2; David Elashoff1; Judith S. Currier4; Alan in HIV-Infected Adults Schooley2 Rebecca Krakora1; Mary McLaughlin2; Adam Rupert3; Michael 1Univ of California Los Angeles, Los Angeles, CA, USA; 2Partners in Hope Proschan4; Colleen Hadigan2; David E. Kleiner5; Theo Heller6; Joseph A. Med Cntr, Lilongwe, Malawi; 3Univ of Colorado, Denver, CO, USA; 4David Kovacs1; Caryn G. Morse1 Geffen Sch of Med at Univ of California Los Angeles, Los Angeles, CA, USA 1NIH Clinical Cntr, Bethesda, MD, USA; 2NIAID, NIH, Bethesda, MD, USA; 3NIAID, NIH, Frederick, MD, USA; 4NIAID, NIH, Rockville, MD, USA; 5NCI, Session TD-15 Themed Discussion Room 312 6 Bethesda, MD, USA; NIDDK, Bethesda, MD, USA 1:45 PM-2:45 PM 553 Statin Therapy Reduces Liver Fat Measured by Pathways to Eliciting Antibody Responses Computed Tomography in Patients With HIV Themed Discussion Leader Janet Lo; Michael Lu; Elli Kim; Eric Nou; Travis R. Hallett; Jakob Park; Michael Seaman, Harvard Medical School, Boston, MA, USA Udo Hoffmann; Steven Grinspoon Massachusetts General Hosp, Boston, MA, USA 301 Oral PrEP Enhances Genital HIV-Neutralizing IgA in HIV-1 Exposed Seronegative Women Session TD-14 Themed Discussion Room 302 Jennifer M. Lund1; Kristina Broliden2; Maria N. Pyra3; Katherine K. 1:45 PM-2:45 PM Thomas3; Deborah Donnell4; Elizabeth Irungu5; Timothy R. Muwonge6; Mind the Gaps: Optimizing the PMTCT Cascade Nelly R. Mugo5; Jared M. Baeten3; Jairam R. Lingappa3 1Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 2Karolinska Univ, Themed Discussion Leader Stockholm, Sweden; 3Univ of Washington, Seattle, WA, USA; 4SCHARP, Marcel Yotebieng, Ohio State University, Columbus, OH, US Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 5Kenya Med Rsr Inst, 6 789 Malawi’s Option B+ 2011-2015: The Impact of Rapid Thika, Kenya; Makerere Univ Coll of Hlth Scis, Kampala, Uganda ART Decentralization 302 Potent Broadly Neutralising Antibody Responses in Sundeep K. Gupta1; Andreas Jahn2; Beth Tippett Barr3; James Slow-Progressing Pediatric HIV Houston4; Alice Maida1; Jen Sabatier4; Crispin Musicha1; Frank Emily Adland1; Maximilian Muenchhoff1; Anna Csala1; Thumbi P. Chimbwandira5 Ndungu2; Pieter Jooste3; Owen Karimanzira4; Carol Crowther4; Penny 1CDC, Lilongwe, Malawi; 2Univ of Washington, Seattle, WA, USA; 3CDC, Moore4; Lynn Morris4; Philip Goulder1 • Thursday, February 25, 2016 25, February Thursday, • Harare, Zimbabwe; 4CDC, Atlanta, GA, USA; 5Malawi Ministry of Hlth, 1Univ of Oxford, Oxford, UK; 2Univ of KwaZulu-Natal, Durban, South Lilongwe, Malawi Africa; 3Kimberley Hosp, Kimberley, South Africa; 4NCID, Johannesburg, 790 Optimizing PMTCT Outcomes in Rural North-Central South Africa Nigeria: A Cluster-Randomized Study 303 Broadly Reactive Neutralizing Activity Within the First Muktar H. Aliyu1; Meridith Blevins1; Carolyn M. Audet1; Marcia 6 Months of HIV-1 Infection OralSessions Kalish1; Mary Lou Lindegren1; Usman I. Gebi1; Obinna Onwujekwe2; Amanda Fabra García1; Nuria Gonzalez2; Alberto Merino-Mansilla3; Bryan E. Shepherd1; C. William Wester1; Sten H. Vermund1 Juan Ambrosioni4; Anke Schultz5; Jose M. Gatell6; José Alcamí2; José M. 1Vanderbilt Inst for Global Hlth, Nashville, TN, USA; 2Univ of Nigeria, Miro4; Eloisa Yuste3; Victor Sanchez-Merino3 Enugu, Nigeria 1IDIBAPS, Barcelona, Spain; 2Inst de Salud Carlos III, Madrid, Spain; 3Inst 4 791 Randomized Trial of a Lay Counselor-Led Combination d Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Hosp Clinic-IDIBAPS, Univ de Barcelona, Barcelona, Spain; 5Fraunhofer Inst Intervention for PMTCT Retention for Biomed Engineering, St Ingbert, Germany; 6Hosp Clinic of Barcelona, 1 2 1 1 Ruby N. Fayorsey ; Duncan Chege ; Chunhui Wang ; William Reidy ; Barcelona, Spain Zach Peters1; Martin W. Sirengo3; Masila Syengo2; Chrisotin W. Barasa4; Mark Hawken4; Elaine J. Abrams1 317 Immunogenicity and Efficacy of ALVAC-HIV/gp120- 1ICAP, Columbia Univ Mailman Sch of PH, New York, NY, USA; 2ICAP at Clade C in Alum Regimen in Macaques Coulmbia Univ, Nairobi, Kenya; 3Natl AIDS and STI Control Prog, Nairobi, Luca Schifanella1; David Venzon1; Susan Barnett2; Sanjay Phogat3; Kenya; 4ICAP at Columbia Univ, Nairobi, Kenya Georgia Tomaras4; David Montefiori4; Massimiliano Bissa1; Veronica Galli1; Ruth M. Ruprecht5; Genoveffa Franchini1 1NIH, Bethesda, MD, USA; 2Novartis, Cambridge, MA, USA; 3Sanofi, Swiftwater, PA, USA; 4Duke Univ, Durham, NC, USA; 5Texas Biomed Rsr Inst, San Antonio, TX, USA
46 CROI 2016 Thursday, February 25, 2016 • Oral Sessions 47 ; 1 ; ; 1 ; Ye 4 3 ; Avi ; Avi ; Timothy ; Timothy 2 1 CROI 2016 Inst of Inst 2 Ballroom Ballroom A Oregon Hlth and and Hlth Oregon ; Trevor A. ; Trevor 2 ; Justin Knox ; Gregory M. 3 ; Santhanam Univ of North of Univ ; Kanokpan 2 2 2 2 3 ; BinYang 2 ; Manhattan E. ; Manhattan 2 ; Wei Chongyi Johns Hopkins Univ, Univ, Hopkins Johns 3 2 Program Agenda and ; Seydou Doumbia; Seydou ICER Mali, Bamako, Mali; Mali; Bamako, Mali, ICER 3 2 ; Hongjie Liu ; Hongjie 2 ; Wannee Chonwattana ; Wannee 1 ; Eileen Dunne; Eileen ; Tomori Cecilia Sch of PH, Univ of Maryland, Maryland, of Sch Univ PH, of 2 2 ; Telly Nouhoum 3 1 ; Anupong Chitwarakorn ; Anupong ; David Celentano ; David 1 3 ; Ligang Yang ; Joseph D. Tucker ; Joseph D. 3 1
; William A. Blattner William ; CDC, Atlanta, GA, USA Atlanta, CDC, 1 3 Univ of California San Francisco, San San Francisco, California of Univ
4 2 CDC, Atlanta, GA, USA Atlanta, CDC, 5
; Traore Bouyagui 1 4 ; for the TRUST Study Group Group Study TRUST the ; for ; Marcel Curlin ; Marcel US Military HIV Rsr Prog, Walter Reed Army Inst Inst Army Reed Walter MilitaryUS Prog, Rsr HIV 1 1 4 ; Rebecca G. Nowak ; Rebecca YRG Cntr for AIDS Rsr and Educ, Chennai, India Chennai, Educ, and Rsr AIDS for Cntr YRG ; Shruti H. Mehta H. ; Shruti 1 3 ; Philip A. Mock 1 ; Shujie Huang SESH Global, Guangzhou, China Guangzhou, Global, SESH 1 1 5 ; Padmaja Patnaik ; Padmaja ; Weiming Tang ; Weiming 1 1 ; Yilu ; Yilu Qin 5 Guangdong Provincial Cntr for Skin Diseases STI for and Cntr Provincial Guangdong 3 ; Boonyos Raengsakulrach ; Boonyos 1 ; Adama N’dir ; Adama 3 ; Stefan Baral ; Stefan 2 ; Sosthenes Ketende 3 4 SunilSolomonS. ; Pachamuthu Balakrishnan ; Pachamuthu
; Wei Zhang ; Wei 1 5 1 ; CDC, Bamako, Mali; Mali; Bamako, CDC, 2 4 YRG Cntr for AIDS Rsr and Educ, Taramani, India; India; Taramani, Educ, and Rsr AIDS for Cntr YRG Thailand Ministry of PH, Muang Nonthaburi, Thailand; Thailand; Nonthaburi, Ministry Muang PH, of Thailand Univ of North Carolina Proj China, Guangzhou, China; China; Guangzhou, China, Proj North of Univ Carolina Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Sch Baltimore, PH, of Bloomberg Hopkins Johns ICAP at Columbia Univ, New York, NY, USA; USA; NY, York, New Univ, ICAP at Columbia Bamako, Sante, la de Sida, le Ministere contre Lutte de Sectorielle Cellule H. Holtz Pancharoen Zhang Charurat College Park, MD, USA; USA; MD, Park, College Francisco, CA, USA; Francisco, Carolina at Chapel Hill Inst for Global Hlth & Infectious Diseases, Chapel Chapel Diseases, Infectious & Hlth Global for Inst Hill at Chapel Carolina USA; NC, Hill, Wanna Leelawiwat Wanna 1 Lucas Mali; Mali; Anand 1 Risk Factors for Acute and Earlyand Infection HIV Acute Among for RiskFactors 2010–2015 Thailand Bangkok, MSM, Thienkrua Warunee Marriedof Men Wives Among HIV of Prevalence High India in Men With Sex Have Who K. Srikrishnan Aylur Group Sex: A Cross-SectionalA Sex: Group Online Survey Among Chinain Men With Sex Have Who Men SongyuanTang 1 1 Implications for Online ImplicationsIntervention for ShaunaStahlman HIV Prevalence and Risk Factors in Men Who Have Sex Have Who Men in Riskand Factors Prevalence HIV Mali Bamako, in Men With MariaLahuerta 1 3 Nigeria:in MSM Among OnlineSex-Seeking Control, Guangzhou, China; China; Guangzhou, Control, Hakim Human Virology, Baltimore, MD, USA; USA; MD, Baltimore, Virology, Human of Rsr, Silver Spring, MD, USA MD, Spring, Silver Rsr, of Tako Ballo Tako Baltimore, MD, USA; USA; MD, Baltimore, Scis Univ, Portland, OR, USA; USA; OR, Portland, Scis Univ, Chuncheng Liu Chuncheng Crowell
927 928 926 SessionTD-17 Themed Discussion PM-2:451:45 PM Middle-Incomeand Countries Low- in MSM Discussion Leader Themed Oxford University, Nuffield, Health, Smith Department Population of D. Adrian Kingdom United Oxford, 921 924 ; 7 ; 2 ; 2 Harvard Harvard ; Frank ; Frank Ministry 4 2 4 RTI, RTI, ; Bart J. 3 ; Supachai 2 3 US MilitaryUS HIV 2 ; Jerome H. Kim H. ; Jerome 6 Room Room 304/306 Academic Med Cntr, Cntr, Med Academic 2 ; Benjamin T. Allaire T. ; Benjamin 1 ; Sydney Rosen ; Sydney 2
4 Boston Univ, Boston, MA, USA; USA; MA, Boston, Univ, Boston ; Marc van der Valk der van ; Marc 2 1 ; Amanda A. Honeycutt ; Amanda 4 US Military HIV Rsr Prog, Bethesda, MilitaryUS Prog, Rsr HIV ; for the RV305 Study Group Group the RV305 Study ; for ; Punnee Pitisuttithum ; Punnee 5 1 2 ; Jean-Louis Excler ; Jean-Louis
5
; Evin Jacobson ; Evin 1 1 ; Matthew P. Fox P. ; Matthew 2 Intl Vaccine Inst, Seoul, Republic of Korea of Republic Seoul, Inst, Vaccine Intl RTI, Research Triangle Park, NC, USA; USA; NC, Park, Triangle Research RTI, 7 Mahidol Univ, Ratchathewi, Thailand; Thailand; Ratchathewi, Univ, Mahidol 2 ; Till ; Till Bärnighausen 3 3
1 RTI Hlth Solutions, Research Triangle Park, NC, USA NC, Park, Triangle Research Solutions, Hlth RTI ; Charles A. Boucher; Charles 4 ; Katherine A. Hicks ; Katherine 1 ; Vasan Sandhya , Clinton Hlth Access Initiative, Boston, MA, USA MA, Boston, Initiative, Access Hlth Clinton , 3 1 ; Sarah-Jane Anderson; Timothy Hallett Timothy Anderson; ; Sarah-Jane ; Nicos Karasavvas ; Nicos 1 ; Paul Farnham ; Paul 1 ; Nelson L. Michael L. ; Nelson 4 ; Shahira Ahmed ; Shahira 1 Henry M. Jackson Fndn for the Advancement of Military Med, Military of Med, Advancement the for Henry Fndn Jackson M. 6 ; David A. van de Vijver de A. van ; David 1 ; Deenan Pillay 3 , Imperial College London, London, United Kingdom United London, London, College Imperial , Erasmus Univ Med Cntr, Rotterdam, Netherlands; Netherlands; Rotterdam, Cntr, Med Univ Erasmus CDC, Atlanta, GA, USA; Atlanta, CDC, Boston Univ Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, Univ of Boston South Africa; Mtubatuba, Studies, Pop and Hlth for Cntr Africa Armed Forces Rsr Inst of Med Scis, Bangkok, Thailand; Thailand; Bangkok, Scis, Med of Inst Rsr Forces Armed Rerks-Ngarm Robert O’Connell Rsr Prog, APO, AP, USA; USA; AP, APO, Prog, Rsr Inc, Bethesda, MD, USA; USA; Bethesda, MD, Inc, Rijnders of PH, Muang Nonthaburi, Thailand; Thailand; Nonthaburi, Muang PH, of Brooke E. Nichols E. Brooke 1 1 thein MSM Among OnlyIs PrEP Cost-Effective Demand on Used When Netherlands Initiating PrEP in the United States, 2015–2020 States, United the in PrEP Initiating Yaylali Emine New ARVs Could Represent More Than USD 3 Billion inBillion 3 USD Than More Represent Could ARVs New 2025 Through Savings Cost Prabhu R. Vineet and Treatment Impactand Care HIV Improving of Tanser HIV Reduce Allocation Optimizingto Resource Sub-Saharan Across Incidence Africa JessicaMcGillen Jacob Bor Jacob 1 3 UK London, London, Coll Imperial Effect of Eliminating CD4 Thresholds on Number of Number on Thresholds CD4 EffectEliminating of Southin Africa Initiators ART New Vaccination of RV144 Subjects RV144 of Vaccination Akapirat Siriwat 1 SpecificBoost SubclassesIgG Late a RV305, in Induced Waltham, MA, USA; USA; MA, Waltham, Amsterdam, Netherlands Amsterdam, Stephanie L. Sansom Stephanie Sch of PH, Boston, MA, USA MA, Sch Boston, PH, of Danielle L. Wagner MD, USA; USA; MD,
1052 1050 1051 1049 Themed Discussion Leader Discussion Leader Themed AnneCori 1048 SessionTD-16 Themed Discussion PM-2:451:45 PM PrEP and Scale ART to Going With 318 Program and Agenda
Session TD-18 Themed Discussion Room 311 Session S-8 Symposium CME Ballroom B/C 1:45 PM-2:45 PM 4:00 PM-6:00 PM Next Generation Sequencing for Detection of Where Are the HIV Hot Spots? Transmitted or Linked Drug Resistance Target audience: This session is directed to clinicians and scientists Themed Discussion Leader who are interested in understanding methods for identifying Jeffrey A. Johnson, Centers for Disease Control and Prevention, hot spots of new infection, drivers of the epidemic in vulnerable Atlanta, GA, USA populations, and approaches to addressing these diverse epidemics. 487 No Evidence of Sexual Transmission of Minority HIV Level of knowledge: It is assumed that participants are familiar Drug Resistance Mutations in MSM with basic concepts of HIV epidemiology and social, cultural, and Antoine Chaillon; Sanjay R. Mehta; Joel O. Wertheim; Ben Murrell; biologic contributions to HIV spread. Susan J. Little; Douglas D. Richman; Davey M. Smith; Sara Gianella Objectives: At the completion of the session, participants will be Univ of California San Diego, San Diego, CA, USA able to: 488 Transmitted Drug Resistance in HIV-1 Subtype C • Describe new methods for identifying HIV hot spots Hyperacute Infection • Identify diverse high risk populations with high HIV incidence, Urisha Singh1; Avashna Singh1; Marc Noguera-Julian2; Manjeetha including fisherfolk, young MSM, and immigrants Jaggernath1; Amber Moodley1; Krista Dong3; Bruce D. Walker3; Thumbi 1 4 • Describe strategies for reducing new infections and improving P. Ndungu ; Michelle Gordon outcomes in these populations 1Univ of KwaZulu-Natal, Durban, South Africa; 2IrsiCaixa Inst for AIDS Rsr, Badalona, Spain; 3Ragon Inst of MGH, MIT and Harvard, Cambridge, Conveners MA, USA; 4Nelson R Mandela Sch of Med, Univ of Kwazulu-Natal, Durban, Z. Michael Chirenje, Univeristy of South Africa Zimbabwe, University of California 489 Integrase Inhibitors-Transmitted Drug Resistance San Francisco Collaborative Research Detected by UltraDeep Sequencing Programme, Harare, Zimbabwe Shannon L. Hader, Centers for Disease Eve Todesco1; Jeremy Jaffre1; Cathia Soulié1; Daniele Armenia2; Marc Control and Prevention, Atlanta, GA, USA Wirden3; Sidonie Lambert1; Christine Katlama1; Francesca Ceccherini- Silberstein2; Vincent Calvez1; Anne-Geneviève Marcelin1 4:00 170 Location and Population: 1Sorbonne Univs, Paris, France; 2Univ of Rome Tor Vergata, Rome, Italy; Response to the Who and Where in 3APHP, Pitie Salpêtrière Hosp, Paris, France the HIV Epidemic 490 Linkage of Rare Drug Resistance Mutations Detected Peter Ghys, UNAIDS, Geneva, Switzerland by New Ultrasensitive SGS Valerie F. Boltz1; Junko Hattori1; Wei Shao2; John M. Coffin3; Frank 4:30 171 HIV in Fishing Communities: Maldarelli1; Mary F. Kearney1 Prevalence, Incidence, Risk 1 2 NCI, Frederick, MD, USA; Leidos Biomed Rsr, Inc, Frederick, MD, USA; Factors, and Interventions 3Tufts Univ, Boston, MA, USA Zachary A. Kwena; for the Lake Victoria • Thursday, February 25, 2016 25, February Thursday, • Consortium for Health Research, Kenya Med Rsr Inst, Kisumu, Kenya 5:00 172 Sex, Stigmas, and Systems: Global Issues in HIV Among Young MSM LaRon E. Nelson, Univ of Rochester, OralSessions Rochester, NY, USA
5:30 173 HIV and Migrants Julia Del Amo, Inst de Salud Carlos III, Madrid, Spain
48 CROI 2016 Thursday, February 25, 2016 • Oral Sessions 49 CROI 2016
Room 304/306 Room
Program Agenda and ew Strategy to to Strategy ew , Stanford Univ, Stanford, Stanford, Univ, Stanford , CME , Case Western Reserve Univ, Univ, Reserve Western Case , , Heinrich Pette Inst, Inst, Pette Heinrich ,
, CRCHUM, Montreal, QC, QC, Montreal, CRCHUM, , It is assumed that participantsassumed that is It familiar are This session is directed to clinicians and scientists CA, USA Finzi Andrés Canada MarcusAltfeld Germany Hamburg, Responses Blish A. Catherine Karn Jonathan USA OH, Cleveland, by Cells HIV-1–Infected Target ADCC of HIV of NK Cell-Mediated Recognition Recognition Cell-Mediated NK Cell NK Protective of Signatures Cure for SuperchargingCells NK N A Exposing Env: , University, of Wisconsin– At completionAt of the session, participantswill be able
, Baylor, College of Med, 180 181 178 179
Describe the state of the field's understanding of the role of NK NK of role understanding the field's of the Describe of state the cells in HIVprevention and control activity NK of antiviral the exploit to opportunities Describe cells for cure direct to antibodies monoclonal using Describefor mechanisms NKcell killing ofreactivated latently infectedcells • • • 5:00 5:30 who are interested in understanding role and mechanisms by which NKcells contribute toHIV prevention,treatment, and cure. knowledge: of Level responses immune against cellular immunology and with basic infectedvirally cells. Objectives: to: Conveners Evans T. David Madison, Madison, WI, USA Paust Silke Houston, TX, USA 4:00 4:30 SessionS-10 Symposium PM-6:004:00 PM Killers Born(e) Natural audience: Target Ballroom A Ballroom , London Sch of Hygiene Sch Hygiene of London , , TREAT Asia, Bangkok, Bangkok, Asia, TREAT , , Johns Hopkins Univ, Univ, Hopkins Johns , , Ann and Robert H. Lurie Ann, Robert and Lurie H. CME
It is assumed that participantsassumed that is It familiar are This session is directed to clinicians and scientists , Imperial College College Imperial , Lisa K.Lisa Simons Allison L. Agwu L. Allison USA MD, Baltimore, With HIV in Low- and Middle-and Low- in HIV With Countries Income Ferrand A. Rashida UK London, Med, Trop & With Adolescents for Transition HIV InfectionAdolescents in SohnH. Annette Thailand Children’s Hosp of Chicago, Chicago, IL, USA Chicago, Chicago, of Hosp Children’s Finding and Engaging Adolescents Adolescents Engaging and Finding Future: the About Thinking Blame It OnBlame It Brain the Global Epidemiology of HIVof Global Epidemiology At theAt completion of thesession, participants will be , Eunice Kennedy Shriver Shriver Kennedy Eunice ,
177 176 175 174
Describe the global epidemiology ofHIV infection in adolescents Discuss the neurodevelopment of theadolescent brain and relationship risk behaviors to Outlineinnovative approaches totesting and linking adolescents with HIV care Describe the process and outcomes of transitioning adolescents from pediatric toadult care services • • • • 5:30 5:00 4:30 4:00 Healthcare NHS Trust, London, United United London, Trust, NHS Healthcare Kingdom Hazra Rohan and Health Child of Institute National Human Development, Bethesda, MD, USA Caroline Foster Caroline able to: Conveners who are interested in understanding the global adolescent HIV HIV adolescent understanding global in interested the are who epidemic knowledge: of Level with basic concepts of HIV acquisition, prevention and treatment of in the adolescent age group Objectives: 4:00 PM-6:004:00 PM Crossroads the at Adolescents me? #HIV-Who audience: Target SessionS-9 Symposium Program and Agenda POSTER SESSIONS, BY CATEGORY
All poster sessions will be held in Hall A/B (poster numbers 182-756 )and Hall D (poster numbers 757-1063) from 2:45 to 4:00 PM on the scheduled day. A. Virology F. HIV Persistence, Reservoirs, Latency, Eradication, Including P-A1 Viral Transmission and Target Cells (Tuesday, February 23, 2016) Gene Therapy P-A2 Viral Proteins: Regulation, Replication, Transcription P-F1 Novel HIV Reservoirs (Tuesday, February 23, 2016) (Wednesday, February 24, 2016) P-F2 HIV Reservoir: Measurement and Mechanisms of Persistence P-A3 Viral Proteins: Insights Into Structure (Wednesday, February 24, (Tuesday, February 23, 2016) 2016) P-F3 Tissue Reservoirs of HIV: Anatomic and Imaging Studies P-A4 Host Factors and Cell Response to Infection (Thursday, February (Tuesday, February 23, 2016) 25, 2016) P-F4 Impact of Antiretroviral Therapy on Viremic Control and Tissue B. Molecular Epidemiology and HIV/SIV Evolution Reservoirs (Wednesday, February 24, 2016) P-B1 Detection and Spread of Genetically Diverse HIV (Tuesday, P-F5 Approaches to Reactivating HIV and Gene Therapy (Wednesday, February 23, 2016) February 24, 2016) P-B2 Identifying Network and Transmission Pairs (Wednesday, P-F6 HIV Integration (Wednesday, February 24, 2016) February 24, 2016) P-F7 Stem Cells (Thursday, February 25, 2016) P-B3 Viral Genetics: Effects on Transmission, Disease, and Reinfection P-F8 HIV Persistence, Latency, and Reactivation (Thursday, February (Thursday, February 25, 2016) 25, 2016) P-B4 Defining the Sequence Characteristics of Transmitted Viruses G. Neuropathogenesis (Thursday, February 25, 2016) P-G1 Neuroimaging: Brain Structure and Functional Response C. Pathogenesis: Human Studies and Animal Models (Tuesday, February 23, 2016) P-C1 HIV and Intestinal Integrity (Tuesday, February 23, 2016) P-G2 Virology and Basic Neuroscience (Wednesday, February 24, P-C2 HIV Effects on CD4+ T Cells (Tuesday, February 23, 2016) 2016) P-C3 Genetics and Cell Biology of HIV Infection (Tuesday, February P-G3 Central Nervous System: HIV Entry, Reservoirs, and 23, 2016) Compartmentalization (Wednesday, February 24, 2016) P-C4 Immunopathogenesis (Tuesday, February 23, 2016) P-G4 Host and Virus Biomarkers and Immune Response (Thursday, P-C5 HIV and Microbiomes (Wednesday, February 24, 2016) February 25, 2016) P-C6 SIV Models of Pathogenesis (Wednesday, February 24, 2016) P-G5 Clinical Distinctions and Therapeutic Response (Thursday, P-C7 Immune Activation and Inflammation (Wednesday, February February 25, 2016) Poster Sessions Poster 24, 2016) H. Clinical Pharmacology P-C8 Pathogenesis of Mucosal Transmission (Thursday, February 25, P-H1 Exposure Response: Learning to Improve Safety and Efficacy 2016) (Tuesday, February 23, 2016) P-C9 Immune Effects of Antiretroviral Therapy (Thursday, February P-H2 Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions 25, 2016) (Wednesday, February 24, 2016) E. Host Immune Responses to Infection, Vaccines, and P-H3 Pharmacogenetics (Wednesday, February 24, 2016) Immunotherapy P-H4 Pharmacokinetics in Compartments (Wednesday, February 24, P-E1 Antibody Responses to HIV Infection: What Drives Them and 2016) How They Affect the Virus (Tuesday, February 23, 2016) P-H5 Clinical Pharmacology of Treating Coinfections (Thursday, P-E2 Cellular Immunity: Change to Cytotoxic T Lymphocyte and NK February 25, 2016) Cells (Tuesday, February 23, 2016) I. Antiretroviral Therapy: Preclinical Studies P-E3 Evaluating HIV Vaccines: Preclinical to Clinical (Wednesday, P-I1 Preclinical Studies of Activity and Resistance (Thursday, February 24, 2016) February 25, 2016) P-E4 Effects of HIV on the Responses to Other Vaccines (Thursday, J. Antiretroviral Therapy: Randomized Clinical Trials February 25, 2016) P-J1 Antiretroviral Therapy: Randomized Clinical Trials (Wednesday, February 24, 2016)
50 CROI 2016 Poster Sessions 51 CROI 2016 Program Agenda and y, February 24, 2016) y, tions (Thursday, February tions (Thursday, tors and Biomarkers (Tuesday, (Tuesday, and Biomarkers tors uberculosis Services (Tuesday, Servicesuberculosis (Tuesday, Wednesday, February 24, 2016) Wednesday, Tuberculosis: Pathogenesis Studies (Tuesday, February 23, (Tuesday, Studies Pathogenesis Tuberculosis: 2016) February 2016) 23, (Tuesday, Transmission Tuberculosis T HIV and of Implementation February23, 2016) and Mortality Outcomes Related (Tuesday, Tuberculosis February23, 2016) February 24, 2016) (Wednesday, Tuberculosis Diagnosis of February (Wednesday, Therapy and Antiretroviral Tuberculosis 2016) 24, February 24, (Wednesday, Tuberculosis Multidrug-Resistant 2016) February 2016) 24, (Wednesday, and Pregnancy Tuberculosis Cryptococcal Disease:Detection (Thursday, and Outcomes February25, 2016) of HIV Disease Other(Thursday, Infectious Complications February25, 2016) Renal Outcomes: TAF and TDF (Tuesday, February 23, 2016) TDF (Tuesday, and TAF Renal Outcomes: Renal and Bone Disease: Risk Fac February23, 2016) February 24, TDF (Wednesday, and Stones, Bone Disease: Sticks, 2016) ( Metabolic Complications Multimorbidity (Wednesda and Aging (Thursday, Therapy and Immune Effects of Antiretroviral Aging February25, 2016) February25, 2016) (Thursday, and Functional Status Frailty Mechanisms of Pulmonary Complica 2016) 25, February 25, 2016) (Thursday, Coinfections Virus Herpes Stroke: Incidence and Risk Factors (Tuesday, February 2016) 23, (Tuesday, and Risk Incidence Factors Stroke: Disease: and Risk, Assessment, Prediction, Cardiovascular February23, 2016) (Tuesday, Management System Role of the Immune Pathogenesis: Atherosclerosis February24, 2016) (Wednesday, Effects Therapy Disease and Antiretroviral Cardiovascular February24, 2016) (Wednesday, February 25, 2016) Metabolism (Thursday, Cholesterol February2016) 25, (Thursday, Toxicities NRTI Impactand Outcomes of With Lipids: Associations Oxidized February 2016) 25, (Thursday, Interventions February 25, 2016) Harm (Thursday, It Can Ways More Smoking: and Middle- Income Diseasesin Low- Noncommunicable February2016) 25, (Thursday, Countries
Other InfectionHIV of Complications Antiretroviral and Therapy Otherand Opportunistic Tuberculosis Infections Cardiovascular Complications of HIV Infection HIV of Complications and Cardiovascular Therapy Antiretroviral
P-R1 P-R2 P-R3 P-R4 P-R5 P-R6 P-R7 P-R8 P-R9 P-R10 Q. P-Q1 P-Q2 P-Q3 P-Q4 P-Q5 P-Q6 P-Q7 P-Q8 P-Q9 R. P. P-P1 P-P2 P-P3 P-P4 P-P5 P-P6 P-P7 P-P8 P-P9 Lymphoma and Kaposi Sarcoma (Thursday, February 2016) 25, (Thursday, and Kaposi Sarcoma Lymphoma and RiskOtherMalignancies in HIV (Thursday, of Cancers February25, 2016) Global Burden and Mortality of Cancer in HIV (Wednesday, and MortalityGlobal Burden in HIV (Wednesday, Cancer of February24, 2016) and Prevention Treatment and CervicalAnal Cancer: February24, 2016) (Wednesday, HCV: The Virus is Gone; The Morbidity Not So Much (Thursday, Morbidity SoNot Much (Thursday, The Gone; is Virus The HCV: February25, 2016) February25, (Thursday, the Liver Beyond HCVMischief from 2016) Acute HCV Infection (Thursday, February 25, 2016) HCV InfectionAcute (Thursday, February2016) 25, and E (Thursday, A, D, Hepatitis of HCVand Exhaustion Infection: Activation Pathogenesis February 25, 2016) (Thursday, HCV Infection: Therapeutic Studies and Drug Resistance Drug and Resistance Studies Therapeutic HCVInfection: February24, 2016) (Wednesday, World” “Real Observationaland Experiences Therapeutics: HCV February 24, 2016) (Wednesday, Studies February23, 2016) and Moderators Disease: Mediators Liver of Progression February2016) 23, (Tuesday, and Prognosticators Prevention, Infection: HBV Prevalence, February24, 2016) (Wednesday, HCV Staging: Stiffen Up! (Tuesday, February 23, 2016) Up! (Tuesday, HCV Stiffen Staging: the to the Patient from the Needle Moving HCVCure: February 23, 2016) (Tuesday, Population Risks and Transmission (Tuesday, Tracking HCVTransmission HIV Diagnostics (Tuesday, February23, 2016) HIV Diagnostics(Tuesday, February 24, 2016) (Wednesday, Trials HIV DetectionClinical in February 25, 2016) DetectingHCV (Thursday, HIV Drug Resistance in Different Drug Classes (Thursday, (Thursday, Drug Classes in Different HIV Drug Resistance February25, 2016) February 25, 2016) (Thursday, Drug Resistance HIV-2 HIV Drug Resistance: Surveillance and Transmission (Tuesday, (Tuesday, Transmission SurveillanceHIV Drug Resistance: and February23, 2016) Studies Clinical and Epidemiologic HIV Drug Resistance: February24, 2016) (Wednesday,
HIV-Related and Non–HIV-Related Malignancies Non–HIV-Related and HIV-Related Hepatitis Viruses Hepatitis HIV DiagnosticsHIV HIV DrugHIV Resistance
P-O3 P-O4 O. P-O1 P-O2 P-N11 P-N12 P-N8 P-N9 P-N10 P-N6 P-N7 P-N4 P-N5 P-N1 P-N2 P-N3 P-M1 P-M2 P-M3 N. P-L3 P-L4 M. P-L1 P-L2 L. Program and Agenda
S. Maternal/Fetal HIV W. Epidemiology P-S1 HIV Acquisition and Health Outcomes During Pregnancy P-W1 Populations at Risk for HIV (Tuesday, February 23, 2016) (Tuesday, February 23, 2016) P-W2 Infection Status, Care, and Mortality (Tuesday, February 23, P-S2 Antiretroviral Therapy Pharmacokinetics and Safety During 2016) Pregnancy and Infancy (Tuesday, February 23, 2016) P-W3 Sex, Drugs, Depression, and HIV (Tuesday, February 23, 2016) P-S3 Partners in Crime: CMV, HIV, and MTCT (Tuesday, February 23, P-W4 MSM in Low- and Middle-Income Countries (Wednesday, 2016) February 24, 2016) P-S4 MTCT: Regimens, Rates, and Early Infant Diagnosis (Tuesday, P-W5 Individuals at Risk of HIV (Thursday, February 25, 2016) February 23, 2016) X. Implementation Science and Health Care Delivery P-S5 Mind the Gaps: Optimizing the PMTCT Cascade (Wednesday, P-X1 Insights from Antiretroviral Therapy Use: High-Income Settings February 24, 2016) (Tuesday, February 23, 2016) P-S6 Viral Dynamics and Drug Resistance During Pregnancy P-X2 Insights from Antiretroviral Therapy Use: Low-Income Settings (Wednesday, February 24, 2016) (Tuesday, February 23, 2016) P-S7 Birth Outcomes and Mortality in HIV- and ARV-Exposed Infants P-X3 HIV Testing and Prevention (Wednesday, February 24, 2016) (Wednesday, February 24, 2016) P-X4 HIV Care in the Global North (Wednesday, February 24, 2016) P-S8 Viral and Immune Mechanisms of MTCT (Thursday, February 25, P-X5 HIV Care, Financing (Wednesday, February 24, 2016) 2016) P-X6 HIV and Other Sexually Transmitted Infections (Thursday, P-S9 Outcomes of HIV and ARV-Exposed Infants, Children, and Youth February 25, 2016) (Thursday, February 25, 2016) P-X7 Access, ART Initiation, Retention, and Outcomes in the Global T. Pediatrics and Adolescents South (Thursday, February 25, 2016) P-T1 Pharmacokinetics: Efficacy and Safety of New ARVs in Children P-X8 Viral Suppression (Thursday, February 25, 2016) (Tuesday, February 23, 2016) Y. Population and Economic Modeling P-T2 Getting a Handle on CNS Disease in Children and Adolescents P-Y1 Modeling: Understanding Epidemics and ART Programs (Tuesday, February 23, 2016) (Tuesday, February 23, 2016) P-T3 Immunopathogenesis in HIV-Infected Children (Tuesday, P-Y2 Going to Scale With ART and PrEP (Wednesday, February 24, February 23, 2016) 2016) P-T4 Test, Treat, and Suppress: Achieving 90-90-90 in Adolescents P-Y3 Modeling the (Cost) Efficiency of Testing and Prevention (Wednesday, February 24, 2016) (Wednesday, February 24, 2016) P-T5 Antiretroviral Therapy and Viral Suppression in Children: Implications for Cure (Wednesday, February 24, 2016) P-T6 Achieving 90-90-90 in Children (Thursday, February 25, 2016) P-T7 HIV Drug Resistance in Children (Thursday, February 25, 2016) P-T8 Complications of HIV and Antiretroviral Therapy in Children
Poster Sessions Poster (Thursday, February 25, 2016) P-T9 Cotreatments of Coinfections in Children (Thursday, February 25, 2016) U. Contraception and Reproductive and Sexual Health in Women P-U1 Contraception and Sexual Health in Women (Thursday, February 25, 2016) V. Prevention and Intervention Studies P-V1 It’s Complicated: Renal Function and STIs in PrEP Users (Tuesday, February 23, 2016) P-V2 Topical and Systemic Preexposure Prophylaxis: New Agents, New Populations (Wednesday, February 24, 2016) P-V3 Predictors of PrEP Coverage and Uptake (Thursday, February 25, 2016) P-V4 PrEP in Primary Care: Pitfalls and Opportunities (Thursday, February 25, 2016)
52 CROI 2016 Poster Listings 53 ; 1 ; ; 2 4 ; Amel ; Amel ; Gavin A. ; Gavin Hall A/B 1 2 Katholieke Katholieke
6 1 ; Anne- CROI 2016 ; Zisis 5 2 ; Angela L. ; Angela 2 ; Julie Yamaguchi 1 ; Carole McArthur ; Carole Vrije Universiteit Universiteit Vrije 1 3 ; Sophie Matheron 4
1 Program Agenda and ; Dora Mbanya 3 Inst of Human Virology, Virology, Human of Inst 4 ; Mélanie Bertine; Mélanie Hosp Bichat-Claude Bernard, Bichat-Claude Bernard, Hosp 1 4 ; Tulio de Oliveira Tulio ; 4 ; Tianchi ; Tianchi Zhang ; Alexandra M. Oster ; Alexandra
Univ of California San Diego, San San Diego, California of Univ 2 7 1 7 Univ Coll London, London, UK; London, London, Coll Univ 2 Univ de Bordeaux, Bordeaux, France; France; Bordeaux, Bordeaux, de Univ ; Barbara Harris ; Vera Holzmayer ; Vera Univ of Yaoundé, Yaoundé, Cameroon; Cameroon; Yaoundé, Yaoundé, of Univ Kansas City, Missouri-Kansas of Univ 2 1 ; for the ANRS CO5 HIV-2 cohort HIV-2 the ANRS CO5 ; for 1 ; Tiziano GalloCassarino Tiziano ; 2 2 4 2 ; Florence Damond ; Florence ; Lazare Kaptue ; Lazare 3 2
Luxembourg Inst of Hlth, Luxembourg, Luxembourg, Hlth, of Inst Luxembourg
4 4 ; Daniel Struck ; Andrew Leigh Brown Leigh ; Andrew 3 ICF Intl, Atlanta, GA, USA; GA, USA; Atlanta, Intl, ICF 3 2 ; Ana S. Vallari S. ; Ana ; Joel O. Wertheim ; Joel O. ; Charlotte Charpentier ; Charlotte ; Neeraja Saduvala ; Neeraja 1 6 1 1 ; BihAwazi ; Catherine Brennan ; Catherine ; Dan Frampton ; Dan 2 3 1 ; MaryA. Rodgers ; Diane Descamps 1 Presbyterian Church (USA), Kinshasa, Democratic Kinshasa, Democratic (USA), Church Presbyterian 5 London Sch of Hygiene & Trop Med, London, UK London, Med, & Trop Sch Hygiene of London 3 Univ of KwaZulu-Natal, Durban, South Africa; South Africa; Durban, KwaZulu-Natal, of Univ 5 5 ; Pieter Libin ; Pieter 1 ; Paul Kellam ; Paul ; Catherine Fagard ; Catherine 2 2 ; Nicaise Ndembi 1 Abbott Lab, Abbott Park, IL, USA; IL, USA; Park, Abbott Lab, Abbott France; Paris, 1137, UMR INSERM France; CMG-EC Bordeaux, U897, INSERM CDC, Atlanta, GA, USA; Atlanta, CDC, IL, USA; Park, Abbott Lab, Abbott Univ of Montagnes, Bangangte, Cameroon; Cameroon; Bangangte, Montagnes, of Univ Univ of Edinburgh, Edinburgh, UK; UK; Edinburgh, Edinburgh, of Univ Hinxton, UK Sanger Inst, Trust Wellcome Paris, France; France; Paris, Hernandez Mieke Vandamme Mieke Besseghir Kozlakidis Jules Kenmegne Larry Sthreshley 1 With Clades2 Displayed France in A Group HIV-2 DistinctGeographical Origins Visseaux Benoit 1 3 1 1 MaryRodgers A. William Switzer William HTLV-3 and N Group HIV-1 Rare of Identification StrainsSouthRural in Cameroon Ana Vallari S. 3 in Diversity HIV-1 Complex Reveal Genomes Complete Congo of Republic Democratic the USA KY, Louisville, Congo, of Republic Phylogenetic Analysis of HIV Full Genomes in London, London, in Genomes Full HIV of Analysis Phylogenetic ICONIC From Results Initial UK: Yebra Gonzalo 1 3 Novel a and Subtyping Tools HIV-1 Three Comparing Method Phylogenetic-Based City, MO, USA; USA; MO, City, Brussel, Brussels, Belgium; Brussels, Brussel, Stephane Hue Stephane Luxembourg; Luxembourg; Universiteit Leuven, Leuven, Belgium; Leuven, Leuven, Universiteit Diego, CA, USA Diego, Cloherty Abuja, Nigeria
214 212 213 Session P-B1 Poster Abstracts Poster SessionP-B1 PM-4:002:45 PM DetectionSpreadand Geneticallyof HIV Diverse 210 211 ; 2 ; 1 ; Cara ; Cara 2 Hall A/B ; Anthony ; Anthony 2 Univ of Univ 2 ; Manish Sagar 1 ; Bonaventura ; Bonaventura 1 Inst of Human Human of Inst 2 ; Beatrice Hahn ; Beatrice 2 ; Lingling Sun; Lingling Lluita Contra la SIDA Fndn, Fndn, SIDA la Contra Lluita ; Stephanie M. Dillon ; Stephanie 2 2 1 Boston Univ, Boston, MA, MA, Boston, Univ, Boston 2 Univ of Colorado Hosp, Aurora, Aurora, Hosp, Colorado of Univ 3 ; Nora G. Ramirez ; Nora ; Maria Pujantell ; Shilpa Iyer 2 1 1
1
2 of Transmitted/Founder HIV-1 in HIV-1 Transmitted/Founder of ; Mark Lafferty 1
; Christophe Vanpouille; Leonid Margolis Margolis Leonid Vanpouille; ; Christophe
1 ; MichaelHarper S. Are Highly Permissive to Productive to Highly Permissive Are 1 Vpr in ProductiveInfectionin Vpr of ; Roger Badia ; José A. Esté 1 1 ; Brad J. Barrett J. ; Brad
; Oscar Gonzalez 1 1 1
; Hisashi Akiyama; Luis Agosto; Andrew Henderson; Henderson; Andrew Agosto; Luis ; Hisashi Akiyama; ; Alexandre Deshiere; Michel Ouellet; Michel J. Tremblay Tremblay Michel Ouellet; Deshiere; Michel J. ; Alexandre ; Kejun Guo ; Kejun 1
; Mario L. Santiago ; Alfredo Garzino-Demo; Alfredo 3 2 ; Ester Ballana ; Ester 2
Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ Univ of Colorado Anschutz Med Campus, Aurora, CO, USA; USA; CO, Aurora, Campus, Med Anschutz Colorado of Univ Boston Univ Sch of Med, Boston, MA, USA; USA; MA, Boston, Sch Med, Univ of Boston IrsiCaixa Inst for AIDS Rsr, Badalona, Spain; Badalona, Rsr, AIDS for Inst IrsiCaixa Martin D. McCarter Martin D. Virology, Baltimore, MD, USA MD, Baltimore, Virology, Rahm Gummuluru Wilson Aurora, CO, USA CO, Aurora, Spread of HIV-1 Is Delayed in T-Cells in the Absence ofAbsence the in T-Cells in Delayed Is SpreadHIV-1 of LFA-1 Integrin Häussinger; Dieter Anika Hain; Renem. Linka; Borkhardt; Arndt Münk Carsten Germany Düsseldorf, Düsseldorf, Heinrich-Heine-Univ HIV InfectionHIV AaronChristensen-Quick 1 1 Cells Th17 Human Enhanced Replication Cells T CD4 Gut Lee L. Eric Hisashi Akiyama Hisashi 1 Cell Membrane Binding Determines Ability of bNAb to Abilityto bNAb of Determines Binding Membrane Cell Cell-to-CellHIV Transfer Prevent VictorBarreto-de-Souza USA Bethesda, MD, NICHD, Shriver Kennedy Eunice for Essential Role HIV-1 by Cells Dendritic CaitlinMiller Rahm Gummuluru USA MA, Boston, Sch Med, Univ of Boston HIV-1 Attached to Monocytes, but Not Lymphocytes, Monocytes, Lymphocytes, to Not but Attached HIV-1 Tissue Infection Human to Transmits HIV-1 Induces p21-Mediated Cellular Senescence Cellular in p21-Mediated Induces HIV-1 PrimaryHuman Macrophages Riveira-Muñoz Eva 1 Identification of MDM2/HDM2 as a Positive Regulator Regulator Positive a as MDM2/HDM2 of Identification Macrophages Human in HIV-1 of Breton Yann Canada QC, Québec, Québec, de CHU du Recherche de - Cntr Laval Univ USA USA; PA, Philadelphia, Pennsylvania, Germans Trias i Pujol Univ Hosp, Barcelona, Spain Barcelona, Hosp, Univ Pujol i Trias Germans Clotet DeVico
POSTER LISTINGS POSTER TUESDAY, FEBRUARY 23, 2016 23, FEBRUARY TUESDAY, 189 188 187 186 185 184 183 182 Session P-A1 Poster Abstracts Poster SessionP-A1 PM-4:002:45 PM Cells Target and Transmission Viral Program and Agenda
Session P-C1 Poster Abstracts Hall A/B 239 Cenicriviroc Decreases sCD14 and LBP Levels Without 2:45 PM-4:00 PM Affecting Gut Permeability HIV and Intestinal Integrity Netanya S. Utay1; Anoma Somasunderam1; Maitreyee Nigalye1; Will Chang2; Star Seyedkazemi2; Eric Lefebvre2 233 Gut Integrity, CD4 T Follicular Helper Cells, and IgA+ B 1Univ of Texas Med Branch at Galveston, Galveston, TX, USA; 2Tobira Cells in GALT Following ART Therapeutics, Inc, San Francisco, CA, USA John J. Zaunders1; Gerald Mak2; Michelle Bailey2; Nabila Seddiki3; Yin Xu2; David Cooper4; Mark Boyd5; Anthony Kelleher2; Mark Danta6; 5 Session P-C2 Poster Abstracts Hall A/B Kersten K. Koelsch 2:45 PM-4:00 PM 1St Vincent's Hosp, Darlinghurst, Australia; 2Univ of New South Wales, Sydney, Australia; 3Universite Paris Est Creteil, Creteil, France; 4Kirby HIV Effects on CD4+ T Cells Inst, Sydney, Australia; 5Kirby Inst, Univ of New South Wales, Sydney, 240 In Vivo Evidence for a Role of Pyroptosis in HIV 6 Australia; St Vincent’s Clinical Sch, Univ of New South Wales, Sydney, Pathogenesis Australia Gilad Doitsh; Stefanie Sowinski; Caroline Miller; Warner C. Greene 234 Microbial Translocation and Inflammation Responses Gladstone Insts, San Francisco, CA, USA to Lubiprostone in HIV Infection 241 Caspase Inhibition Prevents HIV Replication and Cell 1 2 1 Gregory D. Huhn ; Anna L. Hotton ; Andrew G. Sigman ; Sheila M. Death in Human Lymphoid Tissue Keating3 Elisabet Gómez-Mora1; Elisabet Garcia1; Peter Wienberg Ludwig2; 1Ruth M. Rothstein CORE Cntr, Chicago, IL, USA; 2John H. Stroger Jr Hosp Maria Dolores Guerrero Gilabert3; Bonaventura Clotet4; Julià Blanco5; of Cook County, Chicago, IL, USA; 3Blood Systems Rsr Inst, San Francisco, Cecilia Cabrera6 CA, USA 1IrsiCaixa Inst for AIDS Rsr, Badalona, Spain; 2Hosp Sant Joan de Déu, 235 A20 May Contribute to Recovery of Intestinal Epithelial Barcelona, Spain; 3Hosp Universitari Germans Trias i Pujol, Badalona, Function in Treated HIV Spain; 4Lluita Contra la SIDA Fndn, Germans Trias i Pujol Univ Hosp, 5 6 Avantika Chitre; Ma Somsouk; Peter W. Hunt; Charlie C. Kim; Joseph Barcelona, Spain; Univ de Vic, Barcelona, Spain; IrsiCaixa Inst for AIDS M. McCune Rsr, Barcelona, Spain Univ of California San Francisco, San Francisco, CA, USA 242 Follicular Regulatory T Cells Are Highly Permissive to 236 Compartment-Specific Alterations of the Intestinal ILC HIV-1 Ex Vivo Pool in HIV(+) Patients Shannon Miller; Elizabeth Connick Benjamin Krämer1; Philipp Lutz1; Felix Goeser1; Andreas Glässner1; Univ of Colorado, Denver, CO, USA Jürgen K. Rockstroh2; Christoph Boesecke3; Ulrich Spengler1; Jacob 243 Dead Cells Tell No Tales: The Enigma of Discerning HIV- 1 Nattermann Infected Cell Death 1Univ of Bonn, Bonn, Germany; 2Medizinische Univsklinik, Bonn, Nathan Cummins; Sekar Natesampillai; Michele Smart; Scott H. Germany; 3Univ Hosp Bonn, Bonn, Germany Kaufmann; Andrew D. Badley 237 IL-33/ST2 Axis as an Inflammatory and Gut Damage Mayo Clinic, Rochester, MN, USA Marker in Primary HIV Infection Poster Listings Poster 244 Multidimensional Profiling of HIV-Infected Human 1 2 1 3 Vikram Mehraj ; Mohammad-Ali Jenabian ; Wei Cao ; Rosalie Ponte ; CD4 T Memory Stem Cells Bertrand Lebouché4; Réjean Thomas5; Jean-Guy Baril6; Roger LeBlanc7; Lara Manganaro1; Jeffrey Johnson2; Ekta Sharma; Patrick Hong; Cécile Tremblay8; Jean-Pierre Routy1 Benhur Lee3; Nevan Krogan2; Viviana A. Simon 1Rsr Inst of the McGill Univ Hlth Cntr, Montreal, QC, Canada; 2Univ du 1Icahn Sch of Med at Mount Sinai, New York, NY, USA; 2Univ of California Québec à Montréal, Montreal, QC, Canada; 3Rsr Inst of the McGill Univ San Francisco, San Francisco, CA, USA; 3Univ of California Los Angeles, Los Hlth Cntr, Montréal, QC, Canada; 4McGill Univ Hlth Cntr, Montreal, QC, Angeles, CA, USA Canada; 5Clinique Médicale l'Actuel, Montreal, QC, Canada; 6Clinique Médicale Quartier Latin, Montreal, QC, Canada; 7Clinique Médicale OPUS, 245LB Single Cell Transcriptome Sequencing of Human Montreal, QC, Canada; 8CRCHUM, Montreal, QC, Canada Lymph Node HIV-Infected CD4 Cells 238 Probiotics Module Th1/Th17 and IFN Response in HIV Joseph P. Casazza1; Eli Boritz1; David Ambrozak2; Amy R. Henry1; Sam 2 2 1 Patients on Suppressive cART W. Darko ; Costantinos Petrovas ; Rebecca M. Lynch ; Gustavo Reyes Teran3; Daniel C. Douek1; Richard A. Koup1 Ivan Schietroma1; Noemi Giustini1; Sara Serafino1; Gabriella 1VRC, NIAID, NIH, Bethesda, MD, USA; 2NIH, Bethesda, MD, USA; 3Natl Inst De Girolamo1; Mauro Andreotti2; Carolina Scagnolari1; Giancarlo of Respiratory Diseases, Mexico City, Mexico Ceccarelli1; Gabriella D’Ettorre1; Vincenzo Vullo1; for the Carla Selvaggi, Giuseppe Corano, Andrea Mastrangelo, Gianfranco Fanello, Fausto Fiocca, Marileda Indinnimeo 1Sapienza Univ of Rome, Rome, Italy; 2InstSuperiore di Sanità, Rome, Italy
54 CROI 2016 Poster Listings 55
; 1 1 ; 3 ; ; 4 1 Univ of Univ ; 1 3 Univ of Univ 3 CROI 2016 ; James I. 1 ; Johanna
; Colleen Kraft ; Colleen ; David Guidot ; David 1 1
2 1 ; Thumbi P. ; Thumbi P. 2 2
1 ; Merlin L. Robb ; Sofia Appelberg 4 2 Program Agenda and Lund Univ, Lund, Sweden; Sweden; Lund, Univ, Lund San Francisco General General San Francisco 2 5 ; Xintao K.Hu ; Xintao 2 Yerkes Natl Primate Rsr Cntr, Cntr, Rsr Primate Natl Yerkes 2 ; Cristina K. ; Cristina Bergamaschi ; Simon Brackenridge 1 2 ; Korey Demers ; Korey 2 ; Mirko Paiardini ; Mirko NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, Duke Univ Sch of Med, Durham, Durham, Sch Med, Univ of Duke US Military HIV Rsr Prog, Walter Walter MilitaryUS Prog, Rsr HIV 1 2 4 4 ; Bruce D. Walker D. ; Bruce 1 ; Alberto Riva 2 ; MichaelBetts R. ; Vincent C. Marconi Vincent ; 3 1 ; Michael A. Eller 3 ; Maureen Goodenow ; Maureen NCI, Rockville, MD, USA MD, Rockville, NCI, Univ of Florida, Gainesville, FL, USA; Gainesville, Florida, of Univ 4 4 2 ; Sarah L. Rowland-Jones ffects of Recreational Marijuana ffectsRecreational of 1 Ragon Inst of MGH, MIT, and Harvard, Harvard, and MIT, MGH, of Inst Ragon Hokkaido Univ, Sapporo, Japan; Japan; Sapporo, Univ, Hokkaido
2 2 4
1 ; Yamada Chisato Univ of KwaZulu-Natal, Durban, South Africa Durban, KwaZulu-Natal, of Univ ; Valentin Antonio 1 3 1 ; Costantinos Petrovas ; Costantinos ; Lou Ann Brown Ann ; Lou 1 CarlaMavian 1 ; Marianne Jansson ; 1 1 ; Egidio Brocca-Cofano; Jennifer L. Stock; Benjamin B. Benjamin B. L. Stock; Jennifer Brocca-Cofano; ; Egidio ; Tao Dong ; Tao ; Ellen M. Leitman ; Ellen 3 1 ; Annika Karlsson 5 ; Jeffrey L. Lennox L. ; Jeffrey 1 ; John Sleasman 2 ; Anders Sönnerborg ; Anders 3 ; Philip Goulder ; Barbara K. Felber 3 3 NCI at Frederick, Frederick, MD, USA; USA; MD, Frederick, atNCI Frederick, Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, Sweden; Stockholm, Inst, Karolinska Emory Univ Sch of Med, Atlanta, GA, USA; GA, USA; Atlanta, Emory Sch Med, Univ of UK; Oxford, Oxford, of Univ Univ of Pennsylvania, Philadelphia, PA, USA; USA; PA, Philadelphia, Pennsylvania, of Univ Sweden; Stockholm, Inst, Karolinska Univ of Oxford, Oxford, UK; UK; Oxford, Oxford, of Univ Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, Tauriainen Thushan de Silva Thushan Cambridge, MA, USA; USA; MA, Cambridge, Sheffield, Sheffield, UK Sheffield, Sheffield, T Regulatory Cell Depletion in Controller Macaques Controller in Depletion RegulatoryT Cell CTLs Boosts and SIV Reactivates CristianApetrei Pandrea Ivona Xu; Raehtz; Cuiling D. Kevin Tianyu; He Policicchio; USA PA, Pittsburgh, Pittsburgh, of Univ to Trafficking EffectorLymphocyte CD8 Increased hetIL-15 by Induced Nodes Lymph Pavlakis N. George 1 1 3 Mullins Proliferation in Immune Non-Responders Non-Responders Immune in Proliferation SushmaK. Cribbs 1 ImmunityClinical HIV on Effect The KIR-Mediated of OutcomeSouthin Africa Mori Masahiko 1 ImmunomodulatoryE HIV-1 With Living Youth in Use Ashok Dinasarapu 1 3 T-Cell Immunity and Lung Improve Antioxidants Does Reduced HLA-I Downregulation by HIV-2 Nef Nef HIV-2 by HLA-I Reduced Does Downregulation Functional to Cure? Contribute SophieAndrews M. 1 HIV-Specificin CD4+ Eomes and T-bet Selectiveof Loss During Cells T InfectionHIV MarcusBuggert Steven G. Deeks Steven Dionysios Dionysios K. Watson Emory Univ, Atlanta, GA, USA Atlanta, Emory Univ, NC, USA NC, Reed Army Inst of Rsr, Silver Spring, MD, USA; USA; MD, Spring, Silver Rsr, of Inst Army Reed Ndungu Hosp, San Francisco, CA, USA San Francisco, Hosp, David Rimland David Julie Williams
258LB 259LB 256 257 255 253 254 ; ; 1 2 ; 2 Hall A/B Hall A/B Univ of Univ 6 ; Iñaki ; Iñaki Fundació Fundació 3 3 ; for the HIV ; for 1 Scientific Inst ; Irma Univ of Univ 3 2 3 Natl Inst of Inst Natl ; Santiago 2 1 ; Sergio Lo Lo ; Sergio 5
; Nigel Garrett 6 2 ; Ivan Imaz- ; Ivan 1 ; Daria Trabattoni ; Alberto C. Guardo 2 1 IrsiCaixa Inst for AIDS Rsr, Rsr, AIDS for Inst IrsiCaixa 4 ; Tuixent Escribà ; Tuixent ; Mireia Arnedo ; Mireia 2 4 ; Lorena Orozco ; Lorena 2 ; Joaquín Zúñiga
; Vichi Francesca 1 1 3 Natl Inst of Nutrition, Mexico City, City, Mexico Nutrition, of Inst Natl 4 3 ; Lise Jamieson ; Lise 2 ; Mara Biasin ; Mara 2 Univ of Milan, Milan, Italy; Milan, Milan, of Univ 2 Univ de Vic, Barcelona, Spain; Spain; Barcelona, Vic, de Univ
2 ; Felipe García ; Felipe ; Tania Aguilar-García ; Tania 4 1 ; Lorenz David; Vikas Misra; Dana Gabuzda Dana Gabuzda Misra; Vikas David; ; Lorenz Hosp Clínic de Barcelona, Barcelona, Spain Barcelona, Barcelona, de Clínic Hosp 4 ; Wbeimar ; Wbeimar Aguilar-Jiménez 2 ; Vilaplana Elisenda 1 ; Lander Egaña-Gorroño ; Lander 1 S. Maria Annunziata Hosp, Florence, Italy; Florence, Hosp, Annunziata Maria S. 5 ; Enrique Espinosa ; Enrique 3 ; Vivek Naranbhai ; Vivek ; Christian Brander ; Christian ; Thumbi P. Ndungu P. Thumbi ; 1 3 ; Joel Vázquez-Pérez ; Michael M. Lederman; Scott M. Sieg ; MichaelLederman; M. 2 2 ; Meagan K. O’Brien; Natasha D. Durham; Anthony M. Durham; Anthony ; Meagan K. D. O’Brien;Natasha ; Michela Masetti ; Claudia Rangel-Escareño ; Claudia 1 2 ; Mario Clerici 5 ; Josep María Gatell 1 Natl Inst of Respiratory Diseases, Mexico City, Mexico; Mexico; City, Mexico Diseases, Respiratory of Inst Natl IDIBAPS, Barcelona, Spain; Spain; Barcelona, IDIBAPS, Univ of Milan, Brescia, Italy; Brescia, Milan, of Univ HIV Pathogenesis Prog, Univ of Kwa-Zulu Natal, Durban, South Africa; South Africa; Durban, Natal, Kwa-Zulu of Univ Prog, Pathogenesis HIV South Africa; Durban, KwaZulu-Natal, of CAPRISA, Univ Controllers Consortium Spanishthe AIDS of Network Controllers Pérez-Patrigeon Badalona, Spain; Badalona, for Recovery and Care E. Medea, Milan, Italy; Milan, Medea, E. Care and Recovery for Rosshandler Mexico Manel Enric Bargalló Manel Enric KwaZulu-Natal, Durban, South Africa Durban, KwaZulu-Natal, IL-7 Responsiveness Is Impaired in CD4 T Cells From HIV From Cells T CD4 in Impaired Is Responsiveness IL-7 Patients Failure Immune Nguyen Thao USA OH, Cleveland, Univ, Reserve Western Case 1 A Model of CD4 TCM Cell Death in HIV InfectionHIV in Based Death Cell TCM CD4 of Model A Signature Expression Gene a on Olvera-García Gustavo Characterization of Plasma Exosome Protein Cargo inCargo Protein CharacterizationExosome Plasma of ART on Patients HIV SukruthaChettimada USA MA, Boston, Inst, Cancer Dana-Farber P2X7 Purinergic Receptors Are Required for HIV-1 HIV-1 for Required Are Receptors Purinergic P2X7 InfectionInflammation and Swartz Talia 1 Benjamin K. Chen Nina Bhardwaj; Esposito; USA NY, York, at Sinai, New Sch Med Mount of Icahn MicroRNA Profile in CD8 T Cells From HIV-Infected From Cells T CD8 in Profile MicroRNA Diseaseand Individuals Progression Plana Montserrat 1 6-Amino-Acidin Insertion/Deletion Polymorphism Protections HIV1 Against Confers TIM1 SaulleIrma Ravesh Singh Ravesh 1 2 BST-2, TRIM22, and RAD51 in Host Susceptibility Host in RAD51 and TRIM22, to BST-2, Control Virus Infection HIV-1 and Clínic, Barcelona, Spain; Barcelona, Clínic, Manuela Sironi Antioquia, Medellin, Colombia Antioquia, Medellin, Aguilar-Delfín Mexico; City, Mexico Med, Genomic Salim A. Karim Perez Caputo
252 Session P-C4 Poster Abstracts SessionPoster P-C4 PM-4:002:45 PM Immunopathogenesis 251 250 249 248 247 2:45 PM-4:002:45 PM InfectionHIV of Biology Cell and Genetics 246 Session P-C3 Poster Abstracts SessionPoster P-C3 Program and Agenda
Session P-E1 Poster Abstracts Hall A/B 308 Systematic Analysis of Glycan Heterogeneity Guides 2:45 PM-4:00 PM Rational Design of HIV Immunogens Antibody Responses to HIV Infection: What Drives Wen-Han Yu; Monia Draghi; Claudia Arevalo; Peng Zhao; Douglas Them and How They Affect the Virus Lauffenburger; Lance Wells; Galit Alter Ragon Inst of MGH, MIT and Harvard, Cambridge, MA, USA 301 Oral PrEP Enhances Genital HIV-Neutralizing IgA in HIV-1 Exposed Seronegative Women 309LB Optimal Combinations of bnAbs for Prevention and 1 2 3 Treatment of HIV-1 Clade C Infection Jennifer M. Lund ; Kristina Broliden ; Maria N. Pyra ; Katherine K. 1 2 3 4 5 6 Michael Seaman ; Kshitij Wagh ; Tanmoy Bhattacharya Thomas ; Deborah Donnell ; Elizabeth Irungu ; Timothy R. Muwonge ; 2 3 4 4 5 3 3 Bhattacharya ; Carolyn Williamson ; Alex Robles ; Madeleine Bayne ; Nelly R. Mugo ; Jared M. Baeten ; Jairam R. Lingappa 4 4 5 2 1 2 Jetta Garrity ; Michael Rist ; David Montefiori ; Bette Korber Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; Karolinska Univ, 1 2 3 4 Harvard Med School, Boston, MA, USA; Theoretical Division, Los Alamos Stockholm, Sweden; Univ of Washington, Seattle, WA, USA; SCHARP, 3 5 National Laboratory, Los Alamos, NM, USA; Univ of Cape Town and Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; Kenya Med Rsr Inst, 4 Thika, Kenya; 6Makerere Univ Coll of Hlth Scis, Kampala, Uganda National Hlth Laboratory Service, Cape Town, South Africa; Beth Israel Deaconess Med Cntr, Boston, MA, USA; 5Duke Univ, Durham, NC, USA 302 Potent Broadly Neutralising Antibody Responses in Slow-Progressing Pediatric HIV 310LB Informatics-Based Improvement of HIV-1 Neutralizing 1 1 1 Antibody 10E8 Emily Adland ; Maximilian Muenchhoff ; Anna Csala ; Thumbi P. 1 2 2 2 2 3 4 4 Peter D. Kwong ; Young D. Kwon ; Gwo-Yu Chuang ; Baoshan Zhang ; Ndungu ; Pieter Jooste ; Owen Karimanzira ; Carol Crowther ; Penny 3 2 2 4 4 4 1 Tatyana Gindin ; Krisha McKee ; Sijy O’Dell ; Mark Connors ; Lawrence Moore ; Lynn Morris ; Philip Goulder 3 5 1 2 Shapiro ; John R. Mascola Univ of Oxford, Oxford, UK; Univ of KwaZulu-Natal, Durban, South 1 2 3 4 Vaccine Rsr Cntr, NIAID/NIH, Bethesda, MD, USA; Vaccine Rsr Cntr, NIAID, Africa; Kimberley Hosp, Kimberley, South Africa; NCID, Johannesburg, 3 4 South Africa NIH, Bethesda, MD, USA; Columbia Univ, New York, NY, USA; NIAID, NIH, Bethesda, MD, USA; 5VRC, NIAID, NIH, Bethesda, MD, USA 303 Broadly Reactive Neutralizing Activity Within the First Six Months of HIV-1 Infection 311LB Effect of Infusion of Broadly Neutralizing Antibody 1 2 3 VRC01 on HIV Plasma Rebound Amanda Fabra García ; Nuria Gonzalez ; Alberto Merino-Mansilla ; 1 2 1 4 5 6 2 Tae-Wook Chun ; Michael Sneller ; Catherine Seamon ; Jesse S. Juan Ambrosioni ; Anke Schultz ; Jose M. Gatell ; José Alcamí ; José M. 1 1 1 3 4 3 3 Justement ; Mary E. Petrone ; Eric Refsland ; Julie Ledgerwood ; Miro ; Eloisa Yuste ; Victor Sanchez-Merino 1 1 1 1 2 3 Katherine Clarridge ; Susan Moir ; Anthony S. Fauci IDIBAPS, Barcelona, Spain; Inst de Salud Carlos III, Madrid, Spain; Inst 1 2 3 d Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; 4Hosp NIAID, NIH, Bethesda, MD, USA; NIH, Bethesda, MD, USA; VRC, NIAID, Clinic-IDIBAPS, Univ de Barcelona, Barcelona, Spain; 5Fraunhofer Inst NIH, Bethesda, MD, USA for Biomed Engineering, St Ingbert, Germany; 6Hosp Clinic of Barcelona, Barcelona, Spain Session P-E2 Poster Abstracts Hall A/B 304 New Family of Neutralizing Antibodies in HIV 2:45 PM-4:00 PM Asymptomatic Long-Term Nonprogressors Cellular Immunity: Change to Cytotoxic T Lymphocyte Patrice Debre1; Vincent Vieillard2; Olivier Lucar2; Bin Su3; Valérie and NK Cells Poster Listings Poster Potard4; Assia Samri2; Christiane Moog3; for the ANRS CO15 ALT Study 312 CD8 T Cells From HIV Controllers Recognize and Kill Ggroup HIV+ Non-Activated CD4 T Cells 1INSERM, Paris, France; 2INSERM U1135, Paris, France; 3INSERM UMR Blandine Monel1; Julie Boucau2; Yovana Pacheco2; Annmarie S-1109, Strasbourg, France; 4INSERM UMR-S 1136, Paris, France McKeon2; Daniel Kavanagh2; Sylvie Le Gall2; Bruce D. Walker2 305 WITHDRAWN 1Howard Hughes Med Inst/Ragon Inst of MGH, MIT, and Harvard, Cambridge, MA, USA; 2Ragon Inst of MGH, MIT, and Harvard, Cambridge, MA, USA 313 HIV-1-Specific CD8 T Cells Are Poorly Cross-Reactive 306 Neutralization Differences Between CCR5 and CXCR4 During Acute Infection Tropic Viruses in HIV-1B Infection Yimin Du1; Anju Bansal1; Jonathan Carlson2; Jesus Salazar-Gonzalez1; 3 4 1 5 Ludy Registre; Manish Sagar Kristin Ladell ; Stephanie Gras ; Sonya L. Heath ; David Price ; Jamie 4 1 Boston Univ, Boston, MA, USA Rossjohn ; Paul A. Goepfert 1Univ of Alabama at Birmingham, Birmingham, AL, USA; 2Microsoft Rsr, 307 Humoral Immune Pressure Selects for HIV-1 CXCR4- Redmond, WA, USA; 3Cardiff Univ, Cardiff, UK; 4Monash Univ, Clayton, Using Variants Australia; 5NIH, Bethesda, MD, USA Nina Lin1; Oscar Gonzalez1; Carlos Becerril2; Behzad Etemad2; Hong Lu3; Xueling Wu3; Shahin Lockman2; M. Essex4; Daniel Kuritzkes5; Manish Sagar1 1Boston Univ, Boston, MA, USA; 2Brigham and Women's Hosp, Harvard Med Sch, Boston, MA, USA; 3Aaron Diamond AIDS Rsr Cntr, New York, NY, USA; 4Harvard Sch of PH, Boston, MA, USA; 5Harvard Med Sch, Boston, MA, USA
56 CROI 2016 Poster Listings 57 ; 3 ; 2 ; 4 Osaka Osaka 3 ; Rafick 6 CRCHUM, Hall A/B 4 ; Shawn ; Shawn 3 Leidos Leidos
4 CROI 2016 3 ; Eli Boritz ; Eli 1 ; Chester ; Chester ; David Cooper ; David 2 ; Richard A. ; Richard 1 ; Mary F. ; MaryF. 4 6 Case Western Western Case 7 Kirby Inst, Univ of New New of Univ Inst, Kirby ; Yin ; Yin Xu ; Amelie Pagliuzza ; Amelie ; Wu Xiaolin 4 2 3 2 Program Agenda and
; Nicolas Chomont ; Nicolas 7 Yerkes Natl Primate Rsr Cntr, Cntr, Rsr Primate Natl Yerkes Univ of New South Wales, South Wales, New of Univ 5 2 Johns Hopkins Univ Sch of Univ Hopkins Johns 2 2 ; Robert Siliciano 2 ; Andrew Field ; Andrew 1
; David Ambrozak ; David 4 2 ; Alan S. Perelson ; Alan Univ of Pittsburgh, Pittsburgh, PA, PA, Pittsburgh, Pittsburgh, of Univ 2 5 ; Luca Micci ; Luca 2 ; Stephen H. Hughes ; Stephen 5 Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, Tufts Univ, Boston, MA, USA MA, Boston, Univ, Tufts 3 7 HIV Dynamics and Replication Prog, NCI, NCI, Prog, DynamicsHIV Replication and
; Jacob D. Estes D. ; Jacob 2 ; John M. Coffin ; Jonathan Spindler ; Jonathan 1 6 Howard Hughes Med Inst, Baltimore, MD, USA MD, Baltimore, Inst, Med Hughes Howard 1 VRC, NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, VRC, NIAID, ; Brad Milner ; Brad 3 2 2
and B Cells in Lymph Node Fine- Node Lymph in Cells B and 2 Frederick Natl Lab, Leidos Biomed Rsr, Frederick, Frederick, Rsr, Biomed Leidos Lab, Natl Frederick 5 ; Emily Ryan ; Emily 1 Los Alamos Natl Lab, Los Alamos, NM, USA NM, Alamos, Los Lab, Natl Alamos Los Frederick Natl Lab, Frederick, MD, USA; USA; MD, Frederick, Lab, Natl Frederick 4 ; William ; William Hey-Cunningham 3 ; Joseph P. Casazza ; Joseph P. ; Daniel C. Douek 1 Kirby Inst, Sydney, Australia; Australia; Sydney, Inst, Kirby ; Katherine M. Bruner ; Katherine 1 3 ; Kersten K. Koelsch ; Kersten 3 1 2 ; John W. Mellors W. ; John ; Concepcción Casado; Isabel Olivares; Cecilio López- Cecilio Olivares; Isabel Casado; ; Concepcción 4 ; Keith Delman ; Keith 1 Univ de Montréal, Montreal, QC, Canada; Canada; QC, Montreal, Montréal, de Univ 6 ; Frank Maldarelli ; Frank ; Michelle Bailey 6 2 ; Mirko Paiardini ; Mirko 7
NCI, Frederick, MD, USA; USA; MD, Frederick, NCI, 2 6 ; Wei Shao ; Wei 2 Univ of Milan, Milan, Italy; Milan, Milan, of Univ USA; MD, Baltimore, Univ, Hopkins Johns NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, St Vincent’s Hosp, Darlinghurst, Australia; Australia; Darlinghurst, Hosp, Vincent’s St GA, USA; Atlanta, Emory Sch Med, Univ of USA; USA; South Wales, Sydney, Australia Sydney, South Wales, Hill Univ, Osaka, Japan; Japan; Osaka, Univ, Pearson Anthony Kelleher Anthony Takuya Yamamoto Takuya SolAldrete Reserve Univ, Cleveland, OH, USA OH, Cleveland, Univ, Reserve Montreal, QC, Canada; Canada; QC, Montreal, Med, Baltimore, MD, USA; USA; MD, Baltimore, Med, 1 Distinctionthe for Analysis True of Evolution Viral Elite-Controller HIV-1 Patients MariaPernas ConsortiumSpanish of the AIDS HIV Controllers The the for Galindez; Network. Spain Madrid, III, Salud de Carlos Inst Predict to Amplicons PCR of Optimization Clonality of Sequences HIV-1 Full-Length Laskey Sarah B. 1 Sustained HIV Release by Single Persisting CD4+ T CD4+ Single SustainedPersisting by Release HIV During Cells Latency Disruption Hataye M. Jason 1 Clonallyin In Cells Expanded Proviruses HIV of Analysis Vivo SimonettiR. Francesco Germinal Centre T Centre Germinal During Biopsies Needle InfectionHIV Zaunders J. John 1 Immune With Infection Associates T-Cell CD4 Tcm ART on Persistence HIV and Failure Marconi C. Vincent 1 Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, Koup Sekaly Biomed Rsr, Inc, Frederick, MD, USA; USA; MD, Frederick, Inc, Rsr, Biomed Frederick, MD, USA; USA; MD, Frederick, MD, USA; USA; MD, Sydney, Australia; Australia; Sydney, Kearney
338 339 Session P-F2 Poster Abstracts Poster SessionP-F2 PM-4:002:45 PM Reservoir:ofMechanisms HIV and Measurement Persistence 336 337 334 335 ; 3 Inst Inst ; 3 2 ; 5 ; Björn
2 1 Hall A/B
; Archawin ; Archawin 1 3 ; Marcus ; Marcus 2 ; Michio ; Guislaine 3
3 2 ; Debra L. Garcia ; Elyse Singer ; Elyse 2 4 ; Vincent Calvez ; Vincent 2 Gerardo Garcia- Gerardo Lampang Hosp, Lampang, Lampang, Hosp, Lampang 4 ; Luis J. Montaner J. ; Luis ; Brigitte Autran ; Brigitte 2 ; Reiko Miyahara ; Reiko 2 ; Stephanie Jost ; Stephanie 2 ; Mitchell E.Granoff ; Mitchell 2 Emerging Pathogens Inst, Univ Univ Inst, Pathogens Emerging 2 Ragon Inst of MGH, MIT and and MIT MGH, of Inst Ragon 2 2 Univ of Pennsylvania, Pennsylvania, of Univ 2 Sorbonne Univs, Paris, France; France; Paris, Univs, Sorbonne 2 ; Ruxandra Calin ; Ruxandra ; Toshiyuki Miura ; Toshiyuki 2 4 ; David J. Nolan J. ; David 1 ; Cheryl Stoddart 4 AIDS and Cancer Specimen Resource, San Specimen Resource, Cancer and AIDS Massachusetts General Hosp, Boston, Boston, Hosp, General Massachusetts ; Tebas Pablo 3 3 1
Ministry of PH, Nonthaburi, Thailand; Thailand; Ministry Nonthaburi, PH, of ; Lambert Assoumou 2 3 ; Pathom Sawanpanyalert ; Pathom 3 ; Douglas S. Kwon ; Christine Katlama ; Christine 3 2
4 Univ of California San Francisco, San Francisco, CA, San Francisco, San Francisco, California of Univ ; Camille R. Simoneau ; Camille 4 1 ; Brian Ross ; Wichukchinda Nuanjun ; Sidonie Lambert 1 1 1 ; Ekaterina Maidji ; Ekaterina ; SusannaL. Lamers ; Panita Pathipvanich ; Panita 2 1 2 ; Heather M. Michael; Shulin M. Qin; Lawrence Kingsley; Kingsley; M. Michael; Shulin M. Qin; Lawrence ; Heather ; Koya Ariyoshi ; Koya ; Yasmine Dudoit ; Yasmine 3 1
; Eileen P. Scully P. ; Eileen
1 2 Natl Neurological AIDS Bank, Los Angeles, CA, USA Angeles, Bank, AIDS Los Neurological Natl 5 INSERM, UMR-S 1135, Paris, France; France; Paris, 1135, UMR-S INSERM, France Paris, Hosp, Univ Pitié-Salpêtrière APHP, Bioinfoexperts, LLC, Thibodaux, LA, USA; Thibodaux, Bioinfoexperts, LLC, The Wistar Inst, Philadelphia, PA, USA; USA; PA, Philadelphia, Inst, Wistar The Heinrich Pette Inst, Hamburg, Germany; Germany; Hamburg, Inst, Pette Heinrich Univ of Oxford, Oxford, UK; UK; Oxford, Oxford, of Univ Carcelain Thailand Francisco, CA, USA; Francisco, Philadelphia, PA, USA PA, Philadelphia, Dominique Costagliola Yasunami Harvard, Cambridge, MA, USA; USA; MA, Cambridge, Harvard, Mian-er Cong; Chou-Pong Pau; Walid Heneine; Heneine; Walid Pau; Mian-er Chou-Pong Cong; Lerma GA, USA Atlanta, CDC, 1 3 Transient DrugActivity a Has Breakthroughs PrEP in EffectReservoirs DNA SHIV on Role of Transitional-Memory T Cells in ProductiveHIV in Cells T Transitional-Memory of Role Patients ReservoirULTRASTOP in ChirazHamimi 1 Evidence of HIV Evolution in Lymphatic and Cancerand Lymphatic in Evolution HIV of Evidence Patients TissuesART+ in Rose Rebecca Feiyu Hong Feiyu W. Morris; John Alison Deborah McMahon; Meghan E.Fitzpatrick; Mellors USA PA, Pittsburgh, Pittsburgh, of Univ Persistence of HIV-Infected Alveolar Macrophages Alveolar HIV-Infected of Persistence ART Suppressive After 1 IFN-a Augments NK-Mediated ADCC Lysis via VRC01 orVRC01 via Lysis ADCC NK-Mediated Augments IFN-a Infected Subject HIV-1 Plasma Tomescu Costin ChristianKörner 1 Blockadethe Significantly KIR2DL1/3 of Improves Activity Anti-HIV-1 Cells NK KIR+ of ClinicalOutcome CRF01_AE in Mori Masahiko 1 Deleterious Effect of KIR-HLA-Associated Gag EffectSites on KIR-HLA-Associated of Deleterious of Florida, Gainesville, FL, USA; FL, USA; Gainesville, Florida, of MA, USA MA, Michael S. McGrath S. Michael Altfeld Corleis Marco Salemi Marco Rojanawiwat USA; USA; of Trop Med, Nagasaki Univ, Nagasaki, Japan; Japan; Nagasaki, Nagasaki Univ, Med, Trop of
333 332 331 2:45 PM-4:002:45 PM ReservoirsHIV Novel 330 Session P-F1 Poster Abstracts Poster SessionP-F1 316 315 314 Program and Agenda
340 Clonal Expansion of Replication-Competent Proviruses Session P-G1 Poster Abstracts Hall A/B Is Common in Individuals on ART 2:45 PM-4:00 PM Michele D. Sobolewski1; John K. Bui1; Jonathan Spindler2; Andrew Neuroimaging: Brain Structure and Functional Musick3; Brandon Keele4; Wei Shao5; Ann Wiegand3; John M. Coffin6; Response Mary F. Kearney3; John W. Mellors1 1Univ of Pittsburgh, Pittsburgh, PA, USA; 2HIV Dynamics and Replication 381 Advanced MRI Predict Cognition at 1-Year Follow-up in Prog, Natl Cancer Inst, Frederick, MD, USA; 3NCI, Frederick, MD, USA; Mildly Impaired HIV+ Patients 4Frederick Natl Lab, Frederick, MD, USA; 5Leidos Biomed Rsr, Inc, Frederick, Cristina Granziera1; Gaetano Perrotta2; Djalel Eddine Meskaldji3; MD, USA; 6Tufts Univ, Boston, MA, USA Guillaume Bonnier3; Samanta Simioni4; Matthias Cavassini5; Melanie 6 7 6 341 A Novel Assay to Quantify Replication-Competent Metral ; Gunnar Krueger ; Renaud Du Pasquier ; for the Swiss HIV Cohort Study Latent HIV-1 From rCD4+T Cells 1 2 1 1 2 Massachusetts General Hosp, Boston, MA, USA; Hosp Erasme, Univ Phalguni Gupta ; Anwesha Sanyal ; Nicolas Sluis-Cremer ; Deena 3 1 1 2 2 Libre de Bruxelles, Bruxelles, Belgium; École Polytechnique Fédérale de Ratner ; Ming Ding ; Robbie B. Mailliard ; Charles Rinaldo ; Jennifer M. 4 2 3 3 Lausanne, Lausanne, Switzerland; Inst de Lavigny, Lavigny, Switzerland; Zerbato ; Amanda Chargin ; Bruce K. Patterson 5 6 1 2 Univ Hosp Lausanne, Univ of Lausanne, Lausanne, Switzerland; CHUV, Univ of Pittsburgh, Grad Sch of PH, Pittsburgh, PA, USA; Univ of Lausanne, Switzerland; 7Siemens, Renens, Switzerland Pittsburgh, Pittsburgh, PA, USA; 3IncellDx, Inc, Menlo Park, CA, USA 382 Topographies of Cortical and Subcortical Volume Loss 342 Cellular HIV-1 RNA/DNA As Biomarkers of Inducible in HIV and Aging in the cART Era Virion Production 1 2 2 1 1 1 2 2 Anika Guha ; Matthew R. Brier ; Beau M. Ances ; Mario Ortega ; Anthony R. Cillo ; Feiyu Hong ; Angela Tsai ; Alivelu Irrinki ; Jasmine 1 1 2 3 2 2 1 Elizabeth Westerhaus ; Brittany Nelson Kaur ; Jacob Lalezari ; Derek Sloan ; Jeffrey P. Murry ; John W. Mellors 1 2 1 2 Washington Univ Sch of Med, St. Louis, MO, USA; Washington Univ in St. Univ of Pittsburgh, Pittsburgh, PA, USA; Gilead Scis, Inc, Foster City, CA, Louis, St. Louis, MO, USA USA; 3Quest Clinical Rsr, San Francisco, CA, USA 383 Meta-Analysis of Large HIV Cohort Reveals CD4 Effects Session P-F3 Poster Abstracts Hall A/B on Longitudinal Brain Atrophy 2:45 PM-4:00 PM Daniel Schonfeld1; Talia M. Nir1; Christopher R. Ching2; Neda 3 4 5 6 Tissue Reservoirs of HIV: Anatomic and Imaging Studies Jahanshad ; Jaroslaw Harezlak ; Giovanni Schifitto ; Tong Zhu ; Ronald A. Cohen7; Bradford Navia8; Paul M. Thompson1 343 FDG PET/CT Imaging of Lymph Nodes As a Measure of 1Imaging Genetics Cntr, Univ of Southern California, Marina Del Rey, the HIV Reservoir in Humans CA, USA; 2Univ of California Los Angeles Sch of Med, Marina del Rey, CA, 3 4 Priscilla Hsue1; Richard Takx2; Amorina Ishai2; Irini Sereti3; Remi USA; Univ of Southern California, Los Angeles, CA, USA; Indiana Univ 5 Fromentin4; Nicolas Chomont4; Sophia Hur1; Peter Ganz1; Steven G. Fairbanks Sch of PH, Indianapolis, IN, USA; Univ of Rochester, Rochester, 6 7 Deeks1; Ahmed Tawakol2 NY, USA; Univ of Michigan, Ann Arbor, MI, USA; Univ of Florida, 8 1Univ of California San Francisco, San Francisco, CA, USA; 2Massachusetts Gainesville, FL, USA; Tufts Univ Sch of Med, Boston, MA, USA General Hosp, Boston, MA, USA; 3NIH, Bethesda, MD, USA; 4Univ of 384 Brain Volumetric Changes After 2 Years of ART Montreal, Montreal, QC, Canada Initiated During Acute HIV Infection
Poster Listings Poster 344 Activation of Nasopharynx-Associated Lymphoid Kalpana J. Kallianpur1; Donn Colby2; Neda Jahanshad3; James L. Tissue in HIV Infection Fletcher2; Jintanat Ananworanich4; Katherine Clifford5; Khunthalee 6 5 7 5 Danny Li1; Richard Takx2; Amorina Ishai2; Remi Fromentin3; Irini Benjapornpong ; Collin Adams ; Serena S. Spudich ; Victor Valcour ; Sereti4; Nicolas Chomont4; Sophia Hur1; Steven G. Deeks1; Priscilla for the RV254/SEARCH010 Study Group 1 2 3 Hsue1; Ahmed Tawakol2 Univ of Hawaii, Honolulu, HI, USA; SEARCH, Bangkok, Thailand; Univ 4 1Univ of California San Francisco, San Francisco, CA, USA; 2Massachusetts of Southern California, Los Angeles, CA, USA; Military HIV Rsr Prog, 5 General Hosp, Boston, MA, USA; 3Univ of Montreal, Montreal, QC, Canada; Bethesda, MD, USA; Univ of California San Francisco, San Francisco, CA, 6 7 4NIH, Bethesda, MD, USA USA; Thai Red Cross AIDS Rsr Cntr, Bangkok, Thailand; Yale Univ Sch of Med, New Haven, CT, USA 345 HIV DNA Identified in Most Tissues of a Plasma- Negative HIV Autopsy Cohort 385 Regionally Specific Cortical Thinning in HIV+ Patients Susanna L. Lamers1; Rebecca Rose1; David J. Nolan2; Debra L. Garcia3; in the cART Era 1 1 1 Melissa Agsalda-Garcia4; Bruce Shiramizu4; Ekaterina Maidji5; Cheryl Ryan Sanford ; Ana L. Fernandez Cruz ; Lesley K. Fellows ; Beau M. 2 1 Stoddart5; Elyse Singer6; Michael S. McGrath5 Ances ; Louis Collins 1 2 1Bioinfoexperts, LLC, Thibodaux, LA, USA; 2Emerging Pathogens Inst, Univ McGill Univ, Montreal, QC, Canada; Washington Univ in St. Louis, St. of Florida, Gainesville, FL, USA; 3AIDS and Cancer Specimen Resource, San Louis, MO, USA Francisco, CA, USA; 4Univ of Hawaii, Honolulu, HI, USA; 5Univ of California San Francisco, San Francisco, CA, USA; 6Natl Neurological AIDS Bank, Los Angeles, CA, USA
58 CROI 2016 Poster Listings 59 ; 5 ; 1 ; 1 ; 2 ; Antonio ; Antonio Hall A/B 1 Clinical Clinical 6 CROI 2016 ; Karen ; Karen 3 ; Scott
3 ; Martine 1 ; Gene D. ; Gene D. ; Hong Xiao ; Hong 1 3 ; Martina 1 2 ; David R. ; David ; James Mikula 1 6 Clinical Rsr Cntr, Univ Univ Cntr, Rsr Clinical 3 Elisabeth-TweeSteden Elisabeth-TweeSteden 2 ; Evertine Abbink ; Evertine
Univ of California San California of Univ 2 1 2 ; DirkSchuermann Program Agenda and 1 Harvard Med Sch, Boston, Sch, Med Boston, Harvard Nelson R Mandela Sch of Mandela R Nelson
2 2 1 ; Paolo Denti ; Paolo Charité Rsr Organisation Organisation Rsr Charité 1 2 ; Jay Lozier ; Jay ; Chiara Alcantarini ; Chiara 6 1 ; Lori A. Gordon ; Lori 2 Elvitegravir Combination Combination Elvitegravir ; Karen Cohen ; Karen ; Annemie Stewart ; Annemie 1 2 ; Dara Hawthorne ; Dara ; Letizia Marinaro ; Letizia 1 1 ; Reinout van Crevel van ; Reinout 1 Case Western Reserve Univ, Cleveland, Cleveland, Univ, Reserve Western Case ; Grace A. McComsey ; Grace ; Timothy ; Timothy Eley 3 2 Xavier Univ of Louisiana Coll of Pharm, Pharm, of Coll Louisiana of Univ Xavier 3 3 ted as a Source of Atazanavir Sourcea as Atazanavir of ted Univ of Torino, Turin, Italy Turin, Torino, of Univ
2 ; Stefano Bonora ; Stefano 1 oncentrations Predict oncentrations Resistance ; Micol Ferrara ; Micol ; GaryMaartens 1 Bristol-Myers Squibb, Wallingford, CT, USA CT, Wallingford, Squibb, Bristol-Myers 1 3 ; Khanh Nghiem
5 1 1 Univ of North Texas System Coll of Pharm, Fort Pharm, of Coll System North of Univ Texas 4 ; Colleen Hadigan ; Colleen ; Carey Hwang ; Carey 1 ; Palanikumar Ravindran ; Palanikumar 1 ; Jessica Cusato 1 1 ; Michelle Gordon 1 ; Peter W. Hunt W. ; Peter ; Mieke de Hoon ; Mieke Andrzej Bienczak Andrzej 1 1
Leidos Biomed Rsr, Inc, Bethesda, MD, USA; USA; Bethesda, MD, Inc, Rsr, Biomed Leidos ; ; Max Lataillade ; Max 1 5 1 1
1 ; Robin Wood 2 State Univ of New York at Buffalo, Buffalo, NY, USA NY, Buffalo, at Buffalo, York New of Univ State ; Marjolijn Duisenberg-van Essenberg ; Marjolijn Duisenberg-van ; Marco Simiele ; Marco 4 1 1 ; Giovanni Di Perri ; Giovanni 1 ; Anela Kellogg ; Anela 4 ; GaryMaartens ; Susan Messing 1 4 Radboud Univ Med Cntr, Nijmegen, Netherlands; Netherlands; Nijmegen, Cntr, Med Univ Radboud Univ of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of Univ USA; Bethesda, MD, NIH, Cntr, Clinical Lab, Rsr Pharmacokinetics Clinical USA; Bethesda, MD, NIH, NIAID, Univ of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of Univ USA; NY, Rochester, Cntr, Med Rochester of Univ Univ of Torino, Torino, Italy; Torino, Torino, of Univ Bristol-Myers Squibb, Princeton, NJ, USA; USA; NJ, Princeton, Squibb, Bristol-Myers MA, USA MA, Med, Univ of Kwazulu-Natal, Durban, South Africa; South Africa; Durban, Kwazulu-Natal, of Univ Med, Ziekenhuis, Tilburg, Netherlands Tilburg, Ziekenhuis, Worth, TX,Worth, USA; Neelanjana Ray Neelanjana D'Avolio Cohen Kruijssen 1 1 Effectsthe on Dabigatran Increases of Cobicistat Time Volunteers Thrombin in Healthy KristinaBrooks M. 1 2 Crushedof Pharmacokinetics Drip Feed With Given Tablet Colbers Angela Catherine Orrell Catherine 1 Investiga Inflammation Variability Pharmacokinetic CharlesVenuto 1 for Concentration Efavirenz Recommended High Too Is Drug Therapeutic Monitoring 1 C Random Lopinavir ART Lopinavir-Based on CourtG. Richard HIV-1 Maturation Inhibitor BMS-955176: Inhibitor Maturation HIV-1 Exposure-Response and Analysis Pharmacokinetic Sevinsky Heather 1 PredictingTDF-tolerant Drug in Discontinuation StudyProspectivePK/PG A Patients: Calcagno Andrea of Cape Town, Cape Town, South Africa Town, Cape Town, Cape of Bangsberg New Orleans, LA, USA; Orleans, New Parag Kumar Parag OH, USA; USA; OH, Francisco, San Francisco, CA, USA; San Francisco, Francisco, Cntr, NIH, Bethesda, MD, USA Bethesda, MD, NIH, Cntr, Penzak Fiumanò Morse Blisse Vakkalagadda GmbH, Berlin, Germany; Germany; Berlin, GmbH, David M. Burger David
430 431 428 429 427 Session P-H1 Poster Abstracts Poster SessionP-H1 PM-4:002:45 PM Safety and Improve to Learning Response: Exposure Efficacy 425 426 ; 4 ; 2 ; Tufts Tufts 1 8 Rush Rush 4 ; Jianhui ; Cynthia ; Cynthia 2 3 Indiana Indiana 5 ; Kirsten ; Kirsten ; Emily ; Emily 3 2 ; Neda ; Neda ; Francine ; Francine 3 ; Ronald A. 1 6 ; David J. Moore J. ; David George Washington Washington George 3 2 ; Bryan Smith 1 ; Rebecca Barasky ; Rebecca Univ of California San California of Univ 1 ; Wang Lu 6 2 ; Eric N. Miller ; Eric 4 NeuroSci Rsr Australia Australia Rsr NeuroSci ; for the HIV Neuroimaging the HIV Neuroimaging ; for
2 3 1 ; Mark E. Mapstone Johns Hopkins Univ, Baltimore, Baltimore, Univ, Hopkins Johns 2 2 ; Thomas M. Gates Thomas ; Univ of Rochester Med Cntr, Cntr, Med Rochester of Univ 2 2
; Boris A. Gutman ; Xing Qiu; Xing 1 2 2 ; Winston ; Winston Liu ; Seble kassaye ; Lawrence Kingsley ; Lawrence 2 1 1 ; for the Neuropsychology Working Working the Neuropsychology ; for 5 Johns Hopkins Univ Sch of Med, Sch Med, of Univ Hopkins Johns ; Assawin Gongvatana ; Assawin 5 ; Chenglong Liu ; Chenglong St Vincent’s Hosp, Darlinghurst, Australia Darlinghurst, Hosp, Vincent’s St 5 ; Govind Nair ; Govind ; Eileen Martin; Eileen 2 3 1 3
1 Georgetown Univ, Washington, DC, USA; USA; DC, Washington, Univ, Georgetown 3 Univ of Florida, Gainesville, FL, USA; FL, USA; Gainesville, Florida, of Univ 7 Vanderbilt Univ, Nashville, TN, USA TN, Nashville, Univ, Vanderbilt 2 ochemical Alterations Are Slowly Are ochemicalAlterations ; Talia M. Nir M. Talia ; ; Paul M. Thompson M. ; Paul ; Amneris Luque ; Amneris 1 8
2 ; Caroline Rae ; Caroline 1 1 ; Tracie M. Umaki; Lindsay M. Kohorn; Dominic C. M. Kohorn; Lindsay Umaki; M. Tracie ; ; Laurianne Juge; Laurianne Northwestern Univ, Chicago, IL, USA Chicago, Univ, Northwestern 1 6 ; Cristah Artrip; Cristah ; Ned Sacktor ; Ned 1 6 ; Mikhail Popov 1 ; Madalina Tivarus 1 ; Daniel S. Reich ; Manya Magnus ; Manya ; Michael W. Plankey W. ; Michael 1 1 1 ; Andrew J. Levine J. ; Andrew ; Jaroslaw Harezlak ; Jaroslaw 2 4 ; Tyrell Alicia Univ of California Los Angeles, Los Angeles, CA, USA; Angeles, Los Angeles, Los California of Univ 2 Univ of Southern California, Los Angeles, CA, USA; Angeles, Los California, Southern of Univ 3 ; Mary Young 4 4 Giovanni Schifitto Giovanni ; Bruce J. Brew J. ; Bruce ; Ann Ragin; Ann ; ; Bradford Navia ; Bradford 3 5 2 7 Imaging Genetics Cntr, Univ of Southern California, Marina del Rey, Rey, del Marina California, Southern of Univ Cntr, Genetics Imaging 3 Univ of Rochester, Rochester, NY, USA; USA; NY, Rochester, Rochester, of Univ Univ of New South Wales, Sydney, Australia; Australia; Sydney, South Wales, New of Univ Georgetown Univ Med Cntr, Washington, DC, USA; USA; DC, Washington, Cntr, Med Univ Georgetown CA, USA San Diego, San Diego, California of Univ NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, Univ of Pittsburgh, Pittsburgh, PA, USA; USA; PA, Pittsburgh, Pittsburgh, of Univ Univ of California Los Angeles Sch of Med, Marina del Rey, CA, USA; Rey, del Marina Sch Med, Angeles of Los California of Univ CA, Rey, del Marina California, Southern of Univ Cntr, Genetics Imaging Univ, Washington, DC, USA; USA; DC, Washington, Univ, CA, USA; Univ Med Cntr, Chicago, IL, USA; IL, USA; Chicago, Cntr, Med Univ Avindra Nath Avindra Baltimore, MD, USA; USA; MD, Baltimore, Munro Univ Fairbanks Sch of PH, Indianapolis, IN, USA; USA; IN, Sch Indianapolis, PH, of Fairbanks Univ USA; USA; Cuiwei Wang Cuiwei Yuchuan Zhuang Yuchuan 1 EffectFunctionalon cART of Connectivity Cart-Naïvein Individuals HIV-Infected MultifactorialNeur Control Viral Despite Evolving Cysique A. Lucette 1 1 4 Isolated Cingulate Correlates With Reduced Executive Executive Reduced With Correlates Cingulate Isolated FunctionHIV in XiongJiang New Method Measuring Intracranial Vessel Caliber Vessel Intracranial Measuring Method New Arterial HAND In Remodeling Reveals AlwisDe M. Paba 1 1 Brain StructureBrain DiseaseHIV in Becker T. James KalpanaKallianpur Beau M. Shikuma K. ScottSouza; C. Chow; Nakamoto; Cecilia USA HI, Honolulu, Hawaii, of Univ Changeof in Rate the and Risk Factors Cardiovascular Cigarette Pack-Years May Affect Cingulate and Frontal Frontal and Affect Cingulate May Pack-Years Cigarette ChronicInfectionin HIV Cortex 1 2 Analysis ChingR. Christopher NeuroHIV: A Novel High-Resolution Subcortical High-Resolution Novel A Shape NeuroHIV: Consortium Zhong Univ Sch of Med, Boston, MA, USA MA, Boston, Sch Med, Univ of (NeuRA), Randwick, Australia; Randwick, Australia; (NeuRA), Cosimano Diego, San Diego, CA, USA; San Diego, Diego, Barrington Ron Ellis Jahanshad Moffat Rochester, NY, USA NY, Rochester, MD, USA; USA; MD, Cohen Group of the Multicenter AIDS Cohort AIDS Study of the Multicenter Group
392 391 390 389 388 387 386 Program and Agenda
432 Minimal Removal of Dolutegravir by Hemodialysis in Session P-L1 Poster Abstracts Hall A/B HIV-Infected Patients 2:45 PM-4:00 PM José Moltó1; Fredzzia Graterol2; Cristina Miranda1; Ioana Bancu2; Saye HIV Drug Resistance: Surveillance and Transmission Khoo3; Alieu Amara3; Anna Bonjoch1; Bonaventura Clotet1 1Lluita Contra la SIDA Fndn, Germans Trias i Pujol Univ Hosp, Barcelona, 477 HIV Pretreatment Drug Resistance in Mexico: A Spain; 2Hosp Universitari Germans Trias i Pujol, Badalona, Spain; 3Univ of Nationally Representative WHO Survey Liverpool, Liverpool, UK Santiago Avila-Rios1; Claudia García-Morales1; Daniela Tapia-Trejo1; Margarita Matías-Florentino1; Verónica Quiroz-Morales1; Jesús Casillas- 433 A Comparison of the Pharmacokinetics of Efavirenz Rodríguez2; Juan Sierra-Madero3; Eddie León4; Carlos Magis4; Gustavo During Pregnancy and Postpartum Reyes Teran1; for the HIV Drug Resistance Mexican Network Group Stein Schalkwijk1; Brookie M. Best2; Angela Colbers1; Alice Stek3; 1Natl Inst of Respiratory Diseases, Mexico City, Mexico; 2Condesa Jiajia Wang4; David Hawkins5; Mark Mirochnick6; David M. Burger1; for Specialised Clinic, Mexico City, Mexico; 3Natl Inst of Med Scis and the International Maternal Pediatric Adolescent AIDS Clinical Trials Nutrition Salvador Zubirán, Mexico City, Mexico; 4Natl Cntr for HIV/AIDS (IMPAACT) P1026s Protocol Team, and the Pharmacokinetics of Newly Prevention and Control, Mexico City, Mexico Developed Antiretroviral Agents in HIV-infected Pregnant Women (PANNA) Study Network 478 The Dynamics of Drug Resistance Detected During 1Radboud Univ Med Cntr, Nijmegen, Netherlands; 2Univ of California San Acute HIV Infection Diego, San Diego, CA, USA; 3Univ of Southern California, Los Angeles, CA, Ruth M. Kanthula1; Julie Weis2; Chris Warth2; Nelly R. Mugo3; Lisa USA; 4Harvard Sch of PH, Boston, MA, USA; 5Chelsea and Westminster Frenkel4; Connie M. Celum1; Julie M. Overbaugh2; Frederick Matsen2; Hosp NHS Fndn Trust, London, UK; 6Boston Univ Sch of Med, Boston, Jared M. Baeten1; Dara Lehman2 MA, USA 1Univ of Washington, Seattle, WA, USA; 2Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 3Kenya Med Rsr Inst, Thika, Kenya; 4Seattle Children's 434 Contamination of Herbal Medicines With ARVs and Rsr Inst, Seattle, WA, USA Widespread Use by PLWH in Nigeria Joshua Gini1; Bala I. Harri2; Elkanah D. Kabilis3; Mark Stevens4; Paul P. 479LB HIV-1 Infection With Multiclass Resistance Despite Pama5; Alieu Amara1; Dilly P. Sujan1; Justin Chiong1; Saye Khoo1; for the Preexposure Prophylaxis (PrEP) Pharmacology Research Laboratories University of Liverpool David C. Knox1; Darrell H. Tan2; P. Richard Harrigan3; Peter L. 1Univ of Liverpool, Liverpool, UK; 2Dalhatu Araf Specialist Hosp, Lafia, Anderson4 Nassarawa State, Lafia, Nigeria; 3Gombe State Specialist Hosp, Gombe, 1Maple Leaf Med Clinic, Toronto, ON, Canada; 2St Michael’s Hosp, Toronto, Nigeria; 4Faith Alive Fndn, Jos Plateau State, Nigeria; 5Fed Med Cntr ON, Canada; 3BC Cntr for Excellence in HIV/AIDS, Vancouver, BC, Canada; Katsina, Katsina, Nigeria 4Univ of Colorado, Denver, CO, USA 435 TDF/EVG Nanoparticle Formulation: Plasma 480 Large Cluster Clinical Isolates Show Facilitated Escape Pharmacokinetics in Humanized Mice From Integrase Inhibitors Christopher Destache; Subhra Mandal Bluma G. Brenner1; Maureen Oliveira1; Ruxandra Ilinca Ibanescu1; Creighton Univ, Omaha, NE, USA Olga Golubkov1; Bonnie A. Spira2; Mark A. Wainberg2 1Lady Davis Inst, Montreal, QC, Canada; 2McGill Univ AIDS Cntr, Montreal, 436 Antiretroviral Drug Use in a Cross-sectional Population QC, Canada Survey in Africa: HPTN 043 Poster Listings Poster Jessica M. Fogel1; William Clarke1; Michal Kulich2; Estelle Piwowar- 481 An Informatics Approach to Predicting Rates of Manning1; Glenda Gray3; Linda Richter4; Heidi van Rooyen5; Thomas Transmitted HIV-1 Drug Resistance Coates6; Susan H. Eshleman1; for the For the HPTN 043 (NIMH Project Joseph M. Volpe1; Dongmei Yang1; Suqin Cai1; Jay Timmerman2; Accept) Study Team Charles M. Walworth1; Jeannette M. Whitcomb1 1Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; 2Charles Univ, 1Monogram BioScis, South San Francisco, CA, USA; 2LabCorp Informatics, Prague, Czech Republic; 3South African Med Rsr Council, Cape Town, Durham, NC, USA South Africa; 4Univ of the Witwatersrand, Johannesburg, South Africa; 5 6 482 Impact of Transmitted Thymidine Analogue Mutations Human Scis Rsr Council, Durban, South Africa; Univ of California Los on Responses to First-Line ART Angeles, Los Angeles, CA, USA Anna Maria Geretti1; Ellen White2; Apostolos Beloukas3; Chloe Orkin4; 437LB A Single Monotherapy Dose of MK-8591, a Novel NRTI, Anna Tostevin2; Peter Tilston5; David Chadwick6; Caroline Sabin7; David Suppresses HIV for 10 Days Dunn2; for the HIV Drug Resistance Database and CHIC Study Evan Friedman1; Dirk Schuermann2; Deanne J. Rudd3; Sabrina 1Inst of Infection & Global Hlth, Univ of Liverpool, Liverpool, UK; 2Med Fox-Bosetti3; Sandra Zhang3; Martine Robberechts3; Andreas Hueser4; Rsr Council Clinical Trials Unit at Univ Coll London, London, UK; 3Univ of Daria J. Hazuda5; Marian Iwamoto6; Jay Grobler5; for the HIV Early Liverpool, Liverpool, UK; 4Barts Hlth NHS Trust, London, UK; 5Manchester Development Team Royal Infirmary, Manchester, UK; 6South Tees Hosp NHS Fndn Trust, 1Merck & Co, Inc, Rahway, NJ, USA; 2Charité Rsr Organisation GmbH, Middlesbrough, UK; 7Univ Coll London, London, UK Berlin, Germany; 3Merck & Co., Inc, Kenilworth, NJ, USA; 4Charité Universitätsmedizin Berlin, Germany, Rsr Hosp, Berlin, Germany; 5Merck & Co, Inc, West Point, PA, USA; 6Merck & Co, Inc, Kenilworth, NJ, USA
60 CROI 2016 Poster Listings 61 ; ; 1 3 ; Ann ; Ann 7 Univ of Univ 8 ; Robert CDC, Juba, CDC, Hall A/B ; Frank ; Frank 3 3 3 ; Kevin ; Kevin Public Hlth Hlth Public 1 CROI 2016 2 ; Bhavna ; Bhavna Inst de Pesquisa Pesquisa de Inst 1
2 5 ; Gregory Wani
3 2 DAIDS, NIAID, NIAID, DAIDS, 6 ; Michael Hughes 6 ; Catherine Kiptiness ; Catherine Program Agenda and 2 ; Jeffrey B. Joy B. ; Jeffrey ; John M. Coffin 2
2 2 ; DougSider St. Michael’s Hosp/Univ of Hosp/Univ Michael’s St. 4 3 ; Joel Katoro Seattle Children’s Rsr Inst, Inst, Rsr Seattle Children’s 2 2 ; Saran Vardhanabhuti CDC, Atlanta, GA, USA; Atlanta, CDC, 2 2 ; Bharat Parekh ; Bharat ; Christine McGrath ; Christine 2 1 Univ of Washington, Seattle, United United Seattle, Washington, of Univ Public Hlth Ontario, Toronto, ON, ON, Toronto, Ontario, Hlth Public 5 ; Wei Shao ; Wei 5 1 ; Molly Levine Univ of Pittsburgh, Pittsburgh, PA, USA PA, Pittsburgh, Pittsburgh, of Univ 2 9 Ontario Agency for Hlth Protection and and Protection Hlth for Agency Ontario Case Western Reserve Univ, Cleveland, Cleveland, Univ, Reserve Western Case 4 4 Lisa Frenkel Lisa
1 ; ; Catherine Godfrey ; Catherine 3 ; Yen Duong ; Yen 5 2 ; Tony Mazzulli ; Tony Leidos Biomed Rsr, Inc, Frederick, MD, USA; USA; MD, Frederick, Inc, Rsr, Biomed Leidos 4 ; for the A5288 Team Team the A5288 ; for Harvard Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, of Harvard 2 9 7 ; Avi Hakim ; Avi 3 ; Ashleigh B. Sullivan ; Ashleigh B. 1 ; Ingrid Beck Statistical and Data Analysis Cntr, Harvard School of Harvard Data and Analysis Cntr, Statistical ; Benita Yip; Marjorie A. Robbins; Conan K. Woods; Woods; K. Marjorie A. Robbins; Conan Yip; ; Benita Seattle Children’s Rsr Inst, Seattle, United States; States; United Seattle, Inst, Rsr Seattle Children’s ; Beatriz Grinsztejn ; Beatriz 1 ; Junko Hattori ; Junko 3 3 1 1 ; Rachel Silverman 3 Hetal Patel Hetal ; Alex Bolo ; Alex ; 1 1 ; Mary F. Kearney ; MaryF. 1 Joint Clinical Rsr Cntr, Kampala, Uganda; Uganda; Kampala, Cntr, Rsr Clinical Joint ; Peter Mugyenyi ; Peter 5 4 ; Samah Rafie Sakr 1 ; Vanessa G. Allen Vanessa ; ; John W. Mellors W. ; John 3 8 Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ Kenya; Nairobi, Cntr, Hope Coptic Ministry Juba, South Sudan; Hlth, of BARC-SA and Lancet Lab, Johannesburg, South Africa; South Africa; Johannesburg, Lab, Lancet and BARC-SA NCI, Frederick, MD, USA; USA; MD, Frederick, NCI, USA MA, Boston, Univ, Tufts Canada; BC, Vancouver, HIV/AIDS, in Excellence for Cntr BC Promotion, Toronto, ON, Canada; Canada; ON, Toronto, Promotion, Toronto, Toronto, ON, Canada; Canada; ON, Toronto, Toronto, James Munyao States Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, Gough South Sudan NIH, Rockville, MD, USA; USA; MD, Rockville, NIH, Maldarelli 1 Chohan A. Salata Rio (Fiocruz), Cruz Oswaldo (IPEC)/Fundação Chagas Evandro Clínica Brazil; Janeiro, de OH, USA; USA; OH, Seattle, WA, USA; USA; WA, Seattle, Agency of Canada, Toronto, ON, Canada; Canada; ON, Toronto, Canada, of Agency of Kenyans Before First-Line ART First-Line Before Kenyans of MichaelH. Chung Prospective Randomized HIV Drug Resistance Testing Testing DrugHIV Resistance ProspectiveRandomized 1 4 1 in BC, Canada,BC, in 2009–2015 KatherineLepik W Zhang; Rolando A. Wendy Rachel Lima; A. McGovern; D. Viviane Harrigan Richard Barrios; P. Julio Montaner; Canada BC, Vancouver, HIV/AIDS, in Excellence for Cntr BC A5288 ACTG Screening for at Resistance ARV Divergent RLS in StudyART 3rd-Line of Carole Wallis L. 1 3 HIVof Clustering and Large-ScaleTransmission Canada Ontario, in Resistance Protease Harrigan Richard P. 1 Drug Resistance Integrase of Incidence and Prevalence Evaluation of an EIA-Based Testing Algorithm Using Using Algorithm Testing EIA-Based an of Evaluation DriedSouth SpotsBlood Sudan From Hakim Idris Linkage of Rare Drug Resistance Mutations Detected Linkage Drug Mutations Rare Resistance of SGS Ultrasensitive New by Boltz F. Valerie Idris Farouk Idris Collier Public Hlth, Boston, MA, USA; USA; MA, Boston, Hlth, Public Canada
494LB 493LB 491LB 492LB Session P-M1 Poster Abstracts Poster SessionP-M1 PM-4:002:45 PM DiagnosticsHIV 510 490 ; 1 ; 1 ; 4 Inst Inst 6 ; Clare ; Clare 4 ; Marc ; Marc 2
8 ; Thumbi ; Thumbi ; 3 1
2 Karolinska Karolinska 7 Royal Free Free Royal 1 ; Manjeetha ; David Dunn ; David 5 2 7 ; Gilda ; Viviane ; Viviane Bremer ; Anne-Mieke 2 1 1 ; Andrea DeLuca ; Andrea Univ of Siena, Siena, of Univ Brighton and Sussex and Brighton 5 4 ; Simon Collins 3 3 ; Francesca Ceccherini- ; Francesca IrsiCaixa Inst for AIDS AIDS for Inst IrsiCaixa 1 2 ; Daniele Armenia ; Bruce D. Walker D. ; Bruce ; Anna C. Hearps ; Anna 1 3 2 ; Giuseppe Lapadula 7 NorbertBannert ; Deenan Pillay ; 6 2 ; Kirsten Hanke ; Kirsten 1 Univ Coll London, London, UK; London, London, Coll Univ 6 Robert Koch-Inst, Berlin, Germany Berlin, Robert Koch-Inst, BC Cntr for Excellence in HIV/AIDS, HIV/AIDS, in Excellence for Cntr BC 2 2 ; P. Richard Harrigan Richard ; P. DrugCD4on Resistance 3 ; Marc Noguera-Julian ; Marc Univ of Rome Tor Vergata, Rome, Italy; Rome, Vergata, Tor Rome of Univ 1 HIV i-Base, London, UK; UK; London, i-Base, HIV Univ Magna Graecia, Catanzaro, Italy; Catanzaro, Graecia, Magna Univ 2 4 2 ; Krista Dong 1 ; Duncan Churchill ; Cathia Soulie ; Cathia ; Alessandro Cozzi-Lepri ; Alessandro ; Helen Sambatakou ; Helen 2 4 1 2 4 ; Anne-Genevieve Marcelin 1 ; Christine Katlama ; Christine 1 Infectious Diseases Clinic, San Gerardo Hosp, Hosp, San Gerardo DiseasesInfectious Clinic, 8 Univ of Melbourne, Melbourne, Australia Melbourne, Melbourne, of Univ 3 ; Caroline Sabin ; Caroline 1 Ragon Inst of MGH, MIT and Harvard, Cambridge, Cambridge, Harvard, and MIT MGH, of Inst Ragon ; Chanson J. Brumme J. ; Chanson 3 1 ; Con Sonza ; Con 1 ; Claudia Kucherer ; Claudia ; Anders Sönnerborg ; Anders 1 6 ; Sanjay R. Mehta; Joel O. Wertheim; Ben Murrell; Ben Murrell; Wertheim; O. Joel Mehta; R. ; Sanjay ; Torti Carlo 1 ; Alexandra Hofmann ; Alexandra ; Avashna Singh ; Avashna 1 1 ; Jeremy Jaffre ; Jeremy ; Erasmus Smit ; Erasmus 1 1 ; Maurizio Zazzi ; Maurizio ; Amber Moodley ; Amber 3
; Vincent Calvez ; Vincent 1 ; Michelle Gordon 1 2 Nelson R Mandela Sch of Med, Univ of Kwazulu-Natal, Durban, Durban, Kwazulu-Natal, of Univ Sch Med, of R Mandela Nelson 1 4 ; Sidonie Lambert 3 ; Tostevin Anna Hippokration General Hosp, Univ of Athens, Athens, Greece; Greece; Athens, Athens, of Univ Hosp, General Hippokration 5 5 APHP, Pitie Salpêtrière Hosp, Paris, France Paris, Hosp, Salpêtrière Pitie APHP, Sorbonne Univs, Paris, France; France; Paris, Univs, Sorbonne Univ of KwaZulu-Natal, Durban, South Africa; South Africa; Durban, KwaZulu-Natal, of Univ Univ Coll London, London, UK; UK; London, London, Coll Univ Belgium; Leuven, Leuven, Universiteit Katholieke Robert Koch Inst, Berlin, Germany; Germany; Berlin, Robert Inst, Koch Birmingham Heartlands Hosp, Birmingham, UK; UK; Birmingham, Heartlands Hosp, Birmingham South Africa Mtubatuba, Studies, Pop and Hlth for Cntr Africa Med Rsr Council Clinical Trials Unit at Univ Coll London, London, UK; London, London, at Coll Unit Univ Trials Clinical Council Rsr Med Burnet Inst, Melbourne, Australia; Australia; Melbourne, Inst, Burnet P. Ndungu P. Booth Jaggernath Italy; Tachedjian Vancouver, BC, Canada; Canada; BC, Vancouver, South Africa Monza, Italy Monza, Vandamme 1 3 Detected by UltraDeep Sequencing UltraDeep Detectedby Todesco Eve Integrase Inhibitors-Transmitted Drug Resistance Inhibitors-Transmitted Integrase Susan J. Little; Douglas D. Richman; Davey M. Smith; Sara Gianella Richman;Davey Little; DouglasSusan J. D. CA, USA San Diego, San Diego, California of Univ SinghUrisha Antoine Chaillon Antoine Subtype Drug HIV-1 in Resistance C Transmitted Infection Hyperacute No Evidence of Sexual Transmission of Minorityof HIV Transmission Sexual of Evidence No MSM in DrugMutations Resistance 1 3 Influence of Transmitted Transmitted Influence of Patients HIV ART-Naïve Among Decline SchultzeAnna HIV Infections, Germany 2013-14 Germany Infections, HIV Hauser Andrea 1 7 Molecular Surveillance National Acquired Recently of 1 2 No Effect of HIV-1 Subtype C on Virological Failure Rate Rate SubtypeVirologicalEffect Failure No HIV-1 of on C Regimens TDF First-Line With White Ellen Subtype B RT Which Alter Fitness Fitness Alter Which Subtype RT B SushamaTelwatte 1 Increasing Prevalence of Silent Mutations in HIV-1 HIV-1 in Silent of Mutations Prevalence Increasing Silberstein Inst, Stockholm, Sweden; Sweden; Stockholm, Inst, London NHS Fndn Trust, London, UK; UK; London, Trust, Fndn NHS London Barbara Bartmeyer 1 Catherine F. Latham F. Catherine Rsr, Badalona, Spain; Badalona, Rsr, Anna Maria Geretti Anna MA, USA; USA; MA, of Infection & Global Hlth, Univ of Liverpool, Liverpool, UK; UK; Liverpool, Liverpool, of Univ Hlth, Global Infection & of for the UK HIV drug resistance database and the UK Collaborative UK Collaborative and the database resistance the UK HIV drug for HIV cohort Hosps NHS Trust, Brighton, UK; UK; Brighton, Trust, NHS Hosps Wirden
489 488 487 486 485 484 483 Program and Agenda
511 Comparison of Cross-Sectional Incidence Assay Results Stellenbosch, South Africa; 4Bill and Melinda Gates Fndn, Seattle, WA, From DBS and Plasma USA; 5Univ of Cape Town and Stellenbosch Univ, Cape Town, South Africa Katherine Schlusser1; Christopher Pilcher2; Esper G. Kallas3; Breno 518 Acute Retroviral Syndrome: Useful for Guiding Testing R. Santos4; Stephen G. Deeks5; Sheila M. Keating6; Shelley Facente2; for Acute HIV Infection? 7 7 8 Susan H. Eshleman ; Thomas C. Quinn ; Oliver Laeyendecker ; for the Martin Hoenigl; Nella Green; Sanjay R. Mehta; Martha Camacho; Consortium for the Evaluation and Performance of HIV Incidence Sara Gianella; Davey M. Smith; Susan J. Little Assays (CEPHIA) Univ of California San Diego, San Diego, CA, USA 1Johns Hopkins Univ, Baltimore, MD, USA; 2Univ of California San Francisco, San Francisco, CA, USA; 3Univ of Sao Paulo Med Sch, Sao Paulo, 519 Comparative Sensitivity of 8 HIV Rapid Tests in Brazil; 4Hosp Conceição, Porto Alegre, Brazil; 5San Francisco General Hosp, HIV-Positive Patients San Francisco, CA, USA; 6Blood Systems Rsr Inst, San Francisco, CA, USA; Heinrich Scheiblauer1; Siri Göpel2; Tanja Westenberger1; Christoph 7Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; 8NIH, Bethesda, Stephan2 MD, USA 1Paul-Ehrlich-Inst, Langen, Germany; 2Goethe Univ Hosp Frankfurt, 512 Laboratory Evaluation of the GeneXpert® HIV-1 Viral Frankfurt, Germany Load Assay in Zimbabwe 520 Comparison of Methods for HIV Incidence Estimation Zibusiso Ndlovu1; Sekesai Mtapuri-Zinyowera2; Carol Metcalf3; in a Cohort With Subtype C HIV Emmanuel Farjado3; Kekeletso Kao4; Maryam Rumaney3; Daniel Allison R. Kirkpatrick1; Charles Morrison2; Tsungai Chipato3; Orozco4; Elton Mbofana1; Helen Bygrave3 Katherine Schlusser4; Pai-Lien Chen2; Marshall Munjoma5; Thomas C. 1Médecins Sans Frontières, Harare, Zimbabwe; 2Natl Microbiology Quinn6; Susan H. Eshleman6; Oliver Laeyendecker7 Reference Lab, Harare, Zimbabwe; 3Médecins Sans Frontières, Southern 1NIAID, NIH, Baltimore, MD, USA; 2FHI 360, Durham, NC, USA; 3Univ of Africa Med Unit, Cape Town, South Africa; 4FIND, Geneva, Switzerland Zimbabwe, Harare, Zimbabwe; 4Johns Hopkins Univ, Baltimore, MD, USA; 5Univ of California San Francisco Prog, Univ of Zimbabwe, Belgravia, 513 Weakly Reactive HIV Rapid Diagnostic Test Kits Should 6 7 Not Be Reported As Positive Zimbabwe; Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; NIH, Bethesda, MD, USA Patrick Karugaba1; Timothy Amukele2; Ali Elbireer1; Alice Nansamba1 1Makerere Univ Johns Hopkins Univ Rsr Collab Lab, Kampala, Uganda; 2Johns Hopkins Univ Sch of Med, Baltimore, MD, USA Session P-N1 Poster Abstracts Hall A/B 2:45 PM-4:00 PM 514 Extending HIV Avidity Recency Detection by Addition HCV Staging: Stiffen Up! of p24Ag Detection Gary Murphy1; Anne Le Corfec2; Jamie Benson3; Jake Hall1; Alfredo 527 Prognostic Value of Transient Elastography and FIB-4 Villarreal4; Karen Mintern3 in HIV/HCV Coinfection 1PH England, London, UK; 2Bio-Rad Lab, Inc, La Coquette, France; Cristina Díez1; Juan Berenguer1; Rivero-Juárez Antonio2; Víctor 3Bio-Rad Lab, Inc, Hemel Hempstead, UK; 4Bio-Rad Lab, Inc, Benicia, Hontañón3; Leire Pérez-Latorre1; Francisca Cuenca2; Luz Martín- CA, USA Carbonero4; Antonio Rivero2; José M. Bellón1; Juan González-García4 1 2 515 Western Blot Index for Estimating Recency of HIV Hosp General Universitario Gregorio Marañón, Madrid, Spain; Hosp Universitario Reina Sofía, Córdoba, Spain; 3Hosp Universitario La Paz, Infection 4 Poster Listings Poster Madrid, Spain; Inst for Hlth Rsr of La Paz Univ Hosp, Madrid, Spain Mark Manak1; Leigh . Eller2; Jennifer Malia3; Merlin L. Robb2; Sheila Peel2; for the Mark Manak, Ashley Shutt, Jennifer Malia, Leigh Anne 528 Variation in Liver Fibrosis Staging Using FibroTest, Eller, Merlin Robb and Sheila Peel FIB-4, and APRI Scores 1Henry Jackson Fndn, Silver Spring, MD, USA; 2US Military HIV Rsr Prog, Aurielle Thomas1; Charisse Ahmed2; Chloe Gross3; Rachel Silk3; Walter Reed Army Inst of Rsr, Silver Spring, MD, USA; 3Walter Reed Army Elizabeth Akoth3; Eleanor M. Wilson4; Angie Price3; Shyam Kottilil5; Inst of Rsr, Silver Spring, MD, USA Henry Masur6; Sarah Kattakuzhy3 1 2 516 Low Prevalence of False Prior HIV Diagnoses in Chokwe NIH Clinical Cntr, Bethesda, MD, USA; NIH Clinical Cntr, Bethesda, MD, USA; 3Inst of Human Virology, Bethesda, MD, USA; 4Inst of Human District, Mozambique Virology, Baltimore, MD, USA; 5Univ of Maryland Med Cntr, Baltimore, 1 1 2 Rob Nelson ; Duncan MacKellar ; Ricardo Thompson ; Marcelo d. MD, USA; 6NIH, Bethesda, MD, USA Manuel3; Juvencio Bonzela4; Didier Mugabe4; Chunfu Yang1; Bharat Parekh1; Daniel Shodell5; Edgar Monteroso6 529 New Predictive Index Based on the Combination of 1CDC, Atlanta, GA, USA; 2Natl Inst of Hlth Mozambique, Maputo, Liver Stiffness and CTP Mozambique; 3Chókwè District Hosp, Chókwè, Mozambique; 4CITSC, Nicolás Merchante1; Antonio Rivero-Juárez2; Francisco Téllez3; Chókwè, Mozambique; 5Colorado Dept of PH and Environment, Denver, Dolores Merino4; María José Ríos5; Guillermo Ojeda-Burgos6; Mohamed CO, USA; 6CDC, Maputo, Mozambique Omar Mohamed-Balghata7; Patricia Monje-Agudo1; Montserrat Pérez- 8 1 517 HIV Incidence Assay Performance Required to Monitor Pérez ; Juan A. Pineda ; for the HEPAVIR-cirrhosis study group 1Hosp Universitario de Valme, Sevilla, Spain; 2IMIBIC, Córdoba, Spain; Prevention Intervention Impact 3Hosp La Línea de la Concepción (AGS Campo de Gibraltar), La Línea de la 1 2 2 3 Neil T. Parkin ; Stefano Ongarello ; Jennifer Osborn ; Eduard Grebe ; Concepción, Spain; 4Complejo Hospario de Huelva, Huelva, Spain; 5Hosp 3 3 4 5 Simon Daniel ; Alex Welte ; Christine Rousseau ; Reshma Kassanjee ; Universitario Virgen de la Macarena, Seville, Spain; 6Hosp Universitario 2 Peter Dailey Virgen de la Victoria, Málaga, Spain; 7Complejo Hospario de Jaén, Jaén, 1 2 3 FIND, Belmont, CA, USA; FIND, Geneva, Switzerland; SACEMA, Spain; 8Hosp de La Línea de la Concepción, Cádiz, Spain
62 CROI 2016 Poster Listings 63 ; 2 ; 2 ; 5 Univ Univ 5 Inst Inst ; ; David ; David 2 ; 3 1 2 ; ; for the ; for 1
; Risha 7 1 Hall A/B
1 Univ of Univ 7 CROI 2016 ; Pamela ; Pamela 1 ; Tami Pilot- ; Tami ; Veronica ; Veronica 3 3 ; Gretja Schnell ; Gretja 2 Stichting HIV Stichting 2 ; David L. Thomas L. ; David NIAID, NIH, NIH, NIAID, ; Joop E. Arends ; Monica Mix 3 4 4 ; Denali Boon 1 Univ Med Cntr Cntr Med Univ 3 ; for the observational; for 5 7
; Shyam Kottilil ; Shyam Program Agenda and ; Ard van Sighem van ; Ard AbbVie, North Chicago, IL, North Chicago, AbbVie, 1 6 2 2 ; Yury ; Yury Khudyakov Johns Hopkins Univ Sch of Univ Hopkins Johns 1 2
Unity Hlth Care, Washington, Washington, Unity Care, Hlth 1 3 Cntr of Infectious Diseases Infectious of and Cntr ; Carl Latkin ; Carl ; Teferi Gebeyehu 3 1 ; Anupama Shankar; Anupama ; Tripathi Rakesh 2 2 2 ; Nancy S. Shulman ; Sumathi Ramachandran ; Sumathi 3 2 ; Gregory D. Kirk ; Gregory D. ; Bart Rijnders J. NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, 2 3 6 ; Janke Schinkel ; Janke ; Shruti H. Mehta H. ; Shruti 6 2 ; Henry Masur 5 ; Ayesha McAdams-Mahmoud ; Ayesha Sanquin Blood Supply Fndn, Amsterdam, Amsterdam, Sanquin Blood Supply Fndn, 1 6 ; Shruti H. Mehta H. ; Shruti
1 ; Philip Peters 1 ; Daniela Bezemer ; Daniela 1 Johns Hopkins Univ Sch of Med, Baltimore, Baltimore, Sch Med, of Univ Hopkins Johns
2 2 ; Chloe Gross ; Chloe Indiana State Dept of Hlth, Indianapolis, IN, USA IN, Indianapolis, Dept Hlth, of State Indiana 1 2 ; Roger Trinh 2 ; Kathleen Page ; Kathleen ; Sara J. Blosser ; Sara J. 1 2 ; Jessica Gentry 1 ; Preethi Krishnan ; Preethi 1 ; Oliver Laeyendecker ; Oliver Provider Interest in Treating HCV: Treating in Interest Provider 2 ; Andrea L. Cox L. ; Andrea ; William ; William Osburn 1 4 Academic Med Cntr, Amsterdam, Netherlands Amsterdam, Cntr, Med Academic ; Jan T. van der Meer van T. ; Jan 7 2 ; Thijs J. van de Laar van J. Thijs ; 1 ; Mark Sulkowski Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns ; William ; William Switzer 2 Family & Med Counseling Services, Washington, DC, USA; USA; DC, Washington, Services, Counseling Med & Family 3 2 4 ; Benjamin Emmanuel ; Daniel Cohen ; Christine Collins ; Christine 4 2 2 AbbVie Inc, North Chicago, IL, USA North Inc, Chicago, AbbVie ; Alex Niculescu ; Alex 3 1 Erasmus Univ Med Cntr, Rotterdam, Netherlands; Netherlands; Rotterdam, Cntr, Med Univ Erasmus CDC, Atlanta, GA, USA; Atlanta, CDC, Netherlands; Amsterdam, ServicePH Amsterdam, of The Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns The USA; Bethesda, MD, NIH, Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns USA; Bethesda, MD, at Maryland, of Univ Virology Human of Inst Pontones MD, USA; USA; MD, Matias Kathleen A. Backfish Kathleen Netherlands; Netherlands; of Human Virology, Bethesda, MD, USA; USA; Bethesda, MD, Virology, Human of Yan Xie Yan ASCEND Investigators of Maryland, Baltimore, MD, USA; USA; MD, Baltimore, Maryland, of Maria Prins Andrew D. Redd D. Andrew Bethesda, MD, USA Bethesda, MD, Med, Baltimore, MD, USA MD, Baltimore, Med, 4 HCVContactHIV Complements Analysis Phylogenetic OutbreakHIV an in Setting Tracing GalangR. Romeo 1 andHIV of Clusters Transmission in Overlap Limited HCVNetherlands the in MSM Among Vanhommerig W. Joost 1 Immunology Amsterdam, Academic Med Cntr, Amsterdam, Netherlands; Netherlands; Amsterdam, Cntr, Med Academic Amsterdam, Immunology Effect of Baseline Resistance-Associated Variants on Variants Effect Resistance-Associated Baseline of RBV Plus Regimen 3D the With SVR MarkSulkowski 1 Estimate to HCVBiomarker a as Antibody IgG Avidity Incidence Population-Level Patel U. Eshan 1 Maryland Med Cntr, Baltimore, MD, USA MD, Baltimore, Maryland Cntr, Med Primary Care Falade-Nwulia Oluwaseun 1 Primary EfficacyHigh by Care HCVof Treatment StudyASCEND The Providers: SarahKattakuzhy M. 1 DC, USA; USA; DC, Utrecht, Utrecht, Netherlands; Netherlands; Utrecht, Utrecht, irvin USA; USA; Netherlands; Amsterdam, Monitoring, Thomas C. Quinn Thomas Jenkins L. Thomas A Mixed-Methods Study Mixed-Methods A ATHENA and MOSAIC cohort studies ATHENA Colette Smit Colette
541 542 539LB Abstracts Poster SessionP-N3 PM-4:002:45 PM Risks Transmission and Tracking HCVTransmission 540 537 538LB ; 3 ; 2 New ; 4 6 Hosp Hosp 5
; 3 ; Robert
1 Tufts Univ, Univ, Tufts 1 Hall A/B 4 ; Mohamed 6 ; Juan A. 8 Stanford Univ, Univ, Stanford
2
2 ; Payal Desai ; Payal ; David A. van A. van ; David 3 1 ; Tamara ; Tamara 1 ; David L. Thomas L. ; David 2 Hosp Universitario Universitario Hosp Henry Ford Hosp/ Henry Ford 6 2 Medizinische Medizinische 2
; Téllez Francisco 1 2 ; Bart RijndersJ. 1 IMIBIC, Córdoba, Spain; Córdoba, IMIBIC, ; Shruti H. Mehta H. ; Shruti 2 1 ; MaryFord ; Ponni Perumalswami ; Ponni Univ of Florida, Gainesville, Gainesville, Florida, of Univ 2 6 ; Antonio Rivero ; Antonio 2 1 New York City DHMH, Long City Long DHMH, York New 2 ; Sarah K. Pfeil 2 Complejo Hospario de Jaén, Jaén, Jaén, Jaén, de Hospario Complejo 7 Montefiore Med Cntr, Bronx, NY, USA; NY, Bronx, Cntr, Med Montefiore ; Charles A. Boucher; Charles 5 ; GuillermoOjeda-Burgos 2 5 ; Kimberly Baker-Genaw ; Derek A. Cummings ; Derek ; Tarak K. Trivedi ; Tarak 2 1 1 C Virus Screening Emergency on Virus C
; Weiss Jeffrey ; Juan Macías ; Gregory D. Kirk ; Gregory D. 5 7 4 ; Brooke E. Nichols ; Brooke 1 ; Antonio Rivero-Juárez ; Antonio ; Marie P. Bresnahan ; Marie P. 1 1 New York City DHMH, New York City, NY, USA; USA; NY, City, York City New DHMH, York New 3 Complejo Hospario de Huelva, Huelva, Spain; Huelva, Huelva, de Hospario Complejo Erik S. Anderson S. Erik 4 ; ; Indira Brar ; Indira ; Julio Montaner; Mark W. Hull; Viviane D. Lima D. Viviane Hull; W. Mark ; Julio Montaner; 1 1 ; María José Ríos 4 ; for the Project INSPIRE Implementation Team Team Implementation INSPIRE the Project ; for 5 ; Jürgen K. Rockstroh ; Jürgen ; Laura J. Deering J. ; Laura ; John B. Wong ; John B. 1 1 1 ; Shuchin Shukla
4 Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, of Univ Hopkins Johns 1 3 ; for the HEPAVIR-cirrhosis study group study group the HEPAVIR-cirrhosis ; for Hosp Universitario Reina Sofía, Córdoba, Spain Sofía, Córdoba, Reina Universitario Hosp 1 8 Erasmus Univ Med Cntr, Rotterdam, Netherlands; Netherlands; Rotterdam, Cntr, Med Univ Erasmus Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns Mount Sinai Hosp, New York, NY, USA NY, York, New Sinai Hosp, Mount New York City DHMH, Queens, NY, USA; USA; NY, City Queens, DHMH, York New Highland Hosp, Alameda Hlth System, Oakland, CA, USA; Oakland, System, Hlth Alameda Hosp, Highland Henry Ford Hosp/Wayne State Univ, Troy, MI, USA; USA; MI, Troy, Univ, State Hosp/Wayne Henry Ford Hosp Universitario de Valme, Sevilla, Spain; Sevilla, Valme, de Universitario Hosp la de Línea La Gibraltar), de Campo (AGS Concepción la de Línea La Hosp Carl Latkin Carl Todorovich Virgen de la Victoria, Málaga, Spain; Spain; Málaga, Victoria, la de Virgen Universitario Virgen de la Macarena, Seville, Spain; Spain; Seville, Macarena, la de Virgen Universitario York City DHMH, Queens, NY, USA; USA; NY, City Queens, DHMH, York Eric Rude Eric Island City, NY, USA; USA; NY, City, Island Wayne State Univ, Detroit, MI, USA MI, Detroit, Univ, State Wayne HIV-Positive MSM HIV-Positive Concepción, Spain; Spain; Concepción, FL, USA; FL, USA; J. de Knegt de J. Sebastiaan J. Hullegie SebastiaanJ. 1 1 StudyModeling A of HCVIs Possible? Elimination HCV Treatment As Prevention Will Require Massive Massive Require Will As Prevention HCVTreatment Scale-upBenefits See to Prevention Mier-y-Teran-Romero Luis 1 6 Project INSPIRE: A Comprehensive Care Coordination Coordination Care ProjectComprehensive A INSPIRE: HCV for Program Infection Laraque Fabienne Devising a Strategy to Control the HCVthe Control to inEpidemic Strategy a Devising Canada Columbia, British Rozada Ignacio DepartmentStay of Length Douglas A. White 1 Canada BC, Vancouver, HIV/AIDS, in Excellence for Cntr Columbia British KassemBourgi 1 Hepatitis Influence of Hepatitis C Screening and Linkage to Care at a ScreeningC Linkageand at Care to Hepatitis System Health Comprehensive 1 3 Nicolás Merchante Nicolás Liver Stiffness Predicts Variceal Bleeding in Bleeding Stiffness Predicts Variceal Liver Spain; Univsklinik, Bonn, Germany Boston, MA, USA MA, Boston, HIV/HCV-Coinfected Patients de Vijver Omar Mohamed-Balghata Stanford, CA, USA Stanford, Alain LitwinAlain Pineda Dolores Merino Dolores
536 535 534 533 532 HCV Cure: Moving the Needle from the Patient to the to Patient the HCVfrom Needle the Moving Cure: Population 531 Session P-N2 Poster Abstracts Poster SessionP-N2 PM-4:002:45 PM 530 Program and Agenda
543 Tracing the Origin of HCV NS3 Q80K Among HIV- Session P-N4 Poster Abstracts Hall A/B Infected MSM in the Netherlands 2:45 PM-4:00 PM Astrid M. Newsum1; Cynthia K. Ho2; Faydra I. Lieveld3; Thijs J. van de Progression of Liver Disease: Mediators and Moderators Laar4; Jan T. van der Meer5; Anne M. Wensing3; Greet J. Boland3; Joop E. Arends3; Maria Prins1; Janke Schinkel2 548 Liver Disease Progression in a Community-Based 1PH Service of Amsterdam, Amsterdam, Netherlands; 2Academic Sample of HCV-Infected PWID Med Cntr, Amsterdam, Netherlands; 3Univ Med Cntr Utrecht, Utrecht, Javier A. Cepeda1; David L. Thomas2; Jacquie Astemborski1; Netherlands; 4Sanquin Blood Supply Fndn, Amsterdam, Netherlands; Xiangrong Kong3; Gregory D. Kirk3; Shruti H. Mehta3 5Cntr of Infectious Diseases and Immunology Amsterdam, Academic Med 1Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; 2Johns Cntr, Amsterdam, Netherlands Hopkins Univ Sch of Med, Baltimore, MD, USA; 3Johns Hopkins Univ, Baltimore, MD, USA 544 Incidence of Hepatitis C Virus Infection in the HIV Outpatient Study Cohort 2000-2013 549 Protective Effect of Coffee Intake on Mortality of Taraz Samandari1; Kate Buchacz1; Carl Armon2; Dana Franklin2; French HIV/HCV-Infected Patients Rachel Hart2; Joan S. Chmiel3; John T. Brooks1; Ellen Tedaldi4; for the Patrizia Carrieri1; Camelia Protopopescu1; Philippe Sogni2; Linda HIV Outpatient Study Investigators Wittkop3; David Zucman4; Francois Dabis5; Bruno Spire6; Dominique 1CDC, Atlanta, GA, USA; 2Cerner Corporation, Kansas City, MO, USA; Salmon-Ceron2; for the ANRS HEPAVIH CO13 Study Group 3Feinberg Sch of Med, Northwestern Univ, Chicago, IL, USA; 4Temple Univ, 1INSERM, Marseille, France; 2INSERM-APHP, Hosp Cochin, Paris, France; Philadelphia, PA, USA 3CHU de Bordeaux, Bordeaux, France; 4Hosp Foch, Suresnes, France; 5INSERM U897, ISPED, Univ de Bordeaux, Bordeaux, France; 6INSERM 545 Sexual Behaviour Is Associated With Recently Acquired UMR 912, Marseille, France HCV in HIV/HCV Coinfected MSM Marianne Martinello1; Gregory J. Dore1; Jasmine Skurowski1; Janaki 550 Statin Use and Cirrhosis Progression in an HIV/HCV Amin1; Rohan I. Bopage2; Robert Finlayson3; David Baker4; Mark Bloch5; Coinfected Population Gail V. Matthews1 Nora T. Oliver1; Christine Hartman2; Jennifer R. Kramer2; Elizabeth 1Kirby Inst, Univ of New South Wales, Sydney, Australia; 2The Albion Cntr, Chiao1 Sydney, Australia; 3Taylor Square Private Clinic, Sydney, Australia; 4East 1Baylor Coll of Med, Houston, TX, USA; 2Michael E. DeBakey VA Med Cntr, Sydney Doctors, Sydney, Australia; 5Holdsworth House Med Practice, Houston, TX, USA Sydney, Australia 551 Statin Type and Dose Reduce the Risk of Cirrhosis and 546 Prevalence and Factors of HCV Infection Among HCC in HCV Infected Patients HIV-Negative and HIV-Positive MSM Tracey Simon1; Hector Bonilla2; Raymond T. Chung3; Adeel A. Butt4 Nathan J. Lachowsky1; Kristine Stephenson2; Zishan Cui3; Susan 1Massachusetts General Hosp, Boston, MA, USA; 2ImmunoSci Inc, Shurgold3; Troy Grennan4; Jason Wong4; Julio Montaner3; Eric A. Roth5; Pleasanton, CA, USA; 3Harvard Med Sch, Boston, MA, USA; 4Hamad Robert S. Hogg6; David M. Moore1; for the Momentum Health Study Hlthcare Quality Inst, Doha, Qatar 1Univ of British Columbia, Vancovuer, BC, Canada; 2Vancouver Coastal 3 552 Assessment of Hepatic Antifibrotic Effect of Hlth, Vancouver, BC, Canada; BC Cntr for Excellence in HIV/AIDS, Cenicriviroc in Patients With HIV Vancouver, BC, Canada; 4BC Cntr for Disease Control, Vancouver, BC, 5 6 Enass Abdel-hameed; Susan D. Rouster; Kenneth E. Sherman Poster Listings Poster Canada; Univ of Victoria, Victoria, BC, Canada; Simon Fraser Univ, Burnaby, BC, Canada Univ of Cincinnati, Cincinnati, OH, USA 547 The Impact of Host Genes on the Risk of Acquiring 553 Statin Therapy Reduces Liver Fat Measured by Hepatitis C Virus Infection Computed Tomography in Patients With HIV Gaby S. Steba1; Sylvie M. Koekkoek1; Joost W. Vanhommerig2; Kees Janet Lo; Michael Lu; Elli Kim; Eric Nou; Travis R. Hallett; Jakob Park; Brinkman3; Jan T. van der Meer4; Maria Prins2; William A. Paxton5; Udo Hoffmann; Steven Grinspoon Richard Molenkamp1; Janke Schinkel1; for the MOSAIC study group Massachusetts General Hosp, Boston, MA, USA and ACS 554 PEth Improves Detection of Alcohol and Associated 1Academic Med Cntr, Amsterdam, Netherlands; 2PH Service of Mortality Among HIV+/HCV+ 3 Amsterdam, Amsterdam, Netherlands; OLVG Hosp, Amsterdam, 1 2 3 4 4 Amy C. Justice ; Kathleen A. McGinnis ; Janet Tate ; David A. Fiellin ; Netherlands; Cntr of Infectious Diseases and Immunology Amsterdam, 5 6 7 8 5 Vincent Lo Re ; Joseph Jones ; Judith A. Hahn ; Kendall J. Bryant ; for Academic Med Cntr, Amsterdam, Netherlands; Univ of Liverpool, the VACS Project Team Liverpool, UK 1Yale Univ, New Haven, CT, USA; 2VA Pittsburgh Hlthcare System, Pittsburgh, PA, USA; 3VA Med Cntr, West Haven, CT, USA; 4VA Connecticut Hlthcare System, New Haven, CT, USA; 5Univ of Pennsylvania, Philadelphia, PA, USA; 6US Drug Testing Lab, Des Plaines, IL, USA; 7Univ of California San Francisco, San Francisco, CA, USA; 8Natl Inst on Alcohol Abuse and Alcoholism, Bethesda, MD, USA
64 CROI 2016 Poster Listings 65 ; 2 ; ; 6 ; James 1 NCI, NCI, 2 5 Univ Rey Rey Univ 2 Hall A/B Univ of Univ ; Dariela 4 3 ; Joseph A. 6 CROI 2016 Univ Coll Coll Univ 2 ; Joseph A. Massachusetts Massachusetts 1 2 ; Michael 3 ; Stephane de ; Stephane 1 ; Christina Marra ; Christina ; Steven Grinspoon ; Steven 1 Program Agenda and 4 ; Theo ; Theo Heller 5 ; Markella V. Zanni V. ; Markella 2 ; Asuncion Diaz 2 ; Robin Nance 1 Findings of Next Next of Findings ; Lene Ryom ; Lene Univ of California San Francisco, San Francisco, California of Univ ; Adam Rupert; Adam 2 2 2 NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, NIAID, 2 Amsterdam Inst for Global Hlth and and Hlth Global for Inst Amsterdam 5 Infectious Diseases Clinic, San Paolo San Paolo DiseasesInfectious Clinic, 6 ; for the Data Collection on Adverse on Adverse Collection the Data ; for in HIV Is Associated With With Associated Is HIV in 2 ; Antonella d’Arminio Monforte d’Arminio ; Antonella NIAID, NIH, Rockville, MD, USA; USA; MD, Rockville, NIH, NIAID, Wake Forest Baptist Med Cntr, Winston Winston Cntr, Med Baptist Forest Wake 5 ; Kyra J. Becker J. ; Kyra 4 3 2 ; Sara E. Looby ; Steven K. Feske ; Steven
Inst de Salud Carlos III, Madrid, Spain Madrid, III, Salud de Carlos Inst 2 3 3 ; David E. Kleiner ; David 3
2
; RIzwan Kilani 1 1
1 Univ of Washington Sch of PH and Community Community Sch and PH of Washington of Univ ; David Kamara ; David 3 1 St Pierre Univ Hosp, Brussels, Belgium; Brussels, Hosp, Univ Pierre St 3 NIDDK, Bethesda, MD, USA NIDDK, Bethesda, MD, ; Peter Reiss ; Peter 6 ; MaryMcLaughlin 4 1 ; Alejandro Alvaro-Meca ; Alejandro 1 ; Caroline Sabin ; Caroline ; Felicia Chow ; Felicia
1 Brigham and Women's Hosp, Harvard Med Sch, Boston, Sch, Med Boston, Harvard Hosp, Women's and Brigham ; Pedro Staziaki; Richard Takx; Orla Hennessy; Michael Orla Hennessy; Takx; Richard Staziaki; ; Pedro 1 2 4 ; Susan Regan 1 ; Emily L. Ho ; Emily 1 ; Salvador Resino ; Salvador 1 ; Colleen Hadigan ; Colleen ; Cheryl D. Bushnell ; Cheryl D. 4 ; Tirchwell David 2 3 ; Caryn G. Morse 1 ; Matthew Law ; Matthew 3 Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ Spain; Madrid, Marañón, Gregorio Universitario General Hosp Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ Denmark; Copenhagen, Copenhagen, of Univ RigsHospet, NIH Clinical Cntr, Bethesda, MD, USA; USA; Bethesda, MD, Cntr, Clinical NIH USA; MD, Frederick, NIH, NIAID, General Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, General MA, USA MA, Bethesda, MD, USA; USA; Bethesda, MD, Hosp, Univ of Milan, Milan, Italy Milan, Milan, of Univ Hosp, Delaney Med, Seattle, WA, USA WA, Seattle, Med, Develop, Amsterdam, Netherlands; Netherlands; Amsterdam, Develop, Juan Carlos, Alcorcón, Spain; Alcorcón, Carlos, Juan Events of Anti-HIV Drugs Study Group Drugs Study Anti-HIV of Events Jens D. Lundgren Jens D. Virginia A. Triant Virginia San Francisco, CA, USA; San Francisco, Proschan Meigs B. 1 1 Plaque Incidental Carotid Events SubsequentCerebrovascular SumbalJanjua Lu; Markella V. Zanni; Steven Grinspoon; Udo Hoffmann; Tomas G. Tomas Grinspoon; Hoffmann; Udo Steven Zanni; V. Markella Lu; Neilan USA MA, Boston, Hosp, General Massachusetts Stroke in HIV-Infected Patients in the Combination Combination the in Patients HIV-Infected in Stroke Era Therapy Antiretroviral Berenguer Juan Micheloud 1 andIschaemic Predictors in Differences for IndividualsHIV+ in Strokes Haemorrhagic CamillaHatleberg I. 1 RiskHIV- in Stroke Ischemic Increased Persistently InfectedWomen Chow Felicia NASH Is Associated With a Unique Biomarker Signature Signature Biomarker Unique a With Associated Is NASH Adults HIV-Infected in RebeccaKrakora 1 3 and , Design, Implementation HIV in Adjudication Stroke Generation CraneM. Heidi Wit London, London, UK; UK; London, London, Kovacs Joseph Zunt Salem, NC, USA; Salem, USA; NC, New South Wales, Sydney, Australia; Australia; Sydney, South Wales, New
640 639 637 638 561 Abstracts Poster SessionP-P1 PM-4:002:45 PM Riskand Incidence Factors Stroke: 636 ; 1 ; 4 ; Juan 2 ; Univ of Univ ; ; Adriano ; Adriano 4 5 6 1 ; Emanuela ; Emanuela 4 ; Hamid ; Hamid 3 3 ; Diego 3 ; Evangelista ; Evangelista Univ of New New of Univ 4 3 Vita-Salute Univ, Univ, Vita-Salute Vita-Salute Univ, Univ, Vita-Salute ; Wm. ; Wm. Christopher 4 4 ; for the INSIGHT ; for 3 1 ; Jonel Trebicka ; Joseph A. 3 1
1
; for the Center for AIDS for the Center ; for 2 ; Ángela Camacho ; Ángela 1 2 ; Michael J. Vjecha ; Michael J. ; Stefania Salpietro ; Stefania 5 1 ; Stefania Salpietro ; Stefania Univ of California San Francisco, San Francisco, California of Univ Univ of Washington Sch PH of Washington of Univ 1 3 2 ; Sean Emery ; Carolynne Schwarze-Zander ; Carolynne 3 1 ; Francisca Cuenca ; Francisca Vita-Salute San Raffaele Univ, Univ, San Raffaele Vita-Salute Vita-Salute San Raffaele Univ, Univ, San Raffaele Vita-Salute 2 2 2 ; Adriano Lazzarin ; Adriano 1 VA Med Cntr, Washington, DC, USA; USA; DC, Washington, Cntr, Med VA ; Matthew Law ; Matthew Medizinische Univsklinik, Bonn, Medizinische 6 ; Caterina UbertiFoppa ; Caterina ; Caterina UbertiFoppa ; Caterina 2 2 2 2 Univ of Bonn, Bonn, Germany; Bonn, of Bonn,Univ Germany; Hosp Universitario Reina Sofía, Córdoba, Sofía, Córdoba, Reina Universitario Hosp 4 ; Ana Gordon ; Ana 3 4 ; Emanuele Miraglia Del Miraglia ; Emanuele Giudice 1
; Mari M. Kitahata 3
; Evangelista Sagnelli ; Evangelista 5 ; Stephen Van Rompaey Van ; Stephen ; Katerina A. Christopoulos ; Katerina 1 1 1 1 ; Jürgen K. Rockstroh ; Jürgen Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ 1 4 ; Carmine Minichini ; Carmine ; Anna Grandone ; Anna 1 1 ; Deborah Wentworth ; Marco Merli ; Marco ; Marco Merli ; Marco 5 ; Kazuo Suzuki ; Nicola Coppola ; Nicola 1 1 ; Anthony Kelleher ; Anthony 1 4 7 ; Juan Macías ; Christoph Boesecke ; Christoph 2 1 ; Antonio Rivero-Juárez ; Antonio San Raffaele Scientific Inst, Milan, Italy; Milan, San Scientific Inst, Raffaele San Raffaele Scientific Inst, Milan, Italy; Milan, San Scientific Inst, Raffaele 1 3 3 ; Robin Nance 1 ; Antonio Rivero ; Antonio ; Richard Moore ; Richard 4 4 ; Nicola Coppola ; Nicola ; Carmine Minichini ; Carmine ; Heidi M. Crane ; Heidi ; Francesca Rossi ; Francesca 4 4 2 1 ; Giulia Bellini ; Grazia Cirillo ; Grazia IMIBIC, Córdoba, Spain; Spain; Córdoba, IMIBIC, Spain Sevilla, Valme, de Universitario Hosp 4 4 2 4 Univ Hosp Bonn, Bonn, Germany; Bonn, Bonn, Germany; Hosp Univ Royal Free London NHS Fndn Trust, London, UK London, Trust, Fndn NHS London Free Royal Kirby Inst for Infection and Immunity in Society, Sydney, Australia; Australia; Sydney, Society, Immunity in Infection and for Inst Kirby Australia; Sydney, South Wales, New of Univ Inst, Kirby Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ USA MD, Baltimore, Univ, Hopkins Johns Second Univ of Naples, Naples, Italy; Naples, Naples, of Univ Second Second Univ of Naples, Naples, Italy; Naples, Naples, of Univ Second Instituo Maimonides de Investigación Biomédica de Córdoba, Córdoba, Córdoba, Córdoba, de Biomédica Investigación de Maimonides Instituo South Wales, Sydney, Australia; Australia; Sydney, South Wales, Hasson Hasson San Francisco, CA, USA; San Francisco, A. Pineda Research Network of Integrated Clinical Systems Clinical Systems of Integrated Network Research Margaret Johnson Margaret Spain; Messina Spain; Delaney Rodríguez-Cano and Community Med, Seattle, WA, USA; USA; WA, Seattle, Med, Community and Minnesota, Minneapolis, MN, USA; USA; MN, Minneapolis, Minnesota, Milan, Italy;Milan, Milan, Italy;Milan, 1 7 a Play Factors Which Patients: HIV in Fibrosis Liver Role? Mohr Raphael 1 2 Individuals With Liver Disease Liver With Individuals Murray DanielD. 5 Infected HIV-1 of ART+ and -200a in Exosomes MiR-122 Nina KimNina 1 Poorly Controlled HIV Infection Is a Risk Factor for Infectionfor HIV Riska Is Factor Controlled Poorly CohortCNICS in Fibrosis Liver Caterina Sagnelli Caterina 1 The Impact of Cannabinoid Receptor2-63 Variants in Variants Impact The Cannabinoidof Receptor2-63 HIV/HCVof Biopsy Liver Patients Caterina Sagnelli Caterina 1 Impact of PNPLA3 variants on the Liver Histology of Histology ImpactLiver the on PNPLA3of variants HIV/HCV168 Patients Fibrosis in HIV/HCVin Fibrosis Patients MarioFrías 1 HLA-B18 As a Risk Factor of Progression to Severe Liver Liver Severe to HLA-B18Progression of As Riska Factor Jan-Christian Wasmuth ESPRIT and SMART Study Groups Groups Study ESPRIT and SMART Emanuela Messina Emanuela Jacqueline Neuhaus Jacqueline Germany San Raffaele Scientific Inst, Milan, Italy Milan, San Scientific Inst, Raffaele San Raffaele Scientific Inst, Milan, Italy Milan, San Scientific Inst, Raffaele Mathews Lazzarin Sagnelli
560 559 558 557 556 555 Program and Agenda
Session P-P2 Poster Abstracts Hall A/B 647 9-Year Trends in Non-Lipid Cardiovascular Disease 2:45 PM-4:00 PM Prevention Strategies in HIV+ Women Cardiovascular Disease: Risk, Prediction, Assessment, David B. Hanna1; Molly Jung1; Kathryn Anastos1; Jennifer M. and Management Cocohoba2; Mardge Cohen3; Elizabeth Golub4; Nancy A. Hessol2; Tracey E. Wilson5; Mary Young6; Robert C. Kaplan1 641 Atherosclerotic Myocardial Infarction Risk in the NA- 1Albert Einstein Coll of Med, Bronx, NY, USA; 2Univ of California San ACCORD Compared to MESA and ARIC Francisco, San Francisco, CA, USA; 3John H. Stroger Jr. Hosp of Cook Daniel Drozd1; Heidi M. Crane1; Susan Heckbert1; Matthew Budoff2; County and Rush Med Coll, Chicago, IL, USA; 4Johns Hopkins Bloomberg Amy C. Justice3; Frank J. Palella4; Daniel B. Klein5; Mari M. Kitahata1; Sch of PH, Baltimore, MD, USA; 5State Univ of New York Downstate Stephen J. Gange6; Richard Moore7 Med Cntr, Brooklyn, NY, USA; 6Georgetown Univ Med Cntr, Washington, 1Univ of Washington, Seattle, WA, USA; 2Harbor-Univ of California Los DC, USA Angeles Med Cntr, Torrance, CA, USA; 3Yale Univ, New Haven, CT, USA; 4 5 648 HIV Patients Have More High-risk Plaque and Cardiac Northwestern Univ, Chicago, IL, USA; Kaiser Permanente San Leandro Events but Less Intervention Med Cntr, San Leandro, CA, USA; 6Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; 7Johns Hopkins Univ, Baltimore, MD, USA James Nadel; Eoin O’Dwyer; Sam Emmanuel; James Otton; Justyn Huang; Cameron Holloway 642 Cardiovascular Disease Risk Model Comparison and St Vincent’s Hosp, Sydney, Australia Development in HIV-Infected Veterans 649 Diastolic Function Correlates With Pericardial Fat and Meredith E. Clement1; Lawrence Park1; Ann Marie Navar1; N. L. 1 2 1 3 Vascular Remodeling in HIV Okeke ; Michael J. Pencina ; Pamela Douglas ; Susanna Naggie 1 2 2 1 1 2 Chris T. Longenecker ; Sadeer Al Kindi ; Maya Serhal ; Bruce Kinley ; Duke Univ Med Cntr, Durham, NC, USA; Duke Clinical Rsr Inst, Durham, 1 1 NC, USA; 3Duke Univ Sch of Med, Durham, NC, USA Danielle Labbato ; Grace A. McComsey 1Case Western Reserve Univ, Cleveland, OH, USA; 2Univ Hosps Case Med 643 2013 ACC/AHA Guideline Undertreats HIV-Infected Cntr, Cleveland, OH, USA Adults With Atherosclerosis 650 Reduced Ovarian Reserve Relates to Cardiovascular Bernard Weigel1; Binh An P. Phan1; Yifei Ma1; Rebecca Scherzer1; 1 1 1 2 1 Disease Risk in Women With HIV Danny Li ; Sophia Hur ; S.C. Kalapus ; Stephen G. Deeks ; Priscilla Hsue 1 1 1 1 1 2 Sara E. Looby ; Kathleen Fitch ; Suman Srinivasa ; Janet Lo ; Danielle Univ of California San Francisco, San Francisco, CA, USA; San Francisco 1 1 2 1 General Hosp, San Francisco, CA, USA Rafferty ; Amanda Martin ; Judith S. Currier ; Steven Grinspoon ; Markella V. Zanni1 644 Differences by HIV Serostatus in Coronary Artery 1Massachusetts General Hosp, Boston, MA, USA; 2David Geffen Sch of Disease Following Stress Testing Med at Univ of California Los Angeles, Los Angeles, CA, USA Matthew J. Feinstein1; Brian Poole1; Tim S. Provias1; Frank J. Palella2; Chad Achenbach2; Donald M. Lloyd-Jones1 Session P-Q1 Poster Abstracts Hall A/B 1Northwestern Univ, Feinberg Sch of Med, Chicago, IL, USA; 2:45 PM-4:00 PM 2 Northwestern Univ, Chicago, IL, USA Renal Outcomes: TAF and TDF 645 HIV & Obesity Synergistically Increase Interleukin 6 680 Longer-Term Safety of Tenofovir Alafenamide in Renal Poster Listings Poster but Not Soluble CD14 or D-dimer Impairment Barbara S. Taylor1; Kaku So-Armah2; Janet Tate3; Vincent C. Marconi4; Frank A. Post1; Pablo Tebas2; Amanda Clarke3; Laurent Cotte4; William Roger Bedimo5; Adeel A. Butt6; Cynthia Gibert7; Matthew Goetz8; Maria Short5; Michael E. Abram6; Shuping Jiang6; Andrew Cheng6; Moupali Rodriguez-Barradas9; Matthew S. Freiberg10 Das6; Marshall Fordyce6 1Univ of Texas Hlth Sci Cntr San Antonio, San Antonio, TX, USA;2Boston 1King’s Coll Hosp NHS Fndn Trust, London, UK; 2Univ of Pennsylvania, Univ Sch of Med, Boston, MA, USA;3VA Med Cntr, West Haven, CT, Philadelphia, PA, USA; 3Brighton and Sussex Hosps NHS Trust, Brighton, USA;4Emory Univ Sch of Med, Atlanta, GA, USA;5Dallas VA Med Cntr, UK; 4Hospices Civils de Lyon, Lyon, France; 5Perelman Sch of Med, Univ of Dallas, TX, USA;6Hamad Hlthcare Quality Inst, Doha, Qatar;7VA Med Pennsylvania, Philadelphia, PA, USA; 6Gilead Scis, Inc, Foster City, CA, USA Cntr, Washington, DC, USA;8VA Greater Los Angeles Hlthcare System, Los Angeles, CA, USA;9Michael E. DeBakey VA Med Cntr and Baylor Coll of 681 Renal Safety of Tenofovir Alafenamide in Patients at Med, Houston, TX, USA;10Vanderbilt Univ Sch of Med, Nashville, TN, USA High Risk of Kidney Disease 646 BNP Prediction of Cardiovascular Diseases in HIV+ David Wohl1; Anders Thalme2; Robert Finlayson3; Shinichi Oka4; Thai 5 5 5 5 5 Patients and the General Population Nguyen ; Susan Guo ; Andrew Cheng ; Moupali Das ; Marshall Fordyce 1Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2Karolinska Stefan Esser1; Marina Arendt2; Till Neumann3; Lewin Eisele4; Raimund Inst, Stockholm, Sweden; 3Taylor Square Private Clinic, Sydney, Australia; Erbel3; Karl H. Jöckel2; Volker Holzendorf5; Nico Reinsch3; for the HIV 4Natl Cntr for Global Hlth and Med, Tokyo, Japan; 5Gilead Scis, Inc, Foster HEART Study Group and Heinz Nixdorf Recall Investigative Group City, CA, USA 1Univ Hosp Essen, Essen, Germany; 2Inst for Med Informatics, Biometry and Epi (IMIBE), Univ Hosp Essen, Essen, Germany; 3West German Heart Cntr, Univ Hosp Essen, Essen, Germany; 4Inst for MIMIBE, Univ Hosp Essen, Essen, Germany; 5Univ Leipzig, Leipzig, Germany
66 CROI 2016 Poster Listings 67 ; 3
2 ; 7 ; ; Mari 2 3 Hall A/B ; Christoph ; Christoph 3 Mount Mount CROI 2016 Hvidovre Hvidovre Amsterdam Amsterdam ; Gitte ; Gitte 3 Johns Johns 2 2 1 ; George J. J. ; George 2 2 ; Charles ; Charles 2 ; John Gill 1 ; Amanda ; Amanda ; Allison M. ; Allison 7 Mid-Atlantic Mid-Atlantic 1 INSERM, ISPED, ISPED, INSERM, 5 Nice Univ Hosp, Nice, Nice, Hosp, Univ Nice 4 6 ; Isabelle Pellegrin ; Isabelle ; Angel M. Mayor ; Angel 2 6 Hillerød Hosp, Univ Univ Hosp, Hillerød ; Claire Rigothier ; Claire 3 2 Johns Hopkins Univ, Univ, Hopkins Johns Program Agenda and Univ of Calgary, Calgary, Calgary, Calgary, of Univ 9 3 ; Michael Ross 2 ; Troels Bygum Knudsen Bygum Troels ; BC Cntr for Excellence in Excellence for Cntr BC 2 6 Univ of Wisconsin-Madison, Wisconsin-Madison, of Univ 2 ; James H. Stein 1 ; Katie Zook ; Katie 1 ; Estibaliz Lazaro ; Estibaliz CHU de Bordeaux, Bordeaux, Bordeaux, Bordeaux, de CHU 2 2 ; Colette Smith ; Colette ; Susanne D. Nielsen ; Susanne D. Kantonsspital Aarau, Aarau, Aarau, Aarau, Kantonsspital 6 4 4 Aarhus Univ Hosp, Aarhus Nord, Nord, Aarhus Hosp, Univ Aarhus ; Alison Abraham ; Alison
4 2 Univ Central del Caribe, Bayamon, Bayamon, Caribe, del Central Univ 9 ; Mark W. Hull W. ; Mark 7 5 ; Linda Wittkop ; Peter Reiss ; Peter 4 1 ; Niels Mejer 1
2 ; Derek M. Fine ; Derek ; Eric Fontas ; Eric 1 5 ; Pierre Duffau ; Pierre 2 ; Frédéric-Antoin Dauchy ; Frédéric-Antoin 1 ; Mohamed G. Atta 1 Univ of Rochester, Rochester, NY, USA NY, Rochester, Rochester, of Univ 3 ; Michelle Estrella ; Søren K.; Søren Moestrup 1 4 ; Gregory M. Lucas 8 Univ de Bordeaux, Bordeaux, France; France; Bordeaux, Bordeaux, de Univ ; Jens D. Lundgren ; Jens D. Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ 5 1 ; Michael A. Horberg 4 4 ; Sylvie Lawson-Ayayi ; Sylvie ; Thomas ; Thomas Benfield
Northwestern Univ, Chicago, IL, USA; IL, USA; Chicago, Univ, Northwestern 3 2 3 8 ; for the D:A:D Study Group Group the D:A:D Study ; for CHU de Bordeaux, Bordeaux Cedex, France; France; Cedex, Bordeaux Bordeaux, de CHU Univ Coll London, London, UK London, London, Coll Univ 7 3 7 ; Shruti H. Mehta H. ; Shruti ; Philippe Morlat ; Philippe 1 4 Univ de Bordeaux, Bordeaux, France; France; Bordeaux, Bordeaux, de Univ Denmark; Copenhagen, Copenhagen, of Univ RigsHospet, Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Sch Baltimore, PH, of Bloomberg Hopkins Johns Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns RigsHospet, Univ of Copenhagen, Copenhagen, Denmark; Copenhagen, Copenhagen, of Univ RigsHospet, Cécile Le Scanf-Terrien Le Cécile France; France; Schwartz Cazanave McFall Madison, WI, USA; USA; WI, Madison, HIV/AIDS, Vancouver, BC, Canada; Canada; BC, Vancouver, HIV/AIDS, Kronborg PR, USA; USA; PR, Alexandra Ozanne Alexandra 1 SolublePredicts CD163 and ChronicIncident Lung Infection Disease Kidney HIV-1 in Kirkegaard-Klitbo DitteM. 1 The Racial Survival Paradox in HIV+ End-StageHIV+ in Renal SurvivalRacial The Paradox Patients Disease(ESRD) Althoff N. Keri 1 USA MD, Baltimore, Patients HIV Senescencein and Markers Activation Disease Chronic Kidney With 1 Traditional and Viral Factors Associated With Iohexol- With Associated Factors Viral and Traditional Years SlopeGFR 3 Based Over GregoryLucasM. Nature of Immunosuppression and Chronic Kidney Chronicand Kidney Immunosuppression of Nature Persons DiseaseRisk HIV-Positive in Ryom Lene 1 Hosp, Univ of Copenhagen, Hvidovre, Denmark; Hvidovre, Copenhagen, of Univ Hosp, Inst for Global Hlth and Develop, Amsterdam, Netherlands; Netherlands; Amsterdam, Develop, and Hlth Global for Inst Hopkins Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, Univ of Hopkins Canada; AB, A. Fux France; France; Holger J. Møller J. Holger Mocroft M. Kitahata M. Switzerland; Switzerland; Permanente Med Group, Rockville, MD, USA; USA; MD, Rockville, Group, Med Permanente Sinai Sch of Med, New York, NY, USA; USA; NY, York, New Sinai Sch Med, of of Copenhagen, Hillerød, Denmark; Hillerød, Copenhagen, of INSERM U897, Bordeaux, France Bordeaux, U897, INSERM Denmark Frank J. Palella J. Frank
690 688 689 687 Session P-Q2 Poster Abstracts SessionPoster P-Q2 PM-4:002:45 PM Biomarkers and Disease: Bone and RiskRenal Factors 686 ; 4 ; 7 Univ Univ ; ; 7 8 6 ; 4 Univ Univ 5 St 3 Hosp Hosp 4 ; David ; David ; Lisa 4 2 Johns Johns 2 ; Angel M. ; Angel 7 Johns Hopkins Hopkins Johns 2 ; Moupali Das ; Moupali 7 ; Michael; Shlipak Brigham and and Brigham Royal Free London London Free Royal 3 6 7 Gilead Scis, Inc, Inc, Scis, Gilead 7 ; Rachael Jones King’s Coll Hosp NHS NHS Hosp Coll King’s 7 2 ; Teofilo Eugenio 3
1 ; Angela Bailey; Angela
3 1 Univ of Pittsburgh Sch of Pittsburgh of Univ 6 ; Bernard J. Macatangay J. ; Bernard ; Michelle Estrella 5 1 ; Mari M. Kitahata Imperial Coll Hlthcare NHS Trust, Trust, NHS Hlthcare Coll Imperial Johns Hopkins Univ, Baltimore, Baltimore, Univ, Hopkins Johns 6 ; Andrew Cheng ; Andrew 4 3 7 Johns Hopkins Univ Sch of Med, Sch Med, of Univ Hopkins Johns ; Michelle; Estrella 3 2 Univ Central del Caribe, Bayamon, PR, Bayamon, Caribe, del Central Univ 8 ; Armin Rieger; Armin Univ Coll London, London, UK; UK; London, London, Coll Univ 2 2 ; Margaret Johnson ; Margaret
6 9 Chelsea and Westminster Hosp NHS Fndn Fndn NHS Hosp Westminster and Chelsea ; Aseel Hegazi 8 2 ; Michael Shlipak Yale Univ Sch of Med, New Haven, CT, USA; USA; CT, Haven, New Sch Med, Univ of Yale 8 7 ; Alison Abraham ; Alison ; Susan Guo 9 ; Frank J. Palella J. ; Frank Med Univ of Vienna, Vienna, Austria; Austria; Vienna, Vienna, of Univ Med 6 4 3 ; Rebecca Scherzer; Rebecca Univ of California San Francisco, San Francisco, CA, San Francisco, San Francisco, California of Univ 1 4 King’s Coll Hosp NHS Fndn Trust, London, UK London, Trust, Fndn NHS Hosp Coll King’s 9 ; Frank A. Post ; Frank
1 7 ; Michael A. Horberg 5 ; Gregory; Lucas M. ; Frank A. Post ; Frank ; Sophie Jose 1 2 1 ; Joachim Ix 7 South Tees Hosp NHS Fndn Trust, Middlesbrough, UK; UK; Middlesbrough, Trust, Fndn NHS Hosp South Tees 5 ; Paul E. Sax ; Paul 5 ; Deborah Williams Harbor-Univ of California Los Angeles Med Cntr, Torrance, CA, Torrance, Cntr, Angeles Med Los California of Harbor-Univ ; MalloryWitt 5 4 Mid-Atlantic Permanente Med Group, Rockville, MD, USA; USA; MD, Rockville, Group, Med Permanente Mid-Atlantic 3 6 ; Sonia Napravnik 8 Northwestern Univ, Chicago, IL, USA; IL, USA; Chicago, Univ, Northwestern Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA NC, Hill, Chapel Hill, at Chapel North of Univ Carolina British Columbia Cntr for Excellence in HIV/AIDS, Vancouver, BC, BC, Vancouver, HIV/AIDS, in Excellence for Cntr Columbia British 5 9 5 Univ of California San Diego, San Diego, CA, USA San Diego, San Diego, California of Univ Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Sch Baltimore, PH, of Bloomberg Hopkins Johns Brighton and Sussex Hosps NHS Trust, Brighton, UK; UK; Brighton, Trust, NHS Sussex and Hosps Brighton King’s Coll London, London, UK; UK; London, London, Coll King’s Erasmus Univ Med Cntr, Rotterdam, Netherlands; Netherlands; Rotterdam, Cntr, Med Univ Erasmus Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, Univ of of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of London, UK; UK; London, Canada; Canada; Georges’ Hosp NHS Trust, London, UK; UK; London, Trust, NHS Hosp Georges’ Jacobson Chadwick NHS Fndn Trust, London, UK; UK; London, Trust, Fndn NHS Med, Pittsburgh, PA, USA; USA; PA, Pittsburgh, Med, USA; USA; David Wohl David Baltimore, MD, USA; USA; MD, Baltimore, Mayor Trust, London, UK; UK; London, Trust, MD, USA; USA; MD, Chirag Parikh Chirag Caroline Sabin Caroline Marshall Fordyce 8 1 Associations of Tenofovir Disoproxil Fumarate With With Fumarate Disoproxil Tenofovir of Associations Damage Kidney of Biomarkers Urine Jotwani Vasantha Infected Patients in Northin America InfectedPatients Ruibin Wang 1 Short-Term Renal Impact of Tenofovir Among HIV- Among Impact Renal Tenofovir of Short-Term 1 6 Clinical Risk Factors for Severe Tenofovir (TDF) Tenofovir ClinicalSevere for Risk Factors Tubulopathy Associated Renal Hamzah Lisa Tenofovir Disoproxil Fumarate Disoproxil Tenofovir BartRijnders J. 1 Longer-Term Renal Safety of Tenofovir Alafenamide vs vs Alafenamide Safety Tenofovir Renal of Longer-Term of North Carolina at Chapel Hill, Chapel Hill, NC, USA; USA; NC, Hill, Chapel Hill, at Chapel Northof Carolina Fndn Trust, London, UK; UK; London, Trust, Fndn Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Women’s Hosp, Harvard Med Sch, Boston, MA, USA; USA; MA, Sch, Med Boston, Harvard Hosp, Women’s dos Capuchos, Centro Hospar de Lisboa Central, Lisbon, Portugal; Portugal; Lisbon, Central, Lisboa de Hospar Centro Capuchos, dos USA; USA; Marianne Harris USA; USA; Foster City, CA, USA City, Foster
685 684 683 682 Program and Agenda
691 Use of Urine Biomarker-Derived Clusters to Predict CKD Session P-R1 Poster Abstracts Hall A/B Risk and All-Cause Mortality 2:45 PM-4:00 PM Rebecca Scherzer1; Haiqun Lin2; Alison Abraham3; Heather Thiessen- Tuberculosis: Pathogenesis Studies Philbrook2; Chirag Parikh4; Mary Young5; Phyllis Tien1; Vasantha Jotwani1; Michael Shlipak1; for the Women’s Interagency HIV Study 733 Baseline Sputum and Polyfunctional TB-Specific CD4+ Investigators T Cells in HIV-TB Coinfection 1Univ of California San Francisco, San Francisco, CA, USA; 2Yale Univ Sch of David H. Canaday1; Htin Aung2; Brigid Wilson1; Harriet Mayanja- PH, New Haven, CT, USA; 3Johns Hopkins Bloomberg Sch of PH, Baltimore, Kizza3; Sophie Nalukwago4; Joy Baseke4; Michael R. Betts5; W. H. Boom2 MD, USA; 4Yale Univ Sch of Med, New Haven, CT, USA; 5Georgetown Univ 1Cleveland VA Med Cntr, Cleveland, OH, USA; 2Case Western Reserve Univ, Med Cntr, Washington, DC, USA Cleveland, OH, USA; 3Makerere Univ Coll of Hlth Scis, Kampala, Uganda; 4Mulago Hosp, Kampala, Uganda; 5Univ of Pennsylvania, Philadelphia, 692 Differences in Urine Metabolomes With HIV Infection PA, USA and Antiretroviral Drug Exposure Andrew J. Chetwynd1; Amanda Samarawickrama2; Alaa Abdul-Sada1; 734 Neutrophil-Derived MMP-8 Activity Is Associated With Jaime H. Vera2; Stephen G. Holt3; Martin Fisher2; Yvonne Gilleece2; Immunopathology in TB-IRIS Elizabeth M. Hill1 Naomi F. Walker1; Katalin Wilkinson2; Graeme Meintjes3; Rene 1Univ of Sussex, Brighton, UK; 2Brighton and Sussex Hosps NHS Trust, Goliath3; Janique Peyper3; Robert J. Wilkinson1; Jon S. Friedland1; Paul Brighton, UK; 3Univ of Melbourne, Melbourne, Australia T. Elkington4 1Imperial Coll London, London, UK; 2Francis Crick Inst Mill Hill Lab/Univ of 693 Early Markers of Renal Dysfunction Among Cocaine Cape Town, Observatory, South Africa; 3Univ of Cape Town, Cape Town, Users With HIV and HCV Infection South Africa; 4Univ of Southampton, Southampton, UK Edana Cassol1; Vikas Misra2; Shibani S. Mukerji3; Susan Morgello4; Gregory D. Kirk5; Shruti H. Mehta5; Dana Gabuzda2 1 2 Session P-R2 Poster Abstracts Hall A/B Carleton Univ, Ottawa, ON, Canada; Dana-Farber Cancer Inst, Boston, 2:45 PM-4:00 PM MA, USA; 3Massachusetts General Hosp, Boston, MA, USA; 4Mount Sinai Sch of Med, New York, NY, USA; 5Johns Hopkins Univ, Baltimore, MD, USA Tuberculosis Transmission 694 Bone Loss With Antiretroviral Therapy Is Associated 735 Spatiotemporal Distribution of Pediatric Tuberculosis With Phosphaturia in Central Durban, South Africa 1 2 2 1 Robert Kalayjian1; Jeffrey Albert2; Serge Cremers3; Karin Klingman4; Gary Parker ; Natashia Morris ; Thandi Kapwata ; Farina Karim ; 3 4 5 Carl Fichtenbaum5; Joseph J. Eron6; Todd T. Brown7; Babafemi Taiwo8; Tilagavathy Chinappa ; Fernanda Maruri ; Mahomed-Yunus Moosa ; 4 4 1 for the AIDS Clinical Trials Group Protocol Team A5303 Timothy R. Sterling ; Yuri F. van der Heijden ; Alex Pym 1 2 1MetroHlth Med Cntr, Cleveland, OH, USA; 2Case Western Reserve Univ, KwaZulu-Natal Rsr Inst for TB-HIV, Durban, South Africa; South African 3 Cleveland, OH, USA; 3Columbia Univ, New York, NY, USA; 4NIAID, NIH, Med Rsr Council, Durban, South Africa; eThekwini Municipality, Durban, 4 5 Bethesda, MD, USA; 5Univ of Cincinnati, Cincinnati, OH, USA; 6Univ of South Africa; Vanderbilt Univ Sch of Med, Nashville, TN, USA; Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 7Johns Hopkins Univ, KwaZulu-Natal, Durban, South Africa Baltimore, MD, USA; 8Feinberg Sch of Med, Northwestern Univ, Chicago, 736 Does ART Increase Infectiousness of Smear-Positive IL, USA Pulmonary Tuberculosis? Poster Listings Poster 695LB Immunologic Effects of Maraviroc vs Tenofovir and Palwasha Y. Khan1; Katharina Kranzer2; Katherine L. Fielding2; Associations With Bone Loss Themba Mzembe3; Nimrod Mwaungulu3; Olivier Koole2; Judith Glynn2; 2 Ellen S. Chan1; Paria Mirmonsef2; Todd T. Brown3; Alan L. Landay4; Amelia Crampin 1 2 Ighovwerha Ofotokun5; M. N. Weitzmann5; Jeff Martinson2; Jill Plants2; London Sch of Hygiene & Trop Med, Cardiff, UK; London Sch of Hygiene 3 Heather J. Ribaudo6; Babafemi Taiwo7 & Trop Med, London, UK; Karonga Prevention Study, Karonga, Malawi 1Harvard Univ, Boston, MA, USA; 2Rush Univ Med Cntr, Chicago, IL, USA; 737 Are We Overestimating TB Transmission Among 3 4 Johns Hopkins Univ, Baltimore, MD, USA; Rush Univ, Chicago, IL, USA; Immigrants and HIV-Positive People? 5Emory Univ Sch of Med, Atlanta, GA, USA; 6Harvard Sch of PH, Boston, David Stucki1; Marie Ballif2; Kathrin Zürcher2; Matthias Egger3; MA, USA; 7Feinberg Sch of Med, Northwestern Univ, Chicago, IL, USA Sébastien Gagneux1; Lukas Fenner2 1Swiss Trop Inst of PH, Basel, Switzerland; 2Univ of Bern, Bern, Switzerland; 3Univ Hosp Bern, Bern, Switzerland
68 CROI 2016 Poster Listings 69 ; ; 3 Social 5 4 ; Mary ; Per ; Per Hall D 7 2 Univ of Univ 7 ; Kelly ; Kelly 2 CROI 2016 ; Henry 3 ; Quy T. Du T. ; Quy ; Gregory P. ; Gregory P. ICAP, Columbia Columbia ICAP, ; Miyahara ; Miyahara 2 6 4 3 Ohio State Univ, Univ, Ohio State 7 Johns Hopkins Univ Univ Hopkins Johns ; Nuray Güner ; Nuray 2 1 Frontier Sci & Tech Rsr Rsr Sci Tech & Frontier Vanderbilt Inst for for Inst Vanderbilt ; Moses L. Joloba 5 2 4 Program Agenda and
; Yotebieng Marcel City Univ of New York, New New York, New City of Univ 5 6 5 PH Solutions, New York, York, New Solutions, PH ; Xin Sung; Xin 2 2 Univ of Washington, Seattle, Seattle, Washington, of Univ 2 ; Lydia Nakiyingi ; Lydia 2 ; Mary-Ann Chiasson 1 Univ of North Carolina at Chapel at Chapel North of Univ Carolina ; Andrew Zolopa ; Andrew 8 5 ; Meridith Blevins; Meridith Makerere Univ, Kampala, Uganda; Uganda; Kampala, Univ, Makerere 1 5 ; David Hom ; David 4 ; Sten Skogmar ; Sten ; John Ssali Harvard Univ, Boston, MA, USA; USA; MA, Boston, Univ, Harvard 1 5 3 Children’s Hosp 1, Ho Chi Minh City, City, Minh Chi Ho 1, Hosp Children’s 3 ; for the Tuberculosis Clinical DiagnosticClinical Tuberculosis the ; for
6 1 ; Heidi E. Jones ; Heidi Lund Univ, Lund, Sweden Lund, Univ, Lund Stanford Univ, Stanford, CA, USA; Stanford, Univ, Stanford 4 ; Amita Gupta ; Amita 2 6
1 8 ersus IPT in HIV-Infected Persons Persons HIV-Infected in IPT ersus ; Lynne Jones ; Lynne 4 ; Rachel W. Kubiak W. ; Rachel ; Jessica Justman ; Aaron M. Kipp ; Aaron 1 1 1 ; Taye T. Balcha T. ; Taye 1 ; April C. Pettit ; April 2 ; GaryReubenson ; Susan Dorman 4 4 ; Sandra Armakovitch 3 ; Elaine J. Abrams J. ; Elaine
Infectious Diseases Inst, Makerere Univ, Kampala, Uganda; Uganda; Kampala, Univ, Makerere DiseasesInfectious Inst, 3 Univ of Ghana Sch of Med and Dentistry, Accra, Ghana; Accra, Dentistry, and Sch Ghana Med of of Univ 1 3 Ibis Reproductive Hlth, Cambridge, MA, USA; USA; MA, Cambridge, Hlth, Reproductive Ibis 4 3 ; Evelyn Hogg ; Evelyn 3 ; Mina Hosseinipour 7 Masaka Regional Referral Hosp, Masaka, Uganda; Uganda; Masaka, Hosp, Referral Regional Masaka USA; NY, York, New Univ, ICAP at Columbia Vanderbilt Univ Sch of Med, Nashville, TN, USA; USA; TN, Nashville, Sch Med, of Univ Vanderbilt South Africa; Johannesburg, Hosp, Child and Moosa Mother Rahima Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns USA; MA, Boston, Cntr, Med Boston USA MD, Baltimore, Sch Med, of Univ Hopkins Johns Coll of Med John Hopkins Proj, Blantyre, Malawi; Malawi; Blantyre, Proj, Hopkins John Med of Coll Lund Univ, Malmö, Sweden; Sweden; Malmö, Univ, Lund York, NY, USA NY, York, NY, USA; USA; NY, Blanchard & Scientific Systems, Inc, Silver Spring, MD, USA; USA; MD, Spring, Silver Inc, Scientific& Systems, Bisson Research Consortium Research Univ Mailman Sch of PH, New York, NY, USA; USA; NY, York, Sch New PH, of Mailman Univ Jerrold Ellner Jerrold Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, of WA, USA; USA; WA, Hill, Chapel Hill, NC, USA NC, Hill, Chapel Hill, Fndn, Inc, Amherst, NY, USA; USA; NY, Amherst, Inc, Fndn, 6 DuringRiskIncidence HIV of Increased No Pregnancy Chloe Teasdale A. 1 1 5 TB Treatment Outcomes for HIV/TB CoinfectedHIV/TB Outcomes for Treatment TB Countries ChildrenResource-Limited in CarlucciG. James 1 4 6 TB for Investigated MortalityWomen and Men HIV+ in Centers Health Ethiopian at Reepalu Anton Initiating ART (ACTG A5274 48w) A5274 (ACTG ART Initiating Kumwenda J. Johnstone 1 High Mortality Rates in HIV-Infected TB: SuspectsTB: Mortality High HIV-Infected in Who Rates TB OutRule for Manabe C. Yukari 1 V Therapy TB Empiric Lorna Renner Lorna Columbus, OH, USA OH, Columbus, Pennsylvania, Philadelphia, PA, USA; USA; PA, Philadelphia, Pennsylvania, Lindegren Lou Ssekitoleko Björkman Global Hlth, Nashville, TN, USA; USA; TN, Nashville, Hlth, Global Vietnam; Vietnam; Sachiko
Session P-S1 Poster Abstracts Poster SessionP-S1 PM-4:002:45 PM Outcomes Health Duringand Acquisition HIV Pregnancy 770 746 744 743 745
; 1 1 ; 1
; 3 Hall A/B Hall A/B Human ScisHuman 4 ; Bosco
4
; Welile ; Welile 3 ; Marc Antoine Antoine ; Marc 3 ; Marc Mendelson ; Marc
; Connie M. Celum M. ; Connie 1 1 ; Yael Hirsch- ; Yael 1 Clinical Rsr Cntr, Univ of Univ Cntr, Rsr Clinical 2 ; Kieran Hartsough; Kieran 4
Columbia Univ Mailman Sch Mailman Univ Columbia ; Stephen Asiimwe ; Stephen 2 GHESKIO, Port-au-Prince, Port-au-Prince, GHESKIO, 2 2 Univ Coll London, London, UK London, London, Coll Univ
5 Human Scis Rsr Council, Durban, Durban, ScisHuman Council, Rsr 2 Vincent Pallotti Hosp, Cape Town, Town, Cape Hosp, Pallotti Vincent
3 ; Serena P. Koenig P. ; Serena
; Helen van der Plas van ; Helen
; GaryMaartens 2 ; Koen Frederix ; Koen ; Alastair van Heerden van ; Alastair 2
5 1 1 1 ; Jared M. Baeten ; Jared 1
; Tau Pheletso 3
Lesotho Ministry of Hlth, Maseru, Lesotho; Ministry Lesotho; Maseru, Hlth, of Lesotho 3
; Heidi van Rooyen van ; Heidi 1
; Suzue Saito ; Jean W. Pape W. ; Jean 1 1
; Meighan Krows ; Meighan 1 ; Annemie Stewart ; Annemie ; Wafaa M. El-Sadr M. Wafaa ; ; James P. Hughes ; James P. 1 4 3
FIND, Geneva, Switzerland; Switzerland; Geneva, FIND, Kabwohe Clinical Rsr Cntr, Bushenyi, Uganda; Uganda; Bushenyi, Cntr, Rsr Clinical Kabwohe 4 3
; Llang B. Maama ; Llang B.
; Molebogeng Rangaka
2 4 2
Brigham and Women’s Hosp, Harvard Med Sch, Boston, MA, USA MA, Sch, Med Boston, Harvard Hosp, Women’s and Brigham 3 Univ of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of Univ Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ Weill Cornell Med Coll, New York, NY, USA; USA; NY, York, New Coll, Med Cornell Weill ICAP at Columbia Univ, Maseru, Lesotho Maseru, Univ, ICAP at Columbia ICAP at Columbia Univ, New York, NY, USA; USA; NY, York, New Univ, ICAP at Columbia Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of PH, New York, NY, USA; USA; NY, York, New PH, of Sikhondze Rsr Council, Msunduzi, South Africa Msunduzi, Council, Rsr for the Linkages Study Team Team the Linkages for Study South Africa; South Africa; Haiti; Haiti; Jean Juste Rulan Griesel Rulan 1 A ClinicalA Prediction Diagnosisthe of for Rule Seriouslyin Adults Ill Tuberculosis 1 Strengthens Community-Based HIV Care HIV StrengthensCommunity-Based Barnabas V. Ruanne 1 Screening Linkageand HIV-TB of Integration 4 Case Active YieldDiagnosticHousehold-Level of SlumsUrban in Haiti in Finding Rivera R. Vanessa Andrea A. Howard A. Andrea 1 Integrated TB/HIV ServicesTB/HIV andMiners Migrant for Integrated Lesotho in Families Their Charles Mugizi Charles South Africa; South Africa; Moverman Torin Schaafsma Torin Turyamureeba WITHDRAWN
2:45 PM-4:002:45 PM Outcomes Mortalityand Related Tuberculosis 742 Session P-R4 Poster Abstracts Poster SessionP-R4 741LB 740 739 2:45 PM-4:002:45 PM Services Tuberculosis and HIV of Implementation 738 Session P-R3 Poster Abstracts Poster SessionP-R3 Program and Agenda
771 Effect of Pregnancy on Response to Antiretroviral 777 Pharmacokinetics of Daily Nevirapine in Neonates at Therapy Among African Women High Risk of HIV Acquisition Athena P. Kourtis1; Jeffrey Wiener1; Renee Heffron2; Nelly R. Mugo3; Tim R. Cressey1; Baralee Punyawudho2; Saik Urien3; Gonzague Caroline King1; Kavita Nanda4; Connie M. Celum2; Deborah Donnell5; Jourdain4; Sophie Le Coeur5; Nicole Ngo-Giang-Huong6; Pra-ornsuda Jairam R. Lingappa2; Jared M. Baeten2 Sukrakanchana7; Suporn Koetsawang8; Marc Lallemant9; for the 1CDC, Atlanta, GA, USA; 2Univ of Washington, Seattle, WA, USA; 3Kenya PHPT-5 study team. Med Rsr Inst, Thika, Kenya; 4FHI 361, Chapel Hill, NC, USA; 5SCHARP, Fred 1Harvard Sch of PH, Boston, MA, USA; 2Chiang Mai Univ, Chiang Mai, Hutchinson Cancer Rsr Cntr, Seattle, WA, USA Thailand; 3EAU08 Univ Paris Descartes, Paris, France; 4IRD UMI 174-PHPT, 5 772 Trends in Hospitalizations of Pregnant HIV-Infected Marseille, France; Inst d’Etudes Démographiques, Paris, Thailand; 6Prog for HIV Prevention and Treatment/IRD 175, Chiang Mai, Thailand; Women in the USA: 2004–2011 7Prog for HIV Prevention and Treatment/IRD 176, Chiang Mai, Thailand; 1 2 1 1 Alexander Ewing ; Hema Datwani ; Lisa Flowers ; Sascha Ellington ; 8Mahidol Univ, Bangkok, Thailand; 9Prog for HIV Prevention and 1 1 Denise Jamieson ; Athena P. Kourtis Treatment/IRD 174, Chiang Mai, Thailand 1CDC, Atlanta, GA, USA; 2CDC, Philadelphia, PA, USA 778 Haematological Toxicity and Neonatal Prophylaxis in 773 Cost-Effectiveness of Cotrimoxazole Among HIV+ Infants at High MTCT Risk Pregnant Women in Malarious Regions Elena Chiappini1; Luminita Ene2; Luisa Galli1; Catiuscia Lisi1; Ruslan Sung Eun Choi; Eran Bendavid Malyuta3; Antoni Noguera-Julian4; Pablo Rojo Conejo5; Christoph Stanford Univ, Stanford, CA, USA Rudin6; Claire Thorne7; for the European Pregnancy and Paediatric HIV Cohort Collaboration in EuroCoord Session P-S2 Poster Abstracts Hall D 1Univ of Florence, Florence, Italy; 2Victor Babes Hosp, Bucharest, 2:45 PM-4:00 PM Romania; 3Perinatal Prevention of AIDS Initiative, Odessa, Ukraine; Antiretroviral Therapy Pharmacokinetics and Safety 4Hosp Sant Joan de Déu, Barcelona, Spain; 5Hosp 12 de Octubre, Madrid, Spain; 6Univ Children’s Hosp Basel, Basel, Switzerland; 7Univ Coll London, During Pregnancy and Infancy London, UK 774 Intracellular Atazanavir Concentrations Remain Stable During Pregnancy in HIV Women Session P-S3 Poster Abstracts Hall D Emanuele Focà1; Andrea Calcagno2; Andrea Bonito1; Marco Simiele2; 2:45 PM-4:00 PM Elisabetta Domeneghini1; Antonio D'Avolio2; Maria Antonietta Forleo1; Partners in Crime: CMV, HIV, and MTCT Giovanni Di Perri2; Eugenia Quiros Roldan1; Stefano Bonora2 1Univ of Brescia, Brescia, Italy; 2Univ of Torino, Torino, Italy 779 Maternal CMV Urinary Shedding in HIV-Infected Women and Congenital CMV Infection 775 Pharmacokinetics of Increased Dose Darunavir During Kristina Adachi1; Jiahong Xu2; Bonnie Ank3; D. H. Watts4; Esau C. Late Pregnancy and Postpartum Joao5; Jose H. Pilotto6; Yvonne J. Bryson1; Valdilea G. Veloso7; Lynne M. 1 2 2 3 Alice Stek ; Brookie M. Best ; Edmund Capparelli ; Jiajia Wang ; David Mofenson8; Karin Nielsen-Saines1 4 5 6 7 E. Shapiro ; Tim R. Cressey ; Elizabeth Smith ; Regis Kreitchmann ; 1Univ of California Los Angeles, Los Angeles, CA, USA; 2Westat, Inc, 8 9 Nahida Chakhtoura ; Mark Mirochnick Rockville, MD, USA; 3David Geffen Sch of Med at Univ of California Los 1Univ of Southern California, Los Angeles, CA, USA; 2Univ of California 4 Poster Listings Poster Angeles, Los Angeles, CA, USA; Office of the US Global AIDS Coordinator, 3 San Diego, San Diego, CA, USA; Harvard Sch of PH, Boston, MA, USA; US Dept of State, Washington, DC, USA; 5Hosp Fed dos Servidores do 4 Cntr for Biostatistics in AIDS Rsr, Harvard Sch Of PH, Boston, MA, USA; Estado, Rio de Janeiro, Brazil; 6Hosp Geral de Nova Iguaçu, Rio de Janeiro, 5 6 Harvard Sch of PH, Boston, MA, USA; NIAID, NIH, Bethesda, MD, USA; Brazil; 7Fiocruz, Rio de Janeiro, Brazil; 8Previously with NIH, Bethesda, 7 8 Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil; Eunice MD, USA Kennedy Shriver NICHD, Bethesda, MD, USA; 9Boston Univ Sch of Med, Boston, MA, USA 780 TLR9 Variant Is Associated With Earlier HIV, EBV, and CMV Acquisition in Infants 776 High Risk of Liver Enzyme Elevation in Pregnant Kristin Beima-Sofie1; Grace C. John-Stewart1; Dalton Wamalwa2; Women Receiving Protease Inhibitors Elizabeth Maleche-Obimbo2; Jennifer Slyker1 1 1 2 Jeanne Sibiude ; Josiane Warszawski ; Roland Tubiana ; Jérôme Le 1Univ of Washington, Seattle, WA, USA; 2Univ of Nairobi, Nairobi, Kenya Chenadec3; Françoise Meier4; Eliane Galiba5; Albert Faye6; Stéphane Blanche7; Laurent Mandelbrot8; for the ANRS CO1/CO11-EPF French 781 HCMV Induces CCR5 Expression, Activation and HIV Perinatal Cohort Study Group Infection at Feto-Maternal Interface 1CESP, INSERM U1018, Le Kremlin-Bicêtre, France; 2Sorbonne Univ, Paris, Erica L. Johnson1; Sahithi Boggavarapu2; Elan S. Johnson2; Asim Lal2; France; 3INSERM, Le Kremlin-Bicêtre, France; 4APHP, Hosp Louis Mourier, Parth Agrawal2; Rana Chakraborty2 Colombes, France; 5CHU de l’Archet, Nice, France; 6Univ Diderot Paris 7, 1Emory Univ Sch of Med, Atlanta, GA, USA; 2Emory Univ, Atlanta, GA, USA Sorbonne Paris-Cité, Paris, France; 7Hosp Necker Enfants Malades, Paris, France; 8Hosp Louis Mourier, Colombes, France
70 CROI 2016 Poster Listings 71 ; 4 ; ; 2 ; 3 5 ; ; 4 8 Univ Univ Hall D 2
Queen 6 CROI 2016 ; Devi ; Muchaneta 7
1 5 ViiV Hlthcare, Hlthcare, ViiV Eunice Kennedy Kennedy Eunice 9 6 ; Vojnov Lara Gilead Scis, Inc, Inc, Scis, Gilead Harvard Sch of Harvard 3 7 IMPAACT IMPAACT 5 4 ; Kathleen George ; Kathleen Miller Children’s Hosp, Hosp, Children’s Miller 3 4 ; Osvaldo Loquilha ; Osvaldo Botswana Harvard Harvard Botswana ; Michael Hughes 1 2 4 ; Jagmohan Batra Joint Clinical Rsr Cntr, Cntr, Rsr Clinical Joint ; Annie Buchanan; Annie 3 2 Program Agenda and 7 Botswana Harvard AIDS AIDS Harvard Botswana Harvard Sch of PH, Boston, Boston, Sch PH, of Harvard 3 Clinton Hlth Access Initiative, Initiative, Access Hlth Clinton 2 ; Steven Rossi ; Steven 3 ; Yongwu Shao ; Yongwu 2 6
Henry M. Jackson Fndn for the for Henry Fndn Jackson M. 7 ; Roger L. Shapiro 4 7 ; Terry ; Terry Fenton Frontier Sci & Tech Rsr Fndn, Inc, Inc, Fndn, Rsr Sci Tech & Frontier 2 7 ; Vubil Adolfo 1 ; Timothy ; Timothy Bollinger 3 Univ of California San Diego, San San Diego, California of Univ 10 NIH, Rockville, MD, USA; USA; MD, Rockville, NIH, 5 ; Bobbie Graham ; for the IMPAACT P1093 Study Group P1093 Study the IMPAACT ; for 6
; Rana Chakraborty 10 ; Erin Quirk; Erin 2 7
; Patrick Jean-Philippe ; Patrick 5 3 Clinton Hlth Access Initiative, Gabarone, Gabarone, Initiative, Access Hlth Clinton 4 ; Kenneth Maswabi ; Kenneth Ragon Inst of MGH, MIT and Harvard, Cambridge, Cambridge, Harvard, and MIT MGH, of Inst Ragon Khon Kaen Univ, Khon Kaen, Thailand; Thailand; Kaen, Khon Univ, Kaen Khon 1 6 5 ; Daniel Kuritzkes Emory Univ, Atlanta, GA, USA; GA,USA; Atlanta, EmoryUniv, 6 3 ; Wicharn ; Wicharn Luesomboon ; Carmelita Alvero ; Carmelita GSK, Research Triangle Park, NC, USA; USA; NC, Park, Triangle GSK, Research 5 ; Ocean Tobaiwa ; Nedio Mabunda ; Nedio 1 8 3 1 ; Rohan Hazra ; Hilda Kizito 5 1 ; Ilesh V. Jani V. ; Ilesh ; Rolando Viani 4 Inst Nacional de Saude, Maputo, Mozambique Maputo, Saude, de Nacional Inst 9 5 ; Martin S. Rhee Harvard Med Sch, Boston, MA, USA MA, Sch, Med Boston, Harvard USA; MA, Sch Boston, PH, of Harvard SDAC, 7 7 3 ; Sikhulile Moyo 2 St Jude Children’s Rsr Hosp, Memphis, TN, USA; USA; TN, Memphis, Hosp, Rsr Jude Children’s St Albert Einstein Coll of Med, Bronx, NY, USA; USA; NY, Bronx, Med, of Coll Albert Einstein Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ Inst Nacional de Saúde de Mocambique, Maputo, Mozambique; Mozambique; Maputo, Saúde de Mocambique, de Nacional Inst Operations, Durham, NC, USA; USA; NC, Durham, Operations, Cindy Vavro Cindy Foster City, CA, USA City, Foster Mathias Lichterfeld Mathias Botswana; Gaborone, Partnership, Inst AIDS Jorge I. Quevedo Jorge Bhondai SenGupta Savang Vadhana Memorial Hosp, Chon Buri, Thailand; Thailand; Buri, Chon Hosp, Memorial Vadhana Savang Ellen Townley Ellen Uganda; Kampala, Trevor Peter Trevor MA, USA; USA; MA, Long Beach,CA, USA; Long 1 IMPAACT 1093: Dolutegravir in 6- to 12-Year-Old 12-Year-Old to 6- in Dolutegravir 1093: IMPAACT Wiznia Andrew 1 SafetyInfected Efficacy HIV-1 and in E/C/F/TAF of Adolescents Treatment-Naïve Gaur Aditya 1 Edmund Capparelli Edmund Point-of-Care p24 Infant Testing May Increase Patient Patient Increase May Testing Infant Point-of-Care p24 Sensitivity YieldLow Despite Meggi Bindiya 1 HIV-Infectedin Concentrations (NVP) Nevirapine Dosing Therapeutic Receiving Newborns Botswana; Botswana; Diego, CA, USA Diego, Inst Partnership, Gaborone, Botswana; Botswana; Gaborone, Partnership, Inst Pope Kosalaraksa Pope Eduardo Mondlane, Maputo, Mozambique; Mozambique; Maputo, Mondlane, Eduardo MA, USA; USA; MA, USA; NY, Buffalo, Shriver NICHD, Bethesdah, MD, USA; USA; Bethesdah, MD, NICHD, Shriver HIV-Infected Children: 48-Week Results Results Children:48-Week HIV-Infected Maputo, Mozambique; Mozambique; Maputo, Advancement of Military Med, Inc, Rockville, MD, USA; USA; MD, Rockville, Inc, Military of Med, Advancement PH, Boston, MA, USA; USA; MA, Boston, PH, Reserach Triangle Park, NC, USA; USA; NC, Park, Triangle Reserach
816 817 788 Abstracts Poster SessionP-T1 PM-4:002:45 PM Efficacy Pharmacokinetics: in SafetyARVs and New of Children 815 ; 4 ; 3 ; 2 ; 7
Univ Univ 2 2 4 Hall D ; Rachel 2 ; Elaine J. J. ; Elaine 4 ; Gayle ; Gayle 1
1 Médecins SansMédecins 2 ; Gbolahan Ajibola 3 ; Elton Mbofana ; Elton ; Landon Myer ; Landon ; Landon Myer ; Landon 3 ; Sikhulile Moyo 1 1 6 ; Emmanuel Farjado ; Emmanuel Univ of Botswana, Botswana, of Univ McGaw Med Cntr of Cntr Med McGaw 2 2 2 ; Landon Myer ; Landon Univ of Cape Town, Cape Cape Town, Cape of Univ Univ of Cape Town, Cape Cape Town, Cape of Univ 1 2 2 ; Divya Mallampati 1 ICAP, Columbia Univ Mailman Mailman Univ Columbia ICAP, 5 Botswana Harvard AIDS Inst Inst AIDS Harvard Botswana 7 WHO, Geneva, Switzerland; Switzerland; Geneva, WHO, 3 6 FIND, Geneva, Switzerland Geneva, FIND, Univ of the Witwatersrand, Witwatersrand, the of Univ 4 2 ; Taige Hou ; Taige ; Shahin Lockman 3 2 ; Michael Hughes ; Tendesayi Kufa-Chakezha ; Tendesayi ; Kenneth A. Freedberg ; Kenneth ; Wolfgang Preiser ; Wolfgang ; Wolfgang Preiser ; Wolfgang
4 Médecins Sans Frontières, Southern Africa Africa Southern SansMédecins Frontières, 1 1 2 2 3 3 ; Maryam Rumaney ZibusisoNdlovu 4 ;
1 ; Jordan A. Francke A. ; Jordan 1 Brigham and Women's Hosp, Harvard Med Sch, Med Harvard Hosp, Women's and Brigham 3 ; SajiniSouda ; Roger L. Shapiro Botswana Harvard AIDS Inst Partnership, Gaborone, Gaborone, Partnership, Inst AIDS Harvard Botswana 1 4 4 ; Helen Bygrave ; Helen ; Florence Chilisa ; Florence ; Nei-Yuan Hsiao ; Nei-Yuan ; Nei-Yuan Hsiao ; Nei-Yuan ; Kekeletso Kao ; Kekeletso 4 5 1 1 3 ; Martina Penazzato Bennett Statistical Consulting, Inc, Ballston Lake, NY, USA; USA; NY, Lake, Ballston Inc, Consulting, Bennett Statistical 1 5
2 ; Rochelle P. Walensky ; Rochelle P. 5 Natl Microbiology Reference Lab, Harare, Zimbabwe; Zimbabwe; Harare, Lab, Reference Microbiology Natl Massachusetts General Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, General Massachusetts Stellenbosch Univ, Cape Town, South Africa; South Africa; Town, Cape Univ, Stellenbosch Harvard Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, of Harvard Massachusetts General Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, General Massachusetts NICD, Johannesburg, South Africa; South Africa; Johannesburg, NICD, Stellenbosch Univ, Cape Town, South Africa; South Africa; Town, Cape Univ, Stellenbosch Joseph Makhema Sherman Carol Metcalf Carol Town, South Africa Town, Town, South Africa Town, Daniel Orozco L. MacLean 1 Kara BennettKara Sch of PH, New York, NY, USA NY, York, Sch New PH, of EarlyDiagnosisInfant Mtapuri-Zinyowera Sekesai 1 DiagnosticAccuracy Xpert Cepheid of Qual HIV-1 for Diagnosis (EID) Programs Diagnosis(EID) CiaranelloL. Andrea 1 Jean MaritzJean 1 EarlyHIVin Infant Testing Confirmatoryof Value The Botswana; Botswana; 6 Testing DiagnosticInfant Routine of Uptake Low Birth at Testing PCR HIV Following Infant Cotrimoxazole Prophylaxis Associated With With Associated Prophylaxis Cotrimoxazole Infant Bacterial Commensal Resistance KathleenPowis National Consolidated Guidelines Consolidated National MazanderaniHaeri Ahmad 1 Jean MaritzJean 1 Souththe Into African IntroductionBirthof Testing Population-Level Declines in Vertical HIV Transmission Transmission VerticalHIV in Declines Population-Level Guidelines Changing PMTCT With Frontières, Harare, Zimbabwe; Zimbabwe; Harare, Frontières, South Africa; Town, Cape Unit, Med Boston, MA, USA; USA; MA, Boston, Gaborone, Botswana; Botswana; Gaborone, Northwestern Univ, Chicago, IL, USA; IL, USA; Chicago, Univ, Northwestern Johannesburg, South Africa Johannesburg, Abrams Partnership, Gaborone, Botswana Gaborone, Partnership, of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of
787 786 785 784 783 2:45 PM-4:002:45 PM EarlyDiagnosisand Infant Rates, Regimens, MTCT: 782 Session P-S4 Poster Abstracts Poster SessionP-S4 Program and Agenda
818 Pharmacokinetics, Safety, and Efficacy of Maraviroc in 823 Long-term Effects on Basal Ganglia in Youth With Pediatric Patients With R5 HIV Perinatally Acquired HIV Infection Carlo Giaquinto1; Muthuhadini P. Mawela2; Kulkanya Christine Paula de los Angeles1; Paige L. Williams2; Yanling Huo2; Chokephaibulkit3; Annie Fang4; Elna van der Ryst5; Srinivas Rao Valluri4; Kathleen Malee3; John G. Csernansky1; Ram Yogev3; Russell B. Van Manoli Vourvahis4; Rebecca Zhang-Roper6; Lynn McFadyen7; Jayvant Dyke4; Elizabeth R. Sowell5; Lei Wang1; for the Pediatric HIV/AIDS Heera8 Cohort Study (PHACS) 1Univ of Padova, Padova, Italy; 2Sefako Makgatho Hlth Scis Univ, Pretoria, 1Northwestern Univ, Feinberg Sch of Med, Chicago, IL, USA;2Harvard South Africa; 3Siriraj Hosp, Mahidol Univ, Bangkok, Thailand; 4Pfizer, Inc, Sch of PH, Boston, MA, USA;3Ann and Robert H. Lurie Children’s Hosp New York, NY, USA; 5Pfizer Inc, The Rsr Network, Sandwich, UK; 6GSK, of Chicago, Chicago, IL, USA;4Tulane Univ Sch of Med, New Orleans, LA, Stockley Park, UK; 7Pfizer, Inc, Sandwich, UK; 8Pfizer, Inc, Groton, CT, USA USA;5Keck Sch of Med at the Univ of Southern California, Los Angeles, 819 Safety of Tenofovir on Bone Mineral Density in HIV- CA, USA Infected Youths: A 10-Year Study Session P-T3 Poster Abstracts Hall D Vania Giacomet1; Katia Maruca2; Paola Erba1; Maria Puzzovio2; Pilar Nannini3; Silvia Capelli2; Alessandro Ambrosi2; Gianvincenzo Zuccotti4; 2:45 PM-4:00 PM Stefano Mora2 Immunopathogenesis in HIV-Infected Children 1Luigi Sacco Hosp, Univ of Milan, Milan, Italy; 2San Raffaele Scientific 3 4 824 Risk Factors for BCG IRIS in HIV-Infected infants Inst, Milan, Italy; Univ of Milan, Milan, Italy; Ospedale Buzzi, Univ of Starting Antiretroviral Treatment Milan, Milan, Italy Varghese K. George1; Elisa Nemes2; Asma Toefy2; Willem Hanekom2; Mark F. Cotton3; Charles D. Mitchell4; James Oleski5; Bonnie Zimmer6; Session P-T2 Poster Abstracts Hall D Terry Fenton7; Savita Pahwa4; for the IMPAACT P1073 2:45 PM-4:00 PM 1Univ of Miami, Miami, FL, USA; 2Univ of Cape Town, Cape Town, South Getting a Handle on CNS Disease in Children and Africa; 3Stellenbosch Univ and Tygerberg Children’s Hosp, Cape Town, Adolescents South Africa; 4Univ of Miami Miller Sch of Med, Miami, FL, USA; 5New Jersey Med Sch, Newark, NJ, USA; 6Frontier Sci & Tech Rsr Fndn, Inc, 820 HIV Encephalopathy Despite Prolonged Viral Amherst, MA, USA; 7SDAC, Harvard Sch of PH, Boston, MA, USA Suppression With Slow Spontaneous Recovery 825 Enhanced Inflammation and Rotavirus Vaccine Steve Innes; Barbara Laughton; Ronald van Toorn; Els Dobbels; Mark F. Cotton Responses in Perinatal HIV-1 Infection 1 2 3 Stellenbosch Univ and Tygerberg Children's Hosp, Cape Town, South Priyanka Uprety ; Jane Lindsey ; Myron Levin ; Kaitlin Rainwater- 1 1 4 4 Africa Lovett ; Carrie Ziemniak ; Susan Kaplan ; Micki Nelson ; Amanda Zadzilka5; Adriana Weinberg6; Deborah Persaud1 821 A Diffusion Tensor Imaging and Neurocognitive Study 1Johns Hopkins Univ, Baltimore, MD, USA; 2Harvard Sch of PH, Boston, of HIV-Infected Children MA, USA; 3Univ of Colorado Anschutz Med Campus, Aurora, CO, USA; Jacqueline Hoare1; J.P. Fouche1; Nicole Phillips1; John Joska1; Robert 4Merck Rsr Lab, North Wales, PA, USA; 5Frontier Sci & Tech Rsr Fndn, Inc, Paul2; Kirsten Donald1; Kevin Thomas1; Dan Stein1 Amherst, NY, USA; 6Univ of Colorado, Denver, CO, USA 1 2 Univ of Cape Town, Cape Town, South Africa; Missouri Inst of Mental 826 Vitamin D Supplementation Decreases Immune
Poster Listings Poster Hlth, St. Louis, MO, USA Activation and Exhaustion in HIV+ Youth 822 Brain Volumes, HIV Disease Severity, and Substance Allison R. Eckard1; Ann Chahroudi2; Julia C. Rosebush2; Mary Ann Use in Perinatally Infected Youth O'Riordan3; Julie E. Daniels2; Monika Uribe-Leitz2; Bruce Kinley3; Paige L. Williams1; Yanling Huo1; Shirlene D. Wang2; Kristina Uban3; Danielle Labbato3; Vin Tangpricha2; Grace A. McComsey3 Kathleen Malee4; Sharon L. Nichols5; Russell B. Van Dyke6; Lei Wang7; 1Med Univ of South Carolina, Charleston, SC, USA; 2Emory Univ Sch of Elizabeth R. Sowell8; for the Pediatric HIV/AIDS Cohort Study (PHACS) Med, Atlanta, GA, USA; 3Case Western Reserve Univ, Cleveland, OH, USA and the Pediatric Imaging, Neurocognition, and Genetics (PING) Study 827 Contrasting CTL Impact in Distinct Phenotypes of 1Harvard Sch of PH, Boston, MA, USA; 2Northwestern Univ, Chicago, IL, USA; 3Children’s Hosp of Los Angeles, Los Angeles, CA, USA; 4Ann and Nonprogressing Pediatric HIV 1 2 2 1 Robert H. Lurie Children’s Hosp of Chicago, Chicago, IL, USA; 5Univ of Ellen M. Leitman ; Astrid Gall ; Paul Kellam ; Jacqui Brener ; Azim 1 3 1 California San Diego, San Diego, CA, USA; 6Tulane Univ Sch of Med, New Ansari ; Christina F. Thobakgale ; Philippa C. Matthews ; Philip 1 Orleans, LA, USA; 7Northwestern Univ, Feinberg Sch of Med, Chicago, IL, Goulder 1 2 USA; 8Keck Sch of Med at the Univ of Southern California, Los Angeles, Univ of Oxford, Oxford, UK; Wellcome Trust Sanger Inst, Hinxton, UK; 3 CA, USA HIV Pathogenesis Prog, Doris Duke Med Rsr Inst, Univ of KwaZulu-Natal, Durban, South Africa 828 Impact of HLA-B*81-driven Escape Mutation L188F on VRC in Pediatric Slow Progression Ming-Han Tsai1; Maximilian Muenchhoff1; Emily Adland1; Anna Carlqvist1; David Cole2; Andrew K. Sewell2; Jonathan Carlson3; Thumbi P. Ndungu4; Philip Goulder1; for the Professor Philip Goulder's Group 1Univ of Oxford, Oxford, UK; 2Cardiff Univ, Cardiff, UK; 3Microsoft Rsr, Redmond, WA, USA; 4Univ of KwaZulu-Natal, Durban, South Africa
72 CROI 2016 Poster Listings 73 ; ; ;
6 1 3 1 ; 2 Hall D ; ; Allison ; Allison 3 Simon Johns Johns 2 5 8 Univ Univ 4 CROI 2016 ; Suresh ; Suresh ; Paul Sereda ; Paul 1 3 ; Hyman Scott ; Hyman 5 ; Daniela De; Daniela 1 New York City York New ; Valerie Delpech; Valerie 2 1 ; Bisrom Deocharan ; Bisrom ; Pich Seekaew; Pich 1 Univ of California San California of Univ 1 ; Anthony ; Anthony 2 2 ; Chaiwat ; Chaiwat ; Boonyos ; Boonyos 3 3 Program Agenda and ; David M. Moore6; for the for M. Moore6; ; David ; Zishan Cui 5 2 The Fenway Inst, Fenway Fenway Inst, Fenway The YRG Cntr for AIDS Rsr and Rsr AIDS for Cntr YRG ; Santhanam Anand 5 Columbia Univ Mailman Mailman Univ Columbia 2 2 2 ; Noel O. Gill O. ; Noel 1 ; David Celentano ; David ; Kanokpan Pancharoen ; Kanokpan 3 3
; Vijay ; Vijay Nandi 1 1 ; Kenneth H. Mayer ; Kenneth ; Tosswill Jennifer 4 1 ; William ; William Duffy Univ of British Columbia, Vancouver, Vancouver, Columbia, British of Univ 1 BC Cntr for Excellence in HIV/AIDS, HIV/AIDS, in Excellence for Cntr BC 6 3 ; for the HPTN 061 Study Team Team the HPTN 061 Study ; for Connecticut Dept of Hlth, Hartford, Hartford, Dept Hlth, of Connecticut 8 3 Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, 3
; Amado Punsalang ; Amado 2 ; Robert S. Hogg ; Sarika Pattanasin 4 2 ; Shruti H. Mehta1 Mehta1 H. ; Shruti Med Rsr Council Biostatistics Unit, Cambridge, Cambridge, Unit, Biostatistics Council Rsr Med 1 ; Varangrat Anchalee 2 3 ; Henry F. Raymond ; Henry F. Univ of Victoria, Victoria, BC, Canada; Canada; BC, Victoria, Victoria, of Univ Emory Univ Rollins Sch of PH, Atlanta, GA, USA; Atlanta, Sch PH, of Emory Rollins Univ 1 Univ of California San Francisco, San Francisco, San Francisco, San Francisco, California of Univ 4 2 YRG Cntr for AIDS Rsr and Educ, Chennai, India Chennai, Educ, and Rsr AIDS for Cntr YRG 6 3 ; Gwenda Hughes ; Gwenda 3 ; GaryMurphy ; Carl Latkin ; Carl 1 ; Beryl A. Koblin ; Aylur K. Srikrishnan ; Aylur 7 1 1 Timothy H. Holtz H. Timothy ; Lisa A. Forgione ; Warunee Thienkrua ; Warunee 1 ; 3 ; DeMarc A. Hickson ; DeMarc 3 3 ; Eric A. Roth ; Eric ; Weiss Kevin ; Orlin Trochev 3 1 2
3 ; Pachamuthu Balakrishnan ; Pachamuthu 1 Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, of Univ Hopkins Johns 7 ; Ward Helen 2 ; Gregory M. Lucas 2 Imperial Coll London, London, UK London, London, Coll Imperial 3 Thailand Ministry of PH US CDC Collab, Nonthaburi, Thailand Nonthaburi, Ministry Collab, CDC US PH of Thailand Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns GA, USA; Atlanta, CDC, Univ of British Columbia, Vancovuer, BC, Canada; Canada; BC, Vancovuer, Columbia, British of Univ New York Blood Cntr, New York, NY, USA; USA; NY, York, New Blood Cntr, York New PH England, London, UK; UK; London, England, PH USA; NY, City, Island City Long Dept Hlth, of York New Francisco, San Francisco, CA, USA; San Francisco, Francisco, of Mississippi Med Cntr, Jackson, MS, USA; USA; MS, Jackson, Cntr, Med Mississippi of Sch of PH, New York, NY, USA; USA; NY, York, Sch New PH, of UK; UK; McFall M. Angelis Sophia Hussen BC, Canada BC, Dept of Hlth, New York, NY, USA; USA; NY, York, New Dept Hlth, of Hlth, Boston, MA, USA; USA; MA, Boston, Hlth, Pachara Sirivongrangson Pachara AshleighRich Educ, Taramani, India; India; Taramani, Educ, Fraser Univ, Burnaby, BC, Canada; Canada; BC, Burnaby, Univ, Fraser 3 1 Silom Community at Testing STI and HIV of Years 10 Thailand Clinic(SCC) Bangkok, in DunneEileen Raengsakulrach 1 1 Respondent-Driven Sampling: An Epidemiological Tool Sampling: Respondent-Driven EpidemiologicalAn Tool Interventional Potential With SunilSolomonS. Robert Pirillo 1 Sensitivity of Analysis Matter? SizeReally Does Seedsof Number StudyRDS an in Lachowsky J. Nathan Kumar Longitudinal Analysis of Sexual Networks of US BlackUS of Networks Sexual of Analysis Longitudinal 061 HPTN in MSM TieuN. Van Hong National HIV Incidence Estimates Among STI ClinicSTI Among Estimates Incidence HIV National UK England, in Attendees Aghaizu Adamma 1 City York New Attending Men in Incidence HIV High 2009-2012 Clinics, STD and LGBT Torian V. Lucia 1 CT, USA CT, Muyombwe Hopkins Univ, Baltimore, MD, USA MD, Baltimore, Univ, Hopkins Ungsedhapand Momentum Health Study Study Health Momentum CA, USA; Vancouver, BC, Canada; Canada; BC, Vancouver, Vanessa Cummings Vanessa
900 899 898 897 Session P-W1 Poster Abstracts Poster SessionP-W1 PM-4:002:45 PM HIV Risk for at Populations 895 896 ; ; 1 5 ; 1 ; ; 2 5 ; Hall D 1 ; Susan 5 Kenya 4 ; Susan P. ; Susan P. 5 San Francisco San Francisco 2 Hunter HIV/AIDS HIV/AIDS Hunter 3 ; Susanne 1 ; Andrea Branch ; Andrea 4 ; Stephanie Cohen ; Stephanie 3 ; Nora Douglas ; Nora ; Howard Horng ; Howard Univ of California California of Univ Univ of California San California of Univ 3 2 2 2 ; for the Partners PrEP PrEP the Partners ; for ; Richard Elion ; Richard 5 4 ; Mauro Schechter ; Mauro 4
; Connie M. Celum M. ; Connie 1 ; for the Demo; for Project 1 6 Univ of Manitoba, Winnipeg, Winnipeg, Manitoba, of Univ 7 George Washington Univ Sch Univ of Washington George ; Wairimu Chege ; Wairimu SCHARP, Fred Hutchinson Cancer Cancer Hutchinson Fred SCHARP, 5 1 2 Univ of Miami, Miami, FL, USA; FL, USA; Miami, Miami, of Univ 3 ; Susan Philip S. ; Nelly R. Mugo ; Nelly 2 ; Albert Y. Liu Y. ; Albert 3 1 Univ of Michigan Sch of PH, Ann Sch PH, Michigan of of Univ 3 ; Kailip Boonrai Univ of Colorado, Denver, CO, USA; USA; CO, Denver, Colorado, of Univ ; for the iPrEx Study Team Team Study the iPrEx ; for C Levels in PrEP Associated Associated PrEP in Levels C 2 3 1 ; Sybil Hosek ; Sybil DAIDS, NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, NIAID, DAIDS, 1 5 ; Albert Y. Liu Y. ; Albert ; Peter L. Anderson ; Peter 3 ; Wyatt Christina ; Wairimu Chege ; Wairimu 2 7 1 ; Richard Elion ; Richard 4
Icahn Sch of Med at Mount Sinai, New York, York, at Sinai, New Sch Med Mount of Icahn Columbia Univ, New York, NY, USA; USA; NY, York, New Univ, Columbia ; Jared M. Baeten ; Jared 5 3 1
; Oliver Bacon ; Oliver 2 4 ; Vittinghoff Eric 1 ; Robert Grant 6 ; David V. Glidden V. ; David ; Thomas ; Thomas Nickolas 1 2 ; Stephanie Pena ; Stephanie ; Oliver Bacon ; Oliver John H. Stroger Jr Hosp of Cook County, Chicago, IL, USA; IL, USA; Chicago, County, Cook of Jr Hosp Stroger H. John ; Allan Ronald ; Allan 1 3 4 6 ; Michael Kolber ; Vittinghoff Eric 1 ; AsaRadix 1 2 ; Michael Kolber ; Kathleen Mulligan ; Kathleen 1 3 Univ of Nairobi, Nairobi, Kenya; Kenya; Nairobi, Nairobi, of Univ 6 The Fenway Inst, Fenway Hlth, Boston, MA, USA MA, Boston, Hlth, Fenway Inst, Fenway The 6 Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ San Francisco Dept of PH, San Francisco, CA, USA; San Dept PH, of Francisco, San Francisco FL, USA; Miami, Miami, of Univ USA DC, Washington, Sch Med, Univ of Washington George Projeto Praça Onze, Universidade Fed do Rio de Janeiro, Rio de Janeiro, Rio Janeiro, de Rio do Janeiro, de Fed Universidade Onze, Praça Projeto Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ San Francisco Dept of PH, San Francisco, CA, USA; Dept San PH, of Francisco, San Francisco USA; Bethesda, MD, NIH, NIAID, DAIDS, Hunter Coll and the Grad Cntr, City Univ of New York, New York, NY, USA; USA; NY, York, New York, New City of Univ Cntr, Grad the and Coll Hunter USA; NY, York, New Cntr, Hlth Community Callen-Lorde Dept of PH, San Francisco, CA, USA; Dept San PH, of Francisco, Susanne Doblecki-Lewis San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, Francisco, San Francisco, CA, USA; San Francisco, Francisco, Rsr Team (HART), Hunter Coll, New York, NY, USA NY, York, New Coll, (HART), Hunter Team Rsr Doblecki-Lewis Machel Hunt Brazil; Brazil; NY, USA; USA; NY, Med, Washington, DC, USA DC, Washington, Med, Rsr Cntr, Seattle, WA, USA; USA; WA, Seattle, Cntr, Rsr Study Team Team Study 1 Rare Incidence of Proximal Tubular Dysfunction With Tubular Proximal of Incidence Rare Chemoprophylaxis Tenofovir-Based K. Kenneth Mugwanya 1 4 6 PrEP Use in the US Demo ProjectDemo US the in Use PrEP Liu AlbertY. 5 TDF/FTC With ChangesFunction Renal in Associated MonicaGandhi 1 Higher Cumulative TFV/FT Higher Cumulative Function Renal in Decline With 1 4 QuarterlyScreeningSTI DetectionSTI Optimizes ProjectDemo the in Users PrEP Among Cohen Stephanie SaritGolub A. 1 2 STI Data From Community-Based PrEP Community-Based From Data STI Suggest Guidelines CDC Implementation Changes to Med Rsr Inst, Thika, Kenya; Kenya; Thika, Inst, Rsr Med Buchbinder MB, Canada MB, Kenneth H. Mayer Kenneth Deborah Donnell James K. Kairie P. Buchbinder P. K.Amico R. Arbor, MI, USA; USA; MI, Arbor, Team Team
868 867 2:45 PM-4:002:45 PM Function Renal Users PrEP in STIs and Complicated: It's 866 Session P-V1 Poster Abstracts Poster SessionP-V1 870 869 Program and Agenda
901 Why Are Trends in HIV Diagnoses in Sub-Saharan 907 Validation of Self-Reported HIV Status Among Older African Migrants in Europe Changing? Adults in Rural South Africa Julia Del Amo1; Inmaculada Jarrín1; Vicky Hernando1; Debora Alvarez Julia K. Rohr1; Molly S. Rosenberg2; Xavier Gomez-Olive3; Ryan Del Arco1; Susana Monge2; Belen Alejos1; Francisco Bolumar2; Andrew Wagner3; Brian Houle4; Joshua Salomon1; Stephen Tollman5; Kathleen Amato3; Teymur Noori3; Anastasia Pharris3; for the Del Amo J, Jarrín I, Kahn3; Till Bärnighausen2 Hernando V, Álvarez Del-Arco D, Monge S, Alejos S, Bolúmar F, Amato 1Harvard Univ Sch of PH, Boston, MA, USA; 2Harvard Sch of PH, Boston, A, Noori T, Pharris A MA, USA; 3Med Rsr Council/Wits Rural PH and Health Transition Unit, 1Inst de Salud Carlos III, Madrid, Spain; 2Univ de Alcalá, Madrid, Spain; Johannesburg, South Africa; 4Australian Natl Univ, Canberra, Australia; 3European CDC, Stockholm, Sweden 5Univ of the Witwatersrand, Johannesburg, South Africa 902 Migration, HIV Infection, and Combination HIV 908 Demographics and HIV Care Among New Yorkers Living Prevention Access in Rakai, Uganda With HIV by Diagnostic Cohort Mary K. Grabowski1; Justin Lessler1; Jeremiah M. Bazaale2; Larry W. Laura Kersanske1; Graham Harriman1; Lucia V. Torian2; Sarah L. Chang3; Dorean Nabukalu2; Maria J. Wawer4; Fred Nalugoda5; Robert Braunstein1 Sekubugu5; Gertrude Nakigozi6; Ronald H. Gray4 1New York City DHMH, Queens, NY, USA; 2New York City Dept of Hlth, 1Johns Hopkins Univ, Baltimore, MD, USA; 2Rakai Hlth Scis Prog, Kalisizo, Long Island City, NY, USA Uganda; 3Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; 4Johns 5 909 The Impact of HIV on Mortality in Nairobi, Kenya Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; Rakai Hlth Scis Prog, 1 2 3 Entebbe, Uganda; 6Rakai Hlth Scis Prog, Baltimore, MD, USA Catherine N. Kiama ; Peter W. Young ; Aandrea Kim ; Joyce Wamicwe1; Kevin M. De Cock2; Johansen Oduor1; Emily Rogena4; Julius 903 HIV Epidemiology and Service Uptake Among Oyugi4; Marie Downer5; Martin W. Sirengo6 Fisherfolk in Asembo, Western Kenya, 2015 1Ministry of Hlth, Nairobi, Kenya; 2CDC, Nairobi, Kenya; 3CDC, Atlanta, Fredrick S. Odongo1; Emily Zielinski-Gutierrez2; Kennedy Mutai1; GA, USA; 4Sch of Med, Univ of Nairobi, Nairobi, Kenya; 5Cntrs for Disease Paul Ogindo1; George Olilo1; Barbara Burmen; Daniel Kwaro1; Kenneth Control & Prevention-Kenya, Nairobi, Kenya; 6Natl AIDS and STI Control Masamaro1; Caroline Kambona1 Prog, Nairobi, Kenya 1 2 Kenya Med Rsr Inst, Kisumu, Kenya; US CDC, Kenya, Nairobi, Kenya 910 Access to HIV Care in Health Districts Affected by Ebola 904 Young HIV+ Adults in Botswana Less Likely to Seek Epidemic in Sierra Leone Treatment or Be Virally Suppressed Jacques D. Ndawinz1; Kenneth Katumba2; Victor Kamara3; Wogba Vladimir Novitsky1; Tendani Gaolathe2; Mompati Mmalane2; Kamara3; Lamin Bangura4; Victoria Kamara4; Umu N. Nabieu4; Etienne Sikhulile Moyo2; Molly Pretorius Holme1; Kathleen Powis3; Kathleen Guillard1 Wirth1; Eric Tchetgen Tchetgen1; Shahin Lockman4; M. Essex1 1Solthis NGO, Paris, France; 2Solthis NGO, Conakry, Guinea; 3Natl AIDS 1Harvard Sch of PH, Boston, MA, USA; 2Botswana Harvard AIDS Inst Secretariat, Freetown, Sierra Leone; 4Natl AIDS/VIH Control Prog, Partnership, Gaborone, Botswana; 3Massachusetts General Hosp, Boston, Freetown, Sierra Leone MA, USA; 4Brigham and Women’s Hosp, Harvard Med Sch, Boston, MA, USA Session P-W3 Poster Abstracts Hall D 905 High Risk of HIV Transmission and Acquisition Among 2:45 PM-4:00 PM Older South Africans Sex, Drugs, Depression, and HIV Poster Listings Poster Molly S. Rosenberg1; Xavier Gomez-Olive2; Julia K. Rohr3; Brian 911 Effect of Alcohol on All-Cause and Liver-Related 4 5 2 1 Houle ; Stephen Tollman ; Kathleen Kahn ; Till Bärnighausen Mortality Among Individuals With HIV 1Harvard Sch of PH, Boston, MA, USA; 2Med Rsr Council/Wits Rural PH Chelsea Canan1; Bryan Lau1; Mary McCaul2; Richard Moore3; and Health Transition Unit, Johannesburg, South Africa; 3Harvard Univ Geetanjali Chander2 Sch of PH, Boston, MA, USA; 4Australian Natl Univ, Canberra, Australia; 1Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; 2Johns 5Univ of the Witwatersrand, Johannesburg, South Africa Hopkins Univ Sch of Med, Baltimore, MD, USA; 3Johns Hopkins Univ, Baltimore, MD, USA Session P-W2 Poster Abstracts Hall D 2:45 PM-4:00 PM 912 Alcohol Use and Unprotected Sex in HIV-Positive Infection Status, Care, and Mortality Female Sex Workers in Mombasa Darcy White1; Kate S. Wilson1; Linnet Masese2; George Wanje1; Walter 906 Factors Associated With Misreporting HIV Status Jaoko3; Kishor Mandaliya4; Barbra A. Richardson1; Jane Simoni1; Scott Among MSM From Baltimore McClelland1 Danielle German1; Kate Shearer1; Ju Nyeung Park1; Colin Flynn2; Carl 1Univ of Washington, Seattle, WA, USA; 2Kenya Rsr Prog at the Univ of Latkin3; Oliver Laeyendecker4; Thomas C. Quinn5; William Clarke5 Washington, Nairobi, Kenya; 3Univ of Nairobi, Nairobi, Kenya; 4Coast 1Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; 2Maryland Province General Hosp, Mombasa, Kenya DHMH, Baltimore, MD, USA; 3Johns Hopkins Univ, Baltimore, MD, USA; 4NIH, Bethesda, MD, USA; 5Johns Hopkins Univ Sch of Med, Baltimore, MD, USA
74 CROI 2016 Poster Listings 75 ; 1 ; ; 5 2 Univ Univ Hall D 4 Univ of Univ
8 7 Univ of Univ Case Western Western Case CROI 2016 Univ of Univ 2 ; Robert 7 ; Todd T. T. ; Todd 2 5 John H. John 3 2 ; Michael J. ; Michael J. 7 ; Katerina A. ; Katerina 2 Georgetown Georgetown ; Adebola ; Adebola 5 5 ; Mardge Cohen ; Mardge ; P. Richard Harrigan Richard ; P. 1 2 Harvard Sch PH, of Harvard Univ of Wisconsin- of Univ Program Agenda and 3 ; Matthew Mimiaga ; Matthew 4 Johns Hopkins Univ, Univ, Hopkins Johns 6 ; Michael Dube
2 8 ; James H. Stein 2 ; Grace A. McComsey ; Grace 1 ; Heidi M. Crane ; Heidi 1 ; Conall M. O’Cleirigh M. ; Conall 1 ; David McVera ; David 1 ; Whitney ; Whitney Smith ; Daniel Merenstein 1 Univ of California San Francisco, San San Francisco, California of Univ
4 3 1 ; W. C. Mathew C. W. ; 1 Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns 4 Albert Einstein Coll of Med, Bronx, NY, NY, Bronx, Med, of Coll Albert Einstein
6 ; Sheri Weiser 7 ; Carlee B. Moser B. ; Carlee 1 Massachusetts General Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, General Massachusetts ; Heather J. Ribaudo J. ; Heather ; Brian W. Pence W. ; Brian ; Judith S. Currier 7 2 1 1 Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ 4 ; Mark W. Hull W. ; Mark ; Turan Bulent 1 1 ; Ada Adimora ; Ada 3 ; Sonia Napravnik 6 ; Amy D. Heine D. ; Amy ; Julio Montaner 3 1 ; Lisa R. Metsch
; for the HIV-CAUSAL Collaboration, Collaboration, the HIV-CAUSAL ; for 6 8 Harvard Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, of Harvard 2 ; Otto Yang 6 ; Thuy T. Tran T. ; Thuy 4 Columbia Univ Mailman Sch of PH, New York, NY, USA; USA; NY, York, New Sch PH, of Mailman Univ Columbia 7 BC Cntr for Excellence in HIV/AIDS, Vancouver, BC, Canada; Canada; BC, Vancouver, HIV/AIDS, in Excellence for Cntr BC David Geffen Sch of Med at Univ of California Los Angeles, Los Angeles, Angeles, Los Angeles, Los Sch at Med California of of Univ Geffen David CA, USA; Angeles, Los California, Southern of at Sch Univ Med the of Keck USA; IL, Chicago, Sch Med, of Feinberg Univ, Northwestern Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; USA; NC, Hill, Chapel Hill, at Chapel North of Univ Carolina USA; RI, Providence, Sch PH, Univ of Brown AL, USA Birmingham, at Birmingham, Alabama of Univ Univ of Alabama at Birmingham, Birmingham, AL, USA; AL, USA; Birmingham, at Birmingham, Alabama of Univ USA; NY, Brooklyn, Cntr, Med Downstate York New of Univ State Francisco, CA, USA; Francisco, William Chau William Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, California San Francisco, San Francisco, CA, USA San Francisco, San Francisco, California Brown CA, USA; Christopoulos British Columbia, Vancouver, BC, Canada BC, Vancouver, Columbia, British Tracey E.Wilson Tracey 1 Baltimore, MD, USA; USA; MD, Baltimore, Boston, MA, USA MA, Boston, With Exhaustion Therapy HIV Kelesidis Theodoros 1 5 6 Therapy As ShouldRemain First-Line the NNRTIs ChoiceSettings? Resource-Limited in Lima D. Viviane 1 5 8 HIV-Positive in Therapy Start to When Antiretroviral Years 50 Over Aged Persons SaraLodi Senescence and T-Cell of ChangesMarkers in 1 3 Riskthe Mortality of Increases Depression Largea in CohortAdults HIV-Infected of Bengtson Angela Depression and Social Isolation Mediate Effect HIVof Mediate Socialand Depression Isolation Adherence ART Women’s Stigma on Janet Turan M. Richard Moore Richard of North Carolina at Chapel Hill, Chapel Hill, NC, USA; USA; NC, Hill, Chapel Hill, at Chapel Northof Carolina USA; USA; Adedimeji Univ, Washington, DC, USA; USA; DC, Washington, Univ, Murphy Madison, Madison, WI, USA; USA; WI, Madison, Madison, Stroger Jr. Hosp of Cook County and Rush Med Coll, Chicago, IL, USA; IL, USA; Chicago, Coll, Med Rush and County Cook of Hosp Jr. Stroger Reserve Univ, Cleveland, OH, USA OH, Cleveland, Univ, Reserve Mugavero
940 Session P-X1 Poster Abstracts Poster SessionP-X1 PM-4:002:45 PM High-Income Use: Therapy Antiretroviral from Insights Settings 938 939 920 919 ; 3 ; Shruti ; Shruti 1 ; Ron 7 ; Philip Univ Coll Coll Univ 3 3 Georgetown Georgetown Johns Johns Johns Johns 5 2 2 ; for the ; for ; Anthony ; Anthony 1 ; Allison M. ; Allison 3 1 ; Adrian S. ; Adrian Oliver Oliver 3 ; Jacquie ; Jacquie 2 ; 3 ; Caitlin Conrad ; Caitlin 1 Univ of Pittsburgh, Pittsburgh, of Univ 7 ; David Celentano ; David
2 1 ; Ward Helen 2 YRG Cntr for AIDS Rsr and Rsr AIDS for Cntr YRG ; Pamela Pontones ; Pamela ; Lawrence Kingsley ; Lawrence 2 2 6 ; Frank J. Palella J. ; Frank David Geffen Sch at Med of Univ Geffen David 2 ; Gregory D. Kirk ; Gregory D.
; SunilSolomon S. 6 2 1 2 2 PH England, London, UK; UK; London, England, PH Johns Hopkins Univ Sch of Med, Sch Med, of Univ Hopkins Johns Northwestern Univ, Chicago, IL, Chicago, Univ, Northwestern 2 3 3 ; Susan Eshleman H. ; Maryam Shahmanesh 3 2 ; Michael T. Spiller T. ; Michael 2 ; Jordan Lake ; Jordan ors Related to HIV RisksHIV Among to Related ors 5 ; Gregory M. Lucas ; Valerie Delpech; Valerie 2 3 ; Santhanam Anand Clark County Hlth Dept, Jeffersonville, IN, USA; USA; IN, Jeffersonville, Dept, Hlth County Clark 2 2 ; Lisa Jacobson 1 ; Todd T. Brown T. ; Todd ; John T. Brooks T. ; John NIH, Bethesda, MD, USA Bethesda, MD, NIH, Sci Cntr for LGBT Hlth Rsr, Univ of Pittsburgh, Pittsburgh, of Univ Rsr, Hlth LGBT for Sci Cntr 4 3 4 8 ; Shruti H. Mehta H. ; Shruti 1 ; Waterhouse Dorothy ; Heather Bradley; Shikha Garg; Luke Shouse Luke Shikha Garg; Bradley; ; Heather 3 ; for the AIDS Link to Intravenous Experiences (ALIVE) (ALIVE) Experiences Intravenous to the AIDS Link ; for ; Meaghan Kall 4 ; Jesse Shields 1 ; Aylur K. Srikrishnan ; Aylur 1 1 ; Thomas C. Quinn Thomas ; 1 ; Suresh Kumar ; Suresh ; Richard Gilson ; Richard 1 2 ; C.K. Vasudevan ; Joan Duwve 1 1 Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, of Univ Hopkins Johns ; Michael W. Plankey W. ; Michael ; Wendy S. Post Wendy ; 4 4 8 Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Sch Baltimore, PH, of Bloomberg Hopkins Johns CDC, Atlanta, GA, USA; Atlanta, CDC, USA IN, Indianapolis, Dept Hlth, of State Indiana Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Sch Baltimore, PH, of Bloomberg Hopkins Johns Imperial Coll London, London, UK; UK; London, London, Coll Imperial cohort Laeyendecker Nardone Astemborski McFall Baltimore, MD, USA; USA; MD, Baltimore, USA; USA; Educ, Taramani, India Taramani, Educ, Pittsburgh, PA, USA PA, Pittsburgh, Positive Voices Study Group Group Study Voices Positive Univ Med Cntr, Washington, DC, USA; USA; DC, Washington, Cntr, Med Univ Bushra SabriBushra 1 Gender-SpecificFact InjectWho Drugs Indiain People Andrew F. Longosz F. Andrew 1 1 3 Cross-SectionalIncidenceHIV Longitudinal vs InjectWho Drugs People in Estimates CDC, Atlanta, GA, USA Atlanta, CDC, Outbreakan in HIV Persons Among for RiskFactors InjectWho 2015 Indiana Drugs, Patel Monita Prevalence of Opioid Prescriptions and Risk Factors for for RiskOpioidof and Factors Prescriptions Prevalence Adults HIV-Infected in Abuse Pérez Alejandro 1 Testosterone Use and HIV Serostatus Among Men Who Men Among Serostatus HIV and Use Testosterone MACS the in Men With Sex Have SabinaHaberlen A. Positive Men Who Have Sex With Men With Sex Have Who Men Positive EricaPufall L. 1 Chemsex and High-Risk Sexual Behaviours in HIV- in High-RiskBehaviours and Sexual Chemsex Pittsburgh, PA, USA; USA; PA, Pittsburgh, Stall of California Los Angeles, Los Angeles, CA, USA; CA, USA; Angeles, Los Angeles, Los California of Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Peters H. Mehta Dobs Jeremy RoseberryJeremy London, London, UK London, London,
918 917 916 915 914 913 Program and Agenda
941 Lower Mortality Among Patients Starting ART From 947 Comparable Viral Decay in Dual and Triple 2008 to 2010 Than Earlier in the ART Era Dolutegravir-Based Antiretroviral Therapy Adam Trickey1; Margaret May1; Julia Del Amo2; Niels Obel3; Heidi Omar G. Sued1; Maria I. Figueroa1; Maria J. Rolon1; Patricia Patterson2; M. Crane4; Sophie Abgrall5; Colette Smith6; Suzanne Ingle1; Jonathan Dannae Brown3; Ana M. Gun4; Michael Aboud5; Kimberley Y. Smith6; Sterne1; for the Antiretroviral Therapy Cohort Collaboration Pedro Cahn1 1Univ of Bristol, Bristol, UK; 2Inst de Salud Carlos III, Madrid, Spain; 1Fundación Huésped, Buenos Aires, Argentina; 2Hosp Juan A. Fernández, 3Copenhagen Univ Hosp, RigsHospet, Copenhagen, Denmark; 4Univ of Buenos Aires, Argentina; 3ViiV Hlthcare, Abbotsford, Australia; 4Centro Washington, Seattle, WA, USA; 5Univ Hosp Antoine-Béclère, Clamart, Medico Huesped, Buenos Aires, Argentina; 5ViiV Hlthcare, Brentford, UK; France; 6Univ Coll London, London, UK 6ViiV Hlthcare, Research Triangle Park, NC, USA 942 Impact of Each Month Delay in Initiation on the Effect 948 Unexpectedly High Rate of Intolerance for of 1 Year of ART on CD4 Count Dolutegravir in Real-Life Setting Shu Yang1; Susan J. Little2; Davey M. Smith2; Victor De Gruttola1; Guido van den Berk; Josephine Oryszczyn; Willem Blok; Narda van der Judith Lok1 Meche; Rosa Regez; Daoud Ait Moha; Kees Brinkman 1Harvard Sch of PH, Boston, MA, USA; 2Univ of California San Diego, OLVG Hosp, Amsterdam, Netherlands San Diego, CA, USA 949 Association of Antiretroviral Use and Abnormal 943 Outcomes on CART in France According to Geographic Uterine Bleeding in Women With HIV Origin, Sex, and Transmission Group Christina Valiaveettil1; Sheila Caddy2; Mark Yudin3; Anita Benoit4; Laure-Amélie de Monteynard1; Jacques Gilquin2; Juliette Pavie3; Erin Ding5; Angela Kaida6; Alexandra de Pokomandy7; Robert S. Hogg6; Jean-Luc Meynard4; Marie-Aude Khuong5; Anne Simon6; Aba Mona Loutfy4 Mahamat7; David Rey8; Dominique Costagliola9; Sophie Abgrall10 1Univ of Toronto, Toronto, ON, Canada; 2South Hlth Campus, Calgary, 1Inst Pierre Louis d’Epidémiologie et de Santé Publique (IPLESP) UMR-S AB, Canada; 3St Michael’s Hosp, Toronto, ON, Canada; 4Women’s Coll 1136, Paris, France; 2Hosp Hôtel Dieu, Paris, France; 3Hosp Européen Rsr Inst, Univ of Toronto, Toronto, ON, Canada; 5British Columbia Cntr Georges Pompidou, Paris, France; 4APHP, Hosp Saint Antoine, Paris, for Excellence in HIV/AIDS, Vancouver, BC, Canada; 6Simon Fraser Univ, France; 5Hosp Delafontaine, Paris, France; 6La Pitié Salpêtrière Hosp, Burnaby, BC, Canada; 7McGill Univ Hlth Cntr, Montréal, QC, Canada 7 8 Paris, France; Cntr Hospier Andrée Rosemon, Cayenne, France; Hôpitaux 950 No Selection of X4 Viruses by Maraviroc in Cell Universitaires de Strasbourg, Strasbourg, France; 9Sorbonne Univs, Paris, France; 10Univ Hosp Antoine-Béclère, Clamart, France Reservoirs in R5X4 HIV Infections Stéphanie Raymond; Romain Carcenac; Florence Nicot; Nicolas 944 CD4 Cell Response to First-Line cART by HIV Type in Jeanne; Michelle Cazabat; Mary Requena; Lise Cuzin; Pierre Delobel; European Cohort Collaborations Jacques Izopet Linda Wittkop1; Sophie Matheron2; for the COHERE in EuroCoord and CHU Toulouse, Toulouse, France ACHIeV2e study team writing committee 951 Failure Rate in NRTI-Free Treatment Is Higher in 2 1CHU de Bordeaux, Bordeaux, France; 2Hosp Bichat-Claude Bernard, Paris, France Compared to 3 Class Regimens Alexandra Scherrer1; Jürg Böni2; Sabine Yerly3; Thomas Klimkait4; 945 Efficiency (Cost-Effectiveness) of EFV/FTC/TDF vs FTC/ Vincent Aubert5; Matthias Cavassini6; Manuel Battegay7; Christoph RPV/TDF in Naïve Patients 8 9 10 Poster Listings Poster Hauser ; Enos Bernasconi ; Huldrych F. Günthard ; for the Swiss HIV Jose M. Gatell1; Elisa de Lazzari2; Enrique Redondo3; Jose Mallolas2; Cohort Study Esteban Martinez2; Jordi Blanch2; Maria Martinez-Rebollar2; Jose L. 1Univ Hosp Zürich, Zürich, Switzerland; 2Inst of Med Virology, Swiss Natl Blanco2; Berta Torres2 Cntr for Retroviruses, Zurich, Switzerland; 3Geneva Univ Hosp, Geneva, 1Hosp Clinic of Barcelona, Barcelona, Spain; 2Hosp Clínic de Barcelona, Switzerland; 4Univ of Basel, Basel, Switzerland; 5Univ Hosp Lausanne, Barcelona, Spain; 3Gilead Scis, Inc, Madrid, Spain Lausanne, Switzerland; 6Univ Hosp Lausanne, Univ of Lausanne, 7 8 946 Correlations of Pre-ART HIV-DNA With Outcome in Lausanne, Switzerland; Univ Hosp Basel, Basel, Switzerland; Bern Univ Hosp and Univ of Bern, Bern, Switzerland; 9Regional Hosp Lugano, First-Line Treated ART Patients Lugano, Switzerland; 10Univ Hosp Zurich, Zurich, Switzerland Francesca Ceccherini-Silberstein1; Alessandro Cozzi-Lepri2; Esther Merlini3; Giulia Marchetti4; Maria R. Capobianchi5; Andrea De Luca6; 952 The Impact of Medication Adherence on Virologic Nicola Gianotti7; Andrea Antinori5; Carlo Federico Perno8; Antonella Failure in A5202 d’Arminio Monforte9; for the ICONA Foundation Robert A. Parker1; Dustin J. Rabideau1; Paul E. Sax2; Camlin Tierney3; 1Univ of Rome Tor Vergata, Rome, Italy; 2Univ Coll London, London, Eric Daar4; Ann Collier5; Elena Losina2; Kenneth A. Freedberg1 UK; 3Univ of Milan, milan, Italy; 4Clinic of Infectious Diseases, Univ of 1Massachusetts General Hosp, Boston, MA, USA; 2Brigham and Women's Milan, San Paolo Hosp, Milan, Italy; 5Inst Nazionale Malattie Infettive Hosp, Harvard Med Sch, Boston, MA, USA; 3Harvard Sch of PH, Boston, “L. Spallanzani”, Rome, Italy; 6Univ of Siena, Siena, Italy; 7San Raffaele MA, USA; 4Harbor Univ of California Los Angeles Med Cntr, Torrance, CA, Scientific Inst, Milan, Italy; 8Univ of Rome Tor Vergata, Roma, Italy; USA; 5Univ of Washington, Seattle, WA, USA 9Infectious Diseases Clinic, San Paolo Hosp, Univ of Milan, Milan, Italy
76 CROI 2016 Poster Listings 77 ; 1 ; ; 2 ; 1 5 ; 4 Univ Univ 5 ; 8 Cntr Cntr 3 Vanderbilt Vanderbilt 2 CePReF, CePReF, ; Izukanji 2 2 CROI 2016 ; Catherine C. ; Catherine 3 CHU de CHU 5 ; Geoffrey ; Geoffrey ; Khadim Faye Africa Cntr for for Cntr Africa 6 1 6 ; Kathryn 2 ; R. Mougnutou ; for the DynaM-O; for 4 Univ of Washington, Washington, of Univ 8 2 ; Moussa Seydi KhethImpilo Free AIDS ; Adrien Sawadogo ; Adrien ; E. Alessandri-Gradt 7 7 3 Geoffrey S. Gottlieb S. Geoffrey 1 Program Agenda and ; CHU, Souro Sanou, Bobo- Sanou, Souro CHU, 3 4 Inst de Recherches Medes Medes Recherches de Inst 4 ; Fatima Sall ; Fatima ; Andrew Boulle ; Andrew CHU de Fann, Dakar, Senegal Dakar, Fann, de CHU 2 CHU Yalgado Ouedraogo, Ouedraogo, Yalgado CHU ; Tanser Frank
9 8 5 5 10 to HAART Between Between HAART to ; A. Aghokeng ; Bryan E. Shepherd 3 Cntr for Infectious Disease Infectious in Rsr for Cntr 2 Vanderbilt Inst for Global Hlth, Hlth, Global for Inst Vanderbilt 3 Inst Pasteur, Paris, France; France; Paris, Pasteur, Inst 10 ; N. Noumsi ; Mary-Ann Davies Cntr de Prise en Charge des Personnes Personnes des Charge en Prise de Cntr 2
2 1 7 1 Harvard Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, of Harvard ; Albert Minga Cntr Médical de Suivi de Donneurs de de Médical Cntr Cntr for Infectious Disease Epi and Rsr, Rsr, and Disease Infectious Epi for Cntr 8 2 3 2 ; Marcel Zannou ; Marcel 6 ; Moussa Seydi
Service d Hépato-Gastro-Entérologie, 1 1 6 Boston Univ Sch of PH, Boston, MA, USA MA, Boston, Sch PH, Univ of Boston Cntr for Infectious Disease Epi and Rsr, Cape Cape Rsr, and Disease Infectious Epi for Cntr ; Jean-Christophe Plantier ; Jean-Christophe 11 ; Robert A. Smith ; A. Kfutwah 3 ; Gilles Wandeler 7 2 2 8 UMI 233-IRD/U1175-INSERM/Montpellier Univ, Univ, 233-IRD/U1175-INSERM/Montpellier UMI ; Mark Giganti ; Prozesky W. Hans W. ; Prozesky 6 ; Arianna Zanolini ; Arianna 1 4 ; L. Schaeffer 11 Hosp Saint Louis et Univ Paris Diderot, Paris, France; France; Paris, Diderot, Paris Univ et Saint Louis Hosp 2 Univ of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of Univ 7 4 ; Salif Sow CHU de Fann, Dakar, Senegal Dakar, Fann, de CHU 2 ; Matthew P. Fox P. ; Matthew 3 1 Antoine Jaquet Antoine ; M. Vray ; ; F. Simon ; F. 1 ; Eugene Messou ; Eugene 1 ; Moussa Maiga 6 1 5 ; Eduardo Gotuzzo ; Eduardo 2 ; Jacob Bor; Jacob ; Dana N. Raugi 10 ; Robin Wood ; L. Le Fouler ; L. Le 1 3 5 ; Till ; Till Bärnighausen 7 INSERM U897, ISPED, Univ de Bordeaux, Bordeaux, France; France; Bordeaux, Bordeaux, de Univ ISPED, U897, INSERM Univ Hosp Bern, Bern, Switzerland; Bern, Bern, Switzerland; Hosp Univ Clinique des Maladies Infectieuses, Dakar, Senegal; Senegal; Dakar, Infectieuses, Maladies des Clinique Rouen Univ Hosp, Rouen, France Rouen, Hosp, Univ Rouen USA; MA, Boston, Univ, Boston Hosp Central, Yaoundé, Cameroon; Cameroon; Yaoundé, Central, Hosp Inst de Medicina Trop Alexander von Humboldt, Lima, Peru; Peru; Lima, Humboldt, von Alexander Trop Medicina de Inst Francois Dabis Francois Eric Delaporte Eric Univ Sch of Med, Nashville, TN, USA; USA; TN, Nashville, Sch Med, Univ of study group et d’Etudes des Plantes Medicinales, Yaoundé, Cameroon; Cameroon; Yaoundé, Medicinales, Plantes des d’Etudes et Hosp Gabriel Touré, Bamako, Mali; Mali; Bamako, Touré, Gabriel Hosp Cape Town, South Africa; South Africa; Town, Cape Stephen E. Hawes Stephen Living, Cape Town, South Africa; South Africa; Town, Cape Living, Vivant Avec le VIH, CHNU, Cotonou, Benin; Cotonou, CHNU, VIH, le Avec Vivant Pasteur du Cameroun, Yaoundé, Cameroon; Cameroon; Yaoundé, Cameroun, du Pasteur Ouagadougou, Burkina Faso; Faso; Burkina Ouagadougou, G. Unal Zambia, Lusaka, Zambia; Zambia; Lusaka, Zambia, 1 Seattle, WA, USA; USA; WA, Seattle, Selly Ba 9 Elvitegravir-Cobicistat- of Results 24-Week HIV-2 for DF Emtricitabine-Tenofovir Nashville, TN, USA TN, Nashville, 1 on People HIV-Infected in Neutropenia Severe Africa West in Therapy Antiretroviral Leroi Charline 8 ART: in Use Tenofovir Clinical With Outcomes Discontinuity Regression Analysis Brennan Alana 1 1 Dioulasso, Bobo-Dioulasso, Burkina Faso; Faso; Burkina Bobo-Dioulasso, Dioulasso, Rouen, Rouen, France; France; Rouen, Rouen, Response to ART and Mortality in Older HIV Patients In Mortalityand ART to Response Patients HIV Older in American Latin a Cohort GabrielaCarriquiry 1 ImmunovirologicalResponses O- Group HIV-1 M-Infectedand Patients Kouanfack C. of Stellenbosch & Tygerberg, Stellenbosch, South Africa; South Africa; Stellenbosch, Tygerberg, & Stellenbosch of McGowan Fatti ACONDA, Abidjan, Côte d Côte Abidjan, ACONDA, Ivoire; Town, South Africa; South Africa; Town, Sikazwe Montpellier, France; France; Montpellier, Stinson Joseph Drabo Hlth and Pop Studies, Mtubatuba, South Africa; South Africa; Mtubatuba, Studies, Pop and Hlth Sang /CNTS/PRIMO-CI, Abidjan, Côte d Côte Sang Abidjan, /CNTS/PRIMO-CI, Ivoire; for the University of Washington–Dakar HIV-2 Study Group Group Study HIV-2 Washington–Dakar of the University for
961 962 960 958 959 ; 3 ; NIH, NIH, ; 6 4 1 Hall D ; 1 Orlando Orlando 7 ; ; Oliver ; Oliver 2 3 ; Lindsay ; Lindsay ; Joseph D. ; Joseph D. 3 3
; Cassidy ; Cassidy 5 3 ; Maria J. Wawer ; Maria J. 4 ; Edward Vonesh ; Edward 5
8 ; Merlin L. Robb 4 ; Yun Lan ; Yun 3 AltaMed Hlth Services, Services, Hlth AltaMed 2 Rakai Hlth Scis Prog, Entebbe, Entebbe, Scis Hlth Prog, Rakai Boston Univ Sch of PH, Boston, Boston, Sch PH, Univ of Boston ; Suteeraporn Pinyakorn ; Suteeraporn 2 3 2 ; Ronald H. Gray ; Ronald H. HIV-NAT, Thai Red Cross AIDS Rsr AIDS Cross Red Thai HIV-NAT, 2 3 ; Philip Lackey 2 Anthony Mills, MD, Inc, Palm Palm Inc, MD, Mills, Anthony ; Aaron A. Tobian A. ; Aaron 8 5 ; Johanna C. Useem 2 Univ of North Carolina at Chapel Hill, Hill, at Chapel North of Univ Carolina 5 ; Yufeng Hu ; Yufeng 2 Univ of the Witwatersrand, Wits Hlth Hlth Wits Witwatersrand, the of Univ ; Anthony Mills ; Anthony 2 ; Steven J. Reynolds J. ; Steven 4 Johns Hopkins Bloomberg Sch PH, of Bloomberg Hopkins Johns ; Putthachard Kansomlap ; Putthachard 5 2 2
; Robert O’Connell 3
1 ; Michele Funk Jonsson Armed Forces Rsr Inst of Med Scis, Bangkok, Bangkok, Scis, Med of Inst Rsr Forces Armed ; Felix Carpio ; Felix 4 4 1 ; for the RV254/SEARCH010 Study Group Group the RV254/SEARCH010 Study ; for 5 Carolinas Hlthcare System, Charlotte, NC, USA; USA; NC, Charlotte, System, Hlthcare Carolinas ; Joseph Kagaayi 3 1 Northwestern Univ, Chicago, IL, USA; IL, USA; Chicago, Univ, Northwestern
Guangzhou Eighth People's Hosp, Guangzhou, Guangzhou, Hosp, People's Eighth Guangzhou Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, of Univ Hopkins Johns 6 3 3 ; Nittaya Phanuphak ; Nittaya 5 1 ; Lawrence Long ; Lawrence ; Thomas C. Quinn Thomas ; 1 6 ; M. Kumi Smith ; M. Kumi ; Gregory Fusco 1 7 ; William ; William Clarke 4 ; Somporn Tipsuk 2 Military HIV Rsr Prog, Bethesda, MD, USA Bethesda, MD, Military Prog, Rsr HIV SEARCH, Bangkok, Thailand; Thailand; Bangkok, SEARCH, 5 Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Sch Baltimore, PH, of Bloomberg Hopkins Johns 2 ; Jennifer Fusco ; Jennifer ; Matthew P. Fox P. ; Matthew 3 4 3 ; Weiping Cai ; Weiping 1 Boston Univ, Boston, MA, USA; USA; MA, Boston, Univ, Boston US Military HIV Rsr Prog, Walter Reed Army Inst of Rsr, Silver Spring, Spring, Silver Rsr, of Inst Army Reed Walter MilitaryUS Prog, Rsr HIV Univ of North Carolina at Chapel Hill Inst for Global Hlth & Infectious & Hlth Global for Inst Hill at Chapel North of Univ Carolina Makerere Univ Schoool of PH, Kampala, Uganda Schoool Kampala, Univ PH, of Makerere Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns Epividian, Inc, Durham, NC, USA; USA; NC, Durham, Inc, Epividian, AIDS Hlthcare Fndn, Los Angeles, CA, USA; Angeles, Los Fndn, Hlthcare AIDS Cntr, Bangkok, Thailand; Thailand; Bangkok, Cntr, Consortium, Johannesburg, South Africa; South Africa; Johannesburg, Consortium, Thailand; Thailand; MD, USA; USA; MD, Diseases, Chapel Hill, NC, USA; USA; NC, Hill, Chapel Diseases, Uganda; Uganda; Baltimore, MD, USA; USA; MD, Baltimore, Laopraynak Naphassanant Henegar Immunology Cntr, Orlando, FL, USA; FL, USA; Orlando, Cntr, Immunology Donn Colby Alana Brennan Alana 1 A Meta-Analysis Estimating Early Mortality Estimating Meta-Analysis A in ART LMICin ART on Adults HIV-Positive 1 Virologic Failure Is Uncommon After Treatment Is Treatment After Uncommon Is Failure Virologic During InfectionHIV Acute Initiated Crowell A. Trevor Chuanyi Ning Chuanyi 1 6 Outcomes: A Delivery ART Patient and Hospital-Based ProspectiveOpen Cohort Chinain MaryK. Grabowski 1 The Validity of Self-Reported ART Use in Persons Living Persons in Self-Reportedof Use ART Validity The Rakai,in HIV With Uganda 4 SuppressionCohort OPERA the in Wohlfeiler Michael B. 1 INSTI In-Class Switching on Continued Viral Viral In-ClassINSTI Continued on Switching Tucker Laeyendecker Los Angeles, CA, USA; Angeles, Los Chapel Hill, NC, USA; USA; NC, Hill, Chapel MA, USA MA, Springs, CA, USA Springs, Bethesda, MD, USA; USA; Bethesda, MD, Jintanat Ananworanich Jintanat Garrison Edwin DeJesus Edwin China David SerwaddaDavid
957 956 955 954 Session P-X2 Poster Abstracts Poster SessionP-X2 PM-4:002:45 PM Low-Income Use: Therapy Antiretroviral from Insights Settings 953 Program and Agenda
963 Efavirenz Toxicity Manifesting As Cerebellar Ataxia: WEDNESDAY, FEBRUARY 24, 2016 Case Series From South Africa Ebrahim Variava1; Farai R. Sigauke2; Petudzai Muchichwa2; Gary Session P-A2 Poster Abstracts Hall A/B Maartens3; Neil Martinson4 2:45 PM-4:00 PM 1 2 Klerksdorp/Tshepong Hosp, Klerksdorp, South Africa; Klerksdorp Viral Proteins: Regulation, Replication, Transcription Tshepong Hosp Complex, Northwest Dept of Hlth, Klerksdorp, South Africa; 3Univ of Cape Town, Cape Town, South Africa; 4Perinatal HIV Rsr 190 Inhibition of TCR Signaling Is Impaired in Nef Clones Unit, Diepkloof, South Africa Derived From Elite Controllers Steven W. Jin1; Tristan Markle1; Asa Rahimi1; Bruce D. Walker2; Zabrina Session P-Y1 Poster Abstracts Hall D Brumme1; Mark A. Brockman1 2:45 PM-4:00 PM 1Simon Fraser Univ, Burnaby, BC, Canada; 2Ragon Inst of MGH, MIT, and Modeling: Understanding Epidemics and ART Programs Harvard, Cambridge, MA, USA 1042 State-Space Models for Engagement, Retention, and 191 HIV-1 Nef Dimerization Is Important for AP2 Reentry in the HIV Care Cascade Recruitment and CD4 Downregulation Hana Lee1; Becky L. Genberg1; Monicah Nyambura2; Joseph Hogan1; Sherry Shu; Lori A. Emert-Sedlak; Thomas E. Smithgall Paula Braitstein3; Edwin Sang2 Univ of Pittsburgh, Pittsburgh, PA, USA 1Brown Univ, Providence, RI, USA; 2Academic Model Providing Access to 192 Quantification of HIV-1 Splicing Using a PrimerID- Hlthcare, Eldoret, Kenya; 3Univ of Toronto, Toronto, ON, Canada Tagged Deep Sequencing Assay 1043 How Far Are We From Early cART for All? A Nationwide Ann Emery; Ronald I. Swanstrom Population-Based Study in France Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA Virginie Supervie1; Jean-Marc Lacombe2; Rosemary Dray-Spira2; 193 Effects of Differential Cell Signaling in HIV Dominique Costagliola1; for the FHDH-ANRS CO4 study group Transcription 1 2 Sorbonne Univs, Paris, France; INSERM U1136, Paris, France Matthew J. Gagne1; Wilson W. Wong 2; Gillian M. Schiralli Lester 3; 1044 Using Treatment As Prevention Could Eliminate the Andrew Henderson1 HIV Epidemic in MSM in Copenhagen 1Boston Univ Sch of Med, Boston, MA, USA; 2Boston Univ, Boston, MA, 3 Justin Okano1; Danielle Robbins1; Laurence Palk1; Jan Gerstoft2; Niels USA; Univ of Rochester Med Cntr, Rochester, NY, USA Obel2; Sally Blower1 194 High-Frequency Illegitimate Strand-Transfers Result 1Univ of California Los Angeles, Los Angeles, CA, USA; 2Copenhagen Univ in Defective HIV Genomes Hosp, Rigshospitalet, Copenhagen, Denmark Xiaojun Li1; Peihu Fan1; Feng Gao2 1045 Estimated HIV Transmissions to Female Partners of 1Jilin Univ, Changchun, China; 2Human Vaccine Inst, Duke Univ Med Cntr, HIV-Infected Men Durham, NC, USA Cyprian Wejnert1; Eli Rosenberg2; Heather Bradley1; Gabriela Paz-Bailey1; H. Irene Hall1; Jacek Skarbinski1; Jonathan Mermin1; Session P-A3 Poster Abstracts Hall A/B Jeremy Grey2 2:45 PM-4:00 PM Poster Listings Poster 1CDC, Atlanta, GA, USA; 2Emory Univ, Atlanta, GA, USA Viral Proteins: Insights Into Structure 1046 Utility of the 1% HIV Prevalence Threshold in Defining 195 Gag-Protease-Mediated Replication Capacity Differs Concentrated HIV Epidemics According to HIV-1 Subtype Michael Pickles1; Marie-Claude Boily1; Sharmistha Mishra2 Marion W. Kiguoya1; Jaclyn K. Mann1; Saleha Omarjee1; Lyle 1Imperial Coll London, London, UK; 2Univ of Toronto, Toronto, ON, Canada McKinnon2; Festus M. Kiogora2; Kamini Gounder1; Blake Ball3; Joshua 1047 The Role of Young Women in the HIV Epidemic in Kimani2; Thumbi P. Ndungu1 1 2 Benin, West Africa Univ of KwaZulu-Natal, Durban, South Africa; Univ of Nairobi, Nairobi, Kenya; 3Univ of Manitoba, Winnipeg, MB, Canada John R. Williams1; Eugene L. Geidelberg1; Michel Alary2; Sharmistha Mishra3; Marie-Claude Boily1 196 Capsid Plays a Distinct Role in HIV Infection of TCR or 1Imperial Coll London, London, UK; 2Univ Laval, Québec, QC, Canada; TLR2-Activated CD4+ T Cells 3Univ of Toronto, Toronto, ON, Canada Kimyata Valere1; Jian Ding2; Theresa Chang1 1Rutgers Univ, Newark, NJ, USA; 2PH Rsr Inst, Newark, NJ, USA 197 Consequences of p24 Gag Mutations for Capsid Stability and Viral Fitness Philipp Schommers1; Gloria Martrus2; Urte Matschl2; Tom J. Hope3; Gerd Fätkenheuer1; Marcus Altfeld2 1Univ of Cologne, Cologne, Germany; 2Heinrich Pette Inst, Hamburg, Germany; 3Northwestern Univ, Feinberg Sch of Med, Chicago, IL, USA
78 CROI 2016 Poster Listings 79 ; 4 ; ; 2 1 Africa Africa 7 ; ; 6 4 ; Valerie ; Valerie 3 London Sch London ; Richard ; Richard 6 7 CROI 2016 ; David Dunn ; David 3 Amsterdam Inst Inst Amsterdam ; A. M. 6 2 INSERM, CESP CESP INSERM, 7 Imperial Coll Coll Imperial 2 ; Cécile Goujard ; Cécile ; Peter Reiss ; Peter 6 5 Univ Med Cntr Cntr Med Univ ; Ard van Sighem van ; Ard Universite Paris Sud, Sud, Paris Universite 5 2 2 Univ Coll London, London, Coll Univ ; Francis Barin ; Francis 2 3 Hosp Hotel Dieu de Hotel Hosp Program Agenda and ; Tostevin Anna 5 2 ; Deenan Pillay 6
Chelsea and Westminster Hosp Hosp Westminster and Chelsea 5
Ard van Sighem van Ard ; Christopher Monit ; Christopher 8 2 ; EA7327, Univ Paris Descartes, Paris, Paris, Descartes, Paris Univ EA7327, Stichting HIV Monitoring, Monitoring, HIV Stichting INSERM U941, Univ Paris Diderot, Diderot, Paris Univ U941, INSERM 2 3 Imperial Coll London, London, UK; London, London, Coll Imperial 2 8 2 ; Pierre Frange ; Pierre 2
; Oliver Ratmann ; Oliver 6 Med Rsr Council Clinical Trials Unit at Unit Trials Clinical Council Rsr Med 2
; Christine Rouzioux ; Christine 4 UK; London, Council, Rsr Med 2 1 ; Woulter F. Bierman F. Woulter ; 5 4 Royal Liverpool Hosp, Liverpool, UK; UK; Liverpool, Hosp, Liverpool Royal 6 ; Lynne Ashton ; Lynne 5 VU Univ Med Cntr, Amsterdam, Netherlands; Netherlands; Amsterdam, Cntr, Med Univ VU SusanLittle 3 Amsterdam Inst for Global Hlth and Develop, Develop, and Hlth Global for Inst Amsterdam 3 ; Anne Cori ; Anne Necker Hosp, AP-HP, Paris, France; France; Paris, AP-HP, Hosp, Necker ; Asma Essat 1 6 1 ; Oliver Ratmann ; Oliver ; for the ATHENA HIV Observational Cohort the ATHENA ; for 1 1 ; Roberto Murcio Villanueva ; Roberto Murcio ; Marie Laure Chaix ; Marie Laure ; Daniela Bezemer ; Daniela 1 ; Stephane Hue ; Stephane 7 1 5 ; Davey M. Smith ; Davey Med Rsr Council Clinical Trials Unit at Univ Coll London, London, at Coll Univ Unit Trials Clinical Council Rsr Med UK; London, England, PH 5 3 4 ; Christophe Fraser ; Christophe ; Martin Schutten 3 3 ; for the UK HIV Drug Resistance Database Database the UK HIV Drug; for Resistance 2 ; Anton N. Pozniak N. ; Anton François-Rabelais Univ, Tours, France; France; Tours, Univ, François-Rabelais 4 4 London Sch of Hygiene & Trop Med, London, UK; UK; London, Med, & Trop Sch Hygiene of London INSERM UMR 1137, Paris, France; France; Paris, 1137, UMR INSERM UK; London, London, Coll Univ Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ Imperial Coll London, London, UK; UK; London, London, Coll Imperial Netherlands; Rotterdam, Cntr, Med Univ Erasmus Netherlands; Amsterdam, Monitoring, HIV Stichting Amsterdam, Netherlands; Netherlands; Amsterdam, Jade GHOSN INSERM CESP U1018, Paris, France; France; Paris, U1018, CESP INSERM London, UK; UK; London, Univ Coll London, London, UK; UK; London, London, Coll Univ for Global Hlth and Develop, Amsterdam, Netherlands Amsterdam, Develop, and Hlth Global for Paris, Paris, France; France; Paris, Paris, France; France; Goldstein Delpech Paris, France Paris, NHS Fndn Trust, London, UK; UK; London, Trust, Fndn NHS KholoudPorter Probabilistic Estimation of HIV-1 Subtype HIV-1 of B Estimation Probabilistic Phylogenies Viral From Rates Transmission Hue Stephane 1 1 3 PartnerServices EarlyAdults and HIV-Infected Acute in Martin Pond; Kosakovsky Christy Sergei Anderson; Green; Nella M. Smith; Davey Hoenigl; Potential Misclassification Standardin HIV Potential Studies Association Clusters Phylogenetic Visseaux Benoit Spatiotemporal Dynamics of HIV-1 Transmission in Transmission Dynamics HIV-1 Spatiotemporal of 1999–2014 France, Chaillon Antoine 1 Increasing Role of Young MSM to HIV Epidemic Spread Epidemic HIV to MSM Young of Role Increasing Renewal and Ratmann Oliver 1 4 Subtypes Non-B HIV-1 Outbreak in Differences Sizefor Netherlands the in MSM Amongst DanielaBezemer 1 Pettersson Cntr for Hlth and Pop Studies, Mtubatuba, South Africa Mtubatuba, Studies, Pop and Hlth for Cntr Groningen, Univ of Groningen, Groningen, Netherlands; Netherlands; Groningen, Groningen, of Univ Groningen, London, UK; UK; London, London, London, UK; UK; London, London, of Hygiene & Trop Med, London, UK London, Med, & Trop Hygiene of Laurence Meyer Laurence Amsterdam, Netherlands Amsterdam, Peter Reiss Peter France; Kremlin-Bicêtre, Le U1018, Christophe Fraser Christophe Univ of California San Diego, San Diego, CA, USA San Diego, San Diego, California of Univ
225 224 223 222 220 221 ; 4 ;
1 3 ; ; 1 2 NIH, NIH, ; for ; for 3 7 ; James Univ of Univ 1 7 ; William ; William 2 Hall A/B ; Peter A. ; Peter 3 ; Joseph J. ; Joseph J. London London 7 2 ; Nittaya ; Nittaya 5 ; Silvina Chulalongkorn Chulalongkorn 2 4 ; Victoria ; Victoria Mobley ; Donn Colby ; Wei Danlan 3 2 1 CDC, Atlanta, GA, USA Atlanta, CDC, 2 ; Mark A. Wainberg ; Mark A. 2 ; Walid Heneine ; Walid ; Anthony S. Fauci ; Anthony 2 1 North Carolina Division of Division North Carolina US Military HIV Rsr Prog, MilitaryUS Prog, Rsr HIV ; William ; William Miller MSM Epidemic: LargeEpidemic: MSM 3 7 6 ; Hongwei Jia ; Hongwei 2 ; Ruxandra Ilinca Ibanescu; Ruxandra Lab Corporation of America, America, of Corporation Lab Cntr Hospier Univ de Montréal, Montréal, de Univ Hospier Cntr 1 3 ; Lynne A. Sampson ; Lynne Sodsai P. Tovanabutra Sodsai P. 2 2 ; ; Nelson L. Michael L. ; Nelson 6 4 ; Donald Van Ryk Van ; Donald 1 ; Joseph Sebastian North Carolina DHHS, Raleigh, NC, USA NC, Raleigh, DHHS, North Carolina NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, NIAID, 2 4 2 ; Michel Roger ; Frits van Griensven van ; Frits 2 1 Thai Red Cross AIDS Rsr Cntr, Bangkok, Bangkok, Cntr, Rsr AIDS Cross Red Thai ; Claudia Cicala ; Claudia 2 1
; Romeo R. Galang ; SueL. Ledford US Military HIV Rsr Prog, Bethesda, MD, USA; USA; Bethesda, MD, MilitaryUS Prog, Rsr HIV 1 5 5 McGill Univ AIDS Cntr, Montreal, QC, Canada QC, Montreal, Cntr, AIDS Univ McGill ; Michael T. Spiller T. ; Michael 3 Univ of North Carolina at Chapel Hill Sch of Med, Sch Med, Hill of at Chapel North of Univ Carolina 2 4 Lab Corporation of America, Research Triangle Triangle Research America, of Corporation Lab ; Maureen Oliveira ; Maureen ; Irene A. Doherty; Irene 5 1 1 ; Stephane Hue ; Stephane 1 ; Isabelle Hardy ; Isabelle Wake County Human Services, Raleigh, NC, USA; USA; NC, Raleigh, Services, Human County Wake ; Katija Jelicic ; Katija ; Mark de Souza 1 ; Sunee Sirivichayakul 6 1 1 ; Catherine Schwing ; Catherine 3 1 ; Jintanat Ananworanich ; Jintanat 1 ; for the HIV Outbreak Investigation Team Team Investigation Outbreak the HIV ; for Military HIV Rsr Prog, Silver Spring, MD, USA; USA; MD, Spring, Silver Military Prog, Rsr HIV 2 3 ; Philip Peters 2
; Joseph Sebastian 3 4 RTI, Research Triangle Park, NC, USA; USA; NC, Park, Triangle Research RTI, ; Ann M. Dennis; Ann 2 7 Military HIV Rsr Prog, Bethesda, MD, USA; USA; Bethesda, MD, Military Prog, Rsr HIV SEARCH, Bangkok, Thailand; Thailand; Bangkok, SEARCH, Lady Davis Inst, Montreal, QC, Canada; Canada; QC, Montreal, Inst, Davis Lady Univ of North Carolina at Chapel Hill Sch of Global PH, Chapel Hill, NC, Hill, Chapel Sch PH, Global Hill of at Chapel North of Univ Carolina Univ of North Carolina at Chapel Hill, Chapel HIll, NC, USA; USA; NC, HIll, Chapel Hill, at Chapel North of Univ Carolina Oak Ridge Inst of Sci and Educ, Decatur, GA, USA; GA, USA; Decatur, Ridge SciOak of Inst Educ, and NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, NIAID, Olga Golubkov Switzer Phanuphak Eron PH, Raleigh, NC, USA; USA; NC, Raleigh, PH, Masciotra Bethesda, MD, USA Bethesda, MD, Thailand; Thailand; Leone Chapel Hill, NC, USA; USA; NC, Hill, Chapel Sch of Hygiene & Trop Med, London, UK; UK; London, Med, Trop & Sch Hygiene of Park, NC, USA; USA; NC, Park, USA; USA; the RV254/SEARCH010 Study Team and MHRP Viral SequencingCore Viral and MHRP Team the RV254/SEARCH010 Study William Miller; Joseph J. Eron Eron Miller; Joseph J. William Fatima Nawaz Fatima Univ, Bangkok, Thailand; Thailand; Bangkok, Univ, 6 1 Assessing HIV Transmission Networks in a Thai Cohort Thai a in Networks Transmission AssessingHIV InfectionHIV Acute With Kroon Eugène Cluster Viruses Transmission Viruses Cluster Fuel Brenner G. Bluma 1 Metamorphosis of the Montreal Montreal the Metamorphosis of 1 HIV Transmission Hotspot Detection SexualHotspot Combining Transmission HIV Analysis Network Phylogenetic and DanaK. Pasquale Clusters for Intervention for Clusters Dennis M. Ann 1 1 Northin Phylodynamics HIV DetectingCarolina: Active Infer and Characterize a Transmission Network in anin Network Transmission Characterizeand Infer a Outbreak HIV-1 Opioid-Driven CampbellEllsworthM. and Antigenicitygp120 and of Yolitz Jason 1 The HIV Env Signal Peptide Impacts the Glycosylation Impacts Signal Glycosylation the Peptide Env HIV The Peter P. Pham P. Peter Silver Spring, MD, USA MD, Spring, Silver Research Triangle Park, NC, USA; USA; NC, Park, Triangle Research USA NC, Hill, Chapel Hill, at Chapel North Carolina Arthos Montreal, QC, Canada; Canada; QC, Montreal,
219 218 217 216 Identifying Network and Transmission Pairs Transmission and Network Identifying 215 Session P-B2 Poster Abstracts Poster SessionP-B2 PM-4:002:45 PM 198 Program and Agenda
Session P-C5 Poster Abstracts Hall A/B 267 Tryptophan Metabolites Are Associated to Gut 2:45 PM-4:00 PM Microbiota in HIV-1 Infected Patients HIV and Microbiomes Babilonia Barqasho1; Ujjwal Neogi1; Lilly Schwieler1; Göran Engberg1; Marius Troseid2; Anders Sönnerborg1; Piotr Nowak1 260 Distinct Gut Microbiota Composition in Gay Men 1Karolinska Inst, Stockholm, Sweden; 2Oslo Univ Hosp, Ullevål Hosp, 1 1 2 Muntsa Rocafort ; Marc Noguera-Julian ; Yolanda Guillen ; Mariona Oslo, Norway Parera1; Piotr Nowak3; Falk Hildebrand4; Georg Zeller4; Anders 3 4 1 Sönnerborg ; Peer Bork ; Roger Paredes Session P-C6 Poster Abstracts Hall A/B 1IrsiCaixa Inst for AIDS Rsr, Badalona, Spain; 2IrsiCaixa Inst for AIDS Rsr, Barcelona, Spain; 3Karolinska Inst, Stockholm, Sweden; 4Structural and 2:45 PM-4:00 PM Computational Biology, European Molecular Biology Lab, Heidelberg, SIV Models of Pathogenesis Germany 268 Chronic Semen Exposure Reduces SIVmac251 Vaginal 261 Impact of HIV-Associated Changes in the Gut Infection in Rhesus Macaques Microbiome on Disease Progression Shaheed A. Abdulhaqq1; Melween I. Martinez2; Guobin Kang3; Jesús Luévano; David B. Gootenberg; Jeffrey M. Paer; Bruce D. Walker; David Beaumont4; Jan Münch5; Georgia Tomaras4; Preston A. Marx6; Douglas S. Kwon Qingsheng Li7; Edmundo N. Kraiselburd8; Luis J. Montaner9 Ragon Inst of MGH, MIT, and Harvard, Cambridge, MA, USA 1Oregon Hlth & Sci Univ, Beaverton, OR, USA; 2Caribbean Primate Rsr Cntr, San Juan, PR, USA; 3Univ of Nebraska, Lincoln, NE, USA; 4Duke Univ, 262 Altered Gut Microbes Enhance Mucosal CD4 T Cell Durham, NC, USA; 5Univ of Ulm, Ulm, Germany; 6Tulane Univ Sch of PH Infection and Depletion Ex Vivo and Trop Med, New Orleans, LA, USA; 7Sch of Biological Scis and Nebraska Stephanie M. Dillon1; Eric L. Lee1; Andrew M. Donovan1; Kejun Guo1; Cntr for Virology, Univ of Nebraska, Lincoln, NE, USA; 8Sch of Med, Univ of Michael S. Harper1; Daniel N. Frank1; Martin D. McCarter1; Mario L. Puerto Rico, San Juan, PR, USA;9The Wistar Inst, Philadelphia, PA, USA Santiago1; Cara Wilson2 1Univ of Colorado Anschutz Med Campus, Aurora, CO, USA; 2Univ of 269 Single-Cell Expression Profiling Reveals Immune Colorado Hosp, Aurora, CO, USA Dysfunction in Acute SIV Infection Sama Adnan; Premeela A. Rajakumar; James M. Billingsley; R. P. 263 Enhancement of Microbiota in Macaques Leads to Johnson Beneficial Immune Function Modulation Emory Univ, Atlanta, GA, USA Jennifer A. Manuzak1; Tiffany Hensley-McBain1; Charlene Miller1; Alexander Zevin1; Jason M. Brenchley2; Jacob D. Estes3; Stanley 270 CD169 Is a Marker of Immune Activation in SIV Langevin1; R. Keith Reeves4; Elias Haddad5; Nichole Klatt1 Infection but Not Rectal Susceptibility 1Univ of Washington, Seattle, WA, USA; 2Frederick Natl Lab for Cancer Rsr, Magnus Hallor1; Meropi Aravantinou2; Rachel Singer2; Agegnehu Frederick, MD, USA; 3Frederick Natl Lab, Leidos Biomed Rsr, Frederick, MD, Gettie3; James Blanchard4; Jeffrey Lifson5; Michael Piatak5; Andres USA; 4Harvard Univ, Boston, MA, USA;5Drexel Univ, Philadelphia, PA, USA Salazar6; Melissa Robbiani2; Nina Derby2 1Linkoping Univ, Linkoping, Sweden; 2Pop Council, New York, NY, USA; 264 Fecal Microbial Transplantation: Safety and 3Aaron Diamond AIDS Rsr Cntr, New York, NY, USA; 4Tulane Natl Primate Engraftment During Treated HIV Infection Rsr Cntr, Covington, LA, USA; 5Frederick Natl Lab, Frederick, MD, USA; Ma Somsouk1; Ivan Vujkovic-Cvijin2; Montha Pao1; Peter W. Hunt1; 6Oncovir, Inc, Washington, DC, USA Poster Listings Poster Susan V. Lynch1; Joseph M. McCune1 1Univ of California San Francisco, San Francisco, CA, USA; 2NIH, Bethesda, 271 Adipose Tissue and HIV Infection 1 2 MD, USA Abderaouf Damouche ; Thierry Lazure ; Veronique Avettand- Fenoel3; Nicolas Huot4; Christine Rouzioux5; Jacqueline Capeau6; 265 Effects of HAART Treatment on the Microbiome of Michaela Müller-Trutwin4; Nathalie Dereuddre-Bosquet7; Roger Le HIV+ Patients Grand7; Olivier Lambotte8; Christine Bourgeois7 Joshua Shorenstein1; Netanya S. Utay2; Basil Siewe3; David Asmuth4; 1Univ Paris Sud, UMR 1184, Ivry sur seine, France; 2Hôpitaux de Paris, Rob Knight1 Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, France; 3EA7327, 1Univ of California San Diego, San Diego, CA, USA; 2Univ of Texas Med Univ Paris Descartes, Paris, France; 4Inst Pasteur, Paris, France; 5Necker Branch at Galveston, Galveston, TX, USA; 3Rush Univ, Chicago, IL, USA; Hosp, AP-HP, Paris, France; 6INSERM UMR-S 938, CDR Saint-Antoine, 4Univ of California Davis Med Cntr, Sacramento, CA, USA Paris, France; 7Univ Paris Sud, UMR 1184, Le Kremlin-Bicêtre, Fontenay 8 266 Diet Effects on the Gut Microbiome of People Living aux Roses, France; Univ Paris Sud, UMR 1184, Le Kremlin-Bicêtre, France With HIV-1 272 a4-Integrin Antibody Blocks Monocyte Traffic and Javier Rivera Pinto1; Marc Noguera-Julian1; Carla Estany2; Muntsa Decreases SIV Pathology in DRGs Rocafort1; Yolanda Guillen3; Mariona Parera1; Pep Coll1; Bonaventura Jessica R. Lakritz1; Derek Thibault1; Jake A. Robinson1; Jennifer Clotet2; Roger Paredes1; M. Luz Calle4 Campbell1; Andrew D. Miller2; Tricia H. Burdo1 1IrsiCaixa Inst for AIDS Rsr, Badalona, Spain; 2Lluita Contra la SIDA Fndn, 1Boston Coll, Chestnut Hill, MA, USA; 2Cornell Univ, Ithaca, NY, USA Germans Trias i Pujol Univ Hosp, Barcelona, Spain; 3IrsiCaixa Inst for AIDS Rsr, Barcelona, Spain; 4Univ de Vic, Barcelona, Spain
80 CROI 2016 Poster Listings 81
; 2 2 ; ; 1 San 5 4 ; Peter ; Peter 4 ; 1 ; ; Antonio ; Antonio ; Pierre ; Pierre 5 1 1 CROI 2016 Univ of Univ 2 ; Mario Univ of Texas Texas of Univ 5 ; Funmi Lesi ; Funmi 2 2 ; Nikolas I. Wada I. ; Nikolas ; Sandrine 1 3
; Audrey L. Shaw ; Audrey ; Zhong M. Ma 4 5 ; Tzu L. Phang Tzu ; 3 1 Denver Hlth Med Cntr, Cntr, Med Hlth Denver 4 Program Agenda and Univ of California San California of Univ 3 Inst de Genetique Genetique de Inst 2 ; Kristine M. Erlandson ; Philippe Pasero ; Philippe ; Daria Trabattoni ; Irma Saulle 2 3 Coll of Med, Univ of Lagos, Lagos, of Univ Med, of Coll 2
4 2 4
5 ; Bernard J. Macatangay J. ; Bernard Univ of Milan, Brescia, Italy Brescia, Milan, of Univ ; Titilope ; Titilope Adeyemo 4 ctivation in HIV+ in ctivation 5 2 ; Phyllis Kanki ; Phyllis ; Brian Vestal Johns Hopkins Univ, Baltimore, Baltimore, Univ, Hopkins Johns 2 ; Ma Somsouk 1 2
San Gerardo Hosp, Monza, Italy; Monza, Hosp, San Gerardo 2 Cntr for Comparative Med, Univ of Univ Med, Comparative for Cntr 2 3 4 Entera Hlth, Inc, Cary, NC, USA NC, Cary, Inc, Hlth, Entera S and C4b Binding Protein Protein Binding C4b and S 5 ; Christina Psomas ; Christina ; Peter L. Anderson ; Peter 2 2 Univ Hosp Montpellier, Montpellier, Montpellier, Montpellier, Hosp Univ 3 ; Bryon M. Petschow ; Todd T. Brown T. ; Todd Inst of Clinical Infectious Diseases, Catholic Catholic Diseases, Infectious Clinical of Inst 1 1 2 ; Jacques Reynes ; Jacques ; Nicola Squillace ; Nicola 3 1 ; Eric L. Lee ; Eric 1 ; Eric M. Weaver M. ; Eric ; Alessandra Bandera ; Alessandra 5 ; Wilson Cara 4 ; Yea Lih Lin Yea ; 1 ; Massimiliano Fabbiani ; Massimiliano 1 ; Sade Ogunsola 1 3 Univ of Pittsburgh Sch of Med, Pittsburgh, PA, USA; USA; PA, Pittsburgh, Sch Med, of Pittsburgh of Univ ; Netanya S. Utay ; Netanya ; Lisa Jacobson 5 1 AIDS Prevention Initiative in Nigeria, Abuja, Nigeria; Abuja, Nigeria; Nigeria, in Initiative Prevention AIDS 6 ; Suleiman Akanmu ; Edward M. Gardner M. ; Edward 3 1 3 ; Mara Biasin ; Mara 3 Northwestern Univ, Chicago, IL, USA; IL, USA; Chicago, Univ, Northwestern ; Pierre Portales ; Pierre 3
1 ; Surinder K. Mann 1 3 ; Andrea Gori ; Andrea 1 Inst of Human Genetics, Montpellier, France; France; Montpellier, Genetics, Human of Inst USA; CO, Denver, Colorado, of Univ CA, USA Angeles, Los Angeles, Los California of Univ Univ of Milan, Milan, Italy; Milan, Milan, of Univ Nigeria; Lagos, Hosp, Teaching Univ Lagos USA MA, Boston, Sch PH, of Harvard Univ of Colorado Anschutz Med Campus, Aurora, CO, USA; USA; CO, Aurora, Campus, Med Anschutz Colorado of Univ Univ of California Davis Med Cntr, Sacramento, CA, USA; Sacramento, Cntr, Med Davis California of Univ Med Branch at Galveston, Galveston, TX, USA; Galveston, at Galveston, Branch Med MichaelEdwards G. Gerardo General Hosp, Monza, Italy; Monza, Hosp, General Gerardo Elizabeth Breen Elizabeth Gimenez Lagos, Nigeria; Nigeria; Lagos, Francisco, San Francisco, CA, USA; San Francisco, Francisco, Corbeau Denver, CO, USA; USA; CO, Denver, W. Hunt W. 1 Higher With Associated Is Adherence ART Low SuppressionHIV Despite Inflammation Castillo-MancillaR. Jose 1 6 1 Protein Derangement in Adults HIV-Infected in Levels Bello O. Fatai 1 4 ROS Release Patients HIV1 Treated Monocytes From CausingLoss DamageDNA Cell CD4 and Younas Mehwish Christopher J. Detzel J. Christopher ImmunologicalNonresponders MasettiMichela Proteomic Profiles Associated With an Inflammagingan With Associated Profiles Proteomic PhenotypeDuring Infection HIV-1 DillonM. Stephanie 1 A Th17 IInflammasome and 1 Oral Bovine Immunoglobulin Reduces Immune Reduces Immunoglobulin OralBovine Nonresponders Immune HIV+ in Activation Asmuth David USA CO, Aurora, Aurora, Hosp, Colorado Clerici France Frank J. Palella J. Frank Prosper Okonkwo Prosper Humaine, Montpellier, France; France; Montpellier, Humaine, Califlornia Davis, Davis, CA, USA; Davis, Davis, Califlornia Muscatello Univ of Sacred Heart, Rome, Italy; Heart, Rome, Sacred of Univ MD, USA; USA; MD,
283 281 282 279 280 278
6 ; 1 ; John John 1 10 ; Michael ; Kendall ; Kendall 3 7 Hall A/B CNRS, CNRS, ; Celine ; Celine 2 Frederick Natl Frederick ; Jason M. 3 5 4 ; Audrey L. ; Audrey 3 Univ Paris Paris Univ Hektoen Inst Inst Hektoen ; Véronique ; Véronique 4 3 3 Johns Hopkins Hopkins Johns ; Kenta Matsuda ; Kenta 7 2 ; Nicolas Nagot ; Nicolas
4 2 Univ Diderot Paris 7, Paris Diderot Univ 6 ; Anne Couedel-Courteille ; Anne Inst of Human Genetics, Genetics, Human of Inst ; Elizabeth Golub ; Elizabeth 5
2 6 ; Andrew D. Miller D. ; Andrew Natl Inst on Alcohol Abuse Abuse Alcohol on Inst Natl ; Jacob D. Estes D. ; Jacob 10 2 8 3 ; Christelle Reynes ; Christelle 2 CORE Cntr/Cook County Hlth and and Hlth County Cntr/Cook CORE ; BénédicteCharmeteau-De- 2 4 Rush Univ, Chicago, IL, USA; USA; IL, Chicago, Univ, Rush Pathologica LLC, San Francisco, CA, San Francisco, LLC, Pathologica ; Jane Burke-Miller 9 ; Claire Deleage ; Claire 2 2 Univ of California San Francisco, San San Francisco, California of Univ 1 4
; Hua Xu 1 ; Pierre Corbeau ; Pierre 1 ; Suzanne Figueiredo Frederick National Laboratory, Leidos Leidos Laboratory, National Frederick 1 Harvard Univ, Boston, MA, USA; USA; MA, Boston, Univ, Harvard 2 2 Univ Hosp Nimes, Nimes, France Nimes, Nimes, Hosp Univ 3 4 ; Claudine Barbuat ; Claudine 1
; Rémi Cheynier 5 ; Mardge Cohen ; Mardge 9 Univ of California San Francisco, San Francisco, San Francisco, San Francisco, California of Univ INSERM U1016, Paris, France; France; Paris, U1016, INSERM CORE Cntr/John H. Stroger Jr Hosp of Cook Cook of Jr Hosp Stroger H. Cntr/John CORE ; R. Keith Reeves ; R. Keith 5 3 4 1 ; Mark H. Kuniholm 5 INSERM, Paris, France; France; Paris, INSERM, 5 Inst for Functional Genomics, Montpellier Univ, Univ, Montpellier Genomics, Functional for Inst ; Younas Mehwish 3 tion, Cell Turnover, and Exhaustion inExhaustion and Turnover, Cell tion, tion Profile Associated With Metabolic With Associated Profile tion 1 ; Jacques Dutrieux; Jacques ; Alexandra Ortiz; Alexandra 3 ; Weber Kathleen 1 1 ; Walker Joshua 1 ; Magali Rancez 1 ; Jacques Reynes ; Jacques 1 ; Kenneth C. Williams C. ; Kenneth ; Vincent Le Moing Le Vincent ; 4 1 5 Albert Einstein Coll of Med, Bronx, NY, USA; USA; NY, Bronx, Med, of Coll Albert Einstein ; Alan L. Landay ; Alan ; Thomas ; Thomas Guilbert 6 8 3 ; Vanessa Hirsch ; Vanessa ; Marion Peters 1 4 Cornell Univ, Ithaca, NY, USA; USA; NY, Ithaca, Univ, Cornell 3 Rush Univ Med Cntr, Chicago, IL, USA; IL, USA; Chicago, Cntr, Med Univ Rush Univ Hosp Montpellier, Montpellier, France; France; Montpellier, Montpellier, Hosp Univ Frederick Natl Lab, Leidos Biomed Rsr, Frederick, MD, USA; USA; MD, Frederick, Rsr, Biomed Leidos Lab, Natl Frederick NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, NIAID, Rsr Inst of the McGill Univ Hlth Cntr, Montréal, QC, Canada; Canada; QC, Montréal, Cntr, Hlth Univ McGill the of Inst Rsr Boston Coll, Chestnut Hill, MA, USA; USA; MA, Hill, Chestnut Coll, Boston UMR5203, Montpellier, France; France; Montpellier, UMR5203, H. Stroger Jr. Hosp of Cook County and Rush Med Coll, Chicago, IL, USA Chicago, Coll, Med Rush and County Cook of Hosp Jr. Stroger H. of Med, Chicago, IL, USA; IL, USA; Chicago, Med, of CA, USA; UMR8104, Paris, France; France; Paris, UMR8104, Fabre-Mersseman Muylder 1 and Alcoholism, Bethesda, MD, USA; USA; Bethesda, MD, Alcoholism, and Fan Wu Fan Francisco, CA, USA Francisco, Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Baltimore, Sch PH, of Bloomberg County, Chicago, IL, USA; IL, USA; Chicago, County, 1 Immune Activa Heavy Use Alcohol With Women HIV+ SeemaDesai N. 1 Immune Activa Patients HIV-Treated in Syndrome ChristinaPsomas 4 Apoptosis of Innate Lymphoid Cells Precedes CD4 T-Cell T-Cell CD4 Precedes Cells Lymphoid Innate of Apoptosis InfectionSIV Acute in Death Mudd C. Joseph 1 IL-7 and Chemokines Trigger Intestinal Cell Homing in Homing Cell Intestinal Trigger Chemokines and IL-7 Macaques SIV-Infected Ponte Rosalie Macrophage Targeted MGBG Targeted Macrophage Burdo H. Tricia 1 SIV-Associated Pathogenesis Modulation With With Modulation Pathogenesis SIV-Associated Sorbonne Paris-Cité, Paris, France Paris, Paris-Cité, Sorbonne J. Bryant Brenchley BioMed Rsr, Frederick, MD, USA; USA; MD, Frederick, Rsr, BioMed Hosp System and Hektoen Inst of Med, Chicago, IL, USA; IL, USA; Chicago, Med, of Inst Hektoen and System Hosp S. McGrath French Diderot, Paris, France; France; Paris, Diderot, Pierre Portales Pierre Montpellier, France; France; Montpellier, USA; USA; Fernandez Lab for Cancer Rsr, Frederick, MD, USA MD, Frederick, Rsr, Cancer for Lab
277 Immune Activation and Inflammation and Activation Immune 276 Session P-C7 Poster Abstracts SessionPoster P-C7 PM-4:002:45 PM 275LB 274 273 Program and Agenda
Session P-E3 Poster Abstracts Hall A/B Session P-F4 Poster Abstracts Hall A/B 2:45 PM-4:00 PM 2:45 PM-4:00 PM Evaluating HIV Vaccines: Preclinical to Clinical Impact of Antiretroviral Therapy on Viremic Control 317 Immunogenicity and Efficacy of ALVAC-HIV/gp120- and Tissue Reservoirs Clade C in Alum Regimen in Macaques 346 Relationship Among Viral Load Outcomes in HIV Luca Schifanella1; David Venzon1; Susan Barnett2; Sanjay Phogat3; Treatment Interruption Trials 4 4 1 Georgia Tomaras ; David Montefiori ; Massimiliano Bissa ; Veronica Graham C. Treasure1; Evgenia Aga2; Ronald Bosch2; John W. Mellors3; 1 5 1 Galli ; Ruth M. Ruprecht ; Genoveffa Franchini Daniel Kuritzkes4; Rajesh T. Gandhi5; Michael Para6; Jonathan Z. Li1 1 2 3 NIH, Bethesda, MD, USA; Novartis, Cambridge, MA, USA; Sanofi, 1Brigham and Women’s Hosp, Harvard Med Sch, Boston, MA, USA; 4 5 Swiftwater, PA, USA; Duke Univ, Durham, NC, USA; Texas Biomed Rsr 2Harvard Sch of PH, Boston, MA, USA; 3Univ of Pittsburgh, Pittsburgh, PA, Inst, San Antonio, TX, USA USA; 4Harvard Med Sch, Boston, MA, USA; 5Massachusetts General Hosp, 318 Specific IgG Subclasses Induced in RV305, a Late Boost Boston, MA, USA; 6Ohio State Univ, Columbus, OH, USA Vaccination of RV144 Subjects 347 Viral and Immune Characteristics of HIV Post- Siriwat Akapirat1; Sandhya Vasan2; Punnee Pitisuttithum3; Supachai Treatment Controllers in ACTG Studies 4 5 6 7 Rerks-Ngarm ; Nelson L. Michael ; Jean-Louis Excler ; Jerome H. Kim ; Behzad Etemad1; Xiaoming Sun2; Michael M. Lederman3; Rachel Z. 1 1 Robert O’Connell ; Nicos Karasavvas ; for the RV305 Study Group Gottlieb1; Evgenia Aga4; Ronald Bosch4; Jeffrey Jacobson5; Rajesh T. 1 2 Armed Forces Rsr Inst of Med Scis, Bangkok, Thailand; US Military HIV Gandhi6; Xu G. Yu2; Jonathan Z. Li1 3 4 Rsr Prog, APO, AP, USA; Mahidol Univ, Ratchathewi, Thailand; Ministry 1Brigham and Women’s Hosp, Harvard Med Sch, Boston, MA, USA; 5 of PH, Muang Nonthaburi, Thailand; US Military HIV Rsr Prog, Bethesda, 2Ragon Inst of MGH, MIT, and Harvard, Cambridge, MA, USA; 3Case 6 MD, USA; Henry M. Jackson Fndn for the Advancement of Military Med, Western Reserve Univ, Cleveland, OH, USA; 4Harvard Sch of PH, Boston, 7 Inc, Bethesda, MD, USA; Intl Vaccine Inst, Seoul, Republic of Korea MA, USA; 5Drexel Univ Coll of Med, Philadelphia, PA, USA; 6Massachusetts 319 Vaccine Targeting Protease Cleavage Sites Protects General Hosp, Boston, MA, USA Cynomolgus Monkeys Against SIV 348 HIV-1 in the Blood and Intestine Contributes to Ma Luo1; David Tang1; Rupert Capina1; Xin-Yong Yuan1; Jorge Viremia During Treatment Interruption 2 Correia-Pinto Anni Winckelmann1; Kirston Barton2; Bonnie Hiener2; Thomas A. 1 2 Natl Microbiology Lab of Canada, Winnipeg, MB, Canada; Univ of Rasmussen3; Martin Tolstrup1; Wei Shao4; Paul W. Denton1; Sharon R. Santiago de Compostela, Santiago de Compostela, Spain Lewin3; Ole S. Søgaard1; Sarah Palmer2 320 Shaping CTL Immunodominance With Conserved HIV 1Aarhus Univ Hosp, Aarhus Nord, Denmark; 2Cntr for Virus Rsr, Westmead 3 Vaccines After Early Treatment (BCN01) Millennium Inst, Westmead, Australia; Doherty Inst for Infection and Immunity, Univ of Melbourne, Melbourne, Australia; 4Leidos Biomed Rsr, Beatriz Mothe1; Christian Manzardo2; Pep Coll1; Sara Moron-Lopez1; Inc, Frederick, MD, USA Lucy Dorrell3; Bonaventura Clotet4; Javier Martinez-Picado1; Christian Brander1; Tomá Hanke5; for the BCN01 Study Group 349 HIV DNA Set Point Remains Elevated in Untreated vs 1IrsiCaixa Inst for AIDS Rsr, Badalona, Spain; 2Hosp Clinic-IDIBAPS-Univ Treated Acutely Infected Thais 3 4 of Barcelona, Barcelona, Spain; Univ of Oxford, Oxford, UK; Lluita Contra Jintanat Ananworanich1; Nicolas Chomont2; Leigh . Eller3; Eugène 5 Poster Listings Poster la SIDA Fndn, Germans Trias i Pujol Univ Hosp, Barcelona, Spain; The Kroon4; Meera Bose3; Marty Nau3; Suteeraporn Pinyakorn3; Nelson Jenner Inst, Oxford, UK L. Michael5; Nittaya Phanuphak4; Merlin L. Robb3; for the RV254/ 321 DNA/rTV/Protein Vaccination Protects Against SEARCH010 study groups 1 2 Acquisition of SHIV162P3 Challenges Military HIV Rsr Prog, Bethesda, MD, USA; Univ de Montréal, Montreal, QC, Canada; 3US Military HIV Rsr Prog, Walter Reed Army Inst of Rsr, Xuan He; Zhou Zhang; Ying Liu; Yanling Hao; Li Ren; Kunxue Hong; Silver Spring, MD, USA; 4SEARCH, Bangkok, Thailand; 5US Military HIV Rsr Yiming Shao Prog, Bethesda, MD, USA Natl Cntr for AIDS/STD Control and Prevention, Chinese CDC, Beijing, China 350 Impact of Long-term Antiretroviral Therapy (ART) on 322 Poly-ICLC, a TLR Agonist, Is Safe and Tolerable in Cellular HIV and Inflammation 1 2 3 HIV-Infected Individuals Rajesh T. Gandhi ; Deborah McMahon ; Ronald Bosch ; Christina Lalama3; Josh Cyktor2; Bernard J. Macatangay4; Charles Rinaldo2; Ann Elizabeth A. Miller1; Rachel Sabado1; Andres Salazar2; Melissa Collier5; Joseph J. Eron6; John W. Mellors2 LaMar3; Martin Markowitz; Nina Bhardwaj1 1Massachusetts General Hosp, Boston, MA, USA; 2Univ of Pittsburgh, 1Icahn Sch of Med at Mount Sinai, New York, NY, USA; 2Oncovir, Inc, Pittsburgh, PA, USA; 3Harvard Sch of PH, Boston, MA, USA; 4Univ of Washington, DC, USA; 3Aaron Diamond Aids Rsr Cntr, New York, NY, USA Pittsburgh Sch of Med, Pittsburgh, PA, USA; 5Univ of Washington, Seattle, 323 TLR-9 Signaling Rescues Defects in B-Cell Response in WA, USA; 6Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA Needle-Free Immunization Prabhu S Arunachalam1; Ria Mishra1; Sravan Payeli2; Deepak Selvam1; Richard R. Stout3; Udaykumar Ranga1 1Jawaharlal Nehru Cntr for Advanced Scientific Rsr, Bangalore, India; 2Bmom Fertility and Rsr Cntr, Bangalore, India; 3Bioject Med Technologies, Inc, Tigard, OR, USA
82 CROI 2016 Poster Listings 83 ; 3 ; 2 ; 2 CIRCLE ; Alberto 4 ; Shelley 4 Hall A/B ; Rik 1 1 ; Annegret ; Annegret 1 CROI 2016 ; Timothy ; Timothy ; Dale K. 1 2 ; 2 ; Linos 3 Ragon Inst of MGH, MGH, of Inst Ragon 2 Univ of Trento, Trento, Trento, Trento, of Univ ; Simon Mallal ; Ward Spiegelaerde ; Ward 2 3 Sangamo BioSciences, Sangamo BioSciences, 3 2 ; Slim Fourati Howard Hughes Med Hughes Howard ; Michelle Kim 1 Program Agenda and 6 3 ; Frauke Christ ; Frauke ; Oliver Hofmann ; Oliver 1 erplay by LEDGINs by erplay 5 ; Lisa Frenkel 2 ; Maria J. Buzon ; Maria J. Seattle Children's Rsr Inst, Inst, Rsr Seattle Children's ; Martin A. Nowak 1 3 2 Partners HlthCare Personalized Personalized HlthCare Partners 3 ; Geoffrey M. Nichol ; Geoffrey 4
1 ; Jonas Demeulemeester 1 Univ of California San Francisco, San San Francisco, California of Univ
; Sami S. Amr ; Suha Saleh 2 ted HIV DNA by Pulse-FieldGel by DNA HIV ted 1 2 3 ; Clarisse Benne ; Clarisse 2 ; Eva Malantinkova ; Eva 2
Johns Hopkins Univ Sch of Med, Baltimore, Baltimore, Sch Med, of Univ Hopkins Johns 4 ; Vicente Planelles ; Vicente 6 ; Linos Vandekerckhove ; GaryBlick 2 3 ; Louise Hogan ; Louise
1 1 Ghent Univ and Ghent Univ Hosp, Ghent, Belgium Ghent, Hosp, Ghent Univ and Univ Ghent Quest Clinical Rsr, San Francisco, CA, USA; San Francisco, Rsr, Quest Clinical ; Verdin Eric 3 3 ; Mathias Lichterfeld; Mathias 1 3 ; Ward Spiegelaerde ; Ward 1 ; GaryK. Lee
; Rory Kirchner ; Paul U. Cameron U. ; Paul ; Vranckx Lenard ; Jonathan Z. Li ; Jonathan 1 1 1 1 1 2 ; Lily Hu ; Abha Chopra ; Abha 1 ; Caroline Ignacio; Douglas D. Richman; Matt F. Strain Strain Richman; F. Matt Ignacio; Douglas D. ; Caroline 1 ; DonCooper 2 Inst for Immunology & Infectious Diseases, Murdoch Univ, Univ, Murdoch Diseases, Infectious & Immunology for Inst
Univ of Utah, Salt Lake City, UT, USA; USA; UT, City, Utah, Salt of Univ Lake 2 2 5 ; Jacob Lalezari ; Jacob
2 ; Robert Siliciano 1 5 Rafick SekalyRafick Gladstone Inst of Virology and Immunology, San Francisco, CA, USA San Francisco, Immunology, and Virology of Inst Gladstone ; 3 2 ; RikSchrijvers 2 Doherty Inst for Infection and Immunity, Univ of Melbourne, Melbourne, Melbourne, Melbourne, of Univ Doherty Immunity, Infection and for Inst USA; MA, Sch, Med Boston, Harvard Hosp, Women’s and Brigham USA; MA, Boston, Sch PH, of Harvard Case Western Reserve Univ, Cleveland, OH, USA; USA; OH, Cleveland, Univ, Reserve Western Case Katholieke Universiteit Leuven, Leuven, Belgium; Leuven, Leuven, Universiteit Katholieke Ghent Univ and Ghent Univ Hosp, Ghent, Belgium; Ghent, Hosp, Ghent Univ and Univ Ghent Harvard Univ, Boston, MA, USA; USA; MA, Boston, Univ, Harvard K. Wang Seattle, WA, USA WA, Seattle, Vandekerckhove Sherry McLaughlin Italy; Bosque Gijsbers Australia; Australia; Clonal Integration Site Frequency ClonalReplication-and Integration ART on Patients in Virus Competent MajaKiselinova 1 1 2 1 1 Shannan Ho SuiShannan Ho 1 Integra of Measurement ElectrophoresisddPCR and Lada Steven CA, USA San Diego, San Diego, California of Univ int IN-LEDGF/p75 the Inhibition of Latency From Reactivation Reduces Debyser Zeger Integration Analysis of Latently Infected Cell Lines: Infected Cell Latently of Analysis Integration Ongoingof Replication Evidence Symons Jori Viral of Models SitesCellular in Integration HIV Persistence SaraSunshine Predicting Determinants of Long-Term HIV Control Control HIV PredictingLong-Term of Determinants Strategies Therapy Gene With Hill L. Alison 1 Predict Viral Responses CD8 and Homeostasis T-Cell Treatment SB-728-T Post Control Joumana Zeidan Inst, Baltimore, MD, USA MD, Baltimore, Inst, J. Henrich J. MD, USA; USA; MD, Francisco, CA, USA Francisco, Sharon R. Lewin Sharon CARE Cntr, LLC, Norwalk, CT, USA Norwalk, CT, LLC, CARE Cntr, Shay LearyShay Med, Cambridge, MA, USA; USA; MA, Cambridge, Med, Boll Ando Murdoch, Australia; Australia; Murdoch, Richmond, CA, USA; Richmond, MIT and Harvard, Cambridge, MA, USA; USA; MA, Cambridge, Harvard, and MIT
361 362 363 2:45 PM-4:002:45 PM Integration HIV 359 360 357 358LB Abstracts Poster SessionP-F6 ; 1 Case ; Rafick 4 3 ; 4
Hall A/B ; Guido 2 4 Washington Washington INSERM INSERM
4 ; Patricia ; Patricia 2 2 2 Inst Pasteur, Pasteur, Inst ; Javier ; Javier 4 3 ; Benton ; Benton 1 ; Christine ; Christine ; Laurence ; Laurence 3 7 ; Jean-Marie Sangamo BioScis, Sangamo BioScis, 4 2 INSERM, CESP U1018, U1018, CESP INSERM, 8 Aphios Corporation, Aphios Corporation, ; Remi Fromentin 5 2 Yerkes Natl Primate Rsr Rsr Primate Natl Yerkes Hosp Universitario Ramón Ramón Universitario Hosp 4 INSERM U802, Le Kremlin- Le U802, INSERM ; Sergio Serrano-Villar ; Sergio 2 6 1 Univ de Montréal, Montreal, Montreal, Montréal, de Univ ; Audrey Baldessari ; Audrey Mirko Paiardini Mirko 5 ; Mirko Paiardini ; Mirko ; Santiago Moreno 4 ; Coral Barbas ; Coral 6 ; 5 1 ; Michael Holmes 3 2 ; Adeline Mélard ; Adeline ; Diane Carnathan 2 1 ; Christine Rouzioux ; Christine 6 Emory Univ Sch of Med, Atlanta, GA, Atlanta, Emory Sch Med, Univ of Yerkes Natl Primate Rsr Cntr, Emory Cntr, Rsr Primate Natl Yerkes 2 2 Hosp Necker, Paris, France; France; Paris, Necker, Hosp 3
; Trevor Castor ; Trevor ; Jeffrey Lifson ; Jeffrey 4 5 ; Jeffrey Lifson ; Jeffrey ; Steven E. Bosinger ; Steven ; Jianbin Wang 2 2 1 ; María E. Martín ; Michaella Muller-Trutwin Univ of Montreal, Montreal, QC, Canada; Canada; QC, Montreal, Montreal, of Univ ; Robert Murnane ; Luca Micci ; Luca 2 3 3 CEMBIO, San Pablo CEU Univ, Madrid, Spain, Madrid, Univ, CEU San Pablo CEMBIO, 3 1 3 ; Nadia Madrid-Elena 1 Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ
3 1 ; Natalia Soriano-Sarabia; Brigitte Allard; Katherine Soriano-Sarabia; Katherine ; Natalia Allard; Brigitte ; Julia Heitzmann 1 Necker Hosp, AP-HP, Paris, France; France; Paris, AP-HP, Hosp, Necker Córdoba Univ, Córdoba, Spain; Córdoba, Univ, Córdoba 7 4 Angers Hosp, Angers, France; France; Angers, Angers Hosp, ; Camille Lécuroux ; Camille 5 Frederick Natl Lab, Frederick, MD, USA MD, Frederick, Lab, Natl Frederick 5 6 ; Emily Ryan ; Emily 1 ; Shiu-Lok Hu ; Shiu-Lok ; Eduardo Muñoz ; Eduardo
3 ; Ann Chahroudi ; Ann 3 4 1 ; Nicolas Chomont ; Nicolas ; for the ANRS 147 OPTIPRIM Team Team the ANRS 147 OPTIPRIM ; for ; Ludivine David ; Ludivine 4 8 2 Frederick Natl Lab, Frederick, MD, USA; USA; MD, Frederick, Lab, Natl Frederick 3 Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; USA; WA, Seattle, Cntr, Rsr Cancer Hutchinson Fred Ramón y Cajal Hosp, IRYCIS, Madrid, Spain; Madrid, IRYCIS, Hosp, Cajal y Ramón Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, Le Kremlin-Bicêtre Hosp, AP-HP, Le Kremlin-Bicêtre, France; France; Kremlin-Bicêtre, Le AP-HP, Hosp, Kremlin-Bicêtre Le Ruperez SC10-US19, Villejuif, France; France; Villejuif, SC10-US19, y Cajal, Madrid, Spain; Spain; Madrid, Cajal, y Bicêtre, France; France; Bicêtre, Madrid, Spain; Spain; Madrid, Paris, France; France; Paris, Western Reserve Univ, Cleveland, OH, USA; USA; OH, Cleveland, Univ, Reserve Western Richmond, CA, USA; Richmond, USA; USA; Univ, Atlanta, GA, USA; GA, USA; Atlanta, Univ, Le Kremlin-Bicêtre, France Kremlin-Bicêtre, Le QC, Canada; Canada; QC, 1 CCR5 Gene-Edited Cells Undergo Positive Selection in Positive Undergo Cells Gene-Edited CCR5 Primates Nonhuman SHIV-Infected Peterson W. Christopher Capacity to Produce IFN-g Produce Capacity to GarridoCarolina Margolis M. David Nancie M. Archin; Sholtis; USA NC, Hill, Chapel Hill, at Chapel North of Univ Carolina Clinical Administration of Vorinostat Increases NK Cell Cell NK Increases Vorinostat Clinicalof Administration Double-Blind ClinicalTrial Gutiérrez Carolina 1 Bryostatin-1 for Latent-Virus Reactivation: A Phase I,Phase A Reactivation: Latent-Virus for Bryostatin-1 1 Antiretroviral Therapy in SIV Natural Hosts: Hosts: Natural SIV in Therapy Antiretroviral Pathogenesis AIDS Implicationsfor Calascibetta Francesca 1 Predictors of Viral Control After ART Interruption in Interruption ART After Control Viral Predictorsof MacaquesRhesus SIV-Infected LucaMicci 1 HIV-1 Reservoir Primaryin HIV-1 Infection Chéret Antoine Impact of cART & Systemic inflammation on Semenon inflammation ImpactSystemic & cART of Polacino Meyer Lawson Natl Primate Rsr Cntr, Seattle, WA, USA WA, Seattle, Cntr, Rsr Primate Natl Durier Boston, MA, USA MA, Boston, Hans-Peter Kiem Hans-Peter María Jesús Pérez-Elias Sekaly Silvestri Cntr, Emory Univ, Atlanta, GA, USA Atlanta, Emory Univ, Cntr, Chennebault
356 355 Session P-F5 Poster Abstracts Poster SessionP-F5 PM-4:002:45 PM Therapy Gene and HIV Reactivating to Approaches 354 353 352 351 Program and Agenda
Session P-G2 Poster Abstracts Hall A/B Session P-G3 Poster Abstracts Hall A/B 2:45 PM-4:00 PM 2:45 PM-4:00 PM Virology and Basic Neuroscience Central Nervous System: HIV Entry, Reservoirs, and 393 Productive Infection of HIV in Astrocytes via a CD4- Compartmentalization Independent, CXCR4-Dependent Mech 400 CNS Compartmentalization of HIV-1 and Sensitivity to Guanhan Li1; Caroline Anderson1; Eugene O. Major1; Avindra Nath2 Neutralizing Antibodies 1 2 NINDS, NIH, Bethesda, MD, USA; NIH, Bethesda, MD, USA Karl Stefic1; Antoine Chaillon2; Mélanie Bouvin-Pley3; Alain Moreau3; 394 A Unique In Vitro Neuropathic Phenotype of Clade D Martine Braibant3; Guillaume Gras4; Frederic Bastides4; Louis Bernard4; 3 Transmitted/Founder Viruses Francis Barin 1CHU de Tours, Tours, France; 2Univ of California San Diego, San Diego, Analise Gruenewald1; Alexander J. Gill1; George M. Shaw2; Dennis CA, USA; 3François-Rabelais Univ, Tours, France, Tours, France; 4CHU de L. Kolson2 Tours, Tours, France 1Univ of Pennsylvania, Philadelphia, PA, USA; 2Perelman Sch of Med, Univ of Pennsylvania, Philadelphia, PA, USA 401 HIV Compartmentalization in the CNS Is Associated 395 Neurotoxicity Screening of Antiretroviral Drugs With With Neurocognitive Impairment 1 1 1 Human iPSC-Derived Neurons Natalie M. Bowman ; Sarah B. Joseph ; Laura P. Kincer ; Sarah Yosief1; Serena S. Spudich2; Joseph J. Eron1; Richard W. Price3; Ronald I. Sandy Hinckley1; Sean Sherman1; Brookie M. Best2; Jeremiah Swanstrom1; Kevin R. Robertson1; for the THINC Group Momper2; Qing Ma3; Scott R. Letendre2; Ron Ellis2; Anne Bang1 1Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2Yale Univ 1Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA, USA; 2Univ of Sch of Med, New Haven, CT, USA; 3Univ of California San Francisco, San California San Diego, San Diego, CA, USA; 3Univ at Buffalo, State Univ of Francisco, CA, USA New York, Buffalo, NY, USA 396 Chronic Low-Level HIV-1 Tat Expression Promotes a 402 Persistent HIV-1 in the CNS During Therapy: Evidence Neurodegenerative Phenotype of a Viral Reservoir in the CNS Sarah B. Joseph1; Laura P. Kincer1; Natalie M. Bowman1; Sarah Yosief1; Alfred Chin; Alex M. Dickens; Amanda L. Trout; Jackie Lovett; Joelle Angela Kashuba1; Kevin R. Robertson1; Serena S. Spudich2; Joseph J. Dorskind; Norman Haughey Eron1; Richard W. Price3; Ronald I. Swanstrom1 Johns Hopkins Univ Sch of Med, Baltimore, MD, USA 1Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2Yale Univ 397 Glutaminase Regulates Extracellular Vesicles Release Sch of Med, New Haven, CT, USA; 3Univ of California San Francisco, San in HIV-1 Infected Macrophages Francisco, CA, USA Beiqing Wu; Yunlong Huang; Runze Zhao; Yuju Li; Jialin C. Zheng 403 Bone Marrow Macrophages Are a Potential Source of Univ of Nebraska Med Cntr, Omaha, NE, USA CNS Virus With SIV-Encephalitis 398 HIV-1 Replication Dynamics in the CNS of TB- Jaclyn C. Mallard1; Brittany Rife2; David J. Nolan2; Graham Beck1; Coinfected Individuals Emily Papazian1; Russell Simons1; Tricia H. Burdo1; Marco Salemi2; 1 Ikanyeng D. Seipone1; Thumbi P. Ndungu2; Ravesh Singh1; Vinod Kenneth C. Williams 1 2 Patel3 Boston Coll, Chestnut Hill, MA, USA; Emerging Pathogens Inst, Univ of Poster Listings Poster 1HIV Pathogenesis Prog, Univ of Kwa-Zulu Natal, Durban, South Africa; Florida, Gainesville, FL, USA 2Univ of KwaZulu-Natal, Durban, South Africa; 3Inkosi Albert Luthuli Hosp 404 Peripheral Immune Activation Modulates HIV RNA and the Nelson R Mandela Sch of Med, Univ of KwaZulu-Natal, Durban, Entry to CSF in Early Acute Infection South Africa Alexandra Schuetz1; Suteeraporn Pinyakorn2; Leah Le3; Yuwadee 399 Glial Transcriptional Responses Follow HIV-1 Infection Phuang-Ngern1; Eugène Kroon4; Linda Jagodzinski5; Thep in a Humanized Mouse Brain Chalermchai4; Victor Valcour6; Jintanat Ananworanich5; Serena S. 3 Weizhe Li; Li E. Wu; Jaclyn Knibbe-Hollinger; Santhi Gorantla; Howard Spudich ; for the RV254/SEARCH 010 Study Group 1 2 E. Gendelman; Larisa Y. Poluektova US AFRIMS, Bangkok, Thailand; US Military HIV Rsr Prog, Walter Reed 3 Univ of Nebraska Med Cntr, Omaha, NE, USA Army Inst of Rsr, Silver Spring, MD, USA; Yale Univ Sch of Med, New Haven, CT, USA; 4SEARCH, Bangkok, Thailand; 5Military HIV Rsr Prog, Bethesda, MD, USA; 6Univ of California San Francisco, San Francisco, CA, USA 405 Early CSF Viremia and CNS T-Cell Infiltrate in a Nonaccelerated SHIV Infection Model Sandhya Vasan1; Piyanate Sunyakumthorn2; Matthew D. Wegner2; Eric Lombardini2; Joanna M. Hellmuth3; Jintanat Ananworanich4; Victor Valcour3; Robert O’Connell2; Serena S. Spudich5; Nelson L. Michael6 1US Military HIV Rsr Prog, APO, AP, USA; 2Armed Forces Rsr Inst of Med Scis, Bangkok, Thailand; 3Univ of California San Francisco, San Francisco, CA, USA; 4Military HIV Rsr Prog, Bethesda, MD, USA; 5Yale Univ Sch of Med, New Haven, CT, USA; 6US Military HIV Rsr Prog, Bethesda, MD, USA
84 CROI 2016 Poster Listings 85 ; 1 ; ; 1 ; 2 4 ; 2 ; Univ of Univ 1 5 ; Christina ; Christina 5 Hall A/B Hall A/B ; Kristin 1 ; Marylyn D. ; Marylyn D. CROI 2016 Univ of Univ 6 Univ of Univ 2 2 Makerere Univ Univ Makerere Harbor Univ Univ Harbor ; Igor Grant ; Igor 4 Vanderbilt Univ, Univ, Vanderbilt
3 ; Taylor Alford ; Taylor 2 7 5 3 ; David J. Back J. ; David 4 Univ of Rochester Rochester of Univ 4
5 ; Lourdes Adamson ; Lourdes ; for the CHARTER and the CHARTER ; for 1 2 ; J. Victor Garcia Victor ; J. ; Sarah Pendergrass Program Agenda and 2 1 Colorado Sch of PH, Aurora, Aurora, Sch PH, of Colorado 3 ; Paul McLaren ; Paul Intestinal Tissue by Tissueby Intestinal 5 ; Lane R. Bushman; Lane 5 China CDC, Beijing, China; China; Beijing, CDC, China 3 ; Adeniyi Olagunju ; Adeniyi 2 ; Donald Franklin 3 ; Concepta Merry; Concepta ; Peter L. Anderson ; Peter 4 Univ of Nebraska, Omaha, NE, USA NE, Omaha, Nebraska, of Univ ; Craig Sykes ; Craig 3 5 ; Carolyn W. Clayton W. ; Carolyn 1
2 1 ; Paul Luciw ; Paul 1 Infectious Diseases Inst, Makerere Univ, Univ, Makerere DiseasesInfectious Inst, Colorado State Univ, Fort Collins, CO, CO, Fort Collins, Univ, State Colorado 2 3 ; Kimberly K.Scarsi 1 ; Verma Shefali 1 State Univ of New York at Buffalo, Buffalo, Buffalo, at Buffalo, York New of Univ State ; Xia Liu ; Xia ; Scott R. Letendre 5 2 3
; Gene D. Morse ; Gene D. 4
7 ssociation Study (PheWAS) Using Using Study (PheWAS) ssociation ; Xinhui Chen ; Xinhui 1 Northwestern Univ, Chicago, IL, USA; IL, USA; Chicago, Univ, Northwestern ; Yuri Fedoriw ; Yuri 3 1 ; Angela Kashuba; Angela ; Mohammed Lamorde ; Thompson Corbin ; Jose R. Castillo-Mancilla 3 ; Fujie Zhang ; Fujie 1 ; Andrew Owen ; Andrew ; Yuki Bradford ; Yuki 1 4 Geisinger Hlth System, Danville, PA, USA; USA; PA, Danville, System, Hlth Geisinger 4 1 1 2 ; Samantha MaWhinney ; Jennifer Iudicello ; Jennifer 1 ; Venuto Charles PH Agency of Canada, Winnipeg, MB, Canada; Canada; MB, Winnipeg, Canada, of Agency PH Univ of Colorado, Aurora, CO, USA; USA; CO, Aurora, Colorado, of Univ USA; CO, Boulder, Diseases, Infectious for Cntr Beacon 1 ; Pauline Byakika-Kibwika ; Pauline David W. Haas W. David 3 6 2 4 3 ; 1 Univ of California San Diego, La Jolla, CA, USA Jolla, La San Diego, California of Univ USA; NC, Hill, Chapel Hill, at Chapel North of Univ Carolina Univ at Buffalo, State Univ of New York, Buffalo, NY, USA; USA; NY, Buffalo, York, New of Univ State atUniv Buffalo, Univ of Liverpool, Liverpool, UK; UK; Liverpool, Liverpool, of Univ Aurora, Scis, Pharmaceutical and Sch Pharm of Skaggs Colorado of Univ The Cntr for Systems Genomics, Pennsylvania State Univ, University University Univ, State Pennsylvania Genomics, Systems for Cntr The Marco Siccardi Marco Nashville, TN, USA TN, Nashville, CA, USA; San Diego, San Diego, California Kampala, Uganda; Uganda; Kampala, Colorado, Denver, CO, USA CO, Denver, Colorado, Robert Heaton California Davis, Davis, CA, USA; Davis, Davis, California USA Ritchie NY, USA; USA; NY, CO, USA; USA; CO, Park, PA, USA; USA; PA, Park, Coll of Hlth Scis, Kampala, Uganda; Uganda; Kampala, Scis, Hlth of Coll Eric Daar Eric 4 DistributionMultispecies ARV in MassSpectrometry (MSI) Imaging Rosen P. Elias 1 1 CYP2B6 Genotype Effects Neurocognitive on Efavirenz on Patients HIV+ in Impairment QingMa of California Los Angeles Med Cntr, Torrance, CA, USA; Torrance, Cntr, Angeles Med Los California of NearyMegan 1 Cellular TFV-DP/FTC-TP and Genetics Transporter Pharmacology Vivo In SharonSeifertM. 1 Phenome-Wide A Phenome-Wide A5202 Clinical ACTG Trial From Data Verma Anurag 1 PK EffectCYP2B6of Levonorgestrel on Variants Gene ART EFV-Based With Combined When M. Darin M. Med Cntr, Rochester, NY, USA; USA; NY, Rochester, Cntr, Med Ramesh Akkina Aquilante Michelle Mathews CO, USA; USA; CO, Amie L. Meditz Amie China neuroAIDS Study Group Study neuroAIDS China
Session P-H4 Poster Abstracts Poster SessionP-H4 PM-4:002:45 PM Compartmentsin Pharmacokinetics 447 446 445 Session P-H3 Poster Abstracts Poster SessionP-H3 PM-4:002:45 PM Pharmacogenetics 443 444
; 7 3 ; 2 ; David ; David 2 ; 6 ; Nahida Hall A/B 6 ; Philippa Eunice Eunice 3 5 ; Alice Stek ; Alice ; Craig Sykes ; Craig 1 3 Eunice Kennedy Kennedy Eunice 7
1 Boston Univ Sch Univ of Boston 8 ; Jiajia Wang Wake Forest Univ, Univ, Forest Wake 5 5 Univ of Southern Southern of Univ 2 ; Oluseye Bolaji ; Oluseye ; Edmund Capparelli ; Edmund 1 6 Harvard Sch of PH, Bostib, Bostib, Sch PH, of Harvard 6 ; Elizabeth Smith ; Elizabeth Univ of California Los Los California of Univ Univ of California San Diego, San Diego, California of Univ ; Jose H. Pilotto 5 2 2 Univ of Southern California, California, Southern of Univ 2 5 ; Angela Kashuba ; Angela 2 ; Marco Siccardi ; Marco
1 8 ; Edmund Capparelli ; Edmund 1
Obafemi Awolowo Univ, Ile-Ife, Nigeria Ile-Ife, Univ, Awolowo Obafemi 2 Univ of Colorado Anschutz Med Anschutz Colorado of Univ 2 3 ; Alice Stek ; Alice Hosp Geral de Nova Iguaçu, Rio de Iguaçu, Nova de Geral Hosp 4 3 ; David J. Back; Steve Rannard; Andrew Andrew Rannard; Back; J. Steve ; David ; Nahida Chakhtoura
4 NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, NIAID, ; Katherine Luzuriaga ; Katherine Univ of Massachusetts Med Sch, Worcester, Sch, Med Worcester, Massachusetts of Univ 4 5 6 NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, NIAID, 6 ; Rajith Kumar Reddy Rajoli; Rajith Kumar Univ of North Carolina at Chapel Hill, Chapel Hill, NC, Hill, Chapel Hill, at Chapel North of Univ Carolina ; Andrew Owen ; Andrew ; Karin Nielsen-Saines 1 3 1 1 Brookie M. Best M. Brookie ; Jiajia Wang ; ; Brookie M. Best M. ; Brookie 3 ; Mark Mirochnick 1 1 ; Leslie St. Bernard; Jeremy Abolade; Hiroshi Mohri; Hiroshi Abolade; Jeremy Bernard; St. ; Leslie 7 Makerere Univ, Kampala, Uganda; Uganda; Kampala, Univ, Makerere 4 ; Edmund Capparelli ; Edmund 7 ; Elizabeth Smith ; Elizabeth 3 Univ of California San Diego, San Diego, CA, USA San Diego, San Diego, California of Univ Children’s Hosp Boston, Boston, MA, USA; USA; MA, Boston, Boston, Hosp Children’s 7 7 ; Avinash Shetty ; Avinash 4 ; Saye Khoo ; Saye 1 Harvard Sch of PH, Bostib, MA, USA; USA; MA, Bostib, Sch PH, of Harvard 4 Univ of Liverpool, Liverpool, UK; UK; Liverpool, Liverpool, of Univ Boston Univ Sch of Med, Boston, MA, USA; USA; MA, Boston, Sch Med, Univ of Boston Boston Univ Sch of Med, Boston, MA, USA; USA; MA, Boston, Sch Med, Univ of Boston Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ MA, USA; USA; MA, California, Los Angeles, CA, USA; Angeles, Los California, USA; USA; Campus, Aurora, CO, USA; USA; CO, Aurora, Campus, Sandra Burchett Emily BarrEmily MA, USA; USA; MA, PredictingUtility Long-Actingof Injectables in Models PBPK With Patients Paediatric Rajoli Reddy Kumar Rajith Siccardi Marco Owen; UK Liverpool, Liverpool, of Univ Breast Milk Using PBPK Modeling PBPK Using Milk Breast Olagunju Adeniyi 1 Prediction of Infant Exposure to Maternal Drugs From Drugs From PredictionMaternal to Exposure Infant of Life Life MarkMirochnick 1 Nevirapine Dosing for Treatment in the First Month ofMonth First the in Treatment for Dosing Nevirapine Mark Mirochnick 1 Rilpivirine Female Genital Tract Concentrations in Concentrations Tract Genital RilpivirineFemale Women Postpartum and Pregnant 1 Dolutegravir Pharmacokinetics in HIV-Infected in Pharmacokinetics Dolutegravir Women Postpartum and Pregnant Mulligan Nikki Martin Markowitz USA NY, York, New Cntr, Rsr AIDS Diamond Aaron Individual HIV-1 Genomes in HAND in Genomes HIV-1 Individual Evering Teresa Relative Frequency on Drugof Mutations Resistance Relative Angeles, Los Angeles, CA, USA; Angeles, Los Angeles, Los Angeles, CA, USA; Angeles, Los Musoke San Diego, CA, USA; San Diego, Chakhtoura Winston Salem, NC, USA; Salem, USA; NC, Winston Shriver NICHD, Bethesda, MD, USA Bethesda, MD, NICHD, Shriver J. Back J. Med, Boston, MA, USA MA, Boston, Med, Amanda SchauerAmanda Janeiro, Brazil; Brazil; Janeiro, Kennedy Shriver NICHD, Bethesda, MD, USA; USA; Bethesda, MD, NICHD, Shriver Kennedy
442 441 440 439 438 Session P-H2 Poster Abstracts Poster SessionP-H2 PM-4:002:45 PM and Pediatrics, Pregnancy, Clinical Pharmacology: Predictions 406 Program and Agenda
448 Single-Dose Maraviroc Provides High Drug Levels in All 473 Predictors of CD4 Count Recovery in the CIPRA HT-001 Sites: No Gender Differences Trial of Early ART Julie Fox1; JuanManuel Tiraboschi; Laura J. Else2; Carolina Herrera3; Sean E. Collins1; Michaela Calnan2; Marc Antoine Jean Juste3; Patrice Deidre Egan2; Alieu Amara2; Akil Jackson4; Robin Shattock3; David J. Severe3; Rode Secours3; Daphne Bernard3; Ashita Batavia4; Daniel W. Back2; Saye Khoo2; Marta Boffito4 Fitzgerald4; Serena P. Koenig5; Jean W. Pape3 1Guys and St Thomas’ NHS Fndn Trust, london, UK; 2Univ of Liverpool, 1Stanford Univ, Stanford, CA, USA; 2Analysis Group, Boston, MA, USA; Liverpool, UK; 3Imperial Coll London, London, UK; 4Chelsea and 3GHESKIO, Port-au-Prince, Haiti; 4Weill Cornell Med Coll, New York, NY, Westminster Hosp NHS Fndn Trust, London, UK USA; 5Brigham and Women’s Hosp, Harvard Med Sch, Boston, MA, USA 449 PK of FTC, TFV and 3TC in Ugandan and Nigerian 474 Effect of Immediate ART on Risk of Severe Bacterial Breastfeeding Mother-Infant Pairs Infections: The START Trial Catriona J. Waitt1; Adeniyi Olagunju1; Shadia Nakalema2; Isabella Jemma L. O’Connor1; Fred Gordin2; Andrew N. Phillips1; Brian Angus3; Kyohaire2; Andrew Owen1; Mohammed Lamorde2; Saye Khoo1 David Cooper4; Beatriz Grinsztejn5; Gustavo Lopardo6; Satyajit Das7; 1Univ of Liverpool, Liverpool, UK; 2Infectious Diseases Inst, Makerere Univ, Aimee Wilkin8; Jens D. Lundgren9; for the INSIGHT START Study Group Kampala, Uganda 1Univ Coll London, London, UK; 2VA Med Cntr, Washington, DC, USA; 3 4 5 450 Multispecies Differences in Drug Transporter John Radcliffe Hosp, Oxford, UK; Kirby Inst, Sydney, Australia; Inst de Pesquisa Clínica Evandro Chagas (IPEC)/Fundação Oswaldo Cruz Expression and Localization in GI Tissue (Fiocruz), Rio de Janeiro, Brazil; 6La Fundación del Centro de Estudios 1 1 2 Corbin Thompson ; Elias P. Rosen ; Paige Charlins ; Leila Remling- Infectológicos, Buenos Aires, Argentina; 7Coventry and Warwickshire NHS 2 1 1 3 Mulder ; Martina Kovarova ; Yuri Fedoriw ; Paul Luciw ; J. Victor Partnership Trust, Coventry, UK; 8Wake Forest Univ, Winston Salem, NC, 1 2 1 Garcia ; Ramesh Akkina ; Angela Kashuba USA; 9Rigshospitalet, Univ of Copenhagen, Copenhagen, Denmark 1Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2Colorado State Univ, Fort Collins, CO, USA; 3Univ of California Davis, Davis, CA, USA 475 Increased Quality of Life With Immediate ART Initiation: Results From the START Trial Session P-J1 Poster Abstracts Hall A/B Alan Lifson; Birgit Grund; for the INSIGHT START Quality of Life Study 2:45 PM-4:00 PM Group Antiretroviral Therapy: Randomized Clinical Trials Univ of Minnesota, Minneapolis, MN, USA 476 Gender and Racial Disparities in Initial Antiretroviral 470 Doravirine 100mg QD vs Efavirenz +TDF/FTC in ART- Treatment Outcome: ACTG A5257 Naive HIV+ Patients: Week 48 Results 1 2 3 1 2 3 Heather J. Ribaudo ; Raphael J. Landovitz ; Lumine H. Na ; Jeffrey Josep María Gatell ; Francois Raffi ; Andreas Plettenberg ; Don 4 4 5 6 4 5 6 7 L. Lennox ; Ighovwerha Ofotokun ; Susan E. Cohn ; Daniel Kuritzkes ; Smith ; Joaquin Portilla ; Christian Hoffmann ; Keikawus Arasteh ; 2 8 9 9 Judith S. Currier ; for the ACTG A5257 Study Team Melanie Thompson ; Xia Xu ; Hedy Teppler 1 2 1 2 Harvard Sch of PH, Boston, MA, USA; David Geffen Sch of Med at Univ Hosp Clínic de Barcelona, Barcelona, Spain; Chu Hotel Dieu-Chu De 3 3 of California Los Angeles, Los Angeles, CA, USA; Univ of Edinburgh, Nantes, Nantes, France; IFI Inst for Interdisciplinary Med, Hamburg, 4 5 4 5 Edinburgh, UK; Emory Univ Sch of Med, Atlanta, GA, USA; Northwestern Germany; Albion Cntr, Sydney, Australia; Univ Miguel Hernandez, Univ, Chicago, IL, USA; 6Harvard Med Sch, Boston, MA, USA Alicante, Spain; 6IPM StudyCntr, Hamburg and Univ of SchleswigHolstein, Campus Kiel, Hamburg, Germany; 7EPIMED/Vivantes Auguste-Viktoria- Poster Listings Poster Klinikum, Berlin, Germany; 8AIDS Rsr Consortium of Atlanta, Atlanta, GA, Session P-L2 Poster Abstracts Hall A/B USA; 9Merck & Co, Inc, Kenilworth, NJ, USA 2:45 PM-4:00 PM 471 Tolerability and Acceptability of Cabotegravir LA HIV Drug Resistance: Clinical and Epidemiologic Studies Injection: Results From ECLAIR Study 495 More Efficacious Drugs Lead to Hard Selective Sweeps Miranda I. Murray1; Martin Markowitz2; Ian Frank3; Robert Grant4; in HIV Drug Resistance Evolution Kenneth H. Mayer5; David A. Margolis6; Krischan J. Hudson7; Britt S. Alison F. Feder1; Soo-Yon Rhee1; Robert W. Shafer1; Dmitri A. Petrov1; Stancil; Alex R. Rinehart; William Spreen6 Pleuni S. Pennings2 1ViiV Hlthcare, Brentford, UK; 2Aaron Diamond AIDS Rsr Cntr, New York, 1Stanford Univ, Stanford, CA, USA; 2San Francisco State Univ, San NY, USA; 3Perelman Sch of Med, Univ of Pennsylvania, Philadelohia, Francisco, CA, USA 4 5 PA, USA; Univ of California San Francisco, San Francisco, CA, USA; The 496 Pooled Week 48 Analysis of HIV-1 Drug Resistance in Fenway Inst, Fenway Hlth, Boston, MA, USA; 6ViiV Hlthcare, Research Triangle Park, NC, USA; 7ViiV Hlthcare, Reserach triangle Park, NC, USA E/C/F/TAF Phase 3 Studies Michael Abram; Nicolas A. Margot; Stephanie Cox; Renee R. Ram; 472 Attachment Inhibitor Prodrug BMS-663068 in ARV- Danielle P. Porter; Kathryn M. Kitrinos; Marshall Fordyce; Scott Experienced Subjects: Week 96 Analysis McCallister; Michael Miller; Christian D. Callebaut Edwin DeJesus1; Marcelo Martins2; Albrecht Stoehr3; Jaime Andrade- Gilead Scis, Inc, Foster City, CA, USA 4 5 6 6 Villanueva ; Natalia Zakharova ; David A Stock ; Cyril Llamoso ; Samit 497 HIV Drug Resistance Testing Among Patients New to R. Joshi6; George J. Hanna7; Max Lataillade6 1Orlando Immunology Cntr, Orlando, FL, USA; 2Inst Oulton, Córdoba, HIV Care in the United States 1 1 1 1 Argentina; 3IFI Inst for Interdisciplinary Med, Hamburg, Germany; 4Hosp Angela L. Hernandez ; Eduardo Valverde ; John Weiser ; Linda Beer ; 2 1 1 Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico; 5St Yunfeng Tie ; M. Cheryl Banez Ocfemia ; Alexandra M. Oster 1 2 Petersburg AIDS Cntr, St Petersburg, Russian Federation; 6Bristol-Myers CDC, Atlanta, GA, USA; ICF Intl, Atlanta, GA, USA Squibb, Wallingford, CT, USA; 7Bristol-Myers Squibb, Princeton, NJ, USA
86 CROI 2016 Poster Listings 87 ; 2 ; ; 6 4 ; 5 ; Anelet ; Anelet ; Eric ; Eric 1 3 Hall A/B Makerere Makerere 7 Univ of Univ ; Guillemette ; Guillemette CROI 2016 8 7 Hosp de l’Archet, l’Archet, de Hosp 4 Desmond Tutu Desmond Tutu ; Helen Ayles ; Helen INSERM SC10- INSERM 2 ; Patrick ; Patrick 5 ZAMBART, Lusaka, Lusaka, ZAMBART, 2 6 UrviParikh M. 3 ; Susanne Doblecki- 1 ; Univ of California California of Univ 9 London Sch of Hygiene Sch Hygiene of London 2 6 Hopital Saint-Louis, Saint-Louis, Hopital 8 ; Rashika Maharaj ; Wairimu Chege ; Wairimu study group study group 3 DAIDS, NIAID, NIH, NIH, NIAID, DAIDS, 1 Program Agenda and Fred Hutchinson Cancer Cancer Hutchinson Fred 5 ; Nadia Mahjoub CISIH, Nantes, France; France; Nantes, CISIH, 3 ; Kelsey Donohue ; Kelsey
2 6 1 1 ve Detection of Acute ve PERGAY ; Marie Laure Chaix ; Marie Laure Univ of Miami, Miami, FL, USA; FL, USA; Miami, Miami, of Univ 6 3 Stellenbosch Univ and NHLS NHLS and Univ Stellenbosch ; Gert U. van Zyl van ; GertU. 5 4 1 ; Stephanie Cohen ; Stephanie Univ of Zimbabwe, Univ of California San California of Univ Zimbabwe, of Univ 2 ; Albert Y. Liu Y. ; Albert 9 ; Clifton W. Kelly W. ; Clifton ; Shauna Wolf 3 2 ; Z Michael Chirenje 1 ; for the I ; for
8 8 South African Med Rsr Council, Durban, Durban, Council, Rsr Med South African 4 ; Isabelle Charreau ; Isabelle 1 ; Susan P. Buchbinder ; Susan P. 4 Hosp Saint-Louis, Paris, France; France; Paris, Saint-Louis, Hosp ; Nolween Hall ; Nolween 3 5 ; Young Alicia 3 ; Rosetta Lindiwe Nhlangulela ; Rosetta Lindiwe George Washington Univ Sch of Med, Washington, Washington, Sch Med, Univ of Washington George 5 6 ; Amy L. Opest ; Amy ; Vittinghoff Eric ; Susan Eshleman H. 1 1 DRON Hosp, Tourcoing, France; France; Tourcoing, DRON Hosp, 6 ; Michael Kolber Cntr for the AIDS Prog of Rsr in South Africa, Durban, South Durban, South in Africa, Rsr of Prog AIDS the for Cntr 5 6 5 ; Jeanne Marrazzo 7 SCHARP, Seattle, WA, USA; USA; WA, Seattle, SCHARP, 4 Aurum Inst for Hlth Rsr, Johannesburg, South Africa; South Africa; Johannesburg, Rsr, Hlth for Inst Aurum ; Jean-Michel Molina ; BarryKosloff 6 2 ; Megan Coleman 2 Univ of Pittsburgh, Pittsburgh, PA, USA; USA; PA, Pittsburgh, Pittsburgh, of Univ 3 2 ; Armelle Pasquet ; Armelle 4 San Francisco Dept of PH, San Francisco, CA, USA; Dept San PH, of Francisco, San Francisco USA; DC, Washington, Hlth, Whitman-Walker Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, of Univ Hopkins Johns Magee-Womens Hosp of the Univ of Pittsburgh Med Cntr, Pittsburgh, PA, PA, Pittsburgh, Cntr, Med Pittsburgh of Univ the of Hosp Magee-Womens Hosp Saint Louis et Univ Paris Diderot, Paris, France; France; Paris, Diderot, Paris Univ et Saint Louis Hosp France; Paris, Diderot, Paris Univ U941, INSERM Francisco Collaborative Rsr Prog, Harare, Zimbabwe Harare, Prog, Rsr Collaborative Francisco Tygerberg Business Unit, Tygerberg, South Africa; South Africa; Tygerberg, Unit, Business Tygerberg & Trop Med, London, UK London, Med, Trop & San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, Paris, France; France; Paris, Richard Hayes Richard Karugaba USA; USA; Univ Johns Hopkins Univ Rsr Collab Lab, Kampala, Uganda; Uganda; Kampala, Lab, Collab Rsr Univ Hopkins Johns Univ South Africa; South Africa; Zambia; Zambia; DC, USA DC, Paris, France Paris, 1 4 HIV Testing in the US PrEP Demonstration Project: Demonstration PrEP US the rEIA in Testing HIV RNA Antigen/Antibody vs vs Bacon Oliver Usefulness of Rapid Tests for HIV DiagnosisHIV ANRSthe in for Tests Rapid of Usefulness Trial PrEP IPERGAY Delaugerre Constance 1 1 7 InfectionsHIV Identify to Assay Automated an of Use Survey Africain Population a in Piwowar-Manning Estelle 4th Generation Rapid Tests Impro Tests Rapid 4th Generation (VOICE) InfectionMTN-003 in Livant Edward Rsr Cntr, Seattle, WA, USA; USA; WA, Seattle, Cntr, Rsr US19, Villejuif, France; France; Villejuif, US19, Lewis Richard Elion Richard 1 James TB Cntr, Stellenbosch Univ, Cape Town, South Africa; South Africa; Town, Cape Univ, Stellenbosch Cntr, TB Africa; Africa; Natasha Samsunder Natasha Cua Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, Antoni for the VOICE Study Team for the VOICE Team Study Bethesda, MD, USA; USA; Bethesda, MD,
524 522 523 Session P-M2 Poster Abstracts Poster SessionP-M2 PM-4:002:45 PM DetectionHIV Clinicalin Trials 521 ; 1
; ; ; 4 2 1 1 ; Kishor ; 5 4 ; M. Cheryl ; Maureen ; Maureen Emory Univ Amsterdam Amsterdam 1 1 5 4
1
1 Brown Univ, Univ, Brown 7 ; Clement ; Clement ; Ahmad Aliyu ; Ahmad ; Wilkinson Eduan 2 1 2 Lagos Univ Teaching Teaching Univ Lagos ; Joanne Gerber 5 ; Tulio de Oliveira Tulio ; 2 Stanford Univ, Univ, Stanford 2 ; Raph Hamers 2 ; Robert W. Shafer W. ; Robert 3 7 ; for the PanAfrican the PanAfrican ; for Univ of Albany Sch PH, of Albany of Univ 1
2 1 Inst of Human Virology, Virology, Human of Inst 3 ; Sulaimon Akanmu 4 ; Pascale Ondoa ; Pascale 1 Inst of Human Virology, Univ Univ Virology, Human of Inst 2 ; Patrick Dakum ; Patrick 3 Lusaka Trust Hosp, Lusaka, Lusaka, Hosp, Trust Lusaka 3 ; Angela L. Hernandez L. ; Angela ; James Okuma ; Walits Emily 1 ; Alexandra M. Oster ; Alexandra ; Anne Derache ; Anne 1 1 2 1 ; Deenan Pillay ; Rami Kantor ; Alash’le Abimiku ; Alash’le ; Kim Sigaloff; Kim 3 6 1 1 e Poor Predictors of Virologic Virologic Predictors of Poor e Univ of KwaZulu-Natal, Durban, South Durban, KwaZulu-Natal, of Univ 4 ; Cissy Kityo ; Cissy ; Nicaise Ndembi CDC, Atlanta, GA, USA; Atlanta, CDC, 3 2 6 ; Raph Hamers ; Bridget Anderson 1 1 ICF Intl, Atlanta, GA, USA Atlanta, Intl, ICF 2 ; H. Irene Hall ; H. Irene Coast Province General Hosp, Mombasa, Kenya Hosp, General Province Coast ; for the TenoRes Study Team Team Study TenoRes the ; for 1 ssociation of HIV Whole GenomesWhole HIV of ssociation 6 8 Univ Coll London, London, UK London, London, Coll Univ 8 ; Elliot Raizes ; Elliot ; Daniel Gordon ; Siva Davaniah ; Siva Inst of Human Virology, Abuja, Nigeria; Abuja, Nigeria; Virology, Human of Inst 5 ; Fati M. Ibrahim ; Fati 1 1 3 1 ; Neeraja Saduvala ; Neeraja ; Charles Mensah ; Charles 1 ; Michelle Tang 1 ; Lou Smith ; Lou 1 ; Manhattan E. Charurat ; Manhattan 1 ; Ravindra K. Gupta; Ravindra 2 2 ; Margaret Siwale ; Margaret ; Tobias Rinke ; Tobias Wit de 2 6 Joint Clinical Rsr Cntr, Kampala, Uganda; Uganda; Kampala, Cntr, Rsr Clinical Joint 4 Africa Cntr for Hlth and Pop Studies, Mtubatuba, South Africa; South Africa; Mtubatuba, Studies, Pop and Hlth for Cntr Africa 2 London Sch of Hygiene & Trop Med, London, UK; UK; London, Med, & Trop Sch Hygiene of London Inst of Human Virology, Abuja, Nigeria; Abuja, Nigeria; Virology, Human of Inst New York State Dept of Hlth, Albany, NY, USA; USA; NY, Albany, Dept Hlth, of State York New CDC, Atlanta, GA, USA; Atlanta, CDC, Wellcome Trust Africa Cntr for Hlth and Pop Studies, Somkhele, South Somkhele, Studies, Pop and Hlth for Cntr Africa Trust Wellcome UK; London, London, Coll Univ Amsterdam Inst for Global Hlth and Develop, Amsterdam, Netherlands; Netherlands; Amsterdam, Develop, and Hlth Global for Inst Amsterdam Zimbabwe; Harare, Clinic, Newlands Providence, RI, USA; USA; RI, Providence, Baltimore, MD, USA MD, Baltimore, Banez OcfemiaBanez Adebamowo Stanford, CA, USA; Stanford, Albany, NY, USA NY, Albany, Africa Wellington Zambia; Zambia; Mandaliya Africa; Africa; Studies to Evaluate Resistance (PASER) study group group study (PASER) Resistance Evaluate to Studies of Maryland Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Marylandof Sch Med, of Samuel Peters Inst for Global Hlth and Develop, Amsterdam, Netherlands; Netherlands; Amsterdam, Develop, and Hlth Global for Inst 1 Global Tenofovir Resistance Following 1st-Line Following Resistance Tenofovir Global Infection HIV-1 Adult for Regimens John Gregson 1 Immunologic Criteria Ar Immunologic Criteria OutcomesNigeriain NicaiseNdembi HIV Integrase Genotypic Resistance Testing Among Testing Genotypic Resistance Integrase HIV York New in Persons HIV-Infected Wang Zhengyan 1 Testing in the United States United the in Testing SharodaDasgupta 1 3 TimingGenotypicof Drug HIV Resistance and Receipt Genome-Wide A Genome-Wide Drug Resistance Into Insights Provides RobertPower A. 1 1 2 Treatment Failure in Sub-Saharanin Failure Africa Treatment Sonia Boender Tamara Protease Inhibitor Resistance at 2nd-line HIV 2nd-line at Resistance Inhibitor Protease Hosp, Lagos, Nigeria; Nigeria; Lagos, Hosp, Deepa Rajulu Vincent C. Marconi Vincent Frank Tanser Frank Sch of Med, Atlanta, GA, USA; Atlanta, Sch Med, of Ravindra K. Ravindra Gupta
503 502 501 500 499 498 Program and Agenda
Session P-N5 Poster Abstracts Hall A/B 566 Tenofovir and the Incidence of Hepatocellular 2:45 PM-4:00 PM Carcinoma in HIV/HBV-Coinfected Persons HBV Infection: Prevalence, Prevention, and Gilles Wandeler1; David Kraus2; Peter Reiss3; Lars Peters4; Francois Prognosticators Dabis5; Jan Fehr6; Marc van der Valk7; Lars Gjaerde4; Fabrice Bonnet8; Andri Rauch9 562 Early Mortality Risk of HIV/Hepatitis B Virus Coinfected 1Univ Hosp Bern, Bern, Switzerland; 2Inst of Social and Preventive Med, Patients Initiating ART Univ of Bern, Bern, Switzerland; 3Amsterdam Inst for Global Hlth and Mbae M. Japhet1; Amos Ndhere2; Stanley Ndwiga3; Elisha Kirwa4; Develop, Amsterdam, Netherlands; 4Copenhagen HIV Prog, Copenhagen, Ram Yogev5; Robert Murphy6; Joseph N. Jarvis7 Denmark; 5INSERM U897, ISPED, Univ de Bordeaux, Bordeaux, France; 1Consolata Hosp Mathari, Nyeri, Kenya; 2Africa Clinical Rsr Mgmt, LLC, 6Univ Hosp Zurich, Zurich, Switzerland; 7Academic Med Cntr, Amsterdam, Kisumu, Kenya; 3Gertrude’s Children’s Hosp, Nairobi, Kenya; 4Kenyatta Netherlands; 8Univ Hosp Bordeaux, Bordeaux, France; 9Bern Univ Hosp Natl Hosp, Nairobi, Kenya; 5Ann and Robert H. Lurie Children’s Hosp of and Univ of Bern, Bern, Switzerland Chicago, Chicago, IL, USA; 6Northwestern Univ, Feinberg Sch of Med, 7 567 Dually Active HIV/HBV Antiretrovirals Protect Against Chicago, IL, USA; Botswana Univ of Pennsylvania Partnership, Gaborone, Incident Hepatitis B Infections Botswana Mohaned Shilaih1; Alex Marzel1; Alexandra L. Calmy2; Katharine 563 Incidence and Risk Factors for Hepatitis B in HIV- Darling3; Manuel Battegay4; Matthias Hoffmann5; Enos Bernasconi6; Infected Adults in Rakai, Uganda Alexandra Scherrer7; Huldrych F. Günthard7; Roger Kouyos7; for the Emmanuel Seremba1; Victor Ssempijja2; Sarah Kalibbala3; Ronald Swiss HIV Cohort Study H. Gray4; Maria J. Wawer4; Fred Nalugoda5; Corey Casper6; Ponsiano 1Univ Hosp Zurich, Zürich, Switzerland; 2Univ Hosp Geneva, Univ of Ocama1; David Serwadda7; Reynolds Steven8 Geneva, Geneva, Switzerland; 3CHUV, Lausanne, Switzerland; 4Univ 1Makerere Univ Coll of Hlth Scis, Kampala, Uganda; 2Leidos Biomed Rsr, Hosp Basel, Basel, Switzerland; 5Kantonsspital St Gallen, St Gallen, Inc, Frederick, MD, USA; 3Rakai Hlth Scis Prog, Rakai, Uganda; 4Johns Switzerland; 6Regional Hosp Lugano, Lugano, Switzerland; 7Univ Hosp Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; 5Rakai Hlth Scis Prog, Zürich, Zürich, Switzerland Entebbe, Uganda; 6Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 7 8 568 Alcohol Use, Hepatitis B and Liver Fibrosis Among Makerere Univ Schoool of PH, Kampala, Uganda; Johns Hopkins Univ, HIV-Infected Persons in West Africa Baltimore, MD, USA Antoine Jaquet1; Gilles Wandeler2; Marcellin Nouaman3; Didier 564 Long-Term Changes in Liver Fibrosis in HIV and HIV/ Ekouevi4; Judicaël Tine5; Ahuatchi P. Coffie3; Aristophane Tanon6; HBV Infected Nigerians on ART Moussa Seydi5; Alain Attia7; Francois Dabis1 Jennifer L. Grant1; Oche Agbaji2; Muazu Muhammad2; Placid 1INSERM U897, ISPED, Univ de Bordeaux, Bordeaux, France; 2Univ Hosp Ugoagwu2; McHenry Stephen3; Chloe Thio4; Agaba Patricia2; Robert Bern, Bern, Switzerland; 3Prog PACCI, CHU Treichville, Abidjan, Côte Murphy5; Claudia Hawkins1 d Ivoire; 4INSERM U897, ISPED, Univ de Bordeaux, Abidjan, Côte d Ivoire; 1Northwestern Univ, Chicago, IL, USA; 2Jos Univ Teaching Hosp, Jos, 5CHU de Fann, Dakar, Senegal; 6CHU de Treichville, Abidjan, Côte d lvoire; Nigeria; 3AIDS Prevention Initiative in Nigeria, Ltd, Jos, Nigeria; 4Johns 7CHU de Yopougon, Abidjan, Côte d'Ivoire 5 Hopkins Univ, Baltimore, MD, USA; Northwestern Univ, Feinberg Sch of 569 Baseline IL-18 Level Is Associated With HBeAg Med, Chicago, IL, USA Seroconversion in HIV/HBV Coinfection 1 1 1 1 1 Poster Listings Poster 565 Changes in Viral Hepatitis Screening Practices Over Yijia Li ; Jing Xie ; Yang Han ; Huanling Wang ; Nidan Wang ; Ting Time in African HIV Clinics Zhu1; Xiaojing Song1; Yanling Li1; Chloe Thio2; Taisheng Li1 Ahuatchi P. Coffie1; Matthias Egger2; Michael Vinikoor3; Marcel 1Peking Union Med Coll Hosp, Beijing, China; 2Johns Hopkins Univ, Zannou4; Lameck Diero5; Akouda Patassi6; Ponsiano Ocama7; Francois Baltimore, MD, USA 8 2 Dabis ; Gilles Wandeler 570 HBsAg Mutations Correlate With HCC, Affect HBsAg 1Prog PACCI, CHU Treichville, Abidjan, Côte d Ivoire; 2Univ Hosp Bern, 3 Release, and Favor Cell Proliferation Bern, Switzerland; Cntr for Infectious Disease Rsr in Zambia, Lusaka, 1 1 1 2 4 Valentina Svicher ; Romina Salpini ; Matteo Surdo ; Nadia Warner ; Zambia; Cntr de Prise en Charge des Personnes Vivant Avec le VIH, CHNU, 1 1 5 6 Michela Pollicita ; Francesca Ceccherini-Silberstein ; Massimo Cotonou, Benin; Moi Univ, Eldoret, Kenya; Univ Sylvanus Olympio, Lomé, 3 3 2 4 7 8 Andreoni ; Mario Angelico ; Stephen Locarnini ; Carlo Federico Perno Togo; Makerere Univ Coll of Hlth Scis, Kampala, Uganda; INSERM U897, 1 2 ISPED, Univ de Bordeaux, Bordeaux, France Univ of Rome Tor Vergata, Rome, Italy; Victorian Infectious Diseases Reference Lab, Victoria, Australia; 3Tor Vergata Univ, Rome, Italy; 4Univ of Rome Tor Vergata, Roma, Italy
88 CROI 2016 Poster Listings 89 ; 1 ; 8 ; ; John 4 3 Merck & Merck Hall A/B ; Jean- 8 1 Univ of Univ 6 CROI 2016 NIH, Bethesda, NIH, 4 ; Anuoluwapo ; Anuoluwapo ; Lila Poiteau 3 1 ; Wahl Janice 7
6 Hosp of the Univ Univ the of Hosp 5 Program Agenda and Inst of Human Virology, Virology, Human of Inst ; Michael Manns 2 2 VA Pittsburgh Hlthcare Hlthcare Pittsburgh VA 2 ; Raymond T. Chung T. ; Raymond Royal Free Hosp Univ Coll Coll Univ Hosp Free Royal 3 2 ; Hongmei Mo ; Hongmei ; Eric Lawitz ; Eric 2 6 Indiana Univ Sch of Med, Sch Med, Univ of Indiana 6 ; Stephane Chevaliez ; Stephane 2 Univ of Cincinnati, Cincinnati, Cincinnati, Cincinnati, of Univ 5 ; Shyam Kottilil ; Shyam ; Alexandre Soulier ; Alexandre 5 1 Inst Mondor de Recherche Biomédicale Biomédicale Recherche de Mondor Inst 2 ; Paul Kwo ; Paul Univ of Pittsburgh, Pittsburgh, PA, USA; USA; PA, Pittsburgh, Pittsburgh, of Univ 5
3 ; Obaid Shaikh 2 ; Anita Kohli ; Anita Texas Liver Inst, San Antonio, TX, USA; San Antonio, Inst, Liver Texas 4 7 Medizinische Hochschule Hannover, Hannover, Hannover, Hannover, Hochschule Medizinische ; for the ERCHIVES Study Group Group the ERCHIVES Study ; for ; Geoffrey M. Dusheiko ; Geoffrey ; Sarah Kattakuzhy 3 5 Gilead Scis, Inc, Foster City, CA, USA; City, Foster Inc, Scis, Gilead 1 1 3
1 ; Arne Frantzell; Christos Petropoulos; Wei Huang Wei Petropoulos; Christos Frantzell; ; Arne ; Yan Peng
1 ; Christophe Rodriguez ; Christophe ; Christophe Hezode ; Christophe 8 1 1 ; Alicia Newton; Arne Frantzell; Jennifer Cook; Dongmei Cook; Jennifer Frantzell; Arne Newton; ; Alicia ; RajenderReddy 4 Baylor Coll of Med, Houston, TX, Houston, USA; Med, of Coll Baylor Dignity Hlth, St. Joseph’s Hosp, Phoenix, AZ, USA; USA; AZ, Phoenix, Hosp, Joseph’s Dignity St. Hlth, 4 5 ; Henry Masur 3 Hamad Hlthcare Quality Inst, Doha, Qatar; Quality Inst, Hlthcare Hamad USA; MA, Sch, Med Boston, Harvard Inst of Human Virology, Baltimore, MD, USA; USA; MD, Baltimore, Virology, Human of Inst INSERM U955, Créteil, France; France; Créteil, U955, INSERM Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns Kenneth E. Sherman Kenneth Indianapolis, IN, USA; USA; IN, Indianapolis, Maryland Med Cntr, Baltimore, MD, USA MD, Baltimore, Maryland Cntr, Med System, Pittsburgh, PA, USA; USA; PA, Pittsburgh, System, London, London, UK; UK; London, London, of Pennsylvania, Philadelphia, PA, USA; USA; PA, Philadelphia, Pennsylvania, of OH, USA OH, EfficacySafetyand in Sofosbuvir-BasedRegimens of ClinicalPractice Butt A. Adeel 1 4 Polymorphisms at Codon 28 of HCVof 28 Codon at Impact NS5A Polymorphisms NS5A Susceptibility Inhibitor Newton Alicia CA, USA South San BioScis, Francisco, Monogram GenotypicPhenotypicand Characterization Clinicalof HCVDrugNS5A Resistance Huang Wei Whitcomb; M. Jeannette Walworth; M. Charles Volpe; Joseph M. Yang; Petropoulos Christos Reeves; D. Jacqueline CA, USA South San BioScis, Francisco, Monogram NIAIDthe From Data Variants: Associated Resistance Trial SYNERGY Eleanor Wilson M. 1 1 M. Vierling M. 1 HCV Across Daclatasvir/Sofosbuvir to Resistance Life GenotypesReal the in Different SlimFourati Marion Lavert Safety and Tolerability of Elbasvir/Grazoprevir in Elbasvir/Grazoprevir of SafetyTolerability and InfectionC ChronicHepatitis MarkSulkowski S. Osinusi Bethesda, MD, USA; USA; Bethesda, MD, Barbara Haber Co, Inc, Kenilworth, NJ, USA NJ, Kenilworth, Inc, Co, MD, USA; USA; MD, INSERM U955, Créteil, France Créteil, U955, INSERM Michel Pawlotsky Germany; Germany;
Session P-N7 Poster Abstracts Poster SessionP-N7 PM-4:002:45 PM HCVObservationaland Experiences Therapeutics: Studies “Real-World” 581 578 579 580 577 576
1 ; 3 ; 4 Hosp Hosp ; 7 7 ; ; John G. 7 Hall A/B ; Marino 4 Peter J Peter 3 ; Jesús 7 3 Hosp Clínic Clínic Hosp Hosp Clínic Clínic Hosp 2 2 Hosp General General Hosp 6 ; Jenny C. ; Jenny 3 Duke Univ Sch Univ of Duke 2 ; Fiona McPhee ; Fiona ; Yiran B. Hu B. Yiran ; 1
Hosp Clinic-IDIBAPS, Clinic-IDIBAPS, Hosp 3 6 9 Univ of Alabama at Alabama of Univ ; for the Spanish; for 2 8 ; Jacob Lalezari ; Jacob Hosp Universitario Vall Vall Universitario Hosp Hosp Universitario 12 Universitario Hosp 3 7 5 ; Lluis Castells ; for the Spanish Liver the Spanish; for Liver 6 9 Hosp de Bellvitge-IDIBELL, Bellvitge-IDIBELL, de Hosp ; Itxarone Bilbao ; Itxarone Mount Sinai Hosp, New New Sinai Hosp, Mount ; Philip S. Pang 8 6 5 4 Hosp Ramon y Cajal, Cajal, y Ramon Hosp Bristol-Myers Squibb, Squibb, Bristol-Myers 4 2 ; Antoni Rafecas ; Antoni ; Miguel Montejo Ruth M. Rothstein CORE Cntr, Cntr, CORE Rothstein M. Ruth 2 2 5 ; Amit Khatri ; Amit 6 ; Nannan Zhou ; Nannan ; MichaelSaag S. AbbVie Inc, North Chicago, IL, USA; North Inc, Chicago, AbbVie 2 2 3 ; José M. Miro ; Roger Trinh 1 2 ; Mark Sulkowski
5 7 ; José M. Miro Hosp de Bellvitge-IDIBELL, Univ of Univ Bellvitge-IDIBELL, de Hosp Hosp Universitario Cruces, Barakaldo, Barakaldo, Cruces, Universitario Hosp 1 3 3 mbitasvir/Paritaprevir/ tors of Acute Rejection Acute of tors HIV+in Hosp Clinic-IDIBAPS, Univ de Barcelona, Barcelona, de Univ Clinic-IDIBAPS, Hosp
8 Hosp Ramon y Cajal, Madrid, Spain; Spain; Madrid, Cajal, y Ramon Hosp ; Santos del Campo ; Santos 6 5 Univ of Alabama at Birmingham, Birmingham, Birmingham, at Birmingham, Alabama of Univ ; Magdalena Salcedo ; Hadas Dvory-Sobol 3 5 ; Fernando Aguero ; Fernando ; Fernando Aguero ; Fernando 4 1 1 ; Laveeza Bhatti ; Laveeza ; Saumya Pant ; Saumya 5 1 ; Peter Ruane ; Peter ; SusannaNaggie ; Antoni Rimola ; Antoni 3 1 1 AIDS Hlthcare Fndn, Beverly Hills, CA, USA; Hills, Beverly Fndn, Hlthcare AIDS ; MichaelSaag S. 6 1 ; Antoni Rimola ; Antoni Hosp Universitari La Fe, Valencia, Spain; Spain; Valencia, Fe, La Universitari Hosp 8 Johns Hopkins Univ, Baltimore, MD, USA MD, Baltimore, Univ, Hopkins Johns 5 6 ; Douglas Dieterich 4 Gilead Scis, Inc, Foster City, CA, USA; City, Foster Inc, Scis, Gilead 4 ; Marino Blanes ; Manuel Abradelo Hosp Universitari La Fe, Valencia, Spain; Spain; Valencia, Fe, La Universitari Hosp 4 4 4 ; Luisa M. Stamm ; Luisa 4 Bristol-Myers Squibb, Wallingford, CT, USA; USA; CT, Wallingford, Squibb, Bristol-Myers Quest Clinical Rsr, San Francisco, CA, USA; San Francisco, Rsr, Quest Clinical Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ Ottawa Hosp - Univ of Ottawa, Ottawa, ON, Canada; Canada; ON, Ottawa, Ottawa, of - Univ Hosp Ottawa Hosp Clinic-IDIBAPS-Univ of Barcelona, Barcelona, Spain; Barcelona, Barcelona, of Clinic-IDIBAPS-Univ Hosp Hosp Clinic-IDIBAPS-Univ of Barcelona, Barcelona, Spain; Barcelona, Barcelona, of Clinic-IDIBAPS-Univ Hosp Barcelona, L’ Hospitalet de Llobregat, Spain; Llobregat, de Hospitalet L’ Barcelona, Spain; de Octubre, Madrid, Spain; Madrid, Octubre, de Oluwatoyin Adeyemi Oluwatoyin Universitario Gregorio Marañón, Madrid, Spain; Madrid, Marañón, Gregorio Universitario Antoni Rafecas Antoni Med, Durham, NC, USA; USA; NC, Durham, Med, AL, USA; AL, USA; Birmingham, Birmingham, AL, USA; AL, USA; Birmingham, Birmingham, Ruane MD, Inc, Los Angeles, CA, USA Angeles, Los Inc, MD, Ruane Universitario Vall d Vall Universitario Spain; Barcelona, Hebron, Foundation for AIDS Research and Prevention, Liver Transplantation Transplantation Liver and Prevention, AIDS Research for Foundation Investigators AsunciónMoreno Madrid, Spain; Spain; Madrid, NS5A and NS5B Minor Variant Analyses in HCV/HIV in Analyses Variant Minor NS5B and NS5A With DCV/SOF Treatment Failing Patients Hernandez Dennis 1 4 r+Dasabuvir+RBV for HCV/HIV r+Dasabuvir+RBVfor Coinfection David Wyles L. 1 TURQUOISE-I PartO 1b: CurtisCooper L. 1 Retreatment of HCV/HIV-Coinfected Patients Who HCV/HIV-Coinfectedof Retreatment Patients LDV/SOF of Weeks 12 Failed 1 d Spain; Barcelona, Hebron, ChristianManzardo Incidence and RiskIncidence and Fac Recipients Transplant Liver 1 A CohortA Study ChristianManzardo Liver Transplantation in HIV/HBV-Coinfected Patients: HIV/HBV-Coinfected in Patients: Transplantation Liver Univ of Barcelona, L’ Hospitalet de Llobregat, Spain; Spain; Llobregat, de Hospitalet L’ Barcelona, of Univ de Barcelona, Barcelona, Spain; Spain; Barcelona, Barcelona, de de Barcelona, Barcelona, Spain; Spain; Barcelona, Barcelona, de Chicago, IL, USA; IL, USA; Chicago, Nancy S. Shulman Yang York, NY, USA; USA; NY, York, Transplantation in HIV-Infected Patients Working Group. Group. Working Patients in HIV-Infected Transplantation Barcelona, Spain Barcelona, Princeton, NJ, USA NJ, Princeton, McHutchison Fortún Univ de Barcelona, Barcelona, Spain Barcelona, Barcelona, de Univ Blanes
575 574 573 2:45 PM-4:002:45 PM HCV StudiesTherapeutic Infection: and Drug Resistance 572 Session P-N6 Poster Abstracts Poster SessionP-N6 571 Program and Agenda
582 Response to DAA-Based Regimens in HIV-HCV 587 Success of Direct-Acting Antivirals for Hepatitis C in an Coinfected Patients in Real Life, France Indigent Population Lionel Piroth1; Linda Wittkop2; Karine LaCombe3; Eric Rosenthal4; Christina Yek1; Carolina De La Flor1; Amit Singal1; Mamta K. Jain2; Camille Gilbert5; Patrizia Carrieri6; Francois Dabis7; Philippe Sogni8; Ting-Yi Chen1; Cindy L. Zoellner1; Christian Mayorga1; Lisa Casey1 Dominique Salmon-Ceron8; for the ANRS CO13 HEPAVIH Study Group 1Univ of Texas Southwestern, Dallas, TX, USA; 2Univ of Texas 1CHU Dijon, Dijon, France; 2CHU de Bordeaux, Bordeaux, France; Southwestern Med Cntr, Dallas, TX, USA 3 4 5 Sorbonne Univs, Paris, France; CHU Nice, Nice, France; INSERM, 588 Ledipasvir/Sofosbuvir Failures in the Real World: What Bordeaux, France; 6INSERM, Marseille, France; 7INSERM U897, ISPED, Univ de Bordeaux, Bordeaux, France; 8INSERM-APHP, Hosp Cochin, Patients Are at Risk? 1 1 1 Paris, France Dost Sarpel ; Alyson Harty ; Donald Gardenier ; Ponni Perumalswami2; Michael P. Mullen1; Ira M. Jacobson3; Andrea Branch1; 583 Multidisciplinary Approach for the Treatment of 1155 Douglas Dieterich2 HCV/HCV-HIV Coinfected Patients 1Icahn Sch of Med at Mount Sinai, New York, NY, USA; 2Mount Sinai Hosp, Isabelle Poizot-Martin1; Albert Darque2; Isabelle Ravaux3; Amélie New York, NY, USA; 3Mount Sinai Beth Israel, New York, NY, USA 3 3 3 1 Ménard ; Catherine Dhiver ; Christelle Tomei ; Sylvie Brégigeon ; Marc 589 Dolutegravir and Outcome of HCV Therapy With Direct- Bourlière4; Isabelle Portal5; Danielle Botta-Fridlund5 1APHM Hosp Sainte-Marguerite, Marseille, France; 2Pharmacie CHU Acting Antiviral Agents 1 2 3 4 Conception, Assistance Publique Hôpitaux de Marseille, Marseille, France; Stefan Mauss ; Patrick Ingiliz ; Dietrich Hueppe ; Thomas Lutz ; 5 6 7 3Inst Hospo Universitaire Méditerranée Infection, Marseille, France; 4Hosp Karl Georg Simon ; Knud Schewe ; Christoph Boesecke ; Guenther 1 2 8 St Joseph, Marseille, France; 5CHU Timone, AP-HM, Marseille, France Schmutz ; Axel Baumgarten ; Stefan Christensen 1Cntr for HIV and Hepatogastroenterology, Duesseldorf, Germany; 584 Directly Acting Agents Against HCV Results From the 2Med Cntr for Infectious Diseases, Berlin, Germany; 3Practice for German Hepatitis C Cohort (GECCO) Gastroenterology Herne, Herne, Germany; 4Infektiologikum, Frankfurt/ Stefan Christensen1; Stefan Mauss2; Dietrich Hueppe3; Thomas Lutz4; Main, Frankfurt, Germany; 5Practice for Gastroenterology Leverkusen, Knud Schewe5; Jürgen K. Rockstroh6; Axel Baumgarten7; Karl Georg Leverkusen, Germany; 6ICH Hamburg, Hamburg, Germany; 7Univ Hosp Simon8; Heiner Busch1; Patrick Ingiliz7 Bonn, Bonn, Germany; 8Cntr for Interdisciplinary Med, Muenster, 1Cntr for Interdisciplinary Med, Muenster, Germany; 2Cntr for HIV Germany and Hepatogastroenterology, Duesseldorf, Germany; 3Practice for Gastroenterology Herne, Herne, Germany; 4Infektiologikum, Frankfurt/ Session P-O1 Poster Abstracts Hall A/B 5 Main, Frankfurt, Germany; ICH Hamburg, Hamburg, Germany; 2:45 PM-4:00 PM 6Medizinische Univsklinik, Bonn, Germany; 7Med Cntr for Infectious Diseases, Berlin, Germany; 8Practice for Gastroenterology Leverkusen, Global Burden and Mortality of Cancer in HIV Leverkusen, Germany 613 Risk of Cancer in HIV-Positive Adults on ART in South 585 High HCV Cure Rates for Drug Users Treated With DAAs Africa: A Record Linkage Study at an Urban Primary Care Clinic Mazvita M. Sengayi1; Adrian Spoerri2; Matthias Egger3; Janet Giddy4; 5 1 2 Brianna Norton; Julia Fleming; Meredith Steinman; Kim Yu; Joseph Mhairi Maskew ; Elvira Singh ; Julia Bohlius ; for the International Deluca; Chinazo O. Cunningham; Alain Litwin Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) 1Natl Cancer Registry, NHLS, Johannesburg, South Africa; 2Inst of Social Poster Listings Poster Montefiore Med Cntr, Bronx, NY, USA and Preventive Med, Univ of Bern, Bern, Switzerland; 3Univ Hosp Bern, 586 Impact of Liver Stiffness on Response to DAA-Based Bern, Switzerland; 4McCord Hosp, Durban, South Africa; 5Univ of the HCV Therapy In Cirrhotic Patients Witwatersrand, Wits Hlth Consortium, Johannesburg, South Africa 1 2 3 Karin Neukam ; Antonio Rivero-Juárez ; Luis E Morano-Amado ; 614 No Difference in Stage at Cancer Diagnosis by AIDS Rafael Granados4; Antoni o Collado5; Dolores Merino6; Mª José Blanco 7 8 9 Status Among HIV-Infected Adults Rodríguez ; Sergio Reus-Bañuls ; Juan A. Pineda ; for the Grupo de 1 2 3 4 Estudio de Hepatitis Vírica, Sociedad Española de Enfermedades Surbhi Grover ; Heidi M. Crane ; John Gill ; James J. Goedert ; Mari M. Kitahata2; Richard Moore5; Sonia Napravnik6; Anita Rachlis7; Michael J. Infecciosas y Microbiología Clínica: GEHEP-SEIMC; Grupo de Estudio 8 9 de Hepatitis Vírica, Sociedad Andaluza de Enfermedades Infecciosas y Silverberg ; Keri N. Althoff 1Univ of Pennsylvania, Philadelphia, PA, USA; 2Univ of Washington, Microbiología Clínica: HEPAVIR; RIS-HEP07 3 4 1 2 3 Seattle, WA, USA; Univ of Calgary, Calgary, AB, Canada; NIH, Bethesda, Valme Univ Hosp, Seville, Spain; IMIBIC, Córdoba, Spain; Hosp 5 6 4 MD, USA; Johns Hopkins Univ, Baltimore, MD, USA; Univ of North Universitario Alvaro Cunqueiro, Vigo, Spain; Hosp Universitario de 7 5 Carolina at Chapel Hill, Chapel Hill, NC, USA; Sunnybrook Rsr Inst, Gran Canaria Doctor Negrín, Las Palmas, Spain; Hosp Universitario 8 6 Sunnybrook Hlth Scis Cntr, Toronto, ON, Canada; Kaiser Permanente Torrecárdenas, Almería, Spain; Complejo Hospario de Huelva, Huelva, 9 Spain; 7Hosp Jerez de la Frontera (AGS Norte de Cádiz), Jerez de la Northern California, Oakland, CA, USA; Johns Hopkins Bloomberg Sch of Frontera, Spain; 8Hosp General Universitario de Alicante, Alicante, Spain; PH, Baltimore, MD, USA 9Hosp Universitario de Valme, Sevilla, Spain
90 CROI 2016 Poster Listings 91 ; 1 ;
; 1 2 4 Dalla Dalla 4 Mbeya Mbeya Kenya Med Med Kenya 2 Univ of Univ ; Christof ; Christof ; Ritesh ; Hugo De 7 2 ; Mkunde ; Mkunde 2 3 1 CROI 2016 2 ; T. T. Trinh T. ; T. Univ of Texas Texas of Univ 3 ; Evans ; Evans 2 2 ; Matthew ; Matthew ; Tony Antoniou ; Tony Harvard Sch of Harvard Kenya Med Rsr Med Kenya ; James R. 1 3 2 5 2 ; Janet M. Raboud
; Michael H. Chung 1 7 3 Program Agenda and ; Liset Torres ; John France 1 1 Kenya Rsr Prog at Univ the Prog Rsr Kenya 5 ; Hugo De Vuyst ; Hugo De ; Dara Lehman ; Dara 2
2 1 Univ of Ottawa, Ottawa, ON, Ottawa, Ottawa, of Univ 2 Univ of Texas Med Branch at Branch Med Texas of Univ The Univ of Texas Med Sch Med at Texas of Univ The 2 3 Women’s Coll Rsr Inst, Univ of Univ Inst, Rsr Coll Women’s 5 ; Grace C. John-Stewart ; Grace 1 ; Aisha Lofters ; Aisha ; Stephanie Cheng ; Stephanie ; AsliBauer 1 ; Gilhen Rodriguez 2 1 ; Nelly R. Mugo ; Nelly ; Grace C. John-Stewart ; Grace 2 Univ of Munich, Munich, Germany; Germany; Munich, Munich, of Univ ; Stephen Goldstone ; Stephen 6 2 3 Coptic Hosp, Nairobi, Kenya; Kenya; Nairobi, Hosp, Coptic 1 Intl Agency for Rsr on Cancer, Lyon, Lyon, Cancer, on Rsr for Agency Intl Fred Hutchinson Cancer Rsr Cntr, Seattle, Seattle, Cntr, Rsr Cancer Hutchinson Fred 6 3 3 Testing Among HIV-Positive HIV-Positive Among Testing
4 ; Leonard Maboko ; Leonard
Laura J. Benjamins LauraJ. 1 5 2 ; omparing HIV-1 Cervical HIV-1 omparing Shedding 2 ; Rochelle L. Garcia 1 ; Michael H. Chung 5 ; RickGlazier ; Christine J. McGrath J. ; Christine 1 1 ; Samah Sakr ; Ruby Mcharo ; Ruby ; Claire Kendall ; Claire 5 1 1 ; Keith M. Sigel ; Keith 1 Arne Kroidl Arne ; ; Gabriela DelBianco ; Barbra A. Richardson 3 ; Mona Loutfy 1 1 1 ; Iain MacLeod ; Nice Mwinuka ; Nice 1 Intl Agency for Rsr on Cancer, Lyon, France; France; Lyon, Cancer, on Rsr for Agency Intl 1 ; Barbra A. Richardson 4 Inst for Clinical Evaluative Scis, Toronto, ON, Canada; Canada; ON, Toronto, Scis, Evaluative Clinical for Inst 4 ; Gloria P. Heresi ; Gloria P. 3 Kenyatta Natl Hosp, Nairobi, Kenya; Kenya; Nairobi, Hosp, Natl Kenyatta 2 4 ; Nelly R. Mugo ; Nelly 4 Univ of Munich, Munich, Germany Munich, Munich, of Univ USA; NY, York, at Sinai, New Sch Med Mount of Icahn Univ of Texas Med Branch at Galveston, Galveston, TX, Galveston, USA; at Galveston, Branch Med Texas of Univ Univ of Texas Hlth Sci Cntr at Houston, Houston, TX, Houston, USA; at Sci Houston, Hlth Cntr Texas of Univ Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ St Michael’s Hosp, Toronto, ON, Canada; Canada; ON, Toronto, Hosp, Michael’s St Nyongesa-Malava Pamnani Silverstein Murphy France; of Washington, Nairobi, Kenya; Kenya; Nairobi, Washington, of Nelly Yatich Nelly Canada; Canada; Inst, Thika, Kenya Thika, Inst, Chachage Toronto, Toronto, ON, Canada ON, Toronto, Toronto, Galveston, Galveston, TX, Galveston, USA; Galveston, 4 With Distribution Persons HIV-Infected in Type HPV Impactand HSIL Anal Recurrenceon GaisaMichael 1 High Prevalence of HR-HPV Infection HIV-Infected HR-HPV in of Prevalence High Tanzania From Women Lennemann Tessa 1 Feasibility of Post-Partum Testing for HR-HPV Among HR-HPV for Testing Post-Partum of Feasibility Women -Negative and HIV-Positive Dressel Erin 1 Cervicalin Cancer Screening Testing p16 of Role Among Women HIV-Infected McGrath ChristineJ. 1 Pap Annual Decline in Canada Ontario, in Women Burchell N. Ann 1 Rsr Inst, Thika, Kenya Thika, Inst, Rsr Randomized Trial C Trial Randomized LEEP Versus Cryotherapy After SharonGreene A. WA, USA; USA; WA, Vuyst Med Sch at Houston, Houston, TX, Houston, USA; SchMed at Houston, Tanzania; Mbeya, Hosp, Referral Geldmacher Mark Yudin Tanzania; Mbeya, Cntr, Rsr Med Mbeya Rsr Med for Inst 1Natl PH, Boston, MA, USA MA, Boston, PH, Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, Lana Sch of PH, Toronto, ON, Canada; Canada; ON, Sch Toronto, PH, of Lana Ahmed M. Bayoumi Ahmed Houston, Houston, TX, Houston, USA Houston,
626 625 623 624 622 621 ; ; 1 4 ; for ; for ; 7 3 Univ Univ 2 Johns Johns Hall A/B 6
; Memory ; Julia Bohlius 3 7 ; Shahin 3 ; Yi-Ming A. Chen Yi-Ming ; Univ Hosp Bern, Hosp Univ 3 7 ; Matthias Egger ; Matthias ; Mhairi Maskew 6 2 Kaohsiung Med Univ, Univ, Med Kaohsiung Kaohsiung Med Univ, Univ, Med Kaohsiung 4 4 Botswana MinistryBotswana Hlth, of 3 ; Tapela Neo 5 ; Heluf Medhin ; Heluf 2 ; Matthias Egger ; Matthias Univ Hosp Bern, Bern, Switzerland Hosp Univ 6 7 ; Mhairi Maskew 2 Univ of the Witwatersrand, Wits Wits Witwatersrand, the of Univ Univ of the Witwatersrand, Wits Wits Witwatersrand, the of Univ 3 3 ; Lukas Bütikofer ; Lukas 1 ; Chad Achenbach ; Chad 5
; GitaSuneja 1 ; Michael Gaisa; Matthew Silverstein; Keith Keith Silverstein; ; Michael Gaisa; Matthew Gaborone Private Hosp, Gaborone, Botswana; Botswana; Gaborone, Hosp, Private Gaborone 4 Fundación Huésped, Buenos Aires, Argentina; Argentina; Aires, Buenos Huésped, Fundación Inst Nacional de Infectologia Evandro Chagas Chagas Evandro Infectologia de Nacional Inst 5 5 ; Mukendi K. Kayembe ; Mukendi 4 ; Valeria Fink ; Valeria ; Julia Bohlius ; Lukas Bütikofer ; Lukas 4 1 1 ; Julia Bohlius; for the on behalf of the International ; Julia Bohlius; the on behalf of the International for ; Gypsyamber DSouza ; Gypsyamber 5 ; Ruth Pfeiffer; Meredith Shiels; Eric Engels Engels Shiels; Eric Meredith ; Ruth Pfeiffer;
1 Northwestern Univ, Chicago, IL, USA; IL, USA; Chicago, Univ, Northwestern Inst of Social and Preventive Med, Univ of Bern, Bern, Switzerland; Bern, Bern, Switzerland; of Univ Med, Social of Inst Preventive and Bern, Bern, Switzerland; of Univ Inst of Social and Preventive Med, Univ of Bern, Bern, Switzerland; Bern, Switzerland; Bern, of Univ Med, Social of Inst Preventive and Bern, Switzerland; Bern, of Univ Natl Hlth Lab, Gaborone, Botswana Gaborone, Lab, Hlth Natl Brigham and Women’s Hosp, Harvard Med Sch, Boston, MA, USA; USA; MA, Sch, Med Boston, Harvard Hosp, Women’s and Brigham Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Baltimore, Sch PH, of Bloomberg Hopkins (INI), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil; Brazil; Rio Janeiro, de (Fiocruz), Cruz Oswaldo Fundação (INI), Lockman of Utah Sch of Med, Salt Lake City, UT, USA; USA; UT, City, Salt Lake Utahof Sch Med, of Ruth Friedman (IeDEA) AIDS Evaluate to Databases Epidemiologic the International of Observational Research HIV Epidemiological and the Collaboration in EuroCoord (COHERE) in Europe Yi-Ming A. Chen Yi-Ming Gaborone, Botswana; Botswana; Gaborone, Bvochora-Nsingo M. Sigel USA NY, York, at Sinai, New Sch Med Mount of Icahn Long-Term Complications of Radiotherapy For Anal For Radiotherapy of Complications Long-Term CancerHIV in Chockalingam Leela Eliane Rohner Eliane the AIDS Southern Africa, Evaluate to Databases Epidemiologic in Europe of Observational Research HIV Epidemiological Collaboration HIV Observational Database Asia Pediatric TREAT and the in EuroCoord, Bern, Bern, of Switzerland Univ Med, Social of Inst Preventive and 6 KaposiAfrica,Sarcoma From Risk ChildrenART in on Asiaand Europe, 1 2 Global AnalysisGlobal Rohner Eliane Risk of Kaposi Sarcoma in HIV-Positive Adults on ART: A ART: on Adults RiskKaposiof Sarcoma HIV-Positive in 1 2 NCI, Rockville, MD, USA MD, Rockville, NCI, Therapy Antiretroviral on Women Rohner Eliane Patients in the United States United the in Patients Coghill Anna Cervicalof Burden Global Cancer HIV-Positive in 5 MortalityCancer HIV-Infected Among Excess Rates ScottDryden-Peterson 1 Cancer Versus Tuberculosis MortalityTuberculosis Among CancerVersus Kaohsiung, Taiwan; Taiwan; Kaohsiung, Kaohsiung, Taiwan; Taiwan; Kaohsiung, Bern, Switzerland Hlth Consortium, Johannesburg, South Africa; South Africa; Johannesburg, Consortium, Hlth for the International Epidemiologic Databases to Evaluate AIDS (IeDEA) AIDS (IeDEA) Evaluate to Databases Epidemiologic the International for Observational of Research HIV Epidemiological and the Collaboration in EuroCoord (COHERE) in Europe Hlth Consortium, Johannesburg, South Africa; South Africa; Johannesburg, Consortium, Hlth HIV-Infected Individuals in Botswana in Individuals HIV-Infected
620 Session P-O2 Poster Abstracts SessionPoster P-O2 PM-4:002:45 PM Prevention and Cervicaland Anal Treatment Cancer: 619 618 617 616 615 Program and Agenda
627 Multiple HPV Genotypes As a Risk Factor for High 655 CCR5+CD8+ T-Cell Levels Are Associated With Grade AIN in HIV-1 Infected Males Cardiovascular Events in Patients on cART Cristina Rovelli1; Andrea Poli2; Massimo Cernuschi3; Andrea Marco Laura Tarancón1; Rebeca S. de Pablo2; Isaac Rosado3; Beatriz Tamburini3; Sara Racca3; Laura Galli3; Giuseppe Tambussi3; Antonella Dominguez3; Miguel Genebat4; María José Polaino5; Mohammed Castagna3; Adriano Lazzarin4; Silvia Nozza3 Rafii-El-Idrissi Benhnia4; Yolanda M. Pacheco3; Manuel Leal4; Ezequiel 1Università Vita-Salute San Raffaele, Milano, Italy; 2Università Vita- Ruiz-Mateos4 Salute San Raffaele, Milan, Italy; 3San Raffaele Scientific Inst, Milan, 1BioMed Inst of Sevilla, Sevilla, Spain; 2BioMed Inst of Seville, Sevilla, Italy; 4Vita-Salute Univ, San Raffaele Scientific Inst, Milan, Italy Spain; 3Inst of BioMed of Seville (IBiS), Seville, Spain; 4BioMed Inst of 5 628 Prevalence of HPV-Related Lesions in an Urban Cohort Seville, Seville, Spain; BioMed Inst of Seville, Sevilla, Spain of HIV-Positive Men in Germany 656 Soluble TWEAK May Predict Carotid Atherosclerosis in Wolfgang Fuchs1; Ulrike Wieland2; Adriane Skaletz-Rorowski3; Jochen Treated HIV Infection Swoboda4; Alexander Kreuter5; Claudia Michalik6; Anja Potthoff7; Sahera Dirajlal-Fargo1; Abdus Sattar2; Manjusha Kulkarni3; Nicholas Norbert H. Brockmeyer1; for the Competence Network for HIV/AIDS T. Funderburg3; Grace A. McComsey1 1Clinic for Dermatology, Ruhr-Universität Bochum, Germany, Bochum, 1Case Western Reserve Univ, Cleveland, OH, USA; 2Case Western Reserve Germany; 2Natl Reference Cntr for Papilloma- and Polyomaviruses, Univ Univ Sch of Med, Cleveland, OH, USA; 3Ohio State Univ, Columbus, OH, of Cologne, Cologne, Germany; 3Competence Network for HIV/AIDS, Ruhr- USA 4 5 Universität, Bochum, Germany; Inst of Cytology, Bonn, Germany; Helios 657 Diet, Gut Integrity Markers, and Cardiovascular St. Elisabeth Hosp Oberhausen, Oberhausen, Germany; 6KompNet HIV/ AIDS, Bochum, Germany; 7Fachklinikum Borkum, Borkum, Germany Disease Risk in HIV+ Adults Allison R. Webel1; Abdus Sattar2; Nicholas T. Funderburg3; Bruce 1 1 1 3 Session P-P3 Poster Abstracts Hall A/B Kinley ; Chris T. Longenecker ; Danielle Labbato ; Morgan Boucher ; Grace A. McComsey1 2:45 PM-4:00 PM 1Case Western Reserve Univ, Cleveland, OH, USA; 2Case Western Reserve Atherosclerosis Pathogenesis: Role of the Immune Univ Sch of Med, Cleveland, OH, USA; 3Ohio State Univ, Columbus, OH, System USA 651 Correlates and Longitudinal Implications of FGF23 Levels in HIV-Positive Individuals Session P-P4 Poster Abstracts Hall A/B 2:45 PM-4:00 PM Mohamed G. Atta1; Michelle Estrella2; Derek M. Fine1; Katie Zook1; Jose Manuel Monroy Trujillo2; James H. Stein3; Gregory M. Lucas1 Cardiovascular Disease and Antiretroviral Therapy 1Johns Hopkins Univ, Baltimore, MD, USA; 2Johns Hopkins Univ Sch of Effects 3 Med, Baltimore, MD, USA; Univ of Wisconsin-Madison, Madison, WI, 658 Does Pulse-Wave Velocity Normalize With Increasing USA Time on ART? Evidence From CHER 652 Nonclassical Monocyte, MCP-1 Predict Subclinical Steve Innes1; Mark F. Cotton1; Kennedy Otwombe2; Philip G. Herbst3; Atherosclerosis Progression in HIV Barbara Laughton1; Richard Haubrich4; Sara H. Browne4 Dominic C. Chow1; Lishomwa C. Ndhlovu1; Lindsay M. Kohorn1; 1Stellenbosch Univ and Tygerberg Children’s Hosp, Cape Town, South 1 2 3 2 2
Poster Listings Poster Guangxiang Zhang ; Howard N. Hodis ; Matthew Budoff ; Yanjie Li ; Africa; Univ of the Witwatersrand, Johannesburg, South Africa; Sheila M. Keating4; Philip J. Norris4; Cecilia M. Shikuma1 3Stellenbosch Univ and Tygerberg Academic Hosp, Cape Town, South 1Univ of Hawaii, Honolulu, HI, USA; 2Univ of Southern California, Los Africa; 4Univ of California San Diego, San Diego, CA, USA 3 Angeles, CA, USA; Harbor-Univ of California Los Angeles Med Cntr, 659 Changes in CVD Risk Factors With Early and Deferred Torrance, CA, USA; 4Blood Systems Rsr Inst, San Francisco, CA, USA ART in the START Trial 653 Association of T Cell and Macrophage Activation With Jason V. Baker1; Shweta Sharma2; for the The INSIGHT START Vascular Health in HIV (Strategic Timing of AntiRetroviral Treatment) Study Group Heather Grome; Louise Barnett; Cindy Hager; Timothy R. Sterling; 1Hennepin County Med Cntr, Univ of Minnesota, Minneapolis, MN, USA; Spyros A. Kalams; John R. Koethe 2Univ of Minnesota, Minneapolis, MN, USA Vanderbilt Univ Sch of Med, Nashville, TN, USA 660 Cardiovascular Biomarkers After Switch to ABC/ 654 Effect of T-Cell Activation and Inflammation on DTG/3TC: The STRIIVING Study Endothelial Dysfunction in HIV Jordan Lake1; Judith S. Currier1; Justin Koteff2; Clare Brennan2; Arjun Sinha; Yifei Ma; Rebecca Scherzer; Danny Li; Steven G. Deeks; Catherine Granier3; Mark Shaefer2; Martin Gartland2; Brian Wynne4; Peter Ganz; Priscilla Hsue Michael Aboud5 Univ of California San Francisco, San Francisco, CA, USA 1David Geffen Sch of Med at Univ of California Los Angeles, Los Angeles, CA, USA; 2ViiV Hlthcare, Research Triangle Park, NC, USA; 3GSK, Middlesex, UK; 4ViiV Hlthcare, Collegeville, PA, USA; 5ViiV Hlthcare, Brentford, UK
92 CROI 2016 Poster Listings 93 ; 3 ; ; 3 1 ; 8 ; 3 ; Todd ; Todd Univ of Univ 3 Emory Johns Johns 9 2 Harvard Harvard 6 5 Hall A/B ; Grace A. ; Grace 4 CROI 2016
INSERM, CESP CESP INSERM, 6 ; Jacqueline ; Jacqueline 3 Johns Hopkins Hopkins Johns ; Frank J. Palella J. ; Frank 2 2
; Donna Spiegelman 6 1 ; Catherine A. Sugar ; Catherine 5 Univ of Pennsylvania, Pennsylvania, of Univ ; Tebas Pablo Program Agenda and 4 ; Heather J. Ribaudo J. ; Heather 3 7 Harvard Univ, Boston, MA, Boston, Univ, Harvard 2 ; Jean Philippe Bastard Northwestern Univ, Chicago, Chicago, Univ, Northwestern 2 3 ; Grace A. McComsey ; Grace 2 t Changest in Harvard T.H. Chan Sch PH, of Chan T.H. Harvard 2 Univ of North Carolina at Chapel at Chapel North of Univ Carolina ; Keri N. Althoff ; Keri 7 2
Case Western Reserve Univ, Univ, Reserve Western Case CHU Toulouse, Toulouse, France Toulouse, Toulouse, CHU ; Vigouroux Corinne 7 3 7 2 ; Todd T. Brown T. ; Todd INSERM, UMR-S 1018, Paris, France; France; Paris, 1018, UMR-S INSERM, 5 2 INSERM UMR-S 938, CDR Saint-Antoine, Saint-Antoine, CDR 938, UMR-S INSERM ; Todd T. Brown T. ; Todd ; Royce Hardin ; Royce 4 2 6 ; Till ; Till Bärnighausen tors for Overweight Obesityand for tors David Geffen Sch at Med of of Univ Geffen David 2
6 ; Heather J. Ribaudo J. ; Heather 5 Harvard Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, of Harvard 8 ; Beverley Balkau ; Beverley 5 Case Western Reserve Univ, Cleveland, OH, USA; USA; OH, Cleveland, Univ, Reserve Western Case 5 Univ of Pittsburgh, Pittsburgh, PA, USA; USA; PA, Pittsburgh, Pittsburgh, of Univ ; Wang Ruibin 5 1 Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns 4 ; Enju Liu ; Enju 1 Harvard Unviersity, Boston, MA, USA MA, Boston, Unviersity, Harvard Pierre Delobel Pierre ; Ighovwerha Ofotokun 3 ; for the ACTG 5280 Study Team Team 5280 Study the ACTG ; for ; for the Alex Kintu, Enju Liu, Till Baernighausen, Till Liu, Enju Kintu, the Alex ; for 1 ;
9 1 ; Ellen S. Chan ; Ellen 6 6 1 ; Mathilde Ghislain ; Mathilde INSERM, UMR-S 1018, CESP, Paris, France; France; Paris, CESP, 1018, UMR-S INSERM, 1 5 ; Lawrence Kingsley ; Lawrence 4 ; Kathy Melbourne ; Kathy 5 ; Carlee B. Moser B. ; Carlee 4 David Geffen Sch of Med at Univ of California Los Angeles, Angeles, Los Sch at California Med of of Univ Geffen David ; Cecile Goujard ; Cecile 4 4 Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns 3 Gilead Scis, Inc, Foster City, CA, USA; City, Foster Inc, Scis, Gilead Columbia Univ Med Cntr, New York, NY, USA; USA; NY, York, New Cntr, Med Univ Columbia Harvard Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, of Harvard CA, USA; Angeles, Los Sch Angeles PH, of Los California of Univ INSERM 1048, Toulouse, France; France; Toulouse, 1048, INSERM France; Paris, Univs, Sorbonne Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, of Univ Hopkins Johns HIV-Infected Individuals Initiating Therapy Initiating Individuals HIV-Infected Philadelphia, PA, USA; USA; PA, Philadelphia, Laurence Meyer Laurence McComsey Donna Spiegelman, Wafaie Fawzi Fawzi Wafaie Donna Spiegelman, Edgar T. Overton T. Edgar Paris, France; France; Paris, Los Angeles, CA, USA; Angeles, Los Judith S. Currier IL, USA; IL, USA; USA; USA; Fawzi W. Wafaie 6 HIV-1-Infected Treatment-Naive in Microbiome Blood ART Under Hyperglycemia Developing Persons Amar Jacques 1 Incidence and RiskIncidence and Fac ART of Initiation After Kintu Alexander 1 Fa Abdominal of Measurement Bhagwat Priya 1 1 3 Fractures Occur at a Younger Age in HIV+ Men in thein Men HIV+ in Age Younger Fracturesa Occur at Cohort AIDS Multicenter Study Gonciulea R. Anda 1 With D Vitamin Bioavailable in Differences Racial A5280 Supplementation:ACTG Yin T. Michael Cleveland, OH, USA; USA; OH, Cleveland, U1018, Le Kremlin-Bicêtre, France; France; Kremlin-Bicêtre, Le U1018, Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Baltimore, Sch PH, of Bloomberg Hopkins Univ, Baltimore, MD, USA MD, Baltimore, Univ, Hopkins Hill, Chapel Hill, NC, USA; USA; NC, Hill, Chapel Hill, Boston, MA, USA; USA; MA, Boston, California Los Angeles, Los Angeles, CA, USA Angeles, Los Angeles, Los California Jordan Lake Jordan T. Brown T. Capeau Univ Sch of Med, Atlanta, GA, USA; GA, USA; Atlanta, Sch Med, Univ of Alabama at Birmingham, Birmingham, AL, USA Birmingham, at Birmingham, Alabama Sch of PH, Boston, MA, USA; USA; MA, Sch Boston, PH, of WITHDRAWN
Session P-Q4 Poster Abstracts SessionPoster P-Q4 PM-4:002:45 PM Complications Metabolic 701 703 704 702 699 700 ; 3 Inst Inst ;
4 ; 4 1 ; 6 1 ; Eric ; Eric 6 ; Roberto ; 4 1 Hall A/B ; Adriano ; Adriano 5 Cheikh Cheikh ; María 5 Univ Hosp Hosp Univ 1 5 Vita-Salute Univ, Univ, Vita-Salute 6 ; Laura Ciaffi ; Laura ; John Hammer 4 INSERM, Montpellier, Montpellier, INSERM, 3 2
; Amandine Cournil ; Amandine 2 2 ; Benjamin Young Angeles Alvarez Angeles 2 ; 2 ; Andrew N. Phillips N. ; Andrew 5 Denver Infectious Disease Infectious Denver 4 ; Massimo Giuliani CDC, Atlanta, GA, USA; Atlanta, CDC, 4 ; Anna Pia Lassandro Pia ; Anna ; Antonella d’Arminio d’Arminio ; Antonella 2 Catholic Univ, Rome, Italy; Rome, Univ, Catholic 2 2 3 ; Carl Armon ; Carl 2 ; Victor ; Victor Collado-Diaz 1 ; Arsène Héma ; Arsène Chelsea and Westminster Hosp NHS NHS Hosp Westminster and Chelsea Univ de Valencia, Valencia, Spain Valencia, Valencia, de Univ 5 2 ; for the D:A:D Study Group Group the D:A:D Study ; for ; Mark Nelson 2 ; Simona Di Giambenedetto 2 1 4 IRD, Site ANRS Cameroun, Yaoundé, Yaoundé, Cameroun, ANRS Site IRD, 6 Rigshospitalet, Univ of Copenhagen, Copenhagen, of Univ Rigshospitalet, ; John T. Brooks T. ; John 2 ; OleKirk 1 Feinberg Sch of Med, Northwestern Univ, Univ, Northwestern Sch Med, of Feinberg 2 5 ; Rainer Weber
4 INSERM U897, ISPED, Univ de Bordeaux, Bordeaux, de Univ ISPED, U897, INSERM Nice Univ Hosp, Nice, France; France; Nice, Hosp, Univ Nice 6 4 ; Juan V. Esplugues V. ; Juan 1 Infectious Diseases Clinic, San Paolo Hosp, Hosp, San Paolo DiseasesInfectious Clinic, 3 Univ of Alabama at Birmingham, Birmingham, Birmingham, at Birmingham, Alabama of Univ ; Andrea DeLuca ; Andrea 7 1 ; Kate Buchacz ; Kate 1 ; Erica Smyth ; Erica ; Assane Diouf ; Sabrina Eymard-Duvernay ; Samuel Orden 1 4 ; Francesca Lombardi ; Francesca 1 1 3 Internatonal Association of Providers of AIDS Care, Care, AIDS of Association Providers of Internatonal ; Lene Ryom ; Lene ; for the HIV Outpatient Study (HOPS) and SUN Study Study and SUN (HOPS) Study Outpatient the HIV ; for 6 1 7 ; John R. Spear ; Jens D. Lundgren ; Jens D. 5 6 Univ of Siena, Siena, Italy; Siena, Siena, of Univ 2
; Christian Pradier ; Christian 3 3 ; Massimiliano Fabbiani 6 UMI 233-IRD/U1175-INSERM/Montpellier Univ, Montpellier, Montpellier, Univ, 233-IRD/U1175-INSERM/Montpellier UMI Faso; Burkina Bobo-Dioulasso, Sanou, Sourô CHU 3 4
4 Colorado Sch of Mines, Golden, CO, USA; USA; CO, Golden, Sch Mines, of Colorado USA; MO, City, Kansas Corporation, Cerner San Gallicano Dermatological Inst, IRCCS, Rome, Italy; Rome, IRCCS, Inst, Dermatological San Gallicano Inst of Clinical Infectious Diseases -Università Cattolica del Sacro Cuore, Cuore, Sacro del Cattolica Diseases Infectious -Università Clinical of Inst CHU Sourô Sanou, Bobo Dioulasso, Burkina Faso; Faso; Burkina Bobo Sanou, Dioulasso, Sourô CHU Univ of Valencia, Valencia, Spain; Valencia, Valencia, of Univ Imperial Coll London, London, UK; UK; London, London, Coll Imperial Univ Coll London, London, UK; UK; London, London, Coll Univ Univ of Milan, MIlan, Italy; MIlan, Milan, of Univ France; France; Cauda Bordeaux, France Bordeaux, Fndn Trust, London, UK London, Trust, Fndn Consultants, Denver, CO, USA; USA; CO, Denver, Consultants, Copenhagen, Denmark; Copenhagen, Rome, Italy; Rome, Cameroon Nicoletta Ciccarelli Nicoletta AL, USA of Clinical Infectious Diseases, Catholic Univ of Sacred Heart, Rome, Italy; Heart, Rome, Sacred of Univ Catholic Diseases, Infectious Clinical of France; France; 1 3 Jacques Zoungrana Jacques Osteoporosis and Fractures and Adults: HIV-Infected in Osteoporosis Spine? Lumbar the of Afraid Is Who Battalora A. Linda 5 Alessandro D’Avino Alessandro 1 Bone-Mineral Density After Switching to ATV/r+3TC: A ATV/r+3TC: to Bone-MineralSwitching Density After SubstudyAtLaS-Mthe of Trial 1 TDF and Quantitative Ultrasound Bone DensityBone Ultrasound in Quantitative and TDF Second-Lineon ART AfricanPatients KaboreN. Firmin 1 Abacavir Induces Platelet-Endothelium Interactions Platelet-Endothelium AbacavirInduces Receptors P2X7 Endothelial Through Rios-Navarro Cesar Cardiovascular Risk Profile of Abacavir and Tenofovir Tenofovir and Abacavirof Risk Profile Cardiovascular InfectionHIV of Independent Emerson Michael 1 Infarction(MI) SabinCaroline 1 Abacavir (ABC) Use and Risk Recurrentand Myocardial of (ABC) Abacavir Use Francois Dabis Francois Joan S. Chmiel Lazzarin Monforte Ángeles Martínez-Cuesta Ángeles Delaporte Anta Diop Univ, Dakar, Senegal; Dakar, Anta Diop Univ, Zurich, Zurich, Switzerland; Switzerland; Zurich, Zurich, Investigators Investigators Washington, DC, USA; USA; DC, Washington, Chicago, IL, USA; IL, USA; Chicago, San Raffaele Scientific Inst, Milan, Italy Milan, San Scientific Inst, Raffaele Edgar T. Overton T. Edgar
698 697 Bone Disease: Sticks, Stones, and TDF and Disease:Stones, Bone Sticks, 696 Session P-Q3 Poster Abstracts SessionPoster P-Q3 PM-4:002:45 PM 663 662 661 Program and Agenda
705 Metabolic Alterations and Physical Function in Older 712 IGF-1 Levels Predict Advanced Aging in HIV/HCV HIV-Infected Adults Coinfected Persons Mehri McKellar; James Bain; Olga Ilkayeva; Michael Muehlbauer; Jeffrey Quinn1; Jacquie Astemborski2; Gregory D. Kirk1; Shruti H. Thomas O'Connell; Robert Stevens; Miriam Morey; Carl Pieper; William Mehta1; David L. Thomas3; Ashwin Balagopal1 Kraus; Kim Huffman 1Johns Hopkins Univ, Baltimore, MD, USA; 2Johns Hopkins Bloomberg Sch Duke Univ, Durham, NC, USA of PH, Baltimore, MD, USA; 3Johns Hopkins Univ Sch of Med, Baltimore, 706 Superior Glucose Tolerance and Metabolite Profiles in MD, USA Women vs Men on Long-Term ART 713 HLA-B57.01 Promotes Significantly Better Periodontal John R. Koethe1; Cathy Jenkins2; Chris Petucci3; Jeffrey Culver3; Bryan Health in HIV-Positive Patients E. Shepherd4; Spyros A. Kalams1; Timothy R. Sterling1 Gundolf Schuettfort1; Kyu Hyun Park2; Christoph Stephan3; Timo 1Vanderbilt Univ Sch of Med, Nashville, TN, USA; 2Vanderbilt Univ, Wolf4; Annette Haberl4; Eva Herrmann1; Hans-Reinhard Brodt4; Philipp Nashville, TN, USA; 3Sanford Burnham Prebys Metabolomics Core at de Leuw1 the Southeast Cntr for Integrated Metabolomics, Gainesville, FL, USA; 1Univ Hosp Frankfurt, Frankfurt am Main, Germany; 2Dental Office, 4Vanderbilt Inst for Global Hlth, Nashville, TN, USA Schöner Mund Oberursel, Oberursel, Germany; 3Goethe Univ Hosp 4 707 Reduced Dicer and Brown Adipose Tissue (BAT) Gene Frankfurt, Frankfurt, Germany; JW Goethe Univ of Frankfurt, Frankfurt, Germany Expression in HIV Lipodystrophy Martin Torriani1; Suman Srinivasa1; Kathleen Fitch1; Thomas 714 Association of Depressive Symptoms With Biomarkers Thomou2; Kimberly Wong1; Eva Petrow1; Aaron M. Cypess3; Steven in Veterans With and Without HIV Grinspoon1 Jessica R. White1; Kaku So-Armah2; Jesse Stewart3; Samir Gupta4; 1Massachusetts General Hosp, Boston, MA, USA; 2Joslin Diabetes Cntr, Adeel A. Butt5; Cynthia Gibert6; Maria Rodriguez-Barradas7; Roger Boston, MA, USA; 3NIDDK, NIH, Bethesda, MD, USA Bedimo8; Amy C. Justice9; Matthew S. Freiberg10 1Maricopa County Dept of PH, Phoenix, AZ, USA; 2Boston Univ Sch of Med, Session P-Q5 Poster Abstracts Hall A/B Boston, MA, USA; 3Indiana Univ Purdue Univ Indianapolis, Indianapolis, 4 5 2:45 PM-4:00 PM IN, USA; Indiana Univ Sch of Med, Indianapolis, IN, USA; Hamad Hlthcare Quality Inst, Doha, Qatar; 6VA Med Cntr, Washington, DC, USA; Multimorbidity and Aging 7Michael E. DeBakey VA Med Cntr and Baylor Coll of Med, Houston, TX, 708 Hospitalizations With AIDS and Chronic End-Organ USA; 8Dallas VA Med Cntr, Dallas, TX, USA; 9Yale Univ, New Haven, CT, Conditions in HIV Outpatient Study USA; 10Vanderbilt Univ Sch of Med, Nashville, TN, USA Kate Buchacz1; Linda A. Battalora2; Carl Armon3; Rachel Hart3; John T. Brooks1; for the the HIV Outpatient Study Session P-R5 Poster Abstracts Hall A/B 1CDC, Atlanta, GA, USA; 2Colorado Sch of Mines, Golden, CO, USA; 3Cerner 2:45 PM-4:00 PM Corporation, Kansas City, MO, USA Diagnosis of Tuberculosis 709 Ageing With HIV: Emerging Importance of Chronic 747 Urine LAM Testing in Advanced HIV-Infected Adults in a Comorbidities in Patients Over 75 Trial of Empiric TB Therapy 1 1 2 Clotilde Allavena ; Camille Bernaud ; Sylvie Lariven ; Marc-Antoine Gregory P. Bisson1; Amita Gupta2; Sachiko Miyahara3; Xin Sung3; Poster Listings Poster 3 4 5 6 1 Valantin ; Tristan Ferry ; Lise Cuzin ; Alissa Naqvi ; Matthieu Hanf ; Jing Bao4; Carrie L. Fry5; Yukari C. Manabe6; Johnstone J. Kumwenda7; 7 André Cabié ; for the DatAIDS Study Group Mina Hosseinipour8; for the Adult AIDS Clinical Trials Group A5274 1 2 CHU Nantes Univ Hosp, Nantes, France; Hosp Bichat-Claude Bernard, (REMEMBER) Study Team 3 4 Paris, France; Pitié Salpétriêre Hosp, Paris, France; Hosp de la Croix- 1Univ of Pennsylvania, Philadelphia, PA, USA; 2Johns Hopkins Univ Sch 5 6 Rousse, Lyon, France; CHU Toulouse, Toulouse, France; CHU Nice, Nice, of Med, Baltimore, MD, USA; 3Harvard Univ, Boston, MA, USA; 4NIAID, 7 France; CHU Fort de France, Fort de France, France NIH, Bethesda, MD, USA; 5Frontier Sci & Tech Rsr Fndn, Inc, Amherst, NY, 710 Incremental Association Between CD4:CD8 Ratio and USA; 6Johns Hopkins Univ, Baltimore, MD, USA; 7Coll of Med John Hopkins 8 Incidence of Non-AIDS Events Proj, Blantyre, Malawi; Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA Padraig McGettrick1; Willard Tinago1; Aoife Lacey1; Alan Macken2; Ailbhe Ni Fhlatheartaigh1; Sadhbh Tennant1; John Lambert3; Gerard 748 Stool Xpert MTB/RIF and Urine LAM for Diagnosing TB Sheehan3; Patrick Mallon2 in HIV-Infected Kenyan Children 1 HIV Molecular Rsr Group, UCD Sch of Med, Univ Coll Dublin, Dublin 7, Patricia B. Pavlinac1; Lisa M. Cranmer2; Irene N. Njuguna3; Vincent 2 3 Ireland; Univ Coll Dublin, Dublin, Ireland; Mater Misericordiae Univ O. Otieno3; Elizabeth Maleche-Obimbo3; John Gatimu4; Julius Oyugi5; Hosp, Dublin, Ireland Judd L. Walson1; Dalton Wamalwa3; Grace C. John-Stewart1 711 Impact of Monocyte Metabolism on Serious Non-AIDS 1Univ of Washington, Seattle, WA, USA; 2Emory Univ Sch of Med, Atlanta, 3 4 Events in HIV+ Individuals GA, USA; Univ of Nairobi, Nairobi, Kenya; Becton, Dickinson and Company, Nairobi, Kenya; 5Sch of Med, Univ of Nairobi, Nairobi, Kenya Riya Palchaudhuri1; Joshua Anzinger2; Jhingling Zhou1; David Anderson1; Joseph M. McCune3; Suzanne M. Crowe1; Clovis Palmer1 1Burnet Inst, Melbourne, Australia; 2Univ of West Indies, Kingston, Jamaica; 3Univ of California San Francisco, San Francisco, CA, USA
94 CROI 2016 Poster Listings 95 ; 2 ; 4 CDC, CDC, Hall D Hall D 3 ; Prasad ; Prasad ; Neel ; Neel 2 7 ; Landon ; Landon ; Greg ; Greg 5 CROI 2016 3
1
; Marcia ; Marcia ; James 4 1 3 ; Frank ; Frank 1 Montefiore Med Montefiore 7 Univ of Nigeria, Nigeria, of Univ 2 Univ of KwaZulu-Natal, KwaZulu-Natal, of Univ ; Thuli ; Thuli Mthiyane 4 Anova Hlth Inst, Inst, Hlth Anova 3 ; Yuming Ning ; Yuming 4 Program Agenda and 6 Univ Coll London, London, London, London, Coll Univ ; Obinna Onwujekwe 2 1 ; Allison Zerbe ; Allison CDC, Atlanta, GA, USA; Atlanta, CDC, Malawi MinistryMalawi Hlth, of 2 2 5 Byramjee Jeejeebhoy Med Jeejeebhoy Byramjee Johns Hopkins Univ Sch of Univ Hopkins Johns ; Amita Gupta; Amita 2 4 3 ; Elaine J. Abrams J. ; Elaine 4 ; Sten H. Vermund H. ; Sten 1 ; Crispin Musicha ; Crispin ; Carolyn M. Audet ; Carolyn ; Usha Balasubramanian ; Usha ; Beth Tippett Barr Tippett ; Beth 4 1 2 2 ; Salim Allana 2 ; Iqbal Master ; Iqbal 5 ; Usman I. Gebi ; Usman ICAP, Columbia Univ Mailman Sch PH, of Mailman Univ Columbia ICAP, ; Vidya ; Vidya Mave 1
5
2 Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ 2 Univ of KwaZulu-Natal, Durban, South Africa; South Africa; Durban, KwaZulu-Natal, of Univ 5 ; James McIntyre ; Jen Sabatier ; Jen 1 1 Emory Univ Rollins Sch of PH, Atlanta, GA, USA Atlanta, Sch PH, of Emory Rollins Univ ; Andreas Jahn ; Andreas 8 1 CDC, Atlanta, GA, USA; Atlanta, CDC, ; Molebogeng Rangaka ; Wester C. William 4 1 1 ; Meridith Blevins; Meridith ; Ramesh Bhosale 1 1 BJ Med Coll, Pune, India; India; Pune, Coll, Med BJ ; N. Sarita Shah 3 1 ; Pravi Moodley ; Pravi
5 5 ; Savita Kanade; Savita 2 ; Alice Maida ; Alice 4
8 ; Mary Lindegren Lou 1 ; Tamsin Phillips ; Tamsin
1 1 ICAP at Columbia Univ, New York, NY, USA; USA; NY, York, New Univ, ICAP at Columbia 3 CDC, Lilongwe, Malawi; Malawi; Lilongwe, CDC, USA; TN, Nashville, Hlth, Global for Inst Vanderbilt Weill Cornell Med Coll, New York, NY, USA; USA; NY, York, New Coll, Med Cornell Weill Univ of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of Univ Albert Einstein Coll of Med, Bronx, NY, USA; USA; NY, Bronx, Med, of Coll Albert Einstein GA, USA; Atlanta, Emory Sch PH, of Univ, Rollins South Africa; Durban, Complex, Hosp Dinuzuu King Koleka Mlisana Koleka Deshpande Bryan E. Shepherd Johannesburg, South Africa; South Africa; Johannesburg, Harare, Zimbabwe; Zimbabwe; Harare, Enugu, Nigeria Enugu, Petro Med, Baltimore, MD, USA MD, Baltimore, Med, Coll, Pune, India; India; Pune, Coll, Malawi’s Option B+ 2011–2015: The Impact The Option 2011–2015: Rapidof B+ Malawi’s Decentralization ART SundeepK. Gupta 1 Outcomes OptimizingNorth-CentralRural in PMTCT Study Cluster-Randomized A Nigeria: Aliyu H. Muktar 1 1 Jasantha Odayar Jasantha 1 PregnancyIFN-gammathe Suppression Intensifies of HIV TB-Infectedin Women Indian Mathad S. Jyoti 1 3 6 & Pregnant HIV+ in Tuberculosis of Burden South Africa Town, Capein Women Postpartum Hearing Loss and Laboratory Adverse Events in Events Laboratory and Loss Adverse Hearing ART on HIV and TB MDR With Patients Brust C. James Myer Gandhi Houston New York, NY, USA NY, York, New Kalish Westville, South Africa; South Africa; Westville, Lilongwe, Malawi Lilongwe, Chimbwandira UK; UK; Cntr, Bronx, NY, USA; USA; NY, Bronx, Cntr,
789 790 Session P-S5 Poster Abstracts Poster SessionP-S5 PM-4:002:45 PM Gaps:the Mind Cascade Optimizing PMTCT the 758 Session P-R8 Poster Abstracts Poster SessionP-R8 PM-4:002:45 PM Pregnancyand Tuberculosis 757 756 ; 2 ; 2 ; 2 ; Amita ; Amita ; 2 2
Hall A/B Hall A/B 2
; Ajay ; Ajay 3 1 Abbott ; Ning Tang 2 1 ; Gregor Leckie ; Gregor 2 YRG Cntr for AIDS Rsr AIDS for Cntr YRG 2 ; Nicola Zetola ; Nicola 2 ; Robert Bollinger 1 GHESKIO, Port-au-Prince, Port-au-Prince, GHESKIO, ; Pradeep Ambrose ; Pradeep ; Anita Basavaraj ; Anita 2 the Souththe African 2 ; Nagalingeswaran ; Nagalingeswaran 1 1
2 ; Marc Antoine Jean Juste Antoine ; Marc ; Raquel V. Viana ; Raquel V. 2 1 ; Poongulali Selvamuthu ; Poongulali 2 ; Joshua Kostera 3
5
Perinatal HIV Rsr Unit, Johannesburg, Johannesburg, Unit, Rsr HIV Perinatal Bern Univ Hosp and Univ of Bern, of Bern, Univ and Hosp Bern Univ 3 Nikhil Gupte Nikhil ; Sonali Salvi
; 1 1 Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns 2 ; Diessy Decome ; Chawangwa Modongo ; Chawangwa 1 ; for the The Opportunistic Infections Project Team OpportunisticTeam The Infections Project the ; for 1 ; Chitra Devaraj ; Chitra 2 ; Constance A. Benson ; Constance ; Neeshan Ramdin ; Neeshan ; for the Bedaquiline Implementers of the South the Bedaquiline ; for Implementers 1 1 ; Neil Martinson; Neil 4 ; Colette Guiteau Moise Guiteau ; Colette ; Samir Joshi 2 ; Ezhilarasi Chandrasekaran ; Ezhilarasi 1 Klerksdorp/Tshepong Hosp, Klerksdorp, South Africa; South Africa; Klerksdorp, Hosp, Klerksdorp/Tshepong 2 4 ; Modiehi Rakgokong ; Dileep Kadam 2 1
3 Univ of Pennsylvania, Philadelphia, PA, USA PA, Philadelphia, Pennsylvania, of Univ Univ of California Los Angeles Sch of PH, Los Angeles, CA, USA; Angeles, Los Sch Angeles PH, of Los California of Univ Botswana; Gaborone, Partnership, Pennsylvania of Univ Botswana Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ BJ Med Coll, Pune, India; India; Pune, Coll, Med BJ USA MD, Baltimore, Sch Med, of Univ Hopkins Johns Weill Cornell Med Coll, New York, NY, USA; USA; NY, York, New Coll, Med Cornell Weill Perinatal HIV Rsr Unit, Diepkloof, South Africa Diepkloof, Unit, Rsr HIV Perinatal BARC-SA and Lancet Lab, Johannesburg, South Africa; SouthAfrica; Johannesburg, Lab, Lancet and BARC-SA Chandanwale Hong Wang Hong Gupta Patrice Severe Patrice and Educ, Chennai, India Chennai, Educ, and Ebrahim Variava Ebrahim Molecular, Des Plaines, IL, USA; IL, USA; Des Plaines, Molecular, Tokugha Yepthomi Tokugha Haiti 3 Natl Dept of Hlth, Pretoria, South Africa Pretoria, Dept Hlth, Natl of Coinfection in HIV/MDR-TB Outcomes for Treatment Therapy Antiretroviral of Era the SanghyukShinS. 1 2 National TB Programme National NorbertNdjeka TB Programme National African Incorporation of Bedaquiline in Bedaquiline of Incorporation 1 TB Outcomes With ATV/r and Two Rifamycin- Two and ATV/r With OutcomesTB India in HIV/TB In Regimens TB Containing Jenks D. Jeffrey Vidya Mave Vidya 1 3 of the Collaboration of Observational HIV Epidemiological Research in Observational of Research HIV Epidemiological of the Collaboration in EuroCoord, (COHERE) Europe Switzerland Second-Lineon Patients RiskTB HIV-Positive in High India Pune, in Antiretrovirals Association of Tuberculosis With CD4 Recovery and HIVand Recovery CD4 With Tuberculosis of Association Europe in ART on Decline RNA Furrer Hansjakob for HIV Testing in Haiti in Testing HIV for Rivera R. Vanessa 1 5 Who Present for Patients DiagnosticYield Testing TB of INH Resistance Assays Assays Resistance INH Carole Wallis L. 1 High Sensitivity of Abbott RealTime MTB and MTB RIF/ MTB and SensitivityHigh MTB RealTime Abbott of Kumarasamy South Africa; South Africa;
755 Session P-R7 Poster Abstracts Poster SessionP-R7 PM-4:002:45 PM Tuberculosis Multidrug-Resistant 754 753 752 751 Session P-R6 Poster Abstracts Poster SessionP-R6 PM-4:002:45 PM Therapy Antiretroviral and Tuberculosis 750 749 Program and Agenda
791 Randomized Trial of a Lay Counselor-Led Combination 797 HIV Resistance in Pregnant Women With Detectable Intervention for PMTCT Retention HIV-1 RNA at Delivery in Mozambique Ruby N. Fayorsey1; Duncan Chege2; Chunhui Wang1; William Reidy1; Maria Ruperez1; Marc Noguera-Julian2; Raquel González1; Rocio Zach Peters1; Martin W. Sirengo3; Masila Syengo2; Chrisotin W. Barasa4; Bellido2; Anifa Vala3; Cristina Rodríguez2; Esperança Sevene3; Eusebio Mark Hawken4; Elaine J. Abrams1 Macete3; Roger Paredes2; Clara Menéndez1 1ICAP, Columbia Univ Mailman Sch of PH, New York, NY, USA; 2ICAP at 1Barcelona Inst for Global Hlth, Barcelona, Spain; 2IrsiCaixa Inst for Coulmbia Univ, Nairobi, Kenya; 3Natl AIDS and STI Control Prog, Nairobi, AIDS Rsr, Badalona, Spain; 3Manhiça Hlth Rsr Cntr (CISM), Manhiça, Kenya; 4ICAP at Columbia Univ, Nairobi, Kenya Mozambique 792 Continuity of Care Among Pregnant Women Lost to Follow-up After Initiating ART Session P-S7 Poster Abstracts Hall D Kate Clouse1; Sten H. Vermund1; Mhairi Maskew2; Given Malete2; 2:45 PM-4:00 PM Matthew P. Fox3 Birth Outcomes and Mortality in HIV- and ARV-Exposed 1Vanderbilt Inst for Global Hlth, Nashville, TN, USA; 2Univ of the Infants Witwatersrand, Wits Hlth Consortium, Johannesburg, South Africa; 3Boston Univ, Boston, MA, USA 798 Maternal Vitamin D Deficiency Is Associated With Preterm Birth in HIV-Infected Women 793 Disclosure and Knowledge Are Associated With Jennifer Jao1; Laura Freimanis2; Marissa Mussi-Pinhata3; Rachel Retention in Malawi’s Option B+ Program Cohen2; Jacqueline P. Monteiro3; Maria Leticia S. Cruz4; Andrea Branch1; Risa M. Hoffman1; Khumbo Phiri2; Julie Parent2; Jonathan F. Grotts1; Rhoda S. Sperling1; George K. Siberry5; for the National Institute of Sara Yeatman3; Paul Kawale2; David Elashoff1; Judith S. Currier4; Alan Child Health and Human Development (NICHD) International Site Schooley2 Development Initiative (NISDI) 1Univ of California Los Angeles, Los Angeles, CA, USA; 2Partners in Hope 1Icahn Sch of Med at Mount Sinai, New York, NY, USA; 2Westat, Inc., Med Cntr, Lilongwe, Malawi; 3Univ of Colorado, Denver, CO, USA; 4David Rockville, MD, USA; 3Univ of Sao Paulo, Sao Paulo, Brazil; 4Hosp Fed dos Geffen Sch of Med at Univ of California Los Angeles, Los Angeles, CA, USA Servidores do Estado, Rio de Janeiro, Brazil; 5Eunice Kennedy Shriver NICHD, Bethesda, MD, USA Session P-S6 Poster Abstracts Hall D 799 Timing of ART Initiation in Pregnancy and Birth 2:45 PM-4:00 PM Outcomes in South African Women Viral Dynamics and Drug Resistance During Pregnancy Thokozile Malaba1; Tamsin Phillips1; Greg Petro1; Kirsty Brittain1; 794 Initiating cART in Pregnancy: Impact on HIV RNA Decay Allison Zerbe2; Agnes Ronan1; James McIntyre3; Elaine J. Abrams4; 1 1 2 3 Landon Myer Jasmini Alagaratnam ; Sarah Chitty ; Annemiek DeRuiter ; 1 2 4 5 3 5 Univ of Cape Town, Cape Town, South Africa; ICAP at Columbia Univ, Fionnuala Finnerty ; Rebecca Marcus ; Achyuta V. Nori ; Liat Sarner ; 3 4 Rimi Shah6; Graham Taylor1; for the London HIV Perinatal Research New York, NY, USA; Anova Hlth Inst, Johannesburg, South Africa; ICAP, Group (LHPRG) Columbia Univ Mailman Sch of PH, New York, NY, USA 1St Mary’s Hosp, Imperial Coll NHS Trust, London, UK; 2Chelsea and 800 Higher Mortality in HIV-Exposed/Uninfected vs Westminster Hosp NHS Fndn Trust, London, UK; 3Guys and St Thomas’ HIV-Unexposed Infants, Botswana 4 NHS Fndn Trust, London, UK; Brighton and Sussex Hosps NHS Trust, 1 1 2 3 Poster Listings Poster 5 6 Gbolahan Ajibola ; Gloria Mayondi ; Jean Leidner ; Haruna Jibril ; Brighton, UK; Royal London Hosp, London, UK; Royal Free Hosp, Joseph Makhema1; Mompati Mmalane1; Modiegi Diseko1; Roger L. London, UK Shapiro4; Betsy Kammerer5; Shahin Lockman6 795 Viraemic Episodes Occur Frequently in Postpartum 1Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; South African Women on ART 2Goodtables Consulting, Oklahoma, OK, USA; 3Ministry of Hlth, Gaborone, 4 5 1 1 1 1 Botswana; Harvard Sch of PH, Boston, MA, USA; Boston Children’s Landon Myer ; Lorn Dunning ; Nei-Yuan Hsiao ; Tamsin Phillips ; 6 Allison Zerbe2; James McIntyre3; Elaine J. Abrams4 Hosp, Harvard Med Sch, Boston, MA, USA; Brigham and Women’s Hosp, 1Univ of Cape Town, Cape Town, South Africa; 2ICAP at Columbia Univ, Harvard Med Sch, Boston, MA, USA New York, NY, USA; 3Anova Hlth Inst, Johannesburg, South Africa; 4ICAP, 801LB Cotrimoxazole and Reduced Infectious Morbidity in Columbia Univ Mailman Sch of PH, New York, NY, USA HIV-Exposed Uninfected Infants 796 Viral Suppression and Retention 2–5 Years After ART Nicole L. Davis1; Jeffrey Wiener2; Sascha Ellington2; Charles Chasela3; Initiation in Pregnancy in Uganda Dumbani Kayira4; Michael Hudgens5; Charles van der Horst5; Denise 2 2 1 2 2 Jamieson ; Athena P. Kourtis Catherine A. Koss ; Paul Natureeba ; Dalsone Kwarisiima ; Mike 1 2 2 1 1 2 US Cntrs for Disease Control and Prevention, Atlanta, GA, USA; CDC, Ogena ; Tamara Clark ; Deborah Cohan ; Peter Olwoch ; Edwin 3 1 3 1 Atlanta, GA, USA; Univ of the Witwatersrand, Johannesburg, South Charlebois ; Moses R. Kamya ; Diane V. Havlir 4 5 1Univ of California San Francisco, San Francisco, CA, USA; 2Makerere Univ- Africa; Univ of North Carolina Project Malawi, Lilongwe, Malawi; Univ Univ of California San Francisco Rsr Collab, Kampala, Uganda; 3Makerere of North Carolina at Chapel Hill, Chapel Hill, NC, USA Univ Coll of Hlth Scis, Kampala, Uganda
96 CROI 2016 Poster Listings 97
3
3 ; 3
5 Johns Johns 3 ; Robert 2 ; Pat
4 ; Thoa P. ; Thoa P. ; for the ; for CROI 2016 3 9 Rsr Inst Inst Rsr 2 ; Pagakrong ; Pagakrong ; Richard ; Richard 6 3 Univ of Univ 3 Srinagarind Srinagarind ; Nadia Dowshen 7 2 ; Caroline Foster ; Caroline Univ of Hlth Scis Hlth of Univ 2 3 Univ Coll London, London, Coll Univ 5 ; Jennifer Chapman ; Jennifer 2 Program Agenda and Johns Hopkins Univ, Univ, Hopkins Johns ; Katia Prime ; Katia 4 3 Siriraj Hosp, Mahidol Univ, Univ, Mahidol Hosp, Siriraj ; Oliver Laeyendecker ; Oliver 8 2 ; Azar Kariminia 8 ; GabrielAnabwani 2 ; Saramony Sarun ; Saramony 2 ; Susan S. Lee
1 5 ; Joel N. Blankson 2 ; Sarah j. Fidler ; Sarah j. Children’s Hosp 1, Ho Chi Minh City, Minh City, Chi Ho 1, Hosp Children’s 1 4 NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, NIAID, 2 Imperial Coll London, London, UK; London, London, Coll Imperial 2 Med Rsr Council Clinical Trials Unit at Univ Unit Trials Clinical Council Rsr Med ; Caroline Foster ; Caroline Rebound in Perinatally Perinatally in Rebound 2 2 ; Tafireyi Marukutira ; Tafireyi 1 ; Colleen Hadigan ; Colleen ; Rawiwan Hansudewechakul ; Rawiwan Imperial Coll Hlthcare NHS Trust, London, London, Trust, NHS Hlthcare Coll Imperial 3 5 3 ; Aylin Unsal ; Aylin ; Viner Russell 1 6 ; Linda Aurpibul 1 NIH, Bethesda, MD, USA Bethesda, MD, NIH, Kirby Inst, Sydney, Australia Sydney, Inst, Kirby 5 9 ; Ali Judd ; Ali 1 ; Mogomotsi Matshaba 2 ; Elizabeth D. Lowenthal D. ; Elizabeth 1 ; Kulkanya Chokephaibulkit ; Kulkanya Mortimer Market Cntr, London, UK London, Cntr, Mortimer Market 7 ; Jolene Skordis-Worrall 6 Children’s Hosp of Philadelphia, Philadelphia, PA, USA PA, Philadelphia, Philadelphia, of Hosp Children’s 1 3 HIV-NAT, Thai Red Cross AIDS Rsr Cntr, Bangkok, Thailand; Thailand; Bangkok, Cntr, Rsr AIDS Cross Red Thai HIV-NAT, 5 ; Eva Jungmann ; Eva ; Thomas C. Quinn Thomas ; 5 4
1 St George’s & Queen Mary’s Hosp, London, UK; UK; London, Hosp, Queen Mary’s & George’s St 4 ; Torsak Bunupuradah ; Torsak 4 IDEO.org, Oakland, CA, USA; Oakland, IDEO.org, Univ Coll London, London, UK; UK; London, London, Coll Univ UK London, Trust, NHS Hlthcare Coll Imperial Univ of Pennsylvania Perelman Sch of Med, Philadelphia, PA, USA; USA; PA, Philadelphia, Sch Med, of Perelman Pennsylvania of Univ Gaborone, Excellence, of Cntr Clinical Children’s Botswana-Baylor Chiang Rai Prachanukroh Hosp, Chiang Rai, Thailand; Thailand; Rai, Chiang Hosp, Prachanukroh Rai Chiang USA; PA, Philadelphia, Sch Med, of Perelman Pennsylvania of Univ USA; PA, Philadelphia, Philadelphia, of Hosp Children’s Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Sch Baltimore, PH, of Bloomberg Hopkins Johns NIAID, NIH, Baltimore, MD, USA; USA; MD, Baltimore, NIH, NIAID, Moore Vietnam; Vietnam; TREAT Asia Pediatric HIV Observational Database (TApHOD) HIV Observational (TApHOD) Database AsiaPediatric TREAT Bangkok, Thailand; Thailand; Bangkok, Botswana; Botswana; Tookey Lumbiganon Pennsylvania, Philadelphia, PA, USA PA, Philadelphia, Pennsylvania, Hosp, Khon Kaen Univ, Khon Kaen, Thailand; Thailand; Kaen, Khon Univ, Kaen Khon Hosp, 1 Economic Evaluation of a Novel Adherence Strategy in Strategy Adherence Novel a of Evaluation Economic Youth HIV-Infected Perinatally Lin Naomi 1 3 After HIV Perinatal ClinicalWith Outcomes Adults in Care Pediatric From Transfer RebeccaHope L. 1 2 6 Suppression Cohorta Among Virologic of Longitudinal Youth HIV-Infected Behaviorally SarahWood 1 2 for Risk Factor Reactance Novel a Psychological Is Failure Treatment HIV Adolescent Lowenthal D. Elizabeth 1 1 Virologic Incidence of Sudjaritruk Tavitiya Weak HIV Antibody Responses in Perinatally Infected Perinatally in AntibodyHIV Responses Weak Adults Young Kirkpatrick R. Allison Le London, UK; UK; London, Hopkins Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, Univ of Hopkins for Hlth Scis Chiang Mai Univ, Chiang Mai, Thailand; Thailand; Mai, Chiang Univ, Mai Scis Hlth Chiang for Gross HIV-Infected Adolescents on Stableon cART Adolescents HIV-Infected UK; UK; Baltimore, MD, USA; USA; MD, Baltimore, Ontibile Tshume Cambodia, Phnom Penh, Cambodia; Cambodia; Penh, Phnom Cambodia, Coll London, London, UK; UK; London, London, Coll
834 835 832 833 831 830 ; Hall D 4 Makerere Makerere ; Shahin 5 ; Pierre ; Pierre 3 Hosp Hosp 3 Harvard Harvard 3 ; Diane V. ; Diane V. 2 5 CESP, INSERM INSERM CESP, ; Joseph 7 ; Tamara ; Tamara 7 3 ; Emannuelle ; Emannuelle 6 Goodtables 2 Hosp Louis Mourier, Mourier, Louis Hosp Botswana Harvard Harvard Botswana ; for the ANRS CO1/ ; for 5 6 Harvard Sch PH, of Harvard
7 3 5 2 ; Kelebogile Binda ; Kelebogile Massachusetts General General Massachusetts 3 7 ; Roger L. Shapiro 2 ; Moses R. Kamya ; Sophie Matheron 4 2 Groupe Hospier Saint-Louis, Saint-Louis, Hospier Groupe 4 Univ of California San Francisco, San Francisco, California of Univ ; Kathleen Powis ; Kathleen 6 2 ; Elizabeth Bukusi ; Elizabeth 2 INSERM 1154, Paris, France Paris, 1154, INSERM 8 Univ of Botswana, Gaborone, Gaborone, Botswana, of Univ 3 ; Sajini Souda Sorbonne Univs, Paris, France; France; Paris, Univs, Sorbonne ; Wafaie W. Fawzi W. ; Wafaie 2 ; Roger L. Shapiro 2 ; Jérôme Le Chenadec Le ; Jérôme 2 8 5
; Josiane Warszawski ; Tatiana Ramos ; Tatiana 8 1 ; Maya Petersen ; Maya 2 ; Roland Tubiana Brigham and Women’s Hosp, Harvard Med Sch, Med Harvard Hosp, Women’s and Brigham ; for the Sustainable East Africa Research in Research the Sustainable Africa ; for East Cntr for Microbiology Rsr, Kenya Med Rsr Inst, Inst, Rsr Med Kenya Rsr, Microbiology for Cntr 1 8 2 3 ; Sikhulile Moyo 5 INSERM, Le Kremlin-Bicêtre, France; France; Kremlin-Bicêtre, Le INSERM, 6 ; Theodore D. Ruel D. Theodore ; Univ of California Berkeley, Berkeley, CA, USA; Berkeley, Berkeley, California of Univ ; Jean Leidner ; Emily Smith ; Emily 1 4 1 1 Botswana Harvard AIDS Inst Partnership, Gaborone, Gaborone, Partnership, Inst AIDS Harvard Botswana USA; MA, Boston, Sch PH, of Harvard 4 5 ; Shahin Lockman 4
1 ; Laurent Mandelbrot ; Laurent ; GabrielChamie ; Babak Khoshnood 4 2 7 ; Edwin Charlebois ; Edwin 2 Kenya Med Rsr Inst, Kisumu, Kenya; Kenya; Kisumu, Inst, Rsr Med Kenya Brigham and Women’s Hosp, Harvard Med Sch, Boston, MA, USA; USA; MA, Sch, Med Boston, Harvard Hosp, Women’s and Brigham USA; MA, Boston, Hosp, General Massachusetts INSERM 1153, PARIS, France; France; PARIS, 1153, INSERM ICAP, Columbia Univ Mailman Sch of PH, New York, NY, USA; USA; NY, York, New Sch PH, of Mailman Univ Columbia ICAP, Beth Israel Deaconess Med Cntr, Boston, MA, USA; USA; MA, Boston, Cntr, Med Deaconess Beth Israel Clark Heather J. Ribaudo J. Heather Kisumu, Kenya; Kenya; Kisumu, Marel Univ Coll of Hlth Scis, Kampala, Uganda Kampala, Scis, Hlth of Coll Univ Consulting, Oklahoma, OK, USA; Consulting, Sellier Havlir Botswana; Botswana; 1 Mobile Strategy in Uganda and Kenya and Uganda in Strategy Mobile Kadede Kevin Increasing Adolescent HIV Testing With a Hybrid Hybrid a With Testing HIV Adolescent Increasing 2 Maternal ART and Hospitalization or Death Among Death or Hospitalization and ART Maternal Uninfected Infants HIV-Exposed ScottDryden-Peterson 1 Valerie Benhammou Valerie 1 Ayesha Sania Ayesha 1 HCVand HBV Infections Pregnant HIV-Infected in Obstetrical Outcomes Women: Cohort Group Study Perinatal – EPF French CO11 Mortality Risk Associated With Preterm and SGAand Preterm MortalityWith Risk Associated Status HIV Maternal by Stratified 24-Month Mortality 24-Month Botswana in RebeccaZash 1 HIV-Exposed Children Account for More Than Half ofHalf Than More for Children Account HIV-Exposed Botswana; Botswana; Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, Lockman Colombes, France; France; Colombes, Boston, MA, USA MA, Boston, Boston, MA, USA MA, Boston, Sch of PH, Boston, MA, USA MA, Sch Boston, PH, of Makhema Lariboisiere, Fernand Widal, AP-HP, Paris, France; France; Paris, AP-HP, Widal, Fernand Lariboisiere, Community Health Health Community San Francisco, CA, USA; San Francisco, Bichat-Claude Bernard, Paris, France; France; Paris, Bichat-Claude Bernard, AIDS Inst Partnership, Gaborone, Botswana; Botswana; Gaborone, Partnership, Inst AIDS U1018, Le Kremlin Bicêtre, France; France; Bicêtre, Kremlin Le U1018,
2:45 PM-4:002:45 PM in90-90-90 Suppress:and Achieving Treat, Test, Adolescents 829 Session P-T4 Poster Abstracts Poster SessionP-T4 805 804 803 802 Program and Agenda
Session P-T5 Poster Abstracts Hall D Session P-V2 Poster Abstracts Hall D 2:45 PM-4:00 PM 2:45 PM-4:00 PM Antiretroviral Therapy and Viral Suppression in Topical and Systemic Preexposure Prophylaxis: New Children: Implications for Cure Agents, New Populations 836 Strong IFN-g Responses and Limited HIV Reservoirs in 871 Phase I Trial to Assess Safety, PK, and PD of Film and Adolescent Virologic Controllers Gel Formulations of Tenofovir Jason Brophy1; Fatima Kakkar2; Hinatea Dieumegard3; Amelie Katherine E. Bunge1; Charlene S. Dezzutti1; Craig Hendrix2; Mark Pagliuzza4; Ari Bitnun5; Lindy Samson1; Stanley Read5; Nicolas A. Marzinke2; Hans Spiegel3; Bernard Moncla4; Jill Schwartz5; Leslie Chomont6; Hugo Soudeyns7; for the EPIC4 Study Group Meyn4; Lisa Rohan1; Sharon L. Hillier4 1Children’s Hosp of Eastern Ontario, Ottawa, ON, Canada; 2Univ de 1Univ of Pittsburgh, Pittsburgh, PA, USA; 2Johns Hopkins Univ, Baltimore, Montréal, Montréal, QC, Canada; 3CHU Sainte-Justine, Montréal, QC, MD, USA; 3DAIDS, NIAID, NIH, Rockville, MD, USA; 4Magee-Womens Canada; 4CRCHUM, Montreal, QC, Canada; 5Hosp for Sick Children, Univ of Hosp of the Univ of Pittsburgh Med Cntr, Pittsburgh, PA, USA; 5CONRAD, Toronto, Toronto, ON, Canada; 6Univ de Montréal, Montreal, QC, Canada; Arlington, VA, USA 7 CHU Sainte-Justine, Montreal, QC, Canada 872 Safety and Pharmacokinetics of Dapivirine Vaginal 837 Kinetics of Cell-Associated HIV DNA During Viral Rings in Postmenopausal US Women Suppression in HIV-Infected Children Beatrice A. Chen1; Craig Hoesley2; Robert A. Salata3; Jingyang Matias Moragas; Debora Mecikovsky; Solange Arazi Caillaud; Paula Zhang4; Lydia E. Soto-Torres5; Annalene Nel6; Sherri Johnson7; Charlene Aulicino; Rosa Bologna; Luisa Sen; Andrea Mangano S. Dezzutti1; Mark A. Marzinke8; for the MTN-024/IPM 031 Protocol Hosp de Pediatría SAMIC Prof Dr Juan P. Garrahan, Buenos Aires, Team for the Microbicide Trials Network Argentina 1Univ of Pittsburgh, Pittsburgh, PA, USA; 2Univ of Alabama at 3 838 HIV-1 DNA Dynamics Over a Decade or More of Viral Birmingham, Birmingham, AL, USA; Case Western Reserve Univ, Cleveland, OH, USA; 4SCHARP, Seattle, WA, USA; 5NIAID, NIH, Bethesda, Suppression in Perinatal Infection MD, USA; 6Intl Partnership for Microbicides, Paarl, South Africa; 7FHI 360, 1 2 2 Priyanka Uprety ; Kunjal Patel ; Brad Karalius ; Kaitlin Rainwater- Washington DC, DC, USA; 8Johns Hopkins Univ, Baltimore, MD, USA Lovett1; Carrie Ziemniak1; Ya Chen1; Suzanne Siminski3; Russell B. Van Dyke4; George R. Seage2; Deborah Persaud1 873 Adherence and Acceptability of a Dapivirine Vaginal 1Johns Hopkins Univ, Baltimore, MD, USA; 2Harvard Sch of PH, Boston, Ring in Postmenopausal US Women MA, USA; 3Frontier Sci & Tech Rsr Fndn, Inc, Amherst, NY, USA; 4Tulane Ariane van der Straten1; Nicole Laborde1; Helen Cheng1; Craig Univ Sch of Med, New Orleans, LA, USA Hoesley2; Robert A. Salata3; Sherri Johnson4; Annalene Nel5; Lydia E. 6 7 839 Value of Ultrasensitive HIV Assay in Infants With Soto-Torres ; Beatrice A. Chen ; for the MTN-024/IPM 031 Protocol Team for the Microbicide Trials Network Negative Routine Laboratory Results 1RTI, San Francisco, CA, USA; 2Univ of Alabama at Birmingham, 1 1 1 Arjen J. Stam ; Denise van Hout ; Sibyl P. Geelen ; Annelies Riezebos- Birmingham, AL, USA; 3Case Western Reserve Univ, Cleveland, OH, USA; 2 3 2 1 Brilman ; Joop Schellekens ; E. H. Schölvinck ; Kiki Tesselaar ; Tom F. 4FHI 360, Washington DC, DC, USA; 5Intl Partnership for Microbicides, 1 1 1 Wolfs ; Monique Nijhuis ; Anne M. Wensing Paarl, South Africa; 6NIAID, NIH, Bethesda, MD, USA; 7Univ of Pittsburgh, 1 2 Univ Med Cntr Utrecht, Utrecht, Netherlands; Univ Med Cntr Groningen, Pittsburgh, PA, USA Poster Listings Poster Groningen, Netherlands; 3CERTE, Groningen, Netherlands 874 Distinct Pharmacodynamic Activity of Rilpivirine in 840 HIV Antibodies and Reservoir Size in Perinatally Mucosal Explant Tissue Infected Children on HAART Charlene S. Dezzutti1; Laura J. Else2; Sarah E. Yandura3; Cory Shelter3; 1 2 3 Josephine Brice ; Fatoumata Tiguem Telly ; Maxime Grudé ; Anne Julie Russo3; David J. Back2; Ian McGowan4 4 4 5 3 Derache ; Deenan Pillay ; Francis Barin ; Vincent Calvez ; Maryam 1Univ of Pittsburgh, Pittsburgh, PA, USA; 2Univ of Liverpool, Liverpool, UK; 6 7 3 Sylla ; Almoustapha Maiga ; Anne-Geneviève Marcelin 3Magee-Womens Hosp of the Univ of Pittsburgh Med Cntr, Pittsburgh, PA, 1 2 UMR-S 1136 Pierre Louis Inst of Epi and PH, Paris, France; SEREFO, USA; 4Univ of Pittsburgh Sch of Med, Pittsburgh, PA, USA Univ of Scis Techniques and Technologies of Bamako, Bamako, Mali; 3Sorbonne Univs, Paris, France; 4Africa Cntr for Hlth and Pop Studies, 875 A First-in-Human Trial of PC-1005 (MIV-150 and Zinc Mtubatuba, South Africa; 5François-Rabelais Univ, Tours, France, Acetate in a Carrageenan Gel) Tours, France; 6CHU Gabriel Toure, Bamako, Mali; 7SEREFO, Univ of Scis Barbara A. Friedland1; Craig Hoesley2; Marlena Gehret Plagianos1; Techniques and Technologies of Bamako, Bamako, Mali Shimin Zhang1; Elena Hoskin1; Mohcine Alami1; Natalia Teleshova1; Thomas Zydowsky1; José Fernández-Romero1; George Creasy1 1Pop Council, New York, NY, USA; 2Univ of Alabama at Birmingham, Birmingham, AL, USA 876 CVLs From Women Vaginally Dosed With PC-1005 Inhibit Mucosal HIV-1 and HSV-2 Ex Vivo Guillermo Villegas1; Shimin Zhang1; Olga Mizenina1; Kyle Kleinbeck1; Michael Cooney1; Craig Hoesley2; George Creasy1; José Fernández- Romero1; Thomas Zydowsky1; Natalia Teleshova1 1Pop Council, New York, NY, USA; 2Univ of Alabama at Birmingham, Birmingham, AL, USA
98 CROI 2016 Poster Listings 99 ; 2 ; 4 ; ; Ye 4 3 ; Libet 4 Johns Johns ; Julie Ake 6 6 ; Lynn ; Lynn CROI 2016 Johns Johns Inst of Inst 1 2 2 ; Trevor A. ; Trevor ; Teclaire ; Teclaire 3 Johns Hopkins Hopkins Johns Univ of North of Univ 3 3 2 ; Sheree R. ; Sheree ; BinYang Johns Hopkins Hopkins Johns 3 2 3 in Treatment Treatment in ; Manhattan E. ; Manhattan Hlth Communication Communication Hlth 2 4 ; Wei Chongyi 3 ; William A. Blattner William ; 5 Program Agenda and US Military HIV Rsr Prog, MilitaryUS Prog, Rsr HIV
; Bhekie Sithole; Bhekie 2 1 3 Inst of Human Virology, Virology, Human of Inst Inst of Human Virology, Virology, Human of Inst 4 4 ; Hongjie Liu ; Hongjie 2 ; Charlotte Gaydos ; Charlotte ; Stefan Baral ; Stefan 2 2 ; Stefan Baral ; Stefan 2 Sch of PH, Univ of Maryland, Maryland, of Sch Univ PH, of ; Sosthenes Ketende 3 1 ; Ligang Yang ; Joseph D. Tucker ; Joseph D. ; for the TRUST/RV368 Study Group Group TRUST/RV368 Study the ; for 3 1 1 ; Sylvia Adebajo ; Sylvia 4 ; William A. Blattner William ; ; Zandile Mnisi ; Zandile 1 2 Univ of California San Francisco, San San Francisco, California of Univ 4 ; Sheila Peel 5
1
; for the TRUST Study Group Group Study TRUST the ; for ; Julie Ake US Military HIV Rsr Prog, Walter Reed Army Inst Inst Army Reed Walter MilitaryUS Prog, Rsr HIV 1 1 4 4 ; Trevor A. Crowell A. Trevor ; ; Claire Holland ; Claire ; Rebecca G. Nowak ; Rebecca Pop Council Nigeria, Abuja, Nigeria Nigeria, Council Pop 1 1 1 5 ; Manhattan E. Charurat ; Manhattan ; Babjide Keshinro ; Shujie Huang SESH Global, Guangzhou, China Guangzhou, Global, SESH 1 1 1 5 ; Weiming Tang ; Weiming 1 Walter Reed Prog – Nigeria, Abuja, Nigeria; Abuja, Nigeria; Nigeria, – Prog Reed Walter ; Yilu ; Yilu Qin 5 5 Guangdong Provincial Cntr for Skin Diseases STI for and Cntr Provincial Guangdong 3 Walter Reed Prog – Nigeria, Abuja, Nigeria; Abuja, Nigeria; Nigeria, – Prog Reed Walter ; Rebecca G. Nowak ; Rebecca ; Stefan Baral ; Stefan ; Stefan Baral ; Stefan 2 3 ; Duncan Kochelani 2 2 ; Sosthenes Ketende ; Babjide Keshinro 1 4 4 ; Wei Zhang ; Wei 1 Swaziland Ministry of Hlth, Mbabane, Swaziland; Swaziland; Ministry Mbabane, Hlth, of Swaziland China; Guangzhou, China, Proj North of Univ Carolina Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Sch Baltimore, PH, of Bloomberg Hopkins Johns Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Sch Baltimore, PH, of Bloomberg Hopkins Johns US Military HIV Rsr Prog, Walter Reed Army Inst of Rsr, Silver Spring, Spring, Silver Rsr, of Inst Army Reed Walter MilitaryUS Prog, Rsr HIV USA; MD, Baltimore, Virology, Human of Inst Zhang William A. Blattner William Maloney Capacity Collaborative Proj, Mbabane, Swaziland Mbabane, Proj, Collaborative Capacity Charurat Francisco, CA, USA; Francisco, College Park, MD, USA; USA; MD, Park, College Carolina at Chapel Hill Inst for Global Hlth & Infectious Diseases, Chapel Chapel Diseases, Infectious & Hlth Global for Inst Hill at Chapel Carolina USA; NC, Hill, MD, USA; USA; MD, Van Lith Van Abuja, Nigeria; Abuja, Nigeria; Baltimore, MD, USA; USA; MD, Baltimore, 3 Cross-SectionalA Sex: Group Online Survey Among Chinain Men With Sex Have Who Men SongyuanTang 1 1 1 StigmaOpennessAmongand Identity Sexual about Class Analysis Latent A MSM: ShaunaStahlman Online Sex-Seeking Among MSM in Nigeria:in MSM Among OnlineSex-Seeking Online ImplicationsIntervention for ShaunaStahlman Stigma, Access to Care, and HIV Among Men Who SellWho Men Among HIV and Care, to Stigma,Access Nigeria in Sex Crowell A. Trevor 1 1 Manhattan E. Charurat Manhattan Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Baltimore, Sch PH, of Bloomberg Incidence of STIs Among MSM Engaged MSM Among STIs Incidence of Nigeria in Prevention as RebeccaNowak G. Control, Guangzhou, China; China; Guangzhou, Control, Ndomb Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Baltimore, Sch PH, of Bloomberg Hopkins Univ Cntr for Communication Progs, Baltimore, MD, USA; USA; MD, Baltimore, Progs, Communication for Cntr Univ Hopkins Walter Reed Army Inst of Rsr, Silver Spring, MD, USA; USA; MD, Spring, Silver Rsr, of Inst Army Reed Walter Human Virology, Baltimore, MD, USA; USA; MD, Baltimore, Virology, Human of Rsr, Silver Spring, MD, USA MD, Spring, Silver Rsr, of Schwartz Chuncheng Liu Chuncheng Hopkins Univ Sch of Med, Baltimore, MD, USA MD, Baltimore, Sch Med, Univ of Hopkins Crowell
926 925 924 922 923 ; ; 1 1
Hall D ; Avi ; Avi ; Ian
2 3 1 ; Rafick 1 ; Sarit 1
Univ of Univ RTI, San RTI, 4 2 ; Justin Knox 2 ; Stephanie ; Stephanie 2 ; Danijela Maric 1 Hunter Coll and the and Coll Hunter
2 ; John Pyles Univ of Pittsburgh Sch Pittsburgh of Univ
1 ; Patrick Kiser ; Patrick 2 1 3
; Ginger Rothrock ; Seydou Doumbia; Seydou ICER Mali, Bamako, Mali; Mali; Bamako, Mali, ICER Experienced Around Around Experienced 3 3 2
; Martin Markowitz 1 ; Ellen Leucke ; Ellen 1 Johns Hopkins Univ, Baltimore, Baltimore, Univ, Hopkins Johns ; Telly Nouhoum 2 ; Jonathan Su ; Jonathan 1 1 ; Tejal Desai ; Tejal 2 ; Tom J. Hope J. Tom ; 2 ; Wilkinson Peter 1
Leah Johnson Leah CDC, Atlanta, GA, USA Atlanta, CDC, ; 5 3 ; Traore Bouyagui 4
2 ; RachaelAubert; Dinh; Chuong Holder; Angela ; Daniel Johengen RTI, Research Triangle Park, NC, USA; USA; NC, Park, Triangle Research RTI, ; Kristina Rodriguez 1 3 1 ; Padmaja Patnaik ; Padmaja 1 ; Aarthi Talla 1
; Katarina K.; Katarina Halavaty ; Mark A. Marzinke 1 1 ; Adama N’dir ; Adama ; Ariane van der Straten van ; Ariane 3 Northwestern Univ, Feinberg Sch of Med, Chicago, IL, USA Chicago, Sch Med, of Feinberg Univ, Northwestern 4
3
; Phillip Durham 2 3
; Ian McGowan ; Ian
1 5
CDC, Bamako, Mali; Mali; Bamako, CDC, 4 ICAP at Columbia Univ, New York, NY, USA; USA; NY, York, New Univ, ICAP at Columbia Bamako, Sante, la de Sida, le Ministere contre Lutte de Sectorielle Cellule Aaron Diamond AIDS Rsr Cntr, New York, NY, USA; USA; NY, York, New Cntr, Rsr AIDS Diamond Aaron Case Western Reserve Univ, Cleveland, OH, USA; USA; OH, Cleveland, Univ, Reserve Western Case Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ Northwestern Univ, Chicago, IL, USA; IL, USA; Chicago, Univ, Northwestern A. Golub Grad Cntr, City Univ of New York, New York, NY, USA NY, York, New York, City New of Univ Cntr, Grad Mali; Mali; Sekaly Swarner 1 3 HIV Prevalence and Risk Factors in Men Who Have Sex Have Who Men in Riskand Factors Prevalence HIV Mali Bamako, in Men With MariaLahuerta Long-ActingInjectable PrEP KathrineMeyers 1 1 Anxietyand Understanding Pain Assessing Formulations of Tenofovir 1% Gel in HIVin Gel 1% Tenofovir of AssessingFormulations RNA-Seqvia Adults Seronegative MarkCameron Erica B. Schlesinger B. Erica 1 A Long-ActingA Subcutaneous Biodegradable Implant PrEP HIV Tenofovir for MD, USA; USA; MD, Tenofovir Topical Impact of Pharmacokinetics on STI of Macaquesin Makarova Natalia Charles Heneine; Walid McNicholl; Janet Kersh; Ellen Henning; Tara Dobard GA, USA Atlanta, CDC, Treated With a TDF Intravaginal Ring Intravaginal TDF a With Treated K. Adina Ott 1 Transport of Drug and Virus in FRTs of Macaquesof FRTs in Virus Drugof and Transport Hakim Tako Ballo Tako Samuel Sung Pittsburgh Sch of Med, Pittsburgh, PA, USA PA, Pittsburgh, Sch Med, of Pittsburgh of Med, Pittsburgh, PA, USA PA, Pittsburgh, Med, of McGowan Francisco, CA, USA; Francisco, WITHDRAWN WITHDRAWN
MSM in Low- and Middle-Incomeand Countries Low- in MSM 921 Session P-W4 Poster Abstracts Poster SessionP-W4 PM-4:002:45 PM 882LB 881 880 879 878 877 Program and Agenda
927 Risk Factors for Acute and Early HIV Infection Among 969 Tailoring Mass Media MSM HIV Test Interventions to MSM, Bangkok, Thailand 2010–2015 Reach High-Risk Men Warunee Thienkrua1; Marcel Curlin2; Eileen Dunne3; Kanokpan Ngai Sze Wong1; Weiming Tang2; Larry Han3; John Best4; Ye Zhang2; Pancharoen1; Boonyos Raengsakulrach1; Wannee Chonwattana1; Shujie Huang5; Bin Yang5; Lai Sze Tso2; Chongyi Wei4; Joseph D. Tucker6 Wanna Leelawiwat1; Philip A. Mock1; Anupong Chitwarakorn1; 1South China-UNC STI Rsr Training Cntr, Guangzhou, China; 2Univ of Timothy H. Holtz3 North Carolina Proj China, Guangzhou, China; 3Univ of North Carolina at 1Thailand Ministry of PH US CDC Collab, Nonthaburi, Thailand; 2Oregon Chapel Hill, Chapel Hill, NC, USA; 4Univ of California San Francisco, San Hlth and Scis Univ, Portland, OR, USA; 3CDC, Atlanta, GA, USA Francisco, CA, USA; 5Guangdong Provincial Cntr for Skin Diseases and STI 6 928 High Prevalence of HIV Among Wives of Married Men Control, Guangzhou, China; Univ of North Carolina at Chapel Hill Inst for Global Hlth & Infectious Diseases, Chapel Hill, NC, USA Who Have Sex With Men in India Aylur K. Srikrishnan1; Shruti H. Mehta2; Cecilia Tomori2; Santhanam 970 Feasibility of a Social-Entrepreneurship Model to Anand1; Pachamuthu Balakrishnan3; David Celentano2; Gregory M. Promote HIV Self-Testing Among MSM Lucas2; Sunil S. Solomon2 Fei Zhong1; Weiming Tang2; Weibin Cheng1; Peng Lin3; Qiongmiao 1YRG Cntr for AIDS Rsr and Educ, Taramani, India; 2Johns Hopkins Univ, Wu3; Yanshan Cai1; Lili Fan1; Yuteng Zhao1; Xi Chen1; Joseph D. Tucker4; Baltimore, MD, USA; 3YRG Cntr for AIDS Rsr and Educ, Chennai, India Gang Meng1; Huifang Xu1 1Guangzhou Cntr for Disease Control and Prevention, Guangzhou, China; Session P-X3 Poster Abstracts Hall D 2Univ of North Carolina Proj China, Guangzhou, China; 3Guangdong CDC, 4 2:45 PM-4:00 PM Guangzhou, China; Univ of North Carolina at Chapel Hill Inst for Global HIV Testing and Prevention Hlth & Infectious Diseases, Chapel Hill, NC, USA 971 HIV Self-Testing in the Seattle Transgender 964 Effective Disease Intervention Is Key Component to Community: A Mixed-Methods Evaluation Acute HIV Detection 1 2 3 4 1 1 2 3 Julia E. Hood ; Elizabeth W. Forsyth ; Jillian Neary ; Susan Buskin ; JoAnn D. Kuruc ; Sarah Willils ; Nicole Dzialowy ; Jason Maxwell ; 5 5 2 3 1 2 Mathew R. Golden ; David A. Katz John Barnhart ; Victoria Mobley ; Cynthia Gay ; Erika Samoff 1 2 1 2 PH, Seattle & King County, Seattle, WA, USA; Evergreen State Coll, Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; North 3 4 3 Seattle, WA, USA; Univ of Washington, Seattle, WA, USA; Seattle King Carolina Division of PH, Raleigh, NC, USA; North Carolina DHHS, Raleigh, County PH, Seattle, WA, USA; 5Univ of Washington Sch of Med, Seattle, NC, USA WA, USA 965 Late HIV Diagnosis and Missed Opportunities for HIV 972 MSM and TG Accessing HIV VCT in Bangkok: Spatial Testing in South Carolina Characteristics, 2005-2015 1 2 1 Sharon Weissman ; Kristina Kintziger ; Helmut Albrecht ; Terri 1 2 2 3 1 1 Kevin Weiss ; Sarika Pattanasin ; Wipas Wimonsate ; Jirawat Stephens ; Babatunde Edun ; Wayne Duffus 2 2 2 2 1 2 Suksamosorn ; Prin Visavakum ; Wichuda Sukwicha ; Samart Karuchit ; Univ of South Carolina, Columbia, SC, USA; Dept of Med, Georgia 2 3 3 3 Chaiwat Ungsedhapand ; Eileen Dunne ; Timothy H. Holtz Regents Univ, Augusta, GA, USA; South Carolina Dept of Hlth and 1Emory Univ Rollins Sch of PH, Atlanta, GA, USA; 2Thailand Ministry of PH Environmental Control, Columbia, SC, USA US CDC Collab, Nonthaburi, Thailand; 3CDC, Atlanta, GA, USA 966 Missed Opportunities for HIV Testing During Routine 973 Effect of Secondary Distribution of HIV Self-Tests on Poster Listings Poster Doctor Visits, BRFSS, 2011-2013 Women’s Sexual Decision-Making Michelle Van Handel; Patricia Dietz Harsha Thirumurthy1; Samuel H. Masters1; Sue N. Mavedzenge2; CDC, Atlanta, GA, USA Eunice Omanga3; Kawango Agot3 967 Setting a Benchmark for HIV Testing at Visits to US 1Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2RTI, San Physician Offices Francisco, CA, USA; 3Impact Rsr and Develop Org, Kisumu, Kenya Karen Hoover; Charles Rose; Philip Peters 974 Awareness of HIV Status: the Disclosure Gap in Rural CDC, Atlanta, GA, USA Africa 968 Implementation of a Rapid HIV Testing Program in Elisa López Varela1; Laura de la Fuente Soro1; Orvalho J. Augusto2; Psychiatric Inpatient Wards Charfudin Sacoor2; Ariel Nhacolo2; Esmeralda Karajeanes3; Paula M. 3 1 Maryann J. Popiel; Vikram Duvvi; Albert Turkieh; Ethan Cowan; Vaz ; Denise Naniche 1Barcelona Inst for Global Hlth, Barcelona, Spain; 2Centro de Investigação Yvette Calderon; Anuj Rao; Jennifer Zahn; Uttara Gadde; Stephanie 3 Haimowitz; Jason Leider da Manhiça (CISM), Maputo, Mozambique; Fundação Ariel Glaser, Jacobi Med Cntr, Bronx, NY, USA Maputo, Mozambique
100 CROI 2016 Poster Listings 101 ; 1 ; Tamara ; Tamara 3 ; Tendani ; Tendani 4
Makerere Makerere ; David ; David ; Maya ; Maya 2 4 ; John 4 1 1 ; Deborah ; for the ; for CROI 2016 3 2 ; Godfrey ; Godfrey 3 Harvard Sch Harvard ; Lucy 2 ; Sarah j. ; Sarah j. 1 7 ; Erik van van ; Erik ; Ab Schaap ; Ab SCHARP, Fred Fred SCHARP, 1 Johns Hopkins Hopkins Johns 2 4 Tebelopele Tebelopele 4 3 Harvard Sch PH, of Harvard
4 2 Univ of Stellenbosch, Stellenbosch, of Univ 2 ; Norton Sang
1 6 Imperial Coll London, London, Coll Imperial Program Agenda and ZAMBART, Lusaka, Lusaka, ZAMBART, 4 5 ; Helen Ayles ; Helen ; Young Alicia Univ of Stellenbosch, Stellenbosch, of Univ 4 2 7 ; Diane V. Havlir V. ; Diane ; Ronald H. Gray ; Ronald H. 4 Makerere Univ Schoool Univ PH, of Makerere 1 5 Univ of California Berkeley, Berkeley, California of Univ ; Vladimir ; Vladimir Novitsky 5 ; Nulda Beyers ; Sian Floyd 2 Johns Hopkins Univ, Baltimore, Baltimore, Univ, Hopkins Johns 6 1 2 ; Stephanie K. Behel; Stephanie 2 ; Gertrude Nakigozi ; Molly Pretorius Holme ; Molly Pretorius ; Lisa A. Mills 2 1 6 ; Terence Mohammed ; Terence 1 ; Lillian Brown 2 ; RosemaryMusonda ; M. Essex 1 1 Larry W. ChangLarryW. ; Sarah j. Fidler ; Sarah j. London Sch of Hygiene & Trop Med, London, London, Med, & Trop Sch Hygiene of London 2 ; 2 4 ; Nomtha Mandla ; Nomtha SCHARP, Seattle, WA, USA; USA; WA, Seattle, SCHARP, 1 ; Moses R. Kamya ; Ayana Moore ; Ayana 3 Kenya Med Rsr Inst, Nairobi, Kenya; Kenya; Nairobi, Inst, Rsr Med Kenya Imperial Coll London, London, UK London, London, Coll Imperial 1 5 CDC, Gaborone, Botswana; Botswana; Gaborone, CDC, 3 8 ; Robert Sekubugu 2 1
Jan S. Moore S. Jan 1 ; Joseph M. Chaila ; 1 ; Mary Alwano G. 3 1 Johns Hopkins Univ Sch of Med, Baltimore, MD, USA MD, Baltimore, Sch Med, of Univ Hopkins Johns 6 Botswana Harvard AIDS Inst Partnership, Gaborone, Gaborone, Partnership, Inst AIDS Harvard Botswana ; Laura Balzer ; Laura ; Coretah Boleo ; Coretah 5 1 1 ; MaryK. Grabowski 1 SianFloyd ; Richard Hayes ; Richard ; 3 Ministry of Hlth, Gaborone, Botswana Ministry Gaborone, Hlth, of 1 6 ; Maria J. Wawer ; Maria J. ; Joseph Makhema 5 Rakai Hlth Scis Prog, Baltimore, MD, USA; USA; MD, Baltimore, Scis Hlth Prog, Rakai ; Simani Gaseitsiwe 1 ; Refeletswe Lebelonyane ; Refeletswe ; for the SEARCH Collaboration the SEARCH Collaboration ; for 3 1 Family Hlth Intl, Durham, NC, USA; USA; NC, Durham, Intl, Hlth Family 5 5 ; Nkatya Kasese ; Nkatya 6 4 ; Fred Nalugoda ; Fred ; Richard Hayes ; Richard 1 ; Edwin Charlebois ; Edwin 8 ; Winnie ; Winnie Sento 1 FHI 360, Research Triangle Park, NC, USA; USA; NC, Park, Triangle Research 360, FHI 1 3 Rakai Hlth Scis Prog, Entebbe, Uganda; Uganda; Entebbe, Scis Hlth Prog, Rakai Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ CDC, Atlanta, GA, USA; Atlanta, CDC, Botswana; Gaborone, Partnership, Inst AIDS Harvard Botswana USA MA, Boston, Sch PH, of Harvard ZAMBART, Lusaka, Zambia; Zambia; Lusaka, ZAMBART, UK; London, Med, & Trop Sch Hygiene of London HPTN071/PopART HPTN071/PopART Kigozi UK; UK; Tygerberg, South Africa; South Africa; Tygerberg, SamGriffith Cape Town, South Africa; South Africa; Town, Cape Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; USA; WA, Seattle, Cntr, Rsr Cancer Hutchinson Kampala, Uganda; Uganda; Kampala, Clark Counseling and Testing Cntr, Gaborone, Botswana; Botswana; Gaborone, Cntr, Testing and Counseling CA, USA Berkeley, Petersen Serwadda 1 Donnell 1 ain Incidence HIV and Prevention HIV Combination Community Fishing Hotspot Ugandan Joseph Kagaayi Botswana; Botswana; Local Social Network Features Predict HIV Testing Predict Testing HIV LocalFeatures Social Network Community Ugandan Rural a in Uptake Zheng Wenjing HIV Testing and Linkage to Care in the Botswana Linkageand Botswana the in Care to Testing HIV Project Prevention Combination Bachanas J. Pamela 1 Cross-SectionalScale-up at Incidence HIV 24in ART of Botswana in Communities Rural SikhulileMoyo 1 2 Uptake of HIV Testing in the HPTN 071 (PopART) Trial Trial (PopART) 071 HPTN the in Testing HIV of Uptake Zambiain Shanaube Kwame 1 UTTa Before Coverage ART and Testing HIV (PopART) 071 HPTN in Intervention:Findings Ayles Helen 1 Univ Coll of Hlth Scis, KAMPALA, Uganda; Uganda; KAMPALA, Scis, Hlth of Coll Univ Mupfumi Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Baltimore, Sch PH, of Bloomberg Fidler Gaolethe Widenfelt Zambia; Zambia; Wen Boston, MA, USA; USA; MA, Boston, MD, USA; USA; MD, London, UK London, of PH, Boston, MA, USA; USA; MA, Boston, PH, of
986 985 983 984 981 982 ; 1 ; ; 2 6 ; Robert 3 ; Grace ; Diane V. ; Diane V. ; Tamara ; Tamara 1 5 2 ; Paula M. ; Paula 3 ; Mustafa Makerere Univ- Makerere ; Tobias Rinke ; Tobias 3 ; Daniel 2 1 1 ; Kelly Curran ; Kelly Natl Inst of Hlth Hlth of Inst Natl ; Ephraim Sakala; Ephraim 3 3 2 Colorado Dept PH of Colorado 6 Centro de Investigação Investigação de Centro US Agency for Intl Intl for Agency US 2 7 Cntr for Microbiology Microbiology for Cntr 3 ; Orvalho Augusto J.
1 1 Natl AIDS Control Prog, Prog, Control AIDS Natl 4 Fundação Ariel Glaser, Glaser, Ariel Fundação 3 ; Wei Stanley
5 ; Evanson Gichuru ; Evanson ; Moses R. Kamya ; Thompson Ricardo 1 1 4 ; for the HPTN 071/PopART the HPTN 071/PopART ; for 2 ; Sian Floyd Univ of California Berkeley, Berkeley, California of Univ 2 1 ; Mbaraka Amuri ; Mbaraka ; MaryDrake 4 2 5 CITSC, Chókwè, Mozambique; Mozambique; Chókwè, CITSC, ; Henrieke A. Prins ; Henrieke 4 1 Univ of Washington, Seattle, WA, WA, Seattle, Washington, of Univ JHpiego, Maputo, Mozambique Maputo, JHpiego, 3 7 Amsterdam Inst for Global Hlth and and Hlth Global for Inst Amsterdam ; Esmeralda Karajeanes ; Esmeralda ; Emmanuel Ssemmondo ; Emmanuel 2 2
2 7 Kahabuka Consulting, Dar es Salaam, es Dar Consulting, Kahabuka 2 CDC, Atlanta, GA, USA; GA, USA; Atlanta, CDC, London Sch of Hygiene & Trop Med, Med, & Trop Sch Hygiene of London 2 2 ; Bertur Alface ; Eduard J. Sanders J. ; Eduard ; Helen Ayles ; Helen 4 3 ; for the Sustainable East Africa Research for for Research the Sustainable Africa ; for East US Agency for Intl Develop-Tanzania, Dar es Dar Develop-Tanzania, Intl for Agency US 3 1 5 ; Nely Honwana ; Nely ; Maya Petersen ; Maya ; Erick Mlanga ; Erick 7 3 4
; Laura de la Fuente Soro de la Fuente ; Laura 1 ; Duncan MacKellar 1 1 ; Kwame Shanaube ; Kwame Jhpiego, Baltimore, MD, USA; USA; MD, Baltimore, Jhpiego, 1 Makerere Univ Coll of Hlth Scis, KAMPALA, Uganda KAMPALA, Scis, Hlth of Coll Univ Makerere 6 ; Jane Kabami 5 ; Ariel Nhacolo ; Ariel 1 ; Elizabeth W. Wahome ; W. Elizabeth 2 ; Vincent Wong ; Vincent ; Catherine Kahabuka ; Catherine 1 7 1 ; Alexander N. Thiong’o N. ; Alexander FHI 360, Research Triangle Park, NC, USA NC, Park, Triangle Research 360, FHI 1 ; SamGriffith 3 1 Jhpiego, Dar es Salaam, Tanzania; Salaam, es Dar Tanzania; Jhpiego, , Lusaka, Zambia; Zambia; Lusaka, , 3 ; Judite Cardoso ; Judite ; Juvencio Bonzela ; Juvencio 6 ; Susan M. Graham 2 ; Edwin Charlebois ; Edwin 2 1 ; Elizabeth Bukusi ; Elizabeth ; Werner Maokola ; Werner 1 3 ; Denise Naniche 3 AMBART Jhpiego, Chapel Hill, NC, USA; USA; NC, Hill, Chapel Jhpiego, Z Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ Kenya Med Rsr Inst, Kilifi, Kenya; Kenya; Kilifi, Inst, Rsr Med Kenya Barcelona Inst for Global Hlth, Barcelona, Spain; Barcelona, Hlth, Global for Inst Barcelona Provincial Directorate of PH, Xaixai, Mozambique; Mozambique; Xaixai, PH, of Directorate Provincial CDC, Maputo, Mozambique; Mozambique; Maputo, CDC, Team Team USA and Environment, Denver, CO, USA; USA; CO, Denver, Environment, and Nelson Njozi London, UK; UK; London, Charfudin Sacoor Dar es Salaam, Tanzania; Salaam, es Tanzania; Dar Mozambique, Maputo, Mozambique; Mozambique; Maputo, Mozambique, Havlir Shodell Hybrid Mobile Testing in East AfricaEast in Testing Mobile Hybrid GabrielChamie 94% Population HIV Testing Coverage With Repeat Repeat With Coverage Testing HIV Population 94% 1 1 Men Lessons From HPTN071 StudyHPTN071 From Lessons Men Phiri M. Mwelwa 1 by Testing HIV of Uptake Malea Does Increase CHiP MaryaPlotkin Effective, High-Yield HIV Testing for Partners of Newly Partners Newly of for Testing HIV High-Yield Effective, Tanzania in DiagnosedPersons Peter M. Mugo M. Peter 1 Effect of SMS, Phone Call, and In-Person Reminders on Reminders In-Person and EffectCall, Phone SMS, of Kenya in Uptake Test HIV Repeat Community Testing in Rural Mozambique Rural in Testing Community Varela Elisa López 1 5 Clinic Linkage vs After Care HIV Increased to Chókwè District, Chókwè Mozambique Casavant Isabelle 1 Home-Based HIV Testing and New HIV DiagnosesHIV in New and Testing Home-BasedHIV da Manhiça (CISM), Maputo, Mozambique; Mozambique; Maputo, (CISM), Manhiça da Stable BesaStable Clark Mwashigadi Maputo, Mozambique Maputo, Salaam, Tanzania; Salaam, Tanzania; Rsr, Kenya Med Rsr Inst, Kisumu, Kenya; Kenya; Kisumu, Inst, Rsr Med Kenya Rsr, Develop, Washington, DC, USA DC, Washington, Develop, Berkeley, CA, USA; Berkeley, Tanzania; Tanzania; Vaz Charlene Brown Charlene Develop, Amsterdam, Netherlands; Netherlands; Amsterdam, Develop, de Wit Community Health (SEARCH) team (SEARCH) team Health Community Univ of California Rsr Collab, Kampala, Uganda; Uganda; Kampala, Collab, Rsr California of Univ
979 980 978 977 976 975 Program and Agenda
987 Genital Inflammation and HIV Shedding Post-Male 993 UCARE4LIFE: Mobile Texting to Improve HIV Care Circumcision in Rakai, Uganda Continuum Outcomes for Minority Youth Eshan U. Patel1; Mary K. Grabowski2; Godfrey Kigozi3; Ronald H. Carrie Jeffries1; Polly Ross1; Sabrina Matoff-Stepp1; Renata Gray4; Andrew D. Redd5; Allison R. Kirkpatrick5; David Serwadda6; Maria Thompson1; Jennie L. Harris2; Jennifer D. Uhrig2; Laura Cheever1 J. Wawer4; Thomas C. Quinn7; Aaron A. Tobian7 1US DHHS, Rockville, MD, USA; 2RTI, Research Triangle Park, NC, USA 1 2 NIH, Bethesda, MD, USA; Johns Hopkins Univ, Baltimore, MD, USA; 994 Missed Opportunities: Adapting the HIV Care 3Rakai Hlth Scis Prog, Entebbe, Uganda; 4Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; 5NIAID, NIH, Bethesda, MD, USA; 6Makerere Continuum to Reduce HIV-Related Deaths Univ Schoool of PH, Kampala, Uganda; 7Johns Hopkins Univ Sch of Med, Sarah Braunstein; Rebekkah Robbins; Demetre C. Daskalakis Baltimore, MD, USA New York City DHMH, Queens, NY, USA 988 Home-Based HIV Counseling and Testing Using Index 995 A Novel Practical Spatial Analysis of HIV Care Patients in Lesotho Outcomes, Metro Atlanta, 2012-2014 1 2 2 2 Abby L. DiCarlo1; Allison Zerbe1; Zach Peters2; Koen Frederix1; Joanne E. Neela D. Goswami ; Jeffrey McMichael ; Deepali Rane ; Jane Kelly ; 2 3 Mantell3; Robert Remien3; Wafaa M. El-Sadr1 Julie Clennon ; Carlos del Rio; Travis Sanchez 1 2 1ICAP at Columbia Univ, New York, NY, USA; 2ICAP, Columbia Univ Emory Univ Sch of Med, atlanta, GA, USA; Georgia Dept of PH, Atlanta, 3 Mailman Sch of PH, New York, NY, USA; 3HIV Cntr for Clinical and GA, USA; Emory Univ, Atlanta, GA, USA Behavioral Studies, Columbia Univ and New York State Psychiatric Inst, 996 Factors Associated With Retention and Engagement in New York, NY, USA HIV Care (the REACH Survey) Alison R. Howarth1; Fiona Burns1; Caroline Sabin1; Vanessa Apea2 Session P-X4 Poster Abstracts Hall D 1Univ Coll London, London, UK; 2Barts Hlth NHS Trust, London, UK 2:45 PM-4:00 PM 997 Computer-Based Prevention Counseling for HIV- HIV Care in the Global North Infected Persons (HPTN 065) 989 Prevention for HIV-Infected Persons in HPTN 065: Ann Kurth1; Jennifer H. Farrior2; Brett Hanscom3; Laura McKinstry3; Room for Improvement Jill Stanton2; Allison Zerbe4; Richard Elion5; Jason Leider6; Bernard Wafaa M. El-Sadr1; Ann Kurth2; Jennifer H. Farrior3; Kate Buchacz4; Branson7; Wafaa M. El-Sadr4 Brett Hanscom5; Laura McKinstry5; Richard Elion6; Viraj Patel7; Deborah 1New York Univ, New York, NY, USA; 2FHI 360, Durham, NC, USA; Donnell5; Bernard Branson8 3SCHARP, Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 4ICAP at 1ICAP at Columbia Univ, New York, NY, USA; 2New York Univ, New York, Columbia Univ, New York, NY, USA; 5George Washington Univ Sch of NY, USA; 3FHI 360, Durham, NC, USA; 4CDC, Atlanta, GA, USA; 5SCHARP, Med, Washington, DC, USA; 6Jacobi Med Cntr, Bronx, NY, USA; 7Scientific Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 6George Washington Affairs, Atlanta, GA, USA 7 Univ Sch of Med, Washington, DC, USA; Montefiore Med Cntr, Bronx, NY, 998 The Swedish HIV Treatement Cascade USA; 8Scientific Affairs, Atlanta, GA, USA Magnus Gisslén1; Veronica Svedhem2; Lena Lindborg3; Leo Flamholc4; 990 Increased Levels of HIV Baseline Drug Resistance Hans Norrgren5; Suzanne Wendahl6; Anders Sönnerborg2 Testing & Early Treatment Initiation 1Univ of Gothenburg, Gothenburg, Sweden; 2Karolinska Inst, Stockholm, 3 4 Hong-Ha M. Truong1; Sharon Pipkin2; Robert Grant1; Teri Liegler1; Sweden; Venhalsan, Sodersjukhuset, Stockholm, Sweden; Skåne Univ Poster Listings Poster 5 6 Susan Scheer2 Hosp, Malmö, Sweden; Lund Univ, Lund, Sweden; Luleå Hosp, Luleå, 1Univ of California San Francisco, San Francisco, CA, USA; 2San Francisco Sweden Dept of PH, San Francisco, CA, USA 991 HIV Prevalence and Care in the New York State Session P-X5 Poster Abstracts Hall D Department of Corrections 2:45 PM-4:00 PM Lou Smith1; Brenda L. Moncur2; Bridget Anderson1; James Tesoriero3; HIV Care, Financing Carl J. Koenigsmann4; Heidi Reukauf3; Deepa Rajulu1; Daniel A. 999 Antiretroviral Treatment Among Commercially Insured O’Connell1 Persons With HIV in the United States 1New York State Dept of Hlth, Albany, NY, USA; 2Hlth Rsr, Inc, Albany, NY, 3 4 Kashif Iqbal; Ya-Lin A. Huang; Philip Peters; Karen Hoover USA; New York State Dept of Hlth, AIDS Inst, Albany, NY, USA; Dept of CDC, Atlanta, GA, USA Corrections and Community Supervision, Albany, NY, USA 1000 Increases in Health Insurance Coverage Among MSM 992 Frequency and Duration of Churn Among Persons 20 US Cities, 2008–2014 Living With HIV in Washington, DC Laura A. Cooley; Brooke Hoots; Cyprian Wejnert; Rashunda Lewis; Maggie Dorr1; Amanda Castel2; Kerri Dorsey2; Adam Allston3 1 2 Gabriela Paz-Bailey; for the NHBS Study Group George Washington Univ, Washington, DC, USA; George Washington CDC, Atlanta, GA, USA Univ Milken Inst Sch of PH, Washington, DC, USA; 3District of Columbia Dept of Hlth, HIV/AIDS, Hepatitis, STD, and TB Administration, Washington, DC, USA
102 CROI 2016 Poster Listings 103 ; 1
Ume 2 ; Hall D 2 ; 2 ; Khanya ; Khanya ; Deborah 2 ; H. L. 3 Desmond 2 4 Baylor Coll Coll Baylor 4 ; Mercy CROI 2016 3 ; Marelize ; Marelize 1 ; Helen ; Helen ; Helen R. Stagg ; Helen 3 2 Imperial Coll Coll Imperial 2 The World World The 3 ; UrviM. Parikh Program Agenda and ; Lut Van Damme Van ; Lut 3 2 ; Maeve K. Lalor ; Maeve Northeastern Univ, Boston, Boston, Northeastern Univ, ; Marie-Claude Boily 2 ; James P. Hughes ; James P. 2 5 2 ; Sabina Alistar ; Nokwazi Mathabela ; Nokwazi Univ of California San Francisco, San Francisco, California of Univ 1 2 5 ; Peter Kirwan ; Peter Univ of Pittsburgh, Pittsburgh, PA, PA, Pittsburgh, Pittsburgh, of Univ 2 Univ of Nairobi, Nairobi, Kenya Nairobi, Nairobi, of Univ 2 4 ; Sandra G. Sosa-Rubi 2 Bill and Melinda Gates Fndn, Seattle, Seattle, Fndn, Gates Melinda and Bill 2 Natl Emergency Response Council Council Response Emergency Natl ; Greg Hood ; Greg 2 2
4 PH England, London, UK London, England, PH ; Sally Blower ; Sally Blower 1 ; Geoff Garnett 2 2 Wits Reproductive Hlth and HIV Inst, Inst, HIV and Hlth Reproductive Wits ; Robert Grant 4
4
4 ; Futhi Dennis ; Futhi ; Kate M. Mitchell ; Kate ; Sergio Bautista-Arredondo ; Sergio 1 ; Andrew Skingsley ; Andrew 1 3 ; Eran Bendavid ; Eran 2 2 eness of Nondaily PrEP Based on Sexon Based PrEP Nondaily of eness Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ 3 ; Valerie Delpech; Valerie 1 ; Wamai Richard 1 ; Kate Harris ; Kate ; Kerri J. Penrose J. ; Kerri 1
Justin OkanoJustin 1 1 ; Joseph Wang’Ombe INSP, Cuernavaca, Mexico; Mexico; Cuernavaca, INSP, 4 3 ; Venter Francois ; Waligo Allen ; Ibrahim R. Abubakar ; Ibrahim ; Linda-Gail Bekker 3 2 2 1
4 ; David Contreras ; David 4 Pittsburgh Supercomputing Cntr, Pittsburgh, PA, USA; USA; PA, Pittsburgh, Cntr, Supercomputing Pittsburgh 3 Imperial Coll London, London, UK; UK; London, London, Coll Imperial USA; RI, Providence, Sch PH, Univ of Brown Stanford Univ, Stanford, CA, USA; Stanford, Univ, Stanford Cleveland Clinic, Cleveland, OH, USA; USA; OH, Cleveland, Clinic, Cleveland Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; USA; WA, Seattle, Cntr, Rsr Cancer Hutchinson Fred Univ Coll London, London, UK; UK; London, London, Coll Univ Nyakundi USA; USA; Tutu HIV Cntr, Cape Town, South Africa; South Africa; Town, Cape Cntr, HIV Tutu Mabuza on HIV and AIDS (NERCHA), Mbabane, Swaziland; Swaziland; Mbabane, (NERCHA), AIDS and HIV on WA, USA WA, of Med, Houston, TX, Houston, USA Med, of Mugo London, London, UK; UK; London, London, Timothy Hallett Timothy MA, USA; USA; MA, Robert Glaubius Dapivirine Ring: Intravaginal the of Cost-Effectiveness Analysis Modeling A Smith Jennifer 1 Efficiency Economic of Determinants HIVin Kenya ORPHEA From Evidence Prevention: OmarGalarraga 1 1 for Prophylaxis Ring Preexposure Vaginal Dapivirine Southin Africa Prevention HIV 1 1 Preexposure and Scale-upTherapy Antiretroviral of Swaziland in Prophylaxis Richardson T. Eugene Univ of California Los Angeles, Los Angeles, CA, USA Angeles, Los Angeles, Los California of Univ Coverage Data From HPTN067 ADAPT HPTN067 From Data Coverage Dimitrov T. Dobromir Linkage of UK HIV and Tuberculosis Data Using Using Data Tuberculosis Linkageand HIV UK of Methods Deterministic and Probabilistic Joanne Winter R. 1 in As Prevention” “Treatment Optimalof Rollout Equity Africa: Efficiency Versus Coburn; Brian J. Modeled Effectiv Johannesburg, South Africa Johannesburg, Thomas Abbas Bank, Washington, DC, USA; USA; DC, Bank, Washington, Gorgens San Francisco, CA, USA San Francisco, Srividhya Venugopalan Srividhya Donnell
1058 1059 1057 1056 Session P-Y3 Poster Abstracts Poster SessionP-Y3 PM-4:002:45 PM and Efficiency Testing of (Cost) the Modeling Prevention 1053 1054 1055 ; 5 ; 2 ; Hall D 2 Harvard Harvard ; Frank ; Frank 4 2 RTI, RTI, ; Bart J. 3 2 ; Till ; Till 2 ; Richard ; Richard Oregon Hlth Hlth Oregon 3 5 ; Todd Korthuis ; Todd 4 Boston, MA, USA MA, Boston, Academic Med Cntr, Cntr, Med Academic 2 ; Benjamin T. Allaire T. ; Benjamin 1 ; Sydney Rosen ; Sydney 2 ; Deenan Pillay 2
Agency for Hlthcare Rsr and Rsr Hlthcare for Agency 4 Boston Univ, Boston, MA, USA; USA; MA, Boston, Univ, Boston ; Marc van der Valk der van ; Marc 2 2 1 ; Amanda A. Honeycutt ; Amanda 4 ; Baligh R. Yehia ; Baligh R. Africa Cntr for Hlth and Pop Pop and Hlth for Cntr Africa 2 2
; for the HIV Research Network Network Research the HIV ; for ; Evin Jacobson ; Evin 1 1 1 Univ of Texas Southwestern Med Cntr, Cntr, Med Southwestern Texas of Univ 6 ; Matthew P. Fox P. ; Matthew 2 Univ of Pennsylvania, Philadelphia, PA, PA, Philadelphia, Pennsylvania, of Univ
3 ; Wm. Christopher Mathews Christopher Wm. ; 1 RTI, Research Triangle Park, NC, USA; USA; NC, Park, Triangle Research RTI, ; Natsayi Chimbindi ; Natsayi 2 ; Till ; Till Bärnighausen 1 3
1 RTI Hlth Solutions, Research Triangle Park, NC, USA NC, Park, Triangle Research Solutions, Hlth RTI ; Charles A. Boucher; Charles ; John Fleishman 4 ; Katherine A. Hicks ; Katherine 1 , Clinton Hlth Access Initiative, Initiative, Access Hlth , Clinton 1 3 ; Sarah-Jane Anderson; Timothy Hallett Timothy Anderson; ; Sarah-Jane ; Kelly A. Gebo ; Kelly ; Melissa Miller; Coleman Terrell; Sebastian Branca; Terrell; ; Melissa Miller;Coleman 6 ; Paul Farnham ; Paul 1
1 ; Shahira Ahmed ; Shahira 1 ; David A. van de Vijver de A. van ; David 1 ; Deenan Pillay ; Allison L. Agwu ; Allison 3 1 Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ 4 Erasmus Univ Med Cntr, Rotterdam, Netherlands; Netherlands; Rotterdam, Cntr, Med Univ Erasmus CDC, Atlanta, GA, USA; Atlanta, CDC, Boston Univ Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, Univ of Boston South Mtubatuba, Africa; Studies, Pop and Hlth for Cntr Africa Harvard Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, of Harvard Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns Dallas, TX,Dallas, USA Rijnders Quality, Rockville, MD, USA; USA; MD, Rockville, Quality, Brooke E. Nichols E. Brooke 1 1 thein MSM Among OnlyIs PrEP Cost-Effective Demand on Used When Netherlands Impact of Improving HIV Care and Treatment and Treatment Impactand Care HIV Improving of 2015-2020 States, United the in PrEP Initiating Yaylali Emine Imperial Coll London, London, UK London, London, Coll Imperial Cost in Billion 3 USD Over Represent Could ARVs New SavingsThrough 2025 Prabhu R. Vineet Optimizing Resource Allocation to Reduce HIV Reduce Allocation Optimizingto Resource Sub-Saharan Across Incidence Africa JessicaMcGillen Jacob Bor Jacob 1 3 Effect of Eliminating CD4 Thresholds on Number ofNumber on Thresholds CD4 EffectEliminating of Southin Africa initiators ART New Tanser 1 Kathleen Brady Brady Kathleen USA PA, Philadelphia, Dept PH, of Philadelphia Food Causal Impact Household on The Initiation ART of Security BryanPatenaude N. Receipt of Ryan White Care ServicesCare White With Associated Is Ryan of Receipt Outcomes Long-Term Improved Nassau Tanner Following the Affordable Care Act Care Affordable the Following BerryA. Stephen 1 Reliance on Ryan White Coverage for Provider Visits Visits Provider for Coverage White Ryan on Reliance Bärnighausen Waltham, MA, USA; USA; MA, Waltham, USA; USA; Moore Amsterdam, Netherlands Amsterdam, Stephanie L. Sansom Stephanie Sch of PH, Boston, MA, USA MA, Sch Boston, PH, of Danielle L. Wagner Studies, Mtubatuba, South Africa Mtubatuba, Studies, Ank E.Ank Nijhawan & Sci Univ, Portland, OR, USA; USA; OR, Portland, Sci& Univ,
1052 1051 1050 1049 2:45 PM-4:002:45 PM PrEP and Scale ART to Going With 1048 Session P-Y2 Poster Abstracts Poster SessionP-Y2 1003 1002 1001 Program and Agenda
1060 Global Variation in the Impact of Male Circumcision in 202 CBFß Protects HIV-1 Vif From MDM2-Mediated Preventing HIV Among MSM Degradation Lilith K. Whittles1; Kate M. Mitchell1; Romain Silhol1; Dobromir T. Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Noriyoshi Yoshinaga; Dimitrov2; Marie-Claude Boily1 Kotaro Shirakawa; Masayuki Kobayashi; Akifumi Takaori-Kondo 1Imperial Coll London, London, UK; 2Fred Hutchinson Cancer Rsr Cntr, Kyoto Univ, Kyoto, Japan Seattle, WA, USA 203 MARCH8 Restricts HIV-1 Infection by Reducing 1061 What Does Community HIV Testing Really Cost in South Envelope Incorporation Into Virions Africa? Kenzo Tokunaga1; Takuya Tada1; Yanzhao Zhang1; Takayoshi Koyama1; Guillermo Martínez Pérez1; Aline Aurore Niyibizi2; Jessie Kurkunar1; Minoru Tobiume1; Yasuko Tsunetsugu-Yokota1; Shoji Yamaoka2; Hideaki Amir Shroufi3; Sarah Jane Steele4; Gilles Van Cutsem3 Fujita3 1Médecins Sans Frontières, South Africa & Lesotho, Eshowe, South Africa; 1Natl Inst of Infectious Diseases, Tokyo, Japan; 2Tokyo Med and Dental 2Médecins Sans Frontières, Roma, Lesotho; 3Médecins Sans Frontières, Univ, Tokyo, Japan; 3Nagasaki Intl Univ, Nagasaki, Japan 4 Cape Town, South Africa; Médecins Sans Frontières, South Africa & 204 Sirtuins Modulate HIV Integration and Replication: Lesotho, Cape Town, South Africa New Cellular Anti-HIV Targets 1062 Costs of Hybrid Mobile Multi-Disease Testing With High Michelino Di Rosa1; Ilaria Gnemmi2; Beatrice Riva2; Ubaldina Galli2; HIV Test Coverage, East Africa Armando Genazzani2; Pier Luigi Canonico2; Marilia R. Pinzone1; Fabrizio Wei Chang1; Gabriel Chamie1; Harsha Thirumurthy2; Tamara Clark1; Condorelli2; Giuseppe Nunnari1 Edwin Charlebois1; Maya Petersen3; Moses R. Kamya4; Diane V. 1Univ of Catania, Catania, Italy; 2Sch of Pharm, Univ of Piemonte Havlir1; James G. Kahn1; for the Sustainable East Africa Research for Orientale A. Avogadro, Novara, Italy Community Health (SEARCH) Collaboration 205 SAMHD1 Phosphorylation Affects dNTPase Activity and 1Univ of California San Francisco, San Francisco, CA, USA; 2Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 3Univ of California Berkeley, HIV-1 Replication Capacity 1 1 1 Berkeley, CA, USA; 4Makerere Univ Coll of Hlth Scis, Kampala, Uganda Roger Badia ; Eva Riveira-Muñoz ; Maria Pujantell ; Javier Torres- Torronteras2; Bonaventura Clotet3; Luis Menéndez-Arias4; Ramón 1063 Targeting Serodiscordant Couples Within Home HIV Martí2; Ester Ballana1; José A. Esté1 Testing Campaigns: A Modeling Study 1IrsiCaixa Inst for AIDS Rsr, Badalona, Spain; 2Vall d Hebron Inst de Sarah T. Roberts1; Aditya S. Khanna2; Ruanne V. Barnabas1; Steven M. Recerca, Barcelona, Spain; 3Lluita Contra la SIDA Fndn, Germans Trias i Goodreau1; Jared M. Baeten1; Connie M. Celum1; Susan L. Cassels3 Pujol Univ Hosp, Barcelona, Spain; 4Centro de Biología Molecular Severo 1Univ of Washington, Seattle, WA, USA; 2Univ of Chicago, Chicago, IL, Ochoa (Consejo Superior de Investigaciones Científicas UAM), Madrid, USA; 3Univ of California Santa Barbara, Santa Barbara, CA, USA Spain 206 Novel Mutant HIV-1 Strains With Greater Resistance to Cynomolgus Macaque TRIMCyp THURSDAY, FEBRUARY 25, 2016 Tahmina Sultana1; Emi E. Nakayama1; Satoshi E. Tobita2; Yohei Seki3; Akatsuki Saito4; Masako Nomaguchi5; Akio Adachi5; Hirofumi Akari4; Session P-A4 Poster Abstracts Hall A/B Tatsuo E. Shioda1 1 2
Poster Listings Poster 2:45 PM-4:00 PM Rsr Inst for Microbial Diseases, Osaka Univ, Suita, Japan; Osaka Univ, Host Factors and Cell Response to Infection Suita, Japan; 3Kyoto Univ, Kyoto, Japan; 4Inst for Virus Rsr, Kyoto Univ, Kyoto, Japan; 5Inst of Hlth BioScis, The Univ of Tokushima Grad Sch, 199 Transcriptional Regulation of the APOBEC3 Repertoire Tokushima, Japan Through the CBFß/RUNX Axis 207 The G1/S Specific Cyclin D2 Acts As a Viral Restriction Brett D. Anderson1; Reuben S. Harris2 1Univ of Minnesota, Minneapolis, MN, USA; 2Howard Hughes Med Inst, Factor in Primary Macrophages 1 1 1 1 Minneapolis, MN, USA Ester Ballana ; Roger Badia ; Maria Pujantell ; Eva Riveira-Muñoz ; José A. Esté1; Bonaventura Clotet2 200 Is Endogenous APOBEC3H an HIV-1 Transmission 1IrsiCaixa Inst for AIDS Rsr, Badalona, Spain; 2Lluita Contra la SIDA Fndn, Barrier? Germans Trias i Pujol Univ Hosp, Barcelona, Spain 1 1 1 1 Jiayi Wang ; Allison M. Land ; Brian J. Hoium ; Eric W. Refsland ; 208 Characterizing Dynamics of Proteo-Transcriptomic Elizabeth M. Luengas1; Romel D. Mackelprang2; William L. Brown1; Michael Emerman3; Jairam R. Lingappa2; Reuben S. Harris4 Response to HIV-1 Infection 1 2 3 1Univ of Minnesota, Minneapolis, MN, USA; 2Univ of Washington, Seattle, Monica Golumbeanu ; Pejman Mohammadi ; Sébastien Desfarges ; 4 5 6 WA, USA; 3Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 4Howard Céline Hernandez ; Manfredo Quadroni ; Amalio Telenti ; Niko 1 3 Hughes Med Inst, Minneapolis, MN, USA Beerenwinkel ; Angela Ciuffi 1ETH Zürich, Basel, Switzerland; 2New York Genome Cntr, New York, NY, 201 Characterization of Novel Human APOBEC3A Variants USA; 3Inst of Microbiology, Lausanne Univ Hosp and Univ of Lausanne, Matthew Hernandez; Lara Manganaro; Marcel Ooms; Lubbertus C. Lausanne, Switzerland; 4Inst de Biologie de l’École Normale Supérieure, Mulder; Veronica Iannucci; Marsha Dillon-White; Sandra N. Terry; Ekta Paris, France; 5Univ of Lausanne, Lausanne, Switzerland; 6Univ of Sharma; Viviana A. Simon California San Diego, San Diego, CA, USA Icahn Sch of Med at Mount Sinai, New York, NY, USA
104 CROI 2016 Poster Listings 105 ; 2 ; ; ; 2 3 1 ; for ; for 6
; Merlin ; for the ; for 3 2 ; Mark 3 2 Hall A/B ; Douglas D. ; Douglas D. ; Bo 1 1 CROI 2016
; Eric S. ; Eric 1 1 ; Linda Giudice Frederick Cancer Cancer Frederick 2 5 ; Janis A. Müller 2 Heinrich Pette Inst, Inst, Pette Heinrich François-Rabelais 6 2 ; Nittaya Phanuphak ; Nittaya ; Christy Anderson The Fenway Inst, Inst, Fenway The
1 ; Rama Amara 1 3 1 3 ; Kirk A. Easley ; Kirk ; Sergei Kosakovsky Kosakovsky ; Sergei Program Agenda and 1 4 ; Kristina Broliden ; Kristina ; Nitiya Chomchey ; Nitiya 1 2 ; Todd M. Allen Todd ; Military HIV Rsr Prog, Military Prog, Rsr HIV US Military HIV Rsr Prog, MilitaryUS Prog, Rsr HIV 7 6 4 Univ of California San California of Univ ; Jintanat Ananworanich ; Jintanat 2 2 ; Stéphanie Boström ; Stéphanie 1 Södersjukhuset, Stockholm, Stockholm, Södersjukhuset, 2
2 ; Rebecca E.; Rebecca Batorsky 1 Univ of Ulm, Ulm, Germany Ulm, Ulm, of Univ ; Sergei Kosakovsky Pond Kosakovsky ; Sergei 3 SEARCH, Bangkok, Thailand; Thailand; Bangkok, SEARCH, 2 ; Susan J. Little ; Susan J. ; Nargis Kohgadai ; Nargis 2 1 2 HIV Clinic Praxis Jessen, Berlin, Germany; Germany; Berlin, Jessen, Praxis Clinic HIV ; Heiko Jessen ; Heiko Emory Univ Rollins Sch of PH, Atlanta, Atlanta, Sch PH, of Emory Rollins Univ ; Ruth M. Greenblatt 4 3 2 ; Gregory Tharp 3 1 SanjayMehta R.
; ; Steven E. Bosinger ; Steven 1 1 ; Frideborg Bradley ; Frideborg 1 ; Mark de Souza 5 ; Jonathan Carlson ; Jonathan ; Chayada Sajjaweerawan ; Chayada 6 1 Microsoft Rsr, Redmond, WA, USA WA, Redmond, Rsr, Microsoft ; Tantivayakul Ponpen 7 3 Nadia R. Roan R. Nadia ; Jing Yang ; Francis Barin ; Francis 1 ; Jan Münch ; Tjernlund Annelie ; Colin B. Ogilvie B. ; Colin ; ; Joseph Chen 1 1 1 1 ; Sara Gianella 1 1 1 ; Kenneth H. Mayer ; Kenneth ; Anna Gibbs; Anna 2 2 Yerkes Natl Primate Rsr Cntr, Emory Univ, Atlanta, GA, USA Atlanta, Emory Univ, Cntr, Rsr Primate Natl Yerkes ; Patrick Sullivan ; Patrick ; Davey M. Smith ; Davey Karolinska Univ, Stockholm, Sweden Stockholm, Univ, Karolinska 3 1 1 3 ; Robin Dewar 4 ; Marcus Altfeld ; Marcus 5 US AFRIMS, Bangkok, Thailand; Thailand; Bangkok, AFRIMS, US Thailand; Bangkok, Univ, Chulalongkorn Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, Gladstone Insts, San Francisco, CA, USA; San Francisco, Insts, Gladstone Sweden; Stockholm, Inst, Karolinska Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ CA, USA; San Diego, San Diego, California of Univ Ragon Inst of MGH, MIT and Harvard, Cambridge, MA, USA; USA; MA, Cambridge, Harvard, and MIT MGH, of Inst Ragon USA; MA, Boston, Hosp, General Massachusetts Hejdeman Walter Reed Army Inst of Rsr, Silver Spring, MD, USA; USA; MD, Spring, Silver Rsr, of Inst Army Reed Walter Richman Gemma Caballero GA, USA; Hamburg, Germany; Germany; Hamburg, France Tours, Univ, L. Robb Rosenberg Rungsun Rerknimitr Rungsun 1 3 Rsr and Develop Cntr, Frederick, MD, USA; USA; MD, Frederick, Cntr, Develop and Rsr Reduced Peripheral a4ß7+ CD4+ T Cells Correlate With With Correlate Cells T CD4+ a4ß7+ Peripheral Reduced AHIin Loss Cell T CD4+ Mucosal Schuetz Alexandra 1 the RV254/SEARCH 010 and RV304/SEARCH 013 Study Groups Groups 013 Study the RV254/SEARCH 010 and RV304/SEARCH The Effect of Condomless Receptive Anal Intercourse Intercourse Anal EffectReceptive The Condomless of Rectalthe on MSM in Mucosa Kelley F. Colleen 1 Enhancesand SeminalInflammation Induces Plasma Infection HIV-1 Cervicalin Explants Introini Andrea 1 Progesterone (P4) Indirectly(P4) Susceptibility Progesterone Increases Mucosa Genital Within HIV to Jason Neidleman 5 Variants CharacterizingFounder Multiplicity HIV the of During Transmission Sexual Chaillon Antoine 1 Mode of Sexual Transmission Can ExertImpact an on Transmission Sexual of Mode Virus Founder ShapingHIV-1 the Damien Tully C. 1 2 Mulligan Bethesda, MD, USA Bethesda, MD, Warner C. Greene Warner Sweden; Emory Center for AIDS Research AIDS Research for Emory Center Fenway Hlth, Boston, MA, USA; USA; MA, Boston, Hlth, Fenway Pond Francisco, San Francisco, CA, USA; San Francisco, Francisco, Jeremy W. Martin W. Jeremy
287 286 285 Session P-C8 Poster Abstracts SessionPoster P-C8 PM-4:002:45 PM Transmission Mucosal of Pathogenesis 284 232 231 ; 4
; 3 4 ; 3
1 Hall A/B Hall A/B Univ of Univ US MilitaryUS 2 3
2 ; Joel Scott- 2 ; Yap Boum ; Yap 2 ; Jeffrey N. Martin; Jeffrey ; Brandon Keele ; Brandon 4 3 US MilitaryUS Rsr HIV Frederick Natl Lab, Lab, Natl Frederick 2 BC Cntr for Excellence Excellence for Cntr BC ; Nelson L. Michael L. ; Nelson 4 2 2 ; Francis Plummer ; Francis 3
2
; Zandrea Ambrose ; Zandrea ; Ian MacArthur; Ian ; Wendy Zhang ; Wendy Mbarara Univ of Sci and Tech, Sci of Univ Tech, and Mbarara 5 and Archiving Dynamics Archiving and in 2 ; Shiu-Lok Hu ; Shiu-Lok 2 3 2 ; Peter W. Hunt W. ; Peter Univ of Nairobi, Nairobi, Kenya Nairobi, Nairobi, of Univ 4 3 Univ of Pittsburgh, Pittsburgh, Pittsburgh, Pittsburgh, of Univ 2 ; Merlin L. Robb 2
; Joshua Kimani 1 GabrielWagner ; Julie Ake ; P. Richard Harrigan Richard ; P. San Fransisco State Univ, San Francisco, CA, USA San Francisco, Univ, State San Fransisco ; Adarsh Dharan; Sarah Talley Sarah Dharan; ; Adarsh ; Viviane D. Lima D. Viviane ; 1 5 5 Univ of California San Francisco, San Francisco, CA, San Francisco, San Francisco, California of Univ 1 4 ; A. Rain Mocello ; Christopher Kline ; Christopher 3 ; Pleuni S. Pennings 1 1 ; Paul Sandstrom ; Paul Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ ; Raghavan Sampathkumar ; Raghavan 2 3 1 Harvard Med Sch, Boston, MA, USA MA, Sch, Med Boston, Harvard 5 US Military HIV Rsr Prog, Silver Spring, MD, USA; USA; MD, Spring, Silver MilitaryUS Prog, Rsr HIV Stanford Univ, Stanford, CA, USA; Stanford, Univ, Stanford Massachusetts General Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, General Massachusetts Natl Microbiology Lab of Canada, Winnipeg, MB, Canada; Canada; MB, Winnipeg, Canada, of Lab Microbiology Natl PA, USA; USA; PA, Prog, Walter Reed Army Inst of Rsr, Silver Spring, MD, USA; USA; MD, Spring, Silver Rsr, of Inst Army Reed Walter Prog, USA; USA; Mbarara, Uganda; Uganda; Mbarara, Manitoba, Winnipeg, MB, Canada; Canada; MB, Winnipeg, Manitoba, David R. Bangsberg David Dmitri A. Petrov Frederick, MD, USA; USA; MD, Frederick, 1 Limited Evidence for a Bias Toward Consensus Residues Residues Consensus Toward a Bias for Evidence Limited Upon Transmission HIV-1 Rolland Morgane Univ of California San Diego, San Diego, CA, USA San Diego, San Diego, California of Univ Feder F. Alison 1 Spatiotemporal Dynamics DrugSpatiotemporal of Resistance RT-SHIV of Persistence and Evolution Intrahost Viral Competition Competition Viral Intrahost Superinfection HIV-1 M. Smith; Little; Gemma Susan Caballero; J. Davey Chaillon; Antoine Richman; Douglas D. 1 HIV-1 Stop Codon Usage and Its ClinicalIts and Usage Codon Stop Impacts HIV-1 in Patients Ugandan Rural Lee Q. Guinevere HIV-1 Subtypes: 5 LTR-Leader Sequence Variants and Variants Sequence Subtypes: HIV-1 LTR-Leader 5 Seroconversion HIV Late MaLuo 1 Nuclear Import Nuclear DuringHIV of Infection Campbell Edward Kinesin-1 and Nup358 Cooperatively Mediate the Mediate Kinesin-1Cooperatively Nup358 and IL, USA Maywood, Chicago, Univ Loyola Herridge HIV Rsr Prog, Bethesda, MD, USA Bethesda, MD, Prog, Rsr HIV in HIV/AIDS, Vancouver, BC, Canada; Canada; BC, Vancouver, HIV/AIDS, in Simone H. Kigozi
230 Session P-B4 Poster Abstracts Poster SessionP-B4 PM-4:002:45 PM Sequencethe Defining Characteristics Transmitted of Viruses 229 228 227 226 Session P-B3 Poster Abstracts Poster SessionP-B3 PM-4:002:45 PM and Disease, Transmission, EffectsGenetics: on Viral Reinfection 209LB Program and Agenda
288 HIV Infections in Novel CD1a Cells From Human Vaginal 294 Increased Innate Function Following HIV-1 Mucosa Suppression Is Linked to Epigenetic Changes Victor Pena-Cruz1; Luis Agosto2; Hisashi Akiyama2; Jean-Robert Eileen P. Scully1; Ainsley Lockhart2; Wilfredo Garcia-Beltran2; Larrieux3; Rahm Gummuluru2; Manish Sagar1 Christine D. Palmer2; Chelsey Musante2; Eric S. Rosenberg1; Todd M. 1Boston Univ, Boston, MA, USA; 2Boston Univ Sch of Med, Boston, MA, Allen2; J. Judy Chang3; Ronald Bosch4; Marcus Altfeld5 USA; 3Boston Med Cntr, Boston, MA, USA 1Massachusetts General Hosp, Boston, MA, USA; 2Ragon Inst of MGH, 3 289 Influx of Th1 Cells in the Gut Mucosa Impairs the MIT and Harvard, Cambridge, MA, USA; Doherty Inst for Infection and Immunity, Univ of Melbourne, Melbourne, Australia; 4Harvard Sch of PH, Homing of Th17 Cells Under cART Boston, MA, USA; 5Heinrich Pette Inst, Hamburg, Germany Claire Loiseau1; Mary Requena2; Michelle Cazabat2; Nicolas Carrere2; Bertrand Suc2; Bruno Marchou2; Jacques Izopet2; Pierre Delobel2 295 Inhibition of P2X7 Enhances T-Cell Potential of CD34 in 1INSERM 1043, Toulouse, France; 2CHU Toulouse, Toulouse, France HIV+ c-ART Nonresponders 1 1 2 290 Reduced Rectal HIV RNA After Peg-IFN-a2b Added to Inna Menkova-Garnier ; Clarisse Benne ; Hakim Hocini ; Pascaline Tisserand2; Constance Delaugerre3; Emile Foucat4; Laure Bourdery4; ART Together With ART Interruption Yves Lévy1; Jean-Daniel Lelièvre1 1 2 1 3 Emmanouil Papasavvas ; Guobin Kang ; Livio Azzoni ; Faten Aberra ; 1Inst Mondor de Recherche Biomédicale INSERM U955, Univ Paris Est 3 4 5 6 Pablo Tebas ; Karam Mounzer ; Jay R. Kostman ; Douglas D. Richman ; Créteil, Créteil, France; 2Inst Mondor de Recherche Biomédicale INSERM 7 1 Qingsheng Li ; Luis J. Montaner U955, Vaccin Rsr Inst (VRI), Créteil, France; 3Hosp Saint Louis et Univ Paris 1 2 The Wistar Inst, Philadelphia, PA, USA; Univ of Nebraska, Lincoln, Diderot, Paris, France; 4Univ Paris Est-Créteil, Créteil, France NE, USA; 3Univ of Pennsylvania, Philadelphia, PA, USA; 4Jonathan Lax Immune Disorders Treatment Cntr, Philadelphia, PA, USA; 5John Bell Hlth 296 Maraviroc and Immune Recovery in Advanced AIDS Cntr, Philadelphia, PA, USA; 6Univ of California San Diego, San Diego, (CD4 <100) CA, USA; 7Sch of Biological Scis and Nebraska Cntr for Virology, Univ of Pablo F. Belaunzarán-Zamudio1; Livio Azzoni2; Juan Sierra- Nebraska, Lincoln, NE, USA Madero1; Yanink Caro- Vega1; Irini Sereti3; David H. Canaday4; Brian Clagget5; Benigno Rodriguez5; Ian M. Sanne6; Michael M. Lederman5 Session P-C9 Poster Abstracts Hall A/B 1Inst Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico 2 3 2:45 PM-4:00 PM City, Mexico; The Wistar Inst, Philadelphia, PA, USA; NIH, Bethesda, MD, USA; 4Cleveland VA Med Cntr, Cleveland, OH, USA; 5Case Western Immune Effects of Antiretroviral Therapy Reserve Univ, Cleveland, OH, USA; 6Univ of the Witwatersrand, Wits Hlth 291 Effect of Acute HIV Infection on CD4/CD8 Consortium, Johannesburg, South Africa Normalization After ART Initiation 297 Transcriptomic Signature of Atorvastatin Response Thibaut Davy; Sonia Napravnik; Anna Cope; JoAnn D. Kuruc; Cynthia Among ART-Treated Adults in Africa Gay; Joseph J. Eron Damalie Nakanjako1; Khader Ghneim2; Isaac Ssinabulya1; Rose M. Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA Nabantanzi3; Lois Bayigga1; Agnes Kiragga4; Harriet Mayanja-Kizza1; 292 Acute HIV Treatment Reverses CD8 T Cell Activation, Moses R. Kamya; Andrew Kambugu4; Pontiano Kaleebu5; Alison M. Exhaustion, and Apoptosis Elliott6; Rafick Sekaly7 1 2 1 1 2 1 Makerere Univ Coll of Hlth Scis, Kampala, Uganda; Case Western Jessica Eagar ; Sarah D. Sterrett ; Nilesh Amatya ; Anju Bansal ; 3 Poster Listings Poster 3 4 1 Reserve Univ, Ceveland, OH, USA; Coll of Hlth Scis, Makerere Univ, Steffanie Sabbaj ; Katharine J. Bar ; Sonya L. Heath 4 5 1Univ of Alabama at Birmingham, Birmingham, AL, USA; 2Univ of Kampala, Uganda; Infectious Diseases Inst, Kampala, Uganda; Med 3 Rsr Council/Uganda Virus Rsr Inst Uganda Rsr Unit on AIDS, Entebbe, Pittsburgh, Pittsburgh, PA, USA; Univ of Alabama at Birmingham, 6 Birmingham, AL, USA; 4Univ of Pennsylvania, Philadelphia, PA, USA Uganda; Med Researh Council/Uganda Virus Rsr Inst, Entebbe, Uganda; 7Case Western Reserve Univ, Cleveland, OH, USA 293 Inflammatory Biomarker Changes After Antiretroviral Treatment (ART) Initiation 298 ACE-Inhibitors to Decrease Lymphoid Fibrosis and the 1 2 3 Size of the Latent Reservoir Konstantia Angelidou ; Peter W. Hunt ; Alan Tenorio ; Alan L. 1 2 3 4 5 6 7 Leslie R. Cockerham ; Ma Somsouk ; Sunil K. Joshi ; Sharon R. Landay ; Cara Wilson ; Benigno Rodriguez ; Stephen G. Deeks ; Ronald 4 3 5 2 1 8 Lewin ; Steven A. Yukl ; Ajantha Rhodes ; Elizabeth Sinclair ; Marc Bosch ; Michael M. Lederman 6 7 2 1 2 Hellerstein ; Stephen G. Deeks ; Hiroyu Hatano Harvard Sch of PH, Boston, MA, USA; Univ of California San Francisco, 1 2 3 4 Med Coll of Wisconsin, Milwaukee, WI, USA; Univ of California San San Francisco, CA, USA; GSK, Research Triangle Park, NC, USA; Rush 3 5 Francisco, San Francisco, CA, USA; San Francisco VA Med Cntr, San Univ, Chicago, IL, USA; Univ of Colorado Hosp, Aurora, Aurora, CO, 4 6 7 Francisco, CA, USA; Doherty Inst for Infection and Immunity, Univ of USA; Case Western Reserve Univ Sch of Med, Cleveland, OH, USA; San 5 8 Melbourne, Melbourne, Australia; Univ of Melbourne, Melbourne, Francisco General Hosp, San Francisco, CA, USA; Case Western Reserve 6 7 Univ, Cleveland, OH, USA Australia; Univ of California Berkeley, Berkeley, CA, USA; San Francisco General Hosp, San Francisco, CA, USA
106 CROI 2016 Poster Listings 107 ; 1 ; ; 3 3 Cntr Cntr 4 ; 2 Univ Univ Univ of Univ 3 5 Univ of Univ Hall A/B 4 CROI 2016 ; Gabor ; Joseph P. ; Joseph P. ; Dieter ; Scott M. 4 3 1 2 St Vincent’s Vincent’s St VRC, NIAID, NIH, NIH, VRC, NIAID,
2 4 2 ; Kazuo Suzuki 1 ; Melissa Osborn 3 ; Suresh Pallikkuth ; Suresh ; Sam T. Milliken T. ; Sam 2 4 Program Agenda and
Case Western Reserve Univ, Univ, Reserve Western Case 1 2 ; Rainer Haas 1 ; Daniel Popkin ; Nadine Luebke ; Angie Pinto ; Angie 4 Heinrich Pette Inst, Hamburg, Hamburg, Inst, Pette Heinrich 3 2 ; Savita Pahwa ; Savita
5 ; Lesley De Armas ; Lesley 1 1 2 Kirby Inst, Sydney, Australia Sydney, Inst, Kirby Inst for Virology, Heinrich-Heine- Virology, for Inst 6 4 ; for the Sydney HIV SCT Study Group HIV SCT Group Study the Sydney ; for 6 ; Sarah Palmer ; Robert Kalayjian Case Western Reserve Univ Sch of Med, Sch Med, Univ of Reserve Western Case 4 2 5 St Vincent’s Hosp, Sydney, Australia; Australia; Sydney, Hosp, Vincent’s St ; RajendraPahwa 3 5 ; Falk Huettig ; Falk 6
; Donald Anthony ; Elena Knops ; Elena Univ of Miami, Miller Sch of Med, Miami, FL, Miami, Sch Miller Med, Miami, of of Univ 5 2 2 ; John J. Zaunders ; John J. ; Carl Fichtenbaum ; Carl 1 4 Univ of Miami, Miami, FL, USA Miami, Miami, of Univ MetroHlth Med Cntr, Cleveland, OH, USA; USA; OH, Cleveland, Cntr, Med MetroHlth 5 3 ; David Cooper ; David 5 ; Costantinos Petrovas ; Costantinos ; Chelsey Judge ; Chelsey ; Bonnie Hiener 4 1 3 Bjoern-Erik O. Jensen O. Bjoern-Erik ; Louis Edward Gonzalez Edward ; Louis ; Rolf Kaiser ; 2 1 1 Inst of Virology, Univ of Cologne, Cologne, Germany; Germany; Cologne, Cologne, of Univ Virology, of Inst Therapeutics, Cell and Diagnostics Transplantation of Inst 2 6 ; Johannes Fischer 5 ; Varghese K. George Varghese ; 4 Miller Sch of Med, Univ of Miami, Miami, FL, USA; FL, USA; Miami, Miami, of Univ SchMiller Med, of 3 ; Benigno Rodriguez 2 Kirby Inst, Univ of New South Wales, Sydney, Australia; Australia; Sydney, South Wales, New of Univ Inst, Kirby Cleveland VA Med Cntr, Cleveland, OH, USA; USA; OH, Cleveland, Cntr, Med VA Cleveland NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, Duesseldorf Univ Hosp, Heinrich-Heine Univ Duesseldorf, Duesseldorf, Duesseldorf, Duesseldorf, Univ Heinrich-Heine Duesseldorf Hosp, Univ Hosp, Darlinghurst, Australia; Australia; Darlinghurst, Hosp, Kenneth E. Sherman Kenneth USA; USA; Cleveland, OH, USA; USA; OH, Cleveland, Richard A. Koup A. Richard Casazza Anthony Kelleher Anthony A. Dunay Germany; Germany; Bethesda, MD, USA; USA; Bethesda, MD, Sieg 1 HIV-1 Viral Rebound Following Allogeneic Following Rebound Viral HIV-1 Stem-CellTransplantation Hematopoietic K. Kersten Koelsch Carey L. Shive L. Carey 1 CCR5-d32Allogeneic by AML and HIV of Treatment Transplantation Cell Stem Blood Guido Kobbe 1 HCVin Vaccine Infection Are to Responses Impaired Inflammation Baseline to Related 1 Steady State and Post-Vaccination TFH Dynamics TFH in Post-Vaccination and SteadyState With cART Treated HIV Patients Moysi Eirini Cleveland, OH, USA OH, Cleveland, New South Wales, Sydney, Australia; Australia; Sydney, South Wales, New Germany; Germany; Univ, Univ Hosp, Duesseldorf, Germany; Germany; Duesseldorf, Hosp, Univ Univ, for Virus Rsr, Westmead Millennium Inst, Westmead, Australia; Australia; Westmead, Inst, Millennium Westmead Rsr, Virus for Haeussinger Sarah C. Sasson Cincinnati, Cincinnati, OH, USA; USA; OH, Cincinnati, Cincinnati, Clinic of Cologne, Cologne, Germany; Germany; Cologne, Cologne, of Clinic Heinrich-Heine Univ Duesseldorf, Duesseldorf, Germany Duesseldorf, Duesseldorf, Univ Heinrich-Heine WITHDRAWN WITHDRAWN
365 Session P-F7 Poster Abstracts Poster SessionP-F7 PM-4:002:45 PM Cells Stem 364 328 329 327 ; ; 3 1
4 Hall A/B ; Ana M. ; Ana
2 ; Joshua 5 6 ; Alberto ; Juan Sierra- 2 6 ; Manju Karki ; Dayane A. ; Dayane 1 1 Cleveland VA Med VA Cleveland ; Savita Pahwa ; Savita 3 1
; Deborah Bambino GesùBambino 1 ; David H. Canaday ; David 3 3 2 Univ of Pittsburgh, Pittsburgh, of Univ 2 Fundação Oswaldo Cruz, Cruz, Oswaldo Fundação Duke Univ Sch of Med, Sch Med, Univ of Duke 2 Harvard Univ, Boston, MA, Boston, Univ, Harvard 4 5 Ragon Inst of MGH, MIT, and MIT, MGH, of Inst Ragon ; Marcos S. Freire ; Marcos 7 1 ; Christina Lalama ; Christina 5 ; Kaifen Chang
3 1 1 ; Paolo Palma ; Paolo ; Ester C. Sabino; Ester Univ of South Florida, Tampa, Tampa, South of Florida, Univ 1 3 ; Suresh Pallikkuth ; Suresh 2 ; MichaelLederman M. ; Livio Azzoni 2 9 1 ; Benigno Rodriguez ; Rajesh Gandhi 5 2 Ratio Predict Yellow Fever Fever Predict Yellow Ratio Univ of Miami Miller Sch of Med, Miami, Sch Miller Miami Med, of of Univ ; Maureen Goodenow ; Maureen
4 4 ; JiqiangYao Brad Jones Brad ; Karina T. Miyaji T. ; Karina Case Western Reserve Univ, Cleveland, OH, OH, Cleveland, Univ, Reserve Western Case 2 ; Ronald Bosch 1 4 ; ; Paolo Rossi ; Paolo 4 7 ; Irini Sereti 1 ; Huang Yong 8 3 ; Esper G. Kallas Univ of California San Francisco, San Francisco, San Francisco, San Francisco, California of Univ 1 3 Massachusetts General Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, General Massachusetts 3 ; Brian Clagget 4 ; Lesley De Armas ; Lesley 1 ; John W. Mellors W. ; John 1 NIH, Bethesda, MD, USA Bethesda, MD, NIH, The Wistar Inst, Philadelphia, PA, USA; USA; PA, Philadelphia, Inst, Wistar The 6 2 ; John Sleasman ; Joseph Eron 1 2 Moffitt Cancer Cntr, Tampa, FL, USA; FL, USA; Tampa, Cntr, Cancer Moffitt ; Ian M. Sanne; Ian 3 7 ; Peter W. Hunt W. ; Peter ; Bruce D. Walker D. ; Bruce ; Stefano Rinaldi ; Stefano 1 ; Carina Rodriguez ; Carina 2 3 ; Juliana Z. Dias 1 Harvard Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, of Harvard Univ of the Witwatersrand, Wits Hlth Consortium, Johannesburg, Johannesburg, Consortium, Hlth Wits Witwatersrand, the of Univ 1 6 5 Univ of Sao Paulo Med Sch, Sao Paulo, Brazil; Brazil; Sch, Med Sao Paulo, Sao of Univ Paulo Univ of Florida, Gainesville, FL, USA; FL, USA; Gainesville, Florida, of Univ Bambino Gesù Children’s Hosp, Univ of Rome Tor Vergata, Rome, Italy; Rome, Vergata, Tor Rome of Univ Hosp, Gesù Children’s Bambino FL, USA; Miami, Miami, of Univ SchMiller Med, of George Washington Univ, Washington, DC, USA; USA; DC, Washington, Univ, Washington George USA; NC, Hill, Chapel North of Univ Carolina, Inst Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico Mexico Zubirán, Salvador Nutrición y Médicas Ciencias de Nacional Inst FL, USA South Africa; South Africa; USA; USA; Cagigi CA, USA Yanink Vega Caro- Yanink Rio de Janeiro, Brazil; Brazil; Rio Janeiro, de City, Mexico; Mexico; City, Sartori Cytkor Madero McMahon 1 NextGen Sequencing Defines Response to H1N1 Sequencing to Response Defines NextGen Individuals HIV-Infected in Vaccination YinLi 1 1 2 Vivian I. Avelino-Silva I. Vivian CD4/CD8 Ratio and K/T and CD4/CD8 Ratio Patients HIV+ in Response Vaccine DistinctB-cell AbilityDefine to Signatures Gene ChildrenHIV+ in Vaccine H1N1 to Respond Cotugno Nicola 1 4 Only T-Cell Responses to Nef/Tat/Rev Correlate With With Correlate Nef/Tat/Rev to Responses T-Cell Only ART on Frequencies InfectedCell Thomas Allison Restoration in IRISin Restoration Belaunzarán-Zamudio F. Pablo 1 DistinctiveDynamics Phenotypicof Cellular Harvard, Cambridge, MA, USA MA, Cambridge, Harvard, Fahong Yu Fahong Costa Children’s Hosp, Rome, Italy; Rome, Hosp, Children’s Cntr, Cleveland, OH, USA; USA; OH, Cleveland, Cntr, USA; PA, Pittsburgh, Durham, NC, USA NC, Durham, FL, USA; FL, USA; USA; USA;
325 326 Effects of HIV on the Responses to Other Vaccines to EffectsResponses the on HIV of 324 Session P-E4 Poster Abstracts Poster SessionP-E4 PM-4:002:45 PM 300LB 299 Program and Agenda
366 A Tale of Two Stem-Cell Transplantations in HIV+ 374 Effect of Primary CD8 T Cells on Romidepsin and Patients: Clues to Eradicate HIV Bryostatin-Treated CD4 T Cells Maria Salgado1; Mi Kwon2; Monique Nijhuis3; Jan van Lunzen4; Julià Victoria Walker-Sperling; Joel N. Blankson Blanco5; Julian Schulze zur Wiesch4; Gero Hutter6; Anne M. Wensing3; Johns Hopkins Univ Sch of Med, Baltimore, MD, USA 2 1 Jose Luis Diez ; Javier Martinez-Picado ; for the EpiStem Consortium 375 Dendritic Cell T-Cell Culture Facilitates HIV Latency in 1IrsiCaixa Inst for AIDS Rsr, Badalona, Spain; 2Hosp General Universitario Gregorio Marañón, Madrid, Spain; 3Univ Med Cntr Utrecht, Utrecht, Proliferating CD4+ T Cells 1 2 2 Netherlands; 4Univ Med Cntr Hamburg-Eppendorf, Hamburg, Germany; Nitasha A. Kumar ; Renee M. van der Sluis ; Talia Mota ; Sharon R. 3 3 5Univ de Vic, Barcelona, Spain; 6Cellex, Dresden, Germany Lewin ; Paul U. Cameron 1Emory Univ, Atlanta, GA, USA; 2The Peter Doherty Inst, Univ of 367 Ex Vivo Determination of Stem-Cell Transplantation Melbourne, Melbourne, Australia; 3Doherty Inst for Infection and Graft-Versus-HIV Reservoir Effects Immunity, Univ of Melbourne, Melbourne, Australia 1 1 1 Louise Hogan ; Kristen S. Hobbs ; Emily Hanhauser ; Christine D. 376 Role of Dendritic Cell Polarization in the Induction of Palmer2; Marisol Romero-Tejeda2; Yvonne P. Robles3; Stephanie Jost2; Daniel Kuritzkes4; Jerome Ritz5; Timothy J. Henrich1 HIV-1 Latency Reversal 1 1 1 1Univ of California San Francisco, San Francisco, CA, USA; 2Ragon Inst of Robbie B. Mailliard ; Charles Rinaldo ; Jan R. Kristoff ; Margaret 1 1 1 2 MGH, MIT and Harvard, Cambridge, MA, USA; 3Brigham and Women's Carlson ; Jennifer M. Zerbato ; Nicolas Sluis-Cremer ; Phalguni Gupta 1 2 Hosp, Harvard Med Sch, Boston, MA, USA; 4Harvard Med Sch, Boston, Univ of Pittsburgh, Pittsburgh, PA, USA; Univ of Pittsburgh, Grad Sch of MA, USA; 5Dana-Farber Cancer Inst, Boston, MA, USA PH, Pittsburgh, PA, USA 377 Naïve CD4+ T Cells Harbor a Large Inducible Reservoir Session P-F8 Poster Abstracts Hall A/B of Latent HIV-1 2:45 PM-4:00 PM Jennifer Zerbato; Deborah McMahon; Michele D. Sobolewski; John HIV Persistence, Latency, and Reactivation W. Mellors; Nicolas Sluis-Cremer Univ of Pittsburgh, Pittsburgh, PA, USA 368 WITHDRAWN 378 Follicular Tregs Reduce HIV Replication and Reactivation From Latency Ex Vivo Brodie Miles; Elizabeth Connick Univ of Colorado, Denver, CO, USA 369 Differential Effect of Selenium on HIV Replication and 379 A Subset of Infectious Proviruses Persist and Expand Reactivation in Primary Cells Following Activation Ex Vivo Christina Gavegnano1; Raymond F. Schinazi1; Sally Yuan2; Deanna John K. Bui1; Elias Halvas2; Elizabeth Fyne1; Michele D. Sobolewski1; Kulpa3; Nicolas Durier4; Ariana Santos1 Dianna Koontz2; Mary F. Kearney3; Wei Shao4; Feiyu Hong1; John W. 1Emory Univ Sch of Med, Atlanta, GA, USA; 2Janssen Pharmaceuticals, Mellors1 Springhouse, PA, USA; 3Southern Rsr Inst, Frederick, MD, USA; 4TREAT 1Univ of Pittsburgh, Pittsburgh, PA, USA; 2Univ of Pittsburgh Sch of Med, Asia/amfAR, Bangkok, Thailand Pittsburgh, PA, USA; 3NCI, Frederick, MD, USA; 4Leidos Biomed Rsr, Inc, Frederick, MD, USA Poster Listings Poster 370 Kinetics of HIV-1 Latency Reversal Measured by a New Flow-Based Technique 380 Transcription of Novel HIV-1 RNA Species in the Setting Gloria Martrus; Annika Niehrs; Anne Rechtien; Marcus Altfeld of Undetectable Virus Heinrich Pette Inst, Hamburg, Germany Hiromi Imamichi1; Robin Dewar2; Joseph A. Adelsberger3; Catherine A. Rehm4; Catherine Seamon4; Gregg Roby5; Alice Pau4; H. Clifford Lane4 371 Reactivation of Latent HIV-1 in J-Lat T Cells by Type I 1NIAID, NIH, Frederick, MD, USA; 2Frederick Cancer Rsr and Develop Cntr, Interferon Agonists Frederick, MD, USA; 3Leidos Biomed Rsr, Inc, Frederick, MD, USA; 4NIAID, Melanie Alvarado1; Mark A. Alday1; Priscilla Natcher1; Vanessa NIH, Bethesda, MD, USA; 5NIAID, NIH, Rockville, MD, USA Muhlenbruch1; Audrey M. Rutz1; Jonathan C. Rupp1; Benjamin R. Harrison1; Faye D. Schilkey2; Viviana A. Simon3; Eric M. Bortz1 1Univ of Alaska Anchorage, Anchorage, AK, USA; 2Natl Cntr for Genome Resources, Santa Fe, NM, USA; 3Icahn Sch of Med at Mount Sinai, New York, NY, USA 372 CSF1R Antagonists Sensitize HIV-Infected Macrophages to Death Francesc Cunyat; Jennifer N. Rainho; Mario Stevenson Univ of Miami, Miami, FL, USA 373 Effect of HIV-1 Nef on MHC-I After Latency Reversal in Primary CD4 T Cells Thomas Vollbrecht; John Guatelli Univ of California San Diego, San Diego, CA, USA
108 CROI 2016 Poster Listings 109 ; ; 2 2 ; 3 San ; 4 1 Yale Univ Univ Yale Univ of Univ ; for the ; for 4 Military 2 2 Hall A/B 4 ; Eric N. ; Eric 3 ; Eugène ; Eugène ; Serena S. ; Serena CROI 2016 1 5 ; Patrizia ; Patrizia SEARCH, Missouri Inst of Inst Missouri 1 2 2 ; DonnColby ; Carlo Federico Federico ; Carlo 1 1 ; Eric C. Seaberg ; Eric 7 ; for the SEARCH ; for ; Duanghathai 4 3 Univ of Pittsburgh, Pittsburgh, of Univ 7 San Scientific Raffaele ; Roberta Gagliardini 5 5 ; Eugenia Quiros Quiros ; Eugenia Program Agenda and 2 ; Ned Sacktor ; Ned ; Federico Martini ; Federico ; Roberto Cauda 2 1 2 Johns Hopkins Bloomberg Bloomberg Hopkins Johns 2 ; Victor Valcour ; Victor 2 ; Victor Valcour ; Victor 2 ; Carmela Pinnetti ; Carmela 1 ; James T. Becker T. ; James ; Praphan Phanuphak ; Praphan 6 4 Univ of Brescia, Brescia, Italy; Brescia, Brescia, of Univ Thai Red Cross AIDS Rsr Cntr, Bangkok, Bangkok, Cntr, Rsr AIDS Cross Red Thai 3 ; Adriana Ammassari ; Adriana 5 ; Serena S. Spudich ; Serena 2 SEARCH, Bangkok, Thailand; Thailand; Bangkok, SEARCH, ; Linda Jagodzinski 2 3 3 Johns Hopkins Univ Sch of Med, Sch Med, of Univ Hopkins Johns 3 ; Gayle Springer ; Gayle
1 Inst of Clinical Infectious Diseases, Catholic Catholic Diseases, Infectious Clinical of Inst ; Antonella Castagna ; Antonella 2 4 ; Veronica Bordoni ; Veronica 1 ; James L. Fletcher ; Chun-Zi Peng 1 1 ; for the RV254/SEARCH 010 Study Group Group 010 Study the RV254/SEARCH ; for ; Mary Young ; Massimiliano Fabbiani ; Massimiliano 2 ; Shelly Krebs 5 1 Univ of California Los Angeles, Los Angeles, Angeles, Los Angeles, Los California of Univ Rush Univ Med Cntr, Chicago, IL, USA Chicago, Cntr, Med Univ Rush 3 Military HIV Rsr Prog, Bethesda, MD, USA; USA; Bethesda, MD, Military Prog, Rsr HIV 4 8 3 ; Valentina Fedele ; Valentina 1 Univ of Siena, Siena, Italy Siena, Siena, of Univ 6 ; Simona Di Giambenedetto ; Leah Rubin ; Leah 6 1 ; for the Neurocognitive Working Groups of the Women’s Women’s of the Groups Working the Neurocognitive ; for 8 ; Nittaya Phanuphak ; Nittaya Yale Univ Sch of Med, New Haven, CT, USA CT, Haven, New Sch Med, Univ of Yale 2 ; Stefania Carta; Stefania 6 Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ 1 ; Robert Paul 5 6 ; Manuela Colafigli 3 ; Jintanat Ananworanich ; Jintanat ; Victor Valcour ; Victor
2 4 2 Catholic Univ, Rome, Italy; Rome, Univ, Catholic Univ of Illinois at Chicago, Chicago, IL, USA; IL, USA; Chicago, at Chicago, Illinois of Univ USA; DC, Washington, Cntr, Med Univ Georgetown Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ Inst Nazionale Malattie Infettive “L. Spallanzani”, Rome, Italy; Rome, “L. Spallanzani”, Infettive Malattie Nazionale Inst CA, USA; San Francisco, San Francisco, California of Univ ATLAS-M Study Group Group Study ATLAS-M Mental Hlth, St. Louis, MO, USA; USA; MO, Louis, St. Hlth, Mental USA; PA, Pittsburgh, Spudich Thailand; Thailand; Rome Tor Vergata, Rome, Italy Rome, Vergata, Tor Rome Baltimore, MD, USA; USA; MD, Baltimore, Miller Roldan 010/RV254 Study Group Group 010/RV254 Study Ponpen Tantivayakul Ponpen Interagency HIV Study and the Multicenter AIDS Cohort Study Multicenter and the Interagency HIV Study Suttichom Sch of Med, New Haven, CT, USA CT, Haven, New Sch Med, of Sch of PH, Baltimore, MD, USA; USA; MD, Sch Baltimore, PH, of Perno Andrea De Luca Andrea 1 1 6 in SafetyCNS Simplificationof ATV/r+3TC to VirologicallySuppressed Patients HIV+ CiccarelliNicoletta 1 Function in Cognitive in Differences Male/Female Individuals HIV+ Maki Pauline Neurologic Signs and Symptoms Frequently Manifest Manifest Frequently Signs Symptoms and Neurologic InfectionHIV Acute in Hellmuth M. Joanna Role of HCVof Role HIV in Coinfection Biomarkers CSF on Patients Antinori Andrea 1 andHIV Acute in Common Are Symptoms Psychiatric Disease Biomarkers With Correlate Hellmuth M. Joanna 1 Gallicano Dermatological Inst, IRCCS, Rome, Italy; Rome, IRCCS, Inst, Dermatological Gallicano Eileen MartinEileen Francesca Ceccherini-Silberstein Francesca Inst, Milan, Italy; Milan, Inst, CA, USA; Lorenzini Kroon Univ of Sacred Heart, Rome, Italy; Heart, Rome, Sacred of Univ Bangkok, Thailand; Thailand; Bangkok, HIV Rsr Prog, Bethesda, MD, USA; USA; Bethesda, MD, Prog, Rsr HIV
417 416 Session P-G5 Poster Abstracts SessionPoster P-G5 PM-4:002:45 PM ClinicalDistinctions Response Therapeutic and 415 413 414 ; 2 ; ; ; ; 3 6 1 ; 2 1 ; Shelly 3 ; ; Jennifer ; Jennifer Univ Univ
3 2 Hall A/B 4 1 ; Jintanat ; Jintanat ; Ron Ellis ; Ron Ellis 6 3 1 ; Karen ; Karen 3 Univ of Univ 6 Case Western Western Case ; David Samuels ; David Vanderbilt Univ Sch Univ Vanderbilt ; Christine ; Christine 2 5 6 3 ; Donn Colby Rsr Lab, Associates of Associates Lab, Rsr 3 2 ScottLetendre R. Yale Univ Sch of Med, Sch Med, Univ of Yale ; Francine DeSalvador ; Francine ; Brinda Emu 7 ; 2 1 5 Military HIV Rsr Prog, Military Prog, Rsr HIV The Scripps Rsr Inst, Scripps Inst, Rsr The 4 2 ; Josué Pérez-Santiago ; Laurie Andrews ; Laurie 1 ; Victor Valcour ; Victor Yale Univ Sch of Med, New New Sch Med, Univ of Yale 1 3 2 Vanderbilt Univ, Nashville, Nashville, Univ, Vanderbilt Nice Univ Hosp, Nice, France; France; Nice, Hosp, Univ Nice ; Pierre Dellamonica ; Pierre 5 ; Scott R. Letendre 2 2 2 ; Sheldon R. Morris 2 ; Asha R. Kallianpur 2 ; Robert Heaton ; for the SEARCH 010/011/013 ; for Risk of Neurocognitive RiskNeurocognitive of 4 7 ; Leah Le ; Leah ; Jacques Durant ; Jacques ; Eugène Kroon ; Eugène Univ of California San Diego, San San Diego, California of Univ 1 2 2 3 ; Todd Hulgan ; Todd ; Muriel Laffon 4 2 Univ of California San Diego, San Diego, San Diego, San Diego, California of Univ 2
; Serena S. Spudich ; Serena Vanderbilt Univ, Nashville, TN, USA TN, Nashville, Univ, Vanderbilt ; Jintana Intana ; Jintana 1 7 5 ; Michel Ticchioni 3 ; Haley Gittleman 1 ; Yonglong Zhang ; Yonglong ; Igor Grant ; Igor Univ of Hawaii, Honolulu, HI, USA; USA; HI, Honolulu, Hawaii, of Univ ; William ; William Bush ; Diane Trotta ; Cari Kessing ; Cari 2 2 5 4 1 1 ; Roxane Fabre ; Roxane 1 ; Michelli Faria de Oliveira ; MichelliFaria
1 ; Jennifer Iudicello ; Jennifer SEARCH, Bangkok, Thailand; Thailand; Bangkok, SEARCH, 2 1 Case Western Reserve Univ Sch of Med, Cleveland, OH, Cleveland, Sch Med, Univ of Reserve Western Case 3 ; Brigitte Dunais; Brigitte ; Serena S. Spudich ; Serena 4 2 4
; for the CNS HIV Antiretroviral Therapy Effects Research Effects Research Therapy HIV Antiretroviral the CNS ; for 1 7 ; Ron Ellis ; Khadir Raddassi Cleveland Clinic/Lerner Rsr Inst, Cleveland, OH, USA; USA; OH, Cleveland, Inst, Rsr Clinic/Lerner Cleveland 2 1 3 ; Napapon Sailasuta Univ of California San Diego, La Jolla, CA, USA; Jolla, La San Diego, California of Univ 4 5 Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, Yale Univ Sch of Med, New Haven, CT, USA; USA; CT, Haven, New Sch Med, Univ of Yale Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ Cleveland Clinic/Lerner Rsr Inst, Cleveland, OH, USA; USA; OH, Cleveland, Inst, Rsr Clinic/Lerner Cleveland Cntr Hospier de Cannes, Cannes, France; France; Cannes, Cannes, de Hospier Cntr France Nice, Nice, de CHU Military HIV Rsr Prog, Silver Spring, MD, USA; USA; MD, Spring, Silver Military Prog, Rsr HIV USA; USA; Jill Barnholtz-Sloan California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California Malcolm Finkelman Malcolm (CHARTER) Study Group Group Study (CHARTER) Christian Pradier Christian TN, USA TN, Cape Cod, Inc, Falmouth, MA, USA MA, Falmouth, Inc, Cod, Cape Todd Hulgan Todd CA, USA; Diego, CA, USA; Diego, of California San Diego, La Jolla, CA, USA; Jolla, La San Diego, California of Reserve Univ, Cleveland, OH, USA; USA; OH, Cleveland, Univ, Reserve Jupiter, FL, USA; FL, USA; Jupiter, Haven, CT, USA CT, Haven, Krebs Sara Gianella Lebrun-Frenay of Med, Nashville, TN, USA; USA; TN, Nashville, Med, of 1 CNS Drug Distribution and CSF Inflammation During DrugCNS Distribution Inflammation CSF and Therapy Suppressive Antiretroviral Albert Anderson 1 1 (1 3)-ß-D-Glucan Levels Correlate With With 3)-ß-D-Glucan (1 Correlate Levels Functioning InfectionHIV in Neurocognitive MartinHoenigl 1 Jacqueline Cottalorda Jacqueline Disorder (HAND) Neurocognitive AshaKallianpurR. 1 3 HIV-Associated With Associations Biomarker CSF Novel CD4/CD8 Ratio Decline and Decline CD4/CD8 Ratio Deterioration Vassallo Matteo Lydie Trautmann Lydie 1 Dual Role of Activated and HIV-Specific CD8 T Cells in Cells T HIV-SpecificCD8 and DualActivated of Role DuringCSF Infection HIV Acute and Blood in ART-Treated HIV ART-Treated in Blood and Shang-LinChung Use of Mass Cytometry to Study Subsets Massto of Cellular Cytometry CSFin Use New Haven, CT, USA CT, Haven, New Ananworanich Tolentino Bethesda, MD, USA; USA; Bethesda, MD, Chiarella Study Groups Groups Study for the CHARTER Group Group the CHARTER for
412 410 409 408 2:45 PM-4:002:45 PM Response Immune and Biomarkers Virus and Host 407 Session P-G4 Poster Abstracts SessionPoster P-G4 411 Program and Agenda
418 Neurocognitive Improvement With NRTI-Sparing 424LB Neurocognitive Safety After 96-WKs on ATV/r+3TC: Treatment in Acute HIV Infection Results of the Randomized SALT Trial Cynthia Gay1; Sarah Willils1; JoAnn D. Kuruc1; Kara S. McGee2; Angela Ignacio Perez-Valero1; Juan Pasquau2; Rafael Rubio3; Antonio Kashuba1; Mehri S. McKellar2; Charles B. Hicks3; Joseph J. Eron1; David Rivero4; Jesús Santos5; Jose Sanz6; Ana Mariño7; Herminia Esteban8; M. Margolis1; Kevin R. Robertson1 Jose Antonio Perez-Molina9; for the SALT Study Group 1Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2Duke Univ, 1Hosp Universitario La Paz, Madrid, Spain; 2Hosp Virgen de las Nieves, Durham, NC, USA; 3Univ of California San Diego, San Diego, CA, USA Complejo Hospario Universitario Granada, Granada, Spain; 3Hosp 4 419 HIV Associated Neurocognitive Impairment: A Universitario Doce de Octubre, Madrid, Spain; Hosp Universitario Reina Sofía, Córdoba, Spain; 5Hosp Universitario Virgen de la Victoria, Malaga, Randomized Controlled Trial of Lithium Spain; 6Hosp Universitario Principe de Asturias, Madrid, Spain; 7Hosp 1 2 2 Eric H. Decloedt ; Carla S. Freeman ; Maia S. Lesosky ; Gary Arquitecto Marcide, Ferrol, Spain; 8Fundación SEIMC-GESIDA, Madrid, 2 2 Maartens ; John Joska Spain; 9Hosp Universitario Ramón y Cajal, Madrid, Spain 1Stellenbosch Univ, Tygerberg, South Africa; 2Univ of Cape Town, Cape Town, South Africa Session P-H5 Poster Abstracts Hall A/B 420 Week48 Cognitive Improvement in HAND After Switch 2:45 PM-4:00 PM to HAART Based on CHARTER Score +3 Clinical Pharmacology of Treating Coinfections Gilles Force1; Valerie Hahn2; Helene Defferriere3; Natacha Darchy4; Jacques Ropers5; Philippe Aegerter5; Constance Delaugerre6; Gilles 451 Antiretroviral Use and Implications for DAA Therapy in Peytavin7; Pierre De Truchis3 HIV/HCV Coinfection 1Hosp Franco-Britannique, Levallois-Perret, France; 2Cntr Hospier Marianne Martinello1; Gregory J. Dore1; Jasmine Skurowski1; Sainte-Anne, Paris, France; 3Hosp Raymond Poincaré, APHP, Garches, Rohan I. Bopage2; Robert Finlayson3; David Baker4; Mark Bloch5; Gail France; 4Inst Hospier Franco-Britannique, Levallois-Perret, France; 5Hosp V. Matthews1 Ambroise Paré, APHP, Boulogne, France; 6Hosp Saint Louis et Univ Paris 1Kirby Inst, Univ of New South Wales, Sydney, Australia; 2The Albion Cntr, Diderot, Paris, France; 7IAME, INSERM UMR 1137, Univ Paris 7 UF 301, Sydney, Australia; 3Taylor Square Private Clinic, Sydney, Australia; 4East Paris, France Sydney Doctors, Sydney, Australia; 5Holdsworth House Med Practice, Sydney, Australia 42 Statin or ACE/ARB Effects on Neurocognitive Function of HIV-Infected Adults 452 Real-Life Renal Safety of Boosted TDF in HIV/HCV Kristine M. Erlandson1; Douglas Kitch2; C. William Wester3; Robert Patients on SOF/LDV Kalayjian4; Edgar T. Overton5; Jose R. Castillo-Mancilla1; Susan L. M.J. Vivancos-Gallego; A. Moreno; María Jesús Pérez-Elias; A. Díaz Koletar6; Constance A. Benson7; Kevin R. Robertson8; Judith Lok2 de Santiago; Carmen Quereda-Rodriguez; J.L. Casado; Sara Bañón; M. 1Univ of Colorado, Denver, CO, USA; 2Harvard Sch of PH, Boston, MA, USA; Sánchez-Conde; M.L. Mateos; Santiago Moreno 3Vanderbilt Inst for Global Hlth, Nashville, TN, USA; 4MetroHlth Med Cntr, Hosp Universitario Ramón y Cajal, Madrid, Spain 5 Cleveland, OH, USA; Univ of Alabama at Birmingham, Birmingham, 453 Interactions Between ABT-493 Plus ABT-530 AL, USA; 6Ohio State Univ, Columbus, OH, USA; 7Univ of California San 8 Combination and Rilpivirine or Raltegravir Diego, San Diego, CA, USA; Univ of North Carolina at Chapel Hill, Chapel 1 1 1 2 Hill, NC, USA Matthew P. Kosloski ; Sandeep Dutta ; Bifeng Ding ; Stanley Wang ; Jens Kort1; Wei Liu1; Rajneet K. Oberoi1 Poster Listings Poster 422 Liver Fibrosis Linked to Cognition in HIV and HCV: 1AbbVie Inc, North Chicago, IL, USA; 2AbbVie Inc, Redwood City, CA, USA The Women’s Interagency HIV Study 1 2 1 2 454 Pharmacokinetics of Dolutegravir and Rilpivirine in Victor Valcour ; Leah Rubin ; Mary Obasi ; Pauline Maki ; Mary Combination With SMV and SOF Young3; Wendy Mack4; Mardge Cohen5; Ada Adimora6; Phyllis Tien1; for Marco Merli1; Laura Galli2; Letizia Marinaro3; Alexandra Ariaudo4; the Women’s Interagency HIV Study Protocol Team 4 2 2 1 2 Emanuela Messina ; Caterina Uberti Foppa ; Antonella Castagna ; Univ of California San Francisco, San Francisco, CA, USA; Univ of Illinois 4 3 4 3 Adriano Lazzarin ; Stefano Bonora ; Hamid Hasson at Chicago, Chicago, IL, USA; Georgetown Univ Med Cntr, Washington, 1 2 4 5 Vita-Salute San Raffaele Univ, Milan, Italy; San Raffaele Scientific Inst, DC, USA; Univ of Southern California, Los Angeles, CA, USA; John H. 3 4 Stroger Jr. Hosp of Cook County and Rush Med Coll, Chicago, IL, USA; 6Univ Milan, Italy; Univ of Turin, Turin, Italy; Vita-Salute Univ, San Raffaele of North Carolina at Chapel Hill, Chapel Hill, NC, USA Scientific Inst, Milan, Italy 423LB A Randomised Controlled Trial of Maraviroc- 455 Effect of Direct Acting Antivirals on the Intensified bPI ART on Cognitive Function Pharmacokinetics of Calcineurin Inhibitors 1 2 3 4 1 2 3 Thibaut Gelé ; Aurélie Barrail-Tran ; Audrey Coilly ; Claire Laforest ; Alan Winston ; George Bouliotis ; Ranjababu Kulasegaram ; Amanda 5 6 4 5 6 2 Rodolph Anty ; Georges-Philipp Pageaux ; Jean-Charles Duclos- Clarke ; Frank A. Post ; Mark Nelson ; Laura Burgess ; Borja Mora- 3 1 2 7 2 Vallée ; Anne-Marie Taburet ; for the ANRS CO23 CUPILT study team Peris ; Steve Taylor ; Deborah Ashby 1 1 2 Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Imperial Coll of Sci, Tech and Med, London, UK; Imperial College London, 2 3 3 France; Hosp Bicêtre, Kremlin Bicêtre, France; Hosp Paul Brousse, London, United Kingdom; St. Thomas’ Hosp, London, United Kingdom; 4 5 4 5 Villejuif, France; Hosp Pontchaillou, Rennes, France; Hosp Nice, Nice, Brighton and Sussex Hosps NHS Trust, Brighton, UK; King’s Coll Hosp 6 NHS Fndn Trust, London, UK; 6Chelsea and Westminster Hosp NHS Fndn France; Hosp Montpellier, Montpellier, France Trust, London, UK; 7Birmingham Heartlands Hosp, Birmingham, United Kingdom
110 CROI 2016 Poster Listings 111
1
1 ; 1 ; 1 ; José Ira 2 ; Max Hall A/B 3 Tulane Natl Natl Tulane 2 CROI 2016 ; Eric O. Freed O. ; Eric ; Benjamin 2 1 ; Petronella ; Petronella 2 ; Anna Aldovini ; Anna ; Nishani 2 1 ; Neal N. Padte ; Neal Harvard Med School, School, Med Harvard 2 2
2 Program Agenda and ; Zeyu Lin ; Zeyu ; Carl T. Wild ; T. Carl ; Monsef Benkirane ; Chasity D. Andrews ; Chasity D. 2 2 4 1 ; Monique Nijhuis Bristol-Myers Squibb, Squibb, Bristol-Myers 2 Howard Hughes Med Inst, Inst, Med Hughes Howard
2 2 1 Inst de Genetique Humaine, Humaine, Genetique de Inst 2 ; Ronald Veazey 1
; Javier Garcia-Perez ; Javier ; JustinKaplan A. 2 ; Jian Yu 1 ; Verdin Eric 1 1 2 ; Michael Seaman 1 ; Tricia Protack ; Tricia 2 ; Nuria Climent ; Mark Krystal ; José Alcamí 3
1 4 ; Theodore J. Nitz J. Theodore ; Gladstone Inst of Virology and Immunology, Immunology, and Virology of Inst Gladstone 2 2 DFH Pharma, Inc, Gaithersburg, MD, USA MD, Gaithersburg, Inc, Pharma, DFH 2
2 Univ Med Cntr Utrecht, Utrecht, Netherlands Utrecht, Utrecht, Cntr Med Univ ; Vivek Narayan ; Vivek ; Melanie Ott 3 1 Hosp Clinic-IDIBAPS, Univ de Barcelona, Barcelona, Barcelona, Barcelona, de Univ Clinic-IDIBAPS, Hosp 1 3 ; Tianbo ; Tianbo Li ; Yaoxing Huang ; Yaoxing ; Robert Siliciano 1 1 1 ; Mili R. Gajjar 1 ; Mercedes Bermejo ; Mercedes ; Sherimay D. Ablan D. ; Sherimay 1 1 ; Carey Hwang ; Carey
3 1 ; Ira B. Dicker B. ; Ira 2 ; Juan Ambrosioni ; David E. Martin; David 2 1 ; Montserrat Plana ; Montserrat ; Lily Tsai 3 IDIBAPS, Barcelona, Spain Barcelona, IDIBAPS, 1 4 Aaron Diamond AIDS Rsr Cntr, New York, NY, USA; USA; NY, York, New Cntr, Rsr AIDS Diamond Aaron Inst de Salud Carlos III, Madrid, Spain; Madrid, III, Salud de Carlos Inst NCI, Frederick, MD, USA; USA; MD, Frederick, NCI, Boston Children’s Hosp, Harvard Med Sch, Boston, MA, USA; USA; MA, Sch, Med Boston, Harvard Hosp, Children’s Boston Bristol-Myers Squibb, Princeton, NJ, USA; USA; NJ, Princeton, Squibb, Bristol-Myers Kyoto Univ, Kyoto, Japan; Japan; Kyoto, Univ, Kyoto Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns Spain; M. van Ham van M. Boston, MA, USA MA, Boston, Montpellier, France; France; Montpellier, Lataillade Baltimore, MD, USA MD, Baltimore, 1 EfficacyAntibody Anti-HIV Bispecific Engineered an of Mice Humanized in LanziAnastasia 1 Xin Yao Xin Dicker Dicker USA CT, Wallingford, Squibb, Bristol-Myers OmkarChaudhary 1 Model BMS-955176: Inhibitor Integrated Maturation Responses Antiviral Polymorphic of Protack; Tricia Nowicka-Sans; Beata Lu; Hao Cantone; Lin; Joseph Zeyu Mark Krystal; Regueiro-Ren; Alicia Mark Cockett; Drexler; Dieter p38 by Activation Immune ReductionSIV-Mediated of Inhibition Vivo In MAPK 1 With Treatment Chronicon Patients From PBMC InfectionHIV to Resistant Are Dasatinib Coiras Mayte 1 Active Broadly and Potent for Pathways Resistance Inhibitors Maturation HIV-1 Urano Emiko 1 BMS-955176: Inhibitor Activity Maturation Against Clinical PI-Resistant Isolates Ray Neelanjana A Quantitative Model of ART Efficacy ART of Model Quantitative A the Explains ClinicalSuccess Dolutegravir of Laskey Sarah B. 1 Inhibitors p300 New by Inhibition Transcription HIV-1 Shirakawa Kotaro David D. Ho D. David Kuruppu Wallingford, CT, USA; USA; CT, Wallingford, M. Miro M. Descours San Francisco, CA, USA San Francisco, Primate Rsr Cntr, Covington, LA, USA Covington, Cntr, Rsr Primate
469LB 466 467 468 465 464 Session P-I1 Poster Abstracts Poster SessionP-I1 PM-4:002:45 PM PreclinicalStudies Activityof Resistance and 462 463 ; ; 7 1 ; ; 6 1
1 1 ; 3 Indira Indira ; S. 4 ; Li Fan 2 1 Eunice Eunice 6 Harvard Sch Harvard ; Jamal Tazi 2 6 ; Ellen G. ; Ellen 8 ; Mutsawashe ; Mutsawashe 3 Rsr Inst for Hlth Hlth for Inst Rsr 3 ; Rachael Liu Siriraj Hosp, Bangkok, Bangkok, Hosp, Siriraj
1 4 ; Nahida Chakhtoura Government Hosp of Hosp Government 9 5 2 ; Marian Iwamoto 3 Henry M. Jackson Fndn Henry Fndn Jackson M. ; N. Ravichandran Frontier Sci & Tech Rsr Sci Tech & Frontier 5 1 ; Geetha Ramachandran 7 Sarojini Naidu Med Coll, Coll, Med Naidu Sarojini 1 5 ; Regine Rouzier ; Soumya Swaminathan ; Soumya 5 5 Pharma Medica Rsr, Inc, Inc, Rsr, Medica Pharma Drugsand HIV-Infected in ; Supparatpinyo Kuanchai ; Supparatpinyo 2 2
; Rosa Sanchez 1 ; Edmund Capparelli ; Edmund 2 ; Robert Murphy 8 Inst of Child Hlth, Chennai, India; India; Chennai, Hlth, Child of Inst Baylor Coll of Med, Houston, TX, Houston, USA; Med, of Coll Baylor ABIVAX, Paris, France; France; Paris, ABIVAX, ; Chivon McMullen-Jackson ; Chivon 3 Univ of Montpellier, Montpellier, France; France; Montpellier, Montpellier, of Univ ; Heather Jordan ; Heather 8 2 7 7 2 Pharma Medica Rsr, Inc, St. Charles, MO, USA MO, Charles, St. Inc, Rsr, Medica Pharma Northwestern Univ, Feinberg Sch of Med, Sch Med, of Feinberg Univ, Northwestern 3 9 ; Dipti Agarwal ; Patrick Jean-Philippe ; Patrick ; S. Ramesh Kumar tment With Rifabutin Reduces the Rifabutin Reduces With tment Univ of California San Diego, San Diego, CA, San Diego, San Diego, California of Univ 4 4 1 3 ; Yee Kelly 1 Timothy Eley Timothy ; Kiat Ruxrungtham ; Kiat 4 ; Radu Pop ; Pearl Samson ; Pearl 2 Jean-Marc Steens Jean-Marc ; David J. Back; Saye Khoo; Andrew Owen; Marco Marco Owen; Khoo;Andrew Back; J. Saye ; David 1 ; 1 ; Hartmut Ehrlich 8 ; Bonnie Zimmer 7 ; P.K. Bhavani ; P.K.
HIV-NAT, Thai Red Cross AIDS Rsr Cntr, Bangkok, Thailand; Thailand; Bangkok, Cntr, Rsr AIDS Cross Red Thai HIV-NAT, 1 9 5 ; G. N. Sanjeeva ; G. N. 3 Univ of Zimbabwe, Harare, Zimbabwe; Zimbabwe; Harare, Zimbabwe, of Univ 4 Cap Rsr, Phoenix, Mauritius; Mauritius; Phoenix, Rsr, Cap France; Paris, SA, ABIVAX ABIVAX, Montpellier, France; France; Montpellier, ABIVAX, Northwestern Univ, Chicago, IL, USA Chicago, Univ, Northwestern Cntr for Infectious Disease Rsr in Zambia, Lusaka, Zambia; Zambia; Lusaka, Disease Infectious Zambia, in Rsr for Cntr Natl Inst for Rsr in Tuberculosis, Chennai, India; India; Chennai, Tuberculosis, in Rsr for Inst Natl Merck & Co, Inc, Kenilworth, NJ, USA; USA; NJ, Kenilworth, Inc, Co, & Merck Alex Benns Alex Bwakura-Dangarembizi Kalpana Thailand; Thailand; Gandhi Inst of Child Hlth, Bengaluru, India; India; Bengaluru, Hlth, Child of Gandhi Inst Agra, India Agra, Thoracic Med, Chennai, India; India; Chennai, Med, Thoracic Fndn, Inc, Amherst, MA, USA; USA; MA, Amherst, Inc, Fndn, Kennedy Shriver NICHD, Bethesda, MD, USA; USA; Bethesda, MD, NICHD, Shriver Kennedy Ratanasuwan Winai Ratanasuwan of PH, Boston, MA, USA; USA; MA, Boston, PH, of 6 8 Didier Scherrer 1 Early Evidence of Antiviral ActivityAntiviral of EarlySafetyEvidence and of Patients Treatment-Naïve HIV in ABX464 HIV-1 Attachment Inhibitor Prodrug BMS-663068: Prodrug Inhibitor PK Attachment HIV-1 AssessmentWith Rosuvastatin Jian MichaelHesney; Susan Lubin; Vakkalagadda; Landry;Ishani Blisse LaCreta; Frank Wang; USA NJ, Princeton, Squibb, Bristol-Myers Interaction of Darunavir/Ritonavir and Darunavir/ and InteractionDarunavir/Ritonavir of With Rifampicin Vitro In Cobicistat RobertsOwain 9 Siccardi UK Liverpool, Liverpool, of Univ 1 Optimal Use of Efavirenz in HIV+/ TB+ Coinfected TB+ HIV+/ in Efavirenz of OptimalUse months 24 to 3 ChildrenAged CarolynMoore 1 Pharmacokinetics of Anti-TB Anti-TB of Pharmacokinetics -UnInfected TB ChildrenWith Kumar Hemanth Kupparam Agibothu Exposure of Doravirine of Exposure SauzanneKhalilieh 1 Multiple-Dose Trea Multiple-Dose Paul Gineste Paul T. Kannan T. USA; USA; Mississauga, ON, Canada; Canada; ON, Mississauga, Maureen MartellMaureen for the Advancement of Military Med, Inc, Rockville, MD, USA; USA; MD, Rockville, Inc, Military of Med, Advancement the for Sciences, Chiang Mai Univ, Chiang Mai, Thailand; Thailand; Mai, Chiang Univ, Mai Chiang Sciences, Chicago, IL, USA Chicago, Chadwick
461LB 460 459 458 457 456 Program and Agenda
Session P-L3 Poster Abstracts Hall A/B Session P-M3 Poster Abstracts Hall A/B 2:45 PM-4:00 PM 2:45 PM-4:00 PM HIV Drug Resistance in Different Drug Classes Detecting HCV 504 Incompatibility of HIV-1 Resistance to Both 525 Comparison of 4 HCV Viral Load Assays at High Viral Cenicriviroc and Neutralizing Antibodies Load Takeo Kuwata1; Ikumi Enomoto1; Masanori Baba2; Shuzo Matsushita1 Robert Ehret1; Marcel Schütze1; Andrew Moritz1; Hauke Walter2; Gunnar 1Kumamoto Univ, Kumamoto, Japan; 2Kagoshima Univ, Kagoshima, Schalasta3; Annemarie Berger4; Martin J. Obermeier1 Japan 1Med Cntr for Infectious Diseases, Berlin, Germany; 2Medizinisches 3 505 Molecular Dynamics of the CD4-Mimetic Resistant Infektiologiezentrum Berlin, Berlin, Germany; Prof Gisela Enders & Kollegen MVZ GbR, Stuttgart, Germany; 4Inst of Virology, Univ of HIV-1 Gp120 by MD Simulation Frankfurt, Frankfurt, Germany Shigeyoshi Harada1; Masaru Yokoyama2; Shuzo Matsushita3; Hironori Sato2; Tetsuro Matano1; Kazuhisa Yoshimura1 526 HCV Ag Core’s Screening Performance in Mono- 1Natl Inst of Infectious Diseases, Shinjuku, Japan; 2Natl Inst of Infectious Infected, HIV- and HBV-Coinfected Patients Diseases, Musashimurayama, Japan; 3Kumamoto Univ, Kumamoto, Léa Duchesne1; Richard Njouom2; Frédéric L. Lissock2; Ghislaine Japan Flore Tamko-Mella2; Alexandre Soulier3; Stephane Chevaliez3; Karine 4 5 3 6 506 Suppress NNRTI-Resistant Mutants by Doravirine at LaCombe ; Nicolas Rouveau ; Lila Poiteau ; Sandrine Rallier 1INSERM, UMR-S 1136, Paris, France; 2Inst Pasteur of Cameroon, Clinically Relevant Concentrations Yaounde, Cameroon; 3INSERM U955, Créteil, France; 4Sorbonne Univs, Ming-Tain Lai; Nancy Sachs; MeiZhen Feng; Min Xu; Jay Grobler; Paris, France; 5Natl Agency of Rsr on AIDS and Viral Hepatitis, Paris, Wade Blair; Mike Miller; Daria J. Hazuda France; 6Natl Reference Cntr for Viral Hepatitis B, C and Delta, Hosp Henri Merck & Co, Inc, West Point, PA, USA Mondor, Univ Paris-Est, Créteil, France 507 The Effect of E157Q in HIV-1 Integrase on R263K- Mediated Dolutegravir Resistance Session P-N8 Poster Abstracts Hall A/B Kaitlin Anstett1; Vincent Cutillas2; Robert Fusco1; Thibault Mesplede2; 2:45 PM-4:00 PM Bonnie A. Spira2; Mark A. Wainberg2 Acute HCV Infection 1McGill Univ, Montreal, QC, Canada; 2McGill Univ AIDS Cntr, Montreal, QC, Canada 590 Incidence/Deaths Related to Acute Hepatitis C in Spain: Impact of HIV/HCV Coinfection Alejandro Alvaro-Meca1; Asuncion Diaz2; Marta Sánchez-Carrillo2; Session P-L4 Poster Abstracts Hall A/B 2 2 2 2:45 PM-4:00 PM Sonia Vázquez-Morón ; Salvador Resino ; Verónica Briz 1Univ Rey Juan Carlos, Alcorcón, Spain; 2Inst de Salud Carlos III, Madrid, HIV-2 Drug Resistance Spain 508 Drug Resistance Mutations in HIV-2 Patients Failing Raltegravir and Dolutegravir Session P-N9 Poster Abstracts Hall A/B Silvia Requena1; Carmen de Mendoza2; Teresa Cabezas3; Rosa García4; 2:45 PM-4:00 PM Poster Listings Poster Maria Jose Amengual5; Ana Belen Lozano3; Juan Manuel Fernandez3; Hepatitis A, D, and E Vicente Soriano6; Ana Treviño7; for the Spanish HIV-2 Study Group 1Puerta de Hierro Rsr Inst, Majadahonda, Spain; 2La Paz Univ Hosp, 591 Hepatitis A Virus Vaccination and Immunity Among at Madrid, Spain; 3Hosp de Poniente, Almería, Spain; 4Hosp Universitario Risk HIV-Infected Adults Fundación Jiménez Díaz, Madrid, Spain; 5Corporación Sanitaria Parc Nicholas P. DeGroote1; Christine Mattson1; Yunfeng Tie2; John T. Taulí, Barcelona, Spain; 6Hosp La Paz, Madrid, Spain; 7Hosp Universitario Brooks1; Shikha Garg1 Puerta de Hierro de Madrid, Madrid, Spain 1CDC, Atlanta, GA, USA; 2ICF Intl, Atlanta, GA, USA 509 Prevalence of Minority Resistant Variants in HIV-2 592 Antiretroviral Therapy and Hepatitis Delta Replication Naïve Patients: ANRS CO5 Cohort in HIV-Coinfected Patients Alexandre Storto1; Benoit Visseaux2; Gilles Collin1; Catherine Fagard3; Charles Béguelin1; Darius Moradpour2; Roland Sahli3; Huldrych F. Marine Naudin3; Florence Damond1; Marie-Aude Khuong4; Sophie Günthard4; Manuel Battegay5; Alexandra L. Calmy6; Enos Bernasconi7; Matheron1; Diane Descamps5; Charlotte Charpentier2 Andri Rauch1; Gilles Wandeler8; for the Swiss HIV Cohort Study 1Hosp Bichat-Claude Bernard, Paris, France; 2INSERM UMR 1137, 1Bern Univ Hosp and Univ of Bern, Bern, Switzerland; 2CHU Vaudois, Univ Paris, France; 3CMG-EC de l’INSERM U897, Bordeaux, France; 4Hosp of Lausanne, Lausanne, Switzerland; 3Inst of Microbiology, CHU Vaudois, Delafontaine, Paris, France; 5Hosp Bichat-Claude Bernard, Päris, France Univ of Lausanne, Lausanne, Switzerland; 4Univ Hosp Zurich, Zurich, Switzerland; 5Univ Hosp Basel, Basel, Switzerland; 6Univ Hosp Geneva, Univ of Geneva, Geneva, Switzerland; 7Regional Hosp Lugano, Lugano, Switzerland; 8Univ Hosp Bern, Bern, Switzerland
112 CROI 2016 Poster Listings 113 ; ; 3 ; 7 4 ; 1 ; 2 Univ of Univ 8 Hall A/B Eric G.Eric ; Manuel ; 3 3 CROI 2016 ; Jenny C. ; Jenny Janke Janke 2 ;
1 Inst of Human Human of Inst 4 ; Richard Liang ; Richard 5 1 ; Shyam Kottilil ; Shyam 1 NIH, Bethesda, MD, Bethesda, MD, NIH, 2 hanges Markedly Markedly hanges Univ of Oxford, Oxford, Oxford, Oxford, of Univ Duke Univ Sch of Med, Sch Med, Univ of Duke 2 Program Agenda and ; Elana S. Rosenthal ; Elana 4 1 ; José Hernández-Quero 6 ; Shyam Kottilil ; Shyam ; John G. McHutchison 2 2 Hosp Universitario de Valme, Valme, de Universitario Hosp 9 ; Luisa M. Stamm ; Luisa 1 ; Henry Masur 3 ; SusannaNaggie 1 Gilead Scis, Inc, Foster City, CA, City, Foster Inc, Scis, Gilead ; Luis E Morano-Amado ; Luis ; for the Grupo de Estudio de ; for 2 2 9 Hosp Universitario Alvaro Cunqueiro, Cunqueiro, Alvaro Universitario Hosp 3 ; Julia Purdy ; Richard Molenkamp ; Richard Hosp Universitario de Gran Canaria Canaria Gran de Universitario Hosp ; Sylvie M. Koekkoek ; Sylvie 2 2 2 2
; Henry Masur 1 ; María José Ríos 5 Dignity Hlth, St. Joseph’s Hosp, Phoenix, AZ, AZ, Phoenix, Hosp, Joseph’s Dignity St. Hlth, 2 Hosp Universitario Virgen de la Macarena, Macarena, la de Virgen Universitario Hosp 6 ; Patrick R. Shea R. ; Patrick 1 ; Mani Subramanian 2 ; Anita Kohli ; Anita ; Bhawna Poonia ; Bhawna 1 3
; Oliver Pybus ; Oliver ; Juan A. Pineda 5 1 8 ; Rafael Granados ; David V. Goldstein V. ; David 1 3 Hosp Universitario San Cecilio, Granada, Spain; Granada, San Cecilio, Universitario Hosp ; Jayna Raghwani ; Jayna 7 1 Hosp Universitario Virgen de la Victoria, Málaga, Spain; Málaga, Victoria, la de Virgen Universitario Hosp 4
1 1 ; Téllez Francisco ; Johannes Aartun 4 1 Univ of Maryland Med Cntr, Baltimore, MD, USA MD, Baltimore, Maryland of Univ Cntr, Med Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns The Inst of Human Virology, Univ of Maryland, Baltimore, MD, MD, Baltimore, Maryland, of Univ Virology, Human of Inst The USA; MD, Baltimore, Maryland of Univ Cntr, Med ; Philip S. Pang 3 3 3 4 2 BC Cntr for Excellence in HIV/AIDS, Vancouver, BC, Canada BC, Vancouver, HIV/AIDS, in Excellence for Cntr BC 3 Valme Univ Hosp, Seville, Spain; Seville, Hosp, Univ Valme Línea La Gibraltar), de Campo (AGS Concepción la de Línea La Hosp Columbia Univ, New York, NY, USA; USA; NY, York, New Univ, Columbia Netherlands; Amsterdam, Cntr, Med Academic Med Univ of South Carolina, Charleston, SC, USA; USA; SC, Charleston, South Carolina, of Univ Med NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, USA; USA; USA; USA; Hepatitis Vírica, Sociedad Española de Enfermedades Infecciosas y Infecciosas Sociedad Española de Enfermedades Vírica, Hepatitis Hepatitis Grupo de Estudio de Clínica: GEHEP-SEIMC; Microbiología y Microbiología Infecciosas Sociedad de Enfermedades Andaluza Vírica, RIS-HEP07 HEPAVIR; Clínica: Virology, Baltimore, MD, USA MD, Baltimore, Virology, Durham, NC, USA NC, Durham, Schinkel Márquez Mark Sulkowski Shikha Shrivastava Edward R. Cachay Edward Yang Vigo, Spain; Vigo, de la Concepción, Spain; Concepción, la de USA; USA; 1 UK; UK; Meissner USA; USA; 1 5 Treated With LDV/SOF in ION-4 in LDV/SOF With Treated SarahKleinstein E. 1 Intrahepatic Immune Composition C Composition Immune Intrahepatic HCVInterferon-Free With Treatment Orr Cody 1 HIV-1/HCVin Relapse of Patients Coinfected GWAS FrequencyFunction Predictorsand Liver of DAAs With Treated Cirrhoticin Impairment Patients KarinNeukam Pacbio Sequencing of the HCV Envelope: From Early Sequencing From HCVthe of Pacbio Envelope: Chronic Infection to Acute K. Ho Cynthia Hepatic & Peripheral Responses to 2 Different DAA DAA Different 2 to Responses Peripheral & Hepatic HIV/HCVin Regimens Coinfection Howard C. Louisa 1 California San Diego, San Diego, CA, USA; San Diego, San Diego, California Seville, Spain; Spain; Seville, Doctor Negrín, Las Palmas, Spain; Spain; Palmas, Las Doctor Negrín, Sevilla, SpainSevilla, Menno D. de Jong Menno D. Eleanor Eleanor M. Wilson
600 601 603 602 Abstracts Poster SessionP-N11 PM-4:002:45 PM So Morbidity Not Much The Gone; Is Virus HCV:The 599
; 4 1 Univ Univ 4 ; ; ; ; Chloe ; Chloe 1 2 2 5 ; Will ; Will 3 Hall A/B Clinic of Clinic 4 BOOM!Hlth, BOOM!Hlth, 3 ; Shyam ; Shyam Infectious ; Ponsiano ; Ponsiano 3 3 3 ; Melissa LaMar; ; Melissa LaMar; 2 ; Marco ; Marco Office of the US the of Office 3 7 Univ of Maryland of Univ ; Anna De; Anna Bona Johns Hopkins Hopkins Johns Cntr for Drug Use and and Use Drug for Cntr 4 1 5 2 ; Giulia Marchetti 2 ; Natanya Gettie ; Natanya ; Eric C. Seaberg ; Eric 1 4 ; Robert H. Purcell 5 Hologic, Inc., San Diego, San Diego, Inc., Hologic, 2 Johns Hopkins Univ, Univ, Hopkins Johns 6 Med Univ of South Carolina, South Carolina, of Univ Med NIAID, NIH, Bethesda, MD, Bethesda, MD, NIH, NIAID, 2 2
7 ; Arthur Moseley 3 ; Lisa St. Johns-Williams ; Lisa St. Contributions of IDU andIDU of Contributions
; Charles Cleland ; Charles 2 2 4 ; Boris M. Hogema ; for the Rakai; for Sciences Health 2 7 ; Oliver Laeyendecker ; Oliver 2 Makerere Univ Coll of Hlth Scis, Kampala, Kampala, Scis, Hlth of Coll Univ Makerere ; Paul Klenerman ; Paul ; Marion Peters ; Stefania Cannizzo ; Stefania Duke Clinical Rsr Inst, Durham, NC, USA NC, Durham, Inst, Rsr Clinical Duke 4 3 1 1 5
variant T (MAIT)T variant HIV/HCVin Cells ; Ronald H. Gray ; Ronald H. Univ of Oxford, Oxford, UK; UK; Oxford, Oxford, of Univ ; Leslie St. Bernard St. ; Leslie 3 2 2 ; Jeffrey Linnen ; Jeffrey 5 ; Esther Merlini; Bonnie van Wilgenburg ; Esther Merlini; Bonnie van ; Joseph Lucas 1 3 ; Edgar Ong ; Edgar ; Sherry Deren Hologic, Inc, San Diego, CA, USA San Diego, Inc, Hologic, Duke Univ, Durham, NC, USA; USA; NC, Durham, Univ, Duke
1 1 7 3 5 ; Eric G. Meissner ; Eric 1 ; Lara Stabinski ; Lara 6 Icahn Sch of Med at Mount Sinai, New York, NY, USA NY, York, at Sinai, New Sch Med Mount of Icahn 4 ; Saurabh Mehandru ; Andrew D. Redd D. ; Andrew ; Tincati Camilla 4 1 2 ; Pedro Batista ; Pedro ; Kathryn Anastos 3 3 ; Derek Cyr ; Derek 3 Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Sch Baltimore, PH, of Bloomberg Hopkins Johns Sanquin Rsr and Diagnostics, Amsterdam, Netherlands; Netherlands; Amsterdam, Diagnostics, Sanquin and Rsr 5 3 ; Steven J. Reynolds J. ; Steven ; Keyur Patel ; Keyur 4 4 NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, 3 ; Kenrad E. Nelson ; Kenrad 6 Univ of Milan, Milan, Italy; Milan, Milan, of Univ Aaron Diamond AIDS Rsr Cntr, New York, NY, USA; USA; NY, York, New Cntr, Rsr AIDS Diamond Aaron Duke Univ Sch of Med, Durham, NC, USA; USA; NC, Durham, Sch Med, Univ of Duke Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; USA; MD, Baltimore, Sch Med, of Univ Hopkins Johns Johns Hopkins Univ, Baltimore, MD, USA; USA; MD, Baltimore, Univ, Hopkins Johns Albert Einstein Coll of Med, Bronx, NY, USA; USA; NY, Bronx, Med, of Coll Albert Einstein Thompson HIV Rsr, New York Univ Coll of Nursing, New York, NY, USA; USA; NY, York, New Nursing, of Coll Univ York New Rsr, HIV Leo Swadling Leo Med Cntr, Baltimore, MD, USA; USA; MD, Baltimore, Cntr, Med USA; USA; Baltimore, MD, USA; USA; MD, Baltimore, Bloomberg Sch of PH, Baltimore, MD, USA; USA; MD, Baltimore, Sch PH, of Bloomberg CA, USA; Haekyung Lee Coinfection MaddalenaCerrone 1 1 In Mucosal-Associated HCVActivation Immune Systemic on MartinMarkowitz Understanding the Relative Relative Understanding the Liver Disease HCVin Liver Infection SusannaNaggie 1 Oxylipinand Inflammation of As Metabolites Markers 1 6 High Prevalence of Anti-HEV IgG Is Not Associated With With Associated Anti-HEVNot Is of IgG Prevalence High InfectionHIV Rakai,in Uganda Boon Denali Infected United States Women Women States InfectedUnited MarkKuniholm H. 1 Acute and Chronic Hepatitis E Virus Infection HIV- Virus in E ChronicHepatitis and Acute Charleston, SC, USA; USA; SC, Charleston, Infectious Diseases, Univ of Milan, San Paolo Hosp, Milan, Italy Milan, Hosp, San Milan, of Univ Paolo Diseases, Infectious of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Thomas C. Quinn C. Thomas Bronx, NY, USA; USA; NY, Bronx, Evelyn Silva Evelyn Program Program Global AIDS Coordinator, US Dept of State, Washington, DC, USA DC, Washington, Dept US State, of Coordinator, AIDS Global Diseases Clinic, San Paolo Hosp, Univ of Milan, Milan, Italy; Milan, Milan, of Univ Hosp, San Paolo Diseases Clinic, Kottilil Koppelman Uganda; Uganda; Antonella d’Arminio Monforte d’Arminio Antonella Thio Ocama WITHDRAWN
598 597 596 Pathogenesis of HCVof Infection: and Pathogenesis Activation Exhaustion 595 Session P-N10 Poster Abstracts Poster SessionP-N10 PM-4:002:45 PM 594 593 Program and Agenda
604 Liver Cancer After Hep C Cure: Less Cirrhosis and Less 611 Eradication of HCV and Extrahepatic Comorbidities in Liver Fat Than Expected HIV/HCV Coinfection Andrea Branch; Chiara Rocha; M. I. Fiel; Erin Doyle; Nicholas Goosens; Juan Berenguer1; Miguel A. Von Wichmann2; José López-Aldeguer3; Yujin Hoshida; Thomas Schiano; Myron Schwartz María J. Galindo4; Josep Mallolas5; Manel Crespo6; María J. Tellez7; José Icahn Sch of Med at Mount Sinai, New York, NY, USA M. Bellón1; Juan González-García8; for the GeSIDA 3603 Study Group 1 2 605 Residual Risk of Disease Progression After Hepatitis C Hosp General Universitario Gregorio Marañón, Madrid, Spain; Hosp Universitario Donostia, San Sebastián, Spain; 3Hosp Universitari i Cure in HIV-HCV Patients Politècnic La Fe, Valencia, Spain; 4Hosp Clínico Universitario de Valencia, 1 2 1 Dominique Salmon-Ceron ; Camille Gilbert ; Philippe Sogni ; Valencia, Spain; 5Hosp Clínic de Barcelona, Barcelona, Spain; 6Hosp 3 4 5 6 Francois Dabis ; Julie Bottero ; Patrick Miailhes ; Lionel Piroth ; Firouzé Universitari Vall d Hebron, Barcelona, Spain; 7Hosp Clinico San Carlos, 7 8 Bani-Sadr ; Linda Wittkop ; for the the ANRS CO13 Hepavih Study Madrid, Spain; 8Inst for Hlth Rsr of La Paz Univ Hosp, Madrid, Spain Group 1INSERM-APHP, Hosp Cochin, Paris, France; 2INSERM, Bordeaux, France; 612 Hepatitis C and the Risk of Non-Liver-Related 3INSERM U897, ISPED, Univ de Bordeaux, Bordeaux, France; 4Hôpitaux de Morbidity and Mortality in HIV+ Persons Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, France; 5CHU Helen Kovari1; Rainer Weber1; Alexandra L. Calmy2; Matthias Lyon, Lyon, France; 6CHU Dijon, Dijon, France; 7CHU Reims, Reims, France; Cavassini3; Marcel Stoeckle4; Patrick Schmid5; Enos Bernasconi6; Andri 8CHU de Bordeaux, Bordeaux, France Rauch7; Bruno Ledergerber1; for the Swiss HIV Cohort Study 1 2 606 Hepatitis C Genotype 6 Is Associated With Progression Univ Hosp Zurich, Zurich, Switzerland; Univ Hosp Geneva, Univ of Geneva, Geneva, Switzerland; 3Univ Hosp Lausanne, Univ of Lausanne, of Liver Fibrosis in HIV Patients Lausanne, Switzerland; 4Univ Hosp Basel, Basel, Switzerland; 5Cantonal 1 2 Anchalee Avihingsanon ; Suparat Khemnark ; Tanakorn Hosp, St Gall, Switzerland, St Gall, Switzerland; 6Regional Hosp 1 1 1 Apornpong ; Sivaporn Kukanok ; Vorapot Sapsirisavat ; Salyavit Lugano, Lugano, Switzerland; 7Bern Univ Hosp and Univ of Bern, Bern, 2 1 2 Chittmittrapap ; Stephen J. Kerr ; Sombat Treeprasertsuk ; Pisit Switzerland Tankijvanich2; Kiat Ruxrungtham1; for the HCV Study Team 1 HIV-NAT, Thai Red Cross AIDS Rsr Cntr, Bangkok, Thailand; Session P-O3 Poster Abstracts Hall A/B 2Chulalongkorn Univ, Bangkok, Thailand 2:45 PM-4:00 PM 607 Impact of Occult HBV Infection in HCC Presentation in Lymphoma and Kaposi Sarcoma HCV-Related Cirrhosis Nicola Coppola1; Valentina Lodice2; Mario Starace1; Carmine 629 APOBEC3 Boosters Kill Primary Effusion Lymphoma Minichini1; Nunzia Farella2; Lorenzo Onorato1; Giulia Liorre2; and Other Cancer Cell Lines Evangelista Sagnelli1; Giorgio De Stefano2 Chisu Song1; Gary Schiltz2; Meejeon Roh1; Isabelle Clerc1; Neha Malik2; 1Second Univ of Naples, Naples, Italy; 2AORN dei Colli, P.O. Cotugno, Hannah Hudson1; Kiwon Nam2; Richard T. D’Aquila1 Naples, Italy 1Northwestern Univ, Feinberg Sch of Med, Chicago, IL, USA; 2Northwestern Univ, Chicago, IL, USA Session P-N12 Poster Abstracts Hall A/B 630 Risk Factors for Hodgkin (HL) and Non-Hodgkin 2:45 PM-4:00 PM Lymphoma (NHL) in Europe HCV Mischief From Beyond the Liver Leah Shepherd1; Alvaro H. Borges2; Johannes Bogner3; Andrzej Poster Listings Poster 4 5 6 7 608 CB2-63 RR Variant Is Associated With Immune- Horban ; Elena Kuzovatova ; Manuel Battegay ; Marcelo Losso ; Jens D. Lundgren8; Amanda Mocroft1; for the EuroSIDA in EuroCOORD Mediated Disorders in HCV Patients 1Univ Coll London, London, UK; 2CHIP, Rigshospitalet, Univ of Nicola Coppola; Rosa Zampino; Giulia Bellini; Maria Stanzione; Copenhagen, Copenhagen, Denmark; 3Medizinische Poliklinik, Munich, Nicolina Capoluongo; Margherita Macera; Luigi E. Adinolfi; Emanuele Germany; 4Hosp for Infectious Diseases in Warsaw, Med Univ of Warsaw, Miraglia Del Giudice; Evangelista Sagnelli; Francesca Rossi Warsaw, Poland; 5Academician Blokhina Nizhny Novgorod Rsr Inst of Second Univ of Naples, Naples, Italy Epi and Microbiology, Novgorod, Russian Federation; 6Univ Hosp Basel, 609 Prevalence and Risk Factors of Low Muscle Mass in HIV/ Basel, Switzerland; 7Hosp J.M. Ramos Mejia, Buenos Aires, Argentina; 8 Viral Hepatitis Coinfection RigsHospet, Univ of Copenhagen, Copenhagen, Denmark Charitha Gowda1; Todd T. Brown2; Charlene Compher1; Kimberly A. 631 Kaposi Sarcoma Survival in Adults: The South African Forde1; Jay R. Kostman3; Pamela A. Shaw4; Phyllis Tien5; Vincent Lo Re1 Antiretroviral Treatment Era 1 2 Univ of Pennsylvania, Philadelphia, PA, USA; Johns Hopkins Univ, Mazvita M. Sengayi1; Danuta M. Kielkowski1; Matthias Egger2; Lydia 3 4 Baltimore, MD, USA; John Bell Hlth Cntr, Philadelphia, PA, USA; Univ of Dreosti3; Julia Bohlius4 5 Pennsylvania, Phialdelphia, PA, USA; Univ of California San Francisco, 1Natl Cancer Registry, NHLS, Johannesburg, South Africa; 2Univ Hosp San Francisco, CA, USA Bern, Bern, Switzerland; 3Univ of Pretoria and Steve Biko Academic Hosp, 610 Rapid Improving of Glycemic Control in HCV Patients Pretoria, South Africa; 4Inst of Social and Preventive Med, Univ of Bern, Treated With IFN-Free Regimens Bern, Switzerland Paolo Pavone; Tiziana Tieghi; Gabriella D’Ettorre; Miriam Lichtner; Raffaella Marocco; Ivano Mezzaroma; Giulia Passavanti; Claudio M. Mastroianni; Vincenzo Vullo Sapienza Univ of Rome, Rome, Italy
114 CROI 2016 Poster Listings 115 ; 1 ; Peter ; Peter 3 ; Susana 2 Hall A/B ; for the ; for 2 ; Alec ; Alec ; John 1 1 CROI 2016 ; David ; David 2 Kirby Inst, Inst, Kirby 2
Inst de Inst 1 2 ; Maria L. Montes 1 ; Laura Pintado ; Laura Program Agenda and 1 ; David Cooper ; David 1 ; Simon Mallal ; Anton N. Pozniak N. ; Anton 1 Univ de Alcalá, Madrid, Madrid, Alcalá, de Univ 3 3 ; Eoin R. Feeney ; Eoin 1 St Vincent’s Hosp, Sydney, Sydney, Hosp, Vincent’s St 4 ; for the HAMA001 Study Study the HAMA001 ; for 1 ; Anthony Kelleher ; Anthony 1 ; Jose R. Arribas 2
Univ of New South Wales, Sydney, Sydney, South Wales, New of Univ Mater Misericordiae Univ Hosp, Hosp, Univ Misericordiae Mater 2 2 2 ; Ian James ; Ian 1 ; Cecilia Moore ; Cecilia 1
; Ignacio Pérez-Valero ; Graeme Moyle ; Graeme ; Rocío Montejano ter Switch From Failing First-Line First-Line Failing From Switch ter 1 2 1 ; Elena Alvarez ; Elena ; Patrick Mallon ; Patrick
1 ; Robert T. Maughan T. ; Robert 4 1 1 ; Rosario Perona 1 Chelsea and Westminster Hosp NHS Fndn Trust, Trust, Fndn NHS Hosp Westminster and Chelsea ; Kaija Strautins 3 ; Soichiro Takahama; Yu Kaku; Masahiro Yamamoto Kaku; Yu Yamamoto Masahiro ; Takahama; Soichiro 1 Amsterdam Inst for Global Hlth and Develop, Amsterdam, Amsterdam, Develop, and Hlth Global for Inst Amsterdam ; Amanda H. Yao H. ; Amanda 4 1 Elizabeth J. Phillips J. Elizabeth Kirby Inst, Sydney, Australia; Australia; Sydney, Inst, Kirby Vanderbilt Univ Sch of Med, Nashville, TN, USA TN, Nashville, Sch Med, Univ of Vanderbilt ; 2 3 1 ; Gerard Sheehan ; Gerard 2 ; José I. Bernardino ; Andrew Carr ; Andrew 3 3 ; Patrick Mallon ; Patrick 4 Inst for Hlth Rsr of La Paz Univ Hosp, Madrid, Spain; Spain; Madrid, Hosp, Univ Paz La of Rsr Hlth for Inst Kirby Inst, Univ of New South Wales, Sydney, Australia; Australia; Sydney, South Wales, New of Univ Inst, Kirby Murdoch, Univ, Murdoch Diseases, Infectious & Immunology for Inst Ireland; Dublin, Dublin, Coll Univ Univ Coll Dublin, Dublin, Ireland; Ireland; Dublin, Dublin, Coll Univ Sydney, Australia Sydney, Reiss Jesús Mingorance London, UK; UK; London, Spain Cooper Australia; Australia; Monge Natl Hosp Org, Kyushu Med Cntr, Fukuoka, Japan Fukuoka, Cntr, Med Kyushu Org, Hosp Natl 1 Decreased and Length Shortof RiskFactors Telomere Patients HIV in DNA Mitochondrial Minami Rumi Investigators Investigators Antiretroviral Drugs Antiretroviral AscarizStella C. Natalia 1 HLA-B*57:01 Risk Influencees EraP for in Variation AbacavirHypersensitivity Positive Pavlos Rebecca 1 Tissue Adipose AZT/NNRTIGreater Induce Than AZT/PI Toxicity Mitochondrial Maughan RobertT. 1 Activity to Exposed PBMCs in Telomerase of Regulation 1 Af Metabolic Profiles Second-Linethe in ART Study MarkBoyd Dysregulated Monocyte GeneMetabolism Dysregulated Cholesterol Initiation ART With Expression O’HalloranA. Jane Redwood Australia; Australia; Dublin, Ireland; Ireland; Dublin, Netherlands Investigaciones Biomédicas, Madrid, Spain; Madrid, Biomédicas, Investigaciones Lambert Sydney, Australia Sydney, SECOND-LINE Study Group Group Study SECOND-LINE
670 667 668 669 Session P-P6 Poster Abstracts Poster SessionP-P6 PM-4:002:45 PM Toxicities NRTI 666 665 ; 8 ; 9 ; 1 ; Cynthia ; Cynthia 4 Hall A/B Hall A/B
Univ of Univ ; Kathy 2 4 1
1 ; Francisco ; Francisco
3
Hosp Regional Regional Hosp ; Amanda ; Amanda 1 5 1 Yale Univ Sch Univ of Yale 2 ; Daniel H. Low ; Daniel H. VA Med Cntr, West West Cntr, Med VA 1 9 ; José López- 5 Boston Coll, Chestnut Chestnut Coll, Boston 2 ; Corey Casper ; Corey ; Koldo Aguirrebengoa ; Koldo Michael E. DeBakey VA VA DeBakey E. Michael 2 8 Hosp General Universitario Universitario General Hosp 8 Univ of Regensburg, Regensburg, of Univ 2 2 ; Kristina Crothers 3 VA Med Cntr, Washington, Washington, Cntr, Med VA ; Maria Rodriguez-Barradas ; Boris Revollo 5 7 2 Fred Hutchinson Cancer Rsr Cntr, Cntr, Rsr Cancer Hutchinson Fred 2 Prevalence in Prevalence ; Meghan Feldpausch ; Peter Malfertheiner ; Peter 1 2 ; Gregory Robbins 1 ; Ann Duerr; Ann 3 ; Steven K.Grinspoon ; Steven 1 Hosp Clínico Universitario de Valencia, Valencia, de Universitario Clínico Hosp ; Lesley Park ; Lesley 8 2
Hosp German Trias i Pujol, Badalona, Spain; Badalona, Pujol, i Trias German Hosp
Hosp Universitari i Politècnic La Fe, Valencia, Valencia, Fe, La i Politècnic Universitari Hosp 3 10 ; María J. Galindo ; María J. 6 Stanford Univ, Stanford, CA, USA; Stanford, Univ, Stanford 7 3 ; Sheldon Brown ; RachelBender A. Ignacio ; MinHi Park 6 1 2 ; Esperanza Merino ; Esperanza 1 ; Marcial Delgado-Fernández ; Marcial 4 ; Michael Selgrad Uganda Cancer Inst, Kampala, Uganda Kampala, Inst, Cancer Uganda 1 3 ; Jackson Orem Yale Univ Sch of PH, New Haven, CT, USA CT, Haven, Sch New PH, Univ of Yale Hosp de Cruces, Baracaldo, Spain Baracaldo, Cruces, de Hosp 2 ; Brinda Emu ; Markella V. Zanni V. ; Markella 9 1 10 ; for the Grupo de Estudio de Hepatitis Víricas de la de Víricas the Grupo de Estudio de Hepatitis ; for 1 1 Gilead Scis, Inc, Foster City, CA, USA City, Foster Inc, Scis, Gilead Helicobacterpylori 3 ; Michael Fitzgerald 3 ; Robert Dubrow 9 ; Téllez Francisco VA Greater Los Angeles Hlthcare System, Los Angeles, CA, USA; Angeles, Los System, Angeles Hlthcare Los Greater VA 6 6 ; Tricia H. Burdo H. Tricia ; Hosp La Línea de la Concepción (AGS Campo de Gibraltar), La La Gibraltar), de Campo (AGS Concepción la de Línea La Hosp ; Matthew Goetz ; Matthew 1 7 5 Univ of Magdeburg, Magdeburg, Germany; Germany; Magdeburg, Magdeburg, of Univ Massachusetts General Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, General Massachusetts Hosp Universitario de Valme, Sevilla, Spain; Sevilla, Valme, de Universitario Hosp San Donostia, de Sebastián, Spain; Universitario Hosp James J. Peters VA Med Cntr, Bronx, NY, USA; USA; NY, Bronx, Cntr, Med VA Peters J. James Icahn Sch of Med at Mount Sinai, New York, NY, USA; USA; NY, York, at Sinai, New Sch Med Mount of Icahn Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ Línea de la Concepción, Spain; Concepción, la de Línea Gibert Spain; Haven, CT, USA; USA; CT, Haven, Warren T. Phipps T. Warren Janet Tate DC, USA; USA; DC, HIV-Infected Subjects HIV-Infected Rodríguez-Arrondo Seattle, WA, USA; USA; WA, Seattle, Regensburg, Germany Regensburg, de Málaga, Málaga, Spain; Spain; Málaga, Málaga, de Cholesterol Efflux in Newly Diagnosed Effectsand HIV Newly in Efflux Cholesterol Therapy of Antiretroviral MabelToribio ChristianSchulz 1 1 1 4 Nicolás Merchante Nicolás Real-Life Experience With Sorafenib for the Treatment Treatment the Sorafenibfor With Experience Real-Life Patients HIV-Infected in HCC of 1 7 Aldeguer Low CD4/CD8 Ratio As Predictora Ratio CD4/CD8 Cancer of Risk in Low Persons HIV-Infected SigelM. Keith Matine Ghadrshenas Matine 1 HIV Testing, Status, and Treatment Among Patients at at Patients Among Treatment and Status, Testing, HIV Cancer Institute Uganda the Martin Med Cntr and Baylor Coll of Med, Houston, TX, Houston, USA; Med, of Coll Baylor and Cntr Med Hill, MA, USA; USA; MA, Hill, Sociedad Española de Enfermedades Infecciosas y Microbiología y Microbiología Infecciosas Sociedad Española de Enfermedades GEHEP-SEIMC Clínica: Juan A. Pineda de Alicante, Alicante, Spain; Alicante, Alicante, de Washington Sch of Med, Seattle, WA, USA; USA; WA, Seattle, Sch Med, of Washington Med, New Haven, CT, USA; USA; CT, Haven, New Med, Melbourne Valencia, Spain; Valencia, Decreased Decreased
664 Session P-P5 Poster Abstracts Poster SessionP-P5 PM-4:002:45 PM Metabolism Cholesterol 635 634 633 2:45 PM-4:002:45 PM OtherCancers Riskand Malignancies of HIV in 632 Session P-O4 Poster Abstracts SessionPoster P-O4 Program and Agenda
Session P-P7 Poster Abstracts Hall A/B Session P-P9 Poster Abstracts Hall A/B 2:45 PM-4:00 PM 2:45 PM-4:00 PM Oxidized Lipids: Associations With Outcomes and Noncommunicable Diseases in Low- and Middle- Impact of Interventions Income Countries 671 CRP, D-dimer, and Oxidized LDL Predict Myocardial 676 Incidence and Predictors of Hypertension Among HIV Infarction in Treated HIV Infection Patients in Rural Tanzania Peter W. Hunt1; Heidi M. Crane2; Daniel Drozd2; Michelle Floris- Eduardo Rodríguez-Arbolí1; Kim Mwamelo2; Aneth V. Kalinjuma3; Moore3; Richard Moore4; Mari M. Kitahata2; Michael S. Saag5; Michael Hansjakob Furrer4; Christoph Hatz5; Marcel Tanner5; Manuel Battegay6; M. Lederman6; Jeffrey N. Martin1; for the CFAR Network of Integrated Emilio Letang5; for the KIULARCO Study Group Clinical Systems (CNICS) 1Virgen del Rocio Univ Hosp, Seville, Spain; 2Ifakara Hlth Inst, Ifakara, 1Univ of California San Francisco, San Francisco, CA, USA; 2Univ of Tanzania; 3Ifakara Hlth Inst, Morogoro, Tanzania; 4Bern Univ Hosp Washington, Seattle, WA, USA; 3Univ of North Carolina at Chapel Hill, and Univ of Bern, Bern, Switzerland; 5Swiss Trop Inst of PH, Basel, Chapel Hill, NC, USA; 4Johns Hopkins Univ, Baltimore, MD, USA; 5Univ of Switzerland; 6Univ Hosp Basel, Basel, Switzerland 6 Alabama at Birmingham, Birmingham, AL, USA; Case Western Reserve 677 Population-Level Decline in BMI and Blood Pressure Univ, Cleveland, OH, USA Following Mass HIV Treatment 672 Lack of Associations of Oxidized Lipoproteins With Pascal Geldsetzer1; Andrea B. Feigl1; Frank Tanser2; Dickman Gareta2; Atherosclerosis in HIV: ACTG A5260 Deenan Pillay2; Till Bärnighausen1 Theodoros Kelesidis1; Thuy T. Tran2; Todd T. Brown3; Carlee B. Moser2; 1Harvard Sch of PH, Boston, MA, USA; 2Africa Cntr for Hlth and Pop Heather J. Ribaudo2; Michael Dube4; Robert Murphy5; Otto Yang1; Grace Studies, Mtubatuba, South Africa 6 7 1 A. McComsey ; James H. Stein ; Judith S. Currier 678 HIV Infection, ART Use, and Access to Care for NCDs in 1David Geffen Sch of Med at Univ of California Los Angeles, Los Angeles, CA, USA; 2Harvard Sch of PH, Boston, MA, USA; 3Johns Hopkins Univ, Agincourt, South Africa 1 2 Baltimore, MD, USA; 4Keck Sch of Med at the Univ of Southern California, Jennifer Manne-Goehler ; Livia Montana ; Xavier Gomez- 3 4 4 5 Los Angeles, CA, USA; 5Northwestern Univ, Feinberg Sch of Med, Chicago, Olive ; Alisha Wade ; Stephen Tollman ; Thomas A. Gaziano ; Till 2 IL, USA; 6Case Western Reserve Univ, Cleveland, OH, USA; 7Univ of Bärnighausen 1 2 Wisconsin-Madison, Madison, WI, USA Beth Israel Deaconess Med Cntr, Boston, MA, USA; Harvard Sch of PH, Boston, MA, USA; 3Med Rsr Council/Wits Rural PH and Health 673 Statin Effects on oxLDL in Relationship to Plaque and Transition Unit, Johannesburg, South Africa; 4Univ of the Witwatersrand, Arterial Inflammation in HIV Johannesburg, South Africa; 5Brigham and Women’s Hosp, Harvard Med Eric Nou; Michael Lu; Sara E. Looby; Kathleen Fitch; Elli Kim; Hang Lee; Sch, Boston, MA, USA Udo Hoffmann; Steven Grinspoon; Janet Lo 679 The Burden of NCDs Among the HIV-Infected Massachusetts General Hosp, Boston, MA, USA Population in Agincourt, South Africa 1 2 3 Session P-P8 Poster Abstracts Hall A/B Jennifer Manne-Goehler ; Livia Montana ; Xavier Gomez-Olive ; Alisha Wade4; Stephen Tollman4; Till Bärnighausen2; Thomas A. 2:45 PM-4:00 PM Gaziano5
Poster Listings Poster Smoking: More Ways It Can Harm 1Beth Israel Deaconess Med Cntr, Boston, MA, USA; 2Harvard Sch of 3 674 The Effect of Rosuvastatin on Vascular Disease Differs PH, Boston, MA, USA; Med Rsr Council/Wits Rural PH and Health Transition Unit, Johannesburg, South Africa; 4Univ of the Witwatersrand, by Smoking Status 5 1 2 2 Johannesburg, South Africa; Brigham and Women’s Hosp, Harvard Med Corrilynn O. Hileman ; Chris T. Longenecker ; Danielle Labbato ; Sch, Boston, MA, USA Bruce Kinley2; Grace A. McComsey2 1MetroHlth Med Cntr, Cleveland, OH, USA; 2Case Western Reserve Univ, Cleveland, OH, USA Session P-Q6 Poster Abstracts Hall A/B 2:45 PM-4:00 PM 675 Coronary Artery Calcification on Chest Computed Aging and Immune Effects of Antiretroviral Therapy Tomography in HIV-Infected Smokers Alain Makinson1; Sabrina Eymard-Duvernay2; Iskander Bouassida1; 715 Higher Plasma Cell-Free DNA Levels Are Associated François Raffi3; Sophie Abgrall4; Pierre Tattevin5; Vincent Le Moing1; With Younger Age and HIV Infection Jacques Reynes1; Sébastien Bommart1; for the ANRS EP48 HIV CHEST Omair Arshad; Izabelle Gadawski; Beheroze Sattha; Hélène Côté; for Study Team the Canadian Institutes of Health Research Team on Cellular Aging and 1Univ Hosp Montpellier, Montpellier, France; 2INSERM, Montpellier, HIV Comorbidities in Women and Children (CARMA cohort) France; 3Univ Hosp Nantes, Nantes, France; 4Univ Hosp Antoine-Béclère, Univ of British Columbia, Vancouver, BC, Canada Clamart, France; 5Pontchaillou Univ Hosp, Rennes, France
116 CROI 2016 Poster Listings 117
3 ; 2
2
1 ; Stephen ; Stephen Hall A/B Hall A/B 3 Univ of Univ ; David ; David BC Cntr for for Cntr BC 2 4 CROI 2016 4 NIAID, NIH, NIH, NIAID, ; Aaron A. ; Aaron ; Susan L. 3 3 3 ; Jason Okulicz 2 Rakai Hlth Scis Hlth Rakai 6 ; Wan Lam ; Wan Univ of Michigan, Ann Michigan, of Univ 3 2 ; Christine Bowman ; Christine
2 1 ; S. F. Paul Man Paul ; S. F. Program Agenda and 1 ; Tassiopoulos Katherin 6 Ohio State Univ, Columbus, Columbus, Univ, Ohio State San Antonio Military Med Cntr, MilitarySan Antonio Cntr, Med 4 3 ; Thomas C. Quinn Thomas ; 6 ; Thankam ; Thankam Sunil ; Robert Kalayjian 2 2 ; DonSin ; Vucic Emily 4 1 uring HSV-2 and CMVand HSV-2 uring Harvard Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, of Harvard ; Allison R. Kirkpatrick ; Allison 2 2 NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, ; Julia M. Greig Sheffield Teaching Hosps, Sheffield, UK Sheffield, Hosps, Teaching Sheffield 2 1 ; Martha Nason 2 2
; Stella Xu ; Stella ; Frank J. Palella J. ; Frank 2 5 ; Wu Kunling ; James White 1 2 ; Sarah Kalibbala Makerere Univ Schoool of PH, Kampala, Uganda Schoool Kampala, Univ PH, of Makerere 5 7 Johns Hopkins Univ Sch of Med, Baltimore, MD, MD, Baltimore, Sch Med, of Univ Hopkins Johns 4 ; Julio Montaner 1 ; Eshan U. Patel ; Eshan U. 1
1 ; Lindsay M. Kohorn; Tanawan Riangwiwat; Scott Riangwiwat; Tanawan M. Kohorn; ; Lindsay BC Cancer Rsr Cntr, Vancouver, BC, Canada; Canada; BC, Vancouver, Cntr, Rsr Cancer BC ; Martin Bewley ; Marc Sze ; Marc 3 1 1 ; Xiahoe Xu ; Xiahoe 1 ; Steven J. Reynolds J. ; Steven 7 Feinberg Sch of Med, Northwestern Univ, Chicago, IL, USA; Chicago, Univ, Northwestern Sch Med, of Feinberg 5 ; Babafemi Taiwo ; Sara Gianella 4 4 Univ of California San Diego, San Diego, CA, USA; San Diego, San Diego, California of Univ ; Corey Nislow ; Corey 5 3 NIAID, NIH, Bethesda, MD, USA; USA; Bethesda, MD, NIH, NIAID, Univ of British Columbia, Vancouver, BC, Canada; Canada; BC, Vancouver, Columbia, British of Univ Univ of Sheffield, Sheffield, UK; UK; Sheffield, Sheffield, of Univ San Antonio Military Med Cntr, Fort Sam Houston, TX, Fort Sam Houston, USA; MilitarySan Antonio Cntr, Med MetroHlth Med Cntr, Cleveland, OH, USA; USA; OH, Cleveland, Cntr, Med MetroHlth IL, USA Chicago, Univ, Northwestern Univ of Colorado, Denver, CO, USA; USA; CO, Denver, Colorado, of Univ Koletar Tobian OH, USA; USA; OH, Baltimore, MD, USA; USA; MD, Baltimore, Texas San Antonio, San Antonio, TX, USA; San Antonio, San Antonio, Texas TX, USA San Antonio, Lam David H. Dockrell David ImmunologicalSignaling D Initiation ART at Reactivation Vaginal Redd D. Andrew 1 1 Dominic Chow Dominic Individuals HAART-Treated of Lungs the in gp120 HIV PulmonaryImpairs Immunity Collini J. Paul 1 Cell Epithelial Airway HIV the to Response Host The Microbiome Leung Janice 1 With Associated Is Patients HIV-Infected in Frailty Resistance insulin Increased C.C. Souza; Kallianpur; Beau Kalpana J. K. Lishomwa Nakamoto; M. Shikuma Cecilia Ndhlovu; USA HI, Honolulu, Hawaii, of Univ 3 6 Force Air Characteristics Fitness States United of InfectionHIV With Members AshaDe R. Factors Associated With Limitations in Dailyin Activity Limitations With Associated Factors Adults HIV+ Older Among KristineErlandson M. 1 Excellence in HIV/AIDS, Vancouver, BC, Canada BC, Vancouver, HIV/AIDS, in Excellence USA; USA; Prog, Rakai, Uganda; Uganda; Rakai, Prog, Serwadda Arbor, MI, USA; USA; MI, Arbor,
Session P-Q9 Poster Abstracts SessionPoster P-Q9 PM-4:002:45 PM Virus CoinfectionsHerpes 726 Session P-Q8 Poster Abstracts SessionPoster P-Q8 PM-4:002:45 PM Pulmonaryof Mechanisms Complications 724 725 723 722 721
; 2 2 ; ; 2 6 ; 4 Univ Hlth Hlth Univ Hall A/B 4 ; Elizabeth ; Elizabeth ; Scott 7 ; for the ; for 3 ; Robert 1 3 ; Beheroze ; Beheroze 1 ; Mark W. Hull W. ; Mark ; Omar G. Sued 5 BC Cntr for Excellence Excellence for Cntr BC 2 2 Ohio State Univ, Univ, Ohio State ; Susan Holman 2 ; Manjusha Kulkarni 3 State Univ of New York York New of Univ State 2 4
; Tassiopoulos Katherin 3 6 Rutgers Univ, Piscataway, Piscataway, Univ, Rutgers 2 Hélène Côté Hélène
Columbia Univ Med Cntr, New New Cntr, Med Univ Columbia ; 10 2 ; Andrew Cheng ; Andrew Fundación Huésped, Buenos Huésped, Fundación Georgetown Univ Med Cntr, Cntr, Med Univ Georgetown ; Weber Kathleen 10 3 2 5 6 ; Susan Koletar L. 2 ; Meng Ying Lu Ying ; Meng MetroHlth Med Cntr, Cleveland, Cleveland, Cntr, Med MetroHlth 1 4 ; Rupert Kaul ; Qiuhu Shi 4 2 ; Mari J. Rolon ; Mari J. Harvard Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, of Harvard 2 2
2 Univ of Toronto, Toronto, ON, Canada; Canada; ON, Toronto, Toronto, of Univ ; Moupali Das ; Moupali 5 3
; Frank J. Palella J. ; Frank 5 ; Michael T. Yin ; Michael T. ; Jason Dinoso 9 Johns Hopkins Bloomberg Sch of PH, Baltimore, Sch Baltimore, PH, of Bloomberg Hopkins Johns ; Wu Kunling 3 8 1 Univ of California San Francisco, San Francisco, San Francisco, San Francisco, California of Univ ; Nicholas T. Funderburg T. ; Nicholas 6 1 Gilead Scis, Inc, Foster City, CA, USA City, Foster Inc, Scis, Gilead ; P. Richard Harrigan Richard ; P. ; Pedro Cahn ; Pedro ; Amber L. Wheeler L. ; Amber 3 1 4 5 ; Leah Szadkowski ; Leah Dalla Lana Sch of PH, Toronto, ON, Canada; Canada; ON, Toronto, Sch PH, of Lana Dalla 3 3 ; Donald R. Hoover ; Maria I. Figueroa 1 1 ; Jarek Ignas-Menzies ; Jarek 1 ; Marshall Fordyce 3 Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, ; Yafeng Zhang ; Yafeng ; Babafemi Taiwo Feinberg Sch of Med, Northwestern Univ, Chicago, IL, USA; USA; IL, Chicago, Univ, Northwestern Sch Med, of Feinberg CORE Cntr/Cook County Hlth and Hosp System and Hektoen Inst Inst Hektoen and System Hosp and Hlth County Cntr/Cook CORE 9 3 New York Med Coll, Valhalla, NY, USA; USA; NY, Valhalla, Coll, Med York New 4 5 7 3 ; Sara Saberi ; Marcia K. Holstad ; Marcia 1 8 Albert Einstein Coll of Med, Bronx, NY, USA; USA; NY, Bronx, Med, of Coll Albert Einstein Univ of Colorado, Denver, CO, USA; USA; CO, Denver, Colorado, of Univ USA; OH, Columbus, Univ, Ohio State IL, USA Chicago, Univ, Northwestern BC Cntr for Excellence in HIV/AIDS, Vancouver, BC, Canada BC, Vancouver, HIV/AIDS, in Excellence for Cntr BC St Michael’s Hosp, Toronto, ON, Canada; Canada; ON, Toronto, Hosp, Michael’s St Case Western Reserve Univ, Cleveland, OH, USA; USA; OH, Cleveland, Univ, Reserve Western Case Univ of British Columbia, Vancouver, BC, Canada; Canada; BC, Vancouver, Columbia, British of Univ in HIV/AIDS, Vancouver, BC, Canada BC, Vancouver, HIV/AIDS, in Washington, DC, USA; USA; DC, Washington, Sharon Sharon L. Walmsley York, NY, USA NY, York, McCallister Canadian Institute of Health Research Team on Cellular Aging and HIV Aging on Cellular Team Research of Health Institute Canadian (CARMA) Children and Women in Comorbidities of Med, Chicago, IL, USA; IL, USA; Chicago, Med, of Aires, Argentina; Argentina; Aires, CA, USA; NJ, USA; USA; NJ, OH, USA; USA; OH, MD, USA; USA; MD, 1 Prevalence of Falls Among Older Women in thein Women Older Among Falls of Prevalence Interagency StudyHIV Women’s SharmaAnjali 1 3 6 Frailty Is Associated With NNRTI-Based Initial ART and ART Initial NNRTI-Based With Associated Is Frailty 5322 RisksModifiable ACTG in KristineErlandson M. 1 6 Similar Inflammatory Marker Levels With LPV/r+3TC LPV/r+3TC With SimilarLevels Inflammatory Marker Weeks 48 at LPV/r+2NRTIs Versus Darrell Tan H. Grace A. McComsey A. Grace 1 1 With Markers Inflammation in Decline Equivalent DF Tenofovir and Alafenamide Tenofovir Mitochondrial DNA Mutations DNA Mitochondrial S. Ziada Adam Peak HIV Viral Load Is Associated With Increased Blood Increased With Associated Is Load Viral HIV Peak Sattha Downstate Med Cntr, Brooklyn, NY, USA; USA; NY, Brooklyn, Cntr, Med Downstate Michael W. Plankey Michael W. Golub Network, Toronto, ON, Canada; Canada; ON, Toronto, Network, Kalayjian Janet M. Raboud Columbus, OH, USA; USA; OH, Columbus, Hui C. Liu
720 719 Session P-Q7 Poster Abstracts SessionPoster P-Q7 PM-4:002:45 PM Functionaland Frailty Status 718 717 716 Program and Agenda
727 Longitudinal Viral Dynamics in Semen of HIV+ Men Session P-R9 Poster Abstracts Hall D Before and After Early ART 2:45 PM-4:00 PM Sheldon R. Morris; Davey M. Smith; Milenka Vargas; Susan J. Little; Cryptococcal Disease: Detection and Outcomes Sara Gianella Univ of California San Diego, San Diego, CA, USA 759 Evaluation of Provider-Initiated Cryptococcal Antigen Screening, South Africa 728 HSV-2 Acquisition Among HIV-1 Infected Adults With Nicky Longley1; Snigdha Vallabhaneni2; Mariette Smith3; Rachel Tenofovir-Based ART in ACTG 5175 Smith2; Meg Osler3; Nicola Kelly3; Anna Cross3; Andrew Boulle4; Graeme Connie M. Celum1; Ting Hong1; Anne Cent1; Rhoda Morrow1; Jared Meintjes3; Nelesh Govender5 M. Baeten1; Nagalingeswaran Kumarasamy2; Beatriz Grinsztejn3; Mina 1St George’s Univ of London, London, UK; 2CDC, Atlanta, GA, USA; 3Univ Hosseinipour4; Thomas B. Campbell5; for the ACTG 5175 team of Cape Town, Cape Town, South Africa; 4Cntr for Infectious Disease Epi 1Univ of Washington, Seattle, WA, USA; 2YRG Cntr for AIDS Rsr and and Rsr, Cape Town, South Africa; 5Natl Inst of Communicable Diseases, Educ, Chennai, India; 3Inst de Pesquisa Clínica Evandro Chagas (IPEC)/ Johannesburg, South Africa Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil; 4Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 5Univ of Colorado, Denver, 760 Maximizing Detection and Improving Outcomes of CO, USA Cryptococcosis in Rural Tanzania Diana Faini1; Aneth V. Kalinjuma2; Julie Neborak3; Alexa King3; Dorcas 729 CMV Status Is Associated With CD4/CD8 Restoration in Mnzava2; Tracy Glass4; Hansjakob Furrer5; Christoph Hatz4; David R. Primary HIV-Infected Patients Boulware3; Emilio Letang4 Patrick Miailhes1; Christophe Malcus1; Pierre Pradat2; Isabelle 1Ifakara Hlth Inst, Dar es Salaam, Tanzania; 2Ifakara Hlth Inst, Morogoro, Delfour2; Julien Saison2; Jean-Claude Tardy2; Isabelle Cohen-Codar4; Tanzania; 3Univ of Minnesota, Minneapolis, MN, USA; 4Swiss Trop Inst Christian Chidiac2; Guillaume Monneret1; Tristan Ferry2 of PH, Basel, Switzerland; 5Bern Univ Hosp and Univ of Bern, Bern, 1CHU Lyon, Lyon, France; 2CHU de Lyon, Lyon, France; 3Hopital de la Croix Switzerland Rousse, Lyon, France; 4AbbVie, Inc, Rungis, France 761 Neurocognitive Function in HIV-Infected Persons With 730 CD4+ T Cell Dysfunction During Early HIV Infection Cryptococcal Antigenemia Might Trigger CMV Shedding Martha P. Montgomery1; Noeline Nakasujja2; Bozena M. Morawski1; Jennifer M. Dan1; Marta Massanella2; Davey M. Smith1; Milenka Radha Rajasingham1; Elizabeth Nalintya3; Renee Donahue Carlson4; Vargas1; Rachel Schrier1; Susan J. Little1; Sara Gianella1 Jonathan E. Kaplan5; Andrew Kambugu3; David B. Meya3; David R. 1Univ of California San Diego, San Diego, CA, USA; 2CRCHUM, Montreal, Boulware1; for the COAT and ORCAS Trial Teams QC, Canada 1Univ of Minnesota, Minneapolis, MN, USA; 2Makerere Univ Coll of Hlth Scis, Kampala, Uganda; 3Infectious Diseases Inst, Kampala, Uganda; 731 High Anti-CMV IgG Levels Predict HIV Disease 4 5 Progression Emory Univ Sch of Med, Atlanta, GA, USA; CDC, Atlanta, GA, USA Eshan U. Patel1; Sara Gianella2; Kevin Newell3; Aaron A. Tobian4; 762 Immunologic Discrimination of Cryptococcal IRIS From Allison R. Kirkpatrick5; Mary K. Grabowski6; David Serwadda7; Thomas Culture-Positive Relapse C. Quinn4; Andrew D. Redd8; Steven J. Reynolds1 David R. Boulware1; Joshua R. Rhein1; Edward N. Janoff2; Abdu 1NIH, Bethesda, MD, USA; 2Univ of California San Diego, San Diego, CA, Musubire3; Andrew Kambugu3; Paul Bohjanen1; David B. Meya3; for 3
Poster Listings Poster USA; Rsr Data and Communication Technologies, Inc, Garrett Park, MD, the COAT Trial Team USA; 4Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; 5NIAID, NIH, 1Univ of Minnesota, Minneapolis, MN, USA; 2Univ of Colorado, Denver, CO, Baltimore, MD, USA; 6Johns Hopkins Univ, Baltimore, MD, USA; 7Makerere USA; 3Infectious Diseases Inst, Kampala, Uganda Univ Schoool of PH, Kampala, Uganda; 8NIAID, NIH, Bethesda, MD, USA 763 Acute Kidney Injury and Urine Biomarkers in HIV- 732 CX3CR1+ CD8 T Cells Are Promoted by CMV Coinfection Associated Cryptococcal Meningitis in Treated HIV Infection Charlotte Schutz1; David R. Boulware2; Katherine Huppler Hullsiek2; Michael L. Freeman1; Joseph C. Mudd2; Souheil-Antoine Younes1; Joshua R. Rhein2; Kabanda Taseera3; Conrad Muzoora3; David B. Soumya Panigrahi1; Michael M. Lederman1 Meya4; Friedrich Thienemann1; Maximilian von Hohenberg2; Graeme 1Case Western Reserve Univ, Cleveland, OH, USA; 2NIAID, NIH, Bethesda, Meintjes1; for the COAT Trial Team MD, USA 1Univ of Cape Town, Cape Town, South Africa; 2Univ of Minnesota, Minneapolis, MN, USA; 3Mbarara Univ of Sci and Tech, Mbarara, Uganda; 4Infectious Diseases Inst, Kampala, Uganda
118 CROI 2016 Poster Listings 119 ; 3 ; 4 ; 3 Hall D ; Josiane 2 ; Erik van van ; Erik ; Elaine J. J. ; Elaine CROI 2016 3 4 ; Kara ; Kara 3 ; Rachel Cohen 3 Univ of Cape Cape of Univ Univ Diderot Paris Paris Diderot Univ ; Catherine ; Catherine 3 5 3 ; Jennifer S. Read ; Jennifer ; Tamsin Phillips ; Tamsin 3 3 INSERM, UMR 1153, 1153, UMR INSERM,
2 6 Brigham and Women’s Women’s and Brigham Hosp Trousseau, Trousseau, Hosp 2 4 ; Qilu Yu Program Agenda and 2 ; Allison Zerbe ; Allison ; Jacqueline Clavel ; Jacqueline 3 6 Botswana Harvard AIDS Inst Inst AIDS Harvard Botswana ; Sikhulile Moyo 3 6 ; Gbolahan Ajibola Hosp Louis Mourier, Colombes, Colombes, Mourier, Louis Hosp 2 6 ; Roland Tubiana Univ of Sao Paulo, Sao Paulo, Brazil; Brazil; Sao Paulo, Sao of Univ Paulo, Bennett Statistical Consulting, Inc., Inc., Consulting, Bennett Statistical 2 2 4 ; Kirsty Brittain 2 Univ of California San Francisco, San San Francisco, California of Univ ; for the ANRS CO1/CO11-EPF French French the ANRS CO1/CO11-EPF ; for 4 ; Laura Freimanis ; Laura 7 ICAP at Columbia Univ, New York, NY, NY, York, New Univ, ICAP at Columbia 2 4 ; Roger L. Shapiro 3
; Michael Hughes Goodtables Consulting, Oklahoma, OK, USA; Goodtables Consulting, 3 5 5 ; Marissa Mussi-Pinhata ; Laurent Mandelbrot ; Laurent 1 5 ; Jennifer Jao ; Jennifer Eunice Kennedy Shriver NICHD, Bethesda, MD, USA Bethesda, MD, NICHD, Shriver Kennedy Eunice 1 5 ; Shahin Lockman ; for the NISDI, LILAC and CIRAI and study teams the NISDI, LILAC ; for 1 5 Sorbonne Univs, Paris, France; France; Paris, Univs, Sorbonne ; Fan Li; Kyle J. Nakamura; David Lee; Nicole H. Tobin; Tobin; H. Nicole Lee; David Nakamura; J. Li; Kyle ; Fan 3 ; Stéphanie Goujon ; Stéphanie ; Fabiana Amaral ; Fabiana 1 ; Olawaseun A. Olatunbosun ; Olawaseun 2 3 ; Stéphane Blanche ; Stéphane 1 ; Joseph Makhema 3 ; Jean Leidner ; Landon Myer ; Landon Hosp Necker Enfants Malades, Paris, France Paris, Malades, Enfants Necker Hosp 4 ; Albert Faye 5 7 4 ICAP, Columbia Univ Mailman Sch of PH, New York, NY, USA NY, York, New Sch PH, of Mailman Univ Columbia ICAP, 5 CESP, INSERM U1018, Le Kremlin-Bicêtre, France; France; Kremlin-Bicêtre, Le U1018, INSERM CESP, Massachusetts General Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, General Massachusetts USA MA, Boston, Sch PH, of Harvard Westat, Inc., Rockville, MD, USA; USA; MD, Rockville, Inc., Westat, Univ of Colorado, Denver, CO, USA; USA; CO, Denver, Colorado, of Univ Sch of PH & Family Med, Univ of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of Univ Med, Family Sch & PH of USA; NY, York, at Sinai, New Sch Med Mount of Icahn Widenfelt Assistance Publique-Hôpitaux de Paris, Paris, France; France; Paris, Paris, de Publique-Hôpitaux Assistance Villejuif, France; France; Villejuif, 7, Sorbonne Paris-Cité, Paris, France; France; Paris, Paris-Cité, Sorbonne 7, Ballston Lake, NY, USA; USA; NY, Lake, Ballston Francisco, CA, USA; Francisco, Bennett Agnes Ronan Agnes Perinatal Cohort Study Group Cohort Group Study Perinatal Warszawski Volia Almeida Volia 1 6 Didanosine RiskCancerinof Childrento in Exposed Utero Hleyhel Mira 1 3 in Prophylaxis NVP Similarvs ZDV ProtectionHIV From Botswana in Infants Formula-Fed KathleenPowis Severe Respiratory Infections HIV-Exposed in Severe UninfectedSerologicInfants: Analysis Weinberg Adriana 1 1 2 Infant CD4+ T Cells Have a Distincta Immunophenotype Have Cells T CD4+ Infant SingleAnalysis Cell by Lincez Pamela Linearand Utero In Exposure Tenofovir Durationof Life of Year First the in Growth StanziRoux le M. Grace M. Aldrovandi M. Aldrovandi Grace CA, USA Angeles, Los Angeles, Los of Hosp Children’s France; France; Hosp, Harvard Med Sch, Boston, MA, USA; USA; MA, Sch, Med Boston, Harvard Hosp, Partnership, Gaborone, Botswana; Botswana; Gaborone, Partnership, Town, Cape Town, South Africa; South Africa; Town, Cape Town, USA; USA; Abrams Dollfus George K. SiberryGeorge
811 810 809 807 Abstracts Poster SessionP-S9 PM-4:002:45 PM Children, Infants, OutcomesARV-Exposed and HIV of Youth and 808 ; 2 ; Hall D Hall D 1 ; Henry 3 ; Stephen ; Stephen 5 ; for the Toronto Toronto the ; for 3 ; David W. ; W. David Los Alamos Natl Alamos Los 1 2 ; Irene Ayakaka ; Irene 2 ; Dean Everett 1 ; for the Opportunistic; for 3 CEEISCAT, Badalona, Spain; Badalona, CEEISCAT, 2 ; Katherine Luzuriaga ; Katherine Univ of Liverpool, Liverpool, Liverpool, Liverpool, of Univ 1 2 Queen Elizabeth Central Hosp, Hosp, Central Queen Elizabeth 5 Univ Hlth Network, Toronto, ON, Toronto, Network, Hlth Univ ; Allison McGeer; Allison ; Mulinda Nyirenda ; Mulinda 2 Mulago Hosp, Kampala, Uganda; Uganda; Kampala, Hosp, Mulago 2 4 2 ; Alfred Andama ; Alfred ; Hannah Jary 2 2 ; Malcolm Richardson ; Malcolm 3
; Keri Sanborn ; Keri 1 ; Hansjakob Furrer ; Hansjakob 2 ; Antonia Ho ; Antonia 1 Malawi Liverpool Wellcome Trust Clinical Rsr Proga, Proga, Rsr Clinical Trust Wellcome Liverpool Malawi 6 ; Lauren Tantalo; Sharon Sahi; Shelia Dunaway Sahi;Dunaway Shelia Sharon Tantalo; ; Lauren ; Sharon L. Walmsley L. ; Sharon
1 2 ; Robert S. Heyderman ; William Worodria ; William 3 1 ; Laurence Huang ; Laurence 3 ; Anna Esteve ; Anna 1
Univ Coll London, London, UK; UK; London, London, Coll Univ Mount Sinai Hosp, Toronto, ON, Canada ON, Toronto, Sinai Hosp, Mount 1 4 3
6 Malawi Liverpool Wellcome Trust Clinical Rsr Prog, Blantyre, Blantyre, Prog, Rsr Clinical Trust Wellcome Liverpool Malawi 3 Univ of Massachusetts Med Sch, Worcester, MA, USA; USA; MA, Sch, Med Worcester, Massachusetts of Univ Liverpool Sch of Trop Med, Liverpool, UK; UK; Liverpool, Med, Sch Trop of Liverpool Univ of Toronto, Toronto, ON, Canada; Canada; ON, Toronto, Toronto, of Univ Hosp Clinic of Barcelona, Barcelona, Spain; Barcelona, Barcelona, of Clinic Hosp Bern, of Bern, Switzerland Univ and Hosp Bern Univ Univ of California San Francisco, San Francisco, CA, USA San Francisco, San Francisco, California of Univ Univ of Manchester, Manchester, UK; UK; Manchester, Manchester, of Univ Lucian Davis Lucian Thomas Leitner Thomas Lab, Los Alamos, NM, USA NM, Alamos, Los Lab, Mwandumba Canada; Canada; Blantyre, Malawi; Malawi; Blantyre, Infection Team of the Collaboration of ObservationalHIV Collaboration of the Team Infection in EuroCoord (COHERE) in Europe Research Epidemiological Recombination Elevates HIV-1 Evolution Following Following Evolution HIV-1 Elevates Recombination Mother-to-ChildTransmission SomasundaranMohan 1 Pneumonia in HIV-Infected Malawian Adults Malawian HIV-Infected in Pneumonia Aston J. Stephen 1 1 Outcomeand Community-Acquired of Aetiology Univ of Washington, Seattle, WA, USA WA, Seattle, Washington, of Univ Pneumococcal Disease HIV-Infected Among Invasive Canada Toronto, in Individuals Andany Nisha The Cerebrospinal Fluid TPPA for Neurosyphilis Neurosyphilis for TPPA Fluid Cerebrospinal The Diagnosis ChristinaMarra 1 3 Safety of Stopping Primary T. gondii Prophylaxis With With Prophylaxis gondii SafetyPrimaryStopping of T. CD4>100 and Viremia Suppressed Miro Jose Iain D. Page D. Iain 1 3 Pulmonary Aspergillosis May Be Common in AIDS With With PulmonaryAIDS in Common Be Aspergillosis May Tuberculosis Smear Negative Malawi; Malawi; Blantyre, Malawi Blantyre, UK; UK; Denning Gordon Invasive Bacterial Diseases Network Invasive WITHDRAWN
806 Session P-S8 Poster Abstracts Poster SessionP-S8 PM-4:002:45 PM MTCT of Mechanisms Immune and Viral 769 768 767 766 765 2:45 PM-4:002:45 PM OtherInfectious DiseaseHIV of Complications 764 Session P-R10 Poster Abstracts Poster SessionP-R10 Program and Agenda
812 Elevated Mitochondrial DNA Content in HIV-Exposed 844 Family Clinic Day RCT in Uganda: Child Antiretroviral Uninfected Children With Autism Therapy Retention and Adherence Matthew Budd1; Lindy Samson2; Jennifer Bowes2; Kristina Calli1; Justin C. Graves1; Christine J. Schellack2; Margaret L. Prust1; Esther Suzanne Lewis1; Hélène Côté1; Jason Brophy2; for the CIHR Team in Mirembe2; Marta R. Prescott1; Betty Mirembe2; Ivan Lukabwe3; Barbara Cellular Aging and HIV Comorbidities in Women and Children (CARMA) Asire3; Peter Elyanu3; Sarah Moberley4 1Univ of British Columbia, Vancouver, BC, Canada; 2Children’s Hosp of 1Clinton Hlth Access Initiative, Boston, MA, USA; 2Clinton Hlth Access Eastern Ontario, Ottawa, ON, Canada Initiative, Kampala, Uganda; 3Uganda Ministry of Hlth, Kampala, 4 813 ARV Risk for Speech and Language Impairments in Uganda; Clinton Hlth Access Initiative, Melbourne, Australia HEU Children at 3 and 5 Years 845 12-Month Treatment Outcomes Amongst HIV-Positive Mabel L. Rice1; Jonathan S. Russell2; Toni Frederick3; Murli Purswani4; Orphans and Nonorphans Paige L. Williams5; George K. Siberry6; Sean M. Redmond7; Howard Cheryl J. Hendrickson1; Alana Brennan2; Denise Evans1; Ian M. J. Hoffman8; Tzy-Jyun Yao2; for the Pediatric HIV/AIDS Cohort Study Sanne3; Sharon Patz4; Sanlie Untiedt5; Jean Bassett5; Matthew P. Fox2 (PHACS) 1Hlth Economics and Epi Rsr Office, Johannesburg, South Africa; 1Univ of Kansas, Lawrence, KS, USA; 2Harvard Univ, Boston, MA, USA; 2Boston Univ, Boston, MA, USA; 3Univ of the Witwatersrand, Wits Hlth 3Univ of Southern California, Los Angeles, CA, USA; 4Albert Einstein Coll Consortium, Johannesburg, South Africa; 4Alexandra Clinic, Alexandra, of Med, Bronx, NY, USA; 5Harvard Sch of PH, Boston, MA, USA; 6Eunice South Africa; 5Witkoppen Hlth And Welfare Cntr, Johannesburg, South Kennedy Shriver NICHD, Bethesda, MD, USA; 7Univ of Utah, Salt Lake City, Africa 8 UT, USA; Natl Inst on Deafness and Other Communication Disorders, 846 An Audit of Weight-Based Antiretroviral Therapy Bethesda, MD, USA Dosing in Children 814 Longitudinal Evaluation of Language Impairment in Subathira Dakshina1; Lavanya Raman2; Rashida A. Ferrand3; Perinatally HIV Exposed Adolescents Palwasha Y. Khan4; Katharina Kranzer3; Hilda Mujuru5 Sean M. Redmond1; Tzy-Jyun Yao2; Jonathan S. Russell2; Mabel L. 1Barts Hlth NHS Trust, London, UK; 2Southend Univ Hosp, Westcliff on Rice3; Howard J. Hoffman4; George K. Siberry5; Paige L. Williams6; for Sea, UK; 3London Sch of Hygiene & Trop Med, London, UK; 4London Sch of the Pediatric HIV/AIDS Cohort Study (PHACS) team. Hygiene & Trop Med, Cardiff, UK; 5Univ of Zimbabwe, Harare, Zimbabwe 1Univ of Utah, Salt Lake City, UT, USA; 2Harvard Univ, Boston, MA, USA; 3Univ of Kansas, Lawrence, KS, USA; 4Natl Inst on Deafness and Other Session P-T7 Poster Abstracts Hall D Communication Disorders, Bethesda, MD, USA; 5Eunice Kennedy Shriver 6 2:45 PM-4:00 PM NICHD, Bethesda, MD, USA; Harvard Sch of PH, Boston, MA, USA HIV Drug Resistance in Children Session P-T6 Poster Abstracts Hall D 847 Persistence of HIV Drug Resistance in Children Exposed 2:45 PM-4:00 PM to Nevirapine Prophylaxis Achieving 90-90-90 in Children Ruth M. Kanthula1; Ingrid Beck2; Gisela Van Dyk3; Rachel Silverman1; Scott Olson1; Christen Salyer2; Sharon Cassol3; Theresa Rossouw3; Lisa 841 Hybrid HIV Testing Strategy Achieves High Coverage of Frenkel2 Rural East African Children 1Univ of Washington, Seattle, WA, USA; 2Seattle Children’s Rsr Inst, James Ayieko1; Gabriel Chamie2; Craig R. Cohen2; Tamara Clark2; Seattle, WA, USA; 3Univ of Pretoria, Pretoria, South Africa Poster Listings Poster 2 3 4 2 Edwin Charlebois ; Maya Petersen ; Moses R. Kamya ; Diane V. Havlir ; 848 Independent lineages of HIV-1 Multidrug Resistance Theodore D. Ruel2 1Kenya Med Rsr Inst, Kisumu, Kenya; 2Univ of California San Francisco, in Children Failing Early ART 1 2 3 4 San Francisco, CA, USA; 3Univ of California Berkeley, Berkeley, CA, USA; Camille M. Lange ; Stephane Hue ; Avy Violari ; Mark F. Cotton ; 5 6 7 4Makerere Univ Coll of Hlth Scis, Kampala, Uganda Diana Gibb ; Deenan Pillay ; Ravindra K. Gupta 1NIH, Bethesda, MD, USA; 2London Sch of Hygiene & Trop Med, 842 Outcomes of the Test and Treat Policy for HIV-Infected London, UK; 3Univ of the Witwatersrand, Johannesburg, South Africa; Children and Adolescents 4Stellenbosch Univ and Tygerberg Children’s Hosp, Cape Town, South Rita Atugonza; Jacqueline B. Kanywa; Vincent Tukei; Adeodata Africa; 5Med Rsr Council Clinical Trials Unit, London, UK; 6Africa Cntr Kekitiinwa for Hlth and Pop Studies, Mtubatuba, South Africa; 7Univ Coll London, Baylor Coll of Med Children's Fndn Uganda, Kampala, Uganda London, UK 843 48-week Outcomes of African Children Starting ART at 849 Transmitted Drug Resistance and First-Line ART CD4 >500 With Streamlined Care Treatment Outcomes in Ugandan Children Florence Mwangwa1; Diane V. Havlir2; Vivek Jain2; Dathan Cissy Kityo1; Ragna S. Boerma2; Kim Sigaloff2; Elizabeth Kaudha1; Byonanebye3; Dalsone Kwarisiima4; Tamara Clark2; Edwin Charlebois2; Job Calis3; Victor Musiime4; Tamara Sonia Boender2; Henry Mugerwa1; Maya Petersen5; Moses R. Kamya; Theodore D. Ruel2 Tobias Rinke de Wit2; Peter Mugyenyi1 1Infectious Diseases Rsr Collab, Kampala, Uganda; 2Univ of California 1Joint Clinical Rsr Cntr, Kampala, Uganda; 2Amsterdam Inst for Global San Francisco, San Francisco, CA, USA; 3Makerere Univ Coll of Hlth Scis, Hlth and Develop, Amsterdam, Netherlands; 3Academic Med Cntr, Kampala, Uganda; 4Makerere Univ-Univ of California San Francisco Rsr Amsterdam, Netherlands; 4Makerere Univ Coll of Hlth Scis, Kampala, Collab, Kampala, Uganda; 5Univ of California Berkeley, Berkeley, CA, USA Uganda
120 CROI 2016 Poster Listings 121 ; 1 Hall D ; 3 ; Nia ; Oanh 7 4 Kirby Inst, Inst, Kirby ; for the ; for 2 10 ; CROI 2016 3 HIV-NAT, HIV-NAT, ; Rawiwan ; Rawiwan Srinagarind Srinagarind 5 6 9
; Mary Ann 3 ; for the TREAT TREAT the ; for 2 Chiang Rai Rai Chiang 9 7 ; Ankanee 1 ; Watsamon ; Watsamon 2 Emory Sch Univ of ; Bruce Kinley ; Bruce 2 Natl Cntr for HIV/ for Cntr Natl 2 6 Program Agenda and ; Jiratchaya Sophonphan ; Jiratchaya Johns Hopkins Bloomberg Bloomberg Hopkins Johns Cipto Mangunkusumo Mangunkusumo Cipto 1 2 ; Moy Siew Fong ; Moy 10 3 ; Ly Penh Sun Penh ; Ly Natl Hosp of Ped, Hanoi, Hanoi, Ped, of Hosp Natl 5 8 ; Torsak Bunupuradah ; Torsak 6 ; Azar Kariminia ; Truong Huu Khanh Truong ; Worldwide Orphans Fndn, Ho Ho Fndn, Orphans Worldwide 8 2 5 ; Julia C. Rosebush Tavitiya Sudjaritruk Tavitiya 2 ; for the HIV-NAT015 cohort the HIV-NAT015 ; for ; 2 ; Grace A. McComsey ; Grace 9 Children’s Hosp 1, Ho Chi Minh City, City, Minh Chi Ho 1, Hosp Children’s 2 3 ; Kiat Ruxrungtham ; Kiat 1 ; Vibol ; Vibol Ung 2
; MonikaUribe-Leitz 2 Chiang Rai Prachanukroh Hosp, Chiang Rai, Rai, Chiang Hosp, Prachanukroh Rai Chiang Case Western Reserve Univ, Cleveland, OH, USA OH, Cleveland, Univ, Reserve Western Case ; Thomas Macharia; Lino R. Trinidad; Susan Trinidad; Macharia; Lino R. Thomas ; 6 3 ; Torsak Bunupuradah ; Torsak ; Suvaporn Anugulruengkitt ; Suvaporn 1 1 ; Dina Muktiarti 1 ; Torsak Bunupuradah ; Torsak 4 ; Ann Chahroudi ; Ann ; Lam Van Nguyen Van ; Lam 1 Univ of Hlth Scis Cambodia, Phnom Penh, Cambodia; Cambodia; Penh, Phnom Scis Hlth of Cambodia, Univ 7 3 ; Vin Tangpricha ; Vin 3 ; Bunruan Sopa 2 ; Azar Kariminia 1 ; Julie E. Daniels HIV-NAT, Thai Red Cross AIDS Rsr Cntr, Bangkok, Thailand; Thailand; Bangkok, Cntr, Rsr AIDS Cross Red Thai HIV-NAT, YRG Cntr for AIDS Rsr and Educ, Chennai, India; India; Chennai, Educ, and Rsr AIDS for Cntr YRG Australia Sydney, Inst, Kirby ; Thanyawee Puthanakit ; Thanyawee 3 7 2 4 9 ; Pagakrong Lumbiganon ; Pagakrong ; Rawiwan Hansudewechakul ; Rawiwan 8 5 Med Univ of South Carolina, Charleston, SC, USA; USA; SC, Charleston, South Carolina, of Univ Med Rsr Inst for Hlth Scis Chiang Mai Univ, Chiang Mai, Thailand; Thailand; Mai, Chiang Univ, Mai Scis Hlth Chiang for Inst Rsr Malaysia; Kinabalu, Kota Likas, Hosp Jakarta, Indonesia; Hosp, General Mangunkusumo Cipto Univ of New South Wales, Sydney, Australia; Australia; Sydney, South Wales, New of Univ HIV-NAT, Thai Red Cross AIDS Rsr Cntr, Bangkok, Thailand; Thailand; Bangkok, Cntr, Rsr AIDS Cross Red Thai HIV-NAT, Thailand Bangkok, Univ, Chulalongkorn Kurniati Sch of PH, Baltimore, MD, USA MD, Sch Baltimore, PH, of Asia Pediatric HIV Observational Database group HIV Observational group Database Asia Pediatric TREAT Asia Pediatric HIV Observational Database (TApHOD) HIV Observational (TApHOD) Database AsiaPediatric TREAT Thailand; Thailand; Hansudewechakul Med, Atlanta, GA, USA; Atlanta, Med, Chanakul Suneeta Saghayam Ngoc Le AIDS, Dermatology and STDs, Phnom Penh, Cambodia; Cambodia; Penh, Phnom STDs, and Dermatology AIDS, 1 Seroprevalence of Hepatitis B Among HIV-InfectedAmong B Hepatitis of Seroprevalence Asiain ChildrenAdolescents and Linda Aurpibul 1 4 8 Early Weight and Height Changes Asianin Height and Children Weight Early ART With Cotrimoxazole Using Boettiger C. David 1 andSupplementationBMD D on Vitamin Effectsof Youth HIV+ in Markers Bone Eckard R. Allison Patterns of Systemic Hypertension Among Adults With With Hypertension Adults Among Systemic of Patterns HIV Acquired Perinatally Ryscavage A. Patrick Dysfunction Renal in Persistent of Prevalence Adolescents HIV Thai Perinatal Phupitakphol Tanit 1 2 Lovelace; Vicki Tepper; Robert R. Redfield Tepper; Vicki Lovelace; USA MD, Baltimore, Maryland of Univ Sch Med, of Jantarabenjakul Hosp, Khon Kaen Univ, Khon Kaen, Thailand; Thailand; Kaen, Khon Univ, Kaen Khon Hosp, Danielle Labbato General Hosp, Jakarta, Indonesia; Jakarta, Indonesia; Hosp, General Chi Minh City, Vietnam; Vietnam; Minh City, Chi Vietnam; Vietnam; Sydney, Australia; Australia; Sydney, Prachanukroh Hosp, Chiang Rai, Thailand; Thailand; Rai, Chiang Hosp, Prachanukroh O’Riordan Wasana Prasitsuebsai Wasana Thai Red Cross AIDS Rsr Cntr, Bangkok, Thailand; Thailand; Bangkok, Cntr, Rsr AIDS Cross Red Thai Vietnam; Vietnam;
860 Cotreatments of Coinfectionsof Childrenin Cotreatments 858 859 856 857 Abstracts Poster SessionP-T9 PM-4:002:45 PM ; 2 ; for ; for 1 ; for ; for ICAP, ICAP, ; James Hall D 1 4 3 ; Ali ; Ali ; Lisa 1 1 CDC, CDC, ; Kebba ; Kebba 4 3 ; Elaine J. J. ; Elaine Univ of Univ 2 5 ; Hilda ; Violari Avy 1 2 ; Amina ; Amina ; Katharina ; Katharina 4 3 ; Heather J. Zar J. ; Heather Med Rsr Council Council Rsr Med 4 3 The Arctic Univ of Univ Arctic The 2 ; Heather J. Zar J. ; Heather ; Helena Rabie; Helena 1 2 ; Nilesh Bhatt ; Kirsty Brittain CDC, Maputo, Maputo, CDC, ; Mark F. Cotton ; Mark F. 3 2 2 3 Desmond Tutu HIV Cntr, Cntr, HIV Desmond Tutu Stellenbosch Univ, Cape Cape Univ, Stellenbosch Univ of the Witwatersrand, Witwatersrand, the of Univ 2 2 2 ; Ashraf Coovadia ; Ashraf 1 ; Tsitsi Bandason ; Tsitsi 4 ; Renate Strehlau ; Renate ; James Houston 1 2 ; RashidaFerrand A. 2 LandonMyer ; Dulce A. Bila ; Linda-Gail Bekker 2 ; Great Ormond Street Hosp & UCL Inst of Inst UCL & Hosp Street Ormond Great ; Helena Rabie; Helena 1 4 6 1 ; Marc Foca ; Marc 2 ; Jeannie Collins ; Jeannie Columbia Univ, New York, NY, USA; USA; NY, York, New Univ, Columbia 2 ; Linda-Gail Bekker 3
1 London Sch of Hygiene & Trop Med, London, London, Med, & Trop Sch Hygiene of London 3 Stellenbosch Univ, Cape Town, South Africa; South Africa; Town, Cape Univ, Stellenbosch ; John Metcalfe 3 1 ; Charity Alfredo ; for the CHANGES Study Team Team the CHANGES Study ; for
3 3 6
4 Groote Schuur Hosp, Cape Town, South Africa; South Africa; Town, Cape Hosp, Schuur Groote ; Jon O. Odland O. ; Jon ; Paul Roux ; Paul ; Stephen M. Arpadi ; Stephen 1 3 ; Diane Gray 1 1 3 ; James Nuttall ; William C. Buck William ; 1 ; Faeezah Patel ; Faeezah Inst Nacional de Saúde, Maputo, Mozambique; Mozambique; Maputo, Saúde, de Nacional Inst 1 3 3 ; Justin Harvey 1 ; Kirsty Brittain 1 ; Loide Cossa ; Loide 2 ; Louise Kuhn ; Louise ; Grace McHugh ; Grace ; Juan P. Kaski ; Juan P. 4 ; Brian Eley 3 Stellenbosch Univ, Cape Town, South Africa; South Africa; Town, Cape Univ, Stellenbosch 5 ; Paul Roux ; Paul 1 2 ; Yang Chunfu 2 3
3 Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ 4 Stellenbosch Univ and Tygerberg Children’s Hosp, Cape Town, South Town, Cape Hosp, Children’s Tygerberg and Univ Stellenbosch Groote Schuur Hosp, Cape Town, South Africa Town, Cape Hosp, Schuur Groote Univ of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of Univ Biomed Rsr and Training Inst, Harare, Zimbabwe; Zimbabwe; Harare, Inst, Training and Rsr Biomed Desmond Tutu HIV Cntr, Cape Town, South Africa Town, Cape Cntr, HIV Desmond Tutu Univ of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of Univ Columbia Univ Med Cntr, New York, NY, USA; USA; NY, York, New Cntr, Med Univ Columbia Fundação Ariel Glaser, Maputo, Mozambique; Mozambique; Maputo, Glaser, Ariel Fundação Cape Town, South Africa; South Africa; Town, Cape Town, South Africa; South Africa; Town, Sousa Mujuru Nuttall Zimbabwe, Harare, Zimbabwe; Zimbabwe; Harare, Zimbabwe, Africa; Africa; Abrams Atlanta, GA, USA Atlanta, Clinical Trials Unit at Univ Coll London, London, UK London, London, at Coll Unit Univ Trials Clinical Mozambique; Mozambique; Shuang Wang Johannesburg, South Africa; South Africa; Johannesburg, Steve Innes Steve 1 4 ART Outcomes After Lipoatrophy/Lipohypertrophy UK/Ireland Childrenthe in in Switch Infected Adolescents on ART on InfectedAdolescents Liesl Zuhlke 1 Judd Cardiovascular Disease Biomarkers in Perinatally HIV- Perinatally in Disease Biomarkers Cardiovascular Edith D. Majonga D. Edith 1 4 HeartLeft Children inHIV-Infected in Abnormalities Zimbabwe Harare, LandonMyer 1 Timing of Pubertal Onset in Perinatally Infected South TimingPubertalof Onset Perinatally in AfricanART on Adolescents ChildrenART on ShiauStephanie 1 Dysregulated Epigenome in Perinatally HIV-Infected Perinatally in Epigenome Dysregulated Mozambican Children Failing First-Line MozambicanChildrenFailing Vaz M. Paula 1 Drug Resistance Compromises Second-Line in ART Drug Compromises Resistance Norway, Tromsø, Norway; Tromsø, Norway, Frigati Kranzer Cardiovascular Sci, London, UK Sci, London, Cardiovascular UK; UK; Jobarteh the Cape Town Adolescent Antiretroviral Cohort Antiretroviral Adolescent Town the Cape Columbia Univ Mailman Sch of PH, New York, NY, USA NY, York, New Sch PH, of Mailman Univ Columbia the Cape Town Adolescent Antiretroviral Cohort Antiretroviral Adolescent Town the Cape
855 854 853 852 2:45 PM-4:002:45 PM in Therapy Antiretroviral and HIV of Complications Children 851 Session P-T8 Poster Abstracts Poster SessionP-T8 850 Program and Agenda
Session P-U1 Poster Abstracts Hall D Session P-V3 Poster Abstracts Hall D 2:45 PM-4:00 PM 2:45 PM-4:00 PM Contraception and Sexual Health in Women Predictors of PrEP Coverage and Uptake 861 Correlates of Injectable Contraceptive Discontinuation 883LB HPTN 073: PrEP Uptake and Use by Black Men Who Following HIV-1 Seroconversion Have Sex With Men in 3 US Cities Margaret R. Caplan1; Jennie L. McKenney2; Raphael J. Landovitz1; Darrell P. Wheeler1; Sheldon Fields2; LaRon E. Nelson3; Leo Wilton4; Thesla Palanee-Phillips3; Gonasagrie Nair4; Felix Mhlanga5; Jennifer E. Lisa Hightow-Weidman5; Steven Shoptaw6; Manya Magnus7; Geetha Balkus6; Sharon A. Riddler7; Pamina Gorbach8 Beauchamp8; Phaedrea Watkins9; Kenneth H. Mayer10 1David Geffen Sch of Med at Univ of California Los Angeles, Los Angeles, 1State Univ of New York at Albany, Albany, NY, USA; 2Charles R. Drew CA, USA; 2Rollins Sch of PH, Emory Univ, Atlanta, GA, USA; 3Wits Univ of Med and Sci, Los Angeles, CA, USA; 3Univ of Rochester, Rochester, Reproductive Hlth and HIV Inst, Johannesburg, South Africa; 4Univ NY, USA; 4State Univ of New York at Binghamton, Binghamton, NY, USA; of KwaZulu-Natal, Durban, South Africa; 5Univ of Zimbabwe, Univ of 5Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 6David Geffen California San Francisco Collaborative Rsr Prog, Harare, Zimbabwe; School of Medicine at Univ of California Los Angeles, Los Angeles, CA, 6Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 7Univ of Pittsburgh, USA; 7George Washington Univ, Washington, DC, USA; 8Statistical Cntr Pittsburgh, PA, USA; 8Univ of California Los Angeles Sch of PH, Los for HIV/AIDS Rsr & Prevention, Fred Hutchinson Cancer Rsr Cntr, Seattle, Angeles, CA, USA WA, USA; 9FHI 361, Durham, NC, USA; 10The Fenway Inst, Fenway Hlth, 862 Correlation Between Cotherapy of Efavirenz-Based Boston, MA, USA ART and Pregnancy Among Women 884 HPTN 067/ADAPT: Predictors of Coverage of Sex Events Stephen Okoboi; Eunice Ajambo; Irene Bagala; Ronald Oceng; Sophie in PrEP Regimens, Thai MSM-TGW Nantume; Robinah Acham; Bernard Etukoit Timothy H. Holtz1; Anupong Chitwarakorn2; James P. Hughes3; TASO-Uganda, Kampala, Uganda Marcel Curlin4; Anchalee Varangrat5; K. R. Amico6; Teeraparp 5 7 5 8 863 Is Menopause Associated With Unprotected Sex in Watanatanyaporn ; Maoji Li ; Philip A. Mock ; Robert Grant 1CDC, Atlanta, GA, USA; 2Ministry of PH, Muang Nonthaburi, Thailand; High-Risk HIV-Positive Kenyan Women? 3Univ of Washington, Seattle, WA, USA; 4Oregon Hlth and Scis Univ, 1 1 1 2 Marielle S. Goyette ; Kate S. Wilson ; Ruth Deya ; Linnet Masese ; Portland, OR, USA; 5Thailand Ministry of PH US CDC Collab, Nonthaburi, 3 1 4 3 Juma Shafi ; Barbra A. Richardson ; Kishor Mandaliya ; Walter Jaoko ; Thailand; 6Univ of Michigan Sch of PH, Ann Arbor, MI, USA; 7Fred 1 Scott McClelland Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 8Univ of California San 1 2 Univ of Washington, Seattle, WA, USA; Kenya Rsr Prog at the Univ of Francisco, San Francisco, CA, USA Washington, Nairobi, Kenya; 3Univ of Nairobi, Nairobi, Kenya; 4Coast Province General Hosp, Mombasa, Kenya 885 HPTN 067-ADAPT: Factors Associated With PrEP Coverage Among New York City MSM and TGW 864 Fertility Desire, Unprotected Sex, and Viral Load in Sharon Mannheimer1; Yael Hirsch-Moverman2; Julie Franks2; Avelino HIV-Positive FSWs in Kenya Loquere2; James P. Hughes3; Maoji Li4; Vanessa Elharrar5; Michael J. 1 2 2 3 Kate S. Wilson ; Linnet Masese ; Lucy Adala ; Juma Shafi ; Barbra Stirratt6; Robert Grant7; for the HPTN 067/ADAPT Harlem Study Team 1 1 4 3 A. Richardson ; Jane Simoni ; Kishor Mandaliya ; Walter Jaoko ; Scott 1Harlem Hosp, New York, NY, USA; 2Columbia Univ Mailman Sch of 1 McClelland PH, New York, NY, USA; 3Univ of Washington, Seattle, WA, USA; 4Fred 1 2 Poster Listings Poster Univ of Washington, Seattle, WA, USA; Kenya Rsr Prog at the Univ of Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 5DAIDS, NIAID, NIH, 3 4 Washington, Nairobi, Kenya; Univ of Nairobi, Nairobi, Kenya; Coast Bethesda, MD, USA; 6NIMH, NIH, Bethesda, MD, USA; 7Univ of California Province General Hosp, Mombasa, Kenya San Francisco, San Francisco, CA, USA 865 Inaccurate Reporting of Condom Use Among Women 886 On Demand PrEP With Oral TDF-FTC in the Open-Label Using Injectable Contraception Phase of the ANRS IPERGAY Trial 1 2 2 3 Renee Heffron ; Urvi M. Parikh ; Kerri J. Penrose ; Nelly R. Mugo ; Jean-Michel Molina1; Isabelle Charreau2; Bruno Spire3; Laurent 4 1 2 Deborah Donnell ; Connie M. Celum ; John W. Mellors ; Jared M. Cotte4; Gilles Pialoux5; Catherine Capitant2; Cécile Tremblay6; Daniela 1 Baeten Rojas Castro7; Laurence Meyer8; for the ANRS IPERGAY Study Group 1 2 Univ of Washington, Seattle, WA, USA; Univ of Pittsburgh, Pittsburgh, 1Hopital Saint-Louis, Paris, France; 2INSERM SC10-US19, Villejuif, France; 3 4 PA, USA; Kenya Med Rsr Inst, Thika, Kenya; SCHARP, Fred Hutchinson 3INSERM UMR 912, Marseille, France; 4Hospices Civils de Lyon, Lyon, Cancer Rsr Cntr, Seattle, WA, USA France; 5Tenon Hosp, Paris, France; 6CRCHUM, Montreal, QC, Canada; 7AIDES, Mission Recherche Innovation Évaluation, Pantin, France; 8INSERM, CESP U1018, Le Kremlin-Bicêtre, France
122 CROI 2016 Poster Listings 123
2
; 3 2 ; Irene ; Irene New 2 4 Hall D ; 2
Kaiser Kaiser CROI 2016 ; Robert ; Cyprian ; Cyprian 2 2 1
Uniformed Uniformed 1 2
; Hanne Thiede ; Jonathan E. Volk E. ; Jonathan 1 1 1 ; James Peterson 5 ; DongPhuong Infectious DiseaseInfectious 2 State Univ of New York York New of Univ State 3 3 Program Agenda and ; Brian Mustanski 2 ; Madhu Balachandran ; Lina Nerlander 2 1 ; Brian Agan PH, Seattle & King County, SeattlePH, County, & King Louisiana PH Inst, New Orleans, Orleans, New Inst, PH Louisiana 2 2 4 ; Teresa Finlayson ; Teresa San Antonio Military Med Cntr, San MilitarySan Antonio Cntr, Med 4 ; Anuradha Ganesan ; Anuradha 4 1 ; Sheldon Fields 4 ; C. Bradley Hare ; C. Bradley 1 ; Michael J. Silverberg ; Michael J. ; Christine Khosropour ; Christine
2 2 Northwestern Univ, Feinberg Sch of Med, Sch Med, of Feinberg Univ, Northwestern ; Michael Newcomb 2 1 ; Tahaniyat Lalani ; Tahaniyat ; Morgan Byrne ; Morgan 4 1 ; Watson Christopher ; Gabriela Paz-Bailey 1 1 ; William L. Jeffries; Kristen Hess; Alexandra Balaji; Alexandra Hess; L. Jeffries; Kristen William ; PH, Seattle & King County (retired), Seattle, WA, USA WA, Seattle, (retired), Seattle County PH, & King 3 Philadelphia Dept of PH, Philadelphia, PA, USA; USA; PA, Philadelphia, Dept PH, of Philadelphia ; Leo B. Hurley B. ; Leo ; Russell Brewer 3 1 3
; Sarah L. Braunstein 2 3 ; Richard Burt; Richard 1 ; Sulaiman Aizezi ; Sulaiman Aizezi Charles R. Drew Univ of Med and Sci, Los Angeles, CA, USA Angeles, Sci, and Med of Univ Los Drew R. Charles ; Justin Smith 5 ; Tony Phengrasamy ; Tony 1 2 ; Jason Okulicz 3 ; Wilton Leo 2 Univ of Washington, Seattle, WA, USA; USA; WA, Seattle, Washington, of Univ Infectious Disease Clinical Rsr Prog, Rockville, MD, USA; USA; MD, Rockville, Prog, Rsr DiseaseInfectious Clinical CDC, Atlanta, GA, USA; Atlanta, CDC, George Washington Univ Milken Inst Sch of PH, Washington, DC, USA; USA; DC, Washington, Sch PH, Inst of Milken Univ Washington George USA; DC, Washington, Univ, Washington George CA, USA; Oakland, Northern California, Permanente Kaiser Wejnert Kuo Kathleen Brady Kathleen York City DHMH, Queens, NY, USA NY, City Queens, DHMH, York LA, USA; Nguyen Antonio, TX, USA Antonio, Seattle, WA, USA; USA; WA, Seattle, 1 STIs and Predictive Sexual Risk Behaviors Among HIV+Among RiskPredictiveSexual Behaviors and STIs MilitaryCohort Members Macalino E. Grace 1 Patterns Behavior Seroadaptive HIV Intentional 2008-2014 MSM, Seattle Among SaraGlick N. Shelby County Hlth Dept, Memphis, TN, USA TN, Memphis, Dept, Hlth County Shelby Group NHBS Study the for GabrielaPaz-Bailey; GA, USA Atlanta, CDC, Subsequent HIV Disease Risk Following Syphilis Syphilis SubsequentDiseaseHIV Risk Following DiagnosisSoutherna in Population MSM Sweat David Olderand Young Between Differences Behavioral Men With Sex Have Who Men Black Finlayson Teresa and Environment Family Between Association Balaji Alexandra 1 1 2 and Adherence Prophylaxis: Preexposure HIV Clinicalin Discontinuation Practice MarcusL. Julia 1 Correlates of Uptake of HIV Prevention Interventions Prevention HIV of Uptake of Correlates 2013-2014 DC, in MSM Black Among Levy E. Matthew Chicago, IL, USA; IL, USA; Chicago, Services Univ of the Hlth Scis, Bethesda, MD, USA; USA; Bethesda, MD, Scis, Hlth the of Services Univ Deiss at Binghamton, Binghamton, NY, USA; USA; NY, Binghamton, at Binghamton, Permanente Northern California, San Francisco, CA, USA San Francisco, Northern California, Permanente Clinical Rsr Prog, San Diego, CA, USA; San Diego, Prog, Rsr Clinical Manya Magnus Manya HIV-Related Risk Behavior Among Young MSM Young Among Risk Behavior HIV-Related
932 933 2:45 PM-4:002:45 PM Risk HIV of at Individuals 929 930 931 894 Abstracts Poster SessionP-W5 893 ; 3 ; ; 3 ; 4 2 ; 1 Hall D ; 3 INSERM INSERM 4 New York York New 4
; Demetre C. ; Demetre 4 3 ICF Intl, Atlanta, Atlanta, Intl, ICF ; Shayne Zaslow ; Shayne 3 ; Cécile ; Cécile 2 ; Emeka Oraka ; William ; William 5 1 1 ; Dawn Fukuda ; Dawn 4 ; Julie Myers 1 Beth Israel Beth Israel Brown Univ, Univ, Brown 2 2 ; for the ANRS IPERGAY the ANRS IPERGAY ; for ; Daniela Rojas Castro ; Daniela ; Julie Myers 8 1 2 New York City DHMH, Long Long City DHMH, York New 2 ; Zoe R. Edelstein ; Zoe New York City DHMH, Long City Long DHMH, York New 2 2 ; Katherine Goodenberger ; Katherine
Fenway Hlth, Boston, MA, USA; USA; MA, Boston, Hlth, Fenway CISIH, Nantes, France; France; Nantes, CISIH, 2 1 3 3 AIDES, Mission Recherche Recherche Mission AIDES, 2
3 ; Arjee Restar ; Arjee 2 ; Kristina Bowles; Kristina ; Betsey H. John 2 ; Enola K.; Enola Proctor ; Christian Chidiac ; Christian 2 1 4 4 ; Kevin M. Maloney M. ; Kevin INSERM UMR 912, Marseille, France; France; Marseille, 912, UMR INSERM 1 7 o Prescribe PrEP by Primary by PrEP Prescribe o ; Benjamin Tsoi Hosp de la Croix-Rousse, Lyon, France; France; Lyon, Croix-Rousse, la de Hosp 2
5 ; Amy Nunn ; Amy 2 Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, ; Marie Suzan-Monti ; Jean-Michel Molina 2 1 ; Paul M. Salcuni ; Paul 7 1 ; Chris Grasso ; Chris ; Ken Levine ; Ken 2 The Fenway Inst, Fenway Hlth, Boston, MA, USA; USA; MA, Boston, Hlth, Fenway Inst, Fenway The New York City DHMH, Long Island City, NY, USA NY, City, Island City Long DHMH, York New New York City DHMH, Queens, NY, USA; USA; NY, Queens, City DHMH, York New 1 3 3 3 ; Travis Sanchez ; Travis ; Patrick Sullivan ; Patrick ; Paul M. Salcuni ; Paul ; Leandro Mena ; Leandro 1 1 1 3 ; Stephen H. Boswell ; Stephen 4 ; Demetre C. Daskalakis ; Demetre ; Catherine Capitant ; Catherine 2 3 ; Philip Chan 1 ; Nana P. Mensah ; Nana P. 3
; Bruno Spire 1 6 New York City DHMH, Queens, NY, USA; USA; NY, City Queens, DHMH, York New Washington Univ in St. Louis, St. Louis, MO, USA; USA; MO, Louis, St. Louis, St. in Univ Washington USA MS, Jackson, Mississippi, of Univ The Fenway Inst, Fenway Hlth, Boston, MA, USA; USA; MA, Boston, Hlth, Fenway Inst, Fenway The USA MA, Boston, Dept PH, of Massachusetts CDC, Atlanta, GA, USA; Atlanta, CDC, New York City DHMH, Brooklyn, NY, USA; USA; NY, Brooklyn, City DHMH, York New Hopital Saint-Louis, Paris, France Paris, Saint-Louis, Hopital UMR912 SESSTIM, Marseille, France; France; Marseille, SESSTIM, UMR912 Canada; QC, Montreal, CRCHUM, City DHMH, Long Island City, NY, USA NY, City, Island City Long DHMH, Benjamin Tsoi Providence, RI, USA; USA; RI, Providence, SC10-US19, Villejuif, France; France; Villejuif, SC10-US19, Island City, NY, USA; USA; NY, City, Island Island City, NY, USA; USA; NY, City, Island Innovation Évaluation, Pantin, France; France; Pantin, Évaluation, Innovation Deaconess Med Cntr, Boston, MA, USA; USA; MA, Boston, Cntr, Med Deaconess Elizabeth DiNenno Elizabeth Daskalakis Kenneth H. Mayer Kenneth Powderly GA, USA Detailing Campaign,Detailing 2014-2015 Edelstein R. Zoe 1 1 4 ain Prescribing PrEP Incident and EarlyAdopters Missed Opportunitiest Saintin Physicians Care Louis Patel Rupa 4 Increasing HIV Suppression, PrEP Use, and STDs inSTDs and Suppression,HIV Increasing Use, PrEP Primary Accessing MSM Boston Care H. Mayer Kenneth Among Internet Samples Internet Among MSM US of Delaney P. Kevin 1 1 Increasing Be to Appear PrEP of Use and Awareness Increasing PrEP Use Among Men Who Have Sex With With Sex Have Who Men Among Use PrEP Increasing 2013-2015 City, York New Men, KathleenK. Scanlin 1 6 8 IPERGAY Trial IPERGAY Luis SagaonTeyssier PrEP and Condom Use in High Risk MSM in the ANRSthe Risk in High MSM in Use Condom and PrEP Tremblay 1 Nolween Hall Nolween Kevin Cranston Kevin DouglasKrakower S. Study Group Group Study
892 891 890 Session P-V4 Poster Abstracts Poster SessionP-V4 PM-4:002:45 PM Primaryin PrEP Opportunitiesand Pitfalls Care: 889 888 887 Program and Agenda
934 Determinants of HIV Transmission Risk Among 1007 Incident Syphilis, Gonorrhea, and Chlamydia Infection HIV-Infected Persons Engaged in Care Among a Cohort of MSM Charitha Gowda1; Dagan Coppock1; Cristina E. Brickman2; Pamela A. Nathan J. Lachowsky1; Kristine Stephenson2; Zishan Cui3; Susan Shaw1; Robert Gross3 Shurgold3; Ashleigh Rich3; Troy Grennan4; Jason Wong4; Eric A. Roth5; 1Univ of Pennsylvania, Philadelphia, PA, USA; 2Univ of California San Robert S. Hogg6; David M. Moore7; for the Momentum Health Study Francisco, San Francisco, CA, USA; 3Univ of Pennsylvania Perelman Sch of 1Univ of British Columbia, Vancouver, BC, Canada; 2Vancouver Coastal Med, Philadelphia, PA, USA Hlth, Vancouver, BC, Canada; 3BC Cntr for Excellence in HIV/AIDS, 4 935 Food Insecurity Is Associated With HIV Serostatus and Vancouver, BC, Canada; BC Cntr for Disease Control, Vancouver, BC, Canada; 5Univ of Victoria, Victoria, BC, Canada; 6Simon Fraser Univ, Sexually Transmitted Infections Burnaby, BC, Canada; 7Univ of British Columbia, Vancouver, BC, Canada Kartika Palar1; Barbara Laraia2; Alexander C. Tsai3; Mallory Johnson1; Sheri Weiser1 1008 The Importance of Linkage and Engagement of Care in 1Univ of California San Francisco, San Francisco, CA, USA; 2Univ of Post HIV STI Acquisition California Berkeley, Berkeley, CA, USA; 3Massachusetts General Hosp, Kerri Dorsey1; Amanda Castel1; Adam Allston2 Boston, MA, USA 1George Washington Univ Milken Inst Sch of PH, Washington, DC, USA; 2 936 Impact of Male Partners and Schooling on HIV Risk District of Columbia Dept of Hlth, HIV/AIDS, Hepatitis, STD, and TB Administration, Washington, DC, USA Among South African Girls: HPTN 068 Audrey Pettifor1; Jing Wang2; Amanda Selin1; James P. Hughes3; 1009 Evidence of HIV Care Following STD Clinic Visits by Out- Catherine MacPhail4; Xavier Gomez-Olive5; Ryan Wagner5; Estelle of-Care HIV-Positive persons Piwowar-Manning6; Kathleen Kahn5 Olga Tymejczyk1; Kelly Jamison2; Preeti Pathela2; Sarah L. Braunstein3; 1Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2SCHARP, Julia Schillinger2; Denis Nash1 Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 3Univ of Washington, 1Sch of PH, City Univ of New York, New York, NY, USA; 2New York City Seattle, WA, USA; 4Univ of New England, Armidale, Australia; 5Med Rsr DHMH, Long Island City, NY, USA; 3New York City DHMH, Queens, NY, USA Council/Wits Rural PH and Health Transition Unit, Johannesburg, South Africa; 6Johns Hopkins Univ Sch of Med, Baltimore, MD, USA Session P-X7 Poster Abstracts Hall D 937 Correlates of HIV in Large Population Surveys: A 2:45 PM-4:00 PM Comprehensive HIV Association Study Access, ART Initiation, Retention, and Outcomes in the Eran Bendavid1; Chirag Patel2; Jay Bhattacharya1 Global South 1Stanford Univ, Stanford, CA, USA; 2Harvard Univ, Boston, MA, USA 1010 Successful Implementation of Extended ART Initiation Criteria in Rural South Africa Session P-X6 Poster Abstracts Hall D 1 2 3 2:45 PM-4:00 PM Sarah Jane Steele ; Amir Shroufi ; Guillermo Martínez Pérez ; Carol Metcalf4; Tsion Solom3; Gemma Arellano3; Aline Aurore Niyibizi5; Tom HIV and Other Sexually Transmitted Infections Ellman4; Gilles Van Cutsem2 1004 Increased STD Testing Among HIV-Infected Adults in 1Médecins Sans Frontières, South Africa & Lesotho, Cape Town, South Africa; 2Médecins Sans Frontières, Cape Town, South Africa; 3Médecins Care United States, 2009–2013 4
Poster Listings Poster Sans Frontières, South Africa & Lesotho, Eshowe, South Africa; Médecins Christine Mattson; Christopher Johnson; Heather Bradley; Linda Sans Frontières, Southern Africa Med Unit, Cape Town, South Africa; Beer; Roy L. Shouse 5Médecins Sans Frontières, Roma, Lesotho CDC, Atlanta, GA, USA 1005 Increased Gonorrhea and Chlamydia Case Detection in 1011 The Real-World Impact of CD4-Eligibility Criteria on a Multisite US HIV Cohort Retention in HIV Care Jacob Bor1; Matthew P. Fox2; Sydney Rosen2; Atheendar Julia Goldberg Raifman1; Anne K. Monroe2; Kelly A. Gebo3; Venkataramani3; Frank Tanser4; Deenan Pillay4; Till Bärnighausen5 Khalil Ghanem4; Allison L. Agwu3; Todd Korthuis5; Wm. Christopher 1Boston Univ Sch of PH, Boston, MA, USA; 2Boston Univ, Boston, MA, Mathews6; Aditya Gaur7; Stephen A. Berry3; for the HIV Research USA; 3Massachusetts General Hosp, Boston, MA, USA; 4Africa Cntr for Network Hlth and Pop Studies, Mtubatuba, South Africa; 5Harvard Sch of PH, 1Johns Hopkins Bloomberg Sch of PH, Baltimore, MD, USA; 2Johns Boston, MA, USA Hopkins Univ Sch of Med, Baltimore, MD, USA; 3Johns Hopkins Univ, Baltimore, MD, USA; 4Johns Hopkins Bayview Med Cntr, Baltimore, MD, 1012 Do ART Eligibility Expansions Crowd Out the Sickest? USA; 5Oregon Hlth & Sci Univ, Portland, OR, USA; 6Univ of California Evidence From South Africa 7 San Diego, San Diego, CA, USA; St Jude Children’s Rsr Hosp, Memphis, Sheryl A. Kluberg1; Matthew P. Fox2; Michael LaValley1; Till TN, USA Bärnighausen3; Deenan Pillay4; Jacob Bor1 1006 Gonorrhea and Chlamydia Testing in US HIV-Infected 1Boston Univ Sch of PH, Boston, MA, USA; 2Boston Univ, Boston, MA, 3 4 Men Who Have Sex With Men USA; Harvard Sch of PH, Boston, MA, USA; Africa Cntr for Hlth and Pop Studies, Mtubatuba, South Africa Monita Patel1; Shikha Garg1; John T. Brooks1; Yunfeng Tie2; Heather Bradley1 1CDC, Atlanta, GA, USA; 2ICF Intl, Atlanta, GA, USA
124 CROI 2016 Poster Listings 125 ; 3 ; 2 ; 3 ; ; 3 ; 3 2 ; ; ; 4 2 2 ICAP at
4 CROI 2016 Cntr for for Cntr ; Jacob Levi ; Jacob 2 ; Paul Somwe ; Paul
3 2 6 Univ of Oxford, Oxford, of Univ ; Nancy L. Czaicki 4 2 ; Thea ; Thea Savory Univ of California California of Univ 2 3 ; Susie Hoffman 6 Cntr for Infectious for Cntr ; David V. Glidden V. ; David Program Agenda and 2 2 Cntr for Infectious Disease Infectious for Cntr ; Olga Tymejczyk 2 ; Kathryn Stinson 2 2 ; Wafaa M. El-Sadr M. Wafaa ; 3 Sch of PH, City Univ of New Sch City New of PH, of Univ 2 UNITAID, Geneva, Switzerland Geneva, UNITAID, Univ of California San Francisco, San Francisco, California of Univ 6 ; for the IeDEA and MESH and the IeDEA ; for 3 1 ; Thomas ; Thomas Dauncey ; Izukanji Sikazwe 2 2 ; Kafula Mulenga ICAP at Columbia Univ, Maputo, Maputo, Univ, ICAP at Columbia 2 5 ; Carmen Perez Elias Perez ; Carmen 5 Sch of PH, City Univ of New York, New New York, Sch City New PH, of of Univ 2 ; Sarah Kulkarni ; Denis Nash ; Izukanji Sikazwe ; Batya Elul ; Batya 5 1 2 atients on ART Lost to to Lost ART on atients 2 Chelsea and Westminster Hosp NHS Fndn Fndn NHS Hosp Westminster and Chelsea
2 3 1 ; Andrew Boulle ; Andrew ; Mwanza Mwanza ; Mwanza 1 2 Columbia Univ, New York, NY, USA; USA; NY, York, New Univ, Columbia 3 Matthias Egger Matthias ; 1 Imperial Coll London, London, UK; UK; London, London, Coll Imperial ; Charles Holmes ; Charles ; Carolyn Moore ; Carolyn 3 1 2 ; Anton N. Pozniak N. ; Anton ; Shaffiq Essajee 1 4
1 City Univ of New York, New York, NY, USA NY, York, New York, New City of Univ ; Elvin H. Geng ; Elvin ; Elvin H. Geng ; Elvin ; Charles Holmes ; Charles ; Kathrin Zürcher ; Kathrin 6 ; Olga Tymejczyk 1 3 ; Laurence Ahoua ; Laurence 1 1 1 4 ; Thea ; Thea Savory WHO, Geneva, Switzerland; Switzerland; Geneva, WHO,
3 5 2 Liverpool Univ, Liverpool, UK; UK; Liverpool, Univ, Liverpool Univ of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of Univ ICAP at Columbia Univ, Boston, MA, USA; USA; MA, Boston, Univ, ICAP at Columbia Bern, Bern, Switzerland; of Univ Univ of California San Francisco, San Francisco, CA, USA; San Francisco, San Francisco, California of Univ CA, USA; Berkeley, Berkeley, California of Univ Katherine Heath Katherine San Francisco, CA, USA San Francisco, Follow-up in Sub-Saharanin Follow-up Africa Columbia Univ, New York, NY, USA; USA; NY, York, New Univ, Columbia Mariette Smith Mariette Oxford, UK; UK; Oxford, Yingfeng Wu Yingfeng Trust, London, UK; UK; London, Trust, Nancy Padian Disease Rsr in Zambia, Lusaka, Zambia; Zambia; Lusaka, Disease Zambia, in Rsr 1 Monika Roy ClaudineHennessey M. 1 ARV Lower Have Prevalence HIV Lower With Countries Database 2015 UNAIDS Coverage: Hill M. Andrew 1 Declining MortalityP in Mooser Anne 1 Antiretroviral of Transfer Silent The Found: to Lost Southin Africa Patients Therapy Late ART Initiation and 12-Month Mortality12-Month and Initiation ART ART After Late Sub-Saharanin Initiation Africa Vo QuynhT. 1 Among Adherence Poor of Hotspots Identifying Zambiain ART on Patients NancyCzaickiL. 1 Mwanza Mwanza Mwanza Evaluating Appointment Patterns to Improve Improve to Patterns Appointment Evaluating Zambiain SustainabilityTreatment HIV of MonikaRoy Margaret Couvillon Margaret Mozambique; Mozambique; Denis Nash York, NY, USA NY, York, Berkeley, Berkeley, CA, USA Berkeley, Berkeley, York, New York, NY, USA; USA; NY, York, New York, Nancy Padian Consortia Epi and Rsr, Cape Town, South Africa Town, Cape Rsr, and Epi Infectious Disease Rsr in Zambia, Lusaka, Zambia; Zambia; Lusaka, DiseaseInfectious Zambia, in Rsr
1023 1021 1022 1020 1019 1018 ; 6 ; 4 ; ; 2 3 Univ of Univ ; Vanessa ; Vanessa ; Alix ; Alix 7 ; Sergio ; Sergio 2
1 ; Glenda 1 6 1 INSERM INSERM Boston Boston
7 4 1 ; Laura M. ; Laura ; Albert Minga 3 5 ; William ; William B. 3 Midlands Med Cntr, Cntr, Med Midlands 5 ; DominickLeone Univ of Abuja of Univ 3 4 Hlth Economics and and Economics Hlth Boston Univ, Boston, Boston, Univ, Boston Boston Univ Sch Univ of Boston 3 8 2 ; Tessa Govender ; Tessa ; Elena Losina ; Elena Harvard Med Sch, Boston, Sch, Med Boston, Harvard ; Eugene Messou ; Eugene Boston Children’s Hosp, Hosp, Children’s Boston ; Ian M. Sanne; Ian 5 1 8
1 3 5
8 8
Brigham and Women’s Hosp, Hosp, Women’s and Brigham Harvard Sch of PH, Boston, Boston, Sch PH, of Harvard Cntr Médical de Suivi de de Médical Cntr 1 4 4 6 ; Janet Giddy ; Fabienne Homeus ; Fabienne 2 ; Kelly A. Hennessey ; Kelly 1 ; Renaud Becquet 1 7 ; Marcel Zannou ; Marcel 4 Ragon Inst of MGH, MIT, and MIT, MGH, of Inst Ragon 4 ; Garrett M. Fitzmaurice ; Garrett 2 CePReF, ACONDA, Abidjan, Côte Côte Abidjan, ACONDA, CePReF, 2 Analysis Group, Boston, MA, USA; USA; MA, Boston, Analysis Group, ; Laura M. Bogart; Laura 2 Brigham and Women’s Hosp, Harvard Harvard Hosp, Women’s and Brigham 2 Cntr de Prise en Charge des Personnes Personnes des Charge en Prise de Cntr Desmond Tutu HIV Fndn, Cape Town, Town, Cape Fndn, HIV Desmond Tutu 6 ds From Routine Laboratory Routine From ds 5 5 ; Douglas Ross ; Cheryl Hendrickson J. 2 ; Deenan Pillay 2 4 ; Jean W. Pape W. ; Jean 4 ; Matthew P. Fox P. ; Matthew 7 ; Clovy Bellot ; Darley Aubin ; Juan Burgos-Soto 1 1 1 ; Francois Dabis ; Francois ; David R. Bangsberg ; David 1 7 McCord Hosp, Durban, South Africa; South Africa; Durban, Hosp, McCord ; Kenneth A. Freedberg ; Kenneth 3 1 and 1-Year Mortality Newly in 1-Year and ; Vivian ; Vivian Kwaghue ; Sharon M. Coleman ; Sharon 3 1 ; Jacob Bor; Jacob 1 ; Gugu Tshabalala 5 ; Janan Dietrich 1 South African Med Rsr Council, Cape Town, South Africa; South Africa; Town, Cape Council, Rsr Med South African 6 Africa Cntr for Hlth and Pop Studies, Mtubatuba, South Africa; South Mtubatuba, Africa; Studies, Pop and Hlth for Cntr Africa ; Wendy Stevens ; Wendy ; Till ; Till Bärnighausen 5 ; Patrice Severe ; Patrice ; Serena P. Koenig P. ; Serena 6 2 CHU de Treichville, Abidjan, Côte d Côte Abidjan, Treichville, de CHU Ivoire; 3 1 3 ; Christine E.; Christine Chaisson Boston Univ Sch of PH, Boston, MA, USA; USA; MA, Boston, Sch PH, Univ of Boston 4 2 ; Catherine Orrell ; Catherine 6 Weill Cornell Med Coll, New York, NY, USA; USA; NY, York, New Coll, Med Cornell Weill GHESKIO, Port-au-Prince, Haiti; Haiti; Port-au-Prince, GHESKIO, Massachusetts General Hosp, Boston, MA, USA; USA; MA, Boston, Hosp, General Massachusetts INSERM U897, Bordeaux, France; France; Bordeaux, U897, INSERM Univ of Cape Town, Cape Town, South Africa; South Africa; Town, Cape Town, Cape of Univ Brigham and Women’s Hosp, Harvard Med Sch, Boston, MA, USA; USA; MA, Sch, Med Boston, Harvard Hosp, Women’s and Brigham South Africa; Soweto, Unit, Rsr HIV Perinatal Natl Hlth Lab Service/Wits Univ, Johannesburg, South Africa; South Africa; Johannesburg, Univ, Service/Wits Lab Hlth Natl Univ of the Witwatersrand, Wits Hlth Consortium, Johannesburg, South Johannesburg, Consortium, Hlth Wits Witwatersrand, the of Univ the Witwatersrand, Johannesburg, South Africa; South Africa; Johannesburg, Witwatersrand, the R. Rivera Epi Rsr Office, Johannesburg, South Africa; South Africa; Johannesburg, Office, Rsr Epi Aristophane Tanon Aristophane Africa; Africa; d Ivoire; Gray Teaching Hosp, Abuja, Nigeria; Abuja, Nigeria; Hosp, Teaching MA, USA; USA; MA, Rochelle P. Walensky Rochelle P. Pietermaritzburg, South Africa; South Africa; Pietermaritzburg, Harvard Med Sch, Boston, MA, USA MA, Sch, Med Boston, Harvard MA, USA MA, MacLeod 3 Model of Care in Haitiin Care of Model Moise Guiteau Colette 1 Retention of Clinically Stable ART Patients in a Rapida in Clinicallyof Retention Stable Patients ART Ingrid V. Bassett V. Ingrid 1 Barriers to Care Barriers to Southin Africa DiagnosedPersons HIV+ 1 6-Year Retention and Immunologicaland ART to Retention Response 6-Year Africa West Gender: IeDEA by ThierryTiendrebeogo 7 Ingrid T. Katz T. Ingrid 1 2 Prospective Multisite Cohort ProspectiveMultisite Study Pre-ARTLosses of Southin Refusal AfricaART and 6 Data: Date of ART Initiation ART of Date Data: Maskew Mhairi 1 Imputing ClinicalImputing Recor Vivant Avec le VIH, CHNU, Cotonou, Benin; Cotonou, CHNU, VIH, le Avec Vivant Harvard Med Sch, Boston, MA, USA; USA; MA, Sch, Med Boston, Harvard South Africa; South Africa; Med Sch, Boston, MA, USA MA, Sch,Med Boston, Saint-Vil Bogart Harvard, Cambridge, MA, USA; USA; MA, Cambridge, Harvard, PH, Boston, MA, USA; USA; MA, Boston, PH, Ingrid Courtney Donneurs de Sang /CNTS/PRIMO-CI, Abidjan, Côte dDonneurs Sang Côte de /CNTS/PRIMO-CI, Abidjan, Ivoire; Nathalie De Rekeneire Nathalie U897, ISPED, Univ de Bordeaux, Bordeaux, France Bordeaux, Bordeaux, de Univ ISPED, U897, Carmona Children’s Hosp, Harvard Med Sch, Boston, MA, USA; USA; MA, Sch, Med Boston, Harvard Hosp, Children’s MA, USA MA,
1017 1016 1015 1014 1013 Program and Agenda
Session P-X8 Poster Abstracts Hall D 1030 Adherence Predicts Failure on PI-Based Second-Line 2:45 PM-4:00 PM ART in Rural South Africa Viral Suppression Dami A. Collier1; Kathy Baisley2; Dickman Gareta3; Deenan Pillay3; Ravindra K. Gupta1 1024 Feasibility of the Third 90-90-90 Target: Viral Load 1Univ Coll London, London, UK; 2London Sch of Hygiene & Trop Med, Coverage and Outcomes in Rwanda London, UK; 3Africa Cntr for Hlth and Pop Studies, Mtubatuba, South Muhayimpundu Ribakare1; Jean d’Amour Ndahimana1; Byiringiro Africa Rusisiro1; Gad Niyibizi1; Jean Paul Uwizihiwe2; Catherine Kirk3; Sabin Nsanzimana1 1031 Outcomes of Patients Enrolled in ART Adherence Clubs 1Rwanda Biomed Cntr, Kigali, Rwanda; 2Inst of HIV/AIDS Disease After Viral Resuppression Prevention and Control, Rwanda Biomed Cntr, Kigali, Rwanda; 3Partners Joseph T. Sharp1; Lynne Wilkinson2; Vivian Cox2; Carol Cragg3; Gilles In Hlth, Kigali, Rwanda Van Cutsem4; Anna Grimsrud5 1Univ of Cape Town, Cape Town, South Africa; 2Médecins Sans Frontières, 1025 ART Coverage and Viral Load in Tanzania: Bukoba Khayelitsha, South Africa; 3Western Cape Dept of Hlth, Cape Town, South Combination Prevention Baseline Study Africa; 4Médecins Sans Frontières, Cape Town, South Africa; 5IAS, Cape Sarah E. Porter1; Duncan MacKellar1; Rachel Weber2; Haruka Town, South Africa Maruyama3; Sherri Pals1; Gretchen Antelman4; Oscar Ernest5; Robert Josiah6; Jessica Justman7 1032 Substance Use Is a Major Barrier to Viral Suppression 1CDC, Atlanta, GA, USA; 2CTS Global, Inc, Assigned to US CDC, Dar es Among Key Populations in India Salaam, Tanzania; 3ICAP at Columbia Univ, Dar es Salaam, Tanzania; Sunil S. Solomon1; Gregory M. Lucas1; Aylur K. Srikrishnan2; Allison M. 4Elizabeth Glaser Pediatric AIDS Fndn, Dar es Salaam, Tanzania; 5ICAP McFall1; David Celentano1; Shanmugam Saravanan3; Suresh Kumar2; at Columbia Univ, Bukoba, Tanzania; 6Natl AIDS Control Prog, Dar es Shruti H. Mehta1 Salaam, Tanzania; 7ICAP at Columbia Univ, New York, NY, USA 1Johns Hopkins Univ, Baltimore, MD, USA; 2YRG Cntr for AIDS Rsr and Educ, Taramani, India; 3YRG Cntr for AIDS Rsr and Educ, Chennai, India 1026 Heterogeneity in Local Population Viremia Despite >50% Suppression in East Africa 1033 Durable Viral Suppression Among HIV-Diagnosed Vivek Jain1; Dathan Byonanebye2; Teri Liegler1; Dalsone Kwarisiima3; Persons United States, 2012–2013 Norton Sang4; Edwin Charlebois1; Maya Petersen5; Moses R. Kamya; Nicole Crepaz1; Tian Tang2; Gary Marks1; Michael J. Mugavero3; Lorena Diane V. Havlir1; for the SEARCH Collaboration Espinoza1; H. Irene Hall1 1Univ of California San Francisco, San Francisco, CA, USA; 2Makerere Univ 1CDC, Atlanta, GA, USA; 2ICF Intl, Atlanta, GA, USA; 3Univ of Alabama at Coll of Hlth Scis, Kampala, Uganda; 3Makerere Univ-Univ of California Birmingham, Birmingham, AL, USA 4 San Francisco Rsr Collab, Kampala, Uganda; Kenya Med Rsr Inst, Nairobi, 1034 Changes in Viral Load Across US Clinics Over Time Kenya; 5Univ of California Berkeley, Berkeley, CA, USA Jane Simoni1; Robin Nance1; Joseph A. Delaney2; Ira B. Wilson3; Frances 1027 High Rate of Viral Suppression in Late Mortality on Aunon1; Steven A. Safren4; Michael J. Mugavero5; Kenneth H. Mayer6; First-Line ART in Uganda/Zimbabwe Mari M. Kitahata1; Heidi M. Crane1 1 2 David I. Dolling1; Pontiano Kaleebu2; Peter Nkurunziza2; Moira Univ of Washington, Seattle, WA, USA; Univ of Washington Sch of 3 Spyer1; Charles Gilks3; Deenan Pillay4; Ruth Goodall1; for the DART PH and Community Med, Seattle, WA, USA; Brown Univ Sch of PH, Providence, RI, USA; 4Massachusetts General Hosp, Boston, MA, USA; Poster Listings Poster Virology Group 5 6 1Med Rsr Council Clinical Trials Unit at Univ Coll London, London, UK; Univ of Alabama at Birmingham, Birmingham, AL, USA; The Fenway 2Med Rsr Council/Uganda Virus Rsr Inst Uganda Rsr Unit on AIDS, Inst, Fenway Hlth, Boston, MA, USA Entebbe, Uganda; 3Sch of Pop Hlth, Univ of Queensland, Herston, 1035 Differences in HIV Viral Suppression by Frequency and 4 Australia; Africa Cntr for Hlth and Pop Studies, Mtubatuba, South Africa Type of Healthcare Visits 1028 Measuring Viral Load Suppression in South Africa Michael A. Horberg1; Jackie Blank1; Kevin B. Rubenstein1; Leo B. Using a Novel, National Database Hurley2; Julia L. Marcus2; Daniel B. Klein3; Peter M. Kadlecik4; Michael 2 William B. MacLeod1; Jacob Bor1; Nicole Fraser2; Zara Shubber2; Ian J. Silverberg 1 2 M. Sanne3; Wendy Stevens4; Tshepo Molapo5; Mokgadi Phokojoe5; Mid-Atlantic Permanente Med Group, Rockville, MD, USA; Kaiser 3 Yogan Pillay5; Sergio Carmona6 Permanente Northern California, Oakland, CA, USA; Kaiser Permanente 4 1Boston Univ Sch of PH, Boston, MA, USA; 2The World Bank, Washington, San Leandro Med Cntr, San Leandro, CA, USA; Mid-Atlantic Permanente DC, USA; 3Univ of the Witwatersrand, Wits Hlth Consortium, Med Group, Washington, DC, USA Johannesburg, South Africa; 4Univ of the Witwatersrand, Johannesburg, 1036 Community Viral Load: Measure Validation and Public 5 6 South Africa; Natl Dept of Hlth, Pretoria, South Africa; Natl Hlth Lab Health Utility Service/Wits Univ, Johannesburg, South Africa Kathryn M. Leifheit1; Christina Schumacher1; Patrick Chaulk2; 1029 Comparing Adherence Methods: Which Best Predicts Carolyn Nganga-Good2; Jacky M. Jennings1 Virological and Resistance Outcome? 1Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; 2Baltimore City Hlth Catherine Orrell1; Karen Cohen1; Rory Leisegang1; David R. Dept, Baltimore, MD, USA Bangsberg2; Gary Maartens1; Robin Wood1 1Univ of Cape Town, Cape Town, South Africa; 2Harvard Med Sch, Boston, MA, USA
126 CROI 2016 Poster Listings 127 CROI 2016 Program Agenda and ; 4 ; ; Julio 4 5 ; Wendy ; Wendy ; Vincent ; Vincent 2 2 VA Med VA 6 ; Henry F. ; Henry F. ; David Hall ; David 1 2 BC Cntr for Excellence Excellence for Cntr BC 2 ; Brett Hanscom ; Brett Simon Fraser Univ, Univ, Simon Fraser ; James Choi 3 6 3 ; Deborah Donnell 6 ; David Laibson ; David
4 6 ; Paul Sereda ; Paul 2
Univ of California San Francisco, San Francisco, California of Univ ; Ann Kurth; Ann 2 3 2 SCHARP, Fred Hutchinson Cancer Rsr Rsr Cancer Hutchinson Fred SCHARP, 4 Harvard Univ, Boston, MA, USA; USA; MA, Boston, Univ, Harvard ; Fred Gordin ; Fred 2 5 ; Minh Nguyen 2 Emory Univ Sch of Med, Atlanta, GA, USA Atlanta, Emory Sch Med, Univ of ; Nathan J. Lachowsky J. ; Nathan 4 ; Carlos del Rio ; Carlos 2 2 ICAP at Columbia Univ, New York, NY, USA; USA; NY, York, New Univ, ICAP at Columbia ; Robert S. Hogg Scientific Affairs, Atlanta, GA, USA Atlanta, Scientific Affairs, 2 3 7 ; Wendy Hartogensis; David V. Glidden; V. Hartogensis; David Wendy ; ; Ashleigh Rich Univ of Victoria, Victoria, BC, Canada; Canada; BC, Victoria, Victoria, of Univ Montefiore Med Cntr, Bronx, NY, USA; USA; NY, Bronx, Cntr, Med Montefiore 4 4 5 ; Allison Zerbe ; Allison 1 ; Zishan Cui 1 ; Wafaa M. El-Sadr M. Wafaa ; ; BarryZingman 7 ; John Beshears 4 ; Heather Bradley; Shikha Garg; Roy L. Shouse L. Roy Garg; Shikha Bradley; ; Heather 1 ; Bridget Madrian
4 ; Willi ; Willi McFarland 4 ; Eric A. Roth ; Eric 2 3 Vancouver Coastal Hlth, Vancouver, BC, Canada; Canada; BC, Vancouver, Hlth, Coastal Vancouver Univ of British Columbia, Vancouver, BC, Canada; Canada; BC, Vancouver, Columbia, British of Univ Emory Univ, Atlanta, GA, USA; GA, USA; Atlanta, Emory Univ, Stanford Univ, Stanford, CA, USA; Stanford, Univ, Stanford New York Univ, New York, NY, USA; USA; NY, York, New Univ, York New FHI 360, Durham, NC, USA; USA; NC, Durham, 360, FHI in HIV/AIDS, Vancouver, BC, Canada; Canada; BC, Vancouver, HIV/AIDS, in Armstrong C. Marconi San Francisco, CA, USA; San Francisco, Laura McKinstryLaura Raymond 5 David M. Moore M. David 1 Christopher Pilcher; Monica H. Geng Gandhi; Pilcher; Elvin Christopher CA, USA San Francisco, San Francisco, California of Univ Suppression HIV- Among Virologic in Increases Recent Canada Vancouver, in MSM Positive 3 Distribution Clinica Load in QuantifyingViral Curve Lorenz the Using Population Christopoulos Katerina Poorly Adherent HIV+ IndividualsHIV+ Adherent Poorly Alsan Marcela 1 3 Suppression in Virologic Contract Commitment A for Incentives for HIV Care (HPTN 065) (HPTN Care HIV for Incentives Farrior H. Jennifer 1 Depression in the United States United the in Depression Gokhale Runa GA, USA Atlanta, CDC, Financial Toward Attitudes ClinicianPatient and HIV Viral Suppression Among Adults Diagnosed With With Diagnosed Suppression Adults Among Viral HIV Montaner Canada BC, Burnaby, Cntr, Washington, DC, USA; USA; DC, Washington, Cntr, Cntr, Seattle, WA, USA; USA; WA, Seattle, Cntr, Bernard Branson Bernard
1041 1040 1039 1038 1037 Disclosure Information DISCLOSURE OF FINANCIAL RELATIONSHIPS WITH COMMERCIAL CONCERNS Disclosure information is presented generally as submitted by the corresponding presenting abstract author or invited speaker. The authors and speakers below provided all relevant disclosures of financial relationships with commercial entities for themselves and their spouses or partners, as well as funding provided to their institutions.
Abram, Michael Calcagno, Andrea Dicker, Ira Self: Employee and stockholder, Gilead Sciences Self: Research grants from Gilead and Bristol-Myers Self: Employee of Bristol-Myers Squibb Allavena, Clotilde Squibb; speaker’s honoraria from AbbVie, Bristol- Dolling, David Self: Travel grants or hononaria from Mylan, Myers Squibb, Gilead, MSD, Janssen-Cilag, and ViiV Institution: Research support from Bristol-Myers Squibb, Gilead Sciences, Janssen, Chang, Larry GlaxoSmithKline, Gilead Sciences, and Boehringer MSD, and ViiV Healthcare Self: Advisor, stockholder, entitled to royalties, Ingelheim Altfeld, Marcus emocha Mobile Health Eckard, Allison Self: Speaker honorarium from MSD, Bristol-Myers Charpentier, Charlotte Self: Advisor and speaker for Gilead Sciences Squibb, Jansen & Jansen, and Gilead Honorarium from MSD, Gilead, ViiV, Bristol-Myers Institution: Research funding from Althoff, Keri Squibb, and Janssen GlaxoSmithKline, Cubist Pharmaceuticals, and Self: Medical Advisory Board for Gilead Sciences Chen, Beatrice Bristol-Myers Squibb Ananworanich, Jintanat Institution: Research funding from Bayer, Eley, Timothy Self: Advisory boards for ViiV Healthcare and Merck Medicines 360, and Agile Therapeutics Self: Employee and shareholder of Bristol-Myers Squibb Anderson, Peter Chockalingam, Leela Self: Advisor, Gilead Sciences Institution: Bristol-Myers Squibb owned the Self: Contract work and study drug donation from rights to BMS66068 when this study was conducted Gilead Sciences Christensen, Stefan Self: Consulting or speaker grant from AbbVie, Erlandson, Kristine Asmuth, David Self: Research funding from Gilead Sciences Self: Grant and travel funds support from Entera Bristol-Myers Squibb, Gilead, Hexal, Janssen-Cilag, Health MSD, Reckitt-Benckiser, ViiV Healthcare Eron, Joseph Self: Consultant to Bristol-Myers Squibb, Gilead Bernardino, Jose Cohen, Stephanie Self: Study drug and drug-level testing from Gilead Sciences, Janssen, Merck, and ViiV Healthcare Self: Personal fees from Bristol-Myers Squibb, Institution: Research grants from Janssen, Gilead Gilead Sciences, ViiV healthcare, MSD, and Janssen Connick, Elizabeth Sciences, ViiV Healthcare, and AbbVie Berry, Stephen Self: DSMB for a study partially funded by Sangamo Biosciences Fidler, Sarah Self: Advisor for Bristol-Myers Squibb Self: Research funding from GSK and MSD Cooper, Curtis Bisson, Gregory Gallant, Joel Self: Endpoint adjudicator for a post-marketing Self: Advisor and research funding from Gilead and AbbVie; advisor for Merck Self: Consulting and advisory boards: Bristol-Myers surveillance study for Pfizer; consultant for Celgene Squibb, Gilead Sciences, Janssen Therapeutics, Boettiger, David Costagliola, Dominique Merck & Co, and ViiV Healthcare Self: Funding from Gilead Australia Self: Travel grants, honoraria, and study grants Institution: Grant funding from AbbVie, from Gilead Sciences, Janssen-Cilag, Merck Sharp & Bristol-Myers Squibb, Gilead Sciences, Janssen Boyd, Mark Dohme-Chibret, and ViiV Healthcare Therapeutics, Merck & Co, and Sangamo Self: Research funding from AbbVie, Merck, and Gilead; honoraria for service on HIV advisory boards Cranston, Ross Garrett, Katy DisclsoureInformation from Merck, Gilead, and ViiV Healthcare; honoraria Spouse or Partner: Consultant for Novicol Life Institution: Research grant from Gilead Sciences for educational presentations from AbbVie, Bristol- Sciences and ABIVAX; research grants from Janssen R&D and ViiV Healthcare Gatell, Jose María Myers Squibb, Boehringer Ingelheim Self: Honoraria for lectures from AbbVie, Janssen, Brinkman, Kees Cysique, Lucette Gilead, ViiV, and Bristol-Myers Squibb Self: Advisory boards for AbbVie, ViiV Healthcare, Self: Research support from MSD, AbbVie Institution: Grant funding from MSD, AbbVie, Gilead, Janssen, and Bristol-Myers Squibb Institution: Research support from AbbVie Janssen, Gilead, ViiV, and Bristol-Myers Squibb Brockmeyer, Norbert D’Aquila, Richard Gaur, Aditya Self: Congress sponsorship and research funding Self: Honoraria from Janssen Scientific Affairs, Self: Study investigator on clinical trials sponsored from Gilead, MSD, Sanofi Pasteur, ViiV Healthcare, Janssen Therapeutics, and Clinical Care Options by Gilead Sciences and GSK DeJesus, Edwin Giaquinto, Carlo Brophy, Jason Self: Advisory board and speaker fees from Janssen Self: Advisor to ViiV, Merk, Gilead, speaker travel Self: Educational Grant from AbbVie and Gilead Science from ViiV Healthcare Derby, Nina Instruction: Grants from ViiV Healthcare, Gilead, Butt, Adeel Bristol-Myers Squibb, and Johnson and Johnson Institution: Grants funding from AbbVie and Institution: Received Poly-ICLC from Oncovir Gilead 128 CROI 2016 Disclosure Information
Gisslén, Magnus Jain, Vivek Mallon, Patrick Self: Research grants from Abbott/AbbVie, Institution: Grant support from Gilead Sciences Self: Honoraria, travel, and/or consultancy Baxter, Bristol-Myers Squibb, Gilead Sciences, Jensen, Bjoern-Erik from Gilead Sciences, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Pfizer, Roche, and Tibotec; Self: Board membership ViiV (past); payment ViiV Healthcare, Merck Sharpe & Dohme, and honoraria as speaker and/or scientific advisor for lectures from ViiV, Janssen-Cilag, Boehringer Janssen-Cilag from Abbott/AbbVie, Bioinvent, Boehringer Ingelheim, Gilead, AbbVie, and Bristol-Myers Marcus, Julia Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Squibb (past) Self: Research grant support from Merck GlaxoSmithKline/ViiV, Janssen-Cilag, Merck, Pfizer, Roche, and Tibotec Kalayjian, Robert Margolis, David Self: Community advisory board, Sensor-Kinesis Self: Employee of ViiV Healthcare; stockholder Golub, Sarit Corporation in GSK Self: Study drug from Gilead Kattakuzhy, Sarah Martrus, Gloria Gottlieb, Geoffrey Institution: Research grant from Gilead Self: Grant award from Gilead Self: Research support from Gilead Sciences, Alere, and Abbott Molecular Diagnostics Khalilieh, Sauzanne Mauss, Stefan Self: Employee of Merck Sharp & Dohme; may hold Self: Scientific boards, review panels, and board Grant, Alison stock or stock options membership for AbbVie, Bristol-Myers Squibb, Self: Validation panels from Alere Institution: Research funding from Merck & Co Gilead, Janssen, Roche, and ViiV; speaker’s bureau Grant, Robert Kiser, Jennifer for AbbVie, Bristol-Myers Squibb, Gilead, Roche, Self: Study medication from Gilead Sciences Spouse or Partner: Speaker for Astellas and Janssen; Consultant for AbbVie, Bristol-Myers Grobbler, Jay Institution: Research grant from Janssen Squibb Disclosure will be provided prior to the presentation Knox, David Mayer, Kenneth Hamzah, Lisa Self: Hororaria from ViiV Healthcare and Gilead Self: Research grants from Gilead Sciences and ViiV Self: Funding to attend conferences from Gilead Sciences McComsey, Grace Sciences and honoraria from Janssen-Cilag Institution: Funding from Gilead Sciences Self: Employee, advisor to Gilead, ViiV, Bristol- Harrigan, P. Richard Kouanfack, Charles Myers Squibb, and ICON Self: Grants from, advisor to, or speaker for Self: Board member for Bristol-Myers Squibb Institution: Grant support from Gilead, ViiV, Bristol-Myers Squibb, and AstraZeneca events sponsored by Pfizer, GlaxoSmithKline, Krystal, Mark Abbott, Merck, Tobira Therapeutics, Virco, and Self: Employee of Bristol-Myers Squibb McGowan, Ian Quest Diagnostics; consultant for ViiV Healthcare, Self: Advisor, Abivax and Novicol Life Sciences Tobira Therapeutics, Selah Genomics, and Quest La Rosa, Alberto Institution: Research grant from Janssen R&D Self: Employment at Janssen Peru Diagnostics; stockholder in Merck, Illumina, Gilead, Meissner, Eric and EKF Diagnostics; funding support from CIHR/ LaCombe, Karine Institution: Support from Gilead Sciences GSK Research Chair in Clinical Virology Self: Advisor for Bristol-Myers Squibb, Gilead, MSD, Institution: Contracts to perform drug-resistance AbbVie, and Janssen Merat, Sabrina testing for Merck, ViiV, and Janssen Institution: Research grant from Gilead and Self: Employee of AIMM Therapeutics Janssen Institution: AIMM Therapeutics is a joint venture Harris, Reuben of IMMPACT and the Academic Medical Center at Self: Cofounder of ApoGen Biotechnologies Landovitz, Raphael the University of Amsterdam Heath, Sonya Self: Consulting fees, travel, and drug supply from InformationDisclsoure Gilead Sciences Mirochnick, Mark Self: Advisor for and grant from Merck Self: Consultant for Merck; DSMB member, Merck Institution: Research award from Merck Letendre, Scott and ViiV Self: Advisory board: ViiV Healthcare and Merck Hernandez, Dennis Mogalian, Erik Self: Employee of Bristol-Myers Squibb & Co Institution: Research funds from Gilead Sciences Self: Employee of Gilead Sciences Hoenigl, Martin and ViiV Healthcare Molina, Jean-Michel Self: Speaker honorarium from Merck Self: Advisory board for Gilead, Merck, ViiV, Institution: Funding from Gilead Lingappa, Jairam Self: Scientific advisory board, Prosetta Antivirals Janssen, and Bristol-Myers Squibb; grants from Hsue, Priscilla Merck and Gilead Liu, Albert Self: Honoraria from Gilead, Merck, and Bristol- Murray, Miranda Myers Squibb Self: Study drug and drug level testing provided by Gilead Sciences Self: Employee of ViiV Healthcare Huang, Wei Naggie, Susanna Self: Employee of Monogram Biosciences Longley, Nicky Self: Speaker honoraria from Pfizer and MSD, Self: Advisor for Gilead, AbbVie, Bristol-Myers Huhn, Gregory development of educational materials for Squibb, Janssen, Vertex, and Merck Self: Consultant for Gilead Sciences and TerraNova, consultant for Fujifilm Pharmaceuticals Institution: Research grants from Gilead, AbbVie, ViiV; therapeutic advisor for Practice Point Spouse or Partner: Yes Bristol-Myers Squibb, Janssen, Vertex, and Merck Communications Institution: St George’s University of London, Newton, Alicia Hunt, Peter investigator-initiated research grant (Pfizer) Self: Consultant for Monogram Biosciences Self: Consultant for Merck, Gilead, and ViiV Luetkemeyer, Anne Obermeier, Martin Self: Advisor for and travel support from Bristol- Institution: Research grant from Hologic Myers Squibb and Gilead Institution: Research grant support from AbbVie, Bristol-Myers Squibb, Gilead, Merck, and Pfizer
CROI 2016 129 Disclosure Information
Oberoi, Rajneet Silverberg, Michael van Sighem, Ard Self: Employee and stockholder, AbbVie Institution: Research grants from Pfizer and Merck Institution: Travel grants from Gilead Sciences; Spouse or Partner: Employee and stockholder, Spire, Bruno speaker honoraria from Janssen, Bristol-Myers AbbVie Institution: Research support from Abbott France, Squibb, and ViiV Healthcare Patel, Rupa GlaxoSmithKline, Roche, and Schering Plough Vera, Jaime Self: Advisor, Gilead Advisory Meeting for PrEP Steens, Jean-Marc Self: Lecture honoraria from Merck and Janssen- Perez-Valero, Ignacio Self: Stockholder in GlaxoSmithKline and ABIVAX; Cilag; sponsorship to attend scientific conferences Self: Lecture payments from Gilead Sciences SA, chief medical officer at ABIVAX from Janssen-Cilag, Gilead Sciences, AbbVie, and MSD Bristol-Myers Squibb SA, Janssen-Cilag SA, and VIIV Stephan, Christoph Laboratories Self: Travel and speaker grants from Gilead Verna, Elizabeth Phillips, Andrew Sciences, AbbVie, ViiV Healthcare, Janssen, MSD, Self: Grant support from Merck and Salix Self: Honararia (Gilead Sciences, AbbVie), and Bristol-Myers Squibb Volpe, Joseph consultant (GlaxoSmithKline) Sued, Omar Self: Employee of Monogram Biosciences Pickett, James Self: Honorarium and travel grants from Glaxo Waked, Imam Institution: Grants from Gilead and AbbVie Self: Speaker, investigator, and/or consultant for Post, Frank Institution: Research grant from ViiV; support AbbVie, Bristol-Myers Squibb, Gilead Sciences, Self: Support from Gilead Sciences; personal from Merck and Richmond Argentina Hoffmann-La Roche, Janssen, Merck, Onxeo, and fees from Gilead Sciences, ViiV, AbbVie, MSD, and Sulkowski, Mark Pharco Janssen; grants from ViiV and Gilead Self: Fees from AbbVie, Bristol-Myers Squibb, Weinberg, Adriana Ray, Neelanjana Gilead, Janssen, and Tobira; consultant/advisory Spouse or Partner: Patent royalties from Merck Self: Employee of Bristol-Myers Squibb board member for AbbVie, Achillion, Cocrystal, Institution: Patent royalties from Merck Bristol-Myers Squibb, Gilead, and Janssen Weitz, David Rijnders, Bart Institution: Research grants from AbbVie, Self: Research grants, board memberships, Self: Cofounder of several companies that use Boehringer Ingelheim, Bristol-Myers Squibb, and drop-based microfluidics consultancy, lecture payment, and travel Gilead reimbursement from Gilead, MSD, Bristol-Myers Whitney, James Squibb, and Janssen-Cilag Sullivan, Patrick Self: Consultant for Bristol-Myers Squibb Self: Grant from Gilead Sciences Robertson, Kevin Institution: Research grant from Gilead Self: Consultant for GSK Tan, Darrell Wilkin, Timothy Institution: Research grants from Gilead and Rockstroh, Jürgen Institution: Research support from Gilead and ViiV; honoraria from AbbVie, Bristol-Myers Squibb, Bristol-Myers Squibb Self: Honoraria for consulting or speaking from Gilead, Janssen, Merck, and ViiV Abbott, AbbVie, Bionor, Bristol-Myers Squibb, Cipla, Spouse or Partner: Employee of Johnson & Gilead Sciences, Janssen, Merck, and ViiV Thio, Chloe Johnson Institution: Investigator initiated research grant Winston, Alan Rodgers, Mary from Gilead Sciences Self: Employee and shareholder of Abbott Institution: Research grant from ViiV Healthcare Laboratories Thorne, Claire Wittkop, Linda Spouse or Partner: Shareholder of Abbott Self: Grant from AbbVie Self: Board member for Bristol-Myers Squibb Laboratories Tieu, Hong Van Wohl, David Sabin, Caroline Self: Research grant from Merck Self: Advisor to Gilead Sciences and Janssen Self: Advisor, Gilead Sciences, ViiV Healthcare, Trkola, Alexandra Institution: Funding from Gilead Sciences and Janssen-Cilag, Bristol-Myers Squibb Spouse or Partner: DSMB member for Merck; Merck Scherzer, Rebecca advisor to Gilead, Boehringer Ingelheim, and Wyles, David Self: Honorarium from Merck Janssen; research grants from Gilead, Merck, ViiV, Self: Grant/research support from AbbVie, Roche, and Janssen Schinkel, Janke Bristol-Myers Squibb, Gilead, Merck, and Tacere Self: Financial support from Janssen-Cilag and Utay, Netanya Therapeutics; consultant/advisor for AbbVie, Gilead Self: Scientific adviser for Tobira Therapeutics Bristol-Myers Squibb, Gilead, Janssen, and Merck DisclsoureInformation Schuettfort, Gundolf Vallari, Ana Yin, Michael Self: Travel and speaker grants from Gilead Self: Employee and shareholder of Abbott Self: Consultant for Gilead Sciences, ViiV Healthcare, Janssen, MSD, and Laboratories Bristol-Myers Squibb Spouse or Partner: Shareholder of Abbott Laboratories Scully, Eileen Spouse or Partner: CEO of emocha medical software platform Sevinsky, Heather Self: Employee and shareholder of Bristol-Myers Squibb Sigel, Keith Self: Paid consultant to Gilead Sciences
130 CROI 2016 Disclosure Information DISCLOSURE INFORMATION The following have no relevant financial relationships to disclose. Any updates will be reflected in the mobile app.
Abbas, Ume Becker, James Carriquiry, Gabriela Czaicki, Nancy Falade-Nwulia, Oluwaseun Abdel-hameed, Enass Béguelin, Charles Carroll, Michael Dakshina, Subathira Fallah, Mosoka Abdel-Mohsen, Mohamed Belaunzarán-Zamudio, Cartwright, Emily Damouche, Abderaouf Faria de Oliveira, Michelli Abdulhaqq, Shaheed Pablo Casavant, Isabelle Dan, Jennifer Farquhar, Carey Abrams, Elaine Bello, Fatai Casazza, Joseph Dasgupta, Sharoda Farrior, Jennifer Adachi, Kristina Bendavid, Eran Castillo-Mancilla, Jose Davey, Richard Fayorsey, Ruby Adland, Emily Bengtson, Angela Ceccherini-Silberstein, D'Avino, Alessandro Feder, Alison Adnan, Sama Benhammou, Valerie Francesca Davis, Nicole Feinstein, Matthew Aghaizu, Adamma Benito, Jose Celum, Connie Davy, Thibaut Ferrand, Rashida Agwu, Allison Benjamins, Laura Cepeda, Javier De, Asha Finlayson, Teresa Ajibola, Gbolahan Berenguer, Juan Cerrone, Maddalena De Alwis, Paba Finzi, Andrés Akapirat, Siriwat Berry, Stephen Chaillon, Antoine de la Fuente Soro, Laura Floyd, Sian Akiyama, Hisashi Best, Brookie Chamie, Gabriel de los Angeles, Christine Fogel, Jessica Alagaratnam, Jasmini Bezemer, Daniela Chan, Ellen Paula Folkvord, Joy Aliyu, Muktar Bhagwat, Priya Chang, Wei de Monteynard, Laure- Force, Gilles Alsan, Marcela Bibollet-Ruche, Frederic Charpentier, Charlotte Amélie Fourati, Slim Alteri, Claudia Bienczak, Andrzej Chaudhary, Omkar Debre, Patrice Fox, Julie Alvarado, Melanie Blish, Catherine Chéret, Antoine Debyser, Zeger Freeman, Michael Alvarez, Angeles Boender, Tamara Sonia Cherutich, Peter Decloedt, Eric Frenkel, Lisa Alvarez, Xavier Bolay, Fatorma Chettimada, Sukrutha DeGroote, Nicholas Frías, Mario Ances, Beau Boltz, Valerie Chin, Alfred Del Amo, Julia Friedland, Barbara Andany, Nisha Bonito, Andrea Ching, Christopher Delaney, Kevin Friedland, Gerald Anderson, Brett Boon, Denali Chitre, Avantika Delaugerre, Constance Friedman, Evan Anderson, Erik Bor, Jacob Chiu, Calvin Delobel, Pierre Furrer, Hansjakob Andrews, Chasity Borges, Alvaro Choi, Sung Eun Dennis, Ann Gabuzda, Dana Andrews, Sophie Boulware, David Chow, Dominic Desai, Seema Gagne, Matthew Angelidou, Konstantia Bourgi, Kassem Chow, Felicia Destache, Christopher Gaisa, Michael Anstett, Kaitlin Bowman, Natalie Christ, Frauke Dezzutti, Charlene Galang, Romeo Antinori, Andrea Bradley, Heather Christensen-Quick, Aaron Di Rosa, Michelino Galarraga, Omar Apetrei, Cristian Branch, Andrea Christopoulos, Katerina Diacon, Andreas Gandhi, Monica Arpadi, Stephen Braunstein, Sarah Chung, Shang-Lin Dillon, Stephanie Gandhi, Rajesh Aston, Stephen Brennan, Alana Ciaranello, Andrea Dimitrov, Dobromir Gaolathe, Tendani Atta, Mohamed Brenner, Bluma Ciccarelli, Nicoletta Dirajlal-Fargo, Sahera Garcia-Lerma, Gerardo InformationDisclsoure Atugonza, Rita Breton, Yann Cillo, Anthony Doitsh, Gilad Garrido, Carolina Auld, Sara Briz, Verónica Clarridge, Katherine Dorr, Maggie Gavegnano, Christina Avelino-Silva, Vivian Brooks, John Clement, Meredith Dorsey, Kerri Gay, Cynthia Avihingsanon, Anchalee Brooks, Kristina Clouse, Kate Drozd, Daniel Geldsetzer, Pascal Avila-Rios, Santiago Bruner, Katherine Cockerham, Leslie Dryden-Peterson, Scott Geng, Elvin Ayieko, James Brust, James Coffie, Ahuatchi Du, Yimin George, Varghese Ayles, Helen Buchacz, Kate Coghill, Anna Duchesne, Léa Geretti, Anna Maria Azzoni, Livio Budd, Matthew Coiras, Mayte Dunne, Eileen German, Danielle Bachanas, Pamela Buggert, Marcus Colbers, Angela Eaton, Jeffrey Ghadrshenas, Matine Bacon, Oliver Bui, John Collier, Dami Edelstein, Zoe Ghys, Peter Badia, Roger Bunge, Katherine Collini, Paul Egger, Matthias Giacomet, Vania Baeten, Jared Burchell, Ann Collins, Sean El-Diwany, Ramy Gianella, Sara Baker, Jason Burdo, Tricia Coppola, Nicola El-Sadr, Wafaa Giaquinto, Carlo Balagopal, Ashwin Burgener, Adam Côté, Hélène Emerson, Michael Gini, Joshua Balaji, Alexandra Calascibetta, Francesca Cotugno, Nicola Emery, Ann Glick, Sara Ballana, Ester Cameron, Mark Court, Richard Ericsen, Adam Gokhale, Runa Banga, Riddhima Campbell, Edward Crane, Heidi Esser, Stefan Goldberg Raifman, Julia Bannert, Norbert Campbell, Ellsworth Crepaz, Nicole Estes, Jacob Golumbeanu, Monica Bar, Katharine Canaday, David Cressey, Tim Etard, Jean-François Gómez-Mora, Elisabet Barnabas, Ruanne Canan, Chelsea Cribbs, Sushma Euler, Zelda Gonciulea, Anda Barreto-de-Souza, Victor Cannon, Paula Crowe, Suzanne Evering, Teresa Gopalan, Narendran Bassett, Ingrid Caplan, Margaret Crowell, Trevor Ewing, Alexander Gossez, Morgane Batista, Facundo Capparelli, Edmund Cummins, Nathan Fabra García, Amanda Goswami, Neela Battalora, Linda Carlucci, James Cunyat, Francesc Faini, Diana Gowda, Charitha
CROI 2016 131 Disclosure Information
Goyette, Marielle Janjua, Sumbal Lange, Camille Maskew, Mhairi Ndawinz, Jacques Grabowski, Mary Jao, Jennifer Lanzi, Anastasia Mathad, Jyoti Ndembi, Nicaise Grant, Jennifer Japhet, Mbae Laraque, Fabienne Matsui, Yusuke Ndjeka, Norbert Granziera, Cristina Jaquet, Antoine Larmarange, Joseph Mattson, Christine Ndlovu, Zibusiso Graves, Justin Jeffries, Carrie Laskey, Sarah Maughan, Robert Neary, Megan Greene, Sharon Jenks, Jeffrey le Roux, Stanzi Mave, Vidya Nel, Annalene Griesel, Rulan Jiang, Xiong Lee, Eric Mavian, Carla Nelson, LaRon Griffith, Linda Jin, Steven Lee, Guinevere Mayer, Kenneth Nelson, Rob Grimsrud, Anna Johnson, Erica Lee, Hana McCormack, Sheena Neukam, Karin Grobler, Jay Johnson, Leah Leifheit, Kathryn McGettrick, Padraig Newsum, Astrid Grome, Heather John-Stewart, Grace Leitman, Ellen McGillen, Jessica Nguyen, Thao Gruenewald, Analise Jones, Brad Lepik, Katherine McGowan, Ian Nichols, Brooke Guha, Anika Joseph, Sarah Leung, Janice McGrath, Christine Ning, Chuanyi Guiteau Moise, Colette Jotwani, Vasantha Levy, Matthew McGrath, Michael Njuguna, Irene Gulick, Roy Justice, Amy Li, Danny McKellar, Mehri Norton, Brianna Gupta, Ravindra Kabore, Firmin Li, Guanhan Meggi, Bindiya Nou, Eric Gupta, Sundeep Kadede, Kevin Li, Jonathan Mehraj, Vikram Novikova, Mariia Gutiérrez, Carolina Kajubi, Richard Li, Weizhe Mehta, Sanjay Novitsky, Vladimir Haas, David Kallianpur, Asha Li, Xiang Mehta, Shruti Nowak, Piotr Haberlen, Sabina Kallianpur, Kalpana Li, Xiaojun Mendoza, Daniel Nowak, Rebecca Haeri Mazanderani, Ahmad Kanthula, Ruth Li, Yijia Menkova-Garnier, Inna O'Brien, Meagan Hamimi, Chiraz Karn, Jonathan Lifson, Alan Merchante, Nicolás O'Brien, Sean Hanna, David Karugaba, Patrick Lima, Viviane Merli, Marco Ocfemia, M. Cheryl Banez Harada, Shigeyoshi Katz, Ingrid Lin, Naomi Metsch, Lisa O'Connor, Jemma Hare, C. Bradley Kearney, Mary Lincez, Pamela Meyers, Kathrine Odayar, Jasantha Hataye, Jason Kelesidis, Theodoros Little, Susan Miailhes, Patrick Odongo, Fredrick Hatleberg, Camilla Kelley, Colleen Lo, Janet Micci, Luca Ofotokun, Ighovwerha He, Xuan Kersanske, Laura Lodi, Sara Mier-y-Teran-Romero, Luis O'Halloran, Jane Heffron, Renee Khan, Palwasha Loiseau, Claire Miles, Brodie Okano, Justin Hellmuth, Joanna Kiama, Catherine Longenecker, Chris Miller, Caitlin Okoboi, Stephen Hemanth Kumar, Agibothu Kiguoya, Marion López Varela, Elisa Miller, Elizabeth Olagunju, Adeniyi Kupparam Kim, Nina Lowenthal, Elizabeth Miller, Shannon Oldenburg, Catherine Hendrickson, Cheryl Kintu, Alexander Lucas, Gregory Minami, Rumi Oliver, Nora Hennessey, Claudine Kirkegaard-Klitbo, Ditte Luévano, Jesús Miro, Jose Olney, Jack Henrich, Timothy Kirkpatrick, Allison Luo, Ma Mohr, Raphael Olvera-García, Gustavo Hernandez, Matthew Kiselinova, Maja Ma, Qing Moltó, José Orrell, Catherine Hess, Kristen Kityo, Cissy Macalino, Grace Monel, Blandine Ott, Adina Hileman, Corrilynn Kleinstein, Sarah MacBrayne, Christine Montgomery, Martha Ozanne, Alexandra Hill, Alison Kluberg, Sheryl Mackelprang, Romel Moore, Carolyn Page, Iain Hill, Andrew Koelsch, Kersten MacLeod, William Moore, David Palar, Kartika Hinckley, Sandy Koethe, John Mailliard, Robbie Moragas, Matias Palchaudhuri, Riya Hleyhel, Mira Kong, Xiangrong Majonga, Edith Morawski, Bozena Palesch, David Hoare, Jacqueline Körner, Christian Makarova, Natalia Mori, Masahiko Palk, Laurence Hoffman, Risa Koss, Catherine Maki, Pauline Morris, Martina Parikh, Urvi Hoffmann, Christopher Kourtis, Athena Makinson, Alain Mothe, Beatriz Parker, Gary Hogan, Louise Kovari, Helen Malaba, Thokozile Moyo, Sikhulile Parker, Robert Holtz, Timothy Krakora, Rebecca Mallard, Jaclyn Moysi, Eirini Parkin, Neil Hong, Feiyu Kroidl, Arne Manabe, Yukari Mudd, Joseph Pasquale, Dana Hood, Julia Kumar, Nitasha Manak, Mark Mugglin, Catrina Patel, Eshan Hoots, Brooke Kumwenda, Johnstone Manganaro, Lara Mugo, Peter Patel, Hetal DisclsoureInformation Hoover, Karen Kuniholm, Mark Manne-Goehler, Jennifer Mugwanya, Kenneth Patel, Monita Hope, Rebecca Kurth, Ann Mannheimer, Sharon Mujugira, Andrew Patenaude, Bryan Horberg, Michael Kuruc, JoAnn Manuzak, Jennifer Mukerji, Shibani Pavlakis, George Howard, Andrea Kuwata, Takeo Manzardo, Christian Mulligan, Nikki Pavlinac, Patricia Howard, Louisa Kwarisiima, Dalsone Marcelin, Anne-Geneviève Münk, Carsten Pavone, Paolo Howarth, Alison Kwena, Zachary Marconi, Vincent Murnane, Pamela Pena-Cruz, Victor Hue, Stephane Kwong, Peter Maritz, Jean Murphy, Gary Pérez, Alejandro Hughes, Stephen Lachowsky, Nathan Markowitz, Martin Murray, Daniel Pernas, Maria Hullegie, Sebastiaan Lada, Steven Marra, Christina Mwangwa, Florence Peterson, Christopher Hurley, James Laeyendecker, Oliver Martinello, Marianne Myer, Landon Petrovas, Costantinos Imamichi, Hiromi Lahuerta, Maria Martin-Gayo, Enrique Mylvaganam, Geetha Pettifor, Audrey Innes, Steve Lai, Ming-Tain Martinson, Neil Nadel, James Phillips, Elizabeth Introini, Andrea Lake, Jordan Marzel, Alex Nash, Denis Phiri, Comfort Iqbal, Kashif Lakritz, Jessica Mascola, John Nassau, Tanner Phiri, Mwelwa Jahn, Andreas Lamers, Susanna Masetti, Michela Nattermann, Jacob Phupitakphol, Tanit
132 CROI 2016 Disclosure Information
Pickles, Michael Sarpel, Dost Summers, Michael Weigel, Bernard Piwowar-Manning, Estelle Saulle, Irma Sunshine, Sara Weiss, Kevin Pizzato, Massimo Scanlin, Kathleen Svicher, Valentina Weissman, Sharon Plana, Montserrat Schalkwijk, Stein Swartz, Talia Wejnert, Cyprian Plotkin, Marya Scherrer, Alexandra Sweat, David Wetzel, Katherine Poizot-Martin, Isabelle Schietroma, Ivan Switzer, William Wheeler, Darrell Ponte, Rosalie Schifanella, Luca Symons, Jori White, Darcy Porter, Sarah Schifitto, Giovanni Taburet, Anne-Marie White, Jessica Poteat, Tonia Schlusser, Katherine Tang, Songyuan Whittles, Lilith Power, Robert Schommers, Philipp Tang, Weiming Wilkinson, Thomas Powis, Kathleen Schonfeld, Daniel Tarancón, Laura Williams, John Prabhu, Vineet Schuetz, Alexandra Taylor, Barbara Williams, Paige Psomas, Christina Schultze, Anna Teasdale, Chloe Wilson, Eleanor Pufall, Erica Schulz, Christian Telwatte, Sushama Wilson, Kate Pushpakom, Sudeep Schutz, Charlotte Thienkrua, Warunee Winckelmann, Anni Quinn, Jeffrey Seaman, Michael Thio, Chloe Winter, Joanne Rajoli, Rajith Kumar Reddy Seifert, Sharon Thirumurthy, Harsha Wittkop, Linda Ramachandran, Sumathi Seipone, Ikanyeng Thomas, Aurielle Wiznia, Andrew Raymond, Stéphanie Sekaly, Rafick Thompson, Corbin Wohlfeiler, Michael Redd, Andrew Sengayi, Mazvita Tiendrebeogo, Thierry Wong, Ngai Sze Redmond, Sean Seremba, Emmanuel Tippett Barr, Beth Wood, Sarah Reepalu, Anton Severe, Karine Todesco, Eve Worobey, Michael Registre, Ludy Shanaube, Kwame Tokunaga, Kenzo Wu, Beiqing Remera, Eric Shapiro, Roger Tomescu, Costin Wu, Yuanfei Requena, Silvia Sharma, Anjali Torian, Lucia Yang, Shu Ribakare, Muhayimpundu Sharp, Joseph Torriani, Martin Yaylali, Emine Ribaudo, Heather Shepherd, Leah Tovanabutra, Sodsai Yebra, Gonzalo Rice, Mabel Shiau, Stephanie Trautmann, Lydie Yek, Christina Richardson, Eugene Shieh, Eugenie Treasure, Graham Yin, Li Riveira-Muñoz, Eva Shin, Sanghyuk Trickey, Adam Yolitz, Jason Rivera, Vanessa Shirakawa, Kotaro Truong, Hong-Ha Younas, Mehwish Rivera Pinto, Javier Shive, Carey Tsai, Ming-Han Yu, Wen-Han Roan, Nadia Shorenstein, Joshua Tully, Damien Yukl, Steven Roberts, Owain Shu, Sherry Turan, Janet Zahn, Jennifer Roberts, Sarah Siberry, George Underwood, Jonathan Zanni, Markella Rocafort, Muntsa Sibiude, Jeanne Uprety, Priyanka Zash, Rebecca Rodríguez-Arbolí, Eduardo Simon, Tracey Urano, Emiko Zaunders, John Rohner, Eliane Simonetti, Francesco Valcour, Victor Zerbato, Jennifer Rohr, Julia Simonich, Cassandra Valere, Kimyata Zheng, Wenjing Rolland, Morgane Simons, Lisa Valiaveettil, Christina Disclsoure InformationDisclsoure Romerio, Fabio Singh, Ravesh Van Cutsem, Gilles Rosen, Elias Singh, Urisha van der Straten, Ariane Rosen, Sydney Sinha, Arjun Van Handel, Michelle Rosenberg, Molly Sips, Magdalena Vanhommerig, Joost Rovelli, Cristina Sissoko, Daouda Vasan, Sandhya Roy, Monika Sluis-Cremer, Nicolas Vassallo, Matteo Rozada, Ignacio Smith, Jennifer Vaz, Paula Rubin, Eric Smith, Lou Venuto, Charles Ruperez, Maria Sobolewski, Michele Verna, Elizabeth Ryom, Lene Søgaard, Ole Villegas, Guillermo Ryscavage, Patrick Sohn, Annette Visseaux, Benoit S Arunachalam, Prabhu Solomon, Sunil Vivancos-Gallego, M.J. Sabri, Bushra Somasundaran, Mohan Vo, Quynh Sacktor, Ned Somsouk, Ma Vollbrecht, Thomas Sagaon Teyssier, Luis Stahlman, Shauna Wagner, Gabriel Sagar, Manish Stam, Arjen Waitt, Catriona Sagnelli, Caterina Steba, Gaby Walker, Bruce Salantes, Brenda Steele, Sarah Jane Walker, Naomi Salgado, Maria Stefic, Karl Walker-Sperling, Victoria Salmon-Ceron, Dominique Stek, Alice Wallis, Carole Samandari, Taraz Stella Ascariz, Natalia Wandeler, Gilles Samuels, David Stephenson, Kristine Wang, Jiayi Sanford, Ryan Stucki, David Wang, Ruibin Sania, Ayesha Sudjaritruk, Tavitiya Wang, Zhengyan Santiago, Mario Sultana, Tahmina Webel, Allison
CROI 2016 133 Index of Studies Related to Women INDEX OF STUDIES RELATED TO WOMEN The following index lists abstracts that noted women or women’s issues as the focus of the study. This index was developed for attendees with an interest in these issues. We encourage you to refer to the full program for other presentations that may address this subject.
TUESDAY, FEBRUARY 23, 2016 775 Pharmacokinetics of Increased Dose Darunavir During Late Pregnancy and Postpartum, Alice Stek, Univ of Southern California, 33 Breast Milk and In Utero HIV-1 Transmission Select for Unique Los Angeles, CA, USA, et al. (Poster Abstracts Session P-S2) Envelope Signatures, Thomas A. Wilkinson, Children’s Hosp of Los Angeles, Los Angeles, CA, USA, et al. (Oral Abstracts Session O-3) 776 High Risk of Liver Enzyme Elevation in Pregnant Women Receiving Protease Inhibitors, Jeanne Sibiude, CESP, INSERM U1018, 36 Impact of Maternal Tenofovir Use on HIV-Exposed Newborn Bone Le Kremlin-Bicêtre, France, et al. (Poster Abstracts Session P-S2) Mineral, George K. Siberry, Eunice Kennedy Shriver NICHD, Bethesda, MD, USA, et al. (Oral Abstracts Session O-3) 779 Maternal CMV Urinary Shedding in HIV-Infected Women and Congenital CMV Infection, Kristina Adachi, Univ of California Los 49 Male Partner Home HIV Testing vs Clinic Invitation in Pregnancy: Angeles, Los Angeles, CA, USA, et al. (Poster Abstracts Session P-S3) A Randomized Trial, Carey Farquhar, Univ of Washington, Seattle, WA, USA, et al. (Oral Abstracts Session O-5) 823 Long-term Effects on Basal Ganglia in Youth With Perinatally Acquired HIV Infection, Christine Paula de los Angeles, Northwestern 301 Oral PrEP Enhances Genital HIV-Neutralizing IgA in HIV-1 Exposed Univ, Feinberg Sch of Med, Chicago, IL, USA, et al. (Poster Abstracts Seronegative Women, Jairam R. Lingappa, Univ of Washington, Session P-T2) Seattle, WA, USA, et al. (Poster Abstracts Session P-E1) 828 Impact of HLA-B*81-driven Escape Mutation L188F on VRC in 438 Dolutegravir Pharmacokinetics in HIV-Infected Pregnant and Pediatric Slow Progression, Ming-Han Tsai, Univ of Oxford, Oxford, UK, Postpartum Women, Nikki Mulligan, Univ of California San Diego, San et al. (Poster Abstracts Session P-T3) Diego, CA, USA, et al. (Themed Discussion Session TD-1) 904 Young HIV+ Adults in Botswana Less Likely to Seek Treatment or 439 Rilpivirine Female Genital Tract Concentrations in Pregnant Be Virally Suppressed, Vladimir Novitsky, Harvard Sch of PH, Boston, and Postpartum Women, Mark Mirochnick, Boston Univ Sch of Med, MA, USA, et al. (Poster Abstracts Session P-W1) Boston, MA, USA, et al. (Themed Discussion Session TD-1) 919 Depression and Social Isolation Mediate Effect of HIV Stigma 638 Persistently Increased Ischemic Stroke Risk in HIV-Infected on Women’s ART Adherence, Janet M. Turan, Univ of Alabama at Women, Virginia A. Triant, Massachusetts General Hosp, Boston, MA, Birmingham, Birmingham, AL, USA, et al. (Poster Abstracts Session USA, et al. (Poster Abstracts Session P-P1) P-W3) 647 9-Year Trends in Non-Lipid Cardiovascular Disease Prevention 949 Association of Antiretroviral Use and Abnormal Uterine Bleeding Strategies in HIV+ Women, David B. Hanna, Albert Einstein Coll of in Women With HIV, Christina Valiaveettil, Univ of Toronto, Toronto, ON, Med, Bronx, NY, USA, et al. (Poster Abstracts Session P-P2) Canada, et al. (Poster Abstracts Session P-X1) 650 Reduced Ovarian Reserve Relates to Cardiovascular Disease Risk 1047 The Role of Young Women in the HIV Epidemic in Benin, West in Women With HIV, Markella V. Zanni, Massachusetts General Hosp, Africa, John R. Williams, Imperial Coll London, London, UK, et al. (Poster Boston, MA, USA, et al. (Poster Abstracts Session P-P2) Abstracts Session P-Y1) 770 No Increased Risk of HIV Incidence During Pregnancy, Chloe A. Teasdale, ICAP at Columbia Univ, New York, NY, USA, et al. (Poster Abstracts Session P-S1) WEDNESDAY, FEBRUARY 24, 2016 771 Effect of Pregnancy on Response to Antiretroviral Therapy 101 EFV Reduced PK of Piperaquine for Malaria Prevention in HIV+ Among African Women, Athena P. Kourtis, CDC, Atlanta, GA, USA, et al. Ugandan Pregnant Women, Richard Kajubi, Makerere Univ, Kampala,, (Poster Abstracts Session P-S1) Uganda, et al. (Oral Abstracts Session O-8) 772 Trends in Hospitalizations of Pregnant HIV-Infected Women in 102LB Concentrations of TFV and TFVdp in Female Mucosal Tissues After the USA: 2004–2011, Alexander Ewing, CDC, Atlanta, GA, USA, et al. a Single Dose of TAF, Katy L Garrett, Univ of North Carolina at Chapel (Poster Abstracts Session P-S1) Hill, Chapel Hill, USA, et al. (Oral Abstracts Session O-8) 773 Cost-Effectiveness of Cotrimoxazole Among HIV+ Pregnant 1058 Cost-Effectiveness of the Intravaginal Dapivirine Ring: A Women in Malarious Regions, Sung EunChoi, Stanford Univ, Stanford, Modeling Analysis, Jennifer Smith, Imperial Coll London, London, UK, CA, USA, et al. (Poster Abstracts Session P-S1) et al. (Poster Abstracts Session P-Y3) 774 Intracellular Atazanavir Concentrations Remain Stable During 109LB A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Pregnancy in HIV Women, Andrea Bonito, Univ of Brescia, Brescia, Prevention in Women, Jared M. Baeten, Univ of Washington, Seattle,
Index of Studies Related to Women to Studiesof Related Index Italy, et al. (Poster Abstracts Session P-S2) WA, USA, et al. (Oral Abstracts Session O-9)
134 CROI 2016 Index of Studies Related to Women 135 , Jasmini CROI 2016 , Ruby N. Fayorsey, ICAP, Columbia Columbia ICAP, N. Fayorsey, , Ruby , Ariane van der Straten, RTI, San RTI, der Straten, van , Ariane , Risa M. Hoffman, Univ of California Los Los , RisaCalifornia Univ of M. Hoffman, Index of Studies Related to Women , Beatrice A. Chen, Univ of Pittsburgh, Pittsburgh, Univ of A. Chen, , Beatrice , Maria Ruperez, Barcelona Inst for Global Inst for Barcelona , Maria Ruperez, , Muktar H. Aliyu, Vanderbilt Inst for Global Inst for Vanderbilt Aliyu, , Muktar H. , Katherine E. Bunge, Univ of Pittsburgh, Univ of Pittsburgh, E. Bunge, , Katherine , Catherine A. Koss, Univ of California San Univ of California A. Koss, , Catherine , Jennifer Jao, Icahn Sch of Med at Mount Sinai, Mount Sch Icahn of Med at Jao, , Jennifer , Elizabeth D. Lowenthal, Univ of Pennsylvania Pennsylvania Univ of Lowenthal, D. , Elizabeth , Landon Myer, Univ of Cape Town, Cape Town, Town, Cape Town, Univ of Cape Myer, , Landon , Valerie Benhammou, INSERM 1153, PARIS, Benhammou, INSERM 1153, PARIS, Valerie , a Lay Counselor-Led Combination Combination Counselor-Led Lay a , Ayesha Sania, ICAP, Columbia Univ Mailman Sch Univ Columbia Sania, ICAP, , Ayesha , Kate Clouse, Vanderbilt Inst for Global Hlth, Inst for Vanderbilt Clouse, , Kate , Barbara A. Friedland, Pop Council, New York, NY, NY, York, New Council, Pop , Barbara A. Friedland, , Landon Myer, Univ of Cape Town, Cape Town, South Town, Cape Town, Univ of Cape Myer, , Landon Viraemic Episodes Occur Frequently in Postpartum South Postpartum in Occur Episodes African Frequently Viraemic Detectable RNA With HIV-1 Women Pregnant in Resistance HIV Optimizing PMTCT Outcomes OptimizingNorth-CentralRural in PMTCT ANigeria: of Trial Randomized Follow-up to Lost Women Pregnant Among Care of Continuity in Retention With Associated Are DisclosureKnowledge and Pregnancy:in Impact cART Initiating DecayRNA HIV on HBV and HCV Infections in HIV-Infected Pregnant Women: HCVand HBV Women: Infections Pregnant HIV-Infected in Adolescent for Risk Factor Reactance Novel a Psychological Is PK, Geland Film of PD and Assess to Safety, Trial I Phase Rings in SafetyVaginal Dapivirineof Pharmacokinetics and Ring Vaginal Dapivirinea of Acceptability and Adherence in Zincand Acetate (MIV-150 PC-1005 of Trial First-in-Human A Viral Suppression and Retention 2–5 Years After ART Initiation Initiation ART After Years 2–5 Suppression Retention and Viral Birth Preterm DeficiencyD With Vitamin Associated Is Maternal Pregnancyin Initiation TimingART of Birthand Outcomes in by Stratified SGA and Preterm MortalityWith Risk Associated Hlth, Nashville, TN, USA, et al. (Poster Abstracts Session P-S5) (Poster USA, et al. TN, Hlth, Nashville, Abstracts (Poster USA, et al. NY, York, Univ Mailman Sch of PH, New Session P-S5) ART on Women Abstracts Session P-S6) (Poster al. et Africa, Delivery Mozambique in at AbstractsSession P-S6) (Poster Spain, et al. Hlth, Barcelona, Cluster-Randomized Study Cluster-Randomized Retention PMTCT Interventionfor ART Initiating After Abstracts Session P-S5) (Poster et al. TN, USA, Nashville, Option Program B+ Malawi’s AbstractsSession P-S5) (Poster CA, USA, et al. Angeles, Los Angeles, France, et al. (Poster Abstracts Session P-S7) (Poster et al. France, Abstracts Session P-V2) (Poster USA, et al. PA, Pittsburgh, Carrageenana Gel) of PH, New York, NY, USA, et al. (Poster Abstracts Session P-S7) (Poster USA, et al. NY, York, of PH, New ObstetricalOutcomes Failure Treatment HIV Abstracts (Poster USA, et al. Philadelphia, PA, SchMed, of Perelman Session P-T4) Tenofovir of Formulations Women US Postmenopausal Abstracts Session P-V2) (Poster USA, et al. PA, Pittsburgh, Women US Postmenopausal in Abstracts SessionP-V2) (Poster USA, et al. in Pregnancyin Uganda in Abstracts Session P-S6) (Poster CA, al. et USA, SanFrancisco, Francisco, in Women HIV-Infected South AfricanWomen Abstracts Session P-S7) (Poster et al. South Africa, Status HIV Maternal AbstractsSession P-V2) (Poster CA, USA, et al. Francisco, New York, NY, USA, et al. (Poster Abstracts Session P-S7) (Poster et al. USA, NY, York, New Alagaratnam, St Mary’s Hosp, Imperial Coll NHS Trust, London, UK, et al. UK, et al. London, Trust, NHS Imperial Coll Hosp, Mary’s St Alagaratnam, Abstracts Session P-S6) (Poster
795 797 790 791 792 793 794 804 833 871 872 873 875 796 798 799 803 , Seema N. Desai, Rush Univ Med Cntr, , Seema N. Desai, Rush Univ Med Cntr, , Laura J. Benjamins, The Univ of Texas Texas Univ of The Benjamins, J. , Laura , Megan Neary, Univ of Liverpool, of Liverpool, Univ , Megan Neary, , Annalene Nel, Intl Partnership for for Partnership Intl Nel, , Annalene , Jyoti S. Mathad, Weill Cornell Med Coll, Coll, Med Cornell Weill S. Mathad, , Jyoti , Landon Myer, Univ of Cape Town, Cape Cape Town, Univ of Cape Myer, , Landon , Sharon A. Greene, Univ of Washington, Washington, Univ of A. Greene, , Sharon , Mark Mirochnick, Boston Univ Sch of Med, SchBoston Univ , Mark Mirochnick, of Med, , John R. Koethe, Vanderbilt Univ Sch of Med, Univ Sch of Med, Vanderbilt , John R. Koethe, , Eliane Rohner, Inst of Social and Preventive of Social Inst and Preventive Rohner, , Eliane , Nikki Mulligan, Univ of California San Diego, San San Diego, California Mulligan, Univ of , Nikki , Catriona J. Waitt, Univ of Liverpool, Liverpool, UK, Liverpool, Univ of Liverpool, Waitt, J. , Catriona , Julie Fox, Guys and St Thomas’ NHS Fndn Trust, Trust, NHS Fndn Thomas’ GuysSt and , Julie Fox, omparing HIV-1 Cervical HIV-1 omparing Shedding After , Christine J. McGrath, Univ of Texas Med Branch at at Med Branch Texas Univ of McGrath, J. , Christine , Ann N. Burchell, St Michael’s Hosp, Toronto, ON, Toronto, Hosp, Michael’s St N. Burchell, , Ann tion, Cell Turnover, and Exhaustion in HIV+in Exhaustion and Turnover, Cell tion, , Arne Kroidl, Univ of Munich, Munich, Germany, et al. al. et Germany, Munich, Munich, Univ of Kroidl, , Arne , Virginia A. Triant, Massachusetts General Hosp, Boston, MA, Boston, MA, Hosp, Massachusetts General Triant, A. Virginia , PregnancyIFN-gamma the Suppression Intensifies in HIV of Superior Glucose Tolerance and Metabolite Profiles in Women vs vs Women in Profiles Metabolite and Tolerance SuperiorGlucose Women Postpartum & Pregnant HIV+ in Tuberculosis of Burden Persistently Increased Ischemic Stroke Risk HIV-Infectedin Stroke Ischemic Increased Persistently High Prevalence of HR-HPV Infection in HIV-Infected Women Women Infection HIV-Infected HR-HPV in of Prevalence High Feasibility of Post-Partum Testing for HR-HPV Among HIV- Among HR-HPV for Testing Post-Partum of Feasibility Cervicalin Cancer Screening HIV- Among Testing p16 of Role Decline in Annual Pap Testing Among HIV-Positive Women in Women HIV-Positive Among Testing Pap Annual in Decline Randomized Trial C Trial Randomized PK of FTC, TFV and 3TC in Ugandan and Nigerian Breastfeeding Breastfeeding Nigerian and Ugandan in 3TC and TFV FTC, of PK on Women Cervicalof Burden Global Cancer HIV-Positive in Single-Dose Maraviroc Provides High Drug Levels in All Sites; No Sites;All No in DrugHigh Levels Single-DoseProvides Maraviroc Effect of CYP2B6 Gene Variants on Levonorgestrel PK When PK EffectCYP2B6of Levonorgestrel on Variants Gene Dolutegravir Pharmacokinetics in HIV-Infected Pregnant and Pregnant HIV-Infected in Pharmacokinetics Dolutegravir Pregnant in Concentrations Tract Genital RilpivirineFemale Immune Activa SafetyEfficacy and HIV-1 Ring for Vaginal Dapivirineof Nashville, TN, USA, et al. (Poster Abstracts Session P-Q4) (Poster TN, USA, et al. Nashville, TB-Infected Women Indian Abstracts Session P-R8) (Poster et al. USA, NY, York, New Men on Long-Term ART Long-Term on Men South Africa Town, Capein (Poster Abstracts Session P-O2) (Poster Women TD-7) Discussion(Themed Session USA, et al. Abstracts Session P-R8) (Poster al. et South Africa, Town, InfectedWomen Tanzania From Positive and -Negative Women -Negative and Positive Abstracts Session TX, (Poster USA, et al. Houston, Houston, SchMed at P-O2) AbstractsSession P-O2) TX, (Poster USA, et al. Galveston, Galveston, Ontario, Canada Ontario, Abstracts Session P-O2) (Poster et al. Canada, et al. (Poster Abstracts Session P-H4) (Poster et al. LEEP CryotherapyVersus Mother-Infant Pairs Mother-Infant Therapy Antiretroviral AbstractsSession P-O2) (Poster USA, et al. WA, Seattle, Gender Differences Gender Abstracts SessionP-H4) (Poster UK, et al. London, Abstracts Session (Poster et al. Univ of Bern, Bern,Med, Switzerland, P-O1) and Women Postpartum ART EFV-Based With Combined Microbicides, Paarl, South Africa, et al. (Oral Abstracts Session O-9) (Oral et al. SouthAfrica, Paarl, Microbicides, Abstracts Session P-C7) (Poster et al. IL, USA, Chicago, Women Postpartum AbstractsSession P-H2) (Poster CA, USA, et al. Diego, Abstracts Session P-H2) (Poster al. et USA, Boston, MA, Abstracts Session P-H3) (Poster UK,al. et Liverpool, Prevention in African Women African in Prevention Heavy Use Alcohol With Women
758 706 757 638 625 623 624 622 621 449 617 448 444 438 439 277 110LB Index of Studies Related to Women
876 CVLs From Women Vaginally Dosed With PC-1005 Inhibit Mucosal 863 Is Menopause Associated With Unprotected Sex in High-Risk HIV- HIV-1 and HSV-2 Ex Vivo, Guillermo Villegas, Pop Council, New York, Positive Kenyan Women?, Marielle S. Goyette, Univ of Washington, NY, USA, et al. (Poster Abstracts Session P-V2) Seattle, WA, USA, et al. (Poster Abstracts Session P-U1) 973 Effect of Secondary Distribution of HIV Self-Tests on Women’s 864 Fertility Desire, Unprotected Sex, and Viral Load in HIV-Positive Sexual Decision-Making, Harsha Thirumurthy, Univ of North Carolina FSWs in Kenya, Kate S. Wilson, Univ of Washington, Seattle, WA, USA, et at Chapel Hill, Chapel Hill, NC, USA, et al. (Poster Abstracts Session P-X3) al. (Poster Abstracts Session P-U1) 865 Inaccurate Reporting of Condom Use Among Women Using Injectable Contraception, Renee Heffron, Univ of Washington, Seattle, THURSDAY, FEBRUARY 25, 2016 WA, USA, et al. (Poster Abstracts Session P-U1) 168LB Option B+ in Malawi: Have 4 Years of “Treat All” Shown That 90-90-90 Is Achievable?, Beth Tippett Barr, CDC, Harare, Zimbabwe, et al. (Oral Abstracts Session O-15) 285 Seminal Plasma Induces Inflammation and Enhances HIV-1 Infection in Cervical Explants, Andrea Introini, Karolinska Inst, Stockholm, Sweden, et al. (Poster Abstracts Session P-C8) 162 Is Intensive Cervical Cancer Screening Justified in Immunosuppressed Women?, Michael J. Silverberg, Kaiser Permanente Northern California, Oakland, CA, USA, et al. (Oral Abstracts Session O-14) 301 Oral PrEP Enhances Genital HIV-Neutralizing IgA in HIV-1 Exposed Seronegative Women, Jairam R. Lingappa, Univ of Washington, Seattle, WA, USA, et al. (Themed Discussion Session TD-15) 422 Liver Fibrosis Linked to Cognition in HIV and HCV: The Women’s Interagency HIV Study, Victor Valcour, Univ of California San Francisco, San Francisco, CA, USA, et al. (Poster Abstracts Session P-G5) 720 Prevalence of Falls Among Older Women in the Women’s Interagency HIV Study, Anjali Sharma, Albert Einstein Coll of Med, Bronx, NY, USA, et al. (Poster Abstracts Session P-Q7) 726 Immunological Signaling During HSV-2 and CMV Vaginal Reactivation at ART Initiation, Andrew D. Redd, NIAID, NIH, Bethesda, MD, USA, et al. (Poster Abstracts Session P-Q9) 789 Malawi’s Option B+ 2011-2015: The Impact of Rapid ART Decentralizatio, Sundeep K. Gupta, CDC, Lilongwe, Malawi, et al. (Themed Discussion Session TD-14) 790 Optimizing PMTCT Outcomes in Rural North-Central Nigeria: A Cluster-Randomized Study, Muktar H Aliyu, Vanderbilt Inst for Global Hlth, Nashville, TN, USA, et al. (Themed Discussion Session TD-14) 791 Randomized Trial of a Lay Counselor-Led Combination Intervention for PMTCT Retention, Ruby N. Fayorsey, ICAP, Columbia Univ Mailman Sch of PH, New York, NY, USA, et al. (Themed Discussion Session TD-14) 792 Continuity of Care Among Pregnant Women Lost to Follow-up After Initiating ART, Kate Clouse, Vanderbilt Inst for Global Hlth, Nashville, TN, USA, et al. (Themed Discussion Session TD-14) 793 Disclosure and Knowledge Are Associated With Retention in Malawi’s Option B+ Program, Risa M. Hoffman, Univ of California Los Angeles, Los Angeles, CA, USA, et al. (Themed Discussion Session TD-14) 861 Correlates of Injectable Contraceptive Discontinuation Following HIV-1 Seroconversion, Margaret R. Caplan, David Geffen Sch of Med at Univ of California Los Angeles, Los Angeles, CA, USA, et al. (Poster Abstracts Session P-U1) 862 Correlation Between Cotherapy of Efavirenz-Based ART and Index of Studies Related to Women to Studiesof Related Index Pregnancy Among Women, Stephen Okoboi, TASO-Uganda, Kampala, Uganda, et al. (Poster Abstracts Session P-U1)
136 CROI 2016 Author Index 137 , 469LB 293 , 283, 445, CROI 2016 253 105 96 199 Author Index Author , 382, 385 , 946 532
61 507 768 , 384, 404, 405, 407,, 384, 404, 349 415, 956 928 287, 169aLB, 867 169aLB, Anastos, Kathryn:593, 647 Anastos, Beau M.: Ances, Amr, Sami S.: 360 Amr, Timothy: 513 Amukele, 978 Mbaraka: Amuri, Gabriel: 833 Anabwani, Santhanam: 918, 899, Anand, 219, Jintanat: Ananworanich, 764 Alfred: Andama, Nisha: Andany, Albert:Anderson, 412 D.: Brett Anderson, Bridget:991 Anderson, 501, 393 Caroline: Anderson, Christy:Anderson, 224, 232 711 David: Anderson, S.: Erik Anderson, L.: Peter Anderson, Anderson, Sarah-Jane: 1049 Sarah-Jane: Anderson, Dale K.: 358LB Ando, 104 Adriana: Andrade, Jaime: 472 Andrade-Villanueva, Massimo: 570 Andreoni, 238 Mauro: Andreotti, Chasity D.: Andrews, Andrews, Laurie: 411 Laurie: Andrews, 94 Sarah F.: Andrews, Sophie M.: Andrews, Mario: 570 Angelico, Konstantia: Angelidou, B.: Stravinsky Anglade, 75LB Xavier: Anglaret, Brian: 474 Angus, Ank, Bonnie: 779 98 Wendy: Ankrom, Azim: Ansari, 827 Kaitlin: Anstett, 1025 Gretchen: Antelman, Donald: 329 Anthony, Andrea: Antinori, 522 Guillemette: Antoni, 527 Rivero-Juárez: Antonio, 622 Tony: Antoniou, ,
614 , 197, 231, , 371 663 790 178 141 1039 150 18LB , 699 294, 315, 370 639 336 688 Alford, Taylor: 445 Taylor: Alford, Charity:850 Alfredo, Sabina: 1056 Alistar, 502 Ahmad: Aliyu, H.: Muktar Aliyu, 1051 T.: Benjamin Allaire, Salim: Allana, 756 157, 355 Brigitte: Allard, 709 Clotilde: Allavena, Mary:Allen, 90 231, 294 M.: Todd Allen, G.: 491LB Vanessa Allen, 992, 1008 Adam: Allston, 809 Volia: Almeida, Marcela: Alsan, Althoff, Keri N.: Keri Althoff, Alter, Galit: 91, 305, 308 Alter, Claudia: Alteri, Marcus: Altfeld, Alvarez Del Arco, Debora: 901 Del Arco, Alvarez 590, Alejandro: Alvaro-Meca, 816 Carmelita: Alvero, Mary G.: 983 Alwano, Gideon: 112 Amanyire, 701 Jacques: Amar, 432, 434, 448 Alieu: Amara, 286 Rama: 93LB, Amara, 809 Fabiana: Amaral, 901 Andrew: Amato, Nilesh: 292 Amatya, 753 Pradeep: Ambrose, 229 Zandrea: Ambrose, 819 Alessandro: Ambrosi, Juan: 303, 468 Ambrosioni, 94, 245LB, David: Ambrozak, Maria Jose: 508 Amengual, K. R.: 103, 866, 884 Amico, 545 Janaki: Amin, 413 Adriana: Ammassari, Alvarez, Elena: 668 Elena: Alvarez, Xavier: Alvarez, Alvarado, Melanie: Alvarado, Angeles: Alvarez, , 288 186 794
7, 1001, 895 318 17 , 810 1005 800 Agarwal, Dipti:Agarwal, 457 Oche: 564 Agbaji, Adamma: Aghaizu, A.: 959 Aghokeng, 185, 288 Luis: Agosto, 973 Kawango: Agot, 781 Parth: Agrawal, 345 Melissa: Agsalda-Garcia, 571, 572 Fernando: Aguero, Irma: 251 Aguilar-Delfín, 251 Tania: Aguilar-García, Wbeimar: 247 Aguilar-Jiménez, 634 Koldo: Aguirrebengoa, L.: Allison Agwu, 528 Charisse: Ahmed, Rafi: 93LB Ahmed, 1048 Shahira: Ahmed, 1020 Laurence: Ahoua, Moha, Daoud: 948 Ait Sulaiman: 929 Aizezi, 862 Eunice: Ajambo, Gbolahan: 784, 37, Ajibola, Sulaimon: 498 Akanmu, Suleiman: 281 Akanmu, Siriwat: Akapirat, 206 Akari, Hirofumi: Julie:922, 923 230, Ake, Hisashi: 185, Akiyama, Ramesh: 450 447, Akkina, 528 Elizabeth: Akoth, Sadeer:Kindi, Al 649 Jasmini: Alagaratnam, Mohcine: 875 Alami, Michel: 1047 Alary, 694 Albert, Jeffrey: 965 Helmut: Albrecht, José: 303, 468 Alcamí, 426 Chiara: Alcantarini, Mark A.: 371 Alday, 467 Anna: Aldovini, Sol: 335 Aldrete, M.: 33, 807 Grace Aldrovandi, Belen: 901 Alejos, E.:959 Alessandri-Gradt, Bertur:Alface, 975, 975 81
, 680 , 39, 757,, 39,
496 , 828 34 269 779 302
1057
770, 786, 791, 795, 799, 808, 851 AUTHOR INDEX AUTHOR Bold numbers indicate a presenting author role for that abstract. Any updates will be reflectedbe will app. mobile the in updates abstract. Any that for role author presenting a indicate numbers Bold –A– Hadega: 88 Aamer, Aartun, 600 Johannes: Ume: Abbas, Abbink, 431 Evertine: 552 Enass: Abdel-hameed, 153 Mohammed: Abdel-Hamid, Hanaa: 153 Abdel-Maguid, Mohamed: Abdel-Mohsen, Abdul-Sada, 692 Alaa: Shaheed A.: 268 Abdulhaqq, 115 Fareed: Abdullah, Judith:44LB Aberg, 290 Faten: Aberra, Sophie: 675, 941, 943 Abgrall, 502 Alash’le: Abimiku, 465 D.: Sherimay Ablan, 406 Jeremy: Abolade, Michael:947 660, Aboud, Mahmoud: 153 Abouelkhair, Manuel: 571 Abradelo, 691 684, 688, Alison: Abraham, Michael E.: Abram, Lucy: 864 Adala, 384 Collin: Adams, 447 Lourdes: Adamson, 922 Sylvia: Adebajo, 502 Clement: Adebamowo, 919 Adebola: Adedimeji, Joseph A.: 380 Adelsberger, 574 Oluwatoyin: Adeyemi, Titilope: 281 Adeyemo, 422, 919 Ada: Adimora, E.: 608 Luigi Adinolfi, Emily: Adland, Abubakar, Ibrahim R.: 1053 R.: Ibrahim Abubakar, Robinah: 862 Acham, 618, 644 Chad: Achenbach, 206 Akio: Adachi, Kristina: Adachi, Sama S.: Adnan, Aegerter, Philippe: 420 Aegerter, 346, 347 Evgenia: Aga, Brian: 932 Agan, Abrams, Elaine J.: J.: Elaine Abrams, Author Index
Anty, Rodolph: 455 Avettand-Fenoel, Veronique: 271 Ballana, Ester: 183, 205, 207 Barton, Kirston: 348 Anugulruengkitt, Suvaporn: 857 Avihingsanon, Anchalee: 606 Ballell, Lluís: 158LB Basavaraj, Anita: 752 Anzinger, Joshua: 711 Avila-Rios, Santiago: 477 Ballif, Marie: 737 Baseke, Joy: 733 Apea, Vanessa: 996 Awazi, Bih: 212 Ballo, Tako: 921 Bassett, Ingrid V.: 1016 Apetrei, Cristian: 258LB Aweeka, Francesca: 101 Balzer, Laura: 985 Bassett, Jean: 845 Apornpong, Tanakorn: 606 Ayakaka, Irene: 764 Bamshad, Michael J.: 17 Bastard, Jean Philippe: 701 Appelberg, Sofia: 257 Ayieko, James: 116, 841 Bancu, Ioana: 432 Bastides, Frederic: 400 Aquilante, Christina: 445 Ayles, Helen: 114, 120, 156, Bandason, Tsitsi: 853 Bastow, Barbara: 161 Arasteh, Keikawus: 470 165, 523, 980, 981, 982 Bandera, Alessandra: 18LB, 280 Batavia, Ashita: 473 Aravantinou, Meropi: 270 Azzoni, Livio: 290, 296, 299 Bang, Anne: 395 Batista, Facundo: 127 Arazi Caillaud, Solange: 837 Banga, Riddhima: 82 Batista, Pedro: 597 Archin, Nancie M.: 355 –B– Bangsberg, David R.: 227, 429, Batorsky, Rebecca E.: 231 Arellano, Gemma: 1010 Ba, Selly: 961 1014, 1029 Batra, Jagmohan: 817 Arends, Joop E.: 542, 543 Baba, Masanori: 504 Bangura, Lamin: 910 Battalora, Linda A.: 698, 708 Arendt, Marina: 646 Babiker, Abdel: 45, 87, 160 Bani-Sadr, Firouzé: 605 Battegay, Manuel: 567, 592, Arevalo, Claudia: 308 Babusis, Darius: 107 Bannert, Norbert: 485 630, 676, 951 Ariaudo, Alexandra: 454 Bachanas, Pamela J.: 983 Bañón, Sara: 452 Bauer, Asli: 625 Ariyoshi, Koya: 314 Back, David J.: 441, 442, 444, Bansal, Anju: 292, 313 Baumgarten, Axel: 584, 589 Armakovitch, Sandra: 743 448, 459, 874 Bao, Jing: 747 Bautista-Arredondo, Sergio: Armenia, Daniele: 489 Backfish, Kathleen A.: 541 Bar, Katharine J.: 32LB, 92, 292 1059 Armon, Carl: 544, 698, 708 Bacon, Oliver: 524, 867, 870 Baral, Stefan: 922, 923, 924, 925 Bayigga, Lois: 297 Armstrong, Wendy: 1039 Badia, Roger: 183, 205, 207 Barasa, Chrisotin W.: 791 Bayne, Madeleine: 309LB Arnedo, Mireia: 248 Badley, Andrew D.: 243 Barasky, Rebecca: 390 Bayoumi, Ahmed M.: 622 Arpadi, Stephen M.: 40, 851 Baeten, Jared M.: 17, 109LB, Barbas, Coral: 354 Bazaale, Jeremiah M.: 902 Arribas, Jose R.: 45, 669 164, 301, 478, 728, 740, 771, Barbuat, Claudine: 276 Beauchamp, Geetha: 883LB Arshad, Omair: 715 865, 868, 1063 Bardsley, Mark: 32LB Beaumont, David: 268 Arthos, James: 198 Bagala, Irene: 862 Bargalló, Manel Enric: 248 Beaumont, Tim: 152 Artrip, Cristah: 389 Bailer, Robert: 90 Baril, Jean-Guy: 237 Beavogui, Abdoul H.: 75LB Ásbjörnsdóttir, Kristjana H.: 50 Bailey, Angela: 683 Barin, Francis: 222, 232, 400, Becerril, Carlos: 307 Ashby, Deborah: 423LB Bailey, Justin R.: 135 840 Beck, Graham: 403 Ashton, Lynne: 225 Bailey, Michelle: 233, 334 Barnabas, Ruanne V.: 49, 740, Beck, Ingrid: 494LB, 847 Asiimwe, Stephen: 740 Bain, James: 705 1063 Becker, James T.: 388, 416 Asila, Victor: 49 Baisley, Kathy: 169LB, 1030 Barnard, Marinus: 158LB Becker, Kyra J.: 636 Asire, Barbara: 844 Baker, David: 451, 545 Barnes, Tiffany L.: 95LB Becquet, Renaud: 1015 Asmuth, David: 265, 278 Baker, Jason V.: 41, 659 Barnett, Louise: 653 Bedimo, Roger: 645, 714 Assoumou, Lambert: 332 Baker-Genaw, Kimberly: 531 Barnett, Susan: 317 Beer, Linda: 53, 497, 1004 Astemborski, Jacquie: 548, Bakker, Arjen Q.: 152 Barnhart, John: 964 Beerenwinkel, Niko: 208 712, 917 Bakshi, Rahul: 104 Barnholtz-Sloan, Jill: 409 Béguelin, Charles: 592 Aston, Stephen J.: 769 Balachandran, Madhu: 893 Bärnighausen, Till: 167, 169LB, Behel, Stephanie K.: 983 Atta, Mohamed G.: 651, 687 Balagopal, Ashwin: 135, 151, 677, 678, 679, 703, 905, Beima-Sofie, Kristin: 780 Attia, Alain: 568 712 907, 960, 1003, 1011, 1012, Bekker, Linda-Gail: 48LB, 110LB, Atugonza, Rita: 842 Balaji, Alexandra: 930, 931 1013, 1048 852, 854, 1055 Aubert, Rachael: 878 Balakrishnan, Pachamuthu: Barqasho, Babilonia: 267 Belaunzarán-Zamudio, Pablo F.: Aubert, Vincent: 951 899, 928 Barr, Emily: 438 296, 299 Aubin, Darley: 1017 Balasubramaniam, Barrail-Tran, Aurélie: 455 Bellido, Rocio: 797 Audet, Carolyn M.: 790 Muthukumar: 137 Barreto-de-Souza, Victor: 184 Bellini, Giulia: 557, 608 Augusto, Orvalho J.: 974, 976 Balasubramanian, Usha: 758 Barrett, Brad J.: 187 Bello, Fatai O.: 281 Auld, Sara C.: 157 Balcha, Taye T.: 744 Barrett, Stephanie E.: 98 Bellón, José M.: 527, 611 Author Index Author Aulicino, Paula: 837 Baldessari, Audrey: 356 Barrie, Mohamed B.: 72LB Bellot, Clovy: 1017 Aung, Htin: 733 Bale, Michael: 85 Barrington, Francine: 388 Beloukas, Apostolos: 482 Aunon, Frances: 1034 Balestra, Emanuela: 18LB Barrios, Rolando A.: 492LB Bendavid, Eran: 117, 773, 937, Aurpibul, Linda: 831, 860 Balkau, Beverley: 701 Barros-Aguirre, David: 158LB 1056 Autran, Brigitte: 332 Balkus, Jennifer E.: 861 Barry, Moumié: 73LB Bender Ignacio, Rachel A.: 632 Avelino-Silva, Vivian I.: 326 Ball, Blake: 195 Bartmeyer, Barbara: 485 Benfield, Thomas: 690
138 CROI 2016 Author Index 139 960 , 402 , , 480 , 948 401 957 604 CROI 2016 , 915, 1004, Author Index Author 218 53 666 531 590 182 Cofano, Egidio: 258LB Egidio: Cofano, , 1009 1006, 1037, 1045 798, 868 1038 994 263, 275LB 854 Boyd, Mark: 233, Mark: Boyd, Simon: 253 Brackenridge, 443 Yuki: Bradford, 285 Frideborg: Bradley, Heather: Bradley, 931, 1002 Kathleen: Brady, Martine:Braibant, 400 Diana154LB M.: 99, Brainard, 51, 1042 Paula: Braitstein, Branca, Sebastian: 1002 588, Andrea: Branch, Bourdery, Laure: 295 Laure: Bourdery, 271 Christine: Bourgeois, Kassem: Bourgi, 583 Marc: Bourlière, 400 Mélanie: Bouvin-Pley, 812 Jennifer: Bowes, 889 Kristina: Bowles, 724 Bowman,Christine: M.: Bowman,Natalie Brocca- Mark A.: 190 Brockman, Briz, Verónica: Briz, Verónica: Brander, Christian: 247, 320 Christian: Brander, 989, 997, Bernard: Branson, 531 Indira: Brar, DominiqueBraun, L.: 89LB Sarah L.: 908, 931, Braunstein, 169bLB Jennifer: Breakey, 283 Elizabeth: Breen, 583 Sylvie: Brégigeon, Viviane: 485 Bremer, Jason M.: 21, 94, Brenchley, 827 Jacqui: Brener, 845, Alana: Brennan, Brennan, Catherine: 213 Catherine: Brennan, 660 Clare: Brennan, Bluma G.: Brenner, Bresnahan, Marie P.: 534 Marie P.: Bresnahan, Yann: Breton, 391 J.: Bruce Brew, Russell: 893 Brewer, Josephine: 840 Brice, E.: 934 Cristina Brickman, R.: 382 Matthew Brier, 547, Kees: Brinkman, 29 Brinson, Cynthia: Brittain,Kirsty: 799, 808, 852, , 630 160 , 1012, , 594 46 490 1011 774 76LB 1048 , 763 762 1013, 1028, 300LB, 346, 347, 350 300LB, 286, 352 1022 761, oll, Annegret: 363 Annegret: oll, Bordoni, Veronica: 413 Veronica: Bordoni, H.: Alvaro Borges, Boleo, Coretah: 984 Coretah: Boleo, B 901 Francisco: Bolumar, Bommart,Sébastien: 675 951 Böni, Jürg: Bonilla,Hector: 551 Andrea: Bonito, Bollinger, Robert: 752 Bollinger, Timothy: 788 Bollinger, 510 Alex: Bolo, Bologna,Rosa: 837 Boltz,F.: Valerie Bonjoch, 432 Anna: 566 Fabrice: Bonnet, Guillaume: 381 Bonnier, 426, 454, 774 Bonora, Stefano: 975 516, Juvencio: Bonzela, H.: 733 W. Boom, Boon, Denali: 540, 336 Boritz, 245LB, Eli: 260 Bork,Peer: 189 Arndt: Borkhardt, Maarten:110LB Borremans, Doortje: 139 Borrenberghs, 133 Persephone: Borrow, Bortz, M.: 371 Eric Bosch, 43, 293, 294, Ronald: 25, 349 Meera: Bose, E.: 20, 22, Steven Bosinger, Alberto:Bosque, 360 285 Stéphanie: Boström, 890 H.: Stephen Boswell, Danielle: 583 Botta-Fridlund, Julie: 605 Bottero, Bouassida, Iskander: 675 Boucau, Julie: 312 A.: 536, 1052 Charles Boucher, 657 Morgan: Boucher, 423LB George: Bouliotis, 117, 759, 960, Andrew: Boulle, R.: 159, 760, David Boulware, 227 Boum, Yap: Boonrai,Kailip: 869 484 Booth, Clare: I.: 451, 545 Rohan Bopage, 960, Jacob: Bor, Bolay, Fatorma: Fatorma: Bolay, , 133 498 747 858 179 429 924 849 560, 589 619, 631 1055, 1060 Bhosale, Ramesh: 758 Bhosale, 247, 280 Biasin, Mara: Frederic: Bibollet-Ruche, Bienczak, Andrzej: 220 F.: Woulter Bierman, Bila, Dulce A.: 850 572 Itxarone: Bilbao, James M.: 269 Billingsley, 802 Binda, Kelebogile: A.: 55 George Bishopric, Bissa,317 Massimiliano: 745, Bisson, Gregory P.: Bitnun, 836 Ari: 744 Per: Björkman, 35LB Christopher: Blair, 506 Wade: Blair, 945 Blanch, Jordi: James: 270 Blanchard, 770 Kelly: Blanchard, 811 776, Stéphane: Blanche, 945 Jose L.: Blanco, Julià: 241, 366 Blanco, Mª José: 586 Rodríguez, Blanco Marino: 571, 572 Blanes, Blank, 1035 Jackie: Blankson,374, 830 N.: 135, Joel A.: 922, 923, William Blattner, 790 Meridith: 746, Blevins, Blick, Gary: 358LB A.: Blish, Catherine Bloch,545 Mark: 451, Blok, Willem: 948 Jolien: 139 Blokken, 541 149, Sara J.: Blosser, Sally: 1044, 1054 Blower, 114, 165 Bock,Peter: Sonia: Tamara Boender, Boerma, Ragna849 S.: 236, Christoph: Boesecke, C.: David Boettiger, Marta: 448 Boffito, Bogart,1016 M.: 1014, Laura Sahithi: 781 Boggavarapu, Johannes: 630 Bogner, 762 762, Bohjanen, Paul: Julia: 613, 617, 618,Bohlius, Marie-Claude:1047,1046, Boily, 441 Bolaji, Oluseye: 543 J.: Greet Boland, 639 , 542 , , 1005 221 669 611 , 804 , 623 45 920 1001 527 704 596 , 775 Idrissi: 655 Idrissi: 384 612, 951 439 Bhattacharya: 309LB Benhammou, Valerie: Benhammou, Valerie: Benhnia,Rafii-El- Mohammed Jose M.: Benito, J.: Laura Benjamins, Bengtson, Angela: Khunthalee: Benjapornpong, Sarah: 38 Benki-Nugent, Monsef:Benkirane, 468 295, 358LB Clarisse: Benne, 810 784, 37, Kara: Bennett, 458 Alex: Benns, 949 Anita: Benoit, 421, 753 A.: Benson, Constance Benson, Jamie: 514 Juan: Berenguer, Bergamaschi, Cristina K.: Cristina 259LB Bergamaschi, 525 Annemarie: Berger, S.: 44LB Jeffrey Berger, 468 Mercedes: Bermejo, Daphne: 473 Bernard, 400 Louis: Bernard, Jose I.: Bernardino, Bernasconi, Enos: 567, 592,Bernasconi, Enos: 709 Camille: Bernaud, A.: Stephen Berry, 117 Anna: Bershteyn, Bertine, Mélanie: 214 Bertoli, 18LB Ada: Berzins, Baiba: 147 Besa, 980 Stable: John: 1039 Beshears, 138 W.: Julian Bess, 214 Amel: Besseghir, M.: 395, 433, 438, Brookie Best, Nina: 249, 322 Bhardwaj, 850 Nilesh: Bhatt, 937 Bhattacharya, Jay: Bhattacharya, Tanmoy 574 Laveeza: Bhatti, 457 P.K.: Bhavani, Bhondai,Muchaneta: 815 Best, John: 969 Best, Michael R.: 24, 254, 733 Betts, Martin: 724 Bewley, 165, 982 Nulda: Beyers, Daniela: 220, Bezemer, 154LB Bhagani,Sanjay: Priya: Bhagwat, Author Index
Brockmeyer, Norbert H.: 628 Burmen, Barbara: 903 Campbell, Ellsworth M.: 215 Castells, Lluis: 571 Brodt, Hans-Reinhard: 713 Burns, Fiona: 996 Campbell, Jennifer: 272 Castillo-Mancilla, Jose R.: 283, Broliden, Kristina: 285, 301 Burt, Richard: 933 Campbell, Thomas B.: 728 421, 445 Brooks, John T.: 132, 544, 591, Burwitz, Benjamin J.: 21 Canaday, David H.: 296, 299, Castor, Trevor: 354 698, 708, 916, 1006 Busch, Heiner: 584 733 Cauda, Roberto: 417, 697 Brooks, Kristina M.: 430 Bush, William: 409 Canan, Chelsea: 911 Cavassini, Matthias: 82, 381, Brophy, Jason: 812, 836 Bushman, Lane R.: 445 Cannizzo, Stefania: 598 612, 951 Brouckaert, Peter: 91 Bushnell, Cheryl D.: 638 Cannon, Paula M.: 78 Cazabat, Michelle: 289, 950 Brown, Charlene: 978 Buskin, Susan: 971 Canonico, Pier Luigi: 204 Cazanave, Charles: 689 Brown, Dannae: 947 Bütikofer, Lukas: 617, 618 Cantone, Joseph: 466 Ceccarelli, Giancarlo: 238 Brown, Elizabeth R.: 109LB Butt, Adeel A.: 551, 581, 645, Cao, Wei: 237 Ceccherini-Silberstein, Brown, Lillian: 985 714 Capeau, Jacqueline: 271, 701 Francesca: 18LB, 413, 489, Brown, Lou Ann: 255 Buzon, Maria J.: 361 Capelli, Silvia: 819 570, 946 Brown, Nathaniel: 153 Bvochora-Nsingo, Memory: 615 Capina, Rupert: 319 Celentano, David: 899, 918, Brown, Sheldon: 633 Bwakura-Dangarembizi, Capitant, Catherine: 886, 887 928, 1032 Brown, Todd T.: 144, 147, 283, Mutsawashe: 458 Caplan, Margaret R.: 861 Celum, Connie M.: 17, 164, 478, 609, 672, 694, 695LB, 699, Byakika-Kibwika, Pauline: 444 Capobianchi, Maria R.: 946 728, 740, 771, 865, 868, 1063 700, 704, 914, 939 Bygrave, Helen: 512, 787 Capoluongo, Nicolina: 608 Cent, Anne: 728 Brown, William L.: 200 Bygum Knudsen, Troels: 690 Capparelli, Edmund: 32LB, 438, Cepeda, Javier A.: 548 Browne, Sara H.: 658 Byonanebye, Dathan: 116, 439, 440, 458, 775, 815 Cernuschi, Massimo: 627 Browning, Renee: 36 843, 1026 Carballo-Diéguez, Alex: 108LB Cerqueira, Fernanda: 91 Bru, Camille: 152 Byrne, Morgan: 932 Carcelain, Guislaine: 332 Cerrone, Maddalena: 598 Brumme, Chanson J.: 483 Carcenac, Romain: 950 Cespedes, Michelle: 161 Brumme, Zabrina: 190 –C– Cardoso, Judite: 975 Chachage, Mkunde: 625 Bruner, Katherine M.: 83, 339 Caan, Matthan W.: 148 Carlqvist, Anna: 828 Chadwick, David: 482, 683 Brust, James C.: 157, 756 Caballero, Gemma: 228, 232 Carlson, Jonathan: 231, 313, 828 Chadwick, Ellen G.: 458 Bryant, Kendall J.: 277, 554 Cabello, Alfonxo: 596 Carlson, Margaret: 376 Chahroudi, Ann: 22, 353, 826, Bryson, Yvonne J.: 779 Cabezas, Teresa: 508 Carlucci, James G.: 746 859 Buchacz, Kate: 544, 698, 708, Cabié, André: 709 Carmona, Sergio: 1013, 1028 Chaila, Joseph M.: 981 989 Cabrera, Cecilia: 241 Carnathan, Diane: 353 Chaillon, Antoine: 143, 222, Buchanan, Annie: 816 Cachay, Edward R.: 603 Caro- Vega, Yanink: 296, 299 228, 232, 400, 487 Buchbinder, Susan P.: 524, Caddy, Sheila: 949 Carpio, Felix: 953 Chaisson, Christine E.: 1016 867, 870 Cagigi, Alberto: 324 Carr, Andrew: 668 Chaix, Marie Laure: 222, 522 Buck, William C.: 850 Cahn, Pedro: 718, 947 Carrere, Nicolas: 289 Chakhtoura, Nahida: 438, 439, Buckheit, Karen W.: 169bLB Cai, Suqin: 481 Carrieri, Patrizia: 549, 582 458, 775 Buckheit Jr, Robert W.: 169bLB Cai, Weiping: 955 Carriquiry, Gabriela: 958 Chakraborty, Rana: 781, 817 Buckingham, Kati: 17 Cai, Yanshan: 970 Carroll, Michael C.: 128 Chalermchai, Thep: 404 Budd, Matthew: 812 Calascibetta, Francesca: 353 Carroll, Miles W.: 75LB Chamie, Gabriel: 829, 841, Budoff, Matthew: 641, 652 Calcagno, Andrea: 63, 426, 774 Carta, Stefania: 413 979, 1062 Buggert, Marcus: 254 Calderon, Yvette: 968 Cartwright, Emily K.: 22 Chan, Ellen S.: 147, 695LB, 700 Bui, John K.: 340, 379 Calin, Ruxandra: 332 Casado, Concepcción: 338 Chan, Philip: 891 Bukusi, Elizabeth: 829, 979 Calis, Job: 849 Casado, J.L.: 452 Chanakul, Ankanee: 857 Bunge, Katherine E.: 871 Calle, M. Luz: 266 Casavant, Isabelle: 975 Chandanwale, Ajay: 752 Bunupuradah, Torsak: 831, 857, Callebaut, Christian D.: 496 Casazza, Joseph P.: 245LB, Chander, Geetanjali: 911 858, 860 Calli, Kristina: 812 327, 336 Chandrasekaran, Ezhilarasi: 753 Burchell, Ann N.: 622 Calmy, Alexandra L.: 567, Casey, Lisa: 587 Chang, J. Judy: 294 Burchett, Sandra: 438 592, 612 Casillas-Rodríguez, Jesús: 477 Chang, Kaifen: 325 Burdo, Tricia H.: 272, 273, Calnan, Michaela: 473 Casper, Corey: 563, 632 Chang, Larry W.: 902, 986 Author Index Author 403, 664 Calvez, Vincent: 332, 489, 840 Cassels, Susan L.: 1063 Chang, Theresa: 196 Burgener, Adam: 6 Camacho, Ángela: 555 Cassol, Edana: 693 Chang, Wei: 1062 Burger, David M.: 431, 433 Camacho, Martha: 518 Cassol, Sharon: 847 Chang, Will: 239 Burgess, Laura: 423LB Cameron, Mark: 880 Castagna, Antonella: 417, Chao, Chun: 54 Burgos-Soto, Juan: 1015, 1015 Cameron, Paul U.: 359, 375 454, 627 Burke-Miller, Jane: 277 Campbell, Edward M.: 209LB Castel, Amanda: 992, 1008
140 CROI 2016 Author Index 141 , , 812 130 CROI 2016 Author Index Author 716 , 427 573 324 473 724 715 608 1043 , 943, 242, 378 474, 666, 668 607 848, 855 Courtney, Ingrid: 1014 Courtney, 1021 Margaret: Couvillon, 968 Ethan: Cowan, L.: 540 Andrea Cox, Corbeau, Pierre: 276, 282 Pierre: Corbeau, 165, 221 Anne: Cori, 315 Björn: Corleis, 82 Jean-Marc: Corpataux, 319 Jorge: Correia-Pinto, 392 Emily: Cosimano, 850 Loide: Cossa, A.: 326 Dayane Costa, Dominique: 332, Costagliola, Hélène: Côté, Collini, Paul J.: J.: Paul Collini, 310LB Mark: Connors, 916 Caitlin: Conrad, 1059 David: Contreras, 579 Jennifer: Cook, 1000 A.: Laura Cooley, 164 W.: Robert Coombs, Michael: 876 Cooney, Curtis L.: Cooper, 233, 334, 365, David: Cooper, Don: 359 Cooper, Ashraf:Coovadia, 39, 40, 851 291 Anna: Cope, 934 Dagan: Coppock, 556, 557, Nicola: Coppola, Collins, Christine: 539LB Christine: Collins, 855 Jeannie: Collins, 385 Louis: Collins, Sean E.: Collins, Simon: 484 Collins, Ronald: 24 Collman, 153 Richard: Colonno, 609 Charlene: Compher, 204 Fabrizio: Condorelli, Mian-er:333 Cong, 23, Elizabeth: Connick, Cottalorda, Jacqueline: 408 Jacqueline: Cottalorda, 886 680, Laurent: Cotte, 658, 820, 824, Mark F.: Cotton, L.: 102LB Mackenzie Cottrell, Nicola: Cotugno, 274 Anne: Couedel-Courteille, 696 Amandine: Cournil, G.: Richard Court, 870 , 568 642
298 311LB
, 433 565 792 , 616 431 1030 468 792 843, 979, 985, 1062 843, 979, 207, 241, 266, 320, 432 490 647, 919 414, 956 Coates, Thomas: Thomas: 436 Coates, 1054 Brian J.: Coburn, R.: Leslie Cockerham, 97, 466 Mark: Cockett, M.: 647 Jennifer Cocohoba, P.: Ahuatchi Coffie, Clarke, Amanda: 423LB, 680 423LB, Amanda: Clarke, 436, 906, 954 William: Clarke, Katherine: Clarridge, 811 Jacqueline: Clavel, 445 W.: Carolyn Clayton, 597 Charles: Cleland, E.: Meredith Clement, Julie:Clennon, 995 629 Isabelle: Clerc, 247, 280 Mario: Clerici, 384 Katherine: Clifford, Nuria: 468 Climent, A.: 212 Gavin Cloherty, 205, 183, Bonaventura: Clotet, Kate: Clouse, Coffin, John M.: 85, 337, 340, Coffin, E.: Anna Coghill, Cohan, Deborah: 796 Cohan, R.: 841 Craig Cohen, Daniel: 539LB Cohen, 277, 422, Mardge: Cohen, Rachel:798, 809 Cohen, 386 A.: 383, Ronald Cohen, 524, 867, Stephanie: Cohen, 729 Isabelle: Cohen-Codar, Susan E.:476 55, Cohn, 427, 429, 1029 Karen: Cohen, 455 Audrey: Coilly, Mayte: Coiras, Manuela: 417 Colafigli, Angela: Colbers, Colby, Donn:407, 219, 384, Colby, 828 David: Cole, James H.: 148 Cole, Michael:19 Cole, Megan: 524 Coleman, 1016 M.: Sharon Coleman, 266, 320 Pep: Coll, 586 Antonio: Collado, Collado-Diaz, Victor: 663 952 493LB, 30, 350, Ann: Collier, A.: Dami Collier, Gilles: 509 Collin, 723 , 386 188 , 589 , 697 620 652 638 786 342 584 417 235 411 , 636, 773 396 43 115 1040 168LB, 789 168LB, 927 831, 1120 344, 349, 352, 836 920, 621, 624 Clagget, Brian:296, 299 Clagget, 829, 841, 796, Tamara: Clark, Chilisa, Florence: 784 Florence: Chilisa, 1003 Natsayi: Chimbindi, 118, Frank: Chimbwandira, C.: Alfred Chin, 735 Tilagavathy: Chinappa, R.: 383, Christopher Ching, Justin: 434 Chiong, 520 Tsungai: Chipato, Z Michael: 521 Chirenje, S.: Avantika Chitre, 606 Salyavit: Chittmittrapap, Sarah: 794 Chitty, 884, Anupong: Chitwarakorn, Calvin: Chiu, S.: 544, 698 Joan Chmiel, D.: Chockalingam, Leela 494LB Bhavna: Chohan, James: 1039 Choi, SungChoi, Eun: 818, Kulkanya: Chokephaibulkit, 287 Nitiya: Chomchey, 335, 343, Nicolas: Chomont, Jessica:17 Chong, 927 Wannee: Chonwattana, 359 Abha: Chopra, Dominic C.: 387, Chow, Chow, Felicia: Felicia: Chow, Christ, Frauke: 139, 363 Frauke: Christ, Stefan: Christensen, Christensen-Quick,Aaron: A.: 558, Katerina Christopoulos, 310LB Gwo-Yu: Chuang, 311LB Tae-Wook: Chun, Michael H.: 494LB, Chung, 99, 551, 581 T.: Raymond Chung, Shang-Lin: Chung, Duncan:484 Churchill, 155 113LB, Gavin: Churchyard, 696 Laura: Ciaffi, L.: Andrea Ciaranello, 198 Claudia: Cicala, Nicoletta: Ciccarelli, 95LB Tomas: Cihlar, 85, R.: Anthony Cillo, 556 Grazia: Cirillo, 208 Angela: Ciuffi, 509 250 , 873 467 872 50 351 155 1026,841, 843, 979, 985, 1062 Bénédicte: 274 922, 923, 924 682, 717 Chapman, Jennifer: 833 Jennifer: Chapman, Salome: 113LB, Charalambous, 341 Amanda: Chargin, Chariyalertsak, 48LB Suwat: 796, 829, Edwin: Charlebois, 450 Paige: Charlins, Charmeteau-De-Muylder, 214, Charlotte: Charpentier, 522, 886 Isabelle: Charreau, E.: 502, Manhattan Charurat, 801LB Charles: Chasela, Michael: 135 Chattergoon, William: Chau, 940 Omkar: Chaudhary, Chaulk, Patrick: 1036 Chaulk,Patrick: 81 Leonard: Chavez, 993 Laura: Cheever, Duncan: 791 Chege, 867, 870 524, Wairimu: Chege, A.: Beatrice Chen, Chen, BenjaminChen, K.: 249 161 Huichao: Chen, Joseph: 284 Chen, 520 Pai-Lien: Chen, 587 Ting-Yi: Chen, 970 Xi: Chen, 99, 445 Xinhui: Chen, 838 Ya: Chen, 618 A.: 617, Yi-Ming Chen, Ying: Chen, 103 29, 680, 681, Andrew: Cheng, 873 Helen: Cheng, 622 Stephanie: Cheng, 970 Weibin: Cheng, Jean-Marie: 351 Chennebault, Antoine: Chéret, N.: 138 Elena Chertova, Peter: Cherutich, 692 J.: Chetwynd, Andrew 577 526, Stephane: Chevaliez, Glen M.: 81 Chew, Rémi: 274 Cheynier, 161, 550 Elizabeth: Chiao, 778 Elena: Chiappini, 411 Jennifer: Chiarella, Mary-Ann:Chiasson, 770 729, 887 Christian: Chidiac, Chettimada, Sukrutha U.: U.: Sukrutha Chettimada, Author Index
Cox, Stephanie: 496 598, 637, 661, 946 de la Fuente Soro, Laura: 974, 913, 1053 Cox, Vivian: 1031 D’Avino, Alessandro: 697 976 Deluca, Joseph: 585 Cozzi-Lepri, Alessandro: 486, D’Avolio, Antonio: 426, 774 de Lazzari, Elisa: 945 Demers, Korey: 254 946 D’Ettorre, Gabriella: 238, 610 de Leuw, Philipp: 713 Demeulemeester, Jonas: 363 Cragg, Carol: 1031 Daar, Eric: 29, 443, 952 de los Angeles, Christine Paula: Deng, Xutao: 81 Crampin, Amelia: 736 Dabis, Francois: 169LB, 549, 823 Denning, David W.: 764 Crane, Heidi M.: 42, 558, 614, 565, 566, 568, 582, 605, 661, De Luca, Andrea: 417, 486, Dennis, Ann M.: 216, 217 636, 641, 671, 920, 941, 962, 1015 697, 946 Dennis, Futhi: 1056 1034 Dailey, Peter: 517 de Mendoza, Carmen: 508 Denti, Paolo: 429 Cranmer, Lisa M.: 38, 748 Dakshina, Subathira: 846 de Monteynard, Laure-Amélie: Denton, Paul W.: 348 Cranston, Kevin: 890 Dakum, Patrick: 502 943 Deocharan, Bisrom: 896 Cranston, Ross: 104, 108LB, 161 Damond, Florence: 214, 509 de Oliveira, Tulio: 211, 499 Derache, Anne: 499, 840 Creasy, George: 875, 876 Damouche, Abderaouf: 271 de Pablo, Rebeca S.: 655 Derby, Nina: 270 Cremers, Serge: 694 Dan, Jennifer M.: 730 de Pokomandy, Alexandra: 949 Deren, Sherry: 597 Crepaz, Nicole: 1033 Danesh, Ali: 81 De Rekeneire, Nathalie: 1015 Dereuddre-Bosquet, Nathalie: Crespo, Manel: 611 Daniel, Simon: 517 de Silva, Thushan: 253 271 Cressey, Tim R.: 775, 777 Daniels, Julie E.: 826, 859 de Souza, Mark: 219, 287 Cribbs, Sushma K.: 255 Danta, Mark: 233 De Stefano, Giorgio: 607 DeRuiter, Annemiek: 794 Cross, Anna: 759 Darchy, Natacha: 420 De Truchis, Pierre: 420 Desai, Payal: 534 Crothers, Kristina: 633 Darin, Kristin M.: 444 De Vuyst, Hugo: 621, 624 Desai, Seema N.: 277 Crowe, Suzanne M.: 125, 711 Darko, Sam W.: 245LB De Wit, Flore: 139 Desai, Tejal: 879 Crowell, Trevor A.: 922, 923, Darling, Katharine: 567 de Wit, Stephane: 637 DeSalvador, Francine: 408 924, 956 Darque, Albert: 583 Debre, Patrice: 304 Descamps, Diane: 214, 509 Crowther, Carol: 302 Das, Moupali: 27, 680, 681, Debyser, Zeger: 139, 363 Descours, Benjamin: 468 Cruz, Maria Leticia S.: 798 682, 717 Decker, Timothy: 133 Desfarges, Sébastien: 208 Csala, Anna: 302 Das, Satyajit: 474 Decloedt, Eric H.: 419 Deshiere, Alexandre: 182 Csernansky, John G.: 823 Dasgupta, Sharoda: 500 Decome, Diessy: 750 Deshpande, Prasad: 758 Cua, Eric: 522 Daskalakis, Demetre C.: 888, Deeks, Steven G.: 81, 83, 254, Destache, Christopher J.: 435 Cuenca, Francisca: 527, 555 892, 994 293, 298, 343, 344, 511, Detzel, Christopher J.: 278 Cui, Zishan: 546, 898, 1007, Datwani, Hema: 772 643, 654 Devaraj, Chitra: 753 1041 Dauchy, Frédéric-Antoin: 689 Deering, Laura J.: 532 DeVico, Anthony: 188 Culver, Jeffrey: 706 Dauncey, Thomas: 1023 Defferriere, Helene: 420 Devlin, Brid: 110LB Cummings, Derek A.: 535 Davaniah, Siva: 499 DeGroote, Nicholas P.: 591 Dewar, Robin: 287, 380 Cummings, Vanessa: 897 Davey, Richard T.: 77LB Deiss, Robert: 932 Deya, Ruth: 863 Cummins, Nathan W.: 243 David, Lorenz: 145, 250 DeJesus, Edwin: 29, 472, 953 Deyounks, Frank: 107 Cunningham, Chinazo O.: 585 David, Ludivine: 351 Del Amo, Julia: 173, 901, 941 Dezzutti, Charlene S.: 871, Cunyat, Francesc: 372 Davies, Mary-Ann: 960 del Campo, Santos: 571 872, 874 Curlin, Marcel: 884, 927 Davis, Jonathan: 97 Del Prete, Gregory Q.: 84, 138 Dharan, Adarsh: 209LB Curran, Kelly: 978 Davis, Lucian: 764 del Rio, Carlos: 27, 995, 1039 Dhiver, Catherine: 583 Currier, Judith S.: 55, 476, 650, Davis, Nicole L.: 801LB Delaney, Joseph A.: 42, 558, Di Giambenedetto, Simona: 660, 672, 704, 793, 939 Davy, Thibaut: 291 636, 1034 417, 697 Cusato, Jessica: 426 De, Asha R.: 722 Delaney, Kevin P.: 889 Di Perri, Giovanni: 426, 774 Cutillas, Vincent: 507 De Alwis, Paba M.: 389 Delaporte, Eric: 73LB, 696, 959 Di Rosa, Michelino: 204 Cuzin, Lise: 709, 950 De Angelis, Daniela: 895 Delaugerre, Constance: 295, Diacon, Andreas H.: 158LB Cyktor, Josh: 350 De Armas, Lesley: 324, 327 420, 522 Dias, Juliana Z.: 326 Cypess, Aaron M.: 707 De Bona, Anna: 598 DelBianco, Gabriela: 623 Diaz, Asuncion: 590, 639 Cyr, Derek: 595 De Cock, Kevin M.: 909 Deleage, Claire: 275LB Díaz de Santiago, A.: 452 Cysique, Lucette A.: 391 De Francesco, Davide: 148 Delfour, Isabelle: 729 DiCarlo, Abby L.: 988 Author Index Author Cytkor, Joshua: 300LB De Girolamo, Gabriella: 238 Delgado-Fernández, Marcial: Dickens, Alex M.: 396 Czaicki, Nancy L.: 1018, 1019 De Gruttola, Victor: 167, 942 634 Dicker, Ira B.: 464, 466 de Hoon, Mieke: 431 Dellamonica, Pierre: 408 Diero, Lameck: 565 –D– de Jong, Menno D.: 602 Delman, Keith: 335 Dieterich, Douglas: 573, 588 D’Aquila, Richard T.: 629 de Knegt, Robert J.: 536 Delobel, Pierre: 289, 701, 950 Dietrich, Janan: 1014 d’Arminio Monforte, Antonella: De La Flor, Carolina: 587 Delpech, Valerie: 225, 895,
142 CROI 2016 Author Index 143 , 421 , 263, 303 , 31LB, , 31LB, CROI 2016 73LB 25 Author Index Author 129 772 , 406 , 153 21 16 65 646 305 721 , 147, 150, 216, 217, 291, 418, 350, 401, 402, 300LB, 694 520, 523, 917 675, 696 719 335 275LB, 685, 688 417, 697 274 Escribà, Tuixent: 248 Escribà, Tuixent: Eshleman, Susan H.: 436, 511, Gamal: Esmat, Espinosa, Enrique: 251 Espinosa, Enrique: 1033 Lorena: Espinoza, 663 V.: Juan Esplugues, M.: 249 Anthony Esposito, Shaffiq: 1023 Essajee, Asma: 222 Essat, Stefan: Esser, 307, 904, 984 M.: 37, 111, Essex, 266 Carla: Estany, 205, 207 A.: 183, José Esté, 424LB Herminia: Esteban, 22, D.: Jacob Estes, Ernest, Oscar: 1025 Ernest, Joseph J.: Eron, Behzad: 307, 347 Etemad, 862 Bernard: Etukoit, Zelda: Euler, 359 Eva: Malantinkova, Eva Denise:845 Evans, Dean: 769 Everett, H.: Teresa Evering, Alexander: Ewing, 318 Jean-Louis: Excler, Sabrina: Eymard-Duvernay, Engberg, Göran: 267 Göran: Engberg, 616, 616 Eric: Engels, 504 Ikumi: Enomoto, 819 819, Paola: Erba, Raimund: 646 Erbel, J.: Adam Ericsen, 765 Anna: Esteve, 118 Janne: Estill, Michelle: 651, 684, Estrella, Jean-François: Etard, Erlandson, Kristine M.: 283, Erlandson, –F– 280, Massimiliano: Fabbiani, Amanda: García, Fabra 408 Roxane: Fabre, Véronique: Fabre-Mersseman, , 988 859 892 , , 151 1021 117 662 826 135 192 llison R.: , 997, 1020, 1038 , 997, 1020, 989 989, 997 395, 409, 410, 412 617, 618, 631, 737, Elashoff, David: 793 David: Elashoff, 153 Tamer: Elbaz, 513 Ali: Elbireer, Brian: 854 Eley, 460 425, Timothy: Eley, 885 Vanessa: Elharrar, 524, 867, 870, Richard: Elion, 734 T.: Paul Elkington, .: 349, 515 Leigh Eller, MichaelA.: 254 Eller, Sascha: 772, 801LB Ellington, M.: 297 Alison Elliott, Ron: 43, 143, 144, 390, Ellis, 1010 Tom: Ellman, 743 Jerrold: Ellner, 448, 874 J.: Laura Else, 1020 Batya: Elul, 844 Peter: Elyanu, Michael: 200 Emerman, Michael: Emerson, Emert-Sedlak, A.: 191 Lori L.: Ann Emery, Sean: 559 Emery, Benjamin: 538LB Emmanuel, Sam: 648 Emmanuel, Mary:Emond, 17 Brinda:411, 633 142, Emu, 778 Luminita: Ene, Ehret, Robert: 525 Ehret, Hartmut: Ehrlich, 461LB 646 Lewin: Eisele, Didier: 568, 568 Ekouevi, Maissa: 153 Raziky, El Ramy: El-Diwany, M.: 738, Wafaa El-Sadr, Edun, Babatunde: 965 Babatunde: Edun, Michael G.: 279 Edwards, 448 Deidre: Egan, 248 Lander: Egaña-Gorroño, 118, 565, 613, Matthias: Egger, Ebner, Hanna: 89LB Hanna: Ebner, R.: 888, Zoe Edelstein, –E– Jessica:292 Eagar, Kirk A.: 22, 47, 286 Easley, 51, W.: Jeffrey Eaton, A Eckard, Dvory-Sobol, 573 Hadas: 964 Nicole: Dzialowy, , 615 , 671 , 927, 972 641 526 900 313 805 Marjolijn: 431 Douglas, Pamela: 642 Pamela: Douglas, Doumbia, 921 Seydou: 113LB David: Dowdy, Marie: 909 Downer, Dowshen, Nadia: 832 604 Erin: Doyle, Joseph: 962 Drabo, 308 Draghi, Monia: Mary: 978 Drake, Rosemary:Dray-Spira, 1043 631 Lydia: Dreosti, 623 Erin: Dressel, 466 Dieter: Drexler, Daniel: 42, Drozd, Scott: Dryden-Peterson, DSouza, Gypsyamber: 617 DSouza, Gypsyamber: 746 T.: Du,Quy Du, Yimin: Renaud: 381 Du Pasquier, Michael:Dube, 672, 939 Robert:633 Dubrow, Léa: Duchesne, Jean-Charles: 455 Duclos-Vallée, 332 Yasmine: Dudoit, 632 Ann: Duerr, 689 Duffau,Pierre: 965 Wayne: Duffus, William: 896 Duffy, Sophie: Anne 91 Dugast, Essenberg, Duisenberg-van 408 Brigitte: Dunais, Shelia: 767 Dunaway, Gabor A.: 364 Dunay, 50 Matt: Dunbar, 223, 482, 484 Dunn, David: Eileen: Dunne, 795 Lorn: Dunning, 510 Yen: Duong, Daniel: 41 Duprez, Sophie: 75LB Duraffour, 408 Jacques: Durant, 249 D.: Durham, Natasha Durham, 879 Phillip: 351 Christine: Durier, 369 Nicolas: Durier, M.: 576 Geoffrey Dusheiko, Dutrieux, 274 Jacques: 145 Dutta, Anupriya: Dutta, Sandeep:453 Duvvi, Vikram: 968 Duwve, Joan: 916 , 1027 656 , 1055 1008 1027 992 240 279 , 865, 868, 982, 989, 1038, 1055 1060 867, 870 262 Domeneghini, Elisabetta: 774 Domeneghini,Elisabetta: Dominguez, 655 Beatriz: Renee: 761 DonahueCarlson, 821 Kirsten: Donald, Krista: 488 Dong, 253 Tao: Dong, Deborah: 301, 771, Donnell, 523 Kelsey: Donohue, 262 M.: Andrew Donovan, Gregory 451, 545 J.: Dore, 31LB David: Dorey, Dorman, Susan: 155, 743 Maggie: Dorr, Dollfus, Catherine: 811 Catherine: Dollfus, I.: David Dolling, Lucy: 320 Dorrell, 101 Grant: Dorsey, 992, Kerri: Dorsey, Joelle: 396 Dorskind, 336 Douek, Daniel C.: 245LB, 869 Nora: Douglas, DiNapoli, Sarah R.: 21 Ashok: 257 Dinasarapu, 889 Elizabeth: DiNenno, Bifeng: 453 Ding, 949 Erin: Ding, Jian: 196 Ding, Ming: 341 Ding, Dinh, 878 Chuong: 717 Jason: Dinoso, Assane:696 Diouf, Sahera: Dirajlal-Fargo, 139 Dirix, Lieve: Modiegi: 800 Diseko, Ulf: 134 Dittmer, 878 Charles: Dobard, 820 Els: Dobbels, Susanne:524, Doblecki-Lewis, S.: 914 Adrian Dobs, H.: 724 David Dockrell, 217 A.: Irene Doherty, Doitsh, Gilad: Dietz, Patricia: 966 Dietz, Patricia: 836 Hinatea: Dieumegard, 527 Cristina: Díez, 366 Luis: Jose Diez, 134, 187, M.: Dillon, Stephanie 201 Marsha: Dillon-White, T.: Dobromir Dimitrov, Author Index
Facente, Shelley: 511 Fidler, Sarah j.: 87, 114, 156, Foucat, Emile: 295 Furrer, Hansjakob: 676, 751, Fagard, Catherine: 214, 509 165, 834, 981, 982 Fouche, J.P.: 821 760, 765 Faini, Diana: 760, 760 Fiel, M. I.: 604 Fourati, Slim: 358LB Fusco, Gregory: 953 Falade-Nwulia, Oluwaseun: Field, Andrew: 334 Fourati, Slim: 577 Fusco, Jennifer: 953 12, 537 Fielding, Katherine L.: 113LB, Fowler, Mary G.: 36 Fusco, Robert: 507 Fallah, Mosoka: 74LB 155, 736 Fox, Julie: 448 Fux, Christoph A.: 686 Fan, Li: 456 Fields, Sheldon: 883LB, 893 Fox, Matthew P.: 28, 792, 845, Fyne, Elizabeth: 379, 379 Fan, Lili: 970 Fiellin, David A.: 554 957, 960, 1011, 1012, 1013, Fan, Peihu: 194 Figueiredo, Suzanne: 274 1048 –G– Fang, Annie: 818, 1120 Figueroa, Maria I.: 718, 947 Fox-Bosetti, Sabrina: 437LB Gabuzda, Dana: 145, 250, 693 Farella, Nunzia: 607 Fillgrove, Kerry L.: 98 Frampton, Dan: 210 Gachuhi, Averie: 34 Faria de Oliveira, Michelli: Fine, Derek M.: 651, 687 France, John: 625 Gadabu, Oliver: 118 143, 410 Fink, Valeria: 618 Franchini, Genoveffa: 317 Gadawski, Izabelle: 715 Farjado, Emmanuel: 512, 787 Finkelman, Malcolm: 410 Francke, Jordan A.: 786 Gadde, Uttara: 968 Farmer, Paul: 72LB Finlayson, Robert: 451, 545, 681 Frange, Pierre: 222 Gagliardini, Roberta: 417 Farnham, Paul: 1051 Finlayson, Teresa: 930, 931 Frank, Daniel N.: 262 Gagne, Matthew J.: 193 Farouk, Idris: 510 Finnerty, Fionnuala: 794 Frank, Ian: 106, 471 Gagneux, Sébastien: 737 Farquhar, Carey: 49, 50 Finzi, Andrés: 181 Franklin, Dana: 544 Gaisa, Michael: 620, 626 Farrior, Jennifer H.: 989, 997, Fischer, Johannes: 364 Franklin, Donald: 446 Gajjar, Mili R.: 469LB 1038 Fisher, Martin: 692 Franks, Julie: 885 Galang, Romeo R.: 149, 215, Fätkenheuer, Gerd: 197 Fitch, Kathleen: 650, 673, 707 Frantzell, Arne: 578, 579 541 Fatti, Geoffrey: 960 Fitzgerald, Daniel W.: 473, Fraser, Christophe: 165, 220, 221 Galarraga, Omar: 1059 Fauci, Anthony S.: 198, 311LB Fitzgerald, Michael: 664 Fraser, Nicole: 1028 Galiba, Eliane: 776 Fawzi, Wafaie W.: 703, 803 Fitzmaurice, Garrett M.: 1014 Frater, John: 87 Galindo, María J.: 611, 634 Faye, Albert: 776, 811 Fitzpatrick, Meghan E.: 330 Frederick, Toni: 813 Gall, Astrid: 827 Faye, Khadim: 961 Fiumanò, Martina: 426 Frederix, Koen: 738, 988 Gallant, Joel: 29 Fayorsey, Ruby N.: 791 Flamholc, Leo: 998 Freed, Eric O.: 137, 465 Galli, Laura: 454, 627 Feaster, Daniel J.: 27 Fleishman, John: 1001 Freedberg, Kenneth A.: 786, Galli, Luisa: 778 Fedele, Valentina: 413 Fleming, Julia: 585 952, 1016 Galli, Ubaldina: 204 Feder, Alison F.: 229, 495 Fletcher, James L.: 384, 415 Freeman, Carla S.: 419 Galli, Veronica: 317 Fedoriw, Yuri: 447, 450 Florence, Eric: 46 Freeman, Gordon J.: 93LB Gallo Cassarino, Tiziano: 210 Feeney, Eoin R.: 665 Floris-Moore, Michelle: 671 Freeman, Michael L.: 732 Gamal Eldeen, Hadeel: 153 Fehr, Jan: 566 Flowers, Lisa: 772 Freiberg, Matthew S.: 645, 714 Gandhi, Monica: 866, 1040 Feigl, Andrea B.: 677 Floyd, Sian: 114, 156, 165, 980, Freimanis, Laura: 798, 809 Gandhi, Neel: 157, 756 Feinstein, Matthew J.: 42, 644 981, 982 Freire, Marcos S.: 326 Gandhi, Rajesh: 300LB, 346, Felber, Barbara K.: 259LB Flynn, Colin: 906 French, Audrey L.: 277 347, 350 Feldpausch, Meghan: 664 Focà, Emanuele: 774 Frenkel, Lisa: 361, 478, 494LB, Ganesan, Anuradha: 932 Fellows, Lesley K.: 385 Foca, Marc: 851 847 Gange, Stephen J.: 641 Feng, MeiZhen: 506 Fogel, Jessica M.: 436 Frías, Mario: 555 Ganz, Peter: 343, 654 Fenner, Lukas: 737 Folkvord, Joy M.: 23 Friedland, Barbara A.: 875 Gao, Feng: 194 Fenton, Terry: 816, 824 Fong, Moy Siew: 860 Friedland, Gerald H.: 14 Gaolathe, Tendani: 111, 904 Fernandez, Celine: 276 Fontas, Eric: 686 Friedland, Jon S.: 734 Gaolethe, Tendani: 983 Fernandez, Juan Manuel: 508 Force, Gilles: 420 Friedman, Evan: 98, 437LB Garcia, Debra L.: 331, 345 Fernandez Cruz, Ana L.: 385 Ford, Mary: 534 Friedman, Ruth: 617 Garcia, Elisabet: 241 Fernández-Romero, José: Ford, Susan L.: 106 Friedrich, Thomas C.: 21 García, Felipe: 248 875, 876 Forde, Kimberly A.: 609 Frigati, Lisa: 852 Garcia, J. Victor: 447, 450 Ferrand, Rashida A.: 176, Fordyce, Marshall: 496, 680, Fromentin, Remi: 343, 344, 352 Garcia, Rochelle L.: 624 846, 853 681, 682, 717 Fry, Carrie L.: 747 García, Rosa: 508, 596 Author Index Author Ferrando-Martinez, Sara: 94 Forgione, Lisa A.: 896 Fuchs, Edward J.: 169bLB García-Basteiro, Alberto L.: Ferrara, Micol: 426 Forleo, Maria Antonietta: 774 Fuchs, Wolfgang: 628 158LB Ferris, Andrea: 84 Forsyth, Elizabeth W.: 971 Fujita, Hideaki: 203 Garcia-Beltran, Wilfredo: 294 Ferry, Tristan: 709, 729 Fortún, Jesús: 572 Fukuda, Dawn: 890 Garcia-Lerma, Gerardo: 107, Feske, Steven K.: 638 Foster, Antonina: 47 Funderburg, Nicholas T.: 44LB, 333 Fichtenbaum, Carl: 329, 694 Foster, Caroline: 834, 835 656, 657, 717 García-Morales, Claudia: 477
144 CROI 2016 Author Index 145 , 902 934 , CROI 2016 , 1031 863 , 106, 471, 653 381 Author Index Author 621 564 609 844 122 , 437LB, 506 , 437LB, 8 742 48LB 155 98 , 986, 987 866, 884, 885, 990, 1055 954, 986, 987 954 640, 650, 664, 673, 707 728 Griffith,Sam: 156, 980, 981 Griffith,Sandy: 31LB Anna: Grimsrud, 553, 638, Grinspoon, Steven: Granziera, Cristina: Cristina: Granziera, Guillaume: 400 Gras, 313 Stephanie: Gras, 890 Chris: Grasso, 432 Fredzzia: Graterol, JustinC.: Graves, Diane: 852 Gray, Glenda: 1014 436, Gray, 594, 902, Ronald H.: 563, Gray, 517 Eduard: Grebe, 224, 518 Nella: Green, 284 Ruth M.: Greenblatt, Justin M.: 21 Greene, A.: Sharon Greene, 284 C.: 240, Warner Greene, 162 Steven: Gregorich, John: 503 Gregson, Julia M.: 724 Greig, 1007 546, Troy: Grennan, 137 T.: Anna Gres, 1045 Jeremy: Grey, Rulan: Griesel, Griffith,Linda: Graham, Barney: 32LB, 90 Barney: 32LB, Graham, Bobbie:Graham, 816 SusanGraham, M.: 977 Timothy: 140 Granade, Rafael: 586, 603 Granados, 556 Anna: Grandone, 660 Catherine: Granier, E.:315 Mitchell Granoff, Alison: Grant, 446 Igor: 412, Grant, L.: Jennifer Grant, Robert:Grant, Goyette, Marielle S.: Marielle S.: Goyette, MaryGrabowski, K.: 731, 474, 493LB, Beatriz: Grinsztejn, Jay: Grobler, N.: Heather Grome, 528, 538LB Chloe: Gross, Govender, Nelesh: 759 Nelesh: Govender, 1016 Tessa: Govender, Charitha: Gowda, 1005 241 208 961 699 995 , 881 87 869 827, 828 905, 907, 936 527, 611 Gottlieb, Geoffrey S.: Geoffrey Gottlieb, Rachel Z.: 347 Gottlieb, G.: 136 Heinrich Gottlinger, 958 Eduardo: Gotuzzo, 491LB Gough, Kevin: 222, 701 Cécile: Goujard, 811 Goujon, Stéphanie: Philip: 256, 302, Goulder, Kamini: 195 Gounder, Gomaa, Asmaa: 153 Elisabet: Gómez-Mora, 678, 679, Xavier: Gomez-Olive, Gonciulea, R.: Anda 49 Molly Ann: Gone, 386 Assawin: Gongvatana, 327 Edward: Louis Gonzalez, Nuria: 303 Gonzalez, Oscar: 186, 307 Gonzalez, Raquel:González, 797 Juan: 31LB, González-García, Ruth: 1027 Goodall, 27 Gooden, Lauren: 891 Katherine: Goodenberger, 257, 325 Maureen: Goodenow, 1063 M.: Steven Goodreau, Nicholas: 604 Goosens, 261 B.: David Gootenberg, Siri: 519 Göpel, Santhi: 399 Gorantla, 861 Gorbach, Pamina: 474, 1038 Fred: Gordin, 555 Ana: Gordon, Daniel: 501 Gordon, A.: 430 Lori Gordon, Michelle: 427, 488 Gordon, 769 Stephen: Gordon, 1056 Marelize: Gorgens, Miguel: 596 Gorgolas, 280 18LB, Gori, Andrea: Morgane: Gossez, D.: Neela Goswami, Golubkov, Olga:218, 480 Golubkov, Monica: Golumbeanu, Golden, Mathew R.: 50, 971 R.: 50, Golden, Mathew 601 V.: David Goldstein, 225 Richard: Goldstein, 626 Stephen: Goldstone, 734 Rene: Goliath, 277, 647, 720 Elizabeth: Golub, Sarit A.: Golub, Goldberg Raifman, Julia: Goldberg 1120 , 730, 731
998 , , 1037 60 727 819 818 933 434 170 487, 518, 726, 866, 1019, 1040 Goedert,614 J.: James A.: 313 Goepfert, Paul 236 Felix: Goeser, 633, 645 Goetz, Matthew: H.: Runa Gokhale, Gianella, Sara: 143, 232, 410, 946 Gianotti, Nicola: Carlo: Giaquinto, Diana: 848 Gibb, Gibbert, 134 Kathrin: 285 Anna: Gibbs, 20 Richard: Gibbs, 633, 645, 714 Gibert, Cynthia: 977 Evanson: Gichuru, 1016 Janet: 613, Giddy, Mark: 958 Giganti, Rik: 363 Gijsbers, Gilbert,605 582, Camille: 1027 Charles: Gilks, 394 J.: Alexander Gill, John: 614, 688 Gill, 895 O.: Noel Gill, 692 Yvonne: Gilleece, 943 Gilquin, Jacques: 913 Gilson, Richard: Sandrine: Gimenez, 282 310LB Gindin, Tatyana: Marian: 98 Gindy, 461LB Paul: Gineste, Gini, Joshua: Ginindza, Sibuse: 113LB Gisslén, Magnus: 409 Gittleman, Haley: 284 Linda: Giudice, Giuliani, Massimo: 697 238 Giustini,Noemi: 566 Lars: Gjaerde, 760 Tracy: Glass, 236 Andreas: Glässner, Robert:Glaubius, 1057 Rick: 622 Glazier, Glick, SaraN.: 112, 48LB, V.: Glidden, David Glynn, Judith: 736 Gnemmi,204 Ilaria: Theodore: 88 Gobillot, 161, 493LB Catherine: Godfrey, Ghislain, Mathilde: 701 Ghislain, Mathilde: Ghneim, Khader:297 GHOSN, Jade: 222 Peter: Ghys, Vania: Giacomet, , 824 470 , 486 , 1018, 369 632 482 121 , 677 906 355 , 1005 102LB 112 817 , 964 945 418 1037 46 Panagiotis: 1019, 1040 Gates, Thomas M.: 391 Thomas Gates, 748 John: Gatimu, Aditya: Gaur, Christina: Gavegnano, 291, 25, 102LB, Cynthia: Gay, 923 Charlotte: Gaydos, A.: 678, 679 Thomas Gaziano, I.: 790 Gebi, Usman A.: 1001, 1005 Kelly Gebo, 839 P.: Geelen, Sibyl Marlena: 875 Plagianos, Gehret L.: 1047 Eugene Geidelberg, Christof: 625 Geldmacher, Pascal: Geldsetzer, Thibaut: Gelé, 455 Romas: 95LB Geleziunas, Genazzani, 204 Armando: Becky 1042 L.: Genberg, E.: 399 Gendelman, Howard Miguel: 655 Genebat, H.: Elvin Geng, Garrison, Lindsay: 957 Garrison,Lindsay: 309LB Jetta: Garrity, Gartland, Martin: 660 188 Garzino-Demo, Alfredo: Simani: 984 Gaseitsiwe, Jose M.: 303, 248, Gatell, Garcia-Perez, Javier: 468 Javier: Garcia-Perez, 596 Javier: García-Samaniego, Donald: 588 Gardenier, M.: 283 Edward Gardner, Dickman: 677, 1030 Gareta, 1006, Shikha: 591, 915, Garg, Gargalianos-Kakolyris, Geoff: Garnett, 1058 Katy L.: Garrett, 246 Nigel: Garrett, Carolina: Garrido, Gentry, Jessica: 149, 541 Gentry, 36, 816 Kathleen: George, K.: 327, Varghese George, Joanne: 501 Gerber, Maria: Anna Geretti, German, Danielle: Gerstoft, Jan: 1044 Gerstoft, 105, 270 Agegnehu: Gettie, 597 Natanya: Gettie, Matine: Ghadrshenas, Ghanem,Khalil: 1005 Author Index
Gross, Robert: 833, 934 Haeri Mazanderani, Ahmad: 783 Harris, Jennie L.: 993 Héma, Arsène: 696 Grotts, Jonathan F.: 793, 793 Haeussinger, Dieter: 364 Harris, Kate: 1058 Hemanth Kumar, Agibothu Grover, Surbhi: 614 Hager, Cindy: 653 Harris, Marianne: 684 Kupparam: 457 Grudé, Maxime: 840 Hahn, Beatrice: 133, 187 Harris, Reuben S.: 59, 199, 200 Henderson, Andrew: 185, 193 Gruenewald, Analise: 394 Hahn, Judith A.: 554 Harrison, Benjamin R.: 371 Hendrickson, Cheryl J.: 845, Grund, Birgit: 475 Hahn, Valerie: 420 Harrison, Linda J.: 30, 32LB 1013 Grunenberg, Nicole: 90 Haimowitz, Stephanie: 968 Hart, Rachel: 544, 708 Hendrix, Craig: 871, 169bLB Guanira, Juan: 48LB Hain, Anika: 189 Hartman, Christine: 550 Hendrix, Jelle: 139 Guardo, Alberto C.: 248 Hakim, Avi: 510, 921 Hartogensis, Wendy: 1040 Henegar, Cassidy: 953 Guatelli, John: 373 Hakim, Idris: 510 Hartsough, Kieran: 738 Heneine, Walid: 107, 140, 215, Guedj, Jeremie: 75LB Halavaty, Katarina K.: 877 Harty, Alyson: 588 333, 878 Guerrero Gilabert, Maria Hall, David: 1041 Harvey, Justin: 855 Hennessey, Claudine M.: 1022 Dolores: 241 Hall, H. Irene: 52, 500, 1033, Hasenkrug, Kim J.: 134 Hennessey, Kelly A.: 1017 Guha, Anika: 382 1045 Hasson, Hamid: 454, 557 Hennessy, Orla: 640 Guidot, David: 255 Hall, Jake: 514 Hatano, Hiroyu: 298 Henning, Tara: 878 Guilbert, Thomas: 274 Hall, Nolween: 522, 887 Hataye, Jason M.: 25, 336 Henrich, Timothy J.: 86, 357, 367 Guillard, Etienne: 910 Hallett, Timothy: 51, 117, 1049, Hatleberg, Camilla I.: 637 Henry, Amy R.: 245LB Guillen, Yolanda: 260, 266 1058 Hattori, Junko: 490 Henry, Keith: 160 Guiteau Moise, Colette: 750, Hallett, Travis R.: 553 Hatz, Christoph: 676, 760 Hensley-McBain, Tiffany: 263 1017 Hallor, Magnus: 270 Haubrich, Richard: 658 Herbst, Philip G.: 658 Gulick, Roy: 103, 104 Halvas, Elias: 379 Haughey, Norman: 146, 396 Heresi, Gloria P.: 623 Gummuluru, Rahm: 185, 186, Hamers, Raph: 498, 503 Hauser, Andrea: 485 Hernandez, Angela L.: 211, 288 Hamid, Hasson: 556 Hauser, Christoph: 951 497, 500 Gun, Ana M.: 947 Hamimi, Chiraz: 332 Häussinger, Dieter: 189 Hernandez, Céline: 208 Güner, Nuray: 744 Hammer, John: 698 Havlir, Diane V.: 101, 112, 116, Hernandez, Dennis: 575 Günthard, Huldrych F.: 89LB, Hammer, Scott M.: 1 796, 829, 841, 843, 979, 985, Hernandez, Matthew M.: 201 567, 592, 951 Hamzah, Lisa: 683 1026, 1062 Hernández-Quero, José: 603 Gunther, Stephan: 75LB Han, Larry: 969 Hawes, Stephen E.: 961 Hernando, Vicky: 901 Guo, Kejun: 134, 187, 262 Han, Yang: 569 Hawken, Mark: 791 Herrera, Carolina: 448 Guo, Susan: 681, 682 Hanekom, Willem: 824 Hawkins, Claudia: 564 Herrmann, Eva: 713 Guo, Yan: 144 Hanf, Matthieu: 709 Hawkins, David: 433 Hesney, Michael: 460 Gupta, Amita: 745, 747, 752, Hanhauser, Emily: 86, 367 Hawthorne, Dara: 425 Hess, Kristen: 52, 930 758 Hanke, Kirsten: 485 Hayes, Richard: 114, 156, 165, Hesselgesser, Joseph: 95LB Gupta, Phalguni: 341, 376 Hanke, Tomá: 320 523, 981, 982 Hessol, Nancy A.: 647 Gupta, Ravindra K.: 499, 503, Hanna, David B.: 647 Hazra, Rohan: 816 Hey-Cunningham, William: 334 848, 1030 Hanna, George J.: 472 Hazuda, Daria J.: 98, 437LB, 506 Heyderman, Robert S.: 769 Gupta, Samir: 714 Hans, Prozesky W.: 960 He, Xuan: 321 Hezode, Christophe: 577 Gupta, Sundeep K.: 35LB, Hanscom, Brett: 989, 997, 1038 Hearps, Anna C.: 483 Hicks, Charles B.: 418 168LB, 789 Hansudewechakul, Rawiwan: Heath, Katherine: 1023 Hicks, Katherine A.: 1051 Gupte, Nikhil: 752 831, 858, 860 Heath, Laura M.: 33 Hicks, Sakeenah: 93LB Gurakar, Merve: 151 Hao, Yanling: 321 Heath, Sonya L.: 292, 313 Hickson, DeMarc A.: 897 Guthrie, Teresa: 115 Harada, Shigeyoshi: 505 Heaton, Robert: 409, 446 Hiener, Bonnie: 348, 365 Gutiérrez, Carolina: 354 Hardin, Royce: 700 Heckbert, Susan: 42, 641 Hightow-Weidman, Lisa: 883LB Gutman, Boris A.: 386 Hardy, Isabelle: 218 Heera, Jayvant: 818, 1120 Hijdra, Rosanne M.: Hare, C. Bradley: 68, 894 Heffron, Renee: 771, 865 Hildebrand, Falk: 260 –H– Harezlak, Jaroslaw: 383, 386 Hegazi, Aseel: 683 Hileman, Corrilynn O.: 674 Haas, Andreas: 118 Harling, Guy: 167 Heine, Amy D.: 920 Hill, Alison L.: 357 Haas, David W.: 443 Harper, Michael S.: 134, 187, 262 Heitzmann, Julia: 351 Hill, Andrew M.: 1023 Author Index Author Haas, Rainer: 364 Harri, Bala I.: 434 Hejdeman, Bo: 285 Hill, Elizabeth M.: 692 Haber, Barbara: 576 Harrigan, P. Richard: 227, Heller, Theo: 561 Hill, Shawn: 337 Haberl, Annette: 713 169aLB, 483, 491LB, 492LB, Hellerstein, Marc: 298 Hillier, Sharon L.: 109LB, 871 Haberlen, Sabina A.: 914 716, 940 Hellmuth, Joanna M.: 405, Hinckley, Sandy: 395 Haddad, Elias: 263, 263 Harriman, Graham: 908 414, 415 Hirsch, Vanessa: 275LB Hadigan, Colleen: 430, 561, 830 Harris, Barbara: 213 Helmy, Sherine: 153 Hirsch-Moverman, Yael: 738,
146 CROI 2016 Author Index 147 , 168LB
962 1026 CROI 2016 119 , Author Index Author 640 562 , 808 568 798 914 456 739, 750 Jean-Philippe, Patrick: 458, 815 Patrick: Jean-Philippe, 950 Nicolas: Jeanne, –J– 448 Jackson, Akil: 108LB Cindy: Jacobson, 1051 Evin: Jacobson, 588 M.: Ira Jacobson, 347 Jeffrey: Jacobson, Lisa: 150, 283, 685, Jacobson, 140 W.: Harold Jaffe, 489 Jeremy: Jaffre, 101 Prasanna: Jagannathan, 488 Manjeetha: Jaggernath, 415 Linda: 404, Jagodzinski, 386 383, 384, Neda: Jahanshad, 35LB, Jahn, Andreas: Ireland, Terra M.: 138 M.: Terra Ireland, 342 Alivelu: Irrinki, 301 Elizabeth: Irungu, irvin, Risha: 537 344 343, Amorina: Ishai, 157 Nazir: Ismail, 446 412, Jennifer: Iudicello, 98, 437LB, Marian: Iwamoto, 169LB Collins: Iwuji, Joachim: 685 Ix, 187 133, Shilpa: Iyer, 289, 950 Jacques: Izopet, Jarrín, Inmaculada: 901 Jarvis, Joseph N.: 562 Hannah: 769 Jary, 473, Antoine: Marc Jean Juste, Jaoko, Walter: 863, 864, 912 863, Walter: Jaoko, Mbae m.: Japhet, Antoine: Jaquet, Jahn, Andreas: 789 Jahn, Andreas: K.:Jain, Mamta 27, 160, 587 116, 843, Vivek: Jain, 523 Anelet: James, Ian: 667 James, Jamieson, Denise: 772, 801LB Jamieson, Lise: 246 1009 Jamison, Kelly: 46 Tomazic: Janez, 788 V.: Jani, Ilesh SumbalJanjua, A.: N.: 762 Edward Janoff, Jansson, Marianne: 254 857 Watsamon: Jantarabenjakul, Jennifer: Jao, 671 855 , 337 536
, 84 380 820 234 58 , 285 999 658 , 848 225 936, 1055 784, 810, 815 940 264, 278, 293, 326, 428, 763 41, 218, 480 Hurley, Leo B.: 894, 1035 B.: Leo Hurley, 87 Jacob: Hurst, Hussen, Sophia:897 366 Gero: Hutter, 25, 425, 464 Carey: Hwang, RobertHyland, H.: 154LB Jesper: 26LB Højen, Hue, Stephane: 214, 216, 223, Stephane: Hue, Dietrich: 584, 589 Hueppe, 437LB Andreas: Hueser, 364 Falk: Huettig, Huffman, Kim: 705 895 Gwenda: Hughes, 740, 884, 885, James P.: Hughes, Michael: 99, 493LB, 37, Hughes, H.: Stephen Hughes, Huhn, Gregory D.: 144, 409, 412 Todd: Hulgan, 718, 533, 688, W.: Mark Hull, Sebastiaan J.: Hullegie, 869, 869 Machel: Hunt, 227, 235, 44LB, W.: Peter Hunt, 822, 823 Yanling: Huo, 271 Nicolas: Huot, Huppler Hullsiek, Katherine: Sophia: 343, 344, 643 Hur, John: 90 Hural, James H.: Hurley, Imaz-Rosshandler, Ivan: 251 Ivan: Imaz-Rosshandler, 154LB Patrick: Ingiliz, 584, 589 Patrick: Ingiliz, Suzanne: 941 Ingle, Steve: Innes, –I– 201 Veronica: Iannucci, Ilinca: Ruxandra Ibanescu, M.: 502 Fati Ibrahim, 362 Caroline: Ignacio, 716 Jarek: Ignas-Menzies, Olga: 705 Ilkayeva, Imamichi, Hiromi: Iodice, Valentina: 607 Valentina: Iodice, 368 Sergey: Iordanskiy, Kashif:Iqbal, Intana, Jintana: 407 Jintana: Intana, Andrea: Introini, 738 996 , 999 , 344, 643, 599 835 579 967 1000 343 971 1035 688, 745, 747 654 Hong, Ting: Ting: 728 Hong, Zhi: 105 Hong, Víctor: Hontañón, 527 975 Nely: Honwana, 1057 Greg: Hood, Julia E.: Hood, Brooke: Hoots, Donald R.: 720 Hoover, Karen: Hoover, L.: Rebecca Hope, 197, 877 J.: Tom Hope, 630 Andrzej: Horban, Michael A.: 54, 684, Horberg, 866 Howard: Horng, 866 Hosek, Sybil: 604 Yujin: Hoshida, 875 Elena: Hoskin, Mina: 30, 728, Hosseinipour, L.: 234 Anna Hotton, 786 Taige: Hou, 17 Xuanlin: Hou, Brian: 905, 907 Houle, 850 James: 789, Houston, A.: Andrea Howard, C.: Louisa Howard, Howarth, R.: Alison 32LB James A.: Hoxie, 46 Jennifer: Hoy, 795 782, 785, Nei-Yuan: Hsiao, Priscilla: Hsue, Hudgens, Michael: 801LB Hudgens, Hudson, Hannah: 629 106, 471 Hudson, Krischan J.: Hu, Lily: 357 Lily: Hu, 229, 356 Shiu-Lok: Hu, 52 Xiaohong: Hu, K.: 259LB Xintao Hu, 574 B.: Yiran Hu, 955 Yufeng: Hu, Justyn:648 Huang, 764 Laurence: Huang, Liusheng: 101 Huang, 53 Ping: Huang, Shujie: 926, 969 Huang, 578, Wei: Huang, A.: 999 Ya-Lin Huang, 469LB Yaoxing: Huang, 90 Yunda: Huang, 397 Yunlong: Huang, Michael: 89LB Huber, Megan: 162 Huchko, , , 518 , 113LB 367 900 793 , , 410 , 342, 379 821 884 793 330 811 885 876 155 1007, 1041 927, 972 Hleyhel, Mira: Mira: Hleyhel, Hlophe, Thabo: Thabo: Hlophe, 34 769 Antonia: Ho, K.: 602 543, 543, Cynthia Ho, 469LB 105, D.: David Ho, L.: 636, 636 Emily Ho, Sui, 360 Ho Shannan: Jacqueline: Hoare, Hobbs, Kristen S.: 86, 367 Kristen Hobbs, 295 Hakim: Hocini, N.: 652 Howard Hodis, Martin:Hoenigl, 224, 872, 873, 875, Craig: Hoesley, 813, 814 J.: Howard Hoffman, RisaHoffman, M.: 567 Matthias: Hoffmann, 553, 640, 673 Udo: Hoffmann, Johan: 139 Hofkens, 485 Alexandra: Hofmann, 360 Oliver: Hofmann, 51, 1042 Joseph: Hogan, 86, 357, Louise: Hogan, Boris Hogema, 593 M.: 745 Evelyn: Hogg, Robert949, S.: 546, 898, Hogg, 81 Rebecca: Hoh, 200 Brian J.: Hoium, 878 Angela: Holder, 99 Kimberly M.: Hollabaugh, 925 Claire: Holland, 648 Cameron: Holloway, 145 Alexander: Holman, Susan: 720 Holman, 1018, 1019 Charles: Holmes, Michael: 356 Holmes, K.: 720 Marcia Holstad, G.: 692 Stephen Holt, Timothy Holtz, H.: 646 Volker: Holzendorf, 212 Vera: Holzmayer, 743 David: Hom, 1017 Fabienne: Homeus, A.: 1051 Amanda Honeycutt, 85, Feiyu: Hong, 321 Kunxue: Hong, 244 Patrick: Hong, Hoffman, Susie:Hoffman, 1020 160, 470 Christian: Hoffmann, Christopher: Hoffmann, Author Index
Jeffries, Carrie: 993 Joy, Jeffrey B.: 491LB 762 Katz, Ingrid T.: 1014 Jeffries, William L.: 930 Judd, Ali: 835, 855 Kammerer, Betsy: 800 Kaudha, Elizabeth: 849 Jelicic, Katija: 198 Judge, Chelsey: 329 Kampiire, Leatitia: 112 Kaufman, Jonathan J.: 40 Jenabian, Mohammad-Ali: 237 Juge, Laurianne: 391 Kamya, Moses R.: 101, 112, 116, Kaufmann, Scott H.: 243 Jenkins, Cathy: 706 Jung, Molly: 647 297, 796, 829, 841, 843, 979, Kaul, Rupert: 718 Jenkins, Veronica: 538LB Jungmann, Eva: 835 985, 1026, 1062 Kaur, Jasmine: 342 Jenks, Jeffrey D.: 753 Justement, Jesse S.: 311LB Kanade, Savita: 758 Kavanagh, Daniel: 312 Jennings, Jacky M.: 1036 Justice, Amy C.: 150, 554, Kandathil, Abraham J.: 151 Kawale, Paul: 793 Jensen, Bjoern-Erik O.: 364 641, 714 Kang, Guobin: 268, 290 Kayembe, Mukendi K.: 615 Jessen, Heiko: 231 Justman, Jessica: 770, 1025 Kankasa, Chipepo: 33 Kayira, Dumbani: 801LB Jia, Hongwei: 215 Kanki, Phyllis: 281 Kazer, Sam W.: 19 Jiang, Shuping: 680 –K– Kannan, T.: 457 Kazooza, Francis: 159 Jiang, Xiong: 390 Kabami, Jane: 979 Kansomlap, Putthachard: 956 Kearney, Mary F.: 85, 337, 340, Jibril, Haruna: 800 Kabilis, Elkanah D.: 434 Kanters, Steve: 166 379, 490 Jin, Steven W.: 190 Kabore, Firmin N.: 696 Kanthula, Ruth M.: 478, 847 Keating, Sheila M.: 81, 234, Joao, Esau C.: 779 Kadam, Dileep: 752 Kantor, Rami: 503 511, 652 Jobarteh, Kebba: 850 Kadede, Kevin: 829 Kanywa, Jacqueline B.: 842 Keele, Brandon: 84, 138, 229, Jöckel, Karl H.: 646 Kadelka, Claus: 89LB Kao, Kekeletso: 512, 787 340 Johengen, Daniel: 879 Kadlecik, Peter M.: 1035 Kapiga, Saidi: 110LB Keiser, Olivia: 118 John, Betsey H.: 890 Kagaayi, Joseph: 954, 986 Kaplan, Jona E.: 159, 761 Kekitiinwa, Adeodata: 842 John-Stewart, Grace C.: 38, 621, Kahabuka, Catherine: 978 Kaplan, Justin A.: 465 Kelesidis, Theodoros: 672, 939 624, 748, 780 Kahn, James G.: 1062 Kaplan, Robert C.: 647 Kellam, Paul: 210, 827 Johnson, Christopher: 1004 Kahn, Kathleen: 905, 907, 936 Kaplan, Susan: 825 Kelleher, Anthony: 233, 334, Johnson, Elan S.: 781 Kaida, Angela: 949 Kaptue, Lazare: 212 365, 559, 668 Johnson, Erica L.: 781 Kairie, James K.: 868 Kapwata, Thandi: 735 Kelley, Colleen F.: 286 Johnson, Jeffrey: 244 Kaiser, Philipp: 80 Karajeanes, Esmeralda: 974, 976 Kellogg, Anela: 430 Johnson, Leah: 879 Kaiser, Rolf: 364 Karalius, Brad: 838 Kelly, Clifton W.: 521 Johnson, Leigh F.: 115 Kajubi, Richard: 101 Karasavvas, Nicos: 318 Kelly, J. Daniel: 72LB Johnson, Mallory: 935 Kakkar, Fatima: 836 Karat, Aaron: 155 Kelly, Jane: 995 Johnson, Margaret: 559, 683 Kaku, Yu: 670 Karim, Farina: 735 Kelly, Nicola: 759 Johnson, R. P.: 269 Kakuru, Abel: 101 Karim, Mohammed: 153 Kendall, Claire: 622 Johnson, Sherri: 108LB, 872, 873 Kalams, Spyros A.: 653, 706 Karim, Salim A.: 246 Kenmegne, Jules: 212 Johnson, Suzanne: 155 Kalapus, S.C.: 643 Karimanzira, Owen: 302 Kerr, Stephen J.: 606 Joloba, Moses L.: 743 Kalayjian, Robert: 329, 421, Kariminia, Azar: 831, 858, 860 Kersanske, Laura: 908 Jones, Brad: 300LB 694, 719, 721 Karki, Manju: 325 Kersh, Ellen: 878 Jones, Heidi E.: 770 Kaleebu, Pontiano: 87, 297, Karku, Sahr: 72LB Keshinro, Babjide: 922, 923 Jones, James H.: 72LB 1027 Karlsson, Annika: 254 Kessing, Cari: 407 Jones, Joseph: 554 Kalibbala, Sarah: 563, 726 Karn, Jonathan: 180 Ketende, Sosthenes: 924, 925 Jones, Lynne: 745 Kalinjuma, Aneth V.: 676, 760 Karuchit, Samart: 972 Kfutwah, A.: 959 Jones, Rachael: 683 Kalish, Marcia: 790 Karugaba, Patrick: 513, 521 Khalilieh, Sauzanne: 456 Jonsson Funk, Michele: 953 Kalkwarf, Heidi J.: 36 Kasese, Nkatya: 982 Khan, Palwasha Y.: 736, 846 Jooste, Pieter: 302 Kall, Meaghan: 913 Kashanchi, Fatah: 368 Khanh, Truong Huu: 858 Jordan, Heather: 456 Kallas, Esper G.: 326, 511 Kashuba, Angela: 102LB, 402, Khanna, Aditya S.: 1063 Jose, Sophie: 683 Kallianpur, Asha R.: 144, 409, 418, 439, 447, 450 Khatri, Amit: 574 412 Kaski, Juan P.: 853 Khemnark, Suparat: 606 Joseph, Sarah B.: 401, 402 Kallianpur, Kalpana J.: 384, Kassanjee, Reshma: 517 Khoo, Saye: 432, 434, 441, 448, Joshi, Samir: 752 387, 723 kassaye, Seble: 390 449, 459 Joshi, Samit R.: 472 Kalpana, S.: 457 Katlama, Christine: 332, 489 Khoshnood, Babak: 804 Author Index Author Joshi, Sunil K.: 80, 298 Kamara, David: 637, 637 Katoro, Joel: 510 Khosropour, Christine: 933 Josiah, Robert: 1025 Kamara, Victor: 910 Kattakuzhy, Sarah: 528, 538LB, Khudyakov, Yury: 149, 541 Joska, John: 419, 821 Kamara, Victoria: 910 580 Khuong, Marie-Aude: 509, 943 Jost, Stephanie: 315, 367 Kamara, Wogba: 910 Katumba, Kenneth: 910 Kiama, Catherine N.: 909 Jotwani, Vasantha: 685, 691 Kambona, Caroline: 903 Katuramu, Richard: 112 Kielkowski, Danuta M.: 631 Jourdain, Gonzague: 777 Kambugu, Andrew: 297, 761, Katz, David A.: 971 Kiem, Hans-Peter: 356
148 CROI 2016 Author Index 149 , 898 , 964 , 954 , 796, 593 ,
546 917 66 116 CROI 2016 , 1038 , 30 171 Author Index Author 375 10 362 997 310LB 504 , 747 843, 1026 30, 728, 753 728, 30, 745 108LB 367, 476, 815 1007, 1041 526, 582 540, 594, 830, 906, 826, 859 Kwaro, Daniel: 903 Kwaro, Zachary A.: Kwena, 576 Paul: Kwo, Douglas315 S.: 261, Kwon, Mi: 366 Kwon, 310LB D.: Young Kwon, D.: Peter Kwong, 449 Isabella: Kyohaire, Kuruc, JoAnn D.: 291, 418, D.: JoAnn Kuruc, Nishani: 465 Kuruppu, Takeo: Kuwata, 630 Elena: Kuzovatova, Vivian: 1015 Kwaghue, Dalsone: Kwarisiima, Kumar, Parag: 430 Parag: Kumar, 1032 899, 918, Suresh: Kumar, Nagalingeswaran: Kumarasamy, J.: Johnstone Kumwenda, H.: 277, Mark Kuniholm, Ratiya: Na Ayudhya, Kunjara 893 Irene: Kuo, Miriam: 162 Kuppermann, Daniel: 86, 307, 346, Kuritzkes, Jessie: 1061 Kurkunar, Nia: 860 Kurniati, Kurth, 989, Ann: Kumar, Nitasha A.: Nitasha Kumar, Lackey, Philip: 953 Philip: Lackey, 141 Andrew: Lackner, 1043 Jean-Marc: Lacombe, Karine: LaCombe, 460 Frank: LaCreta, M.: Steven Lada, Kristin: 313 Ladell, 511, 520, Oliver: Laeyendecker, Mark: 188 Lafferty, Muriel: 408 Laffon, –L– Rosa, Alberto La M.: Danielle: 649, 657, 674, Labbato, 873 Nicole: Laborde, S.: 86 Ann LaCasce, 710 Aoife: Lacey, J.: Nathan Lachowsky, , 772, 771 561 959 612 625 407, 415 94, 245LB, 327, 336 245LB, 94, 801LB 853 595, 599, 600 Kovarova, Martina: 450 Kovarova, 203 Takayoshi: Koyama, Zisis: 210 Kozlakidis, 255 Colleen: Kraft, N.: 268 Edmundo Kraiselburd, Rebecca: Krakora, 690 Gitte: Kronborg, 219, 349, 404, Eugène: Kroon, Meighan: 740 Krows, Gunnar: 381 Krueger, Martine:Kruijssen, 431 Krykbaeva, Marina: 91 Krystal,464, 466 Mark: 97, 461LB Supparatpinyo: Kuanchai, Griffiths: 113LB Kubeka, 743 W.: RachelKubiak, 485 Claudia: Kucherer, Sagar: 137 Kudchodkar, 783 Tendesayi: Kufa-Chakezha, 33, 39, 40, 851 Louise: Kuhn, 606 Sivaporn: Kukanok, Ranjababu:423LB Kulasegaram, Shalini: 162 Kulasingam, Michal: 436 Kulich, 717 Manjusha: 656, Kulkarni, Sarah: 1020 Kulkarni, Deanna: 369 Kulpa, Kourtis, Athena P.: P.: Kourtis,Athena 567 89LB, Roger: Kouyos, Joseph A.: 561 Kovacs, Helen: Kovari, Douglas S.: 890 Krakower, 49 Daisy: Krakowiak, Benjamin: 236 Krämer, 550 R.: Jennifer Kramer, 846, 736, Katharina: Kranzer, 566 David: Kraus, William: 705 Kraus, 407, 414 Shelly: Krebs, Regis: 775 Kreitchmann, 628 Alexander: Kreuter, 539LB Krishnan, Preethi: R.: 376 Jan Kristoff, 244 Nevan: Krogan, Arne: Kroidl, Koteff, Justin: 660 Koteff, 580, 528, 538LB, Shyam: Kottilil, C.: Kouanfack, 90, 25, 32LB, A.: Richard Koup,
706 601 1012 796 315 169aLB 723 231, 232 547, 602 365 1017 Koetsawang, Suporn: 777 Koetsawang, 284 Nargis: Kohgadai, 580, 599 Anita: Kohli, M.: 387, 652, Lindsay Kohorn, E.: 19 Kellie Kolb, Michael:867, 870 524, Kolber, Susan 719, 721 L.: 421, Koletar, 75LB Jacques: Kolie, DennisL.: 394 Kolson, 548 Xiangrong: Kong, Olivier:736 Koole, Dianna: 379 Koontz, A.: 152 Neeltje Kootstra, 593 Marco: Koppelman, Bette: 309LB Korber, Christian: Körner, Kort, Jens: 453 1005 1001, Todd: Korthuis, 224, Sergei: Pond, Kosakovsky 817 Pope: Kosalaraksa, Barry:523 Kosloff, 453 P.: Matthew Kosloski, A.: Catherine Koss, Joshua: 749 Kostera, R.: 290, 609 Jay Kostman, Knezevic, Andrea: 47 Andrea: Knezevic, Jaclyn: 399 Knibbe-Hollinger, Rob: 265 Knight, 45 Hernando: Knobell, 364 Elena: Knops, C.: David Knox, Justin: 921 Knox, 202 Masayuki: Kobayashi, Guido: 364 Kobbe, BerylKoblin, 140, 897 A.: Duncan:Kochelani, 925 M.: 152, Sylvie Koekkoek, K.: 233, 334, Kersten Koelsch, 739, 473, P.: Serena Koenig, 991 J.: Carl Koenigsmann, John R.: 653, Koethe, Klenerman, Paul: 598 Klenerman, Paul: Thomas: Klimkait, 951 229 Christopher: Kline, 694 Klingman, Karin: 44LB, Sheryl A.: Kluberg, Kleinbeck, Kyle: 876 Kleinbeck, Kyle: E.: 561 David Kleiner, Sarah E.:Kleinstein, 690 , 726, 520 195 703 361 849 , 99
3 , 987 558 830 548, 693, 712, 917 731, 699, 914 826, 859 641, 671, 684, 688, 1034 Kiser, Jennifer: Jennifer: Kiser, Kirwa,562 Elisha: 1053 Kirwan, Peter: Maja: Kiselinova, Kilani, RIzwan:Kilani, 636 909 Kim, Aandrea: C.: 235 Kim, Charlie 553, 673 Kim, Elli: H.: 318 Kim, Jerome Kim, Michelle: 360 80 Kim, Nicholas: Kim, Nina: 965 Kristina: Kintziger, Kinuthia, John: 49 M.: 195 Festus Kiogora, M.: 746 Aaron Kipp, 494LB Catherine: Kiptiness, 159, 297 Agnes: Kiragga, A.: 137 Karen Kirby, Rory: 360 Kirchner, 1024 Kirk, Catherine: 150, 535, 540, Kirk, GregoryD.: Kirk, Ole: 661 M.: Ditte Kirkegaard-Klitbo, Kigozi, Godfrey: 163, 986, 987 163, 986, Godfrey: Kigozi, Simone H.: 227 Kigozi, Kiguoya, W.: Marion 80 Kim, Peggy: 30 S.: Kim, Peter 51 Sylvester: Kimaiyo, 226 Kimani, Joshua: 195, 402 401, P.: Laura Kincer, 760 Alexa: King, 771 Caroline: King, 330, 388, Lawrence: Kingsley, 674, 649, 657, Bruce: Kinley, Alexander: Kintu, R.: Allison Kirkpatrick, Kiser, Patrick: 877 Patrick: Kiser, 558, 614, Mari M.: 42, Kitahata, 421 Douglas:44LB, Kitch, KathrynKitrinos, M.: 496 498, Cissy: Kityo, 115 Eva: Kiwango, 817 Hilda: Kizito, Nichole: 263 Klatt, 54, 641, 1035 Klein, Daniel B.: 117 Klein, Daniel J.: 150 Klein, Marina B.: Author Index
Laforest, Claire: 455 Law, Matthew: 559, 637 Leitman, Ellen M.: 256, 827 Libin, Pieter: 211 Lahiri, Cecile D.: 47 Lawitz, Eric: 576 Leitner, Thomas: 806 Lichterfeld, Mathias: 361, 815 Lahuerta, Maria: 921 Lawson, Benton: 93LB, 353 Lelièvre, Jean-Daniel: 295 Lichtner, Miriam: 610 Lai, Ming-Tain: 98, 506 Lawson-Ayayi, Sylvie: 689 Lennemann, Tessa: 625 Liegler, Teri: 990, 1026 Laibson, David: 1039 Lazaro, Estibaliz: 689 Lennox, Jeffrey L.: 47, 55, Lieveld, Faydra I.: 543 Lake, Jordan: 660, 699, 914 Lazure, Thierry: 271 255, 476 Lifson, Alan: 475 Lakritz, Jessica R.: 272 Lazzarin, Adriano: 454, 556, 557, León, Eddie: 477 Lifson, Jeffrey: 84, 138, 270, Lal, Asim: 781 627, 697 Leone, Dominick: 1014 352, 353 Lalama, Christina: 300LB, 350 Le, Leah: 404, 411 Leone, Peter A.: 217 Lim, So-Yon: 95LB Lalani, Tahaniyat: 932 Le, Oanh Ngoc: 860 Lepik, Katherine J.: 492LB Lima, Viviane D.: 227, 492LB, Lalezari, Jacob: 342, 358LB, 574 Le, Thoa P.: 831 Leroi, Charline: 962 533, 940 Lallemant, Marc: 777 Le Chenadec, Jérôme: 776, 804 Leroy, Sandrine: 73LB Lin, Haiqun: 691 Lalor, Maeve K.: 1053 Le Coeur, Sophie: 777 Lesi, Funmi: 281 Lin, Naomi: 834 Lam, Stephen: 725 Le Corfec, Anne: 514 Lesosky, Maia S.: 419 Lin, Nina: 307 Lam, Wan: 725 Le Fouler, L.: 959 Lessler, Justin: 902 Lin, Peng: 970 Lama, Javier: 108LB Le Gall, Sylvie: 312 Letang, Emilio: 676, 760 Lin, Yea Lih: 282 LaMar, Melissa: 322, 597 Le Grand, Roger: 271 Letendre, Scott R.: 143, 144, Lin, Zeyu: 464, 466 Lambert, John: 665, 710 Le Moing, Vincent: 276, 675 395, 409, 412, 446 Linas, Benjamin P.: 43 Lambert, Sidonie: 332, 489 le Roux, Stanzi M.: 808 Leth, Steffen: 26LB Lincez, Pamela J.: 807 Lambotte, Olivier: 271 Le Scanf-Terrien, Cécile: 689 Leucke, Ellen: 879 Lindborg, Lena: 998 Lamers, Susanna L.: 331, 345 Leadabrand, Kaitlyn S.: 86 Leung, Janice: 725 Lindegren, Mary Lou: 746, 790 Lamorde, Mohammed: 444, 449 Leal, Manuel: 655 Levi, Jacob: 1023 Lindsey, Jane: 825 Lampiris, Harry: 80 Leary, Shay: 359 Levin, Myron: 825 Ling, John: 100 Lan, Yun: 955 Lebelonyane, Refeletswe: Levine, Andrew J.: 388 Lingappa, Jairam R.: 17, 200, Land, Allison M.: 200 111, 983 Levine, Ken: 890 301, 771 Landay, Alan L.: 277, 293, 695LB LeBlanc, Roger: 237 Levine, Molly: 494LB Linka, Rene m.: 189 Landovitz, Raphael J.: 55, 103, Lebouché, Bertrand: 237 Levy, Matthew E.: 893 Linnen, Jeffrey: 593 104, 476, 861 Lebrun-Frenay, Christine: 408 Lévy, Yves: 295 Liorre, Giulia: 607 Landry, Ishani: 460 Leckie, Gregor: 749 Lewin, Sharon R.: 298, 348, Lisi, Catiuscia: 778 Lane, H. Clifford: 380 Lécuroux, Camille: 351 359, 375 Lissock, Frédéric L.: 526 Lange, Camille M.: 848 Ledergerber, Bruno: 612 Lewis, Rashunda: 1000 Little, Susan J.: 143, 224, 228, Lange, Christoph: 158LB Lederman, Michael M.: 252, 293, Lewis, Suzanne: 812 232, 487, 518, 727, 730, 942 Langevin, Stanley: 263 296, 299, 347, 671, 732 Leyden, Wendy: 54, 162 Litwin, Alain: 534, 585 Langwenya, Nontokozo: 34 Ledford, Sue L.: 217 Li, Danny: 344, 643, 654 Liu, Albert Y.: 48LB, 524, 866, Lansky, Amy: 52 Ledgerwood, Julie: 90, 311LB Li, Fan: 807 867, 870 Lanzi, Anastasia: 469LB Lee, Anthony: 147 Li, Fangyong: 142 Liu, Chenglong: 390 Laopraynak, Naphassanant: 956 Lee, Benhur: 33, 244 Li, Guanhan: 393 Liu, Chuncheng: 926 Lapadula, Giuseppe: 486 Lee, David: 807 Li, Jonathan Z.: 346, 347, 360 Liu, Enju: 703 Laraia, Barbara: 935 Lee, Eric L.: 134, 187, 262, 279 Li, Maoji: 884, 885 Liu, Hongbing: 80 Laraque, Fabienne: 534 Lee, Gary K.: 358LB Li, Peilin: 80 Liu, Hongjie: 924 Lariven, Sylvie: 709 Lee, Guinevere Q.: 227 Li, Qingsheng: 268, 290 Liu, Hui C.: 717 Larmarange, Joseph: 169LB Lee, Haekyung: 597 Li, Shengbin: 23 Liu, Rachael: 456 Larrieux, Jean-Robert: 288 Lee, Hana: 1042 Li, Taisheng: 569 Liu, Wei: 453 Laskey, Sarah B.: 83, 339, 462 Lee, Hang: 673 Li, Tianbo: 464 Liu, Winston: 389 Lassandro, Anna Pia: 697 Lee, Susan S.: 832 Li, Weizhe: 399 Liu, Xia: 446 Lataillade, Max: 425, 464, 472 Leech, Robert: 148 Li, Xiang: 142 Liu, Ying: 321 Latham, Catherine F.: 483 Leelawiwat, Wanna: 927 Li, Xiaojun: 194 Liu, Yue: 20 Latkin, Carl: 535, 537, 897, 906 Lefebvre, Eric: 239 Li, Yanjie: 652 Livant, Edward: 521 Author Index Author Lau, Bryan: 911 Lehman, Dara: 478, 621 Li, Yanling: 569 Llamoso, Cyril: 472 Lauck, Michael: 21 Leider, Jason: 968, 997 Li, Yijia: 569 Lloyd-Jones, Donald M.: 644 Lauffenburger, Douglas: 308 Leidner, Jean: 800, 802, 810 Li, Yingying: 133 Lo, Janet: 553, 650, 673 Laughton, Barbara: 658, 820 Leifheit, Kathryn M.: 1036 Li, Yuju: 397 Lo Caputo, Sergio: 247 LaValley, Michael: 1012 Leigh Brown, Andrew: 210 Li, Zhufang: 97 Lavert, Marion: 577 Leisegang, Rory: 1029 Liang, Richard: 602
150 CROI 2016 Author Index 151 , 545 ,
ngeles: , 106 , 1035 19 451 263 767 , 881 CROI 2016 894 Author Index Author 31LB , 785 , 597 54 782 572 840 , 663 366 1010, 1061 322, 406, 471, 106, 471 489, 503, 645, 1039 571 Martínez-Cuesta, María Á 320, Javier: Martinez-Picado, Maria: 945 Martinez-Rebollar, Marks, Gary:Marks, 1033 Raffaella: 610 Marocco, Manuel: 603 Márquez, 36 Caroline: Marr, 636, Christina: Marra, Jeanne: 521 Marrazzo, 456 Martell,Maureen: Martí, Ramón: 205 Martin,664 650, Amanda: Martin, E.: 465 David Martin,388, 416 Eileen: Martin, N.: 227, 671 Jeffrey 284 W.: Martin, Jeremy Martín, María E.:354 527 Luz: Martín-Carbonero, Enrique: Martin-Gayo, Martinez, 945 Esteban: Martinez,I.: 268 Melween Guillermo: Martínez Pérez, Mark, 49 Jennifer: 190 Tristan: Markle, Martin:Markowitz, 105, Marianne: Martinello, Margolis, David M.: 355, 418 David Margolis, 184 Leonid: Margolis, A.: 496 Nicolas Margot, 877 Danijela: Maric, 426, 454 Letizia: Marinaro, 424LB Ana: Mariño, Maritz, Jean: Maokola, Werner: 978 Werner: Maokola, Mark E.: 392 Mapstone, Anne-Geneviève: Marcelin, Giulia: 598, 946 Marchetti, Bruno: 289 Marchou, 255, 335, C.: Vincent Marconi, Julia L.: Marcus, 794 Rebecca: Marcus, 804 Emannuelle: Marel, A.: David Margolis, Manuel, Marcelo d.: 516 d.: Marcelo Manuel, Manuzak, A.: Jennifer 320, Christian: Manzardo, , 376 743 244 885 , 665, 878 799 , 422 853 403 675 126 416 515 679 , ova, Natalia: Natalia: ova, 800, 802, 810, 984 748, 780 678 747 864, 912 804, 811 668, 710 Majid, Rana: 702 Majid, 148 B.: Charles Majoie, D.: Majonga, Edith 393 O.: Eugene Major, Maiga, Almoustapha: 840 Maiga, Almoustapha: 962 Maiga, Moussa: 341, Robbie B.: Mailliard, Mak, 233 Gerald: Makar Alain: Makinson, Malaba, Thokozile: Makhema, Joseph: 37, 111, 784,Makhema, Joseph: 37, Pauline: Maki, 729 Christophe: Malcus, 337, 490 Frank: Maldarelli, 38, Elizabeth: Maleche-Obimbo, 822, 823 Kathleen: Malee, 28, 792 Given: Malete, 635 Peter: Malfertheiner, 515 Malia, Jennifer: Malik, 629 Neha: Simon: 359, 667 Mallal, Divya: Mallampati, 786 Jaclyn C.: Mallard, Jose: 945 Mallolas, Josep: 611 Mallolas, Patrick: Mallon, Mangano, Andrea: 837 Andrea: Mangano, K.:Mann, Jaclyn 195 Mann, Surinder K.: 278 Jennifer: Manne-Goehler, Sharon: Mannheimer, Michael: 576 Manns, Joanne E.:988, 988 Mantell, Manak, Mark: 435 Subhra: Mandal, 498, 863,Kishor: Mandaliya, 776, Laurent: Mandelbrot, 982 Nomtha: Mandla, Raul: 27 Mandler, 201, Lara: Manganaro, Maloney, Kevin M.: 890 Kevin Maloney, Libet: 925 Maloney, Denis: 75LB Malvy, Malyuta, Ruslan: 778 725 Paul: Man, S. F. C.: 159, Yukari Manabe, , 200 99 17 932 446 319 , 226 637, 661, 686 742, 963, 1029 350, 685 1025 1028 893 Lund, Jennifer M.: 301, 301 Jennifer Lund, 474, 630, 46, D.: Jens Lundgren, Ma: Luo, 161, 392 Amneris: Luque, 163 Tom: Lutalo, Philipp: 236 Lutz, 584, 589 154LB, Thomas: Lutz, 440, 806 Katherine: Luzuriaga, M.: 245LB Rebecca Lynch, 264 V.: Susan Lynch, –M– Qing:Ma, 395, 654 643, Yifei: Ma, 278 M.: Zhong Ma, 738 Maama, Llang B.: Maartens, Gary:419, 427, 429, 625 Leonard: Maboko, 788 Mabunda, Nedio: 113LB Tonderai: Mabuto, 1056 Mabuza, Khanya: E.: Grace Macalino, Ian: 226 MacArthur, 283, J.: Bernard Macatangay, E.: Christine MacBrayne, 608 Margherita: Macera, 797 Eusebio: Macete, Macharia, Thomas: 856 Juan: 530, 555 Macías, Mack,422 Wendy: Duncan: 516, 975, MacKellar, Romel D.: Mackelprang, Macken, Alan: 710 Alan: Macken, Rachel L.: 786 MacLean, Iain: 626 MacLeod, 1013, B.: William MacLeod, 936 Catherine: MacPhail, Madrian, Bridget: 1039 Nadia: 354 Madrid-Elena, 477 Carlos: Magis, 390, 883LB, Manya: Magnus, 943 Aba: Mahamat, 305 Mahan, Alison: Rashika: 521 Maharaj, Nadia: 522 Mahjoub, 789 168LB, Maida, Alice: 331, 345 Maidji, Ekaterina: , 976
9 649
261 759 289 938 , 688, 899, 918, 928, 1032 918, 928, , 688, 899, 831, 860 615, 784, 800, 802, 805,615, 784, 800, 802, 810, 904 657, 674 833 687 Lukabwe, Ivan: 844 Ivan: Lukabwe, Pagakrong: Lumbiganon, Lo Re, Vincent: 150, 554, 609 Vincent: Re, Lo 570 Stephen: Locarnini, Joseph: 145 Locascio, 294 Ainsley: Lockhart, Shahin: 37, 111, 307, Lockman, Sara: Lodi, Lofters, Aisha: 622 Aisha: Lofters, Claire: Loiseau, Judith:942 421, Lok, 697 Francesca: Lombardi, 405 Eric: Lombardini, 957 28, Lawrence: Long, T.: Chris Longenecker, Nicky: Longley, José: 611, 634 López-Aldeguer, 338 Cecilio: López-Galindez, 885 Avelino: Loquere, 788 Osvaldo: Loquilha, 413 Patrizia: Lorenzini, 952, 1016 Elena: Losina, 630 Marcelo: Losso, 622, 949 Mona: Loutfy, Susan: 856 Lovelace, 396 Jackie: Lovett, 632 Daniel H.: Low, 832, D.: Elizabeth Lowenthal, Belen: Ana 508 Lozano, 430 Jay: Lozier, Hao: 466 Lu, 307 Hong: Lu, 716 Ying: Meng Lu, Michael:673 553, 640, Lu, Susan: 460 Lubin, Olivier:304 Lucar, Gregory651, 684, M.: Lucas, Jesús M.: Luévano, Longosz, Andrew F.: 917 F.: Andrew Longosz, Sara E.:673 638, 650, Looby, 474 Gustavo: Lopardo, 974, Elisa: Varela, López 595 Joseph: Lucas, 447, 450 Paul: Luciw, Nadine: 364 Luebke, M.: 200 Elizabeth Luengas, Wicharn: 817 Luesomboon, F.: Anne Luetkemeyer, Author Index
Martini, Federico: 413 1004 McGrath, Christine: 494LB Ménard, Amélie: 583 Martins, Marcelo: 472 Maughan, Robert T.: 665, 668 McGrath, Christine J.: 621, 624 Mendelson, Marc: 742 Martinson, Jeff: 695LB Mauss, Stefan: 584, 589 McGrath, Michael S.: 273, Mendoza, Daniel: 328 Martinson, Neil: 749, 963 Mave, Vidya: 752, 758 331, 345 Menéndez, Clara: 797 Martrus, Gloria: 197, 370 Mavedzenge, Sue N.: 973 McGrath, Nuala: 169LB Menéndez-Arias, Luis: 205 Maruca, Katia: 819 Mavian, Carla: 257 Mcharo, Ruby: 625 Meng, Gang: 970 Marukutira, Tafireyi: 833 Mawela, Muthuhadini P.: 818, McHugh, Grace: 853 Menkova-Garnier, Inna: 295 Maruri, Fernanda: 735 1120 McHutchison, John G.: 154LB, Mensah, Charles: 502 Maruyama, Haruka: 1025 MaWhinney, Samantha: 445 573, 601 Mensah, Nana P.: 888 Marx, Preston A.: 268 Maxwell, Jason: 964 McIntyre, James: 757, 795, 799 Merat, Sabrina J.: 152 Marzel, Alex: 567 May, Margaret: 941 McKay, Richard A.: 140 Merchante, Nicolás: 529, 530, Marzinke, Mark A.: 103, 108LB, Mayanja-Kizza, Harriet: 297, 733 McKee, Krisha: 310LB 634 871, 872, 877 Mayer, Kenneth H.: 90, 103, McKellar, Mehri S.: 418, 705 Merenstein, Daniel: 919 Masamaro, Kenneth: 903 104, 106, 167, 231, 471, 866, McKenney, Jennie L.: 861 Merino, Dolores: 529, 530, 586 Masciotra, Silvina: 215 883LB, 890, 891, 897, 1034 McKeon, Annmarie: 312 Merino, Esperanza: 634 Mascola, John R.: 15, 94, 310LB Mayondi, Gloria: 800 McKinnon, Lyle: 195 Merino-Mansilla, Alberto: 303 Masese, Linnet: 863, 864, 912 Mayor, Angel M.: 684, 688 McKinstry, Laura: 989, 997, 1038 Merli, Marco: 454, 556, 557 Masetti, Michela: 247, 280 Mayorga, Christian: 587 McLaren, Paul: 443 Merlini, Esther: 598, 946 Maskew, Mhairi: 28, 613, 617, Mazzulli, Tony: 491LB McLaughlin, Mary: 561 Mermin, Jonathan: 52, 1045 618, 792, 1013 Mbanya, Dora: 212 McLaughlin, Sherry: 361 Merry, Concepta: 444 Mason, Stephen W.: 25 Mbofana, Elton: 512, 787 McMahan, Vanessa: 48LB Meskaldji, Djalel Eddine: 381 Massanella, Marta: 730 McAdams-Mahmoud, Ayesha: McMahon, Deborah: 300LB, 330, Mesman, Annelies W.: 72LB Massud, Ivana: 107 537 350, 377 Mesplede, Thibault: 507 Master, Iqbal: 756 McArthur, Carole: 213 McMahon, Don: 40 Messer, Michael: 32LB Masters, Samuel H.: 973 McArthur, Justin: 146 McMichael, Jeffrey: 995 Messina, Emanuela: 454, Mastroianni, Claudio M.: 610 McCallister, Scott: 102LB, McMullen-Jackson, Chivon: 458 556, 557 Masur, Henry: 528, 538LB, 580, 496, 717 McNally, John: 100 Messing, Susan: 428 599, 600 McCarter, Martin D.: 134, 187, McNicholl, Janet: 878 Messou, Eugene: 962, 1015 Maswabi, Kenneth: 815 262 McPhee, Fiona: 575 Metcalf, Carol: 512, 787, 1010 Matano, Tetsuro: 505 McCaul, Mary: 911 McRobie, Ellen: 51 Metcalfe, John: 853 Mateos, M.L.: 452 McCauley, Marybeth: 103 McVera, David: 940 Metral, Melanie: 381 Mathabela, Nokwazi: 1056 McClelland, Scott: 863, 864, 912 Mecikovsky, Debora: 837 Metsch, Lisa R.: 27, 919 Mathad, Jyoti S.: 758 McComsey, Grace A.: 123, 428, Medhin, Heluf: 615 Meya, David B.: 159, 761, Mathema, Barun: 157 649, 656, 657, 672, 674, 700, Meditz, Amie L.: 445 762, 763 Matheron, Sophie: 214, 509, 704, 717, 826, 859, 939 Meggi, Bindiya: 788 Meyer, Laurence: 222, 351, 804, 944 McCormack, Sheena: 69 Mehandru, Saurabh: 597 701, 886 Matheson, Tim: 27 McCune, Joseph M.: 235, 264, Mehraj, Vikram: 237 Meyer-Rath, Gesine: 115 Mathew, W. C.: 920 711 Mehta, Sanjay R.: 144, 232, Meyers, Kathrine: 881 Mathews, Michelle: 447 McDaniel, Darius: 157 487, 518 Meyn, Leslie: 871 Mathews, Wm. Christopher: 558, McDermott, Adrian B.: 94 Mehta, Shruti H.: 535, 537, 540, Meynard, Jean-Luc: 943 1001, 1005 McDonagh, Thomas: 97 548, 687, 693, 712, 899, 917, Mezzaroma, Ivano: 610 Mathias, Anita: 100 McFadyen, Lynn: 818, 1120 918, 928, 1032 Mhlanga, Felix: 861 Matías-Florentino, Margarita: McFall, Allison M.: 687, 899, Meier, Françoise: 776 Miailhes, Patrick: 605, 729 477 918, 1032 Meigs, James B.: 638 Micci, Luca: 335, 352, 353 Matoff-Stepp, Sabrina: 993 McFarland, Willi: 1041 Meintjes, Graeme: 734, 759, 763 Michael, Heather M.: 330 Matschl, Urte: 197 McGee, Kara S.: 418 Meissner, Eric G.: 595, 600 Michael, Nelson L.: 219, 230, Matsen, Frederick: 478 McGeer, Allison: 768 Mejer, Niels: 690 318, 349, 405 Matshaba, Mogomotsi: 833 McGettrick, Padraig: 710 Mélard, Adeline: 351 Michalik, Claudia: 628 Author Index Author Matsuda, Kenta: 275LB McGillen, Jessica B.: 1049 Melbourne, Kathy: 664, 700 Micheloud, Dariela: 639 Matsui, Yusuke: 202 McGinnis, Kathleen A.: 554 Mellors, John W.: 25, 30, 85, Midkiff, Cecily: 141 Matsushita, Shuzo: 504, 505 McGovern, Rachel A.: 492LB 300LB, 330, 337, 340, 342, Mier-y-Teran-Romero, Luis: 535 Matthews, Gail V.: 451, 545 McGowan, Catherine C.: 958 346, 350, 377, 379, 493LB, Mikula, James: 430 Matthews, Philippa C.: 827 McGowan, Ian: 71, 104, 108LB, 865 Miles, Brodie: 378 Mattson, Christine: 53, 591, 109LB, 874, 879, 880 Mena, Leandro: 891 Miller, Andrew D.: 272, 273
152 CROI 2016 Author Index 153 868 , 693 CROI 2016
118 145 471 Author Index Author 164 39 , 895 559 977 438 189 514 1033, 1034 865, 868 478, 621, 624, 771, 271, 351 564, 672, 939 Mugabe, Didier:516 Mugabe, 920, Michael J.: Mugavero, Mugerwa,Henry: 849 A.: Catrina Mugglin, 738 Mugizi, Charles: Mercy: 1059 Mugo, 301, R.: 17, 164, Nelly Mugo, M.: Peter Mugo, K.: Kenneth Mugwanya, 849 493LB, Peter: Mugyenyi, Muazu: 564 Muhammad, 371 Vanessa: Muhlenbruch, Andrew: Mujugira, 853 Hilda: 846, Mujuru, Shibani S.: Mukerji, Murrell, Ben: 487 Murrell, 342 P.: Jeffrey Murry, 294 Chelsey: Musante, 280 Antonio: Muscatello, 789 Crispin: Musicha, 85, 340 Musick, Andrew: Muktiarti, Dina: 858 Lubbertus C.: 201 Mulder, Mulenga, Kafula: 1018, 1018 166 Mulindabigwi, Augustin: 588 MichaelMullen, P.: A.: 284 Janis Müller, Michaela: Müller-Trutwin, 866 48LB, Mulligan, Kathleen: Mulligan, Mark: 286 Mulligan, Nikki: James I.: 33, 259LB Mullins, Münch, Jan: 268, 284 Munjoma, Marshall: 520 Münk, Carsten: 354 Eduardo: Muñoz, 596 Saray: Muñoz, 146, 388 Cynthia: Munro, James: 494LB Munyao, Mupfumi, Lucy: 984 Roberto: 225 Villanueva, Murcio Pamela: Murnane, Robert:Murnane, 356 Gary: Murphy, R.: 623 James Murphy, Robert: 562, 461LB, Murphy, 83 Alexandra: Murray, Daniel D.: Murray, Megan: 72LB Murray, I.: Miranda Murray, , 761 , 732 159 984 314 , 837 275LB 5 256 320 327 614, 641, 671, 830, 911,614, 641, 920, 1001 302, 828 727 802, 810, 815, 904, 512, 787 Moore, Richard: 42, 150, 558, 42, 150, Richard: Moore, 735 Moosa, Mahomed-Yunus: 1021 Anne: Mooser, 819 Stefano: Mora, Borja: 423LB Mora-Peris, Morano-Amado, Luis E: 586, 603 E: 586, Luis Morano-Amado, M.: Bozena Morawski, Moradpour, Darius: 592 Moradpour, Matias: Moragas, Muehlbauer, Michael: 705 Muehlbauer, Maximilian: Muenchhoff, Moritz, Andrew: 525 Moritz, Andrew: Philippe: 686 Morlat, Sara: 320 Moron-Lopez, 330 Alison: Morris, 302 Lynn: Morris, Martina:Morris, 735 Natashia: Morris, Sheldon R.: 143, 410, Morris, 520 Morrison, Charles: Rhoda: 728 Morrow, CarynMorse, G.: 561 428, 443 Gene D.: Morse, Arthur: 595 Moseley, 672, 704, 939 B.: Carlee Moser, 375 Mota, Talia: Beatriz: Mothe, R.: 959 Mougnutou, 290 Karam: Mounzer, 146 Richard: Moxley, 665 Graeme: Moyle, Sikhulile: 37, 111, 784, Moyo, Eirini: Moysi, Philippe: 73LB Msellati, Malango: 118 Msukwa, Sekesai: Mtapuri-Zinyowera, Simangele:34 Mthethwa-Hleta, 157, 756 Thuli: Mthiyane, 963 Petudzai: Muchichwa, Joseph C.: Mudd, Moreau, Alain: 400 Alain: Moreau, A.: 452 Moreno, Asunción: 572 Moreno, Santiago: 354, 452 Moreno, Miriam: 705 Morey, Tristan: Morey, Susan: 693 Morgello, Mori, Masahiko:
761 , 1018
312 458 560 100 432 1041 , 887 547, 602 886 651 546, 725, 940, 1041 1007, 630, 686 Mohri, Hiroshi: 406 Mohri, Hiroshi: Susan: 311LB Moir, 1028 Tshepo: Molapo, 152, Richard: Molenkamp, Jean-Michel:Molina, 45, 522, José: Moltó, 395 Jeremiah: Momper, 871 Bernard: Moncla, L.: 991 Brenda Moncur, Blandine: Monel, Susana:669, 901 Monge, 28 Constance: Mongwenyana, 223 Christopher: Monit, 529 Patricia: Monje-Agudo, Guillaume: 729 Monneret, K.: Anne 1005 Monroe, Jose Manuel: Trujillo, Monroy 679 Livia: 678, Montana, 533, Julio: 492LB, Montaner, 316 268, 290, J.: Luis Montaner, 317 309LB, David: Montefiori, 798 P.: Jacqueline Monteiro, Rocío: 669 Montejano, Miguel: 571 Montejo, 516 Edgar: Monteroso, Maria L.: 669 Montes, Martha P.: Montgomery, Moodley, Amber: 488 Amber: Moodley, 157, 756 Pravi: Moodley, 304 Christiane: Moog, 982 Ayana: Moore, Carolyn: Moore, 666 Cecilia: Moore, 390 J.: David Moore, 546, 898, M.: David Moore, Jan S.: 983 Moore, 302 Penny: Moore, Mock, 884, 927 Philip A.: 46, 45, Amanda: Mocroft, 755 Chawangwa: Modongo, K.: Søren 690 Moestrup, 779 M.: Lynne Mofenson, 391 Kirsten: Moffat, Mogalian, Erik: 208 Mohammadi, Pejman: 984 Terence: Mohammed, S.: 21 Mariel Mohns, Raphael: Mohr, 242 322 185 670 765 , 775 440 , 607 556, 608 571, 572, 439 Miller, Caitlin M.: Caitlin Miller, N.: 388, 416 Eric Miller, 1002 Melissa: Miller, 107, 496 Michael: 95LB, Miller, 506 Mike: Miller, M.: Shannon Miller, Miller, Caroline: 240 Caroline: Miller, 263 Charlene: Miller, A.: Elizabeth Miller, 216, 217 William: Miller, 365 T.: Sam Milliken, 953 Anthony: Mills, 166 Edward: Mills, Lisa A.: 111, 983 Mills, 334 Brad: Milner, 167, 920 Mimiaga,Matthew: Minami, Rumi: Minga, Albert: 1015 962, Jesús: 669 Mingorance, 556, 557, Minichini, Carmine: 514 Karen: Mintern, Emanuele: DelMiraglia Giudice, 432 Cristina: Miranda, Betty: 844 Mirembe, Esther: 844 Mirembe, 695LB Paria: Mirmonsef, José M.: 303, 303, 468, Miro, Mark: 433, 438, Mirochnick, Mishra, Ria:Mishra, 323 1047 1046, Sharmistha: Mishra, 145, 250, 693 Vikas: Misra, 824 D.: Charles Mitchell, James: 107 Mitchell, M.: 1055, 1060 Kate Mitchell, 160 T.: Ronald Mitsuyasu, 314 Toshiyuki: Miura, Mix, Monica: 537 314 Reiko: Miyahara, 147, 747 Sachiko: Miyahara, 326 T.: Karina Miyaji, Olga: 876 Mizenina, 978 Erick: Mlanga, 756 Mlisana, Koleka: 800, 904 Mompati: Mmalane, 925 Mnisi, Zandile: 760 Dorcas: Mnzava, 580 Hongmei: Mo, Sarah: 844 Moberley, 216, 964 Victoria: Mobley, A. Rain: 227 Mocello, Author Index
Musiime, Victor: 849 Nalugoda, Fred: 163, 563, Nelson, LaRon E.: 172, 883LB Noguera-Julian, Antoni: 778 Musoke, Philippa: 440 902, 986 Nelson, Mark: 154LB, 423LB, 662 Noguera-Julian, Marc: 260, 266, Musonda, Rosemary: 984 Nalukwago, Sophie: 733 Nelson, Micki: 825 488, 797 Mussi-Pinhata, Marissa: 798, Nam, Kiwon: 629 Nelson, Rob: 516 Nolan, David J.: 331, 345, 403 809 Namusobya, Jennifer: 112 Nelson, Robert: 975 Nomaguchi, Masako: 206 Mustanski, Brian: 931 Nance, Robin: 42, 558, 636, 1034 Nemes, Elisa: 824 Noori, Teymur: 901 Musubire, Abdu: 762 Nanda, Kavita: 771 Neogi, Ujjwal: 267 Nori, Achyuta V.: 794 Mutagoma, Mwumvaneza: 166 Nandi, Vijay: 897 Nerlander, Lina: 931 Norrgren, Hans: 998 Mutai, Kennedy: 903 Naniche, Denise: 974, 976 Neuhaus, Jacqueline: 160, 559 Norris, Philip J.: 652 Mutschler, James P.: 21 Nannini, Pilar: 819 Neukam, Karin: 586, 603 Norton, Brianna L.: 585 Muwonge, Timothy R.: 301 Nansamba, Alice: 513 Neumann, Till: 646 Nou, Eric: 553, 673 Muyombwe, Anthony: 896 Nantume, Sophie: 862 Newcomb, Michael: 931 Nouaman, Marcellin: 568 Muzny, Donna: 20 Napravnik, Sonia: 150, 291, 614, Newell, Kevin: 731 Noumsi, N.: 959 Muzoora, Conrad: 763 684, 920 Newsum, Astrid M.: 543 Novikova, Mariia: 137 Mwamelo, Kim: 676 Naqvi, Alissa: 709 Newton, Alicia: 578, 579 Novitsky, Vladimir: 904, 984 Mwandumba, Henry: 769 Naranbhai, Vivek: 246 Nganga-Good, Carolyn: 1036 Nowak, Martin A.: 357 Mwangwa, Florence: 116, 843 Narayan, Vivek: 467 Nghiem, Khanh: 430 Nowak, Piotr: 260, 267 Mwanza, Mwanza: 1018, 1019 Nardone, Anthony: 913 Ngo-Giang-Huong, Nicole: 777 Nowak, Rebecca G.: 922, 923, Mwashigadi, Grace: 977 Nash, Denis: 1009, 1020, 1021 Nguyen, Dong Phuong: 894 924 Mwaungulu, Nimrod: 736 Nason, Martha: 726 Nguyen, Lam Van: 858 Nowicka-Sans, Beata: 466 Mwebaza, Norah: 101 Nassau, Tanner B.: 1002 Nguyen, Minh: 1039 Nozza, Silvia: 627 Mwinuka, Nice: 625 Natcher, Priscilla: 371 Nguyen, Thai: 681 nsanzimana, Sabin: 166, 1024 Myer, Landon: 34, 757, 782, 785, Natesampillai, Sekar: 243 Nguyen, Thao P.: 252 Nunn, Amy: 891 786, 795, 799, 808, 852, 854 Nath, Avindra: 146, 389, 393 Nguyen, Thi Huyen Tram: 75LB Nunnari, Giuseppe: 204 Myers, Julie: 888, 892 Nattermann, Jacob: 236 Nhacolo, Ariel: 974, 976 Nuttall, James: 852, 854 Mylvaganam, Geetha: 93LB Natureeba, Paul: 796 Nhlangulela, Rosetta Lindiwe: Nuwagaba-Biribonwoha, Mzembe, Themba: 736 Nau, Marty: 349 521 Harriet: 34 Møller, Holger J.: 690 Naudin, Marine: 509 Ni Fhlatheartaigh, Ailbhe: 710 Nyakundi, Helen: 1059 Mørk, Alejandra: 26LB Navar, Ann Marie: 642 Nichol, Geoffrey M.: 358LB Nyambura, Monicah: 51, 1042 Navia, Bradford: 383, 386 Nichols, Brooke E.: 536, 1052 Nyirenda, Mulinda: 769 –N– Nawaz, Fatima: 198 Nichols, Sharon L.: 822 Nyongesa-Malava, Evans: 624 N’dir, Adama: 921 Ndahimana, Jean d’Amour: 1024 Nickolas, Thomas: 868 Nyoni, Cynthia: 28 Na, Lumine H.: 476 Ndawinz, Jacques D.: 910 Nicot, Florence: 950 Nabantanzi, Rose M.: 297 Ndembi, Nicaise: 212, 502, 503 Niculescu, Alex: 537 –O– Nabieu, Umu N.: 910 Ndhere, Amos: 562 Niehrs, Annika: 370 O’Brien, Meagan K.: 44LB, 249 Nabukalu, Dorean: 902 Ndhlovu, Lishomwa C.: 81, Nielsen, Susanne D.: 690 O’Brien, Sean P.: 138 Nada, Ola: 153 652, 723 Nielsen-Saines, Karin: 440, 779 O’Cleirigh, Conall M.: 920 Nadel, James: 648 Ndjeka, Norbert: 754 Nigalye, Maitreyee: 239 O’Connell, Daniel A.: 991 Nagata, Kayoko: 202 Ndlovu, Zibusiso: 512, 787 Nijhawan, Ank E.: 1001 O’Connell, Robert: 318, 405, 956 Naggie, Susanna: 99, 573, 595, Ndomb, Teclaire: 923 Nijhuis, Monique: 366, 464, 839 O’Connell, Thomas: 705 601, 642 Nduati, Ruth: 88 Nikiforov, Alexiy: 104 O’Connor, David H.: 21 Nagot, Nicolas: 276 Ndungu, Thumbi P.: 195, 246, Ning, Chuanyi: 955 O’Connor, Jemma L.: 474 Nair, Gonasagrie: 861 256, 302, 398, 488, 828 Ning, Yuming: 756 O’Dwyer, Eoin: 648 Nair, Govind: 389 Ndwiga, Stanley: 562 Nir, Talia M.: 383, 386 O’Halloran, Jane A.: 665 Nakalema, Shadia: 449 Neary, Jillian: 971 Nislow, Corey: 725 O’Riordan, Mary Ann: 826, 859 Nakamoto, Beau K.: 387, 723 Neary, Megan: 444 Nissen, Sara: 26LB Obasi, Mary: 422 Nakamura, Kyle J.: 33, 807 Neborak, Julie: 760 Nitz, Theodore J.: 465 Obel, Niels: 941, 1044 Nakanjako, Damalie: 297 Nega, Melon: 93LB Niyibizi, Aline Aurore: 1010, Obermeier, Martin J.: 525 Author Index Author Nakasujja, Noeline: 761 Neidleman, Jason: 284 1061 Oberoi, Rajneet K.: 453 Nakayama, Emi E.: 206 Neilan, Tomas G.: 640 Niyibizi, Gad: 1024 Ocama, Ponsiano: 563, 565, 594 Nakigozi, Gertrude: 163, 902, Nel, Annalene: 109LB, 110LB, Njouom, Richard: 526 Oceng, Ronald: 862 986 872, 873 Njozi, Mustafa: 978 Ocfemia, M. Cheryl Banez: Nakiyingi, Lydia: 743 Nelson, Brittany: 382 Njuguna, Irene N.: 38, 748 497, 500 Nalintya, Elizabeth: 159, 761 Nelson, Kenrad E.: 593 Nkurunziza, Peter: 1027 Odayar, Jasantha: 757
154 CROI 2016 Author Index 155 424LB 1003 CROI 2016 748 259LB Author Index Author 288 915 610 338 , 1045 1000 452 424LB Patel, Viraj: Viraj: 989 Patel, Bryan N.: Patenaude, 1009 Preeti: Pathela, 314 Panita: Pathipvanich, 921, 921 Padmaja: Patnaik, 564 Agaba: Patricia, Sarika: 972 900, Pattanasin, K.: Bruce 341 Patterson, 947 Patricia: Patterson, 845 Sharon: Patz, 380 Alice: Pau, 333 Chou-Pong: Pau, Robert: 414, 821 Paul, 943 Juliette: Pavie, N.: George Pavlakis, B.: Patricia Pavlinac, 667 Rebecca: Pavlos, Paolo: Pavone, Jean-Michel:577 Pawlotsky, 547 A.: William Paxton, 323 Sravan: Payeli, Gabriela: 930, 931, Paz-Bailey, 334 Chester: Pearson, Sheila: 515, 923 Peel, 102LB Anne: Peery, 94 Amarendra: Pegu, 689 Isabelle: Pellegrin, 869 Stephanie: Pena, Victor: Pena-Cruz, Martina: 786 Penazzato, 920 W.: Brian Pence, 642 Michael J.: Pencina, Sarah:443 Pendergrass, 414 Chun-Zi: Peng, Pleuni S.: 229, 495 Pennings, 1057 865, J.: Kerri Penrose, Sudhir: 145 Penugonda, Scott: 430 Penzak, S.: 151, 336 Alan Perelson, Alejandro: Pérez, 248 Iñaki: Perez, 1023 Carmen: Elias, Perez 354, María Jesús: Pérez-Elias, 527 Leire: Pérez-Latorre, Jose Antonio: Perez-Molina, Santiago: 251 Pérez-Patrigeon, 529 Montserrat: Pérez-Pérez, Josué: 410 Pérez-Santiago, Ignacio: Perez-Valero, Ignacio: 669 Pérez-Valero, Maria: Pernas, , 865, 1057 , 726, 1006 217 , 952 521 540 1044 517 916 735 510 891 987 , 731 927 1017 Palk, Laurence: Laurence: Palk, Pallikkuth, Suresh: 324, 327 Suresh: Pallikkuth, 324 Paolo: Palma, 367 86, 294, D.: Christine Palmer, 711 Clovis: Palmer, Sarah: 348, 365 Palmer, Sherri: 1025 Pals, 434 P.: Paul Pama, Patel, Rupa: Patel, Vinod: 398 Patel, Patel, Faeezah: 39, 40, 851 Faeezah: Patel, Hetal: Patel, 595 Keyur: Patel, 838 Kunjal: Patel, Monita: Patel, Parkin, Neil T.: Parkin, T.: Neil Philippe: 282 Pasero, Dana K.: Pasquale, Juan: 424LB Pasquau, 522 Armelle: Pasquet, Giulia: 610 Passavanti, 565 Akouda: Patassi, 937 Chirag: Patel, Eshan U.: Patel, Park, Benjamin 159 J.: Park, 553 Jakob: Park, 906 Ju Nyeung: Park, 713 Hyun: Kyu Park, 642 Lawrence: Park, 633 Lesley: Park, Min Hi: 664 Park, Gary: Parker, Robert A.: Parker, Pamnani, Ritesh: 624 Pamnani, 900,Kanokpan: Pancharoen, 258LB Ivona: Pandrea, Philip S.: 573, 601 Pang, 732 Soumya: Panigrahi, 575 Saumya: Pant, Giuseppe: 82 Pantaleo, 264, 264 Montha: Pao, 290 Emmanouil: Papasavvas, 403 Emily: Papazian, 473, 739,W.: Jean Pape, Michael:346 Para, 797 Roger: 260, 266, Paredes, 510, 516 Bharat: Parekh, Julie: 793 Parent, Mariona: 260, 266 Parera, 685, 691 Chirag: Parikh, UrviParikh, M.: 689 711 20 935 877 764 497, 500 698, 700 449, 459 335, 352, 353 861 685, 688, 699, 719, 721, 914 Ortega, Mario: 382 Ortiz, 275LB Alexandra: Oryszczyn,948 Josephine: 517 Osborn, Jennifer: 329 Osborn, Melissa: Osburn, William: 540 100, 580 Anuoluwapo: Osinusi, Meg: 759 Osler, 49 Osoti, Alfred: 211, M.: Alexandra Oster, 26LB Lars: Østergaard, E.: 95LB Osuna, Christa A.: 50 Felix Otieno, 38, 748 O.: Vincent Otieno, K.: Adina Ott, Melanie: 463 Ott, Otton, James: 648 658 Kennedy: Otwombe, Michel: 182 Ouellet, Zhengyu: 19 Ouyang, Julie M.: 88, 478 Overbaugh, 421, 32LB, T.: Overton, Edgar Asiphas: 116 Owaraganise, 441, 442, 444, Andrew: Owen, Oyugi, Julius: 748, 909 Alexandra: Ozanne, 310LB O’Dell,Sijy: –P– M.: 655 Yolanda Pacheco, 312 Yovana: Pacheco, 161 Pawel: Paczuski, Nancy:1018, 1019 Padian, N.: 469LB Neal Padte, M.: 261 Jeffrey Paer, Iain D.: Page, 537 Kathleen: Page, 455 Georges-Philipp: Pageaux, 335, 836 Amelie: Pagliuzza, Rajendra: 327 Pahwa, 327, 824 324, Savita: Pahwa, 22, 24, 255, Mirko: Paiardini, Thesla: Palanee-Phillips, 109LB, Kartika: Palar, Riya: Palchaudhuri, 283, 641, 644, J.: Frank Palella, J.: David Palesch, 160 Adrian: Palfreeman, , 55, 251 47 , 444, 167 1054 903 441 862 , 117 550 51 476, 695LB, 704 476, 695LB, 529, 530 449 Mohamed: 529, 530 1029 Ogena, Mike: 796 Ogena, Mike: 231 B.: Colin Ogilvie, 903 Paul: Ogindo, Ogunsola, Sade: 281 Guillermo: Ojeda-Burgos, Oka, 681 Shinichi: Justin: 1044, Okano, Okeke, N. L.: 642 N. L.: Okeke, 34 Velephi: Okello, M.: 38 Helen Okinyi, Stephen: Okoboi, 281 Prosper: Okonkwo, Jason: 722, 932 Okulicz, James: 502 Okuma, Adeniyi: Olagunju, Odland, Jon O.: 853 O.: Jon Odland, S.: Fredrick Odongo, Johansen: 909 Oduor, Ighovwerha: Ofotokun, Olatunbosun, Olawaseun A.: 808 Olawaseun Olatunbosun, Catherine: Oldenburg, Olson, Scott: 847 Gustavo: Olvera-García, 796 Peter: Olwoch, 973 Omanga,Eunice: Omar Mohamed-Balghata, Saleha: Omarjee, 195 498 Ondoa, Pascale: 593 Edgar: Ong, 517 Stefano: Ongarello, 607 Lorenzo: Onorato, Obinna: 790 Onwujekwe, 201 Marcel: Ooms, L.: 521 Amy Opest, Oraka, Emeka: 889 Samuel:663 Orden, 632 Jackson: Orem, 482 Orkin, Chloe: Orne-Gliemann, Joanna: 169LB 787 Daniel: 512, Orozco, 251 Lorena: Orozco, 600 Cody: Orr, 429, 1014, Catherine: Orrell, Oleski, James: 824 Oleski, 903 George: Olilo, 338 Isabel: Olivares, 218, 480 Maureen: oliveira, T.: Nora Oliver, Jack J.: Olney, Author Index
Perno, Carlo Federico: 18LB, 413, Phiri, Mwelwa M.: 980 Pollicita, Michela: 570 Pujari, Sanjay: 160 570, 946 Phogat, Sanjay: 317 Poluektova, Larisa Y.: 399 Punsalang, Amado: 896 Perona, Rosario: 669 Phokojoe, Mokgadi: 1028 Ponte, Rosalie: 237, 274 Punyawudho, Baralee: 777 Perreau, Matthieu: 82 Phuang-Ngern, Yuwadee: 404 Pontones, Pamela: 149, 541, 916 Purcell, Robert H.: 594 Perrotta, Gaetano: 381 Phupitakphol, Tanit: 857 Poole, Brian: 644 Purdy, Julia: 599 Persaud, Deborah: 825, 838 Pialoux, Gilles: 886 Poon, Amanda: 105 Purswani, Murli: 813 Perumalswami, Ponni: 534, 588 Piatak, Michael: 270 Poonia, Bhawna: 599 Pushpakom, Sudeep P.: 702 Peter, Trevor: 788 Pickett, James: 70 Pop, Radu: 456 Puthanakit, Thanyawee: 857 Peters, Lars: 566 Pickles, Michael: 165, 1046 Popiel, Maryann J.: 968 Puzzovio, Maria: 819 Peters, Marion: 277, 593 Pieper, Carl: 705 Popkin, Daniel: 329 Pybus, Oliver: 602 Peters, Philip: 149, 215, 541, Pilcher, Christopher: 511, 1040 Popov, Mikhail: 388 Pyles, John: 880 916, 967, 999 Pillai, Satish: 81 Portal, Isabelle: 583 Pym, Alex: 735 Peters, Samuel: 502 Pillay, Deenan: 167, 169LB, 225, Portales, Pierre: 276, 282 Pyra, Maria N.: 301 Peters, Zach: 791, 988 484, 499, 677, 840, 848, 1003, Porter, Danielle P.: 496 Petersen, Maya: 116, 829, 841, 1011, 1012, 1013, 1027, Porter, Kholoud: 87, 223 –Q– 843, 979, 985, 1026, 1062 1030, 1048 Porter, Sarah E.: 1025 Qin, Shulin M.: 330 Peterson, Christopher W.: 356 Pillay, Yogan: 115, 1028 Portilla, Joaquin: 470 Qin, Yilu: 926, 926 Peterson, James: 893 Pilot-Matias, Tami: 539LB Post, Frank A.: 423LB, 680, Qiu, Xing: 392 Peterson, Julia: 142 Pilotto, Jose H.: 440, 779 682, 683 Quadroni, Manfredo: 208 Petro, Greg: 757, 799 Pineda, Juan A.: 529, 530, 555, Post, Wendy S.: 914 Quereda-Rodriguez, Carmen: Petrone, Mary E.: 311LB 586, 603, 634 Potard, Valérie: 304 452 Petropoulos, Christos: 578, 579 Pinnetti, Carmela: 413 Poteat, Tonia C.: 79 Quesenberry, Charles P.: 54 Petrov, Dmitri A.: 229, 495 Pintado, Laura: 669 Potthoff, Anja: 628 Quevedo, Jorge I.: 788 Petrovas, Costantinos: 94, Pinto, Angie: 365 Powderly, William: 891 Quinn, Jeffrey: 151, 712 245LB, 259LB, 327 Pinyakorn, Suteeraporn: 349, Power, Robert A.: 499 Quinn, Thomas C.: 511, 520, 540, Petrow, Eva: 707 404, 956 Powis, Kathleen: 37, 784, 802, 594, 726, 731, 830, 906, 917, Petschow, Bryon M.: 278 Pinzone, Marilia R.: 204 810, 904 954, 987 Pettersson, A. M.: 220 Piper, Jeanna: 108LB Pozniak, Anton N.: 225, 665, Quirk, Erin: 817 Pettifor, Audrey: 936 Pipkin, Sharon: 990 1023 Quiros Roldan, Eugenia: 417, Pettit, April C.: 746 Pirillo, Robert: 896 Prabhu, Vineet R.: 1050 774 Petucci, Chris: 706 Pirmohamed, Munir: 702 Pradat, Pierre: 729 Quiroz-Morales, Verónica: 477 Peyper, Janique: 734 Piroth, Lionel: 582, 605 Pradier, Christian: 408, 661 Quiwa, Komba: 72LB Peytavin, Gilles: 420 Pitisuttithum, Punnee: 318 Prasitsuebsai, Wasana: 857 Pfeiffer, Ruth: 616 Piwowar-Manning, Estelle: 436, Preiser, Wolfgang: 782, 785 –R– Pfeil, Sarah K.: 532 523, 936 Prescott, Marta R.: 844 Rabideau, Dustin J.: 952 Pham, Peter P.: 219 Pizzato, Massimo: 57 Pretorius Holme, Molly: 111, Rabie, Helena: 852, 854 Phan, Binh An P.: 643 Plana, Montserrat: 248, 468 904, 983 Raboud, Janet M.: 622, 718 Phang, Tzu L.: 279 Planelles, Vicente: 360 Price, Angie: 528 Racca, Sara: 627 Phanuphak, Nittaya: 219, 287, Plankey, Michael W.: 390, Price, David: 313 Rachlis, Anita: 614 349, 415, 956 720, 914 Price, Richard W.: 142, 401, 402 Raddassi, Khadir: 411 Phanuphak, Praphan: 414 Plantier, Jean-Christophe: 959 Prime, Katia: 835 Radix, Asa: 869 Pharris, Anastasia: 901 Plants, Jill: 695LB Prince, Heather M.: 102LB Rae, Caroline: 391 Phengrasamy, Tony: 894 Plazy, Mélanie: 169LB Prins, Henrieke A.: 977 Raehtz, Kevin D.: 258LB Philip, Susan S.: 870 Plettenberg, Andreas: 470 Prins, Maria: 152, 542, 543, 547 Raengsakulrach, Boonyos: Phillips, Andrew N.: 117, 474, Plotkin, Marya: 978 Procopio, Francesco: 82 900, 927 661 Plummer, Andrew: 29 Proctor, Enola K.: 891 Rafecas, Antoni: 571, 572 Phillips, Elizabeth J.: 667 Plummer, Francis: 226 Proschan, Michael: 561 Rafferty, Danielle: 650 Phillips, Nicole: 821 Poiteau, Lila: 526, 577 Protack, Tricia: 464, 466 Raffi, Francois: 29, 45, 470, 675 Author Index Author Phillips, Tamsin: 757, 795, Poizot-Martin, Isabelle: 583 Protopopescu, Camelia: 549 Rafie Sakr, Samah: 494LB 799, 808 Polacino, Patricia: 356 Provias, Tim S.: 644 Raghwani, Jayna: 602 Phipps, Warren T.: 632 Polaino, María José: 655 Prust, Margaret L.: 844 Ragin, Ann: 388 Phiri, Comfort R.: 156 Poli, Andrea: 627 Psomas, Christina: 276, 282 Rahimi, Asa: 190 Phiri, Happy: 35LB Policicchio, Benjamin B.: 258LB Pufall, Erica L.: 913 Rainho, Jennifer N.: 372 Phiri, Khumbo: 793 Pollack, Ross: 83 Pujantell, Maria: 183, 205, 207
156 CROI 2016 Author Index 157 , 676 619 , , 401, 213 , 266 154LB CROI 2016 618 147 , Author Index Author , 450 230 907 , 1011, 1048 260 1063 368 28 617 447 236, 536, 560, 584 299, 329 634 645, 714 402, 418, 421 Roberts, Sarah T.: Roberts, Sarah T.: Robertson, R.: Kevin Rosenberg, Eli: 1045 Eli: Rosenberg, Rodgers, Mary Rodgers, A.: 212, 27 Allan: Rodriguez, Benigno:Rodriguez, 293, 296, 325 Carina: Rodriguez, 577 Christophe: Rodriguez, 797 Cristina: Rodríguez, Gilhen: 623 Rodriguez, 881 Kristina: Rodriguez, Eduardo: Rodríguez-Arbolí, Francisco: Rodríguez-Arrondo, Maria: 633, Rodriguez-Barradas, Diego: 555 Rodríguez-Cano, 909 Rogena, Emily: Michel: 218 Roger, 20 Jeffrey: Rogers, Roh, Meejeon: 629 Rohan, Lisa: 871 Eliane: Rohner, Rocha, Chiara: 604 Rocha, Chiara: Rocha, Susana:139 K.: Jürgen Rockstroh, Robinson, Jake A.: 272 A.: Robinson, Jake 309LB Alex: Robles, 86, 367 P.: Yvonne Robles, 380 380, Gregg: Roby, Rocafort, Muntsa: Rohr, Julia K.: 905, Rohr, 314 Archawin: Rojanawiwat, 887 Daniela: 886, Rojas Castro, 778 Pablo: Rojo Conejo, Morgane: Rolland, 718, 947 Rolon, Maria J.: Fabio: Romerio, Romero-Tejeda, Marisol: 367 Marisol: Romero-Tejeda, 164, 868 Allan: Ronald, 799, 808 Ronan, Agnes: 107 102LB, James: Rooney, 420 Jacques: Ropers, 655 Isaac: Rosado, 967 Charles: Rose, 331, 345 Rebecca: Rose, 916 Jeremy: Roseberry, Rosebush, Julia C.: 826, 859 P.: Rosen, Elias Rosen, Sydney: , , , 682 , 750 , 72LB 183 266 739 459 284 Linda: 436 1017 530, 555 530, 555, 586 349, 515, 956 205, 207 1052 849, 977 232, 290, 362, 487 1056 108LB, 621, 624, 863, 864, 108LB, 912 Rivera Pinto, Javier: Javier: Pinto, Rivera 527, 424LB, Antonio: Rivero, 529, Antonio: Rivero-Juárez, C.: 99 Roa, Jhoanna Roan, Nadia R.: Merlin L.: 230, 254, 287, Robb, Martine: 437LB Robberechts, Robbiani, Melissa: 270 Danielle: 1044 Robbins, Gregory: 664 Robbins, Marjorie A.: 492LB Robbins, Rebekkah: 994 Robbins, Roberts,24 Emily: Roberts, Owain: Rivera, Vanessa R.: Vanessa Rivera, Rimland, David: 255 David: Rimland, 571, 572 Rimola, Antoni: 324 Rinaldi,Stefano: 341, 350, 376 Charles: Rinaldo, Rinehart, R.: 106, 471 Alex 498, Tobias: Rinke de Wit, 603 María José: 529, 530, Ríos, 663 Cesar: Rios-Navarro, Michael: 309LB Rist, 443 Marylyn Ritchie, D.: 367 Ritz, Jerome: Ritz, Justin: 25 Riva, Alberto: 257 204 Riva, Beatrice: Eva: Riveira-Muñoz, Richter, Richter, A.: 861 Sharon Riddler, 682 Armin: Rieger, 839 Annelies: Riezebos-Brilman, 403 Brittany: Rife, 689 Claire: Rigothier, BartRijnders, 536, 542, J.: Richman, Douglas D.: 83, 228, Richman,Douglas D.: Richardson, Malcolm: 764 Malcolm: Richardson, 103 Paul: Richardson, Rich, Ashleigh: 1007, 1041 898, 50, Barbra A.: Richardson, Richardson, T.: Eugene , 1024 476 , 814 744 508 306 813 166 637, 665, 686 477 282, 675 726, 731, 954 672, 695LB, 700, 704, 802, 672, 695LB, 939 Redondo, Enrique: 945 Enrique: Redondo, 667 Alec: Redwood, Anton: Reepalu, 87 Helen: Rees, 579 D.: Jacqueline Reeves, 263, 275LB R. Keith: Reeves, 200 W.: Eric Refsland, 311LB Eric: Refsland, Regan, Susan: 638 Rosa: 948 Regez, Ludy: Registre, 466 Regueiro-Ren, Alicia: A.: 380 Rehm, Catherine Reich, Daniel S.: 389 William: 791 Reidy, 646 Nico: Reinsch, 221, 566, 148, 220, Peter: Reiss, Eric: Remera, Remien, Robert:988 450 Leila: Remling-Mulder, Ren, Li: 321 746 Lorna: Renner, Requena, Mary:289, 950 Requena, Silvia: Rungsun: 287 Rerknimitr, Rerks-Ngarm, Supachai: 318 590, 639 Salvador: Resino, 892 Arjee: Restar, Reubenson, Gary: 746 991 Heidi: Reukauf, 586 Sergio: Reus-Bañuls, Boris: 634 Revollo, 943 David: Rey, 245LB, Gustavo: Teran, Reyes 276 Christelle: Reynes, 45, 276, Jacques: Reynes, 163, 594, J.: Steven Reynolds, MartinRhee, S.: 29, 817 495 Soo-Yon: Rhee, Rhein, Joshua R.: 762, 763 298 Ajantha: Rhodes, 723 Tanawan: Riangwiwat, Muhayimpundu: Ribakare, 55, J.: Heather Ribaudo, Ribeiro, Ruy M.: 151 Ribeiro, 80 Andrew: Rice, Mabel L.: Rice, , 726 814 464 950 442 , 541 825, 838 441, 149 731, 987 Ray, Stuart C.: 135 Ray, 898, 1041 HenryRaymond, F.: Stéphanie: Raymond, S.: 809 Jennifer Read, 836 Stanley: Read, 370 Anne: Rechtien, 540, 594, D.: Andrew Redd, Rainwater, Stephanie: 88 Stephanie: Rainwater, Kaitlin: Rainwater-Lovett, 503 Elliot: Raizes, A.: 269 Premeela Rajakumar, Rajasingham,Radha: 159, 761 Rajoli, Reddy: Rajith Kumar Rajulu, Deepa: 501, 991 23 Rakasz, Eva: Modiehi: 749 Rakgokong, Sandrine: 526 Rallier, Rallon,596 Norma: Ram, R.: 496 Renee Ramachandran, Geetha: 457 Ramachandran, Sumathi: 846 Raman, Lavanya: Ramdin, 749 Neeshan: S.: 457 Ramesh Kumar, G.: 186 Nora Ramirez, Gita:Ramjee, 87 805 Tatiana: Ramos, Sarah: 39 Ramteke, Magali: 274 Rancez, Deepali:Rane, 995 323 Ranga, Udaykumar: Rangaka, 742, 757 Molebogeng: 251 Claudia: Rangel-Escareño, 442, 442 Steve: Rannard, 968 Anuj: Rao, Rasmussen, Thomas: 26LB A.: 348 Thomas Rasmussen, 220, 221, 223 Oliver: Ratmann, Deena: 341 Ratner, Rauch,612 566, 592, Andri: Raugi, Dana N.: 961 583 Isabelle: Ravaux, 20 Muthuswamy: Raveendran, N.: 457 Ravichandran, 425 Palanikumar: Ravindran, 107 Adrian: Ray, 425, Neelanjana: Ray, Rajender: 576 Reddy, RobertRedfield, R.: 856 Sean M.: 813, Redmond, Author Index
Rosenberg, Eric S.: 231, 294 Russo, Julie: 874 Salcuni, Paul M.: 888, 892 Sartori, Ana M.: 326 Rosenberg, Molly S.: 905, 907 Rutherford, George: 72LB Saleh, Suha: 363 Sarun, Saramony: 831 Rosenberg, Zeda: 109LB, 110LB Rutz, Audrey M.: 371 Salemi, Marco: 331, 403 Sasson, Sarah C.: 365 Rosenthal, Elana S.: 599 Ruxrungtham, Kiat: 461LB, Salgado, Maria: 366 Sato, Hironori: 505 Rosenthal, Eric: 582 606, 857 Saliou Sow, Mamadou: 73LB Sattar, Abdus: 656, 657 Rosenthal, Philip: 101 Ryan, Emily: 335, 352 Sall, Fatima: 961 Sattha, Beheroze: 715, 716 Roser, James D.: 138 Ryom, Lene: 637, 661, 686 Salmon-Ceron, Dominique: 549, Saulle, Irma: 247, 280 Ross, Brian: 316 Ryscavage, Patrick A.: 856 582, 605 Savane, Ibrahima: 73LB Ross, Douglas: 1016, 1016 Salomon, Joshua: 907 Savory, Thea: 1018, 1019 Ross, Michael: 686 –S– Salpietro, Stefania: 556, 557 Sawadogo, Adrien: 962 Ross, Polly: 993 S Arunachalam, Prabhu: 323 Salpini, Romina: 570 Sawanpanyalert, Pathom: 314 Rossi, Francesca: 557, 608 Saag, Michael: 42, 573, 574, 671 Salvi, Sonali: 752 Sawaya, George F.: 162 Rossi, Paolo: 324 Sabado, Rachel: 322 Salyer, Christen: 847 Sax, Paul E.: 682, 952 Rossi, Steven: 815, 815 Sabapathy, Kaplana: 114 Samandari, Taraz: 544 Scagnolari, Carolina: 238 Rossjohn, Jamie: 313 Sabatier, Jen: 789 Samarawickrama, Amanda: 692 Scanlin, Kathleen K.: 888 Rossouw, Theresa: 847 Sabbaj, Steffanie: 292 Sambai, Betsy: 50 Scarlatti, Gabriella: 18LB Roth, Eric A.: 546, 898, 1007, Saberi, Sara: 716 Sambatakou, Helen: 486 Scarsi, Kimberly K.: 444 1041 Sabin, Caroline: 148, 482, 484, Samoff, Erika: 964 Schaafsma, Torin: 740 Rothrock, Ginger: 879 637, 661, 683, 996 Sampathkumar, Raghavan: 226 Schaap, Ab: 114, 156, 981 Rousseau, Christine: 517 Sabino, Ester C.: 326 Sampson, Lynne A.: 217 Schaeffer, L.: 959 Rouster, Susan D.: 552 Sabri, Bushra: 918 Samri, Assia: 304 Schalasta, Gunnar: 525 Routy, Jean-Pierre: 237 Sabry, Alyaa: 153 Samson, Lindy: 812, 836 Schalkwijk, Stein: 433 Rouveau, Nicolas: 526 Sacha, Jonah B.: 21 Samson, Pearl: 458 Schanz, Merle: 89LB Roux, Paul: 852, 854 Sachiko, Miyahara: 745 Samsunder, Natasha: 521 Schauer, Amanda: 102LB, 439 Rouzier, Regine: 461LB Sachs, Nancy: 506 Samuels, David: 144, 409 Schechter, Mauro: 48LB, 866 Rouzioux, Christine: 222, 271, Sacktor, Ned: 146, 388, 416 Sanborn, Keri: 806 Scheer, Susan: 990 351 Sacoor, Charfudin: 974, 976 Sanchez, Rosa: 456 Scheiblauer, Heinrich: 519 Rovelli, Cristina: 627 Saduvala, Neeraja: 211, 500 Sanchez, Travis: 889, 995 Scheinfeld, Benjamin: 92 Rowland-Jones, Sarah L.: 253 Safren, Steven A.: 1034 Sánchez-Carrillo, Marta: 590 Schellack, Christine J.: 844 Roy, Monika: 1018, 1019 Sagaon Teyssier, Luis: 887 Sánchez-Conde, M.: 452 Schellekens, Joop: 839 Rozada, Ignacio: 533 Sagar, Manish: 186, 288, 306, Sanchez-Merino, Victor: 303 Scherrer, Alexandra: 567, 951 Ruane, Peter: 29, 574 307 Sanders, Eduard J.: 977 Scherrer, Didier: 461LB Rubenstein, Kevin B.: 1035 Saghayam, Suneeta: 858 Sandstrom, Paul: 226 Scherzer, Rebecca: 643, 654, Rubin, Eric J.: 131 Sagnelli, Caterina: 556, 557 Sanford, Ryan: 385 685, 691 Rubin, Leah: 416, 422 Sagnelli, Evangelista: 556, Sang, Edwin: 51, 1042 Schewe, Knud: 584, 589 Rubio, Rafael: 424LB 607, 608 Sang, Norton: 985, 1026 Schiano, Thomas: 604 Ruby, Eric: 153 Sahabo, Ruben: 34 Sania, Ayesha: 803 Schietroma, Ivan: 238 Rudd, Deanne J.: 437LB Sahi, Sharon: 767 Sanisetty, Srisowmya: 95LB Schifanella, Luca: 317 Rude, Eric: 534 Sahli, Roland: 592 Sanjeeva, G. N.: 457 Schifitto, Giovanni: 383, 392 Rudin, Christoph: 778 Sailasuta, Napapon: 407 Sanne, Ian M.: 28, 296, 299, 845, Schilkey, Faye D.: 371 Ruel, Theodore D.: 829, 841, 843 Saint-Vil, Alix: 1017 1013, 1028 Schillinger, Julia: 1009 Ruiz-Mateos, Ezequiel: 655 Saison, Julien: 729 Sansom, Stephanie L.: 1051 Schiltz, Gary: 629 Rumaney, Maryam: 512, 787 Saito, Akatsuki: 206 Santiago, Mario L.: 134, 187, Schinazi, Raymond F.: 369 Ruperez, Javier: 354 Saito, Suzue: 738 262 Schinkel, Janke: 152, 542, 543, Ruperez, Maria: 797 Sajjaweerawan, Chayada: 287 Santos, Ariana: 369 547, 602 Rupert, Adam: 561 Sajwani, Karim: 100 Santos, Breno R.: 511 Schiralli Lester, Gillian M.: 193 Rupp, Jonathan C.: 371 Sakala, Ephraim: 156, 980 Santos, Jesús: 424LB Schleimann, Mariane: 26LB Ruprecht, Ruth M.: 317, 317 Sakr, Samah: 624 Sanyal, Anwesha: 341 Schlesinger, Erica B.: 879 Author Index Author Rusert, Peter: 89LB Salantes, Brenda: 92 Sanz, Jose: 424LB Schlusser, Katherine: 511, 520 Rusin, David: 147 Salata, Robert A.: 493LB, 872, Sapsirisavat, Vorapot: 606 Schmid, Patrick: 612 Rusisiro, Byiringiro: 1024 873 Sarafianos, Stefan G.: 137 Schmitz, Joern E.: 22 Russell, Jonathan S.: 813, 814 Salazar, Andres: 270, 322 Saravanan, Shanmugam: 1032 Schmutz, Guenther: 589 Russell, Ronnie: 133 Salazar-Gonzalez, Jesus: 313 Sarner, Liat: 794 Schnell, Gretja: 539LB Russell-Lodrigue, Kasi: 105 Salcedo, Magdalena: 572 Sarpel, Dost: 588
158 CROI 2016 Author Index 159 337 88 CROI 2016 , 398 Author Index Author 91 75LB 175 246 551 488 654 , 614, 894, 1035 , 614, 894, 1019 360, 462 162 Singh, Urisha: Sinha, Arjun: Magdalena: Sips, 791, 909 W.: Martin Sirengo, Sunee: 219 Sirivichayakul, 900 Pachara: Sirivongrangson, Manuela: 247 Sironi, Daouda: Sissoko, 925 Bhekie: Sithole, 498 Margaret: Siwale, 628 Adriane: Skaletz-Rorowski, 1045 Skarbinski, Jacek: 1053 Andrew: Skingsley, 23 Pamela: Skinner, 744 Sten: Skogmar, L.: 146 Richard Skolasky, Sikazwe, Izukanji:Sikazwe, 1018, 960, 742 Welile: Sikhondze, Romain: 1060 Silhol, Janet: 83 Siliciano, Robert: 83, 135, 339, Siliciano, Silk, Rachel: 528 597 Evelyn: Silva, 54, 150, MichaelJ.: Silverberg, Rachel: 494LB Silverman, Rachel: 847 Silverman, 626 620, Matthew: Silverstein, Guido:24, 353 20, 22, Silvestri, 426, 774 Marco: Simiele, Suzanne:Siminski, 838 Simioni,Samanta: 381 Simon, 943 Anne: 959 Simon, F.: 584, 589 Simon, Karl Georg: Simon, Tracey: A.: 201, 244, 371 Viviana Simon, R.: 315 Camille Simoneau, R.: Simonetti, Francesco Simoni,1034 Jane: 864, 912, Simonich, Cassandra: Lisa K.: Simons, Russell: 403 Simons, Sin,Don: 725 142, 298 Elizabeth: Sinclair, 587 Amit: Singal, 331, 345 Elyse: Singer, Rachel:270 Singer, 488 Singh, Avashna: 613 Singh, Elvira: Singh, Ravesh: 633 851 463 , 798, 809, 265 755 36 776 630 169bLB 329 191 yan E.: 706, 790, yan eah: 652, 723 552, 581 813, 814 444, 459 299, 477 958 Shen, Gong: 100 Shields, Jesse: 916 Shields, 616 Meredith: Shiels, M.: 387, Cecilia Shikuma, Shilaih, Mohaned: 567 S.: Shin, Sanghyuk Shlipak, Michael: 684, 685, 691 Daniel: 516, 975 Shodell, 355 Katherine: Sholtis, 883LB Steven: Shoptaw, Joshua: Shorenstein, Sherman, Gayle: 783 Gayle: Sherman, E.: 329, Kenneth Sherman, Sean:Sherman, 395 N.: 47 Sheth, Anandi 440 Avinash: Shetty, Shi, Qiuhu: 720 39, 40, Stephanie: Shiau, Shieh, Eugenie: 202 Keisuke: Shindo, E.: 206 Tatsuo Shioda, 202, Kotaro: Shirakawa, 345 Bruce: Shiramizu, L.: Carey Shive, Short, William: 680 915 Luke: Shouse, 53, 1004, 1037 L.: Roy Shouse, Shikha: 599 Shrivastava, 1061 1010, Amir: Shroufi, Shu, Sherry T.: 1028 Zara: Shubber, Shukla, Shuchin: 534 Shulman, Nancy 574 S.: 539LB, Susan: 546, 1007 Shurgold, K.: George Siberry, Jeanne: Sibiude, G.: 234 Sigman, Andrew Siccardi, Marco: 441, 442, Marco: Siccardi, Doug: 491LB Sider, 329 ScottM.: 252, Sieg, Juan: 296, Sierra-Madero, Basil: 265 Siewe, 498, 849 Kim: Sigaloff, R.: 963 Farai Sigauke, M.: 620, 626, Keith Sigel, Shepherd, John A.: 36 Shepherd, L Shepherd, Shepherd, Br Shepherd, 631 , 563 613 , 784, 800, 425 37 1031 720 981 731, 954, 986, 987 980, 379, 490 802, 805, 810, 815 Shelter, Cory: 874 Shelter, Sengayi, Mazvita Sengayi, M.: SenGupta,Devi: 817 Winnie: 983 Sento, Sara: 238 Serafino, 1041 898, Paul: Sereda, Emmanuel: Seremba, 296, 299, 343, 344 Irini: Sereti, 649 Maya: Serhal, 354 Sergio: Serrano-Villar, Serwadda, 163, 563, 726, David: 797 158LB, Esperança: Sevene, 750, 1017 473, Patrice: Severe, Heather: Sevinsky, K.: 828 Andrew Sewell, 568, 961, 962 Moussa: Seydi, 239 Star: Seyedkazemi, Mark: 660 Shaefer, 495, 503 W.: Robert Shafer, Shafi, Juma: 863, 864 Shah, N. Sarita:157, 756 Shah, Rimi: 794 Maryam:Shahmanesh, 913 Shaikh, Obaid:581 K.:Shalek,19 Alex 114, 156, Kwame: Shanaube, Shankar, Anupama: 541 Anupama: Shankar, 348, 85, 337, 340, Wei: Shao, Yiming: 321 Shao, 817 Yongwu: Shao, E.: 775 David Shapiro, 310LB Lawrence: Shapiro, L.: Roger Shapiro, Anjali: Sharma, 201, 244 Ekta: Sharma, Monisha: 49 Sharma, 659 Shweta: Sharma, 148 J.: David Sharp, Sharp, Joseph T.: Robin: 448 Shattock, 278 L.: Audrey Shaw, 133 M.: Christiana Shaw, M.: 133, 394 George Shaw, 934 A.: 609, Pamela Shaw, R.: 601 Shea, Patrick 906 Kate: Shearer, 710 665, Sheehan, Gerard: 151 Jennifer: Shellenberger, 404 , 469LB , , 315 398 713 197 287 294 445 383 309LB 763 635 486 , 880 560 358LB Schooley, Alan: 793 Alan: Schooley, 35LB Erik: Schouten, Rachel:730 Schrier, Rik:363 Schrijvers, Schuermann, Dirk: 425, 437LB Schuettfort,Gundolf: Schölvinck, E. H.: 839 Philipp: Schommers, Daniel: Schonfeld, Schuetz,Alexandra: Schultz, Anke: 303 Schultz, Anke: Anna: Schultze, Schulz, Christian: Julian:366 Wiesch, zur Schulze 1036 Christina: Schumacher, Martin:Schutten, 220 Schutz, Charlotte: 525 Marcel: Schütze, 687 Schwartz, J.: George Schwartz, Jill:871 Schwartz, 109LB Katie: 604 Schwartz, Myron: R.: 922 Schwartz, Sheree Carolynne: Schwarze-Zander, 267 Lilly: Schwieler, 198 Catherine: Schwing, 897 Hyman: Scott, Joel: 226 Scott-Herridge, 86, P.: Eileen Scully, Sekaly, Rafick: 297, 335, 352, Sekaly, 206 Seki, Yohei: Robert:Sekubugu, 902, 986 Michael: 635 Selgrad, Selin,936 Amanda: 804 Pierre: Sellier, Deepak:Selvam, 323 753 Poongulali: Selvamuthu, 112 Collins: Semitala, Fred 33 Katherine: Semrau, 837 Sen,Luisa: Seipone, Ikanyeng D.: D.: Ikanyeng Seipone, Seaberg, Eric C.: 416, 593 Eric Seaberg, R.: 167, 838 George Seage, Seaman, Michael: 380 311LB, Seamon,Catherine: 90 Kelly: Seaton, Sebastian, Joseph: 216, 217 Rode: 473 Secours, Seddiki,233 Nabila: Sedlacek,Dalibor: 46 897 Pich: Seekaew, Seifert, M.: Sharon Author Index
Skordis-Worrall, Jolene: 834 Sonza, Con: 483 Stancil, Britt S.: 106, 471 Suc, Bertrand: 289 Skurowski, Jasmine: 451, 545 Sopa, Bunruan: 857 Stanton, Jill: 997 Sudjaritruk, Tavitiya: 831, 860 Slaymaker, Emma: 117 Sophonphan, Jiratchaya: 857 Stanzione, Maria: 608 Sued, Omar G.: 718, 947 Sleasman, John: 257, 325 Soria, Alessandro: 18LB Starace, Mario: 607 Sugar, Catherine A.: 704 Sloan, Derek: 342 Soriano, Vicente: 508 Staziaki, Pedro: 640 Sujan, Dilly P.: 434 Sluis-Cremer, Nicolas: 341, Soriano-Sarabia, Natalia: 355 Steba, Gaby S.: 547 Sukrakanchana, Pra-ornsuda: 376, 377 Sosa-Rubi, Sandra G.: 1059 Steele, Sarah Jane: 1010, 1061 777 Slyker, Jennifer: 780 Soto-Torres, Lydia E.: 109LB, Steens, Jean-Marc: 461LB Suksamosorn, Jirawat: 972 Smart, Michele: 243 872, 873 Stefic, Karl: 400 Sukwicha, Wichuda: 972 Smit, Colette: 542 Souda, Sajini: 784, 802 Stein, Dan: 821 Sulkowski, Mark: 151, 539LB, Smit, Erasmus: 484 Soudeyns, Hugo: 836 Stein, James H.: 44LB, 651, 672, 573, 537, 576, 601 Smith, Andrew G.: 133 Soulié, Cathia: 489 687, 939 Sullivan, Ashleigh B.: 491LB Smith, Bryan: 389 Soulier, Alexandre: 526, 577 Steiner, Joseph: 146 Sullivan, Patrick: 4, 286, 889 Smith, Colette: 686, 941 Sousa, Amina: 850 Steinman, Meredith: 585 Sultana, Tahmina: 206 Smith, Davey M.: 143, 222, Souza, Scott C.: 387, 723 Stek, Alice: 433, 438, 439, 775 Summers, Michael F.: 56 224, 228, 232, 487, 518, 727, Sow, Salif: 961 Stella Ascariz, Natalia C.: 669 Sumner, Tom: 115 730, 942 Sowell, Elizabeth R.: 822, 823 Stellbrink, Hans-Jürgen: Sun, Lingling: 188 Smith, Don: 470 Sowinski, Stefanie: 240 31LB, 46 Sun, Ly Penh: 858 Smith, Elizabeth: 438, 439, 775 Spear, John R.: 698 Stephan, Christoph: 519, 713 Sun, Xiaoming: 347 Smith, Emily: 803 Spengler, Ulrich: 236 Stephen, McHenry: 564 Sun, Yongnian: 97 Smith, Jennifer: 1058 Sperling, Rhoda S.: 798 Stephens, Terri: 965 Suneja, Gita: 615 Smith, Justin: 931 Spiegel, Hans: 871 Stephenson, Kristine: 546, 1007 Sung, Samuel: 877 Smith, Kimberley Y.: 31LB, 947 Spiegelaerde, Ward: 359, 361 Sterling, Timothy R.: 653, Sung, Xin: 745, 747 Smith, Lou: 501, 991 Spiegelman, Donna: 703 706, 735 Sunil, Thankam: 722 Smith, M. Kumi: 955 Spiller, Michael T.: 215, 916 Stern, Joshua: 38 Sunshine, Sara: 360 Smith, Mariette: 759, 1022 Spindler, Jonathan: 85, 337, 340 Sterne, Jonathan: 941 Sunyakumthorn, Piyanate: 405 Smith, Rachel: 759 Spira, Bonnie A.: 480, 507 Sterrett, Sarah D.: 292 Supervie, Virginie: 1043 Smith, Robert A.: 961 Spire, Bruno: 549, 886, 887 Steven, Reynolds: 563 Surdo, Matteo: 570 Smith, Whitney: 919 Spoerri, Adrian: 613 Stevens, Mark: 434 Suttichom, Duanghathai: 415 Smith-McCune, Karen K.: 162 Spreen, William: 31LB, 105, Stevens, Robert: 705 Suzan-Monti, Marie: 887 Smithgall, Thomas E.: 191 106, 471 Stevens, Wendy: 1013, 1028 Suzuki, Kazuo: 365, 559 Smyth, Erica: 662 Springer, Gayle: 416 Stevenson, Mario: 372 Svedhem, Veronica: 998 Sneller, Michael: 311LB Spudich, Serena S.: 142, 384, Stewart, Annemie: 427, 742 Svicher, Valentina: 570 So-Armah, Kaku: 645, 714 401, 402, 404, 405, 407, 411, Stewart, Jesse: 714 Swadling, Leo: 598 Soars, Matt: 97 414, 415 Sthreshley, Larry: 213 Swaminathan, Soumya: 457, Sobolewski, Michele D.: 340, Spyer, Moira: 1027 Stinson, Kathryn: 960, 1022 Swanstrom, Ronald I.: 62, 192, 377, 379 Squillace, Nicola: 280 Stirratt, Michael J.: 885 401, 402 Sogni, Philippe: 549, 582, 605 Srikrishnan, Aylur K.: 899, 918, Stitzer, Maxine L.: 27 Swarner, Stephanie: 879 Soheilian, Ferri: 137 928, 1032 Stock, David A: 472 Swartz, Talia: 249 Sohn, Annette H.: 174 Srinivasa, Suman: 650, 707 Stock, Jennifer L.: 258LB Sweat, David: 929 Soliman, Mary: 83 Ssali, John: 746 Stoddart, Cheryl: 331, 345 Switzer, William: 149, 211, Solom, Tsion: 1010 Ssekasanvu, Joseph: 163 Stoeckle, Marcel: 612 215, 541 Solomon, Sunil S.: 899, 918, Ssekitoleko, Henry: 743 Stoehr, Albrecht: 472 Swoboda, Jochen: 628 928, 1032 Ssemmondo, Emmanuel: 979 Storto, Alexandre: 509 Syengo, Masila: 791 Somasundaran, Mohan: 806 Ssempijja, Victor: 563 Stout, Richard R.: 323 Sykes, Craig: 102LB, 439, 447 Somasunderam, Anoma: 239 Ssinabulya, Isaac: 297 Strain, Matt F.: 83, 143, 362 Sylla, Maryam: 840 Sommerfelt, Maja: 26LB St. Bernard, Leslie: 105, 406, 597 Stranix-Chibanda, Lynda: 36 Symons, Jori: 359 Somsouk, Ma: 235, 264, 278, St. Johns-Williams, Lisa: 595 Strautins, Kaija: 667 Szadkowski, Leah: 718 Author Index Author 298 Stabinski, Lara: 594 Strehlau, Renate: 39, 40, 851 Sze, Marc: 725 Somwe, Paul: 1019 Stagg, Helen R.: 1053 Struck, Daniel: 211 Søgaard, Ole S.: 26LB, 348 Song, Chisu: 629 Stahlman, Shauna: 924, 925 Stucki, David: 737 Song, Xiaojing: 569 Stall, Ron: 914 Su, Bin: 304 Sönnerborg, Anders: 254, 260, Stam, Arjen J.: 839 Su, Jonathan: 877 267, 486, 998 Stamm, Luisa M.: 100, 573, 601 Subramanian, Mani: 601
160 CROI 2016 Author Index 161 148 990 CROI 2016 346 2 Author Index Author 407 89LB 231 919 828 941 969, 970 1021 556, 557 Traore, Bouyagui: 921 Bouyagui: Traore, Lydie: Trautmann, C.: Graham Treasure, Jonel: 559 Trebicka, 606 Sombat: Treeprasertsuk, 237, 886, 887 Cécile: Tremblay, 182 Michel J.: Tremblay, Randall25 L.: Tressler, 508 Ana: Treviño, A.: 638 Virginia Triant, Adam: Trickey, 574 Roger: 539LB, Trinh, 621 T.: T. Trinh, Lino R.: 856 Trinidad, 539LB Rakesh: Tripathi, K.: 532 Tarak Trivedi, Alexandra: Trkola, Orlin: 896 Trochev, Marius: 267 Troseid, Diane:411 Trotta, L.: 396 Amanda Trout, M.: Hong-Ha Truong, C.: 935 Alexander Tsai, 342 Angela: Tsai, 469LB Lily: Tsai, Ming-Han: Tsai, Gugu: 1014 Tshabalala, Ontibile: 833 Tshume, 969 Sze: Lai Tso, Benjamin:888, 892 Tsoi, 203 Yasuko: Tsunetsugu-Yokota, 811 Roland: 776, 804, Tubiana, 926, 955, D.: Joseph Tucker, 842 Vincent: Tukei, C.: Damien Tully, 919 Bulent: Turan, Janet M.: Turan, Albert: 968 Turkieh, Bosco: 740 Turyamureeba, Olga: 1009, 1020, Tymejczyk, 392 Alicia: Tyrell, –U– 822 Uban, Kristina: 454, Uberti Caterina: Foppa, Placid: 564 Ugoagwu, 993 D.: Jennifer Uhrig, Morenike: Ukpong, M.: 387 Tracie Umaki, G.: 959 Unal, Underwood, Jonathan:
, 219 1015 , 908 35LB 897 203 316 707 896 664 489 , 789 168LB 954, 987 905, 907 Tipsuk, Somporn:Tipsuk, 956 JuanManuel: 448 Tiraboschi, 636 David: Tirchwell, 295 Pascaline: Tisserand, 47 Kehmia: Titanji, Madalina: 392 Tivarus, 285 Annelie: Tjernlund, Mpho: 155 Tlali, Ocean: 788 Tobaiwa, 731, A.: 726, Aaron Tobian, H.: 807 Nicole Tobin, E.: 206 Satoshi Tobita, Minoru: 203 Tobiume, Eve: Todesco, 532 Tamara: Todorovich, Asma: 824 Toefy, Kenzo: Tokunaga, Tolazzi, Monica: 18LB Tolazzi, 412 Karen: Tolentino, 678, 679, Stephen: Tollman, Martin: 348 26LB, Tolstrup, 268, 317 Georgia: Tomaras, 583 Christelle: Tomei, Costin: Tomescu, Tomori, Cecilia: 928 Cecilia: Tomori, 835 Pat: Tookey, V.: Lucia Torian, Mabel: Toribio, 486 Carlo: Torti, 895 Jennifer: Tosswill, 482, 484 225, Anna: Tostevin, I.: 73LB Abdoulaye Toure, Sodsai P.: Tovanabutra, 54 J.: William Towner, 816 Ellen: Townley, Daria: 247, 280 Trabattoni, 939 55, 672, T.: Thuy Tran, Torres, Berta: 945 Torres, Liset: 625 Torres, 205 Javier: Torres-Torronteras, Martin: Torriani, Tien, Phyllis: 422, 609, 691 422, Phyllis: Tien, Thierry: Tiendrebeogo, 952 36, Camlin: Tierney, N.: Van Hong Tieu, Tilston, Peter: 482 Peter: Tilston, 481 Jay: Timmerman, Tinago, Willard: 710 Willard: Tinago, 598 Camilla: Tincati, Judicaël:568 Tine, Beth: Barr, Tippett 927 , 1062 450 973 483 528 , 564, 569, 593 , 564, 569, 778 67 603, 634 691 537, 540, 548, 712 Teferi, Gebeyehu: 538LB Gebeyehu: Teferi, 208 Amalio: Telenti, 876 875, Natalia: Teleshova, 529, 530, Francisco: Téllez, 611 J.: María Tellez, 840 Tiguem: Fatoumata Telly, 921 Nouhoum: Telly, Sushama: Telwatte, Sadhbh: 710 Tennant, 293 Alan: Tenorio, 118 Lyson: Tenthani, 682 Eugenio: Teofilo, Vicki: 856 Tepper, 470 Hedy: Teppler, 1002 Coleman: Terrell, Sandra N.: 201 Terry, 149 Eyasu: Teshale, James: 991 Tesoriero, 839 Kiki: Tesselaar, 681 Anders: Thalme, Gregory: 20, 286 Tharp, 272 Derek: Thibault, Hanne: 933 Thiede, 763 Friedrich: Thienemann, 900, Warunee: Thienkrua, Heather: Thiessen-Philbrook, Deus: 35LB Thindwa, Chloe: Thio, 977 N.: Alexander Thiong'o, Harsha: Thirumurthy, Thobakgale, Christina F.: 827 F.: Christina Thobakgale, 300LB Allison: Thomas, Aurielle: Thomas, 151, 535,L.: 135, David Thomas, H. L.: 1053 Thomas, K.: Katherine 301 Thomas, 821 Kevin: Thomas, Melissa: 23 Thomas, Réjean: 237 Thomas, Thomas: Thomou, 707 447, Corbin: Thompson, Melanie: 470 Thompson, M.: 383, 386 Paul Thompson, 993 Renata: Thompson, 516, 975 Ricardo: Thompson, Will: 595 Thompson, Claire: Thorne, 258LB He: Tianyu, Michel: 408 Ticchioni, 497, 591, 1006 Yunfeng: Tie, Tiziana: Tieghi, 610 970 169aLB 455
770 645 926 655 695LB, 719, 721 695LB, 526 1015 960, 1011, 1048 904 316, 680, 700 Taburet, Anne-Marie: Taburet, Gilda: 483 Tachedjian, 203 Takuya: Tada, Babafemi: 147, 694, 30, Taiwo, 670 Soichiro: Takahama, 202 Akifumi: Takaori-Kondo, 343, 344, 640 Richard: Takx, Aarthi:880 Talla, Sarah: 209LB Talley, 627 Marco: Andrea Tamburini, Giuseppe: 627 Tambussi, Ghislaine Flore: Tamko-Mella, H.: 479LB, Darrell Tan, –T– 319 David: Tang, Michelle: 503 Tang, Ning: 749 Tang, Songyuan: Tang, Tang, Tian: Tian: 1033 Tang, 969, 926, Weiming: Tang, 826, 859 Vin: Tangpricha, 606 Pisit: Tankijvanich, 676 Marcel: Tanner, 568, 568, Aristophane: Tanon, 499, 677, 167, Frank: Tanser, 767 Lauren: Tantalo, 287, 414 Ponpen: Tantivayakul, 615 Neo: Tapela, 38 Ken: Tapia, Daniela: 477 Tapia-Trejo, Laura: Tarancón, 794 Graham: Taylor, 423LB Steve: Taylor, Jamal: 461LB Tazi, 111, Eric: Tchetgen, Tchetgen A.: Chloe Teasdale, 290, 44LB, 32LB, Pablo: Tebas, 544 Ellen: Tedaldi, Tardy, Jean-Claude: 729 Tardy, Kabanda: 763 Taseera, 719, 721 Katherin: Tassiopoulos, 554, 633, 645 Janet: Tate, 675 Pierre: Tattevin, Pheletso: 738 Tau, Johanna: 254 Tauriainen, 73LB Bernard: Taverne, 343, 344 Ahmed: Tawakol, Barbara S.: Taylor, Author Index
Ung, Vibol: 860 Van Handel, Michelle M.: 966 Vig, Pamela: 153 Wallenta, Jeanna: 112 Ungsedhapand, Chaiwat: van Heerden, Alastair: 740 Vigouroux, Corinne: 701 Wallet, Cedrick: 45 900, 972 van Hout, Denise: 839 Vilaplana, Elisenda: 248 Wallis, Carole L.: 30, 493LB, 749 Unsal, Aylin: 830 Van Lith, Lynn: 925 Villarreal, Alfredo: 514 Walmsley, Sharon L.: 718, 768 Untiedt, Sanlie: 845 van Lunzen, Jan: 366 Villegas, Guillermo: 876 Walson, Judd L.: 748 Uprety, Priyanka: 825, 838 van Oosterhout, Joep: 35LB, 118 Viner, Russell: 835 Walter, Hauke: 525 Urano, Emiko: 465 Van Rompaey, Stephen: 558 Vinikoor, Michael: 565 Walworth, Charles M.: 481, 579 Uribe-Leitz, Monika: 826, 859 van Rooyen, Heidi: 436, 740 Violari, Avy: 848, 851 Wamai, Richard: 1059 Urien, Saik: 777 Van Ryk, Donald: 198 Visavakum, Prin: 972 Wamalwa, Dalton: 38, 748, 780 Usami, Yoshiko: 136 van Sighem, Ard: 220, 221, 542 Visseaux, Benoit: 214, 223, 509 Wamicwe, Joyce: 909 Useem, Johanna C.: 957 van Toorn, Ronald: 820 Vittinghoff, Eric: 524, 867, 870 Wamuti, Beatrice: 50 Utay, Netanya S.: 239, 265, 278 van Widenfelt, Erik: 810, 984 Vivancos-Gallego, M.J.: 452 Wandeler, Gilles: 565, 566, 568, Uwizihiwe, Jean Paul: 166, 1024 van Wilgenburg, Bonnie: 598 Vjecha, Michael J.: 559 592, 960 Uzdaviniene, Vilma: 46 van Zyl, Gert U.: 523 Vo, Quynh T.: 1020 wang, Chunhui: 791 Vandamme, Anne-Mieke: Vojnov, Lara: 788 Wang, Cuiwei: 390 –V– 211, 486 Volk, Jonathan E.: 894 Wang, Hong: 749 Vakkalagadda, Blisse: 425, 460 Vandekerckhove, Linos: 359, 361 Vollbrecht, Thomas: 373 Wang, Huanling: 569 Vala, Anifa: 797 Vanderford, Thomas H.: 22 Volpe, Joseph M.: 481, 579 Wang, Jiajia: 433, 438, 439, 775 Valantin, Marc-Antoine: 709 Vanhommerig, Joost W.: 542, Von Groote-Bidlingmaier, Wang, Jian: 460 Valcour, Victor: 384, 404, 405, 547 Florian: 158LB Wang, Jianbin: 356 407, 414, 415, 416, 422 Vanpouille, Christophe: 184 von Hohenberg, Maximilian: 763 Wang, Jiayi: 200 Valentin, Antonio: 259LB Varangrat, Anchalee: 884, 900 von Lettow, Monique: 35LB Wang, Jing: 936 Valere, Kimyata: 196 Vardhanabhuti, Saran: 493LB Von Wichmann, Miguel A.: 611 Wang, Lei: 822, 823 Valiaveettil, Christina: 949 Vargas, Milenka: 727, 730 Vonesh, Edward: 953 Wang, Lu: 392 Vallabhaneni, Snigdha: 759 Variava, Ebrahim: 749, 963 Vourvahis, Manoli: 818, 1120 Wang, Nidan: 569 Vallari, Ana S.: 212, 213 Vasan, Sandhya: 318, 405 Vranckx, Lenard: 363 Wang, Ruibin: 684, 699 Valluri, Srinivas Rao: 818, 1120 Vassall, Anna: 155 Vray, M.: 959 Wang, Shelley K.: 358LB Valverde, Eduardo: 497 Vassallo, Matteo: 408 Vubil, Adolfo: 788 Wang, Shirlene D.: 822 van Crevel, Reinout: 431 Vasudevan, C.K.: 918 Vucic, Emily: 725 Wang, Shuang: 851 Van Cutsem, Gilles: 1010, 1031, Vavro, Cindy: 816 Vujkovic-Cvijin, Ivan: 264 Wang, Stanley: 453 1061 Vaz, Paula M.: 850, 974, 976 Vullo, Vincenzo: 238, 610 Wang, Zhengyan: 501 Van Damme, Lut: 1058 Vázquez-Morón, Sonia: 590 Vunnava, Aswani: 47 Wang'Ombe, Joseph: 1059 van de Berg, Dorien: 152 Vázquez-Pérez, Joel: 251 Wani, Gregory: 510 van de Laar, Thijs J.: 542, 543 Veazey, Ronald: 467 –W– Wanje, George: 912 van de Vijver, David A.: 536, Veloso, Valdilea G.: 48LB, 779 Wada, Nikolas I.: 283 Ward, Helen: 895, 913 1052 Velu, Vijayakumar: 93LB Wade, Alisha: 678, 679 Ward, John: 149 van den Berk, Guido: 948 Venkataramani, Atheendar: Wagh, Kshitij: 309LB Warner, Nadia: 570 van der Heijden, Yuri F.: 735 1011 Wagner, Danielle L.: 1051 Warszawski, Josiane: 776, van der Horst, Charles: 801LB Venter, Francois: 1056 Wagner, Gabriel A.: 228 804, 811 van der Meche, Narda: 948 Venugopalan, Srividhya: 1053 Wagner, Ryan: 907, 936 Warth, Chris: 478 van der Meer, Jan T.: 542, Venuto, Charles: 428, 443 Wahl, Janice: 576 Wasmuth, Jan-Christian: 560 543, 547 Venzon, David: 317 Wahome, Elizabeth W.: 977 Watanatanyaporn, Teeraparp: van der Merwe, Lize: 158LB Vera, Jaime H.: 692 Wainberg, Mark A.: 218, 480, 884 van der Plas, Helen: 742 Verdin, Eric: 363, 463 507 Waterhouse, Dorothy: 916 van der Ryst, Elna: 818, 1120 Verma, Anurag: 443 Waitt, Catriona J.: 449 Watkins, Phaedrea: 883LB van der Sluis, Renee M.: 375 Verma, Shefali: 443 Waked, Imam: 64, 153 Watson, Christopher: 893 van der Straten, Ariane: 873, Vermund, Sten H.: 790, 792 Walensky, Rochelle P.: 786, 1016 Watson, Dionysios K.: 259LB 879 Verna, Elizabeth C.: 11, 124 Waligo, Allen: 1056 Watts, D. H.: 779 Author Index Author van der Valk, Marc: 566, 1052 Vestal, Brian: 279 Walits, Emily: 501 Watts, Thomas D.: 140 Van Dyk, Gisela: 847 Viana, Raquel V.: 749 Walker, Bruce D.: 13, 19, 190, Wawer, Maria J.: 163, 563, 902, Van Dyke, Russell B.: 822, Viani, Rolando: 816 256, 261, 300LB, 312, 488 954, 986, 987 823, 838 Vichi, Francesca: 247 Walker, Joshua: 273 Weaver, Eric M.: 278 van Griensven, Frits: 219 Vieillard, Vincent: 304 Walker, Naomi F.: 734 Webb, Nicholas E.: 33 van Ham, Petronella M.: 464 Vierling, John M.: 576 Walker-Sperling, Victoria E.: 374 Webel, Allison R.: 657
162 CROI 2016 Author Index 163 282 , 720 CROI 2016 Author Index Author 700 , 298 210 80 1051 587 308 198 325 647, 691 Yao, Amanda H.: 666 H.: Amanda Yao, Jiqiang: 325 Yao, 813, 814 Tzy-Jyun: Yao, 469LB Xin: Yao, Michio: 314 Yasunami, 621 Nelly: Yatich, Emine: Yaylali, 31LB Yazdan: Yazdanpanah, Sara: 793 Yeatman, Gonzalo: Yebra, 456 Kelly: Yee, Baligh R.: 1001 Yehia, Christina: Yek, 753 Tokugha: Yepthomi, Sabine: 951 Yerly, 142 Anji: Yi, 24 Yanjie: Yi, Li: Yin, 40, T.: Michael Yin, 154LB Chohee: Yun, 303 Eloisa: Yuste, Yin, Peng: 702 Peng: Yin, Benita: 492LB Yip, Ram:823 562, Yogev, 505 Masaru: Yokoyama, Jason: Yolitz, Huang: 326 Yong, Nir: 19 Yosef, Kazuhisa: 505 Yoshimura, 202 Noriyoshi: Yoshinaga, Sarah: 401, 402 Yosief, 746 Marcel: Yotebieng, 276, Mehwish: Younas, 732 Souheil-Antoine: Younes, 104, 523, 982 103, Alicia: Young, Benjamin: 698 Young, Mary:422, 390, 416, Young, 909 W.: Peter Young, Rebekah: 42 Young, 325 Fahong: Yu, Jian:469LB Yu, Kim: 585 Yu, Qilu:809 Yu, Wen-Han: Yu, 19, 347 G.: Xu Yu, Sally: 369 Yuan, 319 Xin-Yong: Yuan, 949 Mark: 622, Yudin, A.: Steven Yukl, 140 574 832 397 136 942 Wood, Robin: 429, 960, 1029 Robin: 429, 960, Wood, Sandra L.: 98 Wood, Sarah: Wood, K.: 492LB Conan Woods, Kim C.: 20 Worley, Michael: Worobey, Worodria, William: William: 764 Worodria, Beiqing: Wu, 275LB Fan: Wu, 43, 719, 721 Kunling: Wu, Li E.: 399 Wu, Qiongmiao: 970 Wu, 84, 337 Xiaolin: Wu, 307 Xueling: Wu, Yingfeng: 1020 Wu, Yuanfei: Wu, 868 Christina: Wyatt, David: Wyles, 41 Nicole: Engen, Wyman Brian: 660 Wynne, –Y– 253 Chisato: Yamada, Julie: 212 Yamaguchi, 670 Masahiro: Yamamoto, 336 Takuya: Yamamoto, Shoji: 203 Yamaoka, Mingjin: 29 Yan, 581 Peng: Yan, Sarah E.: 874 Yandura, Bin: 926, 969 Yang, Blia: 114 Yang, 516, 850 Chunfu: Yang, Dongmei: 481, 579 Yang, 573, 601 C.: Jenny Yang, Jing: 286 Yang, Ligang: 926 Yang, Otto: 672, 939 Yang, Shu: Yang, –X– 425 Hong: Xiao, Jing: 569 Xie, 539LB Yan: Xie, 258LB Cuiling: Xu, 273 Hua: Xu, Huifang: 970 Xu, Jiahong: 779 Xu, 54 Lanfang: Xu, Min: 506 xu, 725 Stella: Xu, 470 Xia: Xu, 722 Xiahoe: Xu, 233, 334 Yin: Xu, , , 912 , 605, 580 953 33 864 348 582 423LB 1053 1047 , 682 816 969 681 161 944 , 823 160, 273, 403 822 279, 293 599 689, Wong, Joseph K.:80 Wong, 707 Kimberly: Wong, Ngai Sze: Wong, 978 Vincent: Wong, 193 W.: Wilson Wong, Wilkin, Aimee: 474 Aimee: Wilkin, 103, 104, J.: Timothy Wilkin, Wilkinson, Eduan: 499 Eduan: Wilkinson, 734 Katalin: Wilkinson, 1031 Lynne: Wilkinson, 880 Peter: Wilkinson, Robert 734 J.: Wilkinson, Thomas A.: Wilkinson, Deborah:683 Williams, John R.: Williams, Julie: 257 Williams, 88 Katherine: Williams, C.: 141, Kenneth Williams, L.: 813, 814, Paige Williams, 31LB Peter: Williams, 309LB Carolyn: Williamson, Sarah:964 418, Willils, Brigid: 733 Wilson, 134, 187, 262, Cara: Wilson, M.: 528, Eleanor Wilson, 1034 B.: Ira Wilson, 863, S.: Kate Wilson, Michael R.: 43 Wilson, E.:919 647, Tracey Wilson, 893 883LB, Leo: Wilton, Wipas: 972 Wimonsate, 461LB Ratanasuwan: Winai, Anni: Winckelmann, 148, Alan: Winston, Joanne R.: Winter, 489 Marc: Wirden, 904 111, Kathleen: Wirth, Mallory:685 Witt, Linda: 549, Wittkop, Wiznia, Andrew: Andrew: Wiznia, David: Wohl, Michael B.: Wohlfeiler, Shauna: 523 Wolf, Timo: 713 Wolf, 839 F.: Tom Wolfs, 145 Steven: Wolinsky, Jason: 546, 1007 Wong, 535 John B.: Wong, , 825 809 965 95LB 883LB 24 972 1060 484 714 643 7 912 Y.: 161 Y.: 481, 579 1045 839 Weinberg, Adriana: Adriana: Weinberg, Weber, Kathleen: 277, 720 Kathleen: Weber, Rachel:1025 Weber, Rainer:612, 661 Weber, Jennifer Webster-Cyriaque, 405 D.: Matthew Wegner, 926, 969 Chongyi: Wei, Danlan: 198 Wei, 975 Stanley: Wei, Bernard: Weigel, White, James: 722 White, JessicaR.: White, White, DouglasA.: 532 White, 482, Ellen: White, B.: James Whitney, Lilith K.: Whittles, Nuanjun: 314 Wichukchinda, 340 Ann: Wiegand, 628 Ulrike: Wieland, 241 Peter: Ludwig, Wienberg 771, 801LB Jeffrey: Wiener, 465 T.: Carl Wild, Wheelan, Sarah J.: 135 Sarah J.: Wheelan, L.: 720 Amber Wheeler, P.: Darrell Wheeler, M.: Jeannette Whitcomb, Darcy: White, Weis, Julie: 478 Weis, John: 497 Weiser, Sheri: 919, 935 Weiser, 534 Jeffrey: Weiss, 900, Kevin: Weiss, Sharon: Weissman, A.: David Weitz, N.: 47, 695LB M. Weitzmann, 931, 1000, Cyprian: Wejnert, 169bLB Ethel: Weld, 498 Maureen: Wellington, 308 Lance: Wells, 517 Alex: Welte, John: 983 Wen, Suzanne:998 Wendahl, 97 David: Wensel, 543, M.: 366, Anne Wensing, Deborah: 559 Wentworth, 211, 487 O.: Joel Wertheim, 519 Tanja: Westenberger, 421, 790 William: C. Wester, 382 Elizabeth: Westerhaus, Katherine: Wetzel, Author Index
–Z– Ziada, Adam S.: 716 Zadzilka, Amanda: 825 Zielinski-Gutierrez, Emily: 903 Zahn, Jennifer: 968 Ziemniak, Carrie: 825, 838 Zakharova, Natalia: 472 Zimmer, Bonnie: 458, 824 Zampino, Rosa: 608 Zingman, Barry: 1038 Zanni, Markella V.: 638, 640, Zoellner, Cindy L.: 587 650, 664 Zolopa, Andrew: 745 Zannou, Marcel: 565, 962, 1015 Zook, Katie: 651, 687 Zanolini, Arianna: 960 Zoungrana, Jacques: 696 Zapata, Juan: 368 Zuccotti, Gianvincenzo: 819 Zar, Heather J.: 852, 854 Zucman, David: 549 Zash, Rebecca: 802 Zuhlke, Liesl: 854 Zaslow, Shayne: 890 Zúñiga, Joaquín: 251 Zaunders, John J.: 233, 334, 365 Zunt, Joseph: 636 Zazzi, Maurizio: 486 Zürcher, Kathrin: 737, 1021 Zeidan, Joumana: 358LB Zvonar, Ivan: 305 Zeller, Georg: 260 Zwerski, Sheryl: 37 Zerbato, Jennifer M.: 341, Zydowsky, Thomas: 875, 876 376, 377 Zerbe, Allison: 34, 757, 795, 799, 808, 988, 997, 1038 Zetola, Nicola: 755 Zevin, Alexander: 263, 263 Zhang, Baoshan: 310LB Zhang, Fujie: 446 Zhang, Guangxiang: 652 Zhang, Jingyang: 872 Zhang, Sandra: 437LB Zhang, Sharon: 97 Zhang, Shimin: 875, 876 Zhang, Tianchi: 211 Zhang, Wei: 154LB Zhang, Wei: 926, 926 Zhang, Wendy: 227, 492LB Zhang, Yafeng: 717 Zhang, Yanzhao: 203 Zhang, Ye: 926, 969 Zhang, Yonglong: 410 Zhang, Zhou: 321 Zhang-Roper, Rebecca: 818, 1120 Zhao, Peng: 308 Zhao, Runze: 397 Zhao, Yuteng: 970 Zheng, Jialin C.: 397 Zheng, Lu: 30 Zheng, Wenjing: 985 Zhong, Fei: 970 Author Index Author Zhong, Jianhui: 392 Zhou, Jhingling: 711 Zhou, Nannan: 575 Zhu, Ting: 569 Zhu, Tong: 383 Zhuang, Yuchuan: 392
164 CROI 2016 Keyword Index 165
297
1025
- 1014
813,
1041
1023, CROI 2016
1023, 796,
Africa 1012,
Keyword Index 1013,
954, 1012, 771,
1028
1010,
119,
1031 therapy, - 904,
860,
744,
665, 35LB,
950 834, 163, –
789, 122,
- 1014 38,
860
adjunct 27,
39,
- 28, 111, 122,
-
85, 119, - -
953 -
monitoring
- -
821 –
-
evaluation
821, 845, 849, 943, 951, 1022, 1029, 1032 1041, 1056 450, 874 788, 794, 800, 824, 840. 1017 746, 753 458, 734, 741LB, 87, 112, 118, 119, 121, 122, 126, 147, 151, 118, 119, 121, 122, 126, 147, 112, 87, 229, 252, 257, 265,155, 160, 164, 167, 350, 384, 406, 418,280, 290, 293, 330, 446, 462, 465, 473,429, 434, 443, 445, 496, 512, 559, 561, 474, 475, 480, 491LB, 621,566, 567, 592, 613, 617, 618, 619, 692,646, 660, 672, 677, 678, 679, 680, 751,703, 707, 709, 728, 729, 734, 736, 853,755, 761, 805, 812, 838, 844, 851, 944,906, 910, 923, 930, 939, 940, 941, 1020 949, 954, 956, 957, 958, 989, 1003, • Adherence • Care • Cascade • Coverage • Initiation • Intensification • Naïve • Outcomes • Patients • Program • Scale-up • Switch • Atorvastatin 447, - tissue penetration Antiretroviral 552, 697,458, - 55, treatment Antiretroviral - 155, 158LB 180, treatment Antituberculosis activityAntiviral 874 - 247, 464, - 203 Factor Antiviral - 466 therapy Antiviral Anxiety- 414 APOBEC3 - 59, 199, 201, 629 59 - APOBEC3F APOBEC3G/F - 81, 83, 629 - 200 APOBEC3H APOE - 145 - 243 Apoptosis - 977 reminders Appointment - 140 HIV-1 Archival Asia - 314, 349, 569, 831, 858 - 764 Aspergillosis Aspirin - 44LB - 83 Assay study - 937 Association Antiretroviral Therapy (ART) - 16, 22, 41, 53, - 16, (ART) Therapy Antiretroviral
120, 167, 212, 227, 419, 436, 564, 565,120, 167, 212, 227, 833, 840, 771, 801LB, 624, 625, 676, 696, 937, 961, 977, 983,843, 849, 901, 912, 1022, 1042, 1063 985, 1019, 1021, 719,669, 670, 705, 709, 712, 715, 716, 720, 721, 905, 938 911, 912 346, 347 92, - 162, 455 - 180, 181 (ADCC) cytotoxicity 466, 505, 506, 662, 696 439, 440, 442, 443, 449, 453, 454, 774 Africa - 28, 75LB, 109LB, 112, 113LB, 118, 112, 113LB, 109LB, 75LB, - 28, Africa 929 883LB, American - 52, 538LB, African - 118, 220 Age - 904 specific estimates Age - 145, 183, 279, 382, 396, 421, 646, Aging 554, 614 AIDS - 265, 422 - AIDS Dementia Complex malignancy - 616 AIDS-related 651 - Albuminuria - 150, 257, 277, 554, 568, 822, Alcohol - 510, 521 Algorithm 4 beta 7 - 287 Alpha - 317 ALVAC/AIDSVAX - 763 deoxycholate B Amphotericin - 620, 628, , 626, 633 cancer Anal HPV subtypingAnal - 626 HSIL - 626 Anal – 887, 882LB intercourse Anal - 628 swabs Anal – 32LB, (ATI) interruption treatment Analytic - 331, 345 site Anatomical - 852 Anthropometric drugs Anti-calcineurin immunosuppressive - 25 Anti-PD-L1 504, 840 311LB, - 15, Antibodies - 15 Neutralization Antibody - 92, 318, 323, 830 response Antibody Antibody-dependent cell-mediated - 521 assays Antigen/antibody - 63, 71, 702, 961, 999, 1023 Antiretroviral - 32LB agents Antiretroviral 395, 436, 461LB, - 16, 97, drug Antiretroviral transporters drug - 450 Antiretroviral 1031 850, 940, 833, - failure Antiretroviral - 63, 433, pharmacokinetics Antiretroviral
967, 968, 972, 1014, 1042, 1043 478, 495, 741LB 296, 302 590, 602 187, 219, 269, 287, 320, 349, 384, 404, 407, 414, 415, 418, 518, 521, 524, 727, 942, 927, 956, 964 873, 894, 919, 1029, 1034, 1039, 1055 175, 176, 177, 442, 817, 822, 823, 829, 831, 833, 834, 835, 836, 845, 852, 854, 931, 936 940, 948 KEYWORD INDEX –A– - 235 A20/TNFAIP3 663 - 660, 661, Abacavir - 297, 952 ABC-3TC 949 - bleeding uterine Abnormal Abstracts - 478 - 967, 1001 ACA 1014 970, 156, 873, 883LB, - Acceptability 678, 902, - 120, 122, 537, 587, care to Access - 229, 281, 305, resistance drug Acquired immunodeficiency - syndrome Acquired - 305 Actigraphy 826 291, 302, 653, - 251, 290, Activation - 291 Acute 581, 297, 536, C - 99, 154LB, Hepatitis Acute HIV Infection133, 188, - 13, 21, 87, Acute injury kidney Acute - 763 rejection - 572 Acute - 518 Syndrome Retroviral Acute 275LB 23, 274, - SIV Acute - 191 2 (AP2) protein Adaptor 844,99, 283, 476, 793, 795, - 96, Adherence 940, 1019, 1022 - 864, ART to Adherence 668, 702, 707 tissue - 123, 271, Adipose people - 172, 174, young and Adolescent 419, 565, 640, 915, - 17, 55, 349, Adults 948 667, 702, 855, - events Adverse 12-week use - 44LB , 153, 816, 932 , 153, use - 44LB 12-week 745 362, - 196, 211, circles 2-LTR 161, 211 - 2B4 281 - 3TC - 305, 976 4E10 epitope - 521, 523, 964 immunoassay 4th-generation Keyword Index
Astrocyte - 393 • turnover markers - 47, 126, Case-control study - 293, Central nervous system (CNS) - Asymptomatic infection - 72LB 694, 859 640, 824 60, 63, 142, 144, 388, 392, Atazanavir/ritonavir - 417, 428, Boosted - 452 Caspase-1 - 241 395, 398, 400, 405, 412 692, 753, 774 Botswana - 37, 111, 784, 802, Caspase-3/7 - 241 Cerebrospinal fluid (CSF) - 404, Atherosclerosis - 640, 654, 656, 805, 810, 904, 984 Causal inference methods - 942 405, 407, 411, 412, 413, 658, 673 Brain - 175, 822 Cause of death - 941 446, 767 Atorvastatin - 551 Brain structure - 384, 386, 387, Cause-specific mortality - 911, Cerebrovascular - 43, 640 Atripla - 706, 945 388, 389 941 Cervical cancer - 162, 615, 617, Attrition - 118 Breakthrough HIV Infection - CBFβ - 199, 202 621, 625 Awareness - 974 479LB CCR5 - 78, 296, 306, 357, 358LB, Cervical cancer screening - 162, Breastfeeding and breast milk – 552, 781 623, 624, 625 –B– 441, 449, 828 CCR5 expression - 242, 655 CHARTER score - 420 B cell responses - 127, 324 Broadly neutralizing antibodies - CCR6 - 188 Chemokine - 254, 274 B cells - 127 32LB, 89LB, 90, 186, 302, CD1a - 288 Chemokine receptor - 239 B-type Natriuretic Peptide 309LB 303, 311LB CD34+ hematopoietic stem Chemsex - 913 (BNP) - 646 Bryostatin-1 - 354 cells - 295 Children - 302, 442, 619, 840, Bacterial functions - 474 BST-2/Tetherin - 181, 246 CD4 T cell - 58, 186, 244, 254, 841, 842, 843, 850, 1023 Bacterial translocation - 187, Burden of disease - 52, 679 271, 334, 369, 946 · Child mortality - 802 239 Bystander pathogenesis - 243 • Count - 304, 386, 486, 942 · Childhood tuberculosis - 746, Balance - 895 • Death - 187, 241, 243 748 Barriers to care - 1016, 1042 –C– • Depletion - 188, 262 China - 969, 970 Basal ganglia - 823 Cabotegravir - 31LB, 71, 105, • Nadir – 386 Chlamydia - 922, 1005 BCG - 824 106, 881 • Receptor - 191, 193 Chlamydia trachomatis - 1004, Behavioral - 55, 917, 931, 934, Canada - 622 • Reconstitution - 233, 252 1006 969, 993 Cancer - 86, 160, 162, 331, 613, • Recovery - 234, 295, 335, 473, Big data - 4 620, 622, 629, 811 751 Cholesterol - 145, 643, 659 Bimolecular fluorescence • Risk - 604, 615 • Response – 944 CD4 CD8 Chronic Hepatitis B - 564, complementation (BiFC) - 191 • Stage - 614 • Ratio - 278, 291, 326, 408, 568, 569 Biodegradable implant - 879 • Survival - 614, 615, 616 633, 710, 729 Chronic Hepatitis C - 10, 66, 151, Bioenergetics - 144 Cannabinoid receptor 2 - 557 CD8 T cell - 248, 269, 274, 312, 528, 529, 530, 531, 538LB, Bioinformatics - 260, 481, 950 Capsid - 196, 197 313, 407, 732, 827 548, 574, 581, 583, 587, 604 Biomarker - 276, 342, 410, 540, Cardiac abnormalities - 853 CD8 T cell suppression - 22, 374 Chronic HIV infection – 245LB, 660, 671, 685, 691, 715, Cardiometabolic health - 722 CD9 - 250 387, 396, 403, 528, 654, 865, 939 Cardiovascular - 41, 646, 659, CDK - 207 673, 708 Birth outcomes - 799 660, 671 Cell activation - 244, 653 Chronic Inflammation - 240, Birth PCR - 783, 785 Cardiovascular disease - 43, Cell associated HIV DNA - 85, 271, 654 Bispecific antibodies - 94 636, 638, 640, 642, 644, 646, 300LB, 330, 349 Chronic kidney disease - 686, Bispecific antibodies - 469LB 648, 650, 653, 655, 658, 662, Cell associated HIV RNA - 85, 687, 691 Black MSM - 893, 897, 930 664, 665, 673, 675, 676, 687, 245LB, 330 Chronic lung disease - 724, 725 Blimp-1 - 153 854 – Cell cycle - 183, 207, 251 Churn - 992 Blood pressure - 677 • Risk factors - 636, 637, 642, Cell death - 251, 295, 372 Circulating recombinant form BMS-626529 - 460, 472 644, 646, 647, 659, 661, 662, Cell traffic brain macrophages - (CRF) - 213 BMS-663068 - 460, 472 666, 675, 704, 711, 715, 722, 141 Circumcision – 165, 987 BMS-955176 - 425, 464, 466 914 Cell-free mtDNA - 715 Cirrhosis - 124, 422, 527, 550, Body composition - 40, 722 Cardiovascular markers - 657 Cell-to-cell infection - 393 551, 574, 603, 610 Body mass index - 677 Care retention - 993, 1002, 1042 Cell-to-cell transmission - 184, Clade C - 317 Bone - 36, 40, 46, 47, 699, 819 CARE+ - 997 186 Clinical management - 177 • Renal safety - 808 Care-delivery model - 68, 534 Cellular factors/Cytokines - 244 Clinical monitoring - 1005 • Disease - 46, 126, 694, 698 Carotid intima-media thickness - Cellular model - 360 Clinical outcomes - 53, 256, 345, • Marrow - 365 643, 651, 656, 672, 674 Cenicriviroc - 239 587, 611, 960 • Marrow monocytes/ cART - 160, 295, 382, 569, 831 Central fat - 704 Clinical parameters - 227 macrophages - 403 Cascade of care - 28, 120, 1042, Central memory T cells - 251, Clinical pharmacology - 445, • Mineral density (BMD) – 1043, 1051 335 449, 453, 777, 815 48LB, 695LB, 696, 698, 859 Keyword Index Keyword
166 CROI 2016 Keyword Index 167
843, 465,
788
756,
786
453,
659, 462,
787,
CROI 2016 543,
658,
430, -
473,
406,
786,
Keyword Index
504, 942
492LB
100,
320, - 210,
785,
- -
829
957 498,
352, 462
10,
Therapy 1041
976
- –
782,
- 675, 747, 477,
291, 454,
915,
927 35LB
-
412 Therapy - -
(DTG) 16, - 1043
522, 505 155,
- mutations surveillance testing 143,
84 -
913,
- -
-
-
-
Antiretroviral diagnosis
149,
start - infection infection
910 455, 456, 459, 589, 1050 847, 850 480, 483, 487, 488, 499, 505, 507 990 816, 947, 948, 953 • HIV • HIV • Infant • Infant • Infection • Mortality • Treatment - 773, 979, 1062 Africa East 77LB, 76LB, 75LB, 74LB, 73LB, - 72LB, Ebola - 649, 853 Echocardiography - 834 evaluation Economic • Combinations • Discovery • Distribution • Interactions • Resistance • Resistance • Resistance • Resistance • Use - 157, 754, 755 tuberculosis Drug-resistant 424LB - Therapy Dual - 817 DXA Dyslipidemia - 665, 854 –E– - 496, 817 E/C/F/TAF Early • Antiretroviral • ART • Diagnosis Directly-active-antiretroviral - 599 Directly-active-antiretroviral Disability - 721 974 - 906, Disclosure - 765 Discontinuation Disparities1033 721, 902, 990, 994, - Disparity52 - Diversity- 86, 179, 212, 331 - 282, 629 damage DNA - 259LB vaccine DNA 660, - 432, 438, 462, 508, 589, Dolutegravir - 480, 507 resistance Dolutegravir - 492LB resistance Dolutegravir 470, 506 - 456, Doravirine ganglia - 272 Dorsal root Drip - 431 feed PCR - 7 digital Droplet Drug - 363 288, 328 585, 587, 600, 610 520, 540, 976, 984 520, 540, 761 762, 763 320, 374 269, 300LB, 130, 259LB, –D– D-dimer - 645 - 589 therapy DAA-based - 575, 577 Daclatasvir 1058 873, 1057, Dapivirine - 872, Ring - 110LB Vaginal Dapivirine - 459, 574, 692, 775 Darunavir - 468 Dasatinib linkage - 1053 Data 511 - DBS DC-SIGN - 547 ddPCR - 362 immunogen design - 308 De novo - 789 Decentralization Deep231 - sequencing - 83 Defective provirus - 213 Republic of Congo Democratic 185, 186, 270,Dendritic19, 128, - cells 920, 1037 714, 919, - 414, Depression 440 - pharmacology Developmental 610 - Diabetes mellitus - 647, 706 Diabetes Diagnosis - Diagnostic accuracy- 787 studies 767 Didanosine - 811 Diet - 266, 657 821 imaging - Diffusetensor Direct - 184, 220 transmission 97, 455, 583,- Direct-acting (DAA) antiviral Cross-sectional incidence testing - 511, 517, testing incidence Cross-sectional - 715, 1025 study Cross-sectional - 431 Crushing 159, 759, 760,- Cryptococcal antigenemia Cryptococcal 760, meningitis - 159, 759, 762 760, - Cryptococcosis - 159 Cryptococcus titers - 413 CSF biomarkers - 342 Cure CVD664 - CX3CR1 - 732 393 - 306, CXCR4 - 1042 of Engagement Cycling - 206, 319 monkey Cynomolgus CYP2B6 - 458 762 – 259LB, Cytokines 731, 732 730, - 729, (CMV) Cytomegalovirus T lymphocytes – 13, 23, 94, (CTL) Cytotoxic 681, 700, 741LB, 816, 817, 873 681, 700, 741LB, 691, 985 605, 698, 715, 943, 948 - 111, 740, 972, 975, 976, 983, counseling 1059, 1061, 1062 980 402, 406 1052, 1056, 1058 Clinical prediction rule - 742 prediction rule Clinical 494LB, 443, 354, 436, 25, 26LB, - trial Clinical 340, 361 - 84, 85, 337, 339, expansion Clonal - 339, 361 populations HIV Clonal 219, - 50, 155, Trial Randomized Cluster - 779, 780 CMV - 430, 714 Coagulation - 430, 459 Cobicistat - 693 Cocaine 227 bias - Codon-pair - 549 Coffee - 422 Cognition 721 387, 421, - 144, impairment Cognitive performance822 - 148, Cognitive Cohort - 283, 860 Cohort421, 582, 584, study - 54, 227, 350, 528, 583, 596, 755 526, - Coinfection - 728 ART Combination 983, 985 - 70, 538LB, based Community 1025, 1036 - load viral Community - 769 Pneumonia Community-Acquired and HIV testing Community-based 120, 436, - intervention Community-based - 126, 612, 637, 690, 709, 713 Comorbidity - 801LB Comorbidity 398, 400,- 143, Compartmentalization - 997 intervention counseling Computer 336 - model simulation Computer - 863, 887, 1041 Condoms - 738, 994, 1002 of care Continuum - 261, 338 Controllers - 201 Variation Number Copy - 306, 307 switch Coreceptor arteryCoronary - 644, 648, 675 disease arteryCoronary plaque - 648 - 179 protection of Correlates - 385 Thickness Cortical 1061, 1062 - 1050, 1059, Cost model - 115 Cost Cost-effectiveness - 115, 536, 773, 945, 858 801LB, - 37, 773, 784, Cotrimoxazole - 49 Couples - 314 CRF01_AE - 222 CRF02_AG - 313 Cross-reactivity Keyword Index
Efavirenz - 429, 433, 441, 444, 446, 458, 470, False-recent rate - 540 Global - 174, 1060 862, 945, 963 Family environment - 931 Global Hepatitis Outbreak and Surveillance EFdA - 98 FDG-PET/CT - 343, 344 Technology (GHOST) - 149 Effectiveness - 121, 1055 Female reproductive tract - 268, 284, 285 Glucose metabolism - 711 Effector/memory - 254, 299 Female sex workers - 226, 912, 973, 1047, Glutaminase - 397 Efficacy – 469LB, 495, 810, 818, 1120 1059 Glycosylation - 81 Efficacy and safety - 472 Fertility desire - 864 Gonorrhea - 922, 1005 Efficiency - 945 Feasibility - 970 gp120 - 181, 724 EFV - 40, 101 Fetal - 36 gp160 trimer - 138 EFV400 - 1050 FGF-23 - 651 gp41 motif - 304 eGFR - 693, 857 FibroScan - 606 Group sex - 926 Electronic adherence monitoring - 1029 Fibrosis - 273, 298, 528, 551 Growth - 852, 858 Elimination - 1044 Financial incentives - 1038 Guidelines - 643, 832, 869 ELISA 4th generation - 522 First-line ART failure - 476, 482 Guinea - 75LB Elite controller - 19, 190 Fisherfolk – 903, 954, 986 Gut associated lymphoid tissue (GALT) - 233, Elvitegravir - 431, 480 Fixed-dose combination - 963 238, 348, 450 Emergency department - 532 Flagellin - 239 Gut homing - 274, 289 Emtricitabine - 104, 107, 449, 866 Flow cytometry - 253, 411 Gut immunology - 187, 235, 237, 262 End-stage liver disease - 11, 150 Fluconazole prophylaxis - 159, 760, 761 Gut microbiome - 261, 262, 657 End-stage renal disease - 688 Food insecurity - 935 Gut microbiota - 21, 260, 266 Endothelial dysfunction - 653, 654 Fracture - 46, 698, 699 GWAS - 601 Endothelium - 663 Frailty - 709, 719, 723 Engagement in care - 996, 1008, 1009 Functionality - 720 –H– Entry inhibition - 97, 505 Fungal infection - 764 HAART - 589, 707, 724, 959, 1039 Env - 398, 505 Fusion inhibitors - 97 Hair concentrations - 866 Envelope - 33, 303, 307, 398, 505, 602 Haiti - 473, Eomes - 254 –G– HAND - 144, 146, 388, 389, 406, 420 Epidemic classification - 1046 Gag - 137, 195, 197, 314, 465 Harm reduction - 533 Epidemiology - 51, 52, 64, 174, 216, 526, Galectin-9 - 81 HAV/HBV responsiveness - 329 536, 541, 583, 590, 616, 624, 736, 890, Gastric cancer - 635 HBsAg - 570 905, 915, 974, 1036, 1060 Gastrointestinal - 236 Health care providers - 892, 966 Epigenetics - 294, 463, 725, 851 GBV-C - 326 Health district - 910 Epithelial cells - 235, 725 Gender - 416, 744, 918 Helicobacter pylori - 635 Epitope - 152, 303, 313 Gender Disparities - 416, 476, 531, 1015 Heme oxygenase-1 - 394 Epstein-Barr virus - 630, 780 Gene editing - 78 Hemodialysis - 432 Eradication - 25, 353 Gene editing - 358LB Hepatitis - 124, 591 ERAP - 667 Gene expression - 251, 324, 880 Hepatitis B Virus (HBV) - 150, 562, 563, 566, ERCHIVES - 581 Gene therapy - 78, 356, 357 567, 571, 607, 804 ESRD - 432 Genetic diversity - 226, 959 Hepatitis B Virus (HBV)-HIV co-infection Europe - 486, 630, 1044 Genetic polymorphism - 247 – 567 EWAS - 851 Genetic polymorphisms - 444, 445 Hepatitis C virus (HCV) - 11, 64, 149, 150, Ex vivo - 245LB, 285 Genetic variant - 149, 780 329, 525, 526, 527, 532, 533, 534, 535, Executive function - 390 Genetics - 17 537, 539LB, 540, 542, 543, 544, 546, 549, Exercise - 719 Genital - 284 551, 554, 556, 557, 575, 577, 578, 579, Exhaustion - 269, 596, 826 Genital tract of women - 102LB 595, 597, 600, 606, 607, 608, 611, 639, Exosomes - 250, 559 Genital tract sampling - 439, 987 693, 804 Explant - 874 Genome - 20 • Continuum of care – 587 Exposure-Response - 425 Genome-wide association - 499 • Genotype 6 - 606 Extended Duration - 98 Genomics - 737 • HIV coinfection – 9, 100, 329, 413, 527, Extracellular Vesicles - 397 Genotype - 525 541, 545, 550, 556, 559, 573, 574, 575, Geographic differences - 214 582, 584, 605, 610 –F– Geographic origin - 943 • Incidence - 64, 544, 546 Falls - 720 Germinal center - 233, 334 • Inhibitors - 525 False-positive diagnoses - 516, 786 GHESKIO - 750, 1017 • NS5A - 578, 579 Keyword Index Keyword
168 CROI 2016 Keyword Index 169
176, 284,
1034,
937 1036,
352,
120, 268,
480
991
CROI 2016 1033, 935,
303
1026 380
800
135 350, 1033, 990
1026
232,
472, 217
981, - 137
Keyword Index
- 1007 113LB, 991,
931,
352
224,
988, 372 - 5
692,
336, 915, – 182 909,
-
- 687,
230, 973 -
260
460, 216, -
907,
300LB, 226
- - -
806 247 822,
946
929,
135,
factors
–
366, -
271, -
217, 165, 516,
234,
133, 971,
906, - 376
- 18LB 917 195,
228
192, 987 495 794,
904,
918,
-
- host
RNA couples 17,
-
-
17,
maturation infection
485, 318 -
95LB,
970,
- clusters networks prevention
903,
- data -
inhibitor
469LB -
counselling 259LB,
control 463 –
uninfected
621, 338, and 512,
290,
89LB, 829,
- as
213
-
259LB,
and - 212 - -
–
inhibition phenotypes
-
–
-
644,
– Trial and
(early)
- N
192,
770,
evolution load - suppression -
1053 909,510, 513, 516, 524, 829, 901, 903, 965, 966, 967, 973, 978, 979, 982, 988 285, 286, 864, 903, 926, 1036, 1045, 1049 1036 733, 1016 741LB, 325, 367, 464, 202, 205, 223, 303, 311LB, 498, 776, 811, 999 298, 300LB, 334, 343, 348, 370, 377, 417, 298, 300LB, 450 • Assembly • Attachment • Cell-associated • Diversity • Eradication • Evolution • Group • Infection • Infection • Inhibition • Risk • RNA • RNA • Self-testing • Seroconversion • Serodiscordant • Shedding • Status • Subtype • Superinfection • Surveillance • Surveillance • Susceptibility • Testing • Transmission • Transmission • Transmission • Treatment • Treatment • Unexposed • Vaccine • Vaccine • Viral • Viral coinfection - 615, 740, HIV-Tuberculosis coinfection 730, 732, 781 - HIV/CMV coinfection - 591 HIV/HAV HIV/STD coinfection1009 - 1008, 137, 185, 192, 199, 200, 31LB, – 18LB, HIV-1 • Recent • Recombination • Replication • Reservoir • Restriction
-
791,
517,
848, 981 1026
810 895, – 97,
135,
500, 802,
813,
990
178, - 397, 363,
-
939 men 374
775,
837, 947, 982, 409
808, 886,
820
470,
800, 802 1044
469LB, 501,
-
135, 298,
362,
- 437LB, 298,
348,
380 with 771,
824, 698, 852 622, 408,
784, 830,
168LB responses 271,
247, 893,
172, 500,
360, –
sex
activation
282,
26LB, 244, -
308 345,
193,
622,
209LB, - 820, - 672, adolescents 175, 591,
17,
-
782, 517,
267, - - 834,
- children 632 165,
35LB,
355,
childhood
224 276, have
380 236,
38,
-
337,
609, vaccine
36,
- - and
cells
791
994
- 436,
of
69,
- 514, - 1038
1047 89LB,
testing 177,
disorder
-
171,
615,
immune 13,
-
354,
- – NK who - 139, - and
298,
137 68, 983
781, 909, -
- 511, - -
222,
171,
337 - 83, –
193, -
-
program
230 infants uninfected uninfected CD4, children men patients population Adolescent adults -
-
children unaware women transcription
survey
- 779, heterogeneity
- resistance
226,
-
598 858, 860 792 524, 872, 881, 884, 888, 891, 892, 893, 902, 936, 973, 1000, 1049, 1058 341 814, 821, 857 222, 351, 542, 591, 627, 922, 923 552, 563, 696 571, 637, 648, 669, 804, 861, 991 269, 297, 380, 411, 674, 781 369, 370, 373, 375, 377 814 313, 327 309LB, 901, 917, 936, 965, 984 • Production • Proviral • Provirus • Malignancies • Mortality • MTCT • National • Neurocognitive • Pathogenesis • Patient • Persistence • Positive • Positive • Positive • Prevalence • Prevention • Infected • Infected • Infected • Infected • Infected • Infection • Inflammation, • Interventions • Latency • LTR • Drug • Encephalopathy • Epidemic • Exposed • Exposed • Exposed • Fitness • Glycan • Immunology • Immunology • Incidence • Infected • Infected
-
731 901
1011 950
580,
743 39,
487,
302,
1033 1043 899,
839,
536,
565,
485, disorders impairment
248, Non-
996,
992,
365,
153,
169LB, 591,
710 482,
195, 523, -
946 991,
364, 12, -
376
579
113LB, 117, 590,
838 952 1038 481,
11, 514, – 362,
908, -
-
351,
Long-Term 364, 51,
632 - 578,
976
546, - 10, -
837, 835,
- 541 513,
350, - - neurocognitive neurocognitive non-AIDS 849,
–
- - 363,
312 525, survey
progression - -
539LB, 94, 143,
761,
- resistance - - decay reservoir
cascade continuum -
Progressors - 304 Progressors 494LB, 496, 502 494LB, 382, 410 (HAND) - 60, 146, 381, 389, 390, 392, 398, - 60, 146, 381, 389, 390, (HAND) 821 399, 403, 412, 417, 419, 424LB, 581, 582, 588, 598, 600, 611 581, 582, 588, 598, 634 161, 627 226, 235, 246, 261, 267, 343, 344, 365, 474, 491LB, 382, 389, 393, 427, 437LB, 511, 549, 553, 554, 562, 572, 617, 618, 619, 623, 690, 714, 720, 823, 841, 863, 898, 918, 928, 957, 958, 772, 775, 960, 999, 1015 • Drug • Disease • DNA • DNA • DNA • Comorbidity • Control • Cure • Diagnosis • Care • Care • Clinician • Coinfection • Associated • Asymptomatic • Care • Associated • Associated • Adherence • Sequence • Testing • Treatment D - 592 Hepatitis - 593, 594 E virus Hepatitis 566, 604, - 551, carcinoma Hepatocellular - 935 virus simplex Herpes - 1049 Heterogeneity - 231 Heterosexual - 1045 women Heterosexual - 594 HEVseroprevalence load - 952 viral High screening HIV - 138 High-Env neoplasia - High-grade anal intraepithelial - 986, 1031 High-risk - 268 seronegative Highly exposed - 463 acetyltransferase Histone - 348 deacetylase inhibitor Histone 345 - 272, Histopathology HIV - 50, 51, 70, 115, 116, 139, 166, 181, 196, • RAVs Keyword Index
• Integration - 360 –I– Inflammation markers - 44LB, 351, 412, 414, • Latency – 26LB, 180, 341, 359, 371, 374, IFN - 19, 238 428, 600, 653, 656, 854, 946 376 IFN-g - 355, 730 Inflammatory biomarkers - 234, 239, 264, • Mouse model - 399, 447 IgG - 593 283, 293, 671, 695LB, 714, 717, 718, 825 • Neutralization - 311LB IgG Subclasses - 318 Influenza vaccination – 324, 325 • Persistence - 81, 95LB, 255, 300LB, 330, IL-18 - 569 Inhibitors of tirosin kinases - 468 379, 380, 402 IL-33 - 237 Inhibitory quotient - 506 • Prevention - 109LB IL-6 - 278 Injectable contraception - 861, 865 • Prevention Microbicides - 110LB IL-7 - 252 Injection drug use - 12, 152, 546, 597, 712, • Reactivation kinetics – 32LB, 369, 370 Illumina MiSeq - 360 898, 916, 918 • Reservoir - 182, 468 Imaging - 61, 447 Innate immunity - 256, 294, 371, 597 • RNA – 164, 437LB Immigrant - 173 Innate lymphoid cells - 275LB • Single-copy assay - 25 Immune - 236 Insulin - 610 • Specific t cells - 19, 25 • Activation - 21, 44LB, 142, 237, 238, 264, Insurance - 999, 1000, 1001 • Subtype c - 520, 904 270, 276, 277, 278, 280, 282, 326, 404, Integrase - 139, 507 • Subtypes - 210, 485 408, 467, 597, 599, 656, 689, 717, 729, Integrase Inhibitor (INI) - 106, 947, 961, 1034 • Subtyping - 211 731, 825 Integrase Resistance - 481, 492LB, 501 • Transmission – 18LB, 351, 487 • Exhaustion - 277, 939 Integrase strand transfer inhibitor - 438, 953 • Vaccine - 19, 195, 317 • Reconstitution - 280, 294 Integrated care – 534, 789 • Viral load - 864, 1035 • Reconstitution inflammatory syndrome Integrated DNA - 204, 359, 362 HIV-2 - 214, 253, 508, 509, 944, 961 (IRIS) - 299, 726, 734, 762, 824 Integration sites - 337 HLA - 713 • Recovery - 562 Interferon alpha - 133, 134, 290 HLA alleles - 555 • Response – 89LB, 179, 248, 731 Interferon gamma - 758 HLA class I - 253, 256, 314, 315, 667, 827 • Restoration – 278 Interferon responses - 209LB HLA-associated polymorphisms - 828 • Senescence - 689 Interleukin 6 - 645 HLA-B57.01 - 197, 667, 713 Immunodeficiency - 686 Interleukin-7 - 274 Home testing and counseling - 49, 51, 980, Immunodiscordant individuals - 335 Internet - 889, 924 981, 988, 1063 Immunoglobulin A - 233 Intra-dermal immunization - 323 Hormonal contraception - 6, 284, 862 Immunohistochemistry - 405 Intrauterine growth - 799 Hospitalizations – 38, 590, 708, 772 Immunologic biomarker - 695LB Invasive Pneumococcal Disease - 768 Host factors - 182, 189, 248, 284, 371 Immunologic failure - 502 Host genetics - 20, 201, 547, 601 Immunologic response - 347, 365, 473, 1015 –K– Host restriction factors - 134, 201, 205, 207 Immunoprophylaxis - 90 K65R - 503 Host-pathogen interaction - 59, 189, 205 Immunosenescence - 291, 709, 939 Kaposi sarcoma - 618, 619, 631 Host-pathogen interaction - 209LB Immunotherapy - 77LB Kenya - 562, 621, 909 Host-virus interactions - 139, 189, 208 Impact evaluation - 163 Key populations – 220, 899, 979, 1032, 1046 Hotspots – 72LB, 1019 Impairment - 147 Kidney - 685, 686, 689, 690, 693 HPV - 623, 625, 626, 627, 628 Implantable - 71 Kidney function - 680, 681, 682, 686, 687 HSCs - 78 Implementation science - 869, 891, 981, Killer-cell immunoglobulin-like receptor HSIL - 625 1019 (KIR) - 256, 314, 315 HSP70 - 250 Incidence - 166, 517, 563, 639 KIR2D - 315 HSV-2 - 728 • Assay - 511, 517, 895 KIR3DL1/S1 - 178 HTLV-3 - 212 • Rate – 617, 896, 1007 Kynurenine-to-tryptophan (KT) ratio - 267, Human herpesviruses - 727 • Tuberculosis – 757 326 Human immunodeficiency virus - 686, India - 918, 928, 1032 785, 968 Inducible HIV-1 - 80, 377 –L– Human papillomavirus - 161, 628 Infant - 88, 440, 441, 807, 815, 803 Lamivudine - 563, 815 Humanized mice - 469LB Infant antiretroviral prophylaxis - 778, Language impairments - 813, 814 Humans - 242 801LB, 810 Late HIV diagnosis - 965, 1043 Humoral response - 325 Infected CD4+ T cells - 208 Latency – 359, 375 Hyperacute infection - 488 Infection risk - 55 Latency models - 193, 204, 359, 367, 370, Hypertension - 637, 647, 676, 856 Inflammasome - 280, 880 373, 375, 378 Inflammation - 279, 283, 285, 350, 561, 609, Latency reversing agents - 81, 204, 371, 373, 374, 379 Keyword Index Keyword 656, 711, 987
170 CROI 2016 Keyword Index 171 CROI 2016 287
Keyword Index 286,
880
287
262, -
874 301,
cells 188,
- T
263, 263,
- -
609, 685 273, 645 800, 803, 920, 941, 958, 994, 1016, 1020, 1021, 1027 791, 794, 802, 806, 1023 • CD4+CCR5+ • Immunity • Immunology • Protection Multi-trajectory modelling - 887 - 283, AIDS Cohort (MACS) Study Multicenter Multicohort618, 619 study - 617, 848 483, – 479LB, resistance Multidrug - 479LB resistance Multidrug 828 - 716, Mutation Meta-analysis - 383, 957 - 383, Meta-analysis - 702 syndrome Metabolic Metabolism - 706 705, 706 595, 692, 693, - Metabolomics 373 MHC-1 - 58, 275LB 21, 261, - translocation Microbial 875, 876 872, 871, – 109LB, Microbicide 265, 701, 725 - 6, 263, 264, Microbiome - 264, 267 Microbiota 702 - 248, 559, MicroRNA - 209LB Microtubules - 250 Microvesicles - 738, 901, 902 Migration - 422 Encephalopathy MinimalHepatic - 489 variants Minority-resistant Missed- 965, 966 diagnosis - 1013 imputation Missing data 144 - Mitochondria injuryMitochondrial - 670, 716 812, 855 - 395, 668, toxicity Mitochondrial - 875 MIV-150 - 98 MK-8591 902 Mobility– 169LB, Modeling - 115, 225, 481, 536, 1056 - 1031 Models of Care - 78, 357 T cells CD4 Modified - 358LB T cells CD4 Modified Molecular208 dynamics - Molecular542 epidemiology - 218, 224, Monocyte - 184, 652, 711 239, 142, Monocyte – 44LB, activation - 665 metabolism Monocyte cholesterol Mortality590, 611, 639, 691, - 37, 548, 549, Mortuary surveillance297, 909 - - 33, Mother-to-child (MTCT) transmission 148, 381, 389, 396 - MRI MSM - 218, 886, 887 - 716 mutation mtDNA – 6, 133 Mucosal 394, 402 - 273 818, 950, 1120 1051, 1052, 1055,1049, 786, 1046, 1047, 1057, 1063 172, 216, 231, 286, 543, 546, 547, 108LB, 628, 870, 884, 885, 888, 889, 896, 897, 898, 900, 913, 914, 922, 924, 925, 926, 927, 928, 929, 931, 933, 969, 970, 972, 1045,1000, 1006, 1007, 1041, 1044, 1052, 1060 343 –M– - 372 macrophages M2-like Macaque877 - Macaque – 130, 405 model 369,255, 272, 330, - 182, 203, Macrophage - 207, 273 activation Macrophage - 402 tropism Macrophage Macrophage-specific adjunctive therapy out of CNS - 141 travel macrophages 386, 390 - 385, imaging Magnetic resonance - 391 spectroscopy Magnetic resonance - 31LB therapy Maintenance 598 - cell MAIT - 101, 773 Malaria 118 - Malawi 1059, 1060 - 163, 165, Male circumcision Male partners790 - 49, Mali - 921 - 735 Mapping 694, 695LB, - 103, 104, 147, 448, Maraviroc 203 - MARCH8 Marijuana - 257 - 411 (CyTOF) Mass Cytometry Mass media - 969 - 772, 773 Health Maternal 533, model - 51, 442, 466, Mathematical 319 - Maturation 465, 466 - 425, 464, inhibitor Maturation MDM2 - 202 - 906 Measurement Medicaid534, 1001 - 53, 1037 project- Medical monitoring - 952 Adherence Medication Memory - 152 B cells 980 Men - 935, with men (MSM) – 48LB, sex Men who have 863, 872 Menopause - 650, - 920 disorders health Mental Lymph node - 127, 130, 245LB, 259LB 334, 130, 245LB, node - 127, Lymph 242 tissue - 23, 130, 184, 241, Lymphoid 630 - 629, Lymphoma 606 712
568, 611,
594
572
560, 586,
561,
571,
558, 548,
558, 10
712 - 455,
911
- 600
776
555,
530,
- 554,
11,
557 - 612,
556,
- 552, 529,
603
422,
steatosis -
556,
10, 586 151, -
66, 527, - -
- 570
elevation
death
- progression - test
-
553
-
442, 471 833, 859 378, 379 788, 974, 976, 983, 990, 1008, 1009 Long-acting - 106 Long-acting 97, 71, injectionsLong-acting – 31LB, - 1002 follow-up Long-term 826,384, 388, 814, study - Longitudinal - 427 Lopinavir 121, 796, 1021, 1022 - 34, follow-up to Loss birth - 803 Low weight - 512 countries Low-income LRA95LB - 234 - Lubiprostone - 633 cancer Lung function255 - Lung • Histological • Histology • Stiffness • Transplantation • Related • Enzyme • Fat • Fibrosis • Fuction • Cancer • Cirrhosis • Disease • Disease • Biopsies Latent HIV - 80, 359 Latent 363, 370, - 80, reactivation HIV-1 Latent - 83, 375 reservoir HIV-1 Latent - 336, 375 reservoir Latent 958 - America Latin 588, 601 - LDV/SOF 363 LEDGF - 139, 584 - 573, Ledipasvir - 532 of stay Length - 738, 988 Lesotho - 444 Levonorgestrel expectancyLife - 54, 941 risk - 52 Lifetime - 486 models Linear mixed Linkage - 220, 490 500, 531, 176, – 113LB, HIV care Linkage to 664, 672 Lipid - 553, Lipid abnormalities - 644 - 145, 666 Lipid profile 668, 855 - Lipoatrophy 707 - 45, 123, 668, Lipodystrophy - 45, 123, 707, 855 Lipohypertrophy - 419 Lithium - 528, 553, 562 Liver Keyword Index
Mycobacterium tuberculosis - 157, 737 Non-Hodgkin lymphoma - 630 People who inject drugs (PWID) – 27, 533 Myocardial infarction - 42, 641, 661, 662, 671 Nonhuman primate models – 20, 24, 107, Peptide - 667 258LB, 263, 333, 447 Pericardial fat - 649 –N– Nonnucleoside reverse transcriptase inhibitor Perinatal HIV exposure - 796, 805, 825 NAFLD - 124, 553 (NNRTI) - 456, 506, 668, 719 Perinatal HIV infection - 823, 825, 830, 834, Naive CD4 T cell - 377 Non–AIDS-defining cancers - 160, 620, 632 836, 838, 851, 856, 857 Naive patients - 437LB, 461LB, 486, 946 NPC1L1 - 547 Periodontitis - 713 Nasopharynx-associated Lymphoid Tissue - NRTI - 30, 811, 951 Peripheral blood mononuclear cells (PBMCs) 344 NRTI-free Antiretroviral Therapy - 30, 418, - 730 Natural history and recovery - 855 951 Peripheral neuropathy - 272, 415 Natural Killer cells (NK) - 178, 179, 180, NS5A Drug Resistance - 578, 579 Persistence - 80, 86, 229, 340, 402 315, 355 NS5A inhibitor - 100 Persistent replication - 333 NCDs - 703 NS5A mutation - 577 Persistent viremic control - 836 Needle-free technology - 323 Nuclear Import - 209LB Persons who inject drugs (PWID) - 132, 215, Needle-sharing - 916 Nucleoside reverse transcriptase inhibitor 535, 585, 899, 1032 Nef - 57, 58, 136, 181, 190, 191, 253, 373 - 437LB Pharmacodynamics - 104, 430 Neisseria gonorrhoeae - 1004, 1006 Nuke-sparing - 45 Pharmacogenetics - 426, 429, 443, 445 NeuroAIDS - 60, 61, 385, 423LB Pharmacogenomics - 443 Neurocognition - 381, 416, 423LB –O– Pharmacokinetics - 98, 99, 104, 425, 426, Neurocognitive - 148, 175, 415 OATP1B1/B3 - 460 428, 431, 438, 441, 448, 453, 454, 455, • Disorders - 63, 812 Obesity - 123, 645, 703 456, 457, 458, 574, 775, 818, 882LB, 1120 • Functioning - 386, 410, 418, 761 Observational cohort - 708, 721, 778, 951, Pharmacologic measures - 96 • Impairment - 145 962 Phase I - 876 • Performance - 147, 387 Older population - 705, 958 Phase I/II – 461LB, 816 • Safety - 424LB Opioid prescriptions - 915, 916 Phosphate - 651 Neuroimaging - 148, 381, 382, 383, 390, Opportunistic infection - 768 Phylodynamics – 216, 228 423LB, 823 Option B+ - 34, 757, 789, 792, 793, 796, 808 Phylogenetic partioning - 211 Neuroinflammation - 391, 397, 407, 411, Oral HPV infection - 161 Phylogenetics analysis - 210, 214, 217, 221, 413, 414 Oraquick - 519 223, 225, 232, 379, 400, 490, 541 Neurologic - 415 Orphanhood - 845 Phylogenomics - 140 Neuromotor dysfunction - 415, 820 Osteoporosis - 126 Physical function - 705 Neuronal injury - 395 Outbreak - 215, 221, 541, 916 Physical performance - 705 Neuropath - 402 Outcomes - 174, 746, 842, 1030 PI-containing ARV regimens - 666 Neuropathogenesis - 394, 396, 405, 413 Oxidative stress - 255 Piperaquiine - 101 Neuropsychological impairment - 401 Oxidized LDL - 671, 673 Plasma - 250 Neurosyphilis - 767 Plasmacytoid dendritic cell - 134 Neurotoxicity - 63, 394, 395, 397 –P– Platelet function - 662 Neutralization escape – 306, 309LB p24 - 137 Platelets – 44LB, 663 Neutralizing antibodies - 7, 88, 92, 301, 304, P2X - 249 PLWH - 434 307, 310LB, 400 P2X7 ATP receptors - 249, 663 Pneumococcal vaccine - 328, 768 Neutropenia - 962 p38 MAPK - 467 PNPLA3 variants - 556 Nevirapine - 444, 777, 815, 847 Partner notification - 978 Pnumococci - 724 New oral HCV drugs - 66, 525 Partner services - 50, 224 Point of care - 28, 512, 788 Next Generation Sequencing (NGS) - 192, Partner testing - 49, 224 Poly-ICLC - 322 210, 213, 232, 260, 325, 399, 487, 490, Passive infusion - 309LB, 311LB Polymerase - 223 539LB, 602 Pathogenesis - 24, 243 Polymorphism - 507 NF-kappaB - 463 PCR - 339, 593, 785, 839 Population based cohort – 116, 218, 917, NHBS - 906, 933 Peak HIV viral load - 716 954, 982 NNRTIs - 418 Pediatric Antiretroviral Therapy - 39, 40, 735, Population based intervention - 759, 982 Non liver-related death - 612 812, 816, 817, 849 Population effectiveness - 1026 Non-AIDS malignancy - 160, 616, 633 Pediatric HIV - 40, 324, 735, 780, 827, 828, Population level ART coverage - 114, 982 Non-AIDS mortality - 616, 710 835 Population level impact - 163 Non-B subtype - 485 Pediatric Tuberculosis - 735 Population survey methods - 937 Non-communicable diseases - 676, 678, 679 Pediatrics - 37, 735, 816, 818, 1120 Population viral load - 1026 Keyword Index Keyword
172 CROI 2016 Keyword Index 173 CROI 2016 Keyword Index 740, 869, 966, 1005 666, 752, 850, 1030 996, 1010, 1015, 1021, 1022, 1035, 1040 996, 1010, 1015, 936, 1046 –S– 810, 818, 1120 Safety - 116, 461LB, Safety - 461LB Salicylate - 463 205, 207, 468 - SAMHD1 sCD14 - 239 sCD163 - 690 565, 622, 648, - 156, 531, 532, Screening - 498, Therapy Second-line Antiretroviral Self-report - 704, 907, 954 use - 865 Self-reportedcondom 730 351, 164, 268, 285, Semen – 75LB, - 864 Semen biological marker Seminalshedding - 727 - 183 Senescence - 519 testing Sensitive Sequaela73LB - Sequencing219 - 201, - 806 Sequential Envs 962 - events Serious adverse - 559, 711 Events Serious Non-AIDS - 519, 894 Seroconversion - 519, 569 Seroconverters 200, 301, 1063 - 167, couples Serodiscordant - 72LB Serology Restriction factor 136, 199, 200 - 57, 789, 1011 - 34, Retention 121, 790, 792, 844, - 116, in care Retention - 992, 1021 care Return to - 468 transcription Reverse Rhesus macaque 105, 268, 272, 273 - 84, 99, 573 - Ribavirin Rif - 749 Resistance and INH Rifabutin - 456, 753 Rifampicin - 459, 754 945 71, 453, 874, Rilpivirine – 31LB, - 260, 770, 932 Riskbehavior Riskfactor 670, 913, 951 analysis - 215, Riskfactors 833, 916,171, 630, 744, - 54, 55, - 898, 913, 973 Risky behavior sexual - 459 Ritonavir - 851 lopinavir Ritonavir-boosted RNA seq - 807, 880 RNA splicing - 192 Romidepsin - 26LB - 674 Rosuvastatin - 676, 965 Rural RV144 - 317 1002 - 1001, White Ryan 857
682,
426,
153,
683
-
867
426,
- 866,
683
684,
452, - impairment
disease -
1031, 1027 787, 844, 899, 845, 907, 957, 960, 1013, 113LB, 470, 747, 790 113LB, 419, 681, 103, trial – 79LB, controlled 682, 875 1048 Respondent-driven sampling - 898 Respondent-driven fMRI - 390, 392 Resting state • Function • Function • Toxicity • Tubular 900, 977, 979 - testing Repeat Repertoire - 179 - 189 Replication - 82 virus Replication-competent - 336 reservoir Replication-competent - 1053 integrity data Research 353, 807 332, Reservoir – 85, 258LB, 1029 575, 849, 940, - 434, 491LB, Resistance - 577, 580 variants associated Resistance 506 – 490, mutation Resistance 497 – 493LB, testing Resistance 731, Setting493LB, - 30, Limited Resource –R– Racial 476, 531, 700 disparities - 43, RAD51 - 246 620 - Radiotherapy 508, 953 - 30, Raltegravir 424LB clinicaltrial - 109LB, Randomized - 27, 28, 41, trial controlled Randomized double-blindRandomized placebo- 621, 980 - 475, trial Randomized 968 - 519, 522, Rapiddiagnostic tests - 1017 RapidPathway - 153 Ravidasvir Re-engagement - 27, 992 in Care - 369 Reactivation species (ROS) - 282 Reactiveoxygen Real-time PCR - 812 - 92 Rebound virus Recency of HIV Infection – 485, 515 - 210, 213, 806 Recombinants linkage- 613 Record use - 1034 substance Recreational 880, 882LB Rectal – 108LB, microbicides Rectal tissue - 102LB 960, 1011, 1012,– discontinuity Regression - 242 T cells Regulatory Reinfection533 - Relapse - 573, 588, 601 Renal Quasispecies - 149 464
-
427 1030
-
319 776,
-
498,
sites - cross-resistance mutation
764, 995 68, 69, 70, 71, 96, 103, 105, 106, 107,71, 96, 103, 105, 70, 69, 68, 301, 333, 448, 471, 478, 521, 522, 109LB, 866, 868, 869, 870, 877, 524, 567, 479LB, 884, 885, 883LB, 878, 879, 881, 882LB, 890, 891, 892, 894,886, 887, 888, 889, 1051, 1052, 1055, 1056, 1057 795,772, 774, 775, 776, 791, 792, 794, 798, 799, 804, 811, 862 861, 870, 894, 934, 1025 441, 776,119, 433, 438, - 34, (PMTCT) 777, 778, 790, 795, 805 –Q– - 341 Q-VOA Q80K - 543 Quality - 994, 1035 (QoC) of care Quality475 - of life • Inhibitor 202 - interaction Protein-protein - 208 Proteome - 6, 279 Proteomics - 892 education Provider tubule – 691, 868 Proximal 700 - PTH Puberty - 852 733, 736, Pulmonary – 158LB, tuberculosis 658 - velocity wave Pulse - 249 Purinergic - 240, 295 Pyroptosis • Cleavage • Inhibitor • Inhibitor Postpartum - 623, 791 - 623, Postpartum 347, 352, 358LB - 87, control Posttreatment 477 346, - Pre-ART 15, 48LB, – (PrEP) prophylaxis Preexposure 771,439, 757, 770, Pregnancy - 49, 433, 438, - 799, 803 Prematurity - 798, 803 Preterm 903, 905, 928 - 64, 483, 829, 860, Prevalence 844, 79, 101, 103, 108LB, - 4, 5, Prevention 989, 997 - Positives for Prevention mother-to-child of transmission Prevention 757, 782 option B plus – 35LB, · and Primary - 79, 585, 788, 1035 health care Primary HIV infection142, 218 - infectionPrimary522, 729 - 237, HIV-1 263 - 238, Probiotics - 163, 782 effectiveness Program HAND - 381 of Progression 37, 768 - Prophylaxis observational762, 942 - study Prospective - 319 Protease Keyword Index
Seroprevalence - 927 Special populations - 496 Tenofovir - 46, 147, 426, 434, 452, 484, 503, Serosorting - 933 Speech impairments - 813 592, 669, 680, 681, 682, 695LB, 728, 813, Serum cholesterol - 854 Spontaneous clearance – 75LB, 152 866, 867, 871 Set-point viral load - 346 ST2 - 237 • Alafenamide - 107, 680, 681, 682, 717 Severe immunodeficiency - 686 State Space Models - 1042 • disoproxil fumarate - 36, 48LB, 104, 449, Sex Difference - 43, 79, 416, 943 Statins - 421, 550, 553, 643, 673 683, 684, 685, 694, 728, 808, 819, 877 Sex partners - 897 Statistics - 266 • virological suppression, mortality, ART - Sex workers - 863, 922, 1046, 1059 Stem-cell transplantation - 357, 364, 365, 562 Sexual 366, 367 Tenofovir/Emtricitabine - 103, 479LB, 867 • Behavior - 890, 905, 925, 926, 930 Stigma – 2, 606, 919, 925 Test and treat - 168LB, 169LB, 842 • Event coverage - 1055 Stillbirth - 799 Testes - 867 • Networks - 897, 964 Stool Xpert MTB/RIF - 748 Testing - 841, 969, 985, 1006 • Risk behavior - 863, 900, 1045 Stroke - 43, 636, 637, 638, 639 Testosterone Therapy - 914 • Transmission - 225, 987, 1045 Structure - 56, 58 Tetherin - 58 • Transmitted infection (STI) – 69, 770, 869, Sub-Saharan Africa - 498, 563, 658, 744, 751, Text Messaging - 977, 993 870, 875, 878, 890, 900, 912, 923, 924, 760, 786, 850, 861, 924, 925, 1049, 1054 Tfh cells - 233, 245LB, 334 932, 964, 1004, 1005, 1007 Subtype – 221, 219, 227 TFV-DP - 102LB SGA - 803 Subtype B - 507 Th1 - 289 SHIV - 229, 317, 321 Subtype C - 484 Th17 cells – 188, 238, 280 Shock and kill - 320 Suppression - 1024 Thailand - 219, 384, 606, 857, 927, 956, 972 Side effects - 756 Suppressive ART - 143, 276, 322, 710, 820 The North American AIDS Cohort Sierra Leone - 72LB Surveillance - 212, 477, 510, 520, 540, Collaboartion on Research and Design Simplification - 417 908, 921 (NA-ACCORD) - 150, 684, 688 Single cell analysis - 807 Surveillance data - 53 Therapeutic vaccine – 26LB, 320, 322 Single genome sequencing - 86, 92, 348, Survival - 54, 631, 688 Third-Line - 493LB 379, 400, 406, 806, 848 Survivor – 72LB, 73LB, 74LB, 75LB, 929 Thrombocytopenia - 962 Single-cell laser capture microdissection - Sustained virologic response (SVR) - 539LB TIM-1 - 247 151 SVR - 589, 604 Time to ART initiation - 790, 1010 siRNA - 182 Swaziland - 1056 Tissue - 290, 345, 448 SIV - 21, 22, 23, 24, 84, 94, 95LB, 130, 270, Switching Antiretroviral Therapy - 680 Tissue Distribution - 84 273, 352, 353, 877 Symptoms - 518 Tissue macrophages - 331, 402 SIV coreceptor - 24 Synonymous mutations - 483 TLR - 196, 270, 322, 323 SIV encephalitis - 273 Syphilis - 767, 870, 900, 929, 970, 1004, 1007 TLR7 - 95LB SIV/HIV chimeric viruses - 356 Systems biology - 6, 324 Tolerability - 471 Small-for-gestational-age - 803 Toxicity - 778, 867, 963 Smoking - 257, 387, 647, 674, 675 –T– Toxoplasma gondii prophylaxis - 765 SNP - 547 T cell - 596 Traditional medicines - 434 Social media - 70 T cell activation - 142, 190, 255 TRAIL - 372 Social network - 217, 924, 985 T cell exhaustion - 596 Transcription - 80 Social support - 919 T cell subsets - 807 Transcriptome - 208, 257, 725 Socioeconomic status - 476 T follicular - 94, 242, 378 Transgender women - 48LB, 108LB SOF/LDV - 452 T follicular helper cells - 23, 82 Transgendered - 79, 884, 971 SOF/LDV - 154LB T-bet - 254 Transient Elastography - 527, 529, 530, 560 Sofosbuvir - 100, 573, 575, 577, 584, 585 TAF – 102LB, 050 Transition to adult units - 177, 835 Solo LTR - 337 Tanzania - 978, 1025 Transitional-memory T cells - 332 Sooty mangabey - 20, 24, 827 Targeted sequence capture - 360 Transmission - 231, 736, 934 Sorafenib - 634 TasP - 1044 • Cluster - 602 South Africa - 14, 39, 115, 155, 157, 167, Tat – 361, 396 • Group - 221, 943 169LB, 256, 523, 613, 631, 734, 756, 759, Tele-mentoring - 534 • Network - 149, 215, 221, 222 783, 792, 845, 905, 907, 936, 981, 1010, Telomerase activity - 669 • Risk - 221, 934, 1033 1011, 1014, 1016, 1028, 1048, 1057, 1061 Telomere length - 670 Transmitted drug resistance - 477, 483, South Sudan - 510 Temporal trends - 888, 933 486, 489 Spatial analysis - 972 Transmitted founder – 187, 231, 232, 394, Spatial mapping - 1054 602 Keyword Index Keyword
174 CROI 2016 Keyword Index 175 CROI 2016 Keyword Index 706, 720, 793, 794, 861, 1047, 1058 793, 794, 861, 706, 720, Y chromosomal DNA - 865 Y chromosomal - 326 vaccine fever Yellow 900 830, 856, 859, adults - 177, 826, Young 993 - 217, 832, 930, black MSM Young –Z– 962 - 205, Zidovudine Zinc356, 358LB nucleases – finger acid - 47 Zoledronic Women – 109LB, 162, 277, 593, 647, 650,593, 647, 162, 277, – 109LB, Women –X– – 742, 750 Xpert MTB/RIF –Y–
828
1002,
372,
1029
592,
832,
361,
465, 1027, 832
116,
356,
609 1040
832
378, 831,
1024, 111,
336, 347
333
594,
218 953,
795,
1039
195,
346,
53,
339 -
502
993,
333, 956
545, 215, 371 391,
73LB, 27,
956,
502 151,
361 947 209LB, -
- -
331,
346,
- - – 32LB, 952, -
796
64, - 229, 311LB 33, - 357,
-
–
- - - - 39,
197
484,
–
751,
- -
-
304,
-
monitoring -
agonist
1047 666, 1011, 1020, 1048 guidelines - 837 1027, 1028, 1035, 1037 • Outcomes • Response • Suppression adipose tissue - 704 Visceral 859 - 700, 798, 826, D Vitamin VMMC - 165 - 355 Vorinostat 185 - Vpr 79 - populations Vulnerable –W– - 704 circumference Waist gain - 858 Weight 962, 1015,568, 923, 961, - 434, Africa West - 75LB Africa West Blot - 515 Western abnormalities - 148 matter White (WHO) Organization - 477 Health World (WHO) Organization Health World • Load • Outgrowth • Persistence • Rebound • Replication • reservoir • reservoir • RNA • sequences • suppression 795 - Viremia Virologic • Control • Failure • Monitoring • Decay • Diversity • Fitness • Hepatitis • Kinetics • Load Vaginal film - 871 film Vaginal - 875 gel Vaginal - 288 mucosa Vaginal 877, 1057, 1058 ring - 872, 873, Vaginal - 907 study Validation disease - 41 Vascular - 839 transmission Vertical - 714 Veterans 59, 199, 200, 202 - Vif Viral
989, 738,
758
535, 734,
749,
167, 457,
747,
758
509
398,
14
746, 169LB, 1048
- 1048
757,
– 470, 1053 332 472
157,
- 747
- - - -
752
- 755
742,
112,
172,
-
- –
14, -
- –
adults
resistance
HIV
prevention pregnancy
1006, 1051 741LB, 744, 746, 747, 751, 753, 755, 756, 744, 746, 747, 741LB, 758, 1053 1054, 1063 481, 482 –V– - 161 Vaccination 319, 321, 591 – 76LB, Vaccine - 325, 328, 825 response Vaccine - 645 VACS –U– – 444, 594 Uganda sequencing - 489, 509, 827, 950 Ultradeep load - 839 viral Ultrasensitive UNAIDS 90-90-90 - 111 - 216, 593, 772, 830, 935, States United - 114, 117 coverage ART Universal - 286, 912 intercourse Unprotected - 883LB Uptake - 763 Urine biomarkers - 747 testing Urine LAM - 748 Urine lipoarabinomannan 917 883LB, - USA - 883LB Usage • In • Prophylaxis • Surveillance 322, 781 - 135, 1 interferon Type - 341 TZA-Assay • Diagnosis • Drug • Incidence • And • Initiation • Interruption • Naïve • Outcomes TREG - 258LB - 895 Trends TRIM22 - 246 TRIM5alpha - 206 - 206 TRIMCyp 509 - Tropism 888, 892, 894 - 885, Truvada 769 115, 156, 743, – Tuberculosis • As • Cascade • Experienced Transmitted HIV drug resistance - 478, resistance drug HIV Transmitted - 264, 356 Transplantation - 180 Transport 605, 999 - 146, 156, Treatment
2nd Floor Plaza Level
3rd Floor
Conference Schedule Overview Monday, February 22, 2016 Tuesday, February 23, 2016 Wednesday, February 24, 2016 Thursday, February 25, 2016 8:30 AM PLENARY SESSION Auditorium PLENARY SESSION Auditorium PLENARY SESSION Auditorium PL1: Harnessing Antibodies for HIV-1 Prevention PL3: Progress in Gene Therapy for HIV Cure PL5: Tuberculosis: Why Do I Have To Take So and Treatment PL4: HIV in Transgender Populations: Charted Many Pills? 9:00 AM Program Committee Workshop for New PL2: Antiretroviral Therapy: Where Are We Now? and Uncharted Waters PL6: The Evolving Epidemiology of HIV Infection in Investigators and Trainees Where Are We Going? Persons Who Inject Drugs: Indiana 2015 9:30 AM Ballroom B/C 10:00 AM CONCURRENT ORAL ABSTRACT SESSIONS CONCURRENT ORAL ABSTRACT SESSIONS CONCURRENT ORAL ABSTRACT SESSIONS O-1: SIV and HIV Pathogenesis Room 302 O-6: Reservoirs, Relapse, and Remission O-11: HIV Virology: Putting It All Together Room 312 O-2: Viral Reservoirs/Antiretroviral Therapy Ballroom B/C O-12: Central Nervous System: Viral Dynamics, Randomized Clinical Trials Ballroom B/C O-7: Pushing Frontiers of Adaptive Immunity Biomarkers, and Cognition 304/306 O-3: Prevention and Treatment of Pediatric HIV Room 304/306 O-13: HCV: Curing the Patient but Not the Population Infections Room 304/306 O-8: Drugs: From Discovery to Challenges in Clinical Ballroom B/C O-4: Complications from Head to Toe Auditorium Use Room 302 O-14: Tuberculosis and Other Opportunistic Q-5: Strategies for Testing and Linkage to Care: Are O-9: Expanding the Toolbox for Prevention Infections/Cancer Prevention: Hits and Misses We Closing the Gap? Ballroom A Auditorium Ballroom A O-10: Getting to 90-90-90 Ballroom A O-15: Focus on HIV Acquisition and Challenges in the Cascade Room 311 12:00 PM LUNCH LUNCH LUNCH 12:30 PM 12:15 PM to 1:45 PM 12:15 PM to 1:45 PM 12:15 PM to 1:45 PM 1:00 PM Martin Delaney Presentation 1:45 PM Panel on Stigma, Trauma, and Stress: CONCURRENT THEMED DISCUSSION SESSIONS CONCURRENT THEMED DISCUSSION SESSIONS CONCURRENT THEMED DISCUSSION SESSIONS Considerations for HIV Research and Programs TD-1: Clinical Pharmacology: Pregnancy, Pediatrics, TD-7: Stroke: Incidence and Risk Factors TD-13: HIV Effects on Liver Fibrosis and Steatosis Ballroom B/C and Predictions Room 311 Room 304/306 Ballroom B/C TD-2: Global Burden and Mortality of Cancer in HIV TD-8: HIV and Microbiomes Room 302 TD-14: Mind the Gaps: Optimizing the PMTCT Room 312 TD-9: Cryptococcal Disease: Detection and Cascade Room 302 TD-3: Rants About HCV RAVS Ballroom B/C Complications Room 312 TD-15: Pathways to Eliciting Antibody Responses TD-4: Learning from Experience: Shaping the Future TD-10: New Drugs for Kids: What’s Taking so Long? Room 312 2:00 PM of Antiretroviral Therapy in Sub-Saharan Room 311 TD-16: Going to Scale With ART and PrEP Room Africa Room 304/306 TD-11: Innovations to Enhance Treatment 304/306 TD-5: HIV Testing: A Crucial Foundation Room 302 Outcomes Ballroom A TD-17: MSM in Low- and Middle-Income Countries TD-6: HIV Persistence and Latency Reversal TD-12: It’s Complicated: Renal Function and STIs in Ballroom A Ballroom A PrEP Users Ballroom B/C TD-18: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance 2:30 PM CONCURRENT WORKSHOPS Room 311 Clinical Trial Design and Analysis Ballroom B/C 2:45 PM Frontiers in Laboratory Science Ballroom A POSTER SESSIONS POSTER SESSIONS POSTER SESSIONS Interactive Case-Based Workshop on Hepatitis C Poster Halls A/B and D Poster Halls A/B and D Poster Halls A/B and D 4:00 PM Room 304 CONCURRENT SYMPOSIA CONCURRENT SYMPOSIA CONCURRENT SYMPOSIA S-1: Molecular Interplay from Virus to Host S-5: Reaching 90-90-90 and Beyond: Challenges S-8: Where Are the HIV Hot Spots? Ballroom B/C Room 304/306 and Innovations Ballroom A S-9: #HIV - Who Me? Adolescents at the Crossroads 5:00 PM Opening Session Auditorium S-2: A Beautiful Mind: Keeping It Ballroom A S-6: Pathogenesis and Consequences of Metabolic Ballroom A Complications Ballroom B/C Bernard Fields Lecture S-3: Global Impact of Hepatitis Ballroom B/C S-10: Natural Born(e) Killers Room 304/306 N’Galy-Mann Lecture S-4: Innovations in PrEP Auditorium S-7: Location, Location, Location: The Lymph Node Room 304/306 CROI Foundation Special Event 6:00 PM 6:15 PM SPECIAL SESSION 7:00 PM Welcome Reception 6:15 PM to 7:45 PM 7:00 PM to 9:30 PM Prefunction area and Ebola: One Year Later Ballroom B/C Poster Hall